Code | Display | Bezeichnung_Arzneispezialitaet_Zulassung | ZulassungsNummer | ELGA_Zulassungsstatus | ELGA_Inhaber | ELGA_Gültigkeit | ELGA_MedikationPackungsstatusLieferbar | GroesseGewicht | ELGA_MedikationMengenart_code | ELGA_MedikationMengenart_text | ELGA_MedikationRezeptpflichtStatus_code | ELGA_MedikationRezeptpflichtStatus_text | ELGA_Packaging_01_code | ELGA_Packaging_01_text | ELGA_whoATC_01_code | ELGA_whoATC_01_text | ELGA_MedikationArtAnwendung_01_code | ELGA_MedikationArtAnwendung_01_text | ELGA_MedikationArtAnwendung_02_code | ELGA_MedikationArtAnwendung_02_text | ELGA_MedikationArtAnwendung_03_code | ELGA_MedikationArtAnwendung_03_text | ELGA_Substanz_01_code | ELGA_Substanz_01_text | ELGA_ActiveIngredient_01_code | ELGA_ActiveIngredient_01_text | ELGA_Ingredient_role_01_text | ELGA_Ingredient_low_strength_01 | ELGA_Ingredient_low_strength_unit_01 | ELGA_ReferenceIngredient_01_code | ELGA_ReferenceIngredient_01_text | ELGA_Reference_low_strength_01 | ELGA_Reference_low_strength_unit_01 | ELGA_MedikationDarreichungsform_01_code | ELGA_MedikationDarreichungsform_01_text | ELGA_MedikationWechselwirkungsRelevant | Domaene | ELGA_PackageReferenceNumber | ELGA_Substanz_02_code | ELGA_Substanz_02_text | ELGA_ActiveIngredient_02_code | ELGA_ActiveIngredient_02_text | ELGA_Ingredient_role_02_text | ELGA_Ingredient_low_strength_02 | ELGA_Ingredient_low_strength_unit_02 | ELGA_ReferenceIngredient_02_code | ELGA_ReferenceIngredient_02_text | ELGA_Reference_low_strength_02 | ELGA_Reference_low_strength_unit_02 | ELGA_Substanz_03_code | ELGA_Substanz_03_text | ELGA_ActiveIngredient_03_code | ELGA_ActiveIngredient_03_text | ELGA_Ingredient_role_03_text | ELGA_Ingredient_low_strength_03 | ELGA_Ingredient_low_strength_unit_03 | ELGA_ReferenceIngredient_03_code | ELGA_ReferenceIngredient_03_text | ELGA_Reference_low_strength_03 | ELGA_Reference_low_strength_unit_03 | ELGA_whoATC_02_code | ELGA_whoATC_02_text | ELGA_MedikationArtAnwendung_04_code | ELGA_MedikationArtAnwendung_04_text | ELGA_MedikationArtAnwendung_05_code | ELGA_MedikationArtAnwendung_05_text | ELGA_Substanz_04_code | ELGA_Substanz_04_text | ELGA_ActiveIngredient_04_code | ELGA_ActiveIngredient_04_text | ELGA_Ingredient_role_04_text | ELGA_Ingredient_low_strength_04 | ELGA_Ingredient_low_strength_unit_04 | ELGA_ReferenceIngredient_04_code | ELGA_ReferenceIngredient_04_text | ELGA_Reference_low_strength_04 | ELGA_Reference_low_strength_unit_04 | ELGA_Substanz_05_code | ELGA_Substanz_05_text | ELGA_ActiveIngredient_05_code | ELGA_ActiveIngredient_05_text | ELGA_Ingredient_role_05_text | ELGA_Ingredient_low_strength_05 | ELGA_Ingredient_low_strength_unit_05 | ELGA_ReferenceIngredient_05_code | ELGA_ReferenceIngredient_05_text | ELGA_Reference_low_strength_05 | ELGA_Reference_low_strength_unit_05 | ELGA_Substanz_06_code | ELGA_Substanz_06_text | ELGA_ActiveIngredient_06_code | ELGA_ActiveIngredient_06_text | ELGA_Ingredient_role_06_text | ELGA_Ingredient_low_strength_06 | ELGA_Ingredient_low_strength_unit_06 | ELGA_ReferenceIngredient_06_code | ELGA_ReferenceIngredient_06_text | ELGA_Reference_low_strength_06 | ELGA_Reference_low_strength_unit_06 | ELGA_MedikationDarreichungsform_02_code | ELGA_MedikationDarreichungsform_02_text | ELGA_MedikationDarreichungsform_03_code | ELGA_MedikationDarreichungsform_03_text | ELGA_Substanz_07_code | ELGA_Substanz_07_text | ELGA_ActiveIngredient_07_code | ELGA_ActiveIngredient_07_text | ELGA_Ingredient_role_07_text | ELGA_Ingredient_low_strength_07 | ELGA_Ingredient_low_strength_unit_07 | ELGA_ReferenceIngredient_07_code | ELGA_ReferenceIngredient_07_text | ELGA_Reference_low_strength_07 | ELGA_Reference_low_strength_unit_07 | ELGA_Substanz_08_code | ELGA_Substanz_08_text | ELGA_ActiveIngredient_08_code | ELGA_ActiveIngredient_08_text | ELGA_Ingredient_role_08_text | ELGA_Ingredient_low_strength_08 | ELGA_Ingredient_low_strength_unit_08 | ELGA_ReferenceIngredient_08_code | ELGA_ReferenceIngredient_08_text | ELGA_Reference_low_strength_08 | ELGA_Reference_low_strength_unit_08 | ELGA_MedikationDarreichungsform_04_code | ELGA_MedikationDarreichungsform_04_text | ELGA_Packaging_02_code | ELGA_Packaging_02_text | ELGA_Substanz_09_code | ELGA_Substanz_09_text | ELGA_ActiveIngredient_09_code | ELGA_ActiveIngredient_09_text | ELGA_Ingredient_role_09_text | ELGA_ReferenceIngredient_09_code | ELGA_ReferenceIngredient_09_text | ELGA_Substanz_10_code | ELGA_Substanz_10_text | ELGA_ActiveIngredient_10_code | ELGA_ActiveIngredient_10_text | ELGA_Ingredient_role_10_text | ELGA_ReferenceIngredient_10_code | ELGA_ReferenceIngredient_10_text | ELGA_Substanz_11_code | ELGA_Substanz_11_text | ELGA_ActiveIngredient_11_code | ELGA_ActiveIngredient_11_text | ELGA_Ingredient_role_11_text | ELGA_ReferenceIngredient_11_code | ELGA_ReferenceIngredient_11_text | ELGA_Substanz_12_code | ELGA_Substanz_12_text | ELGA_ActiveIngredient_12_code | ELGA_ActiveIngredient_12_text | ELGA_Ingredient_role_12_text | ELGA_ReferenceIngredient_12_code | ELGA_ReferenceIngredient_12_text | ELGA_Substanz_13_code | ELGA_Substanz_13_text | ELGA_ActiveIngredient_13_code | ELGA_ActiveIngredient_13_text | ELGA_Ingredient_role_13_text | ELGA_ReferenceIngredient_13_code | ELGA_ReferenceIngredient_13_text | ELGA_Substanz_14_code | ELGA_Substanz_14_text | ELGA_ActiveIngredient_14_code | ELGA_ActiveIngredient_14_text | ELGA_Ingredient_role_14_text | ELGA_ReferenceIngredient_14_code | ELGA_ReferenceIngredient_14_text | ELGA_Substanz_15_code | ELGA_Substanz_15_text | ELGA_ActiveIngredient_15_code | ELGA_ActiveIngredient_15_text | ELGA_Ingredient_role_15_text | ELGA_ReferenceIngredient_15_code | ELGA_ReferenceIngredient_15_text | ELGA_Substanz_16_code | ELGA_Substanz_16_text | ELGA_ActiveIngredient_16_code | ELGA_ActiveIngredient_16_text | ELGA_Ingredient_role_16_text | ELGA_ReferenceIngredient_16_code | ELGA_ReferenceIngredient_16_text | ELGA_Substanz_17_code | ELGA_Substanz_17_text | ELGA_ActiveIngredient_17_code | ELGA_ActiveIngredient_17_text | ELGA_Ingredient_role_17_text | ELGA_ReferenceIngredient_17_code | ELGA_ReferenceIngredient_17_text | ELGA_Substanz_18_code | ELGA_Substanz_18_text | ELGA_ActiveIngredient_18_code | ELGA_ActiveIngredient_18_text | ELGA_Ingredient_role_18_text | ELGA_ReferenceIngredient_18_code | ELGA_ReferenceIngredient_18_text | ELGA_Substanz_19_code | ELGA_Substanz_19_text | ELGA_ActiveIngredient_19_code | ELGA_ActiveIngredient_19_text | ELGA_Ingredient_role_19_text | ELGA_ReferenceIngredient_19_code | ELGA_ReferenceIngredient_19_text | ELGA_Substanz_20_code | ELGA_Substanz_20_text | ELGA_ActiveIngredient_20_code | ELGA_ActiveIngredient_20_text | ELGA_Ingredient_role_20_text | ELGA_ReferenceIngredient_20_code | ELGA_ReferenceIngredient_20_text | ELGA_Substanz_21_code | ELGA_Substanz_21_text | ELGA_ActiveIngredient_21_code | ELGA_ActiveIngredient_21_text | ELGA_Ingredient_role_21_text | ELGA_ReferenceIngredient_21_code | ELGA_ReferenceIngredient_21_text | ELGA_Substanz_22_code | ELGA_Substanz_22_text | ELGA_ActiveIngredient_22_code | ELGA_ActiveIngredient_22_text | ELGA_Ingredient_role_22_text | ELGA_ReferenceIngredient_22_code | ELGA_ReferenceIngredient_22_text | ELGA_Substanz_23_code | ELGA_Substanz_23_text | ELGA_ActiveIngredient_23_code | ELGA_ActiveIngredient_23_text | ELGA_Ingredient_role_23_text | ELGA_ReferenceIngredient_23_code | ELGA_ReferenceIngredient_23_text | ELGA_Substanz_24_code | ELGA_Substanz_24_text | ELGA_ActiveIngredient_24_code | ELGA_ActiveIngredient_24_text | ELGA_Ingredient_role_24_text | ELGA_ReferenceIngredient_24_code | ELGA_ReferenceIngredient_24_text | ELGA_Substanz_25_code | ELGA_Substanz_25_text | ELGA_ActiveIngredient_25_code | ELGA_ActiveIngredient_25_text | ELGA_Ingredient_role_25_text | ELGA_ReferenceIngredient_25_code | ELGA_ReferenceIngredient_25_text | ELGA_MedikationArtAnwendung_06_code | ELGA_MedikationArtAnwendung_06_text | ELGA_MedikationArtAnwendung_07_code | ELGA_MedikationArtAnwendung_07_text | ELGA_MedikationArtAnwendung_08_code | ELGA_MedikationArtAnwendung_08_text | ELGA_whoATC_03_code | ELGA_whoATC_03_text | ELGA_MedikationArtAnwendung_09_code | ELGA_MedikationArtAnwendung_09_text | ELGA_Ingredient_low_strength_09 | ELGA_Ingredient_low_strength_unit_09 | ELGA_Reference_low_strength_09 | ELGA_Reference_low_strength_unit_09 | ELGA_Ingredient_low_strength_10 | ELGA_Ingredient_low_strength_unit_10 | ELGA_Reference_low_strength_10 | ELGA_Reference_low_strength_unit_10 | ELGA_Ingredient_low_strength_11 | ELGA_Ingredient_low_strength_unit_11 | ELGA_Reference_low_strength_11 | ELGA_Reference_low_strength_unit_11 | ELGA_Ingredient_low_strength_12 | ELGA_Ingredient_low_strength_unit_12 | ELGA_Reference_low_strength_12 | ELGA_Reference_low_strength_unit_12 | ELGA_Ingredient_low_strength_13 | ELGA_Ingredient_low_strength_unit_13 | ELGA_Reference_low_strength_13 | ELGA_Reference_low_strength_unit_13 | ELGA_Ingredient_low_strength_14 | ELGA_Ingredient_low_strength_unit_14 | ELGA_Reference_low_strength_14 | ELGA_Reference_low_strength_unit_14 | ELGA_Ingredient_low_strength_15 | ELGA_Ingredient_low_strength_unit_15 | ELGA_Reference_low_strength_15 | ELGA_Reference_low_strength_unit_15 | ELGA_Ingredient_low_strength_16 | ELGA_Ingredient_low_strength_unit_16 | ELGA_Reference_low_strength_16 | ELGA_Reference_low_strength_unit_16 | ELGA_Ingredient_low_strength_17 | ELGA_Ingredient_low_strength_unit_17 | ELGA_Reference_low_strength_17 | ELGA_Reference_low_strength_unit_17 | ELGA_Ingredient_low_strength_18 | ELGA_Ingredient_low_strength_unit_18 | ELGA_Reference_low_strength_18 | ELGA_Reference_low_strength_unit_18 | ELGA_Ingredient_low_strength_19 | ELGA_Ingredient_low_strength_unit_19 | ELGA_Reference_low_strength_19 | ELGA_Reference_low_strength_unit_19 | ELGA_Ingredient_low_strength_20 | ELGA_Ingredient_low_strength_unit_20 | ELGA_Reference_low_strength_20 | ELGA_Reference_low_strength_unit_20 | ELGA_Ingredient_low_strength_21 | ELGA_Ingredient_low_strength_unit_21 | ELGA_Reference_low_strength_21 | ELGA_Reference_low_strength_unit_21 | ELGA_whoATC_04_code | ELGA_whoATC_04_text | ELGA_Substanz_26_code | ELGA_Substanz_26_text | ELGA_ActiveIngredient_26_code | ELGA_ActiveIngredient_26_text | ELGA_Ingredient_role_26_text | ELGA_ReferenceIngredient_26_code | ELGA_ReferenceIngredient_26_text | ELGA_Ingredient_low_strength_22 | ELGA_Ingredient_low_strength_unit_22 | ELGA_Reference_low_strength_22 | ELGA_Reference_low_strength_unit_22 | ELGA_Ingredient_low_strength_23 | ELGA_Ingredient_low_strength_unit_23 | ELGA_Reference_low_strength_23 | ELGA_Reference_low_strength_unit_23 | ELGA_Ingredient_low_strength_24 | ELGA_Ingredient_low_strength_unit_24 | ELGA_Reference_low_strength_24 | ELGA_Reference_low_strength_unit_24 | ELGA_Ingredient_low_strength_25 | ELGA_Ingredient_low_strength_unit_25 | ELGA_Reference_low_strength_25 | ELGA_Reference_low_strength_unit_25 | ELGA_Ingredient_low_strength_26 | ELGA_Ingredient_low_strength_unit_26 | ELGA_Reference_low_strength_26 | ELGA_Reference_low_strength_unit_26 | ELGA_Substanz_27_code | ELGA_Substanz_27_text | ELGA_ActiveIngredient_27_code | ELGA_ActiveIngredient_27_text | ELGA_Ingredient_role_27_text | ELGA_Ingredient_low_strength_27 | ELGA_Ingredient_low_strength_unit_27 | ELGA_ReferenceIngredient_27_code | ELGA_ReferenceIngredient_27_text | ELGA_Reference_low_strength_27 | ELGA_Reference_low_strength_unit_27 | ELGA_Substanz_28_code | ELGA_Substanz_28_text | ELGA_ActiveIngredient_28_code | ELGA_ActiveIngredient_28_text | ELGA_Ingredient_role_28_text | ELGA_Ingredient_low_strength_28 | ELGA_Ingredient_low_strength_unit_28 | ELGA_ReferenceIngredient_28_code | ELGA_ReferenceIngredient_28_text | ELGA_Reference_low_strength_28 | ELGA_Reference_low_strength_unit_28 | ELGA_MedikationDarreichungsform_05_code | ELGA_MedikationDarreichungsform_05_text |
0000974 | AETHOXYSKLEROL AMP 0,5% 2ML | Aethoxysklerol 0,5 % - Ampullen | 1.2.40.0.34.4.17:13905 | GA - zugelassen | Chemische Fabrik Kreussler & Co. GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C05BB02 | Polidocanol | 1.2.40.0.10.1.4.3.4.3.4:900000000008 | subepitheliale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075554 | submuköse Anwendung | 1.2.40.0.34.5.156:1707369 | POLIDOCANOL | 1.2.40.0.34.5.221:100000085336 | POLIDOCANOL | active | 10 | mg | 1.2.40.0.34.5.221:100000085336 | POLIDOCANOL | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:126159001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0000980 | AETHOXYSKLEROL AMP 1% 2ML | Aethoxysklerol 1 % - Ampullen | 1.2.40.0.34.4.17:13906 | GA - zugelassen | Chemische Fabrik Kreussler & Co. GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C05BB02 | Polidocanol | 1.2.40.0.10.1.4.3.4.3.4:900000000008 | subepitheliale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075554 | submuköse Anwendung | 1.2.40.0.34.5.156:1707369 | POLIDOCANOL | 1.2.40.0.34.5.221:100000085336 | POLIDOCANOL | active | 20 | mg | 1.2.40.0.34.5.221:100000085336 | POLIDOCANOL | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:127936001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0000997 | AETHOXYSKLEROL AMP 2% 2ML | Aethoxysklerol 2 % - Ampullen | 1.2.40.0.34.4.17:13907 | GA - zugelassen | Chemische Fabrik Kreussler & Co. GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C05BB02 | Polidocanol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707369 | POLIDOCANOL | 1.2.40.0.34.5.221:100000085336 | POLIDOCANOL | active | 40 | mg | 1.2.40.0.34.5.221:100000085336 | POLIDOCANOL | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:127937001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0001005 | AETHOXYSKLEROL AMP 3% 2ML | Aethoxysklerol 3 % - Ampullen | 1.2.40.0.34.4.17:13908 | GA - zugelassen | Chemische Fabrik Kreussler & Co. GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C05BB02 | Polidocanol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075554 | submuköse Anwendung | | | 1.2.40.0.34.5.156:1707369 | POLIDOCANOL | 1.2.40.0.34.5.221:100000085336 | POLIDOCANOL | active | 60 | mg | 1.2.40.0.34.5.221:100000085336 | POLIDOCANOL | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:127938001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0001063 | AGAFFIN ABFUEHRGEL TB | Agaffin - Abführgel | 1.2.40.0.34.4.17:6274 | GA - zugelassen | P&G Health Germany GmbH | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:A06AB08 | Natriumpicosulfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707244 | NATRIUM PICOSULFAT | 1.2.40.0.34.5.221:100000085034 | SODIUM PICOSULFATE | active | 36 | mg | 1.2.40.0.34.5.221:100000085034 | SODIUM PICOSULFATE | 36 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073363 | Gel zum Einnehmen | true | human | 1.2.40.0.34.4.26:123023001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0001086 | AGAFFIN ABFUEHRGEL FL | Agaffin - Abführgel | 1.2.40.0.34.4.17:6274 | GA - zugelassen | P&G Health Germany GmbH | true | true | 500 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A06AB08 | Natriumpicosulfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707244 | NATRIUM PICOSULFAT | 1.2.40.0.34.5.221:100000085034 | SODIUM PICOSULFATE | active | 180 | mg | 1.2.40.0.34.5.221:100000085034 | SODIUM PICOSULFATE | 180 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073363 | Gel zum Einnehmen | true | human | 1.2.40.0.34.4.26:123023002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0001175 | AGIOLAX GRAN | Agiolax-Granulat | 1.2.40.0.34.4.17:1-11936 | GA - zugelassen | Viatris Austria GmbH | true | false | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A06AB56 | Sennoside, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707903 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | 1.2.40.0.34.5.221:100000087827 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | active | 2.2 | g | 1.2.40.0.34.5.221:100000087827 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | 2.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073372 | Granulat | true | human | 1.2.40.0.34.4.26:123049001 | 1.2.40.0.34.5.156:6987758 | SENNAE FRUCTUS ANGUSTIFOLIAE | 1.2.40.0.34.5.221:900000004238 | SENNAE FRUCTUS ANGUSTIFOLIAE | active | 6.74 | g | 1.2.40.0.34.5.221:900000004238 | SENNAE FRUCTUS ANGUSTIFOLIAE | 6.74 | g | 1.2.40.0.34.5.156:1706309 | PLANTAGINIS OVATAE SEMEN | 1.2.40.0.34.5.221:100000079851 | ISPAGHULA SEED | active | 52 | g | 1.2.40.0.34.5.221:100000079851 | ISPAGHULA SEED | 52 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0001181 | AGIOLAX GRAN | Agiolax-Granulat | 1.2.40.0.34.4.17:1-11936 | GA - zugelassen | Viatris Austria GmbH | true | true | 250 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A06AB56 | Sennoside, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707903 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | 1.2.40.0.34.5.221:100000087827 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | active | 5.5 | g | 1.2.40.0.34.5.221:100000087827 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | 5.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073372 | Granulat | true | human | 1.2.40.0.34.4.26:123049003 | 1.2.40.0.34.5.156:6987758 | SENNAE FRUCTUS ANGUSTIFOLIAE | 1.2.40.0.34.5.221:900000004238 | SENNAE FRUCTUS ANGUSTIFOLIAE | active | 16.85 | g | 1.2.40.0.34.5.221:900000004238 | SENNAE FRUCTUS ANGUSTIFOLIAE | 16.85 | g | 1.2.40.0.34.5.156:1706309 | PLANTAGINIS OVATAE SEMEN | 1.2.40.0.34.5.221:100000079851 | ISPAGHULA SEED | active | 130 | g | 1.2.40.0.34.5.221:100000079851 | ISPAGHULA SEED | 130 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0001198 | AGIOLAX GRAN | Agiolax-Granulat | 1.2.40.0.34.4.17:1-11936 | GA - zugelassen | Viatris Austria GmbH | true | true | 1000 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A06AB56 | Sennoside, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707903 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | 1.2.40.0.34.5.221:100000087827 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | active | 22 | g | 1.2.40.0.34.5.221:100000087827 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | 22 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073372 | Granulat | true | human | 1.2.40.0.34.4.26:123049002 | 1.2.40.0.34.5.156:6987758 | SENNAE FRUCTUS ANGUSTIFOLIAE | 1.2.40.0.34.5.221:900000004238 | SENNAE FRUCTUS ANGUSTIFOLIAE | active | 67.4 | g | 1.2.40.0.34.5.221:900000004238 | SENNAE FRUCTUS ANGUSTIFOLIAE | 67.4 | g | 1.2.40.0.34.5.156:1706309 | PLANTAGINIS OVATAE SEMEN | 1.2.40.0.34.5.221:100000079851 | ISPAGHULA SEED | active | 520 | g | 1.2.40.0.34.5.221:100000079851 | ISPAGHULA SEED | 520 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0001318 | AKINETON TBL 2MG | Akineton 2 mg - Tabletten | 1.2.40.0.34.4.17:8853 | GA - zugelassen | Desma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N04AA02 | Biperiden | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708527 | BIPERIDEN HYDROCHLORID | 1.2.40.0.34.5.221:100000090297 | BIPERIDEN HYDROCHLORIDE | active | 2 | mg | 1.2.40.0.34.5.221:100000090297 | BIPERIDEN HYDROCHLORIDE | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122894004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0001324 | AKINETON TBL 2MG | Akineton 2 mg - Tabletten | 1.2.40.0.34.4.17:8853 | GA - zugelassen | Desma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N04AA02 | Biperiden | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708527 | BIPERIDEN HYDROCHLORID | 1.2.40.0.34.5.221:100000090297 | BIPERIDEN HYDROCHLORIDE | active | 2 | mg | 1.2.40.0.34.5.221:100000090297 | BIPERIDEN HYDROCHLORIDE | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122894001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0001376 | AKNICHTHOL LOT | Aknichthol - Lotio | 1.2.40.0.34.4.17:13866 | GA - zugelassen | Ichthyol-Gesellschaft Cordes, Hermanni & Co. (GmbH & Co.) KG | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D10AX30 | Verschiedene Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705770 | NATRIUM SULFOBITUMINOSUM | 1.2.40.0.34.5.221:100000077657 | ICHTHAMMOL SODIUM | active | 0.3 | g | 1.2.40.0.34.5.221:100000077657 | ICHTHAMMOL SODIUM | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073732 | Suspension zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:127667001 | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 0.15 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 0.15 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0001732 | ALKERAN FTBL 2MG | Alkeran 2 mg - Filmtabletten | 1.2.40.0.34.4.17:13299 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L01AA03 | Melphalan | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708842 | MELPHALAN | 1.2.40.0.34.5.221:100000091410 | MELPHALAN | active | 2 | mg | 1.2.40.0.34.5.221:100000091410 | MELPHALAN | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122409001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0002453 | ANAESTHERIT SLB 10% | Anaestherit 10% Salbe | 1.2.40.0.34.4.17:573 | GA - zugelassen | Dr. Ritsert Pharma GmbH & Co KG | true | true | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D04AB04 | Benzocain | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708383 | BENZOCAIN | 1.2.40.0.34.5.221:100000089829 | BENZOCAINE | active | 2 | g | 1.2.40.0.34.5.221:100000089829 | BENZOCAINE | 2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:121354001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0002513 | ANAFRANIL AMP 2ML | Anafranil Ampullen | 1.2.40.0.34.4.17:14191 | GA - zugelassen | Essential Pharma (M) Limited | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N06AA04 | Clomipramin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708620 | CLOMIPRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090503 | CLOMIPRAMIN HYDROCHLORID | active | 25 | mg | 1.2.40.0.34.5.221:100000090503 | CLOMIPRAMIN HYDROCHLORID | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:126355001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0002973 | ANTIBIOPHILUS HKPS | Antibiophilus - Hartkapseln | 1.2.40.0.34.4.17:1-23448 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A07FA01 | Milchsäurebildner | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710410 | LACTOBACILLUS CASEI | 1.2.40.0.34.5.221:900000000641 | LACTOBACILLUS CASEI | active | 200000000 | CFU | 1.2.40.0.34.5.221:900000000641 | LACTOBACILLUS CASEI | 200000000 | CFU | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | false | human | 1.2.40.0.34.4.26:929798001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0003582 | APREDNISLON TBL 5MG | Aprednislon 5 mg - Tabletten | 1.2.40.0.34.4.17:11258 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 5 | mg | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122762002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0003599 | APREDNISLON TBL 25MG | Aprednislon 25 mg - Tabletten | 1.2.40.0.34.4.17:12106 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 25 | mg | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123024001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0004050 | ARTAMIN KPS 250MG | Artamin 250 mg - Kapseln | 1.2.40.0.34.4.17:13611 | GA - aufgehoben | Sandoz GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01CC01 | Penicillamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706759 | PENICILLAMIN | 1.2.40.0.34.5.221:100000082481 | PENICILLAMINE | active | 250 | mg | 1.2.40.0.34.5.221:100000082481 | PENICILLAMINE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:121501001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0004297 | ASCORBISAL TBL | Ascorbisal - Tabletten | 1.2.40.0.34.4.17:6696 | GA - zugelassen | G.L. Pharma GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BA51 | Acetylsalicylsäure, Kombinationen exkl. Psycholeptika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 20 | mg | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120526002 | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 500 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0004340 | ASPIRIN TBL 500MG | Aspirin 500 mg Tabletten | 1.2.40.0.34.4.17:3155 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BA01 | Acetylsalicylsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129844001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0004386 | ASPIRIN C BRTBL | Aspirin + C Brausetabletten | 1.2.40.0.34.4.17:14079 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:A11GB | Ascorbinsäure (Vitamin C), Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 0.24 | g | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 0.24 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073681 | Brausetablette | true | human | 1.2.40.0.34.4.26:100000013232 | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 0.4 | g | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 0.4 | g | | | | | | | | | | | | 2.16.840.1.113883.6.73:N02BA01 | Acetylsalicylsäure | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0004392 | ASPRO CLASSIC TBL | Aspro Classic 320 mg ASS - Tabletten | 1.2.40.0.34.4.17:6307 | GA - zugelassen | M.C.M. Klosterfrau Healthcare GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BA01 | Acetylsalicylsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 320 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 320 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123549001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0004400 | ASPRO CLASSIC TBL | Aspro Classic 320 mg ASS - Tabletten | 1.2.40.0.34.4.17:6307 | GA - zugelassen | M.C.M. Klosterfrau Healthcare GmbH | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BA01 | Acetylsalicylsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 320 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 320 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123549002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0004920 | ATARAX FTBL 25MG | Atarax 25 mg Filmtabletten | 1.2.40.0.34.4.17:16161 | GA - zugelassen | UCB Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BB01 | Hydroxyzin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710358 | HYDROXYZIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000153303 | HYDROXYZINE DIHYDROCHLORIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000153303 | HYDROXYZINE DIHYDROCHLORIDE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:125861002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0005078 | AUREOCORT SLB | Aureocort 1 mg/g + 30 mg/g Salbe | 1.2.40.0.34.4.17:13273 | GA - zugelassen | Dermapharm GmbH | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07CB01 | Triamcinolon und Antibiotika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707146 | CHLORTETRACYCLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000084806 | CHLORTETRACYCLINE HYDROCHLORIDE | active | 0.45 | g | 1.2.40.0.34.5.221:100000092152 | CHLORTETRACYCLINE | 0.418163 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:124942002 | 1.2.40.0.34.5.156:1708563 | TRIAMCINOLON ACETONID | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | active | 0.015 | g | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | 0.015 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0005865 | BANEOCIN SLB | Baneocin - Salbe | 1.2.40.0.34.4.17:9452 | GA - zugelassen | Sandoz GmbH | true | true | 5 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D06AX | Andere Antibiotika zur topischen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708440 | NEOMYCIN SULFAT | 1.2.40.0.34.5.221:100000090029 | NEOMYCIN SULFATE | active | 0.037481 | g | 1.2.40.0.34.5.221:100000090456 | NEOMYCIN | 0.000055 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:120105001 | 1.2.40.0.34.5.156:1708583 | ZINK BACITRACIN | 1.2.40.0.34.5.221:100000090427 | BACITRACIN ZINC | active | 0.0183825 | g | 1.2.40.0.34.5.221:100000090427 | BACITRACIN ZINC | 0.0183825 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0005871 | BANEOCIN SLB | Baneocin - Salbe | 1.2.40.0.34.4.17:9452 | GA - zugelassen | Sandoz GmbH | true | true | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D06AX | Andere Antibiotika zur topischen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708440 | NEOMYCIN SULFAT | 1.2.40.0.34.5.221:100000090029 | NEOMYCIN SULFATE | active | 0.149924 | g | 1.2.40.0.34.5.221:100000090456 | NEOMYCIN | 0.113958 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:120105002 | 1.2.40.0.34.5.156:1708583 | ZINK BACITRACIN | 1.2.40.0.34.5.221:100000090427 | BACITRACIN ZINC | active | 0.07353 | g | 1.2.40.0.34.5.221:100000090427 | BACITRACIN ZINC | 0.07353 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0005888 | BANEOCIN SLB | Baneocin - Salbe | 1.2.40.0.34.4.17:9452 | GA - zugelassen | Sandoz GmbH | true | false | 200 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:D06AX | Andere Antibiotika zur topischen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708440 | NEOMYCIN SULFAT | 1.2.40.0.34.5.221:100000090029 | NEOMYCIN SULFATE | active | 1.49924 | g | 1.2.40.0.34.5.221:100000090456 | NEOMYCIN | 0.002205 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:120105003 | 1.2.40.0.34.5.156:1708583 | ZINK BACITRACIN | 1.2.40.0.34.5.221:100000090427 | BACITRACIN ZINC | active | 0.7353 | g | 1.2.40.0.34.5.221:100000090427 | BACITRACIN ZINC | 0.7353 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0006296 | BEKUNIS KR.TEE | Bekunis - Kräutertee | 1.2.40.0.34.4.17:13426 | GA - aufgehoben | Roha Arzneimittel GmbH | false | false | 80 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A06AB06 | Sennoside | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708673 | SENNAE FOLIUM | 1.2.40.0.34.5.221:100000090680 | SENNAE FOLIUM | active | 2000 | g | 1.2.40.0.34.5.221:100000090680 | SENNAE FOLIUM | 2000 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073370 | Arzneitee | true | human | 1.2.40.0.34.4.26:121105002 | 1.2.40.0.34.5.156:1712672 | SENNAE FRUCTUS | 1.2.40.0.34.5.221:900000004286 | SENNAE FRUCTUS | active | 6000 | g | 1.2.40.0.34.5.221:900000004286 | SENNAE FRUCTUS | 6000 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0006907 | BEPANTHEN WUND-HEILSLB | Bepanthen - Wund- und Heilsalbe | 1.2.40.0.34.4.17:7158 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D03AX02 | Dextranomer | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709167 | DEXPANTHENOL | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | active | 1.5 | g | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | 1.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:129748003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0007031 | BETNESOL AMP 1ML | Betnesol - Ampullen | 1.2.40.0.34.4.17:13193 | GA - aufgehoben | Alfasigma S.p.A. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB | Glucocorticoide | 1.2.40.0.10.1.4.3.4.3.4:100000073597 | intraläsionale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075264 | retrobulbäre Anwendung | 1.2.40.0.34.5.156:1708451 | BETAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | active | 5.3 | mg | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | 5.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:121659002 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0007054 | BETNESOL AU-OH-NA-TR | Betnesol Augen-, Ohren- und Nasentropfen | 1.2.40.0.34.4.17:13501 | GA - zugelassen | Alfasigma S.p.A. | true | true | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S03BA03 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073564 | Anwendung am Ohr | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | 1.2.40.0.34.5.156:1708451 | BETAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | active | 0.005 | g | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | 0.005 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116151 | Augen-/Ohren-/Nasentropfen, Lösung | true | human | 1.2.40.0.34.4.26:121715001 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:R01AD06 | Betamethason | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0007077 | BETNESOL BRTBL | Betnesol - Brausetabletten | 1.2.40.0.34.4.17:12867 | GA - zugelassen | Alfasigma S.p.A. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708451 | BETAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | active | 0.671 | mg | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | 0.671 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073681 | Brausetablette | true | human | 1.2.40.0.34.4.26:122813001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0007114 | BETNESOL N AU-OH-NA-TR | Betnesol N - Augen-, Ohren- und Nasentropfen | 1.2.40.0.34.4.17:13503 | GA - zugelassen | Alfasigma S.p.A. | true | true | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S03BA03 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073564 | Anwendung am Ohr | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | 1.2.40.0.34.5.156:1708440 | NEOMYCIN SULFAT | 1.2.40.0.34.5.221:100000090029 | NEOMYCIN SULFATE | active | 0.025 | g | 1.2.40.0.34.5.221:100000090456 | NEOMYCIN | 0.000037 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000116151 | Augen-/Ohren-/Nasentropfen, Lösung | true | human | 1.2.40.0.34.4.26:122806001 | 1.2.40.0.34.5.156:1708451 | BETAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | active | 0.005 | g | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | 0.005 | g | | | | | | | | | | | | 2.16.840.1.113883.6.73:R01AD06 | Betamethason | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0007137 | BETNOVATE CR | Betnovate - Creme | 1.2.40.0.34.4.17:13310 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709477 | BETAMETHASONVALERAT | 1.2.40.0.34.5.221:100000092622 | BETAMETHASONE VALERATE | active | 0.122 | g | 1.2.40.0.34.5.221:100000092622 | BETAMETHASONE VALERATE | 0.122 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:122808002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0007143 | BETNOVATE CR | Betnovate - Creme | 1.2.40.0.34.4.17:13310 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709477 | BETAMETHASONVALERAT | 1.2.40.0.34.5.221:100000092622 | BETAMETHASONE VALERATE | active | 0.122 | g | 1.2.40.0.34.5.221:100000092622 | BETAMETHASONE VALERATE | 0.122 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:122808003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0007189 | BETNOVATE SLB | Betnovate - Salbe | 1.2.40.0.34.4.17:13311 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709477 | BETAMETHASONVALERAT | 1.2.40.0.34.5.221:100000092622 | BETAMETHASONE VALERATE | active | 0.0366 | g | 1.2.40.0.34.5.221:100000092622 | BETAMETHASONE VALERATE | 0.0366 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:122809003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0007278 | BETNOVATE CRIN LSG | Betnovate - Crinale Lösung | 1.2.40.0.34.4.17:14435 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709477 | BETAMETHASONVALERAT | 1.2.40.0.34.5.221:100000092622 | BETAMETHASONE VALERATE | active | 0.0366 | g | 1.2.40.0.34.5.221:100000092622 | BETAMETHASONE VALERATE | 0.0366 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:120397003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0008639 | BUERLECITHIN DRG | Buerlecithin plus Vitamine Dragees | 1.2.40.0.34.4.17:HERB-00043 | GA - aufgehoben | Takeda Pharma Ges.m.b.H. | false | false | 36 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:A13A | Tonika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 0.3 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 0.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:956773001 | 1.2.40.0.34.5.156:1705659 | LECITHIN | 1.2.40.0.34.5.221:100000077103 | LECITHIN | active | 750 | mg | 1.2.40.0.34.5.221:100000077103 | LECITHIN | 750 | mg | 1.2.40.0.34.5.156:1708612 | CALCIUM PANTOTHENAT | 1.2.40.0.34.5.221:100000090485 | CALCIUM PANTOTHENATE | active | 0.8 | mg | 1.2.40.0.34.5.221:100000090485 | CALCIUM PANTOTHENATE | 0.8 | mg | | | | | | | 1.2.40.0.34.5.156:1708142 | RIBOFLAVIN | 1.2.40.0.34.5.221:100000089010 | RIBOFLAVIN | active | 0.3 | mg | 1.2.40.0.34.5.221:100000089010 | RIBOFLAVIN | 0.3 | mg | 1.2.40.0.34.5.156:1706334 | ALPHA-TOCOPHEROLACETAT | 1.2.40.0.34.5.221:100000079921 | ALPHATOCOPHEROL ACETATE | active | 5.5 | mg | 1.2.40.0.34.5.221:100000079921 | ALPHATOCOPHEROL ACETATE | 5.5 | mg | 1.2.40.0.34.5.156:1709249 | THIAMIN NITRAT | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | active | 0.544 | mg | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | 0.544 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0008697 | BUERLECITHIN FL | Buerlecithin flüssig | 1.2.40.0.34.4.17:HERB-00042 | GA - registriert | Orifarm Healthcare A/S | true | true | 250 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A13A | Tonika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705659 | LECITHIN | 1.2.40.0.34.5.221:100000077103 | LECITHIN | active | 22500 | mg | 1.2.40.0.34.5.221:100000077103 | LECITHIN | 22500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | false | human | 1.2.40.0.34.4.26:956772002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0008705 | BUERLECITHIN FL | Buerlecithin flüssig | 1.2.40.0.34.4.17:HERB-00042 | GA - registriert | Orifarm Healthcare A/S | true | true | 500 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A13A | Tonika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705659 | LECITHIN | 1.2.40.0.34.5.221:100000077103 | LECITHIN | active | 45000 | mg | 1.2.40.0.34.5.221:100000077103 | LECITHIN | 45000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | false | human | 1.2.40.0.34.4.26:956772003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0008711 | BUERLECITHIN FL | Buerlecithin flüssig | 1.2.40.0.34.4.17:HERB-00042 | GA - registriert | Orifarm Healthcare A/S | true | true | 1000 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A13A | Tonika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705659 | LECITHIN | 1.2.40.0.34.5.221:100000077103 | LECITHIN | active | 90000 | mg | 1.2.40.0.34.5.221:100000077103 | LECITHIN | 90000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | false | human | 1.2.40.0.34.4.26:956772001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0008728 | BURONIL FTBL 25MG | Buronil 25 mg - Filmtabletten | 1.2.40.0.34.4.17:14476 | GA - zugelassen | Medilink A/S | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:N05AD03 | Melperon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709160 | MELPERON HYDROCHLORID | 1.2.40.0.34.5.221:100000092068 | MELPERONE HYDROCHLORIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000092068 | MELPERONE HYDROCHLORIDE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124003002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0008763 | BUSCOPAN SUPP 10MG | Buscopan 10 mg - Zäpfchen | 1.2.40.0.34.4.17:7647 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A03BB01 | Butylscopolamin | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709622 | BUTYLSCOPOLAMINIUMBROMID | 1.2.40.0.34.5.221:100000093055 | HYOSCINE BUTYLBROMIDE | active | 0.01 | g | 1.2.40.0.34.5.221:100000093055 | HYOSCINE BUTYLBROMIDE | 0.01 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:924635001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0010234 | CATAPRESAN TBL 0,15MG | Catapresan 0,15 mg - Tabletten | 1.2.40.0.34.4.17:13874 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C02AC01 | Clonidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708541 | CLONIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090325 | CLONIDINE HYDROCHLORIDE | active | 0.15 | mg | 1.2.40.0.34.5.221:100000090325 | CLONIDINE HYDROCHLORIDE | 0.15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:128191001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0010257 | CATHEJELL DIPHENH.TB | Cathejell Diphenhydramin 1 % / Chlorhexidin 0,05 % Gel (in Tuben) | 1.2.40.0.34.4.17:16076 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | false | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:N01BX | Andere Lokalanästhetika | 1.2.40.0.10.1.4.3.4.3.4:100000073638 | Anwendung in der Harnröhre | | | | | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 0.2 | g | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 0.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073880 | Gel zur Anwendung in der Harnröhre | true | human | 1.2.40.0.34.4.26:127178002 | 1.2.40.0.34.5.156:1709371 | CHLORHEXIDIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDINE DIHYDROCHLORIDE | active | 0.01 | g | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDINE DIHYDROCHLORIDE | 0.01 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0010381 | CEBION BRTBL 1G BLUTORANGE | Cebion Blutorange 1 g - Brausetabletten | 1.2.40.0.34.4.17:10713 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:900000000009 | Behältnis (NE) | 2.16.840.1.113883.6.73:A11GA01 | Ascorbinsäure (Vitamin C) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 1000 | mg | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073681 | Brausetablette | false | human | 1.2.40.0.34.4.26:128281001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0010659 | CE-LIMO ZITRONE BRTBL 3X10 | Ce-Limo Zitrone - Brausetabletten | 1.2.40.0.34.4.17:10253 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:A11GA01 | Ascorbinsäure (Vitamin C) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 1000 | mg | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073681 | Brausetablette | false | human | 1.2.40.0.34.4.26:122893001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0010719 | CEREBROLYSIN AMP 1ML | Cerebrolysin - parenterale Lösung | 1.2.40.0.34.4.17:1-21380 | GA - zugelassen | EVER Neuro Pharma GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N07X | Andere Mittel für das Nervensystem | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1710680 | PEPTIDE | 1.2.40.0.34.5.221:100000124442 | PEPTIDES | active | 215.2 | mg | 1.2.40.0.34.5.221:100000124442 | PEPTIDES | 215.2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000116188 | Solution for injection/concentrate for solution for infusion | true | human | 1.2.40.0.34.4.26:934071001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0012026 | COLDAN NA-TR | Coldan - Nasentropfen | 1.2.40.0.34.4.17:6460 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AA08 | Naphazolin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1708567 | NAPHAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073794 | Nasentropfen, Lösung | true | human | 1.2.40.0.34.4.26:129415001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0012032 | COLDARGAN LSG | Coldargan Lösung | 1.2.40.0.34.4.17:11378 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AB05 | Ephedrin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073621 | zur Anwendung im Mund- und Rachenraum | | | 1.2.40.0.34.5.156:1708106 | PROTEIN-SILBER | 1.2.40.0.34.5.221:100000088825 | SILVER PROTEIN | active | 250 | mg | 1.2.40.0.34.5.221:100000088825 | SILVER PROTEIN | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073691 | Lösung zur Anwendung in der Mundhöhle | true | human | 1.2.40.0.34.4.26:126270001 | 1.2.40.0.34.5.156:7191449 | EPHEDRIN HEMIHYDRAT | 1.2.40.0.34.5.221:100000091960 | EPHEDRINE HEMIHYDRATE | active | 123.9 | mg | 1.2.40.0.34.5.221:100000091960 | EPHEDRINE HEMIHYDRATE | 123.9 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073958 | Nasenspray | 1.2.40.0.10.1.4.3.4.3.5:100000073794 | Nasentropfen, Lösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0012049 | COLDISTAN NA-TR | Coldistan Nasentropfen | 1.2.40.0.34.4.17:7506 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AB02 | Naphazolin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1708567 | NAPHAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073796 | Nasenspray, Lösung | true | human | 1.2.40.0.34.4.26:127392001 | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 10 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073794 | Nasentropfen, Lösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0012285 | COMBITHYREX TBL FTE | Combithyrex forte - Tabletten | 1.2.40.0.34.4.17:1-18085 | GA - aufgehoben | Sandoz GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:H03AA03 | Kombinationen von Levothyroxin und Liothyronin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708423 | NATRIUM LIOTHYRONINAT | 1.2.40.0.34.5.221:100000089973 | LIOTHYRONINE SODIUM | active | 0.025 | mg | 1.2.40.0.34.5.221:100000089973 | LIOTHYRONINE SODIUM | 0.025 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120411002 | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.1 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.1 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0012291 | COMBITHYREX TBL MTE | Combithyrex mite - Tabletten | 1.2.40.0.34.4.17:1-18084 | GA - aufgehoben | Sandoz GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:H03AA03 | Kombinationen von Levothyroxin und Liothyronin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708423 | NATRIUM LIOTHYRONINAT | 1.2.40.0.34.5.221:100000089973 | LIOTHYRONINE SODIUM | active | 0.0125 | mg | 1.2.40.0.34.5.221:100000089973 | LIOTHYRONINE SODIUM | 0.0125 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120410002 | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.05 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.05 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0012581 | CONTRACTUBEX GEL | Contractubex Gel | 1.2.40.0.34.4.17:13883 | GA - zugelassen | Merz Pharma Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D03AX | Andere Wundbehandlungsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1712596 | ALLII CEPAE BULBUS (AUSZUG) | 1.2.40.0.34.5.221:900000004017 | ALLII CEPAE BULBUS (EXTRACT) | active | 500 | g | 1.2.40.0.34.5.221:900000004017 | ALLII CEPAE BULBUS (EXTRACT) | 500 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:124075003 | 1.2.40.0.34.5.156:1705858 | ALLANTOIN | 1.2.40.0.34.5.221:100000078014 | ALLANTOIN | active | 50 | g | 1.2.40.0.34.5.221:100000078014 | ALLANTOIN | 50 | g | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 250000 | IU | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 250000 | IU | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0013445 | CRATAEGAN TR | Crataegan - Tropfen | 1.2.40.0.34.4.17:7868 | GA - aufgehoben | Austroplant-Arzneimittel GmbH | false | false | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C01EB | Andere Herzmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710151 | CRATAEGI FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000000382 | CRATAEGI FRUCTUS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000382 | CRATAEGI FRUCTUS (EXTRACT) | | | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | false | human | 1.2.40.0.34.4.26:923789001 | 1.2.40.0.34.5.156:1712610 | CRATAEGI FOLIUM CUM FLORE (AUSZUG) | 1.2.40.0.34.5.221:900000004087 | CRATAEGI FOLIUM CUM FLORE (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000004087 | CRATAEGI FOLIUM CUM FLORE (EXTRACT) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0013474 | CRATAEGUTT TR | Crataegutt - Tropfen | 1.2.40.0.34.4.17:9789 | GA - aufgehoben | Austroplant-Arzneimittel GmbH | false | false | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C01EB | Andere Herzmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710151 | CRATAEGI FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000000382 | CRATAEGI FRUCTUS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000382 | CRATAEGI FRUCTUS (EXTRACT) | | | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | false | human | 1.2.40.0.34.4.26:125495003 | 1.2.40.0.34.5.156:1710150 | CRATAEGI FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000381 | CRATAEGI FOLIUM (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000381 | CRATAEGI FOLIUM (EXTRACT) | | | 1.2.40.0.34.5.156:1710153 | CRATAEGI OXYACANTHAE FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000000384 | CRATAEGI OXYACANTHAE FLOS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000384 | CRATAEGI OXYACANTHAE FLOS (EXTRACT) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0013793 | CYKLOKAPRON FTBL | Cyklokapron 500 mg - Filmtabletten | 1.2.40.0.34.4.17:13086 | GA - zugelassen | Viatris Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:900000000009 | Behältnis (NE) | 2.16.840.1.113883.6.73:B02AA02 | Tranexamsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708717 | TRANEXAMSÄURE | 1.2.40.0.34.5.221:100000091040 | TRANEXAMIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000091040 | TRANEXAMIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124357004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0013824 | CYNARIX DRG | Cynarix Dragees | 1.2.40.0.34.4.17:HERB-00108 | GA - registriert | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A05AX | Andere Mittel zur Gallentherapie | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712762 | CYNARAE FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000004455 | CYNARAE FOLIUM (EXTRACT) | active | 55 | mg | 1.2.40.0.34.5.221:900000004455 | CYNARAE FOLIUM (EXTRACT) | 55 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | false | human | 1.2.40.0.34.4.26:958112001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0014485 | DECADURABOLIN AMP 25MG 1ML | Deca-Durabolin 25 mg/ml Injektionslösung | 1.2.40.0.34.4.17:11666 | GA - aufgehoben | Aspen Pharma Trading Limited | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A14AB01 | Nandrolon | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708569 | NANDROLON DECANOAT | 1.2.40.0.34.5.221:100000090393 | NANDROLONE DECANOATE | active | 25 | mg | 1.2.40.0.34.5.221:100000090393 | NANDROLONE DECANOATE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:124009001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0014491 | DECA-DURABOLIN AMP 50MG/1ML | Deca-Durabolin 50 mg/ml Injektionslösung | 1.2.40.0.34.4.17:11667 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A14AB01 | Nandrolon | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708569 | NANDROLON DECANOAT | 1.2.40.0.34.5.221:100000090393 | NANDROLONE DECANOATE | active | 50 | mg | 1.2.40.0.34.5.221:100000090393 | NANDROLONE DECANOATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920642001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0014580 | DECODERM CR | Decoderm - Creme | 1.2.40.0.34.4.17:14349 | GA - zugelassen | Almirall Hermal GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AB07 | Flupredniden | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709051 | FLUPREDNIDEN ACETAT | 1.2.40.0.34.5.221:100000091890 | FLUPREDNIDENE ACETATE | active | 0.03 | g | 1.2.40.0.34.5.221:100000091890 | FLUPREDNIDENE ACETATE | 0.03 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:923996003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0014597 | DECODERM CR | Decoderm - Creme | 1.2.40.0.34.4.17:14349 | GA - zugelassen | Almirall Hermal GmbH | true | false | 150 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AB07 | Flupredniden | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709051 | FLUPREDNIDEN ACETAT | 1.2.40.0.34.5.221:100000091890 | FLUPREDNIDENE ACETATE | active | 0.15 | g | 1.2.40.0.34.5.221:100000091890 | FLUPREDNIDENE ACETATE | 0.15 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:923996002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0014628 | DECODERM CP CR | Decoderm compositum - Creme | 1.2.40.0.34.4.17:14082 | GA - zugelassen | Almirall Hermal GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07CB02 | Flupredniden und Antibiotika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 50.1 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 35.341442 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:123128003 | 1.2.40.0.34.5.156:1709051 | FLUPREDNIDEN ACETAT | 1.2.40.0.34.5.221:100000091890 | FLUPREDNIDENE ACETATE | active | 30 | mg | 1.2.40.0.34.5.221:100000091890 | FLUPREDNIDENE ACETATE | 30 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0014634 | DECODERM CP CR | Decoderm compositum - Creme | 1.2.40.0.34.4.17:14082 | GA - zugelassen | Almirall Hermal GmbH | true | false | 150 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07CB02 | Flupredniden und Antibiotika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 250.5 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 176.707209 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:123128001 | 1.2.40.0.34.5.156:1709051 | FLUPREDNIDEN ACETAT | 1.2.40.0.34.5.221:100000091890 | FLUPREDNIDENE ACETATE | active | 150 | mg | 1.2.40.0.34.5.221:100000091890 | FLUPREDNIDENE ACETATE | 150 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0015272 | DERMODRIN SLB | Dermodrin - Salbe | 1.2.40.0.34.4.17:9199 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D04AA32 | Diphenhydramin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 0.4 | g | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 0.4 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:122104002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0015289 | DERMODRIN SLB | Dermodrin - Salbe | 1.2.40.0.34.4.17:9199 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D04AA32 | Diphenhydramin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 2 | g | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:122104001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0015384 | DESITIN SBL | Desitin - Salbe | 1.2.40.0.34.4.17:2111 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D03AA | Lebertransalben | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708243 | ZINKOXID | 1.2.40.0.34.5.221:100000089333 | ZINC OXIDE | active | 600 | g | 1.2.40.0.34.5.221:100000089333 | ZINC OXIDE | 600 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:124935002 | 1.2.40.0.34.5.156:1708881 | JECORIS ASELLI OLEUM | 1.2.40.0.34.5.221:100000091501 | COD-LIVER OIL | active | 260 | g | 1.2.40.0.34.5.221:100000091501 | COD-LIVER OIL | 260 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0015510 | DEXAMETHASON NYC AMP 4MG 1ML | Dexamethason "Nycomed" 4 mg - Ampulle | 1.2.40.0.34.4.17:12755 | GA - aufgehoben | Takeda Austria GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB02 | Dexamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709464 | DEXAMETHASON | 1.2.40.0.34.5.221:100000092605 | DEXAMETHASONE | active | 4 | mg | 1.2.40.0.34.5.221:100000092605 | DEXAMETHASONE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920722002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0015680 | DIAMOX TBL 250MG | Diamox 250 mg - Tabletten | 1.2.40.0.34.4.17:8366 | GA - zugelassen | Amdipharm Limited | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:S01EC01 | Acetazolamid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709499 | ACETAZOLAMID | 1.2.40.0.34.5.221:100000092652 | ACETAZOLAMIDE | active | 250 | mg | 1.2.40.0.34.5.221:100000092652 | ACETAZOLAMIDE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120128001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0015800 | DIBONDRIN AMP 2ML | Dibondrin Ampullen | 1.2.40.0.34.4.17:7162 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:R06AA02 | Diphenhydramin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 30 | mg | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:127534001 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:N05CM | Andere Hypnotika und Sedativa | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0015823 | DIBONDRIN DRG | Dibondrin Dragees | 1.2.40.0.34.4.17:7163 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AA02 | Diphenhydramin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:126226002 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:N05CM | Andere Hypnotika und Sedativa | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0016188 | DIGIMERCK AMP 0,25MG | Digimerck 0,25 mg - Ampullen | 1.2.40.0.34.4.17:6805 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C01AA04 | Digitoxin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709550 | DIGITOXIN | 1.2.40.0.34.5.221:100000092778 | DIGITOXIN | active | 1.25 | mg | 1.2.40.0.34.5.221:100000092778 | DIGITOXIN | 1.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:924910001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0016231 | DIGIMERCK TBL 0,1MG | Digimerck 0,1 mg - Tabletten | 1.2.40.0.34.4.17:1-18969 | GA - zugelassen | Merck Ges.m.b.H. | true | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01AA04 | Digitoxin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709550 | DIGITOXIN | 1.2.40.0.34.5.221:100000092778 | DIGITOXIN | active | 0.1 | mg | 1.2.40.0.34.5.221:100000092778 | DIGITOXIN | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:121428001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0017302 | DIVINAL-CARL-BADERS SLB | Carl-Bader`S DIVINALSALBE | 1.2.40.0.34.4.17:1544 | GA - aufgehoben | Apotheke zum hl. Rupertus, Mag.pharm. Wilhelm Wulz e.U. | false | false | 22 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709094 | TEREBINTHINAE AETHEROLEUM | 1.2.40.0.34.5.221:100000091958 | TURPENTINE OIL | active | 177.1 | g | 1.2.40.0.34.5.221:100000091958 | TURPENTINE OIL | 177.1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:922870002 | 1.2.40.0.34.5.156:7255602 | LEVOMENTHOL | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | active | 29.48 | g | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | 29.48 | g | 1.2.40.0.34.5.156:1707183 | METHYLSALICYLAT | 1.2.40.0.34.5.221:100000084885 | METHYL SALICYLATE | active | 73.92 | g | 1.2.40.0.34.5.221:100000084885 | METHYL SALICYLATE | 73.92 | g | | | | | | | 1.2.40.0.34.5.156:1712128 | ALKOHOLISCHE KAMPFERLÖSUNG | 1.2.40.0.34.5.221:900000002379 | CAMPHORAE SPIRITUOSA SOLUTIO | active | 73.92 | g | 1.2.40.0.34.5.221:900000002379 | CAMPHORAE SPIRITUOSA SOLUTIO | 73.92 | g | 1.2.40.0.34.5.156:1709036 | RACEMISCHER CAMPHER | 1.2.40.0.34.5.221:100000091848 | CAMPHOR, RACEMIC | active | 147.62 | g | 1.2.40.0.34.5.221:100000091848 | CAMPHOR, RACEMIC | 147.62 | g | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 73.92 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 73.92 | g | | | | | 1.2.40.0.34.5.156:1706021 | ROSMARINI AETHEROLEUM | 1.2.40.0.34.5.221:100000078648 | ROSEMARY OIL | active | 73.92 | g | 1.2.40.0.34.5.221:100000078648 | ROSEMARY OIL | 73.92 | g | 1.2.40.0.34.5.156:1706200 | SALIZYLSÄUREPHENYLESTER | 1.2.40.0.34.5.221:100000079433 | PHENYL SALICYLATE | active | 73.92 | g | 1.2.40.0.34.5.221:100000079433 | PHENYL SALICYLATE | 73.92 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0017319 | DIVINAL-CARL-BADERS SLB | Carl-Bader`S DIVINALSALBE | 1.2.40.0.34.4.17:1544 | GA - aufgehoben | Apotheke zum hl. Rupertus, Mag.pharm. Wilhelm Wulz e.U. | false | false | 95 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709094 | TEREBINTHINAE AETHEROLEUM | 1.2.40.0.34.5.221:100000091958 | TURPENTINE OIL | active | 764.75 | g | 1.2.40.0.34.5.221:100000091958 | TURPENTINE OIL | 764.75 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:922870001 | 1.2.40.0.34.5.156:7255602 | LEVOMENTHOL | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | active | 127.3 | g | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | 127.3 | g | 1.2.40.0.34.5.156:1707183 | METHYLSALICYLAT | 1.2.40.0.34.5.221:100000084885 | METHYL SALICYLATE | active | 319.2 | g | 1.2.40.0.34.5.221:100000084885 | METHYL SALICYLATE | 319.2 | g | | | | | | | 1.2.40.0.34.5.156:1712128 | ALKOHOLISCHE KAMPFERLÖSUNG | 1.2.40.0.34.5.221:900000002379 | CAMPHORAE SPIRITUOSA SOLUTIO | active | 319.2 | g | 1.2.40.0.34.5.221:900000002379 | CAMPHORAE SPIRITUOSA SOLUTIO | 319.2 | g | 1.2.40.0.34.5.156:1709036 | RACEMISCHER CAMPHER | 1.2.40.0.34.5.221:100000091848 | CAMPHOR, RACEMIC | active | 637.45 | g | 1.2.40.0.34.5.221:100000091848 | CAMPHOR, RACEMIC | 637.45 | g | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 319.2 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 319.2 | g | | | | | 1.2.40.0.34.5.156:1706021 | ROSMARINI AETHEROLEUM | 1.2.40.0.34.5.221:100000078648 | ROSEMARY OIL | active | 319.2 | g | 1.2.40.0.34.5.221:100000078648 | ROSEMARY OIL | 319.2 | g | 1.2.40.0.34.5.156:1706200 | SALIZYLSÄUREPHENYLESTER | 1.2.40.0.34.5.221:100000079433 | PHENYL SALICYLATE | active | 319.2 | g | 1.2.40.0.34.5.221:100000079433 | PHENYL SALICYLATE | 319.2 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0017615 | DOMINAL FTBL FTE 80MG | Dominal forte 80 mg - Filmtabletten | 1.2.40.0.34.4.17:10557 | GA - zugelassen | Viatris Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AX07 | Prothipendyl | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707282 | PROTHIPENDYLHYDROCHLORID | 1.2.40.0.34.5.221:100000085134 | PROTHIPENDYL HYDROCHLORIDE | active | 80 | mg | 1.2.40.0.34.5.221:100000085134 | PROTHIPENDYL HYDROCHLORIDE | 80 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:127202001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0018017 | DULCOLAX SUPP | Dulcolax - Zäpfchen | 1.2.40.0.34.4.17:9012 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:A06AB02 | Bisacodyl | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709088 | BISACODYL | 1.2.40.0.34.5.221:100000091949 | BISACODYL | active | 0.01 | g | 1.2.40.0.34.5.221:100000091949 | BISACODYL | 0.01 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:921860001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0018023 | DULCOLAX SUPP | Dulcolax - Zäpfchen | 1.2.40.0.34.4.17:9012 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:A06AB02 | Bisacodyl | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709088 | BISACODYL | 1.2.40.0.34.5.221:100000091949 | BISACODYL | active | 0.01 | g | 1.2.40.0.34.5.221:100000091949 | BISACODYL | 0.01 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:921860002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0018419 | ECHNATOL DRG | Echnatol - Dragees | 1.2.40.0.34.4.17:11769 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AE03 | Cyclizin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707941 | CYCLIZIN HYDROCHLORID | 1.2.40.0.34.5.221:100000087968 | CYCLIZINE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000087968 | CYCLIZINE HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:124617001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0018589 | EFFORTIL TR | Effortil 7,5 mg/ml - Tropfen | 1.2.40.0.34.4.17:9106 | GA - zugelassen | N.V. Serb S.A. | true | true | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C01CA01 | Etilefrin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707831 | ETILEFRIN HYDROCHLORID | 1.2.40.0.34.5.221:100000087496 | ETILEFRINE HYDROCHLORIDE | active | 0.1125 | g | 1.2.40.0.34.5.221:100000087496 | ETILEFRINE HYDROCHLORIDE | 0.1125 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:121345001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0018595 | EFFORTIL TR | Effortil 7,5 mg/ml - Tropfen | 1.2.40.0.34.4.17:9106 | GA - zugelassen | N.V. Serb S.A. | true | true | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C01CA01 | Etilefrin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707831 | ETILEFRIN HYDROCHLORID | 1.2.40.0.34.5.221:100000087496 | ETILEFRINE HYDROCHLORIDE | active | 0.375 | g | 1.2.40.0.34.5.221:100000087496 | ETILEFRINE HYDROCHLORIDE | 0.375 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:121345002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0018951 | EKZEMSLB-F AGE | Ekzemsalbe "F" - Agepha | 1.2.40.0.34.4.17:11119 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AA02 | Hydrocortison | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709281 | HYDROCORTISON ACETAT | 1.2.40.0.34.5.221:100000092260 | HYDROCORTISONE ACETATE | active | 0.2 | g | 1.2.40.0.34.5.221:100000092260 | HYDROCORTISONE ACETATE | 0.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:124414001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0019293 | ENDOXAN TRSTAMP 200MG | Endoxan "Baxter" 200 mg - Trockenstechampulle | 1.2.40.0.34.4.17:10823 | GA - zugelassen | Baxter Healthcare GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:L01AA01 | Cyclophosphamid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708517 | CYCLOPHOSPHAMID | 1.2.40.0.34.5.221:100000090277 | CYCLOPHOSPHAMIDE | active | 213.8 | mg | 1.2.40.0.34.5.221:100000090277 | CYCLOPHOSPHAMIDE | 213.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:920231002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0019962 | ERYCYTOL DEP AMP 1MG 1ML | Erycytol Depot 1 mg - Ampullen | 1.2.40.0.34.4.17:12254 | GA - zugelassen | G.L. Pharma GmbH | true | true | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B03BA03 | Hydroxocobalamin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708152 | HYDROXOCOBALAMIN ACETAT | 1.2.40.0.34.5.221:100000089042 | HYDROXOCOBALAMIN ACETATE | active | 1.045 | mg | 1.2.40.0.34.5.221:100000089042 | HYDROXOCOBALAMIN ACETATE | 1.045 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:125842001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0020066 | BERICARD TR | BERICARD Tropfen zum Einnehmen | 1.2.40.0.34.4.17:HERB-00142 | GA - registriert | Sigmapharm Arzneimittel GmbH | true | true | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C01EB | Andere Herzmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712610 | CRATAEGI FOLIUM CUM FLORE (AUSZUG) | 1.2.40.0.34.5.221:900000004087 | CRATAEGI FOLIUM CUM FLORE (EXTRACT) | active | 24 | g | 1.2.40.0.34.5.221:900000004087 | CRATAEGI FOLIUM CUM FLORE (EXTRACT) | 24 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | false | human | 1.2.40.0.34.4.26:958650001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0020209 | EST TBL | Est - Tabletten | 1.2.40.0.34.4.17:8315 | GA - aufgehoben | Bano Healthcare GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:D04AX | Andere Antipruriginosa | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708886 | CALCIUMCARBONAT | 1.2.40.0.34.5.221:100000091518 | CALCIUM CARBONATE | active | 0.28 | g | 1.2.40.0.34.5.221:100000091518 | CALCIUM CARBONATE | 0.28 | g | 1.2.40.0.10.1.4.3.4.3.5:100000174052 | Tablette zur Herstellung einer Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:923490001 | 1.2.40.0.34.5.156:1706047 | WEINSÄURE | 1.2.40.0.34.5.221:100000078782 | TARTARIC ACID | active | 0.16 | g | 1.2.40.0.34.5.221:100000078782 | TARTARIC ACID | 0.16 | g | 1.2.40.0.34.5.156:1705775 | ALUMINIUMKALIUMSULFAT | 1.2.40.0.34.5.221:100000077680 | ALUMINIUM POTASSIUM SULFATE | active | 2.4 | g | 1.2.40.0.34.5.221:100000077680 | ALUMINIUM POTASSIUM SULFATE | 2.4 | g | | | | | | | 1.2.40.0.34.5.156:1709134 | CALCIUMACETAT | 1.2.40.0.34.5.221:100000092034 | CALCIUM ACETATE | active | 1.4 | g | 1.2.40.0.34.5.221:100000092034 | CALCIUM ACETATE | 1.4 | g | 1.2.40.0.34.5.156:1708509 | CALCIUMSULFAT | 1.2.40.0.34.5.221:100000090253 | CALCIUM SULFATE | active | 0.2 | g | 1.2.40.0.34.5.221:100000090253 | CALCIUM SULFATE | 0.2 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0020362 | EUCARBON TBL | Eucarbon Tabletten | 1.2.40.0.34.4.17:735895 | GA - registriert | F. Trenka Chem.-Pharm. Fabrik GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A06AB | Kontaktlaxanzien | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712648 | RHEI RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000004221 | RHEI RADIX (EXTRACT) | active | 13.75 | mg | 1.2.40.0.34.5.221:900000004221 | RHEI RADIX (EXTRACT) | 13.75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:7321600002 | 1.2.40.0.34.5.156:7091649 | HOLZKOHLE | 1.2.40.0.34.5.221:900000004484 | WOOD CHARCOAL | active | 180 | mg | 1.2.40.0.34.5.221:900000004484 | WOOD CHARCOAL | 180 | mg | 1.2.40.0.34.5.156:1708673 | SENNAE FOLIUM | 1.2.40.0.34.5.221:100000090680 | SENNAE FOLIUM | active | 105 | mg | 1.2.40.0.34.5.221:100000090680 | SENNAE FOLIUM | 105 | mg | | | | | | | 1.2.40.0.34.5.156:1708592 | SCHWEFEL | 1.2.40.0.34.5.221:100000090444 | SULFUR | active | 50 | mg | 1.2.40.0.34.5.221:100000090444 | SULFUR | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0020385 | EUCILLIN-B SLB | Eucillin "B" - Salbe | 1.2.40.0.34.4.17:7762 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D06AX05 | Bacitracin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709207 | BACITRACIN | 1.2.40.0.34.5.221:100000092135 | BACITRACIN | active | 7500 | IU | 1.2.40.0.34.5.221:100000092135 | BACITRACIN | 7500 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:921123001 | 1.2.40.0.34.5.156:1708738 | DEQUALINIUM CHLORID | 1.2.40.0.34.5.221:100000091069 | DEQUALINIUM CHLORIDE | active | 0.06 | g | 1.2.40.0.34.5.221:100000091069 | DEQUALINIUM CHLORIDE | 0.06 | g | 1.2.40.0.34.5.156:1707843 | DIPHENYLPYRALIN HYDROCHLORID | 1.2.40.0.34.5.221:100000087536 | DIPHENYLPYRALINE HYDROCHLORIDE | active | 0.015 | g | 1.2.40.0.34.5.221:100000087536 | DIPHENYLPYRALINE HYDROCHLORIDE | 0.015 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0020391 | EUCILLIN-B SLB | Eucillin "B" - Salbe | 1.2.40.0.34.4.17:7762 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 150 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:D06AX05 | Bacitracin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709207 | BACITRACIN | 1.2.40.0.34.5.221:100000092135 | BACITRACIN | active | | | 1.2.40.0.34.5.221:100000092135 | BACITRACIN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1708738 | DEQUALINIUM CHLORID | 1.2.40.0.34.5.221:100000091069 | DEQUALINIUM CHLORID | active | | | 1.2.40.0.34.5.221:100000091069 | DEQUALINIUM CHLORID | | | 1.2.40.0.34.5.156:1707843 | DIPHENYLPYRALIN HYDROCHLORID | 1.2.40.0.34.5.221:100000087536 | DIPHENYLPYRALIN HYDROCHLORID | active | | | 1.2.40.0.34.5.221:100000087536 | DIPHENYLPYRALIN HYDROCHLORID | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0021002 | EUSAPRIM TBL | Eusaprim - Tabletten | 1.2.40.0.34.4.17:14247 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01EE01 | Sulfamethoxazol und Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | 80 | mg | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | 80 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122415001 | 1.2.40.0.34.5.156:1709475 | SULFAMETHOXAZOL | 1.2.40.0.34.5.221:100000092618 | SULFAMETHOXAZOLE | active | 400 | mg | 1.2.40.0.34.5.221:100000092618 | SULFAMETHOXAZOLE | 400 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0021545 | FENISTIL DRG 1MG | Fenistil 1 mg - Dragees | 1.2.40.0.34.4.17:12146 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AB03 | Dimetinden | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707840 | DIMETINDEN MALEAT | 1.2.40.0.34.5.221:100000087512 | DIMETINDENE MALEATE | active | 1 | mg | 1.2.40.0.34.5.221:100000087512 | DIMETINDENE MALEATE | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:120511003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0021551 | FENISTIL TR | Fenistil - Tropfen | 1.2.40.0.34.4.17:12147 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | false | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R06AB03 | Dimetinden | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707840 | DIMETINDEN MALEAT | 1.2.40.0.34.5.221:100000087512 | DIMETINDENE MALEATE | active | 10 | mg | 1.2.40.0.34.5.221:100000087512 | DIMETINDENE MALEATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | true | human | 1.2.40.0.34.4.26:122162001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0021657 | FENTRINOL NA-TR | Fentrinol - Nasentropfen | 1.2.40.0.34.4.17:14022 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 12 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AA | Sympathomimetika, rein | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1707772 | AMIDEFRIN MESILAT | 1.2.40.0.34.5.221:100000087202 | AMIDEFRINE MESILATE | active | 1200 | mg | 1.2.40.0.34.5.221:100000087202 | AMIDEFRINE MESILATE | 1200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073794 | Nasentropfen, Lösung | true | human | 1.2.40.0.34.4.26:121003001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0021841 | FERRO-GRADUMET FTBL | Ferro - Gradumet 105 mg Filmtabletten | 1.2.40.0.34.4.17:14076 | GA - zugelassen | Teofarma S.r.l. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B03AA07 | Eisen(II)sulfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705968 | EISEN(II)-SULFAT | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | active | 325 | mg | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | 325 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:120005002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0022792 | FUCIDIN FTBL | Fucidin - Filmtabletten | 1.2.40.0.34.4.17:13998 | GA - zugelassen | Leo Pharma GmbH | true | true | 36 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01XC01 | Fusidinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706178 | NATRIUM FUSIDAT | 1.2.40.0.34.5.221:100000079317 | SODIUM FUSIDATE | active | 250 | mg | 1.2.40.0.34.5.221:100000079317 | SODIUM FUSIDATE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:923329003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0023082 | FURADANTIN RET KPS | Furadantin retard Kapseln | 1.2.40.0.34.4.17:14328 | GA - zugelassen | Amdipharm Limited | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01XE01 | Nitrofurantoin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709377 | NITROFURANTOIN | 1.2.40.0.34.5.221:100000092406 | NITROFURANTOIN | active | 100 | mg | 1.2.40.0.34.5.221:100000092406 | NITROFURANTOIN | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:920914002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0023099 | FURADANTIN RET KPS | Furadantin retard Kapseln | 1.2.40.0.34.4.17:14328 | GA - zugelassen | Amdipharm Limited | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01XE01 | Nitrofurantoin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709377 | NITROFURANTOIN | 1.2.40.0.34.5.221:100000092406 | NITROFURANTOIN | active | 100 | mg | 1.2.40.0.34.5.221:100000092406 | NITROFURANTOIN | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:920914003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0023171 | GALLE-DONAU DRG | Galle - Donau - Dragees | 1.2.40.0.34.4.17:10202 | GA - zugelassen | Phafag Pharma Research & Trading GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:A05AX | Andere Mittel zur Gallentherapie | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705931 | 1-NAPTHYLESSIGSÄURE | 1.2.40.0.34.5.221:100000078271 | 1-NAPHTHALENEACETIC ACID | active | 75 | mg | 1.2.40.0.34.5.221:100000078271 | 1-NAPHTHALENEACETIC ACID | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | false | human | 1.2.40.0.34.4.26:126078003 | 1.2.40.0.34.5.156:13623722 | 1-(4-METHYLPHENYL)ETHYLNICOTINAT | 1.2.40.0.34.5.221:100000178341 | 1-(4-METHYLPHENYL) ETHYL NICOTINATE | active | 37.5 | mg | 1.2.40.0.34.5.221:100000178341 | 1-(4-METHYLPHENYL) ETHYL NICOTINATE | 37.5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0024762 | HAEDENSA SLB | Hädensa - Salbe | 1.2.40.0.34.4.17:2465 | GA - aufgehoben | Merz Pharma Austria GmbH | false | false | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05AX03 | Andere Hämorrhoidenmittel, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | 50 | g | 1.2.40.0.34.5.221:100000091364 | MENTHOL | 50 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:921457002 | 1.2.40.0.34.5.156:1709854 | 5-CHLORCARVACROL | 1.2.40.0.34.5.221:100000080071 | 5-CHLORCARVACROL | active | 1 | g | 1.2.40.0.34.5.221:100000080071 | 5-CHLORCARVACROL | 1 | g | 1.2.40.0.34.5.156:1709356 | ICHTHAMMOLUM | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | active | 10 | g | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | 10 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0024779 | HAEDENSA SLB | Hädensa - Salbe | 1.2.40.0.34.4.17:2465 | GA - aufgehoben | Merz Pharma Austria GmbH | false | false | 42 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05AX03 | Andere Hämorrhoidenmittel, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | 105 | g | 1.2.40.0.34.5.221:100000091364 | MENTHOL | 105 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:921457001 | 1.2.40.0.34.5.156:1709854 | 5-CHLORCARVACROL | 1.2.40.0.34.5.221:100000080071 | 5-CHLORCARVACROL | active | 2.1 | g | 1.2.40.0.34.5.221:100000080071 | 5-CHLORCARVACROL | 2.1 | g | 1.2.40.0.34.5.156:1709356 | ICHTHAMMOLUM | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | active | 21 | g | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | 21 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0024785 | DELTA-HAEDENSA SLB | Delta - Hädensa - Salbe | 1.2.40.0.34.4.17:14326 | GA - aufgehoben | Merz Pharma Austria GmbH | false | false | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05AA04 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | 2.5 | g | 1.2.40.0.34.5.221:100000091364 | MENTHOL | 2.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:121286002 | 1.2.40.0.34.5.156:1708775 | NATRIUM PREDNISOLON M-SULFOBENZOAT | 1.2.40.0.34.5.221:100000091240 | PREDNISOLONE METASULFOBENZOATE SODIUM | active | 0.2355 | g | 1.2.40.0.34.5.221:100000091240 | PREDNISOLONE METASULFOBENZOATE SODIUM | 0.2355 | g | 1.2.40.0.34.5.156:1709854 | 5-CHLORCARVACROL | 1.2.40.0.34.5.221:100000080071 | 5-CHLORCARVACROL | active | 0.01 | g | 1.2.40.0.34.5.221:100000080071 | 5-CHLORCARVACROL | 0.01 | g | | | | | | | 1.2.40.0.34.5.156:1709356 | ICHTHAMMOLUM | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | active | 0.2 | g | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | 0.2 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0024940 | HALOMYCETIN AU-SLB | Halomycetin - Augensalbe | 1.2.40.0.34.4.17:10144 | GA - zugelassen | Wabosan Arzneimittelvertriebs GmbH | true | false | 5 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:S01AA01 | Chloramphenicol | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709547 | CHLORAMPHENICOL | 1.2.40.0.34.5.221:100000092772 | CHLORAMPHENICOL | active | 5 | g | 1.2.40.0.34.5.221:100000092772 | CHLORAMPHENICOL | 5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073772 | Augensalbe | true | human | 1.2.40.0.34.4.26:922910001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0024957 | HALDOL TBL 1MG | Haldol 1 mg - Tabletten | 1.2.40.0.34.4.17:14106 | GA - zugelassen | Essential Pharma Limited | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AD01 | Haloperidol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709494 | HALOPERIDOL | 1.2.40.0.34.5.221:100000092645 | HALOPERIDOL | active | 1 | mg | 1.2.40.0.34.5.221:100000092645 | HALOPERIDOL | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123703002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0024963 | HALDOL TR | Haldol 2 mg/ml Lösung zum Einnehmen | 1.2.40.0.34.4.17:11814 | GA - zugelassen | Essential Pharma Limited | true | false | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:N05AD01 | Haloperidol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709494 | HALOPERIDOL | 1.2.40.0.34.5.221:100000092645 | HALOPERIDOL | active | | | 1.2.40.0.34.5.221:100000092645 | HALOPERIDOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0025106 | HELOPANFLAT DRG | Helopanflat Dragees | 1.2.40.0.34.4.17:14200 | GA - zugelassen | Bano Healthcare GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A09AA02 | Multienzyme (Lipase, Protease etc.) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708384 | SIMETICON | 1.2.40.0.34.5.221:100000089833 | SIMETICONE | active | 42 | mg | 1.2.40.0.34.5.221:100000089833 | SIMETICONE | 42 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | false | human | 1.2.40.0.34.4.26:127486001 | 1.2.40.0.34.5.156:1706275 | PANKREAS(EXTRAKT) | 1.2.40.0.34.5.221:100000079736 | PANCREAS EXTRACT | active | 135 | mg | 1.2.40.0.34.5.221:100000079736 | PANCREAS EXTRACT | 135 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0025514 | HERPOSICC LIPPENSBL | Herposicc - Lippensalbe | 1.2.40.0.34.4.17:6309 | GA - zugelassen | Pharmaselect International Beteiligungs GmbH | true | true | 8 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D02AB | Zink-haltige Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708243 | ZINKOXID | 1.2.40.0.34.5.221:100000089333 | ZINC OXIDE | active | 288 | mg | 1.2.40.0.34.5.221:100000089333 | ZINC OXIDE | 288 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:922832001 | 1.2.40.0.34.5.156:1708383 | BENZOCAIN | 1.2.40.0.34.5.221:100000089829 | BENZOCAINE | active | 112 | mg | 1.2.40.0.34.5.221:100000089829 | BENZOCAINE | 112 | mg | | | | | | | | | | | | 2.16.840.1.113883.6.73:D04AB04 | Benzocain | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0025684 | HEXORAL LSG GURGELN | Hexoral - Lösung zum Gurgeln | 1.2.40.0.34.4.17:14495 | GA - zugelassen | Johnson & Johnson Ges.m.b.H. | true | false | 200 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:A01AB12 | Hexetidin | 1.2.40.0.10.1.4.3.4.3.4:100000073578 | Anwendung am Zahnfleisch | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | 1.2.40.0.10.1.4.3.4.3.4:100000073621 | zur Anwendung im Mund- und Rachenraum | 1.2.40.0.34.5.156:1709419 | HEXETIDIN | 1.2.40.0.34.5.221:100000092531 | HEXETIDIN | active | | | 1.2.40.0.34.5.221:100000092531 | HEXETIDIN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073678 | Lösung zur Anwendung am Zahnfleisch | false | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073691 | Lösung zur Anwendung in der Mundhöhle | 1.2.40.0.10.1.4.3.4.3.5:100000073673 | Gurgellösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0025738 | HIRUDOID SLB | Hirudoid - Salbe | 1.2.40.0.34.4.17:8527 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA01 | Heparinoide | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705406 | MUCOPOLYSACCHARIDPOLYSCHWEFELSÄUREESTER | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | active | 0.12 | g | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | 0.12 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:121004004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0026117 | HUMATIN KPS | Humatin - Kapseln | 1.2.40.0.34.4.17:11902 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 16 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A07AA06 | Paromomycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707441 | PAROMOMYCIN SULFAT | 1.2.40.0.34.5.221:100000085520 | PAROMOMYCIN SULFATE | active | 357.2 | mg | 1.2.40.0.34.5.221:100000082818 | PAROMOMYCIN | 0.3572 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:122523001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0026241 | HYDERGIN TR 1MG/ML | Hydergin 1 mg/ml - Tropfen | 1.2.40.0.34.4.17:6599 | GA - aufgehoben | Alfasigma S.p.A. | false | false | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C04AE01 | Ergoloidmesylat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706283 | DIHYDROERGOCORNIN METHANSULFONAT | 1.2.40.0.34.5.221:100000079764 | DIHYDROERGOCORNINE MESILATE | active | 0.033 | g | 1.2.40.0.34.5.221:100000079764 | DIHYDROERGOCORNINE MESILATE | 0.033 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:125483001 | 1.2.40.0.34.5.156:1706142 | DIHYDROERGOCRYPTIN METHANSULFONAT | 1.2.40.0.34.5.221:100000079201 | DIHYDROERGOCRYPTINE MESILATE | active | 0.033 | g | 1.2.40.0.34.5.221:100000079201 | DIHYDROERGOCRYPTINE MESILATE | 0.033 | g | 1.2.40.0.34.5.156:1708734 | DIHYDROERGOCRISTIN METHANSULFONAT | 1.2.40.0.34.5.221:100000091063 | DIHYDROERGOCRISTINE MESILATE | active | 0.033 | g | 1.2.40.0.34.5.221:100000091063 | DIHYDROERGOCRISTINE MESILATE | 0.033 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0026258 | HYDERGIN TR 1MG/ML | Hydergin 1 mg/ml - Tropfen | 1.2.40.0.34.4.17:6599 | GA - aufgehoben | Alfasigma S.p.A. | false | false | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C04AE01 | Ergoloidmesylat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706283 | DIHYDROERGOCORNIN METHANSULFONAT | 1.2.40.0.34.5.221:100000079764 | DIHYDROERGOCORNINE MESILATE | active | 0.033 | g | 1.2.40.0.34.5.221:100000079764 | DIHYDROERGOCORNINE MESILATE | 0.033 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:125483002 | 1.2.40.0.34.5.156:1706142 | DIHYDROERGOCRYPTIN METHANSULFONAT | 1.2.40.0.34.5.221:100000079201 | DIHYDROERGOCRYPTINE MESILATE | active | 0.033 | g | 1.2.40.0.34.5.221:100000079201 | DIHYDROERGOCRYPTINE MESILATE | 0.033 | g | 1.2.40.0.34.5.156:1708734 | DIHYDROERGOCRISTIN METHANSULFONAT | 1.2.40.0.34.5.221:100000091063 | DIHYDROERGOCRISTINE MESILATE | active | 0.033 | g | 1.2.40.0.34.5.221:100000091063 | DIHYDROERGOCRISTINE MESILATE | 0.033 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0026407 | HYDROCORTONE TBL | Hydrocortone - Tabletten | 1.2.40.0.34.4.17:7483 | GA - zugelassen | Teva B.V. | true | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:H02AB09 | Hydrocortison | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709485 | HYDROCORTISON | 1.2.40.0.34.5.221:100000092635 | HYDROCORTISON | active | | | 1.2.40.0.34.5.221:100000092635 | HYDROCORTISON | | | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0026502 | HYLAK TR FTE | Hylak forte - Tropfen | 1.2.40.0.34.4.17:10835 | GA - zugelassen | Teva B.V. | true | true | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A07FA | Mikrobielle Antidiarrhoika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712677 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:900000004291 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | active | 374.223 | g | 1.2.40.0.34.5.221:900000004291 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | 374.223 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | false | human | 1.2.40.0.34.4.26:922885002 | 1.2.40.0.34.5.156:1707902 | LACTOBACILLUS ACIDOPHILUS (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:100000087825 | LACTOBACILLUS ACIDOPHILUS DSM 4149; AQUAEOUS SUBSTRATE OF METABOLIC PRODUCTS | active | 374.223 | g | 1.2.40.0.34.5.221:100000087825 | LACTOBACILLUS ACIDOPHILUS DSM 4149; AQUAEOUS SUBSTRATE OF METABOLIC PRODUCTS | 374.223 | g | 1.2.40.0.34.5.156:1710225 | ESCHERICHIA COLI (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:900000000456 | ESCHERICHIA COLI (EXTRACT) | active | 748.443 | g | 1.2.40.0.34.5.221:900000000456 | ESCHERICHIA COLI (EXTRACT) | 748.443 | g | | | | | | | 1.2.40.0.34.5.156:1705655 | LACTOBACILLUS HELVETICUS (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:100000077073 | LACTOBACILLUS HELVETICUS | active | 1496.88 | g | 1.2.40.0.34.5.221:100000077073 | LACTOBACILLUS HELVETICUS | 1496.88 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0026519 | HYLAK TR FTE | Hylak forte - Tropfen | 1.2.40.0.34.4.17:10835 | GA - zugelassen | Teva B.V. | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A07FA | Mikrobielle Antidiarrhoika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712677 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:900000004291 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | active | 1247.41 | g | 1.2.40.0.34.5.221:900000004291 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | 1247.41 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | false | human | 1.2.40.0.34.4.26:922885001 | 1.2.40.0.34.5.156:1707902 | LACTOBACILLUS ACIDOPHILUS (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:100000087825 | LACTOBACILLUS ACIDOPHILUS DSM 4149; AQUAEOUS SUBSTRATE OF METABOLIC PRODUCTS | active | 1247.41 | g | 1.2.40.0.34.5.221:100000087825 | LACTOBACILLUS ACIDOPHILUS DSM 4149; AQUAEOUS SUBSTRATE OF METABOLIC PRODUCTS | 1247.41 | g | 1.2.40.0.34.5.156:1710225 | ESCHERICHIA COLI (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:900000000456 | ESCHERICHIA COLI (EXTRACT) | active | 2494.81 | g | 1.2.40.0.34.5.221:900000000456 | ESCHERICHIA COLI (EXTRACT) | 2494.81 | g | | | | | | | 1.2.40.0.34.5.156:1705655 | LACTOBACILLUS HELVETICUS (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:100000077073 | LACTOBACILLUS HELVETICUS | active | 4989.6 | g | 1.2.40.0.34.5.221:100000077073 | LACTOBACILLUS HELVETICUS | 4989.6 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0027393 | INDERAL FTBL 10MG | Inderal 10 mg - Filmtabletten | 1.2.40.0.34.4.17:13294 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AA05 | Propranolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708790 | PROPRANOLOL HYDROCHLORID | 1.2.40.0.34.5.221:100000091292 | PROPRANOLOL HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000091292 | PROPRANOLOL HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:120862002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0027430 | INDOCID KPS 25MG | Indocid 25 mg Kapseln | 1.2.40.0.34.4.17:12789 | GA - zugelassen | H.A.C. Pharma | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB01 | Indometacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709537 | INDOMETACIN | 1.2.40.0.34.5.221:100000092758 | INDOMETACIN | active | 25 | mg | 1.2.40.0.34.5.221:100000092758 | INDOMETACIN | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:124779001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0027594 | INOTYOL SLB | Inotyol - Salbe | 1.2.40.0.34.4.17:2484 | GA - zugelassen | C. Brady GmbH & Co. KG | true | true | 25 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D02AB | Zink-haltige Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708243 | ZINKOXID | 1.2.40.0.34.5.221:100000089333 | ZINC OXIDE | active | 3.75 | g | 1.2.40.0.34.5.221:100000089333 | ZINC OXIDE | 3.75 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:923141001 | 1.2.40.0.34.5.156:1710324 | HAMAMELIDIS FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000555 | HAMAMELIDIS FOLIUM (EXTRACT) | active | 0.25 | g | 1.2.40.0.34.5.221:900000000555 | HAMAMELIDIS FOLIUM (EXTRACT) | 0.25 | g | 1.2.40.0.34.5.156:1709356 | ICHTHAMMOLUM | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | active | 0.25 | g | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | 0.25 | g | 2.16.840.1.113883.6.73:D05AA | Teere | | | | | 1.2.40.0.34.5.156:1709259 | TITANDIOXID | 1.2.40.0.34.5.221:100000092217 | TITANIUM DIOXIDE | active | 1.25 | g | 1.2.40.0.34.5.221:100000092217 | TITANIUM DIOXIDE | 1.25 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0027602 | INOTYOL SLB | Inotyol - Salbe | 1.2.40.0.34.4.17:2484 | GA - zugelassen | C. Brady GmbH & Co. KG | true | true | 50 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D02AB | Zink-haltige Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1710324 | HAMAMELIDIS FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000555 | HAMAMELIDIS FOLIUM (EXTRACT) | active | 0.5 | g | 1.2.40.0.34.5.221:900000000555 | HAMAMELIDIS FOLIUM (EXTRACT) | 0.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:923141002 | 1.2.40.0.34.5.156:1708243 | ZINKOXID | 1.2.40.0.34.5.221:100000089333 | ZINC OXIDE | active | 7.5 | g | 1.2.40.0.34.5.221:100000089333 | ZINC OXIDE | 7.5 | g | 1.2.40.0.34.5.156:1709356 | ICHTHAMMOLUM | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | active | 0.5 | g | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | 0.5 | g | 2.16.840.1.113883.6.73:D05AA | Teere | | | | | 1.2.40.0.34.5.156:1709259 | TITANDIOXID | 1.2.40.0.34.5.221:100000092217 | TITANIUM DIOXIDE | active | 2.5 | g | 1.2.40.0.34.5.221:100000092217 | TITANIUM DIOXIDE | 2.5 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0028524 | IROMIN TBL | Iromin - Tabletten | 1.2.40.0.34.4.17:6200 | GA - aufgehoben | Dr. A. & L. Schmidgall GmbH & Co. KG | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BA15 | Carbasalat calcium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706552 | CARBASALAT CALCIUM | 1.2.40.0.34.5.221:100000081316 | CARBASALATE CALCIUM | active | 500 | mg | 1.2.40.0.34.5.221:100000081316 | CARBASALATE CALCIUM | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:128878001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0028866 | ISOPTIN AMP 5MG/2ML | Isoptin 5 mg - Ampullen | 1.2.40.0.34.4.17:1-12539 | GA - zugelassen | Viatris Austria GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:122675001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0028895 | ISOPTIN DRG 80MG | Isoptin 80 mg - Dragees | 1.2.40.0.34.4.17:1-14265 | GA - aufgehoben | Viatris Austria GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 80 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 80 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:122577001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0028903 | ISOPTIN DRG 80MG | Isoptin 80 mg - Dragees | 1.2.40.0.34.4.17:1-14265 | GA - aufgehoben | Viatris Austria GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 80 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 80 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:122577002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0029392 | KALIORAL FRE PLV 8G | Kalioral "Fresenius" - Pulver | 1.2.40.0.34.4.17:12132 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:A12BA30 | Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709470 | CITRONENSÄURE | 1.2.40.0.34.5.221:100000092612 | CITRIC ACID | active | 1.874 | g | 1.2.40.0.34.5.221:100000092612 | CITRIC ACID | 1.874 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073364 | Pulver zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:123557001 | 1.2.40.0.34.5.156:1709004 | KALIUMCITRAT | 1.2.40.0.34.5.221:100000091779 | POTASSIUM CITRATE | active | 1.94 | g | 1.2.40.0.34.5.221:100000091779 | POTASSIUM CITRATE | 1.94 | g | 1.2.40.0.34.5.156:1706312 | KALIUMHYDROGENCARBONAT | 1.2.40.0.34.5.221:100000079863 | POTASSIUM HYDROGEN CARBONATE | active | 2 | g | 1.2.40.0.34.5.221:100000079863 | POTASSIUM HYDROGEN CARBONATE | 2 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0029529 | KAMILLOSAN TR | Kamillosan-Flüssigkeit | 1.2.40.0.34.4.17:1660 | GA - aufgehoben | MEDA Pharma GmbH | false | false | 500 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D02AX | Andere Emollientia und Hautschutzmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706736 | LEVOMENOL | 1.2.40.0.34.5.221:100000082277 | LEVOMENOL | active | 0.09 | g | 1.2.40.0.34.5.221:100000082277 | LEVOMENOL | 0.09 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073950 | Flüssigkeit zur Anwendung in der Mundhöhle | false | human | 1.2.40.0.34.4.26:120642004 | 1.2.40.0.34.5.156:1710480 | MATRICARIAE FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000000713 | MATRICARIAE FLOS (EXTRACT) | active | 99.1835 | g | 1.2.40.0.34.5.221:900000000713 | MATRICARIAE FLOS (EXTRACT) | 99.1835 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073854 | Flüssigkeit zur Herstellung eines Dampfs zur Inhalation | 1.2.40.0.10.1.4.3.4.3.5:100000073645 | Flüssigkeit zum Einnehmen | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073717 | Flüssigkeit zur Anwendung auf der Haut | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0029699 | KEMADRIN TBL 5MG | KEMADRIN Tabletten | 1.2.40.0.34.4.17:10809 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N04AA04 | Procyclidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707273 | PROCYCLIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000085102 | PROCYCLIDINE HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000085102 | PROCYCLIDINE HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122440003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0029908 | KINDER LUUF BLS | Kinder Luuf Balsam | 1.2.40.0.34.4.17:740562 | GA - registriert | Apomedica Pharmazeutische Produkte Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073530 | Mehrdosenbehältnis | 2.16.840.1.113883.6.73:R05X | Andere Kombinationspräparate gegen Erkältungskrankheiten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | 1.2.40.0.34.5.156:1709094 | TEREBINTHINAE AETHEROLEUM | 1.2.40.0.34.5.221:100000091958 | TURPENTINE OIL | active | 1500 | mg | 1.2.40.0.34.5.221:100000091958 | TURPENTINE OIL | 1500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073862 | Salbe zur Herstellung eines Dampfs zur Inhalation | false | human | 1.2.40.0.34.4.26:959098001 | 1.2.40.0.34.5.156:1706333 | EUCALYPTI AETHEROLEUM | 1.2.40.0.34.5.221:100000091979 | EUCALYPTUS OIL | active | 450 | mg | 1.2.40.0.34.5.221:100000091979 | EUCALYPTUS OIL | 450 | mg | 1.2.40.0.34.5.156:7255602 | LEVOMENTHOL | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | active | 825 | mg | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | 825 | mg | | | | | | | 1.2.40.0.34.5.156:1709036 | RACEMISCHER CAMPHER | 1.2.40.0.34.5.221:100000091848 | CAMPHOR, RACEMIC | active | 150 | g | 1.2.40.0.34.5.221:100000091848 | CAMPHOR, RACEMIC | 150 | g | 1.2.40.0.34.5.156:1709002 | THYMOL | 1.2.40.0.34.5.221:100000091776 | THYMOL | active | 7.5 | g | 1.2.40.0.34.5.221:100000091776 | THYMOL | 7.5 | g | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000137702 | Behältnis | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0030314 | KUEHLPREDNON SLB | Kühlprednon - Salbe | 1.2.40.0.34.4.17:13352 | GA - aufgehoben | G.L. Pharma GmbH | false | false | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:D07AA03 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 0.16 | g | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 0.16 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:127572002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0030320 | KUEHLPREDNON SLB | Kühlprednon - Salbe | 1.2.40.0.34.4.17:13352 | GA - aufgehoben | G.L. Pharma GmbH | false | false | 50 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:D07AA03 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 0.16 | g | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 0.16 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:127572001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0030389 | LACTAT OR WABO FL | Lactat - oral "Wabo" flüssig | 1.2.40.0.34.4.17:13377 | GA - zugelassen | Wabosan Arzneimittelvertriebs GmbH | true | false | 250 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:G04BX | Andere Urologika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708455 | NATRIUMLACTAT | 1.2.40.0.34.5.221:100000090101 | SODIUM LACTATE | active | 6666.75 | g | 1.2.40.0.34.5.221:100000090101 | SODIUM LACTATE | 6666.75 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:923973001 | 1.2.40.0.34.5.156:1709182 | SORBITOL | 1.2.40.0.34.5.221:100000092096 | SORBITOL (E420) | active | 1400 | g | 1.2.40.0.34.5.221:100000092096 | SORBITOL (E420) | 1400 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0031118 | LASIX AMP 20MG 2ML BP5X5 | Lasix 20 mg/2 ml Ampullen | 1.2.40.0.34.4.17:12584 | GA - zugelassen | Sanofi-Aventis GmbH | true | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C03CA01 | Furosemid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1707308 | NATRIUM FUROSEMID | 1.2.40.0.34.5.221:100000085198 | FUROSEMIDE SODIUM | active | 21.328 | mg | 1.2.40.0.34.5.221:100000085198 | FUROSEMIDE SODIUM | 21.328 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:124724004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0031130 | LASIX TBL 40MG | Lasix 40 mg Tabletten | 1.2.40.0.34.4.17:12585 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03CA01 | Furosemid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:121649002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0031294 | LECICARBON SUPP | Lecicarbon - Zäpfchen | 1.2.40.0.34.4.17:3437 | GA - zugelassen | C. Brady GmbH & Co. KG | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:A06AX02 | Kohlendioxid-freisetzende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1706182 | NATRIUMHYDROGENCARBONAT | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | active | 0.54 | g | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | 0.54 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | false | human | 1.2.40.0.34.4.26:128754003 | 1.2.40.0.34.5.156:1708363 | KALIUMHYDROGENTARTRAT | 1.2.40.0.34.5.221:100000089671 | POTASSIUM HYDROGEN TARTRATE | active | 0.9 | g | 1.2.40.0.34.5.221:100000089671 | POTASSIUM HYDROGEN TARTRATE | 0.9 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0031302 | LECICARBON SUPP | Lecicarbon - Zäpfchen | 1.2.40.0.34.4.17:3437 | GA - zugelassen | C. Brady GmbH & Co. KG | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:A06AX02 | Kohlendioxid-freisetzende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1706182 | NATRIUMHYDROGENCARBONAT | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | active | 0.54 | g | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | 0.54 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | false | human | 1.2.40.0.34.4.26:128754001 | 1.2.40.0.34.5.156:1708363 | KALIUMHYDROGENTARTRAT | 1.2.40.0.34.5.221:100000089671 | POTASSIUM HYDROGEN TARTRATE | active | 0.9 | g | 1.2.40.0.34.5.221:100000089671 | POTASSIUM HYDROGEN TARTRATE | 0.9 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0031331 | LEDERMIX PASTE | Ledermix Paste | 1.2.40.0.34.4.17:12356 | GA - zugelassen | Esteve Pharmaceuticals GmbH | true | true | 5 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:A01AC01 | Triamcinolon | 1.2.40.0.10.1.4.3.4.3.4:900000000015 | zur Wurzelkanalbehandlung | | | | | 1.2.40.0.34.5.156:1708563 | TRIAMCINOLON ACETONID | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | active | 0.05 | g | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | 0.05 | g | 1.2.40.0.10.1.4.3.4.3.5:900000000034 | Dentalpaste (alt) | true | human | 1.2.40.0.34.4.26:127411001 | 1.2.40.0.34.5.156:1708021 | DEMECLOCYCLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000088394 | DEMECLOCYCLINE HYDROCHLORIDE | active | 0.15 | g | 1.2.40.0.34.5.221:100000088394 | DEMECLOCYCLINE HYDROCHLORIDE | 0.15 | g | | | | | | | | | | | | 2.16.840.1.113883.6.73:A01AB13 | Tetracyclin | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0031696 | LEUKERAN FTBL 2MG | Leukeran 2 mg - Filmtabletten | 1.2.40.0.34.4.17:10754 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L01AA02 | Chlorambucil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706605 | CHLORAMBUCIL | 1.2.40.0.34.5.221:100000081577 | CHLORAMBUCIL | active | 2 | mg | 1.2.40.0.34.5.221:100000081577 | CHLORAMBUCIL | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122421001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0032649 | LUUF AETH.OELE BLS | Luuf ätherische Öle Balsam | 1.2.40.0.34.4.17:740563 | GA - registriert | Apomedica Pharmazeutische Produkte Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073530 | Mehrdosenbehältnis | 2.16.840.1.113883.6.73:R05X | Andere Kombinationspräparate gegen Erkältungskrankheiten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | 825 | mg | 1.2.40.0.34.5.221:100000091364 | MENTHOL | 825 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073862 | Salbe zur Herstellung eines Dampfs zur Inhalation | false | human | 1.2.40.0.34.4.26:959089001 | 1.2.40.0.34.5.156:1709094 | TEREBINTHINAE AETHEROLEUM | 1.2.40.0.34.5.221:100000091958 | TURPENTINE OIL | active | 1500 | mg | 1.2.40.0.34.5.221:100000091958 | TURPENTINE OIL | 1500 | mg | 1.2.40.0.34.5.156:1706333 | EUCALYPTI AETHEROLEUM | 1.2.40.0.34.5.221:100000091979 | EUCALYPTUS OIL | active | 1500 | mg | 1.2.40.0.34.5.221:100000091979 | EUCALYPTUS OIL | 1500 | mg | 2.16.840.1.113883.6.73:R05FA | Opium-Derivate und Expektoranzien | | | | | 1.2.40.0.34.5.156:7255602 | LEVOMENTHOL | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | active | 825 | mg | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | 825 | mg | 1.2.40.0.34.5.156:1707968 | PINI PUMILIONIS AETHEROLEUM | 1.2.40.0.34.5.221:100000088075 | PINUS PUMILIO OIL | active | 900 | mg | 1.2.40.0.34.5.221:100000088075 | PINUS PUMILIO OIL | 900 | mg | 1.2.40.0.34.5.156:1706212 | PINI SILVESTRIS AETHEROLEUM | 1.2.40.0.34.5.221:100000079470 | PINUS SYLVESTRIS OIL | active | 750 | mg | 1.2.40.0.34.5.221:100000079470 | PINUS SYLVESTRIS OIL | 750 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000137702 | Behältnis | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0033318 | MARCOUMAR TBL 3MG | Marcoumar - Tabletten | 1.2.40.0.34.4.17:8096 | GA - zugelassen | Viatris Austria GmbH | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B01AA04 | Phenprocoumon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706733 | PHENPROCOUMON | 1.2.40.0.34.5.221:100000082261 | PHENPROCOUMON | active | 3 | mg | 1.2.40.0.34.5.221:100000082261 | PHENPROCOUMON | 3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:100000003909 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0033376 | MARIAZELLER MA-TR | Mariazeller - Magentropfen | 1.2.40.0.34.4.17:276 | GA - aufgehoben | Apotheke und Drogerie "Zur Gnadenmutter" Mag. pharm. Dr. Angelika Riffel e.U. | false | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073512 | Tropfbehältnis | 2.16.840.1.113883.6.73:A15 | Appetit stimulierende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709974 | AURANTII AMARI FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000000205 | AURANTII AMARI FLOS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000205 | AURANTII AMARI FLOS (EXTRACT) | | | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | false | human | 1.2.40.0.34.4.26:920256002 | 1.2.40.0.34.5.156:1710131 | CNICI BENEDICTI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000000362 | CNICI BENEDICTI HERBA (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000362 | CNICI BENEDICTI HERBA (EXTRACT) | | | 1.2.40.0.34.5.156:1709970 | AURANTII AMARI EPICARPIUM ET MESOCARPIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000201 | AURANTII AMARI EPICARPIUM ET MESOCARPIUM (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000201 | AURANTII AMARI EPICARPIUM ET MESOCARPIUM (EXTRACT) | | | 2.16.840.1.113883.6.73:A09 | Digestiva, Inkl. Enzyme | | | | | 1.2.40.0.34.5.156:1709728 | ZINGIBERIS RHIZOMA (AUSZUG) | 1.2.40.0.34.5.221:100000124338 | GINGER EXTRACT | active | | | 1.2.40.0.34.5.221:100000124338 | GINGER EXTRACT | | | 1.2.40.0.34.5.156:1712606 | CINCHONAE CORTEX (AUSZUG) | 1.2.40.0.34.5.221:900000004076 | CINCHONAE CORTEX (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000004076 | CINCHONAE CORTEX (EXTRACT) | | | 1.2.40.0.34.5.156:1710112 | CINNAMOMI CORTEX (AUSZUG) | 1.2.40.0.34.5.221:900000000343 | CINNAMOMI CORTEX (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000343 | CINNAMOMI CORTEX (EXTRACT) | | | | | | | 1.2.40.0.34.5.156:1709982 | AURANTII FRUCTUS IMMATURUS (AUSZUG) | 1.2.40.0.34.5.221:900000000213 | AURANTII FRUCTUS IMMATURUS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000213 | AURANTII FRUCTUS IMMATURUS (EXTRACT) | | | 1.2.40.0.34.5.156:1710494 | MENYANTHIDIS TRIFOLIATAE FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000727 | MENYANTHIDIS TRIFOLIATAE FOLIUM (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000727 | MENYANTHIDIS TRIFOLIATAE FOLIUM (EXTRACT) | | | | | | | 1.2.40.0.34.5.156:1710146 | CORIANDRI FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000000377 | CORIANDRI FRUCTUS (EXTRACT) | active | 1.2.40.0.34.5.221:900000000377 | CORIANDRI FRUCTUS (EXTRACT) | 1.2.40.0.34.5.156:1710530 | MYRISTICAE SEMEN (AUSZUG) | 1.2.40.0.34.5.221:900000000763 | MYRISTICAE SEMEN (EXTRACT) | active | 1.2.40.0.34.5.221:900000000763 | MYRISTICAE SEMEN (EXTRACT) | 1.2.40.0.34.5.156:1710480 | MATRICARIAE FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000000713 | MATRICARIAE FLOS (EXTRACT) | active | 1.2.40.0.34.5.221:900000000713 | MATRICARIAE FLOS (EXTRACT) | 1.2.40.0.34.5.156:1710379 | IVAE MOSCHATAE HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000000610 | IVAE MOSCHATAE HERBA (EXTRACT) | active | 1.2.40.0.34.5.221:900000000610 | IVAE MOSCHATAE HERBA (EXTRACT) | 1.2.40.0.34.5.156:1710732 | SANTALI RUBRI LIGNUM (AUSZUG) | 1.2.40.0.34.5.221:900000000966 | SANTALI RUBRI LIGNUM (EXTRACT) | active | 1.2.40.0.34.5.221:900000000966 | SANTALI RUBRI LIGNUM (EXTRACT) | 1.2.40.0.34.5.156:1709865 | ABSINTHII HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000000094 | ABSINTHII HERBA (EXTRACT) | active | 1.2.40.0.34.5.221:900000000094 | ABSINTHII HERBA (EXTRACT) | 1.2.40.0.34.5.156:1710487 | MELISSAE FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000720 | MELISSAE FOLIUM (EXTRACT) | active | 1.2.40.0.34.5.221:900000000720 | MELISSAE FOLIUM (EXTRACT) | 1.2.40.0.34.5.156:1705433 | CENTAURII HERBA (AUSZUG) | 1.2.40.0.34.5.221:100000076318 | CENTAURY EXTRACT | active | 1.2.40.0.34.5.221:100000076318 | CENTAURY EXTRACT | 1.2.40.0.34.5.156:1710068 | CARYOPHYLLI FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000000299 | CARYOPHYLLI FLOS (EXTRACT) | active | 1.2.40.0.34.5.221:900000000299 | CARYOPHYLLI FLOS (EXTRACT) | 1.2.40.0.34.5.156:1710099 | CHAMOMILLAE ROMANAE FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000000330 | CHAMOMILLAE ROMANAE FLOS (EXTRACT) | active | 1.2.40.0.34.5.221:900000000330 | CHAMOMILLAE ROMANAE FLOS (EXTRACT) | 1.2.40.0.34.5.156:1710386 | JUNIPERI LIGNUM (AUSZUG) | 1.2.40.0.34.5.221:900000000617 | JUNIPERI LIGNUM (EXTRACT) | active | 1.2.40.0.34.5.221:900000000617 | JUNIPERI LIGNUM (EXTRACT) | 1.2.40.0.34.5.156:1710301 | GENTIANAE RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000000532 | GENTIANAE RADIX (EXTRACT) | active | 1.2.40.0.34.5.221:900000000532 | GENTIANAE RADIX (EXTRACT) | 1.2.40.0.34.5.156:1709981 | AURANTII FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000212 | AURANTII FOLIUM (EXTRACT) | active | 1.2.40.0.34.5.221:900000000212 | AURANTII FOLIUM (EXTRACT) | 1.2.40.0.34.5.156:1712634 | MILLEFOLII HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000004178 | MILLEFOLII HERBA (EXTRACT) | active | 1.2.40.0.34.5.221:900000004178 | MILLEFOLII HERBA (EXTRACT) | 1.2.40.0.34.5.156:1710279 | GALANGAE RHIZOMA (AUSZUG) | 1.2.40.0.34.5.221:900000000510 | GALANGAE RHIZOMA (EXTRACT) | active | 1.2.40.0.34.5.221:900000000510 | GALANGAE RHIZOMA (EXTRACT) | 1.2.40.0.34.5.156:1710318 | GUAIACI LIGNUM (AUSZUG) | 1.2.40.0.34.5.221:900000000549 | GUAIACI LIGNUM (AUSZUG) | active | 1.2.40.0.34.5.221:900000000549 | GUAIACI LIGNUM (AUSZUG) | 1.2.40.0.34.5.156:1710060 | CARDAMOMI FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000000291 | CARDAMOMI FRUCTUS (EXTRACT) | active | 1.2.40.0.34.5.221:900000000291 | CARDAMOMI FRUCTUS (EXTRACT) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0034163 | MESTINON DRG 60MG | Mestinon - Dragees | 1.2.40.0.34.4.17:8485 | GA - zugelassen | Viatris Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N07AA02 | Pyridostigmin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709039 | PYRIDOSTIGMIN BROMID | 1.2.40.0.34.5.221:100000091854 | PYRIDOSTIGMINE BROMIDE | active | 60 | mg | 1.2.40.0.34.5.221:100000091854 | PYRIDOSTIGMINE BROMIDE | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:124093002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0034186 | MESTINON DRG 60MG | Mestinon - Dragees | 1.2.40.0.34.4.17:8485 | GA - zugelassen | Viatris Austria GmbH | true | true | 150 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N07AA02 | Pyridostigmin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709039 | PYRIDOSTIGMIN BROMID | 1.2.40.0.34.5.221:100000091854 | PYRIDOSTIGMINE BROMIDE | active | 60 | mg | 1.2.40.0.34.5.221:100000091854 | PYRIDOSTIGMINE BROMIDE | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:124093001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0034660 | MIDRO TEE | Midro - Tee | 1.2.40.0.34.4.17:14744 | GA - zugelassen | Midro Lörrach GmbH | true | true | 70 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:A06AB | Kontaktlaxanzien | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708673 | SENNAE FOLIUM | 1.2.40.0.34.5.221:100000090680 | SENNAE FOLIUM | active | 4812.5 | g | 1.2.40.0.34.5.221:100000090680 | SENNAE FOLIUM | 4812.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073370 | Arzneitee | true | human | 1.2.40.0.34.4.26:124547001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0035145 | MOGADON TBL | Mogadon 5 mg - Tabletten | 1.2.40.0.34.4.17:13096 | GA - zugelassen | Viatris Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05CD02 | Nitrazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708998 | NITRAZEPAM | 1.2.40.0.34.5.221:100000091767 | NITRAZEPAM | active | 5 | mg | 1.2.40.0.34.5.221:100000091767 | NITRAZEPAM | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120841001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0035151 | MOGADON TBL | Mogadon 5 mg - Tabletten | 1.2.40.0.34.4.17:13096 | GA - zugelassen | Viatris Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05CD02 | Nitrazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708998 | NITRAZEPAM | 1.2.40.0.34.5.221:100000091767 | NITRAZEPAM | active | 5 | mg | 1.2.40.0.34.5.221:100000091767 | NITRAZEPAM | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120841002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0035398 | MONTANA HAUSTR | MONTANA HAUSTROPFEN Flüssigkeit zum Einnehmen | 1.2.40.0.34.4.17:738049 | GA - registriert | Pharmonta Dr. Fischer GmbH | true | true | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A15 | Appetit stimulierende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709272 | MENTHAE PIPERITAE AETHEROLEUM | 1.2.40.0.34.5.221:100000092241 | PEPPERMINT OIL | active | | | 1.2.40.0.34.5.221:100000092241 | PEPPERMINT OIL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073645 | Flüssigkeit zum Einnehmen | true | human | 1.2.40.0.34.4.26:958261003 | 1.2.40.0.34.5.156:1712632 | LUPULI FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000004166 | LUPULI FLOS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000004166 | LUPULI FLOS (EXTRACT) | | | 1.2.40.0.34.5.156:1710066 | CARVI FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000000297 | CARVI FRUCTUS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000297 | CARVI FRUCTUS (EXTRACT) | | | | | | | | | 1.2.40.0.34.5.156:1709970 | AURANTII AMARI EPICARPIUM ET MESOCARPIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000201 | AURANTII AMARI EPICARPIUM ET MESOCARPIUM (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000201 | AURANTII AMARI EPICARPIUM ET MESOCARPIUM (EXTRACT) | | | 1.2.40.0.34.5.156:1710112 | CINNAMOMI CORTEX (AUSZUG) | 1.2.40.0.34.5.221:900000000343 | CINNAMOMI CORTEX (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000343 | CINNAMOMI CORTEX (EXTRACT) | | | 1.2.40.0.34.5.156:1710301 | GENTIANAE RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000000532 | GENTIANAE RADIX (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000532 | GENTIANAE RADIX (EXTRACT) | | | | | | | 1.2.40.0.34.5.156:1710813 | TARAXACI RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000001048 | TARAXACI RADIX (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000001048 | TARAXACI RADIX (EXTRACT) | | | 1.2.40.0.34.5.156:1712761 | MISCHEXTRAKT | 1.2.40.0.34.5.221:900000004454 | MIXED EXTRACT | active | 50 | ml | 1.2.40.0.34.5.221:900000004454 | MIXED EXTRACT | 50 | ml | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0035955 | MULTODRIN SLB | Multodrin - Salbe | 1.2.40.0.34.4.17:13232 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07XB05 | Dexamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709464 | DEXAMETHASON | 1.2.40.0.34.5.221:100000092605 | DEXAMETHASONE | active | 0.015 | g | 1.2.40.0.34.5.221:100000092605 | DEXAMETHASONE | 0.015 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:127201001 | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 0.225 | g | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 0.225 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0036067 | MYCOSTATIN SUS OR | Mycostatin - orale Suspension | 1.2.40.0.34.4.17:10729 | GA - zugelassen | Dermapharm GmbH | true | true | 24 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A07AA02 | Nystatin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708425 | NYSTATIN | 1.2.40.0.34.5.221:100000089986 | NYSTATIN | active | 2520000 | IU | 1.2.40.0.34.5.221:100000089986 | NYSTATIN | 2520000 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:122563002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0036127 | MYDRIATICUM AGE AU-TR | Mydriaticum "Agepha" 0,5% - Augentropfen | 1.2.40.0.34.4.17:12970 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:S01FA06 | Tropicamid | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709092 | TROPICAMID | 1.2.40.0.34.5.221:100000091954 | TROPICAMIDE | active | 0.5 | mg | 1.2.40.0.34.5.221:100000091954 | TROPICAMIDE | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:129351002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0036245 | MYLERAN FTBL 2MG | Myleran 2 mg Filmtabletten | 1.2.40.0.34.4.17:10775 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L01AB01 | Busulfan | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707329 | BUSULFAN | 1.2.40.0.34.5.221:100000085245 | BUSULFAN | active | 2 | mg | 1.2.40.0.34.5.221:100000085245 | BUSULFAN | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122425001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0036446 | MYSOLINE TBL | Mysoline 250 mg Tabletten | 1.2.40.0.34.4.17:7676 | GA - zugelassen | SANOVA Pharma GesmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AA03 | Primidon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706620 | PRIMIDON | 1.2.40.0.34.5.221:100000081656 | PRIMIDONE | active | 250 | mg | 1.2.40.0.34.5.221:100000081656 | PRIMIDONE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129778001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0037049 | NEDA FRWUERFEL | Neda-Früchtewürfel | 1.2.40.0.34.4.17:7436 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 15 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A06AB06 | Sennoside | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708673 | SENNAE FOLIUM | 1.2.40.0.34.5.221:100000090680 | SENNAE FOLIUM | active | 0.5 | g | 1.2.40.0.34.5.221:100000090680 | SENNAE FOLIUM | 0.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073684 | Kautablette | true | human | 1.2.40.0.34.4.26:122934001 | 1.2.40.0.34.5.156:1712672 | SENNAE FRUCTUS | 1.2.40.0.34.5.221:900000004286 | SENNAE FRUCTUS | active | 0.5 | g | 1.2.40.0.34.5.221:900000004286 | SENNAE FRUCTUS | 0.5 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0037138 | NEO-ANGIN PAS | Neo - angin - Pastillen | 1.2.40.0.34.4.17:13315 | GA - zugelassen | M.C.M. Klosterfrau Healthcare GmbH | true | true | 24 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R02AA20 | Verschiedene | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707726 | AMYLMETACRESOL | 1.2.40.0.34.5.221:100000086938 | AMYLMETACRESOL | active | 0.6 | mg | 1.2.40.0.34.5.221:100000086938 | AMYLMETACRESOL | 0.6 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073704 | Pastille | false | human | 1.2.40.0.34.4.26:126156001 | 1.2.40.0.34.5.156:7255602 | LEVOMENTHOL | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | active | 5.9 | mg | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | 5.9 | mg | 1.2.40.0.34.5.156:1709393 | 2,4-DICHLORBENZYLALKOHOL | 1.2.40.0.34.5.221:100000092427 | DICHLOROBENZYL ALCOHOL | active | 1.2 | mg | 1.2.40.0.34.5.221:100000092427 | DICHLOROBENZYL ALCOHOL | 1.2 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0037262 | NEO-EMEDYL DRG | Neo - Emedyl - Dragees | 1.2.40.0.34.4.17:12288 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AA61 | Dimenhydrinat, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708366 | COFFEIN | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | active | 50 | mg | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:124704001 | 1.2.40.0.34.5.156:1709065 | DIMENHYDRINAT | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | active | 50 | mg | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0037799 | NERVENRUH FTE DRG | Nervenruh forte - Dragees | 1.2.40.0.34.4.17:736028 | GA - registriert | M.C.M. Klosterfrau Healthcare GmbH | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05CX | Hypnotika und Sedativa in Kombination, exkl. Barbiturate | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712632 | LUPULI FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000004166 | LUPULI FLOS (EXTRACT) | active | 15 | mg | 1.2.40.0.34.5.221:900000004166 | LUPULI FLOS (EXTRACT) | 15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | false | human | 1.2.40.0.34.4.26:7731069002 | 1.2.40.0.34.5.156:1712638 | PASSIFLORAE HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000004191 | PASSIFLORAE HERBA (EXTRACT) | active | 18 | mg | 1.2.40.0.34.5.221:900000004191 | PASSIFLORAE HERBA (EXTRACT) | 18 | mg | 1.2.40.0.34.5.156:1710857 | VALERIANAE RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000001092 | VALERIANAE RADIX (EXTRACT) | active | 30 | mg | 1.2.40.0.34.5.221:900000001092 | VALERIANAE RADIX (EXTRACT) | 30 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0037931 | NEUROBION AMP 3ML | Neurobion - Ampullen | 1.2.40.0.34.4.17:11892 | GA - zugelassen | P&G Health Germany GmbH | true | true | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A11DB | Vitamin-B1 in Kombination mit Vitamin-B6 und/oder Vitamin-B12 | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | 1 | mg | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:122900001 | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 100 | mg | 1.2.40.0.34.5.156:1708752 | THIAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0037948 | NEUROBION AMP 3ML BP5X3 | Neurobion - Ampullen | 1.2.40.0.34.4.17:11892 | GA - zugelassen | P&G Health Germany GmbH | true | false | 15 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A11DB | Vitamin-B1 in Kombination mit Vitamin-B6 und/oder Vitamin-B12 | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | 1 | mg | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:122900002 | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 100 | mg | 1.2.40.0.34.5.156:1708752 | THIAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0037954 | NEUROBION DRG FTE | Neurobion forte - Dragees | 1.2.40.0.34.4.17:13292 | GA - zugelassen | P&G Health Belgium | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:A11DB | Vitamin-B1 in Kombination mit Vitamin-B6 und/oder Vitamin-B12 | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | | | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1708059 | THIAMIN DISULFID | 1.2.40.0.34.5.221:100000088589 | THIAMIN DISULFID | active | | | 1.2.40.0.34.5.221:100000088589 | THIAMIN DISULFID | | | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXIN HYDROCHLORID | active | | | 1.2.40.0.34.5.221:100000089922 | PYRIDOXIN HYDROCHLORID | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0037960 | NEUROBION DRG FTE | Neurobion forte - Dragees | 1.2.40.0.34.4.17:13292 | GA - zugelassen | P&G Health Belgium | true | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:A11DB | Vitamin-B1 in Kombination mit Vitamin-B6 und/oder Vitamin-B12 | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | | | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1708059 | THIAMIN DISULFID | 1.2.40.0.34.5.221:100000088589 | THIAMIN DISULFID | active | | | 1.2.40.0.34.5.221:100000088589 | THIAMIN DISULFID | | | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXIN HYDROCHLORID | active | | | 1.2.40.0.34.5.221:100000089922 | PYRIDOXIN HYDROCHLORID | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0038037 | NEUROLEPSIN TBL | Neurolepsin - Tabletten | 1.2.40.0.34.4.17:14185 | GA - zugelassen | Wabosan Arzneimittelvertriebs GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:N05AN01 | Lithium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708906 | LITHIUMCARBONAT | 1.2.40.0.34.5.221:100000091569 | LITHIUM CARBONATE | active | 300 | mg | 1.2.40.0.34.5.221:100000091569 | LITHIUM CARBONATE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923337002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0038043 | NEUROLEPSIN TBL | Neurolepsin - Tabletten | 1.2.40.0.34.4.17:14185 | GA - zugelassen | Wabosan Arzneimittelvertriebs GmbH | true | false | 250 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:N05AN01 | Lithium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708906 | LITHIUMCARBONAT | 1.2.40.0.34.5.221:100000091569 | LITHIUM CARBONATE | active | 300 | mg | 1.2.40.0.34.5.221:100000091569 | LITHIUM CARBONATE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923337001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0038528 | NORGESIC TBL 35/450MG | Norgesic 35 mg/450 mg Tabletten | 1.2.40.0.34.4.17:12948 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M03BC01 | Orphenadrin (citrat) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | 450 | mg | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | 450 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129620001 | 1.2.40.0.34.5.156:1709164 | ORPHENADRIN DIHYDROGENCITRAT | 1.2.40.0.34.5.221:100000092072 | ORPHENADRINE CITRATE | active | 35 | mg | 1.2.40.0.34.5.221:100000092072 | ORPHENADRINE CITRATE | 35 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0038801 | NOVALGIN AMP 1,0G 2ML | Novalgin 1,0 g Ampullen | 1.2.40.0.34.4.17:3191 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N02BB02 | Metamizol-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708977 | METAMIZOL NATRIUM | 1.2.40.0.34.5.221:100000091714 | METAMIZOLE SODIUM | active | 1 | g | 1.2.40.0.34.5.221:100000091714 | METAMIZOLE SODIUM | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:127861002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0038824 | NOVALGIN AMP 2,5G 5ML | Novalgin 2,5 g Ampullen | 1.2.40.0.34.4.17:5139 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N02BB02 | Metamizol-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708977 | METAMIZOL NATRIUM | 1.2.40.0.34.5.221:100000091714 | METAMIZOLE SODIUM | active | 2.5 | g | 1.2.40.0.34.5.221:100000091714 | METAMIZOLE SODIUM | 2.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:933294004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0038876 | NOVALGIN FTBL | Novalgin Filmtabletten | 1.2.40.0.34.4.17:3192 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BB02 | Metamizol-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708977 | METAMIZOL NATRIUM | 1.2.40.0.34.5.221:100000091714 | METAMIZOLE SODIUM | active | 500 | mg | 1.2.40.0.34.5.221:100000091714 | METAMIZOLE SODIUM | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122948001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0038882 | NOVALGIN TR | Novalgin Tropfen | 1.2.40.0.34.4.17:6704 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N02BB02 | Metamizol-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:8023400 | METAMIZOL NATRIUM MONOHYDRAT | 1.2.40.0.34.5.221:100000085944 | METAMIZOLE SODIUM MONOHYDRATE | active | 5000 | mg | 1.2.40.0.34.5.221:100000085944 | METAMIZOLE SODIUM MONOHYDRATE | 5000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:122947002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0038988 | NOVANAEST-PUR AMP 2% 2ML | Novanaest purum 2% - Ampullen | 1.2.40.0.34.4.17:17968 | GA - zugelassen | Gebro Pharma GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01BA02 | Procain | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:1708754 | PROCAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091094 | PROCAINE HYDROCHLORIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000091094 | PROCAINE HYDROCHLORIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923920001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0038994 | NOVANAEST-PUR AMP 2% 5ML | Novanaest purum 2% - Ampullen | 1.2.40.0.34.4.17:17968 | GA - zugelassen | Gebro Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01BA02 | Procain | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:1708754 | PROCAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091094 | PROCAINE HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000091094 | PROCAINE HYDROCHLORIDE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923920002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0039657 | OLEOVIT AU-SLB | Oleovit Augensalbe | 1.2.40.0.34.4.17:13670 | GA - aufgehoben | Fresenius Kabi Austria GmbH | false | false | 5 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:S01XA02 | Retinol | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709167 | DEXPANTHENOL | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | active | 250 | mg | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073772 | Augensalbe | true | human | 1.2.40.0.34.4.26:122861001 | 1.2.40.0.34.5.156:1708781 | RETINOLPALMITAT | 1.2.40.0.34.5.221:100000091269 | RETINOL PALMITATE | active | 147.05 | mg | 1.2.40.0.34.5.221:100000091269 | RETINOL PALMITATE | 147.05 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0039841 | OLEOVIT D3 TR | Oleovit D3 Tropfen | 1.2.40.0.34.4.17:10989 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 12.5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A11CC05 | Colecalciferol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709523 | COLECALCIFEROL | 1.2.40.0.34.5.221:100000092724 | COLECALCIFEROL | active | 4.5 | mg | 1.2.40.0.34.5.221:100000092724 | COLECALCIFEROL | 4.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | true | human | 1.2.40.0.34.4.26:923944002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0040040 | OMNIFLORA KPS | Omniflora - Kapseln | 1.2.40.0.34.4.17:1-23657 | GA - zugelassen | Heilpflanzenwohl GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A07FA01 | Milchsäurebildner | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710411 | LACTOBACILLUS GASSERI | 1.2.40.0.34.5.221:900000000642 | LACTOBACILLUS GASSERI | active | 25 | mg | 1.2.40.0.34.5.221:900000000642 | LACTOBACILLUS GASSERI | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | false | human | 1.2.40.0.34.4.26:929634003 | 1.2.40.0.34.5.156:1709740 | BIFIDOBACTERIUM | 1.2.40.0.34.5.221:100000124509 | BIFIDOBACTERIUM | active | 25 | mg | 1.2.40.0.34.5.221:100000124509 | BIFIDOBACTERIUM | 25 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0040100 | OPHTAGUTTAL AU-TR | Ophtaguttal "Agepha" - Augentropfen | 1.2.40.0.34.4.17:10826 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073512 | Tropfbehältnis | 2.16.840.1.113883.6.73:S01AX03 | Zink-haltige Verbindungen | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1708567 | NAPHAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | active | 4 | mg | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | false | human | 1.2.40.0.34.4.26:120352001 | 1.2.40.0.34.5.156:1708179 | ZINKSULFAT | 1.2.40.0.34.5.221:100000089121 | ZINC SULPHATE | active | 20 | mg | 1.2.40.0.34.5.221:100000089121 | ZINC SULPHATE | 20 | mg | | | | | | | | | | | | 2.16.840.1.113883.6.73:S01GA51 | Naphazolin, Kombinationen | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0040407 | ORGAMETRIL TBL | Orgametril - Tabletten | 1.2.40.0.34.4.17:12352 | GA - zugelassen | Organon Healthcare GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03DC03 | Lynestrenol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708820 | LYNESTRENOL | 1.2.40.0.34.5.221:100000091360 | LYNESTRENOL | active | 5 | mg | 1.2.40.0.34.5.221:100000091360 | LYNESTRENOL | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921352001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0040726 | OSPEN-1000 FTBL | Ospen 1000 - Filmtabletten | 1.2.40.0.34.4.17:13904 | GA - aufgehoben | Sandoz GmbH | false | false | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708554 | PHENOXYMETHYLPENICILLIN | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | active | 588 | mg | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | 588 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:120116002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0040904 | OTRIVIN NA-TR 0,05% | Otrivin 0,05 % - Nasentropfen | 1.2.40.0.34.4.17:11546 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AA07 | Xylometazolin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1709513 | XYLOMETAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092670 | XYLOMETAZOLINE HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000092670 | XYLOMETAZOLINE HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073794 | Nasentropfen, Lösung | true | human | 1.2.40.0.34.4.26:127979001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0041269 | PANKREOFLAT DRG | Pankreoflat - Dragees | 1.2.40.0.34.4.17:13968 | GA - zugelassen | Pharmaselect International Beteiligungs GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A09AA02 | Multienzyme (Lipase, Protease etc.) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708482 | DIMETICON | 1.2.40.0.34.5.221:100000090171 | DIMETICONE | active | 80.028 | mg | 1.2.40.0.34.5.221:100000090171 | DIMETICONE | 80.028 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | false | human | 1.2.40.0.34.4.26:122911002 | 1.2.40.0.34.5.156:1706275 | PANKREAS(EXTRAKT) | 1.2.40.0.34.5.221:100000079736 | PANCREAS EXTRACT | active | 170 | mg | 1.2.40.0.34.5.221:100000079736 | PANCREAS EXTRACT | 170 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0041660 | PANTOTHEN SLB 5% | Pantothen Pharmaselect 5 % - Salbe | 1.2.40.0.34.4.17:11397 | GA - zugelassen | Pharmaselect International Beteiligungs GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D03AX03 | Dexpanthenol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709167 | DEXPANTHENOL | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | active | 1.5 | g | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | 1.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:125638002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0041677 | PANTOTHEN SLB 5% | Pantothen Pharmaselect 5 % - Salbe | 1.2.40.0.34.4.17:11397 | GA - zugelassen | Pharmaselect International Beteiligungs GmbH | true | true | 130 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D03AX03 | Dexpanthenol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709167 | DEXPANTHENOL | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | active | 6.5 | g | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | 6.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:125638001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0041849 | PARACODIN TBL | Paracodin Tabletten | 1.2.40.0.34.4.17:2975 | GA - zugelassen | Teofarma S.r.l. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R05DA | Opium-Alkaloide und Derivate | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705856 | DIHYDROCODEIN BITARTRAT | 1.2.40.0.34.5.221:100000078009 | DIHYDROCODEINE TARTRATE | active | 10 | mg | 1.2.40.0.34.5.221:100000078009 | DIHYDROCODEINE TARTRATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124527001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0041855 | PARACODIN TR | Paracodin - Tropfen | 1.2.40.0.34.4.17:8202 | GA - zugelassen | Teofarma S.r.l. | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05DA | Opium-Alkaloide und Derivate | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707836 | DIHYDROCODEIN THIOCYANAT | 1.2.40.0.34.5.221:100000087506 | DIHYDROCODEINE THIOCYANATE | active | 0.15 | g | 1.2.40.0.34.5.221:100000087506 | DIHYDROCODEINE THIOCYANATE | 0.15 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:121781001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0042205 | PARKEMED SUPP 125MG | Parkemed 125 mg - Suppositorien | 1.2.40.0.34.4.17:14290 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:M01AG01 | Mefenaminsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1708971 | MEFENAMINSÄURE | 1.2.40.0.34.5.221:100000091703 | MEFENAMIC ACID | active | 125 | mg | 1.2.40.0.34.5.221:100000091703 | MEFENAMIC ACID | 125 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:121465001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0042211 | PARKEMED SUPP 500MG | Parkemed 500 mg - Suppositorien | 1.2.40.0.34.4.17:14291 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:M01AG01 | Mefenaminsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1708971 | MEFENAMINSÄURE | 1.2.40.0.34.5.221:100000091703 | MEFENAMIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000091703 | MEFENAMIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:122168001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0042346 | PASPERTIN AMP 10MG 2ML | Paspertin 10 mg - Ampullen | 1.2.40.0.34.4.17:13762 | GA - zugelassen | Viatris Austria GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A03FA01 | Metoclopramid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:7447024 | METOCLOPRAMIDHYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000091552 | METOCLOPRAMIDE HYDROCHLORIDE MONOHYDRATE | active | 10.54 | mg | 1.2.40.0.34.5.221:100000091552 | METOCLOPRAMIDE HYDROCHLORIDE MONOHYDRATE | 10.54 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:123349001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0042381 | PASPERTIN FTBL | Paspertin - Filmtabletten | 1.2.40.0.34.4.17:13764 | GA - zugelassen | Viatris Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A03FA01 | Metoclopramid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708404 | METOCLOPRAMIDHYDROCHLORID | 1.2.40.0.34.5.221:100000089920 | METOCLOPRAMIDE HYDROCHLORIDE | active | 10.54 | mg | 1.2.40.0.34.5.221:100000089920 | METOCLOPRAMIDE HYDROCHLORIDE | 10.54 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122122001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0042398 | PASPERTIN FTBL | Paspertin - Filmtabletten | 1.2.40.0.34.4.17:13764 | GA - zugelassen | Viatris Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A03FA01 | Metoclopramid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708404 | METOCLOPRAMIDHYDROCHLORID | 1.2.40.0.34.5.221:100000089920 | METOCLOPRAMIDE HYDROCHLORIDE | active | 10.54 | mg | 1.2.40.0.34.5.221:100000089920 | METOCLOPRAMIDE HYDROCHLORIDE | 10.54 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122122002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0043564 | PERSANTIN AMP 2ML | Persantin - Ampullen | 1.2.40.0.34.4.17:10818 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B01AC07 | Dipyridamol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708987 | DIPYRIDAMOL | 1.2.40.0.34.5.221:100000091735 | DIPYRIDAMOLE | active | 10 | mg | 1.2.40.0.34.5.221:100000091735 | DIPYRIDAMOLE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:924904001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0043989 | PETINIMID SIR | Petinimid - Sirup | 1.2.40.0.34.4.17:11686 | GA - zugelassen | G.L. Pharma GmbH | true | true | 250 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N03AD01 | Ethosuximid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709576 | ETHOSUXIMID | 1.2.40.0.34.5.221:100000092816 | ETHOSUXIMIDE | active | 12500 | mg | 1.2.40.0.34.5.221:100000092816 | ETHOSUXIMIDE | 12500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073652 | Sirup | true | human | 1.2.40.0.34.4.26:126934001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0044434 | PILOCARPIN PUROPT AU-TR 1% | Pilocarpin Puroptal - Augentropfen 1% | 1.2.40.0.34.4.17:10758 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 10 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01EB01 | Pilocarpin | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1707759 | HYPROMELLOSE | 1.2.40.0.34.5.221:100000087131 | HYPROMELLOSE | active | 0.05 | g | 1.2.40.0.34.5.221:100000087131 | HYPROMELLOSE | 0.05 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:125837001 | 1.2.40.0.34.5.156:1708988 | PILOCARPIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091736 | PILOCARPINE HYDROCHLORIDE | active | 0.1 | g | 1.2.40.0.34.5.221:100000091736 | PILOCARPINE HYDROCHLORIDE | 0.1 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0044440 | PILOCARPIN PUROPT AU-TR 2% | Pilocarpin Puroptal - Augentropfen 2 % | 1.2.40.0.34.4.17:10759 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 10 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01EB01 | Pilocarpin | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1707759 | HYPROMELLOSE | 1.2.40.0.34.5.221:100000087131 | HYPROMELLOSE | active | 0.05 | g | 1.2.40.0.34.5.221:100000087131 | HYPROMELLOSE | 0.05 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:127257001 | 1.2.40.0.34.5.156:1708988 | PILOCARPIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091736 | PILOCARPINE HYDROCHLORIDE | active | 0.2 | g | 1.2.40.0.34.5.221:100000091736 | PILOCARPINE HYDROCHLORIDE | 0.2 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0045244 | PRAXITEN TBL 15MG | Praxiten 15 mg - Tabletten | 1.2.40.0.34.4.17:13465 | GA - zugelassen | Viatris Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA04 | Oxazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709067 | OXAZEPAM | 1.2.40.0.34.5.221:100000091921 | OXAZEPAM | active | 15 | mg | 1.2.40.0.34.5.221:100000091921 | OXAZEPAM | 15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923345001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0045250 | PRAXITEN TBL 15MG | Praxiten 15 mg - Tabletten | 1.2.40.0.34.4.17:13465 | GA - zugelassen | Viatris Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA04 | Oxazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709067 | OXAZEPAM | 1.2.40.0.34.5.221:100000091921 | OXAZEPAM | active | 15 | mg | 1.2.40.0.34.5.221:100000091921 | OXAZEPAM | 15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923345003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0045267 | PRAXITEN TBL 50MG | Praxiten 50 mg - Tabletten | 1.2.40.0.34.4.17:13963 | GA - zugelassen | Viatris Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA04 | Oxazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709067 | OXAZEPAM | 1.2.40.0.34.5.221:100000091921 | OXAZEPAM | active | 50 | mg | 1.2.40.0.34.5.221:100000091921 | OXAZEPAM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922996002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0045385 | PREDNISOLON NYC TBL 5MG | Prednisolon "Nycomed" 5 mg - Tabletten | 1.2.40.0.34.4.17:11046 | GA - zugelassen | Takeda Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 5 | mg | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:127113001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0045416 | PREDNISOLON NYC TBL 5MG | Prednisolon "Nycomed" 5 mg - Tabletten | 1.2.40.0.34.4.17:11046 | GA - zugelassen | Takeda Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 5 | mg | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:127113002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0045480 | PREGNYL TRAMP 1500IE +LSM | Pregnyl 1500 I. E. - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | 1.2.40.0.34.4.17:6596 | GA - aufgehoben | Merck Sharp & Dohme Ges.m.b.H. | false | false | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:G03GA01 | Choriongonadotrophin | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708285 | GONADOTROPES HORMON | 1.2.40.0.34.5.221:100000089485 | SERUM GONADOTROPHIN | active | 1500 | IU | 1.2.40.0.34.5.221:100000089485 | SERUM GONADOTROPHIN | 1500 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073868 | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:125859001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0046344 | PROGYNOVA DRG MTE | Progynova mite - Dragees | 1.2.40.0.34.4.17:14422 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03CA03 | Estradiol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708616 | ESTRADIOL VALERAT | 1.2.40.0.34.5.221:100000090493 | ESTRADIOL VALERATE | active | 1 | mg | 1.2.40.0.34.5.221:100000090493 | ESTRADIOL VALERATE | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:121903001 | 1.2.40.0.34.5.156:1707705 | SACCHAROSE | 1.2.40.0.34.5.221:100000086724 | SACCHAROSE | active | 33.546 | mg | 1.2.40.0.34.5.221:100000086724 | SACCHAROSE | 33.546 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0046456 | PROLUTON DEP AMP 250MG 1ML | Proluton - Depot 250 mg - Ampullen | 1.2.40.0.34.4.17:16765 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | false | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:G03DA03 | Hydroxyprogesteron | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1709580 | HYDROXYPROGESTERON CAPROAT | 1.2.40.0.34.5.221:100000092822 | HYDROXYPROGESTERONE CAPROATE | active | 250 | mg | 1.2.40.0.34.5.221:100000092822 | HYDROXYPROGESTERONE CAPROATE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:124861001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0046611 | PROSPAN HU-TR | Prospan - Hustentropfen | 1.2.40.0.34.4.17:11754 | GA - zugelassen | Engelhard Arzneimittel GmbH & Co. KG | true | true | 20 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CA | Expektoranzien | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | 1.2.40.0.34.5.156:1712622 | HEDERAE FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000004140 | HEDERAE FOLIUM (EXTRACT) | active | 40 | g | 1.2.40.0.34.5.221:900000004140 | HEDERAE FOLIUM (EXTRACT) | 40 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | false | human | 1.2.40.0.34.4.26:121930002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0046628 | PROSPAN HU-TR | Prospan - Hustentropfen | 1.2.40.0.34.4.17:11754 | GA - zugelassen | Engelhard Arzneimittel GmbH & Co. KG | true | true | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CA | Expektoranzien | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | 1.2.40.0.34.5.156:1712622 | HEDERAE FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000004140 | HEDERAE FOLIUM (EXTRACT) | active | 100 | g | 1.2.40.0.34.5.221:900000004140 | HEDERAE FOLIUM (EXTRACT) | 100 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | false | human | 1.2.40.0.34.4.26:121930003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0046781 | PROTHIUCIL TBL | Prothiucil - Tabletten | 1.2.40.0.34.4.17:6066 | GA - zugelassen | Phafag Pharma Research & Trading GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:H03BA02 | Propylthiouracil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706560 | PROPYLTHIOURACIL | 1.2.40.0.34.5.221:100000081364 | PROPYLTHIOURACIL | active | 20 | mg | 1.2.40.0.34.5.221:100000081364 | PROPYLTHIOURACIL | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:125381001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0047065 | PURI-NETHOL TBL 50MG | Puri - Nethol - 50mg-Tabletten | 1.2.40.0.34.4.17:8931 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L01BB02 | Mercaptopurin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:10880107 | MERCAPTOPURIN MONOHYDRAT | 1.2.40.0.34.5.221:100000085529 | 6-MERCAPTOPURINE MONOHYDRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000085529 | 6-MERCAPTOPURINE MONOHYDRATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122436001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0047220 | PYRALVEX LSG | Pyralvex - Lösung | 1.2.40.0.34.4.17:6205 | GA - aufgehoben | MEDA Pharma GmbH | false | false | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A01AD | Andere Mittel zur oralen Lokalbehandlung | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | | | 1.2.40.0.34.5.156:1712648 | RHEI RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000004221 | RHEI RADIX (EXTRACT) | active | 0.425 | g | 1.2.40.0.34.5.221:900000004221 | RHEI RADIX (EXTRACT) | 0.425 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073691 | Lösung zur Anwendung in der Mundhöhle | false | human | 1.2.40.0.34.4.26:120803001 | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 0.1 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 0.1 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0047272 | PYRAZINAMID PROV TBL 0,5G | Pyrazinamid "Provita" - Tabletten | 1.2.40.0.34.4.17:9934 | GA - aufgehoben | Sigmapharm Arzneimittel GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:J04AK01 | Pyrazinamid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706476 | PYRAZINAMID | 1.2.40.0.34.5.221:100000080846 | PYRAZINAMIDE | active | | | 1.2.40.0.34.5.221:100000080846 | PYRAZINAMIDE | | | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923260003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0048018 | REFOBACIN AMP 10MG 2ML | Refobacin 10 mg - Ampullen | 1.2.40.0.34.4.17:14374 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 33.4 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 23.560961 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:120305001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0048024 | REFOBACIN AMP 40MG 1ML | Refobacin 40 mg - Ampullen | 1.2.40.0.34.4.17:13548 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 66.7 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 47.051381 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:127740002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0048030 | REFOBACIN AMP 80MG 2ML | Refobacin 80 mg - Ampullen | 1.2.40.0.34.4.17:14375 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 133.3 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 94.032219 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:123029001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0048053 | REFOBACIN CR | Refobacin 1mg/g Creme | 1.2.40.0.34.4.17:13258 | GA - zugelassen | Almirall Hermal GmbH | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D06AX07 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 25.05 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 17.670721 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:120750001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0048076 | REFOBACIN CR | Refobacin 1mg/g Creme | 1.2.40.0.34.4.17:13258 | GA - zugelassen | Almirall Hermal GmbH | true | false | 150 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D06AX07 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 250.5 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 176.707209 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:120750002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0048277 | REPARIL DRG 20MG | Reparil 20 mg - Dragees | 1.2.40.0.34.4.17:12947 | GA - zugelassen | Viatris Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C05CX | Andere kapillarstabilisierende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7249184 | AESCIN WASSERLÖSLICH (ALPHA) | 1.2.40.0.34.5.221:100000130090 | AESCIN WATER SOLUBLE (ALPHA) | active | 20 | mg | 1.2.40.0.34.5.221:100000130090 | AESCIN WATER SOLUBLE (ALPHA) | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:128346001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0048308 | REPARIL GEL | Reparil-Gel | 1.2.40.0.34.4.17:14243 | GA - zugelassen | Viatris Austria GmbH | true | true | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708722 | AESCIN | 1.2.40.0.34.5.221:100000091047 | ESCIN | active | 0.4 | g | 1.2.40.0.34.5.221:100000091047 | ESCIN | 0.4 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:123762003 | 1.2.40.0.34.5.156:1706241 | DIETHYLAMINSALICYLAT | 1.2.40.0.34.5.221:100000079574 | DIETHYLAMINE SALICYLATE | active | 2 | g | 1.2.40.0.34.5.221:100000079574 | DIETHYLAMINE SALICYLATE | 2 | g | | | | | | | | | | | | 2.16.840.1.113883.6.73:C05CX | Andere kapillarstabilisierende Mittel | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0048389 | RESOCHIN FTBL 0,25G | Resochin - Filmtabletten | 1.2.40.0.34.4.17:8313 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:P01BA01 | Chloroquin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709481 | CHLOROQUIN DI(DIHYDROGENPHOSPHAT) | 1.2.40.0.34.5.221:100000092628 | CHLOROQUINE PHOSPHATE | active | 250 | mg | 1.2.40.0.34.5.221:100000092628 | CHLOROQUINE PHOSPHATE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:125267001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0049064 | RHINON NA-TR | Rhinon Nasentropfen | 1.2.40.0.34.4.17:6672 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AA08 | Naphazolin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1708567 | NAPHAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | active | 0.01 | g | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | 0.01 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073794 | Nasentropfen, Lösung | true | human | 1.2.40.0.34.4.26:920942001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0049070 | RHINON NA-TR | Rhinon Nasentropfen | 1.2.40.0.34.4.17:6672 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AA08 | Naphazolin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1708567 | NAPHAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | active | 0.1 | g | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | 0.1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073794 | Nasentropfen, Lösung | true | human | 1.2.40.0.34.4.26:920942002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0049093 | RHINOPERD NA-TR | Rhinoperd - Nasentropfen | 1.2.40.0.34.4.17:6368 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AA08 | Naphazolin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1708567 | NAPHAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | active | 0.01 | g | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | 0.01 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073794 | Nasentropfen, Lösung | true | human | 1.2.40.0.34.4.26:922238001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0049259 | RIFOLDIN KPS 150MG | Rifoldin 150 mg Kapseln | 1.2.40.0.34.4.17:13853 | GA - zugelassen | Sanofi-Aventis GmbH | true | false | 16 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J04AB02 | Rifampicin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706447 | RIFAMPICIN | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | active | 150 | mg | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:121250002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0049265 | RIFOLDIN KPS 150MG | Rifoldin 150 mg Kapseln | 1.2.40.0.34.4.17:13853 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J04AB02 | Rifampicin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706447 | RIFAMPICIN | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | active | 150 | mg | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:121250001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0049271 | RIFOLDIN KPS 300MG | Rifoldin 300 mg Kapseln | 1.2.40.0.34.4.17:14242 | GA - zugelassen | Sanofi-Aventis GmbH | true | false | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J04AB02 | Rifampicin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706447 | RIFAMPICIN | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | active | 300 | mg | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:122943002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0049288 | RIFOLDIN KPS 300MG | Rifoldin 300 mg Kapseln | 1.2.40.0.34.4.17:14242 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J04AB02 | Rifampicin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706447 | RIFAMPICIN | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | active | 300 | mg | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:122943001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0049986 | ROWACHOL TR | Rowachol - Tropfen | 1.2.40.0.34.4.17:10256 | GA - zugelassen | Wabosan Arzneimittelvertriebs GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:G04BX | Andere Urologika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | 320 | g | 1.2.40.0.34.5.221:100000091364 | MENTHOL | 320 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | false | human | 1.2.40.0.34.4.26:122923001 | 1.2.40.0.34.5.156:1705500 | P-MENTHAN-3-ON | 1.2.40.0.34.5.221:100000076540 | MENTHONE | active | 60 | g | 1.2.40.0.34.5.221:100000076540 | MENTHONE | 60 | g | 1.2.40.0.34.5.156:1709829 | 2-PINEN + 2(10)-PINEN | 1.2.40.0.34.5.221:100000135701 | MIXTURE OF ALFA-PINEN AND BETA-PINEN | active | 170 | g | 1.2.40.0.34.5.221:100000135701 | MIXTURE OF ALFA-PINEN AND BETA-PINEN | 170 | g | | | | | | | 1.2.40.0.34.5.156:1709312 | CINEOL | 1.2.40.0.34.5.221:100000092312 | CINEOLE | active | 20 | g | 1.2.40.0.34.5.221:100000092312 | CINEOLE | 20 | g | 1.2.40.0.34.5.156:1705603 | BORNEOL | 1.2.40.0.34.5.221:100000076878 | BORNEOL | active | 50 | g | 1.2.40.0.34.5.221:100000076878 | BORNEOL | 50 | g | 1.2.40.0.34.5.156:1705525 | CAMPHEN | 1.2.40.0.34.5.221:100000076601 | CAMPHENE | active | 50 | g | 1.2.40.0.34.5.221:100000076601 | CAMPHENE | 50 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0049992 | ROWACHOL KPS | Rowachol - Kapseln | 1.2.40.0.34.4.17:13343 | GA - zugelassen | Wabosan Arzneimittelvertriebs GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A05AX | Andere Mittel zur Gallentherapie | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | 32 | mg | 1.2.40.0.34.5.221:100000091364 | MENTHOL | 32 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | false | human | 1.2.40.0.34.4.26:921550001 | 1.2.40.0.34.5.156:1705500 | P-MENTHAN-3-ON | 1.2.40.0.34.5.221:100000076540 | MENTHONE | active | 6 | mg | 1.2.40.0.34.5.221:100000076540 | MENTHONE | 6 | mg | 1.2.40.0.34.5.156:1709829 | 2-PINEN + 2(10)-PINEN | 1.2.40.0.34.5.221:100000135701 | MIXTURE OF ALFA-PINEN AND BETA-PINEN | active | 17 | mg | 1.2.40.0.34.5.221:100000135701 | MIXTURE OF ALFA-PINEN AND BETA-PINEN | 17 | mg | | | | | | | 1.2.40.0.34.5.156:1709312 | CINEOL | 1.2.40.0.34.5.221:100000092312 | CINEOLE | active | 2 | mg | 1.2.40.0.34.5.221:100000092312 | CINEOLE | 2 | mg | 1.2.40.0.34.5.156:1705603 | BORNEOL | 1.2.40.0.34.5.221:100000076878 | BORNEOL | active | 5 | mg | 1.2.40.0.34.5.221:100000076878 | BORNEOL | 5 | mg | 1.2.40.0.34.5.156:1705525 | CAMPHEN | 1.2.40.0.34.5.221:100000076601 | CAMPHENE | active | 5 | mg | 1.2.40.0.34.5.221:100000076601 | CAMPHENE | 5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0050015 | ROWATINEX KPS | Rowatinex - Kapseln | 1.2.40.0.34.4.17:13342 | GA - zugelassen | Wabosan Arzneimittelvertriebs GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G04BX | Andere Urologika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709829 | 2-PINEN + 2(10)-PINEN | 1.2.40.0.34.5.221:100000135701 | MIXTURE OF ALFA-PINEN AND BETA-PINEN | active | 31 | mg | 1.2.40.0.34.5.221:100000135701 | MIXTURE OF ALFA-PINEN AND BETA-PINEN | 31 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | true | human | 1.2.40.0.34.4.26:921548001 | 1.2.40.0.34.5.156:1709312 | CINEOL | 1.2.40.0.34.5.221:100000092312 | CINEOLE | active | 3 | mg | 1.2.40.0.34.5.221:100000092312 | CINEOLE | 3 | mg | 1.2.40.0.34.5.156:1705603 | BORNEOL | 1.2.40.0.34.5.221:100000076878 | BORNEOL | active | 10 | mg | 1.2.40.0.34.5.221:100000076878 | BORNEOL | 10 | mg | | | | | | | 1.2.40.0.34.5.156:1705718 | ANETHOL | 1.2.40.0.34.5.221:100000077400 | ANETHOLE | active | 4 | mg | 1.2.40.0.34.5.221:100000077400 | ANETHOLE | 4 | mg | 1.2.40.0.34.5.156:1706038 | 1,3,3-TRIMETHYLNORBORNAN-2-ON | 1.2.40.0.34.5.221:100000078736 | FENCHONE | active | 4 | mg | 1.2.40.0.34.5.221:100000078736 | FENCHONE | 4 | mg | 1.2.40.0.34.5.156:1705525 | CAMPHEN | 1.2.40.0.34.5.221:100000076601 | CAMPHENE | active | 15 | mg | 1.2.40.0.34.5.221:100000076601 | CAMPHENE | 15 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0050251 | SALAZOPYRIN FTBL 500MG | Salazopyrin 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-13306 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073530 | Mehrdosenbehältnis | 2.16.840.1.113883.6.73:A07EC01 | Sulfasalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708908 | SULFASALAZIN | 1.2.40.0.34.5.221:100000091572 | SULFASALAZINE | active | 535 | mg | 1.2.40.0.34.5.221:100000091572 | SULFASALAZINE | 535 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122488002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0050825 | SAROTEN FTBL 10MG | Saroten 10 mg - Filmtabletten | 1.2.40.0.34.4.17:11734 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N06AA09 | Amitriptylin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708532 | AMITRIPTYLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090311 | AMITRIPTYLINE HYDROCHLORIDE | active | 11.31 | mg | 1.2.40.0.34.5.221:100000090311 | AMITRIPTYLINE HYDROCHLORIDE | 11.31 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122966002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0050848 | SAROTEN FTBL 25MG | Saroten 25 mg - Filmtabletten | 1.2.40.0.34.4.17:11735 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N06AA09 | Amitriptylin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708532 | AMITRIPTYLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090311 | AMITRIPTYLINE HYDROCHLORIDE | active | 28.28 | mg | 1.2.40.0.34.5.221:100000090311 | AMITRIPTYLINE HYDROCHLORIDE | 28.28 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122960002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0050989 | SCHERIPROCT SLB | Scheriproct - Salbe | 1.2.40.0.34.4.17:10260 | GA - zugelassen | Karo Healthcare AB | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05AA04 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709205 | CINCHOCAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092133 | CINCHOCAINE HYDROCHLORIDE | active | 0.15 | g | 1.2.40.0.34.5.221:100000092133 | CINCHOCAINE HYDROCHLORIDE | 0.15 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:125128001 | 1.2.40.0.34.5.156:1708748 | PREDNISOLON HEXANOAT | 1.2.40.0.34.5.221:100000091081 | PREDNISOLONE CAPROATE | active | 0.057 | g | 1.2.40.0.34.5.221:100000091081 | PREDNISOLONE CAPROATE | 0.057 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0050995 | SCHERIPROCT SUPP | Scheriproct - Suppositorien | 1.2.40.0.34.4.17:10261 | GA - zugelassen | Karo Healthcare AB | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C05AA04 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709205 | CINCHOCAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092133 | CINCHOCAINE HYDROCHLORIDE | active | 1 | mg | 1.2.40.0.34.5.221:100000092133 | CINCHOCAINE HYDROCHLORIDE | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:125142001 | 1.2.40.0.34.5.156:1708748 | PREDNISOLON HEXANOAT | 1.2.40.0.34.5.221:100000091081 | PREDNISOLONE CAPROATE | active | 1.3 | mg | 1.2.40.0.34.5.221:100000091081 | PREDNISOLONE CAPROATE | 1.3 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0051339 | SCOTTOPECT GEL | Scottopect - Gelee | 1.2.40.0.34.4.17:736262 | GA - registriert | Orifarm Healthcare A/S | true | true | 45 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:R05X | Andere Kombinationspräparate gegen Erkältungskrankheiten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | 135 | g | 1.2.40.0.34.5.221:100000091364 | MENTHOL | 135 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:958424002 | 1.2.40.0.34.5.156:1709094 | TEREBINTHINAE AETHEROLEUM | 1.2.40.0.34.5.221:100000091958 | TURPENTINE OIL | active | 270 | g | 1.2.40.0.34.5.221:100000091958 | TURPENTINE OIL | 270 | g | 1.2.40.0.34.5.156:1706333 | EUCALYPTI AETHEROLEUM | 1.2.40.0.34.5.221:100000091979 | EUCALYPTUS OIL | active | 135 | g | 1.2.40.0.34.5.221:100000091979 | EUCALYPTUS OIL | 135 | g | | | | | | | 1.2.40.0.34.5.156:1708766 | THYMI TYPO THYMOLO AETHEROLEUM | 1.2.40.0.34.5.221:100000091153 | ESSENTIAL OIL - THYMUS VULGARIS | active | 90 | g | 1.2.40.0.34.5.221:100000091153 | ESSENTIAL OIL - THYMUS VULGARIS | 90 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0052847 | SOLU-DACORTIN PLV+LSM 25MG | Solu - Dacortin 25 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung oder Infusionslösung | 1.2.40.0.34.4.17:9894 | GA - zugelassen | Merck Ges.m.b.H. | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709059 | NATRIUM PREDNISOLON SUCCINAT | 1.2.40.0.34.5.221:100000091910 | PREDNISOLONE SODIUM SUCCINATE | active | 25 | mg | 1.2.40.0.34.5.221:100000091910 | PREDNISOLONE SODIUM SUCCINATE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:129371001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0052853 | SOLU-DACORTIN PLV+LSM 25MG | Solu - Dacortin 25 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung oder Infusionslösung | 1.2.40.0.34.4.17:9894 | GA - zugelassen | Merck Ges.m.b.H. | true | false | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709059 | NATRIUM PREDNISOLON SUCCINAT | 1.2.40.0.34.5.221:100000091910 | PREDNISOLONE SODIUM SUCCINATE | active | 25 | mg | 1.2.40.0.34.5.221:100000091910 | PREDNISOLONE SODIUM SUCCINATE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:129371002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0052876 | SOLU-DACORTIN PLV+LSM 50MG | Solu - Dacortin 50 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung oder Infusionslösung | 1.2.40.0.34.4.17:13017 | GA - zugelassen | Merck Ges.m.b.H. | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709059 | NATRIUM PREDNISOLON SUCCINAT | 1.2.40.0.34.5.221:100000091910 | PREDNISOLONE SODIUM SUCCINATE | active | 50 | mg | 1.2.40.0.34.5.221:100000091910 | PREDNISOLONE SODIUM SUCCINATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:129372001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0052899 | SOLUT CORDES 0,5% DERM LSG | Solutio Cordes 0,5% - dermatologische Lösung | 1.2.40.0.34.4.17:13449 | GA - zugelassen | Ichthyol-Gesellschaft Cordes, Hermanni & Co. (GmbH & Co.) KG | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D11AC08 | Schwefel-haltige Verbindungen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705770 | NATRIUM SULFOBITUMINOSUM | 1.2.40.0.34.5.221:100000077657 | ICHTHAMMOL SODIUM | active | 0.5 | g | 1.2.40.0.34.5.221:100000077657 | ICHTHAMMOL SODIUM | 0.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:120644001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0053054 | SOVENTOL BAMIPINLACTAT GEL | Soventol Bamipinlactat Gel | 1.2.40.0.34.4.17:7453 | GA - zugelassen | Medice Pharma GmbH & Co. KG | true | true | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:D04AA15 | Bamipin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707215 | BAMIPIN LACTAT | 1.2.40.0.34.5.221:100000084971 | BAMIPIN LACTAT | active | | | 1.2.40.0.34.5.221:100000084971 | BAMIPIN LACTAT | | | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0053060 | SOVENTOL GEL | Soventol Bamipinlactat Gel | 1.2.40.0.34.4.17:7453 | GA - zugelassen | Medice Pharma GmbH & Co. KG | true | true | 50 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:D04AA15 | Bamipin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707215 | BAMIPIN LACTAT | 1.2.40.0.34.5.221:100000084971 | BAMIPIN LACTAT | active | | | 1.2.40.0.34.5.221:100000084971 | BAMIPIN LACTAT | | | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0053545 | SPASMO-URGENIN DRG | Spasmo - Urgenin - Dragees | 1.2.40.0.34.4.17:14406 | GA - aufgehoben | Madaus GmbH | false | false | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:G04BD | Urologische Spasmolytika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712613 | ECHINACEAE ANGUSTIFOLIAE RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000004108 | ECHINACEAE ANGUSTIFOLIAE RADIX (EXTRACT) | active | 30 | mg | 1.2.40.0.34.5.221:900000004108 | ECHINACEAE ANGUSTIFOLIAE RADIX (EXTRACT) | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:125817001 | 1.2.40.0.34.5.156:1709331 | TROSPIUM CHLORID | 1.2.40.0.34.5.221:100000092335 | TROSPIUM CHLORIDE | active | 2 | mg | 1.2.40.0.34.5.221:100000092335 | TROSPIUM CHLORIDE | 2 | mg | 1.2.40.0.34.5.156:1709761 | SABALIS SERRULATAE FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:100000126098 | SERENOA SERRULATA FRUIT EXTRACT | active | 25 | mg | 1.2.40.0.34.5.221:100000126098 | SERENOA SERRULATA FRUIT EXTRACT | 25 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0054728 | SYMBIOFLOR ENTEROCOCCUS TR | Symbioflor Enterococcus – Tropfen zum Einnehmen, Suspension | 1.2.40.0.34.4.17:1-23622 | GA - zugelassen | SymbioPharm GmbH | true | true | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L03A | Zytokine und Immunmodulatoren | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712676 | STREPTOCOCCUS SPEC./ENTEROCOCCUS | 1.2.40.0.34.5.221:900000004290 | STREPTOCOCCUS SPEC./ENTEROCOCCUS | active | | | 1.2.40.0.34.5.221:900000004290 | STREPTOCOCCUS SPEC./ENTEROCOCCUS | | | 1.2.40.0.10.1.4.3.4.3.5:100000073643 | Tropfen zum Einnehmen, Suspension | false | human | 1.2.40.0.34.4.26:929746001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0054846 | SYNACTHEN DEP AMP 1ML | Synacthen Depot Ampullen | 1.2.40.0.34.4.17:14001 | GA - aufgehoben | Alfasigma S.p.A. | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H01AA02 | Tetracosactid | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1707311 | TETRACOSACTID | 1.2.40.0.34.5.221:100000085201 | TETRACOSACTIDE | active | 1.123 | mg | 1.2.40.0.34.5.221:100000085201 | TETRACOSACTIDE | 1.123 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:121936001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0054852 | SYNACTHEN DEP AMP 1ML | Synacthen Depot Ampullen | 1.2.40.0.34.4.17:14001 | GA - aufgehoben | Alfasigma S.p.A. | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H01AA02 | Tetracosactid | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1707311 | TETRACOSACTID | 1.2.40.0.34.5.221:100000085201 | TETRACOSACTIDE | active | 1.123 | mg | 1.2.40.0.34.5.221:100000085201 | TETRACOSACTIDE | 1.123 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:121936002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0055076 | SYNKAPTON DRG | Synkapton - Dragees | 1.2.40.0.34.4.17:10490 | GA - aufgehoben | Strallhofer Pharma GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N02CA52 | Ergotamin, Kombinationen exkl. Psycholeptika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708366 | COFFEIN | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | active | 100 | mg | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:128513001 | 1.2.40.0.34.5.156:1708745 | ERGOTAMIN TARTRAT | 1.2.40.0.34.5.221:100000091078 | ERGOTAMINE TARTRATE | active | 1 | mg | 1.2.40.0.34.5.221:100000091078 | ERGOTAMINE TARTRATE | 1 | mg | 1.2.40.0.34.5.156:1709065 | DIMENHYDRINAT | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | active | 25 | mg | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | 25 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0055188 | SYNTOCINON SPRAY | Syntocinon Spray | 1.2.40.0.34.4.17:11266 | GA - aufgehoben | Alfasigma S.p.A. | false | false | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:H01BB02 | Oxytocin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1709372 | OXYTOCIN | 1.2.40.0.34.5.221:100000092397 | OXYTOCIN | active | 4 | IU | 1.2.40.0.34.5.221:100000092397 | OXYTOCIN | 4 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073796 | Nasenspray, Lösung | true | human | 1.2.40.0.34.4.26:125901002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0055455 | TANNOSYNT FL BADEKONZ | Tannosynt flüssig - Badekonzentrat | 1.2.40.0.34.4.17:12741 | GA - zugelassen | Almirall Hermal GmbH | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D04AX | Andere Antipruriginosa | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073568 | Badebehandlung | | | 1.2.40.0.34.5.156:1710628 | PHENOL-METHANAL-HARNSTOFF-POLYKONDENSAT, SULFONIERT, NATRIUMSALZ | 1.2.40.0.34.5.221:100000134330 | UREA-PHENOL-FORMALDEHYDERESIN | active | 40 | g | 1.2.40.0.34.5.221:100000134330 | UREA-PHENOL-FORMALDEHYDERESIN | 40 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073711 | Badezusatz | false | human | 1.2.40.0.34.4.26:120428001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0055828 | TEGRETOL TBL 200MG | Tegretol 200 mg - Tabletten | 1.2.40.0.34.4.17:1-12844 | GA - zugelassen | Novartis Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AF01 | Carbamazepin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709201 | CARBAMAZEPIN | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | active | 200 | mg | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:128587001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0056489 | TETANOL PUR FSPR 0,5ML | Tetanol pur Injektionssuspension in einer Fertigspritze | 1.2.40.0.34.4.17:2-00079 | GA - aufgehoben | GSK Vaccines GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:J07AM01 | Tetanus-Toxoid | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1708219 | CLOSTRIDIUM TETANI (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:100000089278 | CLOSTRIDIUM TETANI | active | 0 | IU | 1.2.40.0.34.5.221:100000089278 | CLOSTRIDIUM TETANI | 0 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:929064002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0058494 | TRIJODTHYRONIN TBL 25 GAMMA | Trijodthyronin "Sandoz" 25 Gamma - Tabletten | 1.2.40.0.34.4.17:10705 | GA - aufgehoben | Sandoz GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA02 | Liothyronin-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708423 | NATRIUM LIOTHYRONINAT | 1.2.40.0.34.5.221:100000089973 | LIOTHYRONINE SODIUM | active | 0.02585 | mg | 1.2.40.0.34.5.221:100000089973 | LIOTHYRONINE SODIUM | 0.02585 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:127237001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0058815 | TRUXAL FTBL 15MG | Truxal 15 mg - Filmtabletten | 1.2.40.0.34.4.17:10986 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073530 | Mehrdosenbehältnis | 2.16.840.1.113883.6.73:N05AF03 | Chlorprothixen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709549 | CHLORPROTHIXEN HYDROCHLORID | 1.2.40.0.34.5.221:100000092777 | CHLORPROTHIXENE HYDROCHLORIDE | active | 15 | mg | 1.2.40.0.34.5.221:100000092777 | CHLORPROTHIXENE HYDROCHLORIDE | 15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:129456002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0058821 | TRUXAL FTBL 50MG | Truxal 50 mg - Filmtabletten | 1.2.40.0.34.4.17:10987 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073530 | Mehrdosenbehältnis | 2.16.840.1.113883.6.73:N05AF03 | Chlorprothixen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709549 | CHLORPROTHIXEN HYDROCHLORID | 1.2.40.0.34.5.221:100000092777 | CHLORPROTHIXENE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000092777 | CHLORPROTHIXENE HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:129714003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0058838 | TRUXAL FTBL 50MG | Truxal 50 mg - Filmtabletten | 1.2.40.0.34.4.17:10987 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073530 | Mehrdosenbehältnis | 2.16.840.1.113883.6.73:N05AF03 | Chlorprothixen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709549 | CHLORPROTHIXEN HYDROCHLORID | 1.2.40.0.34.5.221:100000092777 | CHLORPROTHIXENE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000092777 | CHLORPROTHIXENE HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:129714002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0058991 | TUSCALMAN HU-SIR | Tuscalman - Hustensirup | 1.2.40.0.34.4.17:14397 | GA - zugelassen | Laboratorio Farmaceutico S.I.T. - Specialita' Igienico Terapeutiche S.r.l. | true | true | 120 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05FA02 | Opium-Derivate und Expektoranzien | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707503 | NOSCAPINHYDROCHLORID | 1.2.40.0.34.5.221:100000085744 | NOSCAPINE HYDROCHLORIDE | active | 0.18 | g | 1.2.40.0.34.5.221:100000085744 | NOSCAPINE HYDROCHLORIDE | 0.18 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073652 | Sirup | true | human | 1.2.40.0.34.4.26:121037001 | 1.2.40.0.34.5.156:1708576 | GUAIFENESIN | 1.2.40.0.34.5.221:100000090413 | GUAIFENESIN | active | 1.2 | g | 1.2.40.0.34.5.221:100000090413 | GUAIFENESIN | 1.2 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0059714 | ULTRALAN SLB | Ultralan - Salbe | 1.2.40.0.34.4.17:12899 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC05 | Fluocortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709368 | FLUOCORTOLON HEXANOAT | 1.2.40.0.34.5.221:100000092391 | FLUOCORTOLONE CAPROATE | active | 0.25 | g | 1.2.40.0.34.5.221:100000092391 | FLUOCORTOLONE CAPROATE | 0.25 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:121949002 | 1.2.40.0.34.5.156:1706463 | FLUOCORTOLON | 1.2.40.0.34.5.221:100000080734 | FLUOCORTOLONE | active | 0.262 | g | 1.2.40.0.34.5.221:100000080734 | FLUOCORTOLONE | 0.262 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0060048 | URALYT-U GRAN | Uralyt U - Granulat | 1.2.40.0.34.4.17:13320 | GA - zugelassen | Viatris Austria GmbH | true | true | 280 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:G04BC | Harnkonkrement lösende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705857 | HEXAKALIUMHEXANATRIUMTRIHYDROGENPENTACITRAT | 1.2.40.0.34.5.221:100000078010 | POTASSIUM SODIUM HYDROGEN CITRATE | active | 271.9024 | g | 1.2.40.0.34.5.221:100000078010 | POTASSIUM SODIUM HYDROGEN CITRATE | 271.9024 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073365 | Granulat zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:922321001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0060114 | URBASON TBL 4MG | Urbason 4 mg Tabletten | 1.2.40.0.34.4.17:10807 | GA - zugelassen | Fidia Farmaceutici S.p.A. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB04 | Methylprednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709015 | METHYLPREDNISOLON | 1.2.40.0.34.5.221:100000091803 | METHYLPREDNISOLONE | active | 4 | mg | 1.2.40.0.34.5.221:100000091803 | METHYLPREDNISOLONE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120953002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0060120 | URBASON TBL 4MG | Urbason 4 mg Tabletten | 1.2.40.0.34.4.17:10807 | GA - zugelassen | Fidia Farmaceutici S.p.A. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB04 | Methylprednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709015 | METHYLPREDNISOLON | 1.2.40.0.34.5.221:100000091803 | METHYLPREDNISOLONE | active | 4 | mg | 1.2.40.0.34.5.221:100000091803 | METHYLPREDNISOLONE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120953001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0061504 | VENORUTON TR | Venoruton - Tropfen | 1.2.40.0.34.4.17:13997 | GA - aufgehoben | Haleon - Gebro Consumer Health GmbH | false | false | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C05CA01 | Rutoside | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710572 | O-(BETA-HYDROXYETHYL)RUTOSIDE | 1.2.40.0.34.5.221:100000129760 | O-BETA-HYDROXYETHYL-RUTOSIDE | active | 0.1 | g | 1.2.40.0.34.5.221:100000129760 | O-BETA-HYDROXYETHYL-RUTOSIDE | 0.1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | false | human | 1.2.40.0.34.4.26:122153001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0061935 | VERTIROSAN DRG 50MG | Vertirosan 50 mg - Dragees | 1.2.40.0.34.4.17:6990 | GA - zugelassen | UMIP Limited | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AA02 | Diphenhydramin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709065 | DIMENHYDRINAT | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | active | 50 | mg | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:127726002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0061941 | VERTIROSAN DRG 50MG | Vertirosan 50 mg - Dragees | 1.2.40.0.34.4.17:6990 | GA - zugelassen | UMIP Limited | true | true | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AA02 | Diphenhydramin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709065 | DIMENHYDRINAT | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | active | 50 | mg | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:127726003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0061958 | VERTIROSAN SUPP 100MG | Vertirosan 100 mg - Zäpfchen | 1.2.40.0.34.4.17:6991 | GA - zugelassen | UMIP Limited | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AA02 | Diphenhydramin | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709065 | DIMENHYDRINAT | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | active | 100 | mg | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:128115001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0061964 | VERTIROSAN SUPP 50MG KIND | Vertirosan 50 mg - Zäpfchen für Kinder | 1.2.40.0.34.4.17:6992 | GA - zugelassen | UMIP Limited | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AA02 | Diphenhydramin | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709065 | DIMENHYDRINAT | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | active | 50 | mg | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:128114001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0061970 | VERTIROSAN B6 VIT MDRG | Vertirosan Vitamin B6 - Manteldragees | 1.2.40.0.34.4.17:11830 | GA - zugelassen | UMIP Limited | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AA52 | Diphenhydramin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:126272001 | 1.2.40.0.34.5.156:1709065 | DIMENHYDRINAT | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | active | 50 | mg | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0061987 | VERTIROSAN B6 VIT MDRG | Vertirosan Vitamin B6 - Manteldragees | 1.2.40.0.34.4.17:11830 | GA - zugelassen | UMIP Limited | true | true | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AA52 | Diphenhydramin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:126272003 | 1.2.40.0.34.5.156:1709065 | DIMENHYDRINAT | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | active | 50 | mg | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0062283 | VILAN AMP 1ML | Vilan - Ampullen | 1.2.40.0.34.4.17:9764 | GA - aufgehoben | G.L. Pharma GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N02AA04 | Nicomorphin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073572 | epidurale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1707563 | NICOMORPHIN HYDROCHLORID | 1.2.40.0.34.5.221:100000086038 | NICOMORPHINE HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000086038 | NICOMORPHINE HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:126820001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0062308 | VILAN SUPP 10MG | Vilan - Zäpfchen | 1.2.40.0.34.4.17:9921 | GA - aufgehoben | G.L. Pharma GmbH | false | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N02AA04 | Nicomorphin | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1707563 | NICOMORPHIN HYDROCHLORID | 1.2.40.0.34.5.221:100000086038 | NICOMORPHINE HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000086038 | NICOMORPHINE HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:126926001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0062314 | VILAN TBL 5MG | Vilan - Tabletten | 1.2.40.0.34.4.17:9922 | GA - aufgehoben | G.L. Pharma GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N02AA04 | Nicomorphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707563 | NICOMORPHIN HYDROCHLORID | 1.2.40.0.34.5.221:100000086038 | NICOMORPHINE HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000086038 | NICOMORPHINE HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:920669001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0062403 | VISADRON AU-TR | Visadron - Augentropfen | 1.2.40.0.34.4.17:8753 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:S01GA05 | Phenylephrin | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1708484 | PHENYLEPHRINHYDROCHLORID | 1.2.40.0.34.5.221:100000090176 | PHENYLEPHRINE HYDROCHLORIDE | active | 125 | mg | 1.2.40.0.34.5.221:100000090176 | PHENYLEPHRINE HYDROCHLORIDE | 125 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | false | human | 1.2.40.0.34.4.26:920045001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0062886 | VOLON TBL 4MG | Volon 4 mg - Tabletten | 1.2.40.0.34.4.17:13566 | GA - zugelassen | Dermapharm GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB08 | Triamcinolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709241 | TRIAMCINOLON | 1.2.40.0.34.5.221:100000092178 | TRIAMCINOLONE | active | 4 | mg | 1.2.40.0.34.5.221:100000092178 | TRIAMCINOLONE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120447002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0062900 | VOLON TBL 8MG | Volon 8 mg - Tabletten | 1.2.40.0.34.4.17:14347 | GA - zugelassen | Dermapharm GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB08 | Triamcinolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709241 | TRIAMCINOLON | 1.2.40.0.34.5.221:100000092178 | TRIAMCINOLONE | active | 8 | mg | 1.2.40.0.34.5.221:100000092178 | TRIAMCINOLONE | 8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:127003001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0062917 | VOLON TBL 8MG | Volon 8 mg - Tabletten | 1.2.40.0.34.4.17:14347 | GA - zugelassen | Dermapharm GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB08 | Triamcinolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709241 | TRIAMCINOLON | 1.2.40.0.34.5.221:100000092178 | TRIAMCINOLONE | active | 8 | mg | 1.2.40.0.34.5.221:100000092178 | TRIAMCINOLONE | 8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:127003002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0062975 | VOLON-A AMP 10MG/1ML | Volon A 10 mg - Kristallsuspension - Ampulle | 1.2.40.0.34.4.17:13039 | GA - zugelassen | Dermapharm GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB08 | Triamcinolon | 1.2.40.0.10.1.4.3.4.3.4:100000073597 | intraläsionale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000002 | subläsionale Anwendung | 1.2.40.0.34.5.156:1708563 | TRIAMCINOLON ACETONID | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:128741001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0062981 | VOLON-A AMP 40MG/1ML | Volon A 40 mg - Kristallsuspension - Ampulle | 1.2.40.0.34.4.17:14008 | GA - zugelassen | Dermapharm GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB08 | Triamcinolon | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000002 | subläsionale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | 1.2.40.0.34.5.156:1708563 | TRIAMCINOLON ACETONID | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:123662002 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0063532 | XYLOCAIN GEL 2% | Xylocain 2 % - Gel | 1.2.40.0.34.4.17:8456 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:N01BB02 | Lidocain | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | 1.2.40.0.34.5.156:7211713 | LIDOCAIN HYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | active | 0.639 | g | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | 0.639 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:121572001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0063578 | XYLOCAIN VISCOES OR 2% | Xylocain - viscös oral 2 % | 1.2.40.0.34.4.17:8840 | GA - aufgehoben | Aspen Pharma Trading Limited | false | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N01BB02 | Lidocain | 1.2.40.0.10.1.4.3.4.3.4:100000073621 | zur Anwendung im Mund- und Rachenraum | | | | | 1.2.40.0.34.5.156:1708657 | LIDOCAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | active | 2 | g | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | 2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073673 | Gurgellösung | true | human | 1.2.40.0.34.4.26:121574001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0063584 | XYLONEURAL AMP 5ML | Xyloneural - Ampullen | 1.2.40.0.34.4.17:14379 | GA - zugelassen | Gebro Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01BB02 | Lidocain | 1.2.40.0.10.1.4.3.4.3.4:100000073595 | intradermale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073624 | perineurale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000003 | perivasale Anwendung | 1.2.40.0.34.5.156:7211713 | LIDOCAIN HYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | active | 53.3 | mg | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | 53.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:126687001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073623 | periartikuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075554 | submuköse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0063638 | ZYLORIC TBL 100MG | Zyloric 100 mg - Tabletten | 1.2.40.0.34.4.17:13512 | GA - aufgehoben | Aspen Pharma Trading Limited | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M04AA01 | Allopurinol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709057 | ALLOPURINOL | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122429001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0063650 | ZYMAFLUOR TBL 0,25MG | Zymafluor 0,25 mg - Tabletten | 1.2.40.0.34.4.17:8423 | GA - zugelassen | Viatris Austria GmbH | true | true | 300 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:A01AA01 | Natriumfluorid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708898 | NATRIUMFLUORID | 1.2.40.0.34.5.221:100000091554 | SODIUM FLUORIDE | active | 0.553 | mg | 1.2.40.0.34.5.221:100000091554 | SODIUM FLUORIDE | 0.553 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | false | human | 1.2.40.0.34.4.26:122692001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0063756 | HIRUDOID GEL | Hirudoid Gel | 1.2.40.0.34.4.17:14830 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA01 | Heparinoide | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705406 | MUCOPOLYSACCHARIDPOLYSCHWEFELSÄUREESTER | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | active | 0.12 | g | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | 0.12 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:921777004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0063816 | THROMBOPHOB GEL | Thrombophob - Gel | 1.2.40.0.34.4.17:14865 | GA - zugelassen | Nordmark Pharma GmbH | true | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA03 | Heparin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 4.84 | g | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 4.84 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:124526001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0063880 | LANITOP AMP 0,2MG 2ML | Lanitop 0,2 mg - Ampullen | 1.2.40.0.34.4.17:14952 | GA - zugelassen | Herbrand PharmaChemicals GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C01AA08 | Metildigoxin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708866 | METILDIGOXIN | 1.2.40.0.34.5.221:100000091460 | METILDIGOXIN | active | 0.2 | mg | 1.2.40.0.34.5.221:100000091460 | METILDIGOXIN | 0.2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:121771003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0063928 | LIORESAL TBL 10MG | Lioresal 10 mg - Tabletten | 1.2.40.0.34.4.17:14892 | GA - zugelassen | Novartis Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M03BX01 | Baclofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708544 | BACLOFEN | 1.2.40.0.34.5.221:100000090335 | BACLOFEN | active | 10 | mg | 1.2.40.0.34.5.221:100000090335 | BACLOFEN | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123129001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0063934 | LIORESAL TBL 25MG | Lioresal 25 mg - Tabletten | 1.2.40.0.34.4.17:14893 | GA - zugelassen | Novartis Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M03BX01 | Baclofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708544 | BACLOFEN | 1.2.40.0.34.5.221:100000090335 | BACLOFEN | active | 25 | mg | 1.2.40.0.34.5.221:100000090335 | BACLOFEN | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123130001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0064081 | SOLCOSERYL SLB 5% | Solcoseryl Salbe | 1.2.40.0.34.4.17:11673 | GA - zugelassen | Viatris Austria GmbH | true | false | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D03AX | Andere Wundbehandlungsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1710184 | DEPROTEINISIERTES HAEMODERIVAT AUS KÄLBERBLUT | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | active | 4.14 | g | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | 4.14 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:921325001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0064129 | TEMESTA TBL 1MG | Temesta 1,0 mg - Tabletten | 1.2.40.0.34.4.17:14794 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA06 | Lorazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709228 | LORAZEPAM | 1.2.40.0.34.5.221:100000092162 | LORAZEPAM | active | 1 | mg | 1.2.40.0.34.5.221:100000092162 | LORAZEPAM | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:121304001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0064135 | TEMESTA TBL 1MG | Temesta 1,0 mg - Tabletten | 1.2.40.0.34.4.17:14794 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA06 | Lorazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709228 | LORAZEPAM | 1.2.40.0.34.5.221:100000092162 | LORAZEPAM | active | 1 | mg | 1.2.40.0.34.5.221:100000092162 | LORAZEPAM | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:121304003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0064141 | TEMESTA TBL 2,5MG | Temesta 2,5 mg - Tabletten | 1.2.40.0.34.4.17:14795 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA06 | Lorazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709228 | LORAZEPAM | 1.2.40.0.34.5.221:100000092162 | LORAZEPAM | active | 2.5 | mg | 1.2.40.0.34.5.221:100000092162 | LORAZEPAM | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:121305001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0064359 | CE-LIMO ORANGE BRTBL | Ce-Limo Orange - Brausetabletten | 1.2.40.0.34.4.17:14876 | GA - zugelassen | Viatris Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:A11GA01 | Ascorbinsäure (Vitamin C) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 1000 | mg | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073681 | Brausetablette | false | human | 1.2.40.0.34.4.26:120292001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0064365 | CE-LIMO ORANGE BRTBL 3X10 | Ce-Limo Orange - Brausetabletten | 1.2.40.0.34.4.17:14876 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:A11GA01 | Ascorbinsäure (Vitamin C) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 1000 | mg | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073681 | Brausetablette | false | human | 1.2.40.0.34.4.26:120292002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0064543 | EUSAPRIM SUS OR KIND | Eusaprim orale Suspension für Kinder | 1.2.40.0.34.4.17:14631 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01EE01 | Sulfamethoxazol und Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | 400 | mg | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:122417002 | 1.2.40.0.34.5.156:1709475 | SULFAMETHOXAZOL | 1.2.40.0.34.5.221:100000092618 | SULFAMETHOXAZOLE | active | 2000 | mg | 1.2.40.0.34.5.221:100000092618 | SULFAMETHOXAZOLE | 2000 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0065293 | COLDISTOP NA-OEL | Coldistop Nasenöl | 1.2.40.0.34.4.17:14956 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AX30 | Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1706334 | ALPHA-TOCOPHEROLACETAT | 1.2.40.0.34.5.221:100000079921 | ALPHATOCOPHEROL ACETATE | active | 200 | mg | 1.2.40.0.34.5.221:100000079921 | ALPHATOCOPHEROL ACETATE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073794 | Nasentropfen, Lösung | true | human | 1.2.40.0.34.4.26:126271001 | 1.2.40.0.34.5.156:1708781 | RETINOLPALMITAT | 1.2.40.0.34.5.221:100000091269 | RETINOL PALMITATE | active | 150 | mg | 1.2.40.0.34.5.221:100000091269 | RETINOL PALMITATE | 150 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0065459 | ANXIOLIT TBL FTE 50MG | Anxiolit forte 50 mg - Tabletten | 1.2.40.0.34.4.17:14857 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA04 | Oxazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709067 | OXAZEPAM | 1.2.40.0.34.5.221:100000091921 | OXAZEPAM | active | 50 | mg | 1.2.40.0.34.5.221:100000091921 | OXAZEPAM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:121195001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0065525 | BETASERC TBL 8MG | Betaserc 8 mg - Tabletten | 1.2.40.0.34.4.17:14785 | GA - zugelassen | Viatris Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N07CA01 | Betahistin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708429 | BETAHISTIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000089998 | BETAHISTINE DIHYDROCHLORIDE | active | 8 | mg | 1.2.40.0.34.5.221:100000089998 | BETAHISTINE DIHYDROCHLORIDE | 8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:126634002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0065548 | BURONIL FTBL 25MG | Buronil 25 mg - Filmtabletten | 1.2.40.0.34.4.17:14476 | GA - zugelassen | Medilink A/S | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:N05AD03 | Melperon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709160 | MELPERON HYDROCHLORID | 1.2.40.0.34.5.221:100000092068 | MELPERONE HYDROCHLORIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000092068 | MELPERONE HYDROCHLORIDE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124003001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0066016 | QUILONORM RET TBL | Quilonorm retard 450 mg - Filmtabletten | 1.2.40.0.34.4.17:14721 | GA - zugelassen | Teofarma S.r.l. | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N05AN01 | Lithium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708906 | LITHIUMCARBONAT | 1.2.40.0.34.5.221:100000091569 | LITHIUM CARBONATE | active | 450 | mg | 1.2.40.0.34.5.221:100000091569 | LITHIUM CARBONATE | 450 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:123019001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0066453 | CALMURID SLB | Calmurid - Salbe | 1.2.40.0.34.4.17:15010 | GA - aufgehoben | Galderma International | false | false | 50 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D02AE51 | Harnstoff, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707758 | MILCHSÄURE | 1.2.40.0.34.5.221:100000087110 | LACTIC ACID | active | 5 | g | 1.2.40.0.34.5.221:100000087110 | LACTIC ACID | 5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:128393002 | 1.2.40.0.34.5.156:1709102 | HARNSTOFF | 1.2.40.0.34.5.221:100000091977 | UREA | active | 10 | g | 1.2.40.0.34.5.221:100000091977 | UREA | 10 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0066476 | CLOMIPHEN ARC TBL | Clomiphen Arcana Tabletten | 1.2.40.0.34.4.17:14669 | GA - zugelassen | Arcana Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03GB02 | Clomifen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708650 | CLOMIFEN DIHYDROGENCITRAT | 1.2.40.0.34.5.221:100000090573 | CLOMIFENE CITRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000090573 | CLOMIFENE CITRATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124304001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0066499 | COMBANTRIN SUS OR | Combantrin 250 mg/5 ml Suspension zum Einnehmen | 1.2.40.0.34.4.17:14823 | GA - zugelassen | INFECTOPHARM Arzneimittel und Consilium GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:P02CC01 | Pyrantel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708155 | PYRANTEL EMBONAT | 1.2.40.0.34.5.221:100000089059 | PYRANTEL EMBONATE | active | 1.44 | g | 1.2.40.0.34.5.221:100000089059 | PYRANTEL EMBONATE | 1.44 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:121159001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0066795 | REFOBACIN AMP 80MG 2ML | Refobacin 80 mg - Ampullen | 1.2.40.0.34.4.17:14375 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 133.3 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 94.032219 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:123029003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0067091 | ALDACTONE UEBERZ.TBL 50MG | Aldactone 50 mg - überzogene Tabletten | 1.2.40.0.34.4.17:15037 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03DA01 | Spironolacton | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 50 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:121357001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0067116 | ALDACTONE UEBERZ.TBL 50MG | Aldactone 50 mg - überzogene Tabletten | 1.2.40.0.34.4.17:15037 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03DA01 | Spironolacton | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 50 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:121357002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0067180 | HIRUDOID SLB | Hirudoid - Salbe | 1.2.40.0.34.4.17:8527 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA01 | Heparinoide | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705406 | MUCOPOLYSACCHARIDPOLYSCHWEFELSÄUREESTER | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | active | 0.3 | g | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:121004003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0067292 | RIFOLDIN SIR 20MG/ML | Rifoldin Sirup | 1.2.40.0.34.4.17:14759 | GA - zugelassen | Sanofi-Aventis GmbH | true | false | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J04AB02 | Rifampicin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706447 | RIFAMPICIN | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | active | 1.2 | g | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | 1.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073652 | Sirup | true | human | 1.2.40.0.34.4.26:122944002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0067352 | ZYMAFLUOR TBL 1MG | Zymafluor 1 mg - Tabletten | 1.2.40.0.34.4.17:11027 | GA - zugelassen | Viatris Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:A01AA01 | Natriumfluorid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708898 | NATRIUMFLUORID | 1.2.40.0.34.5.221:100000091554 | SODIUM FLUORIDE | active | 2.211 | mg | 1.2.40.0.34.5.221:100000091554 | SODIUM FLUORIDE | 2.211 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | false | human | 1.2.40.0.34.4.26:121214001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0067553 | OSPEN- 400 SFT | Ospen 400 - Saft | 1.2.40.0.34.4.17:15094 | GA - zugelassen | Sandoz GmbH | true | true | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707357 | PHENOXYMETHYLPENICILLIN BENZATHIN | 1.2.40.0.34.5.221:100000085294 | PHENOXYMETHYLPENICILLIN BENZATHINE | active | 4.368 | g | 1.2.40.0.34.5.221:100000085294 | PHENOXYMETHYLPENICILLIN BENZATHINE | 4.368 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:121060001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0067932 | PK-MERZ FTBL | PK - Merz - Schoeller 100 mg Filmtabletten | 1.2.40.0.34.4.17:15018 | GA - zugelassen | Merz Pharma Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N04BB01 | Amantadin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709202 | AMANTADIN SULFAT | 1.2.40.0.34.5.221:100000092128 | AMANTADINE SULFATE | active | 100 | mg | 1.2.40.0.34.5.221:100000092128 | AMANTADINE SULFATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:129849002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0068340 | SYNACTHEN AMP 0,25MG/1ML | Synacthen 0,25 mg/1 ml Ampulle | 1.2.40.0.34.4.17:13387 | GA - zugelassen | Alfasigma S.p.A. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H01AA02 | Tetracosactid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1707311 | TETRACOSACTID | 1.2.40.0.34.5.221:100000085201 | TETRACOSACTIDE | active | 0.28 | mg | 1.2.40.0.34.5.221:100000085201 | TETRACOSACTIDE | 0.28 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:123220001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0068481 | CELESTAN BIPHASE AMP 1ML | Celestan biphase 5,7 mg/ml Injektionssuspension | 1.2.40.0.34.4.17:14257 | GA - zugelassen | Organon Healthcare GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073597 | intraläsionale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000007 | intratendineale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073595 | intradermale Anwendung | 1.2.40.0.34.5.156:1708451 | BETAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | active | 3.945 | mg | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | 3.945 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:120680001 | 1.2.40.0.34.5.156:1707190 | BETAMETHASON ACETAT | 1.2.40.0.34.5.221:100000084907 | BETAMETHASONE ACETATE | active | 3 | mg | 1.2.40.0.34.5.221:100000084907 | BETAMETHASONE ACETATE | 3 | mg | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073623 | periartikuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073589 | intrabursale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0068788 | NEDA FRWUERFEL | Neda-Früchtewürfel | 1.2.40.0.34.4.17:7436 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A06AB06 | Sennoside | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708673 | SENNAE FOLIUM | 1.2.40.0.34.5.221:100000090680 | SENNAE FOLIUM | active | 0.5 | g | 1.2.40.0.34.5.221:100000090680 | SENNAE FOLIUM | 0.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073684 | Kautablette | true | human | 1.2.40.0.34.4.26:122934002 | 1.2.40.0.34.5.156:1712672 | SENNAE FRUCTUS | 1.2.40.0.34.5.221:900000004286 | SENNAE FRUCTUS | active | 0.5 | g | 1.2.40.0.34.5.221:900000004286 | SENNAE FRUCTUS | 0.5 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0069084 | TEMESTA TBL 2,5MG | Temesta 2,5 mg - Tabletten | 1.2.40.0.34.4.17:14795 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA06 | Lorazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709228 | LORAZEPAM | 1.2.40.0.34.5.221:100000092162 | LORAZEPAM | active | 2.5 | mg | 1.2.40.0.34.5.221:100000092162 | LORAZEPAM | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:121305002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0069397 | FERRO-GRADUMET FTBL | Ferro - Gradumet 105 mg Filmtabletten | 1.2.40.0.34.4.17:14076 | GA - zugelassen | Teofarma S.r.l. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B03AA07 | Eisen(II)sulfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705968 | EISEN(II)-SULFAT | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | active | 325 | mg | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | 325 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:120005001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0069434 | LEPONEX TBL 25MG | Leponex 25 mg - Tabletten | 1.2.40.0.34.4.17:15132 | GA - zugelassen | Viatris Healthcare Limited | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AH02 | Clozapin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709562 | CLOZAPIN | 1.2.40.0.34.5.221:100000092795 | CLOZAPINE | active | 25 | mg | 1.2.40.0.34.5.221:100000092795 | CLOZAPINE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122034031 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0069664 | CRATAEGUTT TR | Crataegutt - Tropfen | 1.2.40.0.34.4.17:9789 | GA - aufgehoben | Austroplant-Arzneimittel GmbH | false | false | 250 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C01EB | Andere Herzmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710151 | CRATAEGI FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000000382 | CRATAEGI FRUCTUS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000382 | CRATAEGI FRUCTUS (EXTRACT) | | | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | false | human | 1.2.40.0.34.4.26:125495001 | 1.2.40.0.34.5.156:1710150 | CRATAEGI FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000381 | CRATAEGI FOLIUM (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000381 | CRATAEGI FOLIUM (EXTRACT) | | | 1.2.40.0.34.5.156:1710153 | CRATAEGI OXYACANTHAE FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000000384 | CRATAEGI OXYACANTHAE FLOS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000384 | CRATAEGI OXYACANTHAE FLOS (EXTRACT) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0069813 | SAROTEN RET KPS 25MG | Saroten Retard 25 mg - Kapseln | 1.2.40.0.34.4.17:15089 | GA - aufgehoben | Lundbeck Austria GmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N06AA09 | Amitriptylin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708532 | AMITRIPTYLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090311 | AMITRIPTYLINE HYDROCHLORIDE | active | 28.28 | mg | 1.2.40.0.34.5.221:100000090311 | AMITRIPTYLINE HYDROCHLORIDE | 28.28 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:122994002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0069919 | URBASON TBL 40MG | Urbason 40 mg Tabletten | 1.2.40.0.34.4.17:12208 | GA - zugelassen | Fidia Farmaceutici S.p.A. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB04 | Methylprednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709015 | METHYLPREDNISOLON | 1.2.40.0.34.5.221:100000091803 | METHYLPREDNISOLONE | active | 40 | mg | 1.2.40.0.34.5.221:100000091803 | METHYLPREDNISOLONE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120952001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0070147 | AKINETON RET FTBL 4MG | Akineton 4 mg - Retardtabletten | 1.2.40.0.34.4.17:15197 | GA - zugelassen | Desma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N04AA02 | Biperiden | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708527 | BIPERIDEN HYDROCHLORID | 1.2.40.0.34.5.221:100000090297 | BIPERIDEN HYDROCHLORIDE | active | 4 | mg | 1.2.40.0.34.5.221:100000090297 | BIPERIDEN HYDROCHLORIDE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:122123004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0070420 | SCOTTOPECT HU-SFT | Scottopect - Hustensaft | 1.2.40.0.34.4.17:735227 | GA - registriert | Orifarm Healthcare A/S | true | true | 200 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CA10 | Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712642 | PLANTAGINIS LANCEOLATAE FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000004203 | PLANTAGINIS LANCEOLATAE FOLIUM (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000004203 | PLANTAGINIS LANCEOLATAE FOLIUM (EXTRACT) | | | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | false | human | 1.2.40.0.34.4.26:958425001 | 1.2.40.0.34.5.156:1712655 | SERPYLLI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000004241 | SERPYLLI HERBA (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000004241 | SERPYLLI HERBA (EXTRACT) | | | 1.2.40.0.34.5.156:1712761 | MISCHEXTRAKT | 1.2.40.0.34.5.221:900000004454 | MIXED EXTRACT | active | 1200 | g | 1.2.40.0.34.5.221:900000004454 | MIXED EXTRACT | 1200 | g | | | | | | | 1.2.40.0.34.5.156:1710828 | THYMI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001063 | THYMI HERBA (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000001063 | THYMI HERBA (EXTRACT) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0070437 | SOLU-DACORTIN PLV+LSM 250MG | Solu - Dacortin 250 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung oder Infusionslösung | 1.2.40.0.34.4.17:15085 | GA - zugelassen | Merck Ges.m.b.H. | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709059 | NATRIUM PREDNISOLON SUCCINAT | 1.2.40.0.34.5.221:100000091910 | PREDNISOLONE SODIUM SUCCINATE | active | 250 | mg | 1.2.40.0.34.5.221:100000091910 | PREDNISOLONE SODIUM SUCCINATE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:125955001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0070733 | OSPEN-1500 FTBL | Ospen 1500 - Filmtabletten | 1.2.40.0.34.4.17:15203 | GA - aufgehoben | Sandoz GmbH | false | false | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708554 | PHENOXYMETHYLPENICILLIN | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | active | 882 | mg | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | 882 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:120569002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0071129 | TROMMCARDIN FTBL | Trommcardin - Filmtabletten | 1.2.40.0.34.4.17:15016 | GA - zugelassen | Jacoby GM Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01EX | Andere Herzmittel, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705588 | MAGNESIUM HYDROGENASPARTAT | 1.2.40.0.34.5.221:100000076822 | MAGNESIUM HYDROGEN ASPARTATE | active | 360.57 | mg | 1.2.40.0.34.5.221:100000076822 | MAGNESIUM HYDROGEN ASPARTATE | 360.57 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:120903001 | 1.2.40.0.34.5.156:1706196 | KALIUM HYDROGENASPARTAT | 1.2.40.0.34.5.221:100000079418 | POTASSIUM HYDROGEN ASPARTATE | active | 360.42 | mg | 1.2.40.0.34.5.221:100000079418 | POTASSIUM HYDROGEN ASPARTATE | 360.42 | mg | | | | | | | | | | | | 2.16.840.1.113883.6.73:A12CC05 | Magnesiumaspartat | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:A12BA | Kalium | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0071158 | ALKA-SELTZER BRTLB | Alka-Seltzer - Brausetabletten | 1.2.40.0.34.4.17:8050 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:N02BA01 | Acetylsalicylsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 324 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 324 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073681 | Brausetablette | true | human | 1.2.40.0.34.4.26:123227001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0071810 | DAKTARIN CR 2% | Daktarin 2 % - Creme | 1.2.40.0.34.4.17:15307 | GA - zugelassen | Johnson & Johnson Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D01AC02 | Miconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709041 | MICONAZOL NITRAT | 1.2.40.0.34.5.221:100000091859 | MICONAZOLE NITRATE | active | 600 | mg | 1.2.40.0.34.5.221:100000091859 | MICONAZOLE NITRATE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | false | human | 1.2.40.0.34.4.26:120553002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0071951 | HIRUDOID GEL | Hirudoid Gel | 1.2.40.0.34.4.17:14830 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA01 | Heparinoide | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705406 | MUCOPOLYSACCHARIDPOLYSCHWEFELSÄUREESTER | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | active | 0.3 | g | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:921777003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0072040 | PRAXITEN TBL 50MG | Praxiten 50 mg - Tabletten | 1.2.40.0.34.4.17:13963 | GA - zugelassen | Viatris Austria GmbH | true | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA04 | Oxazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709067 | OXAZEPAM | 1.2.40.0.34.5.221:100000091921 | OXAZEPAM | active | 50 | mg | 1.2.40.0.34.5.221:100000091921 | OXAZEPAM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922996001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0072413 | KAMILLOSAN TR | Kamillosan-Flüssigkeit | 1.2.40.0.34.4.17:1660 | GA - aufgehoben | MEDA Pharma GmbH | false | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D02AX | Andere Emollientia und Hautschutzmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706736 | LEVOMENOL | 1.2.40.0.34.5.221:100000082277 | LEVOMENOL | active | 0.09 | g | 1.2.40.0.34.5.221:100000082277 | LEVOMENOL | 0.09 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073950 | Flüssigkeit zur Anwendung in der Mundhöhle | false | human | 1.2.40.0.34.4.26:120642001 | 1.2.40.0.34.5.156:1710480 | MATRICARIAE FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000000713 | MATRICARIAE FLOS (EXTRACT) | active | 99.1835 | g | 1.2.40.0.34.5.221:900000000713 | MATRICARIAE FLOS (EXTRACT) | 99.1835 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073854 | Flüssigkeit zur Herstellung eines Dampfs zur Inhalation | 1.2.40.0.10.1.4.3.4.3.5:100000073645 | Flüssigkeit zum Einnehmen | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073717 | Flüssigkeit zur Anwendung auf der Haut | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0072643 | X-PREP OR LSG | X-Prep Lösung zum Einnehmen | 1.2.40.0.34.4.17:14756 | GA - aufgehoben | Mundipharma Ges.m.b.H. | false | false | 75 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A06AB06 | Sennoside | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712673 | SENNAE FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000004287 | SENNAE FRUCTUS (AUSZUG) | active | | | 1.2.40.0.34.5.221:900000004287 | SENNAE FRUCTUS (AUSZUG) | | | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:129541001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0072821 | FERROGRAD-FOL FTBL | Ferrograd - Fol 105 mg / 0,35 mg Filmtabletten | 1.2.40.0.34.4.17:14814 | GA - zugelassen | Teofarma S.r.l. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B03AD03 | Eisen(II)sulfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707468 | FOLSÄURE | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | active | 0.35 | mg | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | 0.35 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:129431001 | 1.2.40.0.34.5.156:1705968 | EISEN(II)-SULFAT | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | active | 325 | mg | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | 325 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0072850 | MUNDISAL GEL | Mundisal Gel | 1.2.40.0.34.4.17:15079 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | true | 8 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:A01AD11 | Verschiedene | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:1709237 | CHOLIN SALICYLAT | 1.2.40.0.34.5.221:100000092173 | CHOLINE SALICYLATE | active | 696.8 | mg | 1.2.40.0.34.5.221:100000092173 | CHOLINE SALICYLATE | 696.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:921872001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0072962 | BEKUNIS DRG | Bekunis - Dragees | 1.2.40.0.34.4.17:1-18940 | GA - aufgehoben | Roha Arzneimittel GmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A06AB06 | Sennoside | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:6987761 | SENNAE FRUCTUS ANGUSTIFOLIAE (AUSZUG) | 1.2.40.0.34.5.221:900000004239 | SENNAE FRUCTUS ANGUSTIFOLIAE (EXTRACT) | active | 150 | mg | 1.2.40.0.34.5.221:900000004239 | SENNAE FRUCTUS ANGUSTIFOLIAE (EXTRACT) | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:923715001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0073016 | LASIX TBL 40MG | Lasix 40 mg Tabletten | 1.2.40.0.34.4.17:12585 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03CA01 | Furosemid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:121649001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0073134 | NOVOTHYRAL TBL | Novothyral - Tabletten | 1.2.40.0.34.4.17:15364 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA03 | Kombinationen von Levothyroxin und Liothyronin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708423 | NATRIUM LIOTHYRONINAT | 1.2.40.0.34.5.221:100000089973 | LIOTHYRONINE SODIUM | active | 0.02 | mg | 1.2.40.0.34.5.221:100000089973 | LIOTHYRONINE SODIUM | 0.02 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123715002 | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.1 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.1 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0073252 | AKTIFERRIN KPS | Aktiferrin - Kapseln | 1.2.40.0.34.4.17:15246 | GA - aufgehoben | Teva B.V. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B03AE10 | Verschiedene Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705968 | EISEN(II)-SULFAT | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | active | 109.116 | | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | 109.116 | | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | true | human | 1.2.40.0.34.4.26:121691001 | 1.2.40.0.34.5.156:1707010 | SERIN | 1.2.40.0.34.5.221:100000084137 | SERINE | active | 129 | mg | 1.2.40.0.34.5.221:100000084137 | SERINE | 129 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0073269 | AKTIFERRIN KPS | Aktiferrin - Kapseln | 1.2.40.0.34.4.17:15246 | GA - aufgehoben | Teva B.V. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B03AE10 | Verschiedene Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705968 | EISEN(II)-SULFAT | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | active | 109.116 | | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | 109.116 | | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | true | human | 1.2.40.0.34.4.26:121691002 | 1.2.40.0.34.5.156:1707010 | SERIN | 1.2.40.0.34.5.221:100000084137 | SERINE | active | 129 | mg | 1.2.40.0.34.5.221:100000084137 | SERINE | 129 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0073401 | NOVOTHYRAL TBL | Novothyral - Tabletten | 1.2.40.0.34.4.17:15364 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA03 | Kombinationen von Levothyroxin und Liothyronin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708423 | NATRIUM LIOTHYRONINAT | 1.2.40.0.34.5.221:100000089973 | LIOTHYRONINE SODIUM | active | 0.02 | mg | 1.2.40.0.34.5.221:100000089973 | LIOTHYRONINE SODIUM | 0.02 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123715001 | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.1 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.1 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0073476 | UROSIN TBL 100MG | Urosin 100 mg - Tabletten | 1.2.40.0.34.4.17:15358 | GA - zugelassen | Teofarma S.r.l. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M04AA01 | Allopurinol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709057 | ALLOPURINOL | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129390001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0073507 | ARTAMIN KPS 150MG | Artamin 150 mg - Kapseln | 1.2.40.0.34.4.17:15157 | GA - aufgehoben | Sandoz GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01CC01 | Penicillamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706759 | PENICILLAMIN | 1.2.40.0.34.5.221:100000082481 | PENICILLAMINE | active | 150 | mg | 1.2.40.0.34.5.221:100000082481 | PENICILLAMINE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:122376001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0073602 | GYNODIAN DEP FSPR 1ML | Gynodian Depot - Fertigspritze | 1.2.40.0.34.4.17:15426 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:G03EA03 | Prasteron und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708616 | ESTRADIOL VALERAT | 1.2.40.0.34.5.221:100000090493 | ESTRADIOL VALERATE | active | 4 | mg | 1.2.40.0.34.5.221:100000090493 | ESTRADIOL VALERATE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:125730001 | 1.2.40.0.34.5.156:1707427 | PRASTERON ENANTAT | 1.2.40.0.34.5.221:100000085481 | PRASTERONE ENANTATE | active | 200 | mg | 1.2.40.0.34.5.221:100000085481 | PRASTERONE ENANTATE | 200 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0073743 | CANESTEN VAG-TBL 0,1G | Canesten Clotrimazol 0,1 g - Vaginaltabletten | 1.2.40.0.34.4.17:15395 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G01AF02 | Clotrimazol | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1709166 | CLOTRIMAZOL | 1.2.40.0.34.5.221:100000092074 | CLOTRIMAZOLE | active | 100 | mg | 1.2.40.0.34.5.221:100000092074 | CLOTRIMAZOLE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073824 | Vaginaltablette | true | human | 1.2.40.0.34.4.26:126525001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0073973 | ATROVENT DOSAER 200 | Atrovent - Dosieraerosol | 1.2.40.0.34.4.17:15563 | GA - zugelassen | Boehringer Ingelheim RCV GmbH & Co KG | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:R03BB01 | Ipratropiumbromid | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1709469 | IPRATROPIUM BROMID | 1.2.40.0.34.5.221:100000092610 | IPRATROPIUM BROMIDE | active | 0.021 | mg | 1.2.40.0.34.5.221:100000092610 | IPRATROPIUM BROMIDE | 0.021 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073848 | Druckgasinhalation, Lösung | true | human | 1.2.40.0.34.4.26:120574001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0074027 | FX PASSAGE SPRUDELSALZ | F.X. Passage - Sprudelsalz | 1.2.40.0.34.4.17:15314 | GA - aufgehoben | Wörwag Pharma GmbH & Co. KG | false | false | 200 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:A06AD04 | Magnesiumsulfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709459 | MAGNESIUMSULFAT | 1.2.40.0.34.5.221:100000092599 | MAGNESIUM SULFATE | active | 30 | g | 1.2.40.0.34.5.221:100000092599 | MAGNESIUM SULFATE | 30 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073656 | Brausepulver | true | human | 1.2.40.0.34.4.26:121457001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0074197 | GUTRON TBL 5MG | Gutron 5 mg - Tabletten | 1.2.40.0.34.4.17:15434 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01CA17 | Midodrin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708518 | MIDODRIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090278 | MIDODRINE HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000090278 | MIDODRINE HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:121078004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0074292 | MICROGYNON-30 DRG | Microgynon 30 - Dragees | 1.2.40.0.34.4.17:1-15618 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 21 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AA07 | Levonorgestrel und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.03 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.03 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:120820002 | 1.2.40.0.34.5.156:1708731 | LEVONORGESTREL | 1.2.40.0.34.5.221:100000091059 | LEVONORGESTREL | active | 0.15 | mg | 1.2.40.0.34.5.221:100000091059 | LEVONORGESTREL | 0.15 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0074300 | MICROGYNON-30 DRG 3X21 | Microgynon 30 - Dragees | 1.2.40.0.34.4.17:1-15618 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 63 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AA07 | Levonorgestrel und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.03 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.03 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:120820001 | 1.2.40.0.34.5.156:1708731 | LEVONORGESTREL | 1.2.40.0.34.5.221:100000091059 | LEVONORGESTREL | active | 0.15 | mg | 1.2.40.0.34.5.221:100000091059 | LEVONORGESTREL | 0.15 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0074317 | MICROGYNON-30 DRG 6X21 | Microgynon 30 - Dragees | 1.2.40.0.34.4.17:1-15618 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 126 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AA07 | Levonorgestrel und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.03 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.03 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:120820003 | 1.2.40.0.34.5.156:1708731 | LEVONORGESTREL | 1.2.40.0.34.5.221:100000091059 | LEVONORGESTREL | active | 0.15 | mg | 1.2.40.0.34.5.221:100000091059 | LEVONORGESTREL | 0.15 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0074501 | ESSENTIALE KPS FTE | Essentiale forte - Kapseln | 1.2.40.0.34.4.17:15587 | GA - zugelassen | Opella Healthcare Austria GmbH | true | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A05BA | Lebertherapie | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710631 | PHOSPHOLIPIDE AUS SOJABOHNEN | 1.2.40.0.34.5.221:100000156707 | SOYBEAN PHOSPHOLIPIDS | active | 300 | mg | 1.2.40.0.34.5.221:100000156707 | SOYBEAN PHOSPHOLIPIDS | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:120239001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0074665 | OSPEN- 400 SFT | Ospen 400 - Saft | 1.2.40.0.34.4.17:15094 | GA - zugelassen | Sandoz GmbH | true | true | 150 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707357 | PHENOXYMETHYLPENICILLIN BENZATHIN | 1.2.40.0.34.5.221:100000085294 | PHENOXYMETHYLPENICILLIN BENZATHINE | active | 10.92 | g | 1.2.40.0.34.5.221:100000085294 | PHENOXYMETHYLPENICILLIN BENZATHINE | 10.92 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:121060002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0074688 | OSPEN-1000 FTBL | Ospen 1000 - Filmtabletten | 1.2.40.0.34.4.17:13904 | GA - aufgehoben | Sandoz GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708554 | PHENOXYMETHYLPENICILLIN | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | active | 588 | mg | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | 588 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:120116003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0074694 | OSPEN-1500 FTBL | Ospen 1500 - Filmtabletten | 1.2.40.0.34.4.17:15203 | GA - aufgehoben | Sandoz GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708554 | PHENOXYMETHYLPENICILLIN | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | active | 882 | mg | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | 882 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:120569003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0074719 | SALAZOPYRIN TBL 500MG | Salazopyrin 500 mg - Tabletten | 1.2.40.0.34.4.17:1-08860 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073530 | Mehrdosenbehältnis | 2.16.840.1.113883.6.73:A07EC01 | Sulfasalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708908 | SULFASALAZIN | 1.2.40.0.34.5.221:100000091572 | SULFASALAZINE | active | 535 | mg | 1.2.40.0.34.5.221:100000091572 | SULFASALAZINE | 535 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:127669001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0074814 | VENORUTON GEL | Venoruton - Gel | 1.2.40.0.34.4.17:15559 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05CA01 | Rutoside | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1710572 | O-(BETA-HYDROXYETHYL)RUTOSIDE | 1.2.40.0.34.5.221:100000129760 | O-BETA-HYDROXYETHYL-RUTOSIDE | active | 0.8 | g | 1.2.40.0.34.5.221:100000129760 | O-BETA-HYDROXYETHYL-RUTOSIDE | 0.8 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:122160003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0074820 | VENORUTON GEL | Venoruton - Gel | 1.2.40.0.34.4.17:15559 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05CA01 | Rutoside | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1710572 | O-(BETA-HYDROXYETHYL)RUTOSIDE | 1.2.40.0.34.5.221:100000129760 | O-BETA-HYDROXYETHYL-RUTOSIDE | active | 2 | g | 1.2.40.0.34.5.221:100000129760 | O-BETA-HYDROXYETHYL-RUTOSIDE | 2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:122160001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0075021 | COMBITHYREX TBL FTE | Combithyrex forte - Tabletten | 1.2.40.0.34.4.17:1-18085 | GA - aufgehoben | Sandoz GmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:H03AA03 | Kombinationen von Levothyroxin und Liothyronin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708423 | NATRIUM LIOTHYRONINAT | 1.2.40.0.34.5.221:100000089973 | LIOTHYRONINE SODIUM | active | 0.025 | mg | 1.2.40.0.34.5.221:100000089973 | LIOTHYRONINE SODIUM | 0.025 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120411001 | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.1 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.1 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0075038 | COMBITHYREX TBL MTE | Combithyrex mite - Tabletten | 1.2.40.0.34.4.17:1-18084 | GA - aufgehoben | Sandoz GmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:H03AA03 | Kombinationen von Levothyroxin und Liothyronin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708423 | NATRIUM LIOTHYRONINAT | 1.2.40.0.34.5.221:100000089973 | LIOTHYRONINE SODIUM | active | 0.0125 | mg | 1.2.40.0.34.5.221:100000089973 | LIOTHYRONINE SODIUM | 0.0125 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120410001 | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.05 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.05 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0075297 | SORMODREN TBL | Sormodren - Tabletten | 1.2.40.0.34.4.17:15643 | GA - zugelassen | Viatris Austria GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N04AA11 | Bornaprin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709061 | BORNAPRIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091913 | BORNAPRINE HYDROCHLORIDE | active | 4 | mg | 1.2.40.0.34.5.221:100000091913 | BORNAPRINE HYDROCHLORIDE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120465001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0075305 | SORMODREN TBL | Sormodren - Tabletten | 1.2.40.0.34.4.17:15643 | GA - zugelassen | Viatris Austria GmbH | true | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N04AA11 | Bornaprin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709061 | BORNAPRIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091913 | BORNAPRINE HYDROCHLORIDE | active | 4 | mg | 1.2.40.0.34.5.221:100000091913 | BORNAPRINE HYDROCHLORIDE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120465002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0075914 | TARDYFERON RETARDTBL 80MG | Tardyferon 80 mg Retardtabletten | 1.2.40.0.34.4.17:15668 | GA - zugelassen | Pierre Fabre Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B03AA07 | Eisen(II)sulfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7409854 | EISEN(II)-SULFAT, GETROCKNETES | 1.2.40.0.34.5.221:100000163619 | FERROUS SULFATE, DRIED | active | 247.25 | mg | 1.2.40.0.34.5.221:100000163619 | FERROUS SULFATE, DRIED | 247.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:120290001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0076196 | DIPRODERM CR | Diproderm - Creme | 1.2.40.0.34.4.17:15576 | GA - zugelassen | Organon Healthcare GmbH | true | false | 500 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASON DIPROPIONAT | active | | | 1.2.40.0.34.5.221:100000091514 | BETAMETHASON DIPROPIONAT | | | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0076204 | DIPRODERM SLB | Diproderm - Salbe | 1.2.40.0.34.4.17:15575 | GA - zugelassen | Organon Healthcare GmbH | true | false | 500 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASON DIPROPIONAT | active | | | 1.2.40.0.34.5.221:100000091514 | BETAMETHASON DIPROPIONAT | | | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0078462 | AKINETON AMP 5MG 1ML | Akineton 5 mg - Injektionslösung | 1.2.40.0.34.4.17:10234 | GA - zugelassen | Desma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N04AA02 | Biperiden | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708458 | BIPERIDEN | 1.2.40.0.34.5.221:100000090107 | BIPERIDEN | active | 3.88 | mg | 1.2.40.0.34.5.221:100000090107 | BIPERIDEN | 3.88 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:124884002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0079645 | AMPHO-MORONAL LTBL | Ampho - Moronal - Lutschtabletten | 1.2.40.0.34.4.17:15122 | GA - zugelassen | Dermapharm GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A01AB04 | Amphotericin B | 1.2.40.0.10.1.4.3.4.3.4:100000073621 | zur Anwendung im Mund- und Rachenraum | | | | | 1.2.40.0.34.5.156:1709185 | AMPHOTERICIN B | 1.2.40.0.34.5.221:100000092100 | AMPHOTERICIN B | active | 10 | mg | 1.2.40.0.34.5.221:100000092100 | AMPHOTERICIN B | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073703 | Lutschtablette | true | human | 1.2.40.0.34.4.26:129773001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0079674 | AMPHO-MORONAL TBL | Ampho - Moronal - Tabletten | 1.2.40.0.34.4.17:15121 | GA - zugelassen | Dermapharm GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07AA07 | Amphotericin B | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709185 | AMPHOTERICIN B | 1.2.40.0.34.5.221:100000092100 | AMPHOTERICIN B | active | 100 | mg | 1.2.40.0.34.5.221:100000092100 | AMPHOTERICIN B | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129375001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0079697 | AMPHOTERICIN-B PLV DFL 50MG | Amphotericin B "CHEPLAPHARM" 50 mg - Pulver zur Herstellung einer Infusionslösung | 1.2.40.0.34.4.17:14538 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J02AA01 | Amphotericin B | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | | | 1.2.40.0.34.5.156:1709185 | AMPHOTERICIN B | 1.2.40.0.34.5.221:100000092100 | AMPHOTERICIN B | active | 50 | mg | 1.2.40.0.34.5.221:100000092100 | AMPHOTERICIN B | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:129836001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0080022 | ANDROCUR TBL 50MG | Androcur 50 mg - Tabletten | 1.2.40.0.34.4.17:15347 | GA - zugelassen | Advanz Pharma Limited | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03HA01 | Cyproteron | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708539 | CYPROTERON ACETAT | 1.2.40.0.34.5.221:100000090321 | CYPROTERONE ACETATE | active | 50 | mg | 1.2.40.0.34.5.221:100000090321 | CYPROTERONE ACETATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921215001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0080476 | ANTIBIOPHILUS HKPS | Antibiophilus - Hartkapseln | 1.2.40.0.34.4.17:1-23448 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 200 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A07FA01 | Milchsäurebildner | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710410 | LACTOBACILLUS CASEI | 1.2.40.0.34.5.221:900000000641 | LACTOBACILLUS CASEI | active | 200000000 | CFU | 1.2.40.0.34.5.221:900000000641 | LACTOBACILLUS CASEI | 200000000 | CFU | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | false | human | 1.2.40.0.34.4.26:929798002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0081145 | AQUAPHORIL TBL | Aquaphoril - Tabletten | 1.2.40.0.34.4.17:15539 | GA - aufgehoben | Viatris Austria GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C03BA10 | Xipamid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706185 | XIPAMID | 1.2.40.0.34.5.221:100000079360 | XIPAMIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000079360 | XIPAMIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923787002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0081151 | AQUAPHORIL TBL | Aquaphoril - Tabletten | 1.2.40.0.34.4.17:15539 | GA - aufgehoben | Viatris Austria GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C03BA10 | Xipamid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706185 | XIPAMID | 1.2.40.0.34.5.221:100000079360 | XIPAMIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000079360 | XIPAMIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923787003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0084882 | BLEOMYCIN PLV DFL 15000IE | Bleomycin "Baxter" 15 000 I.E. - Durchstechflasche | 1.2.40.0.34.4.17:14829 | GA - zugelassen | Baxter Healthcare GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01DC01 | Bleomycin | 1.2.40.0.10.1.4.3.4.3.4:900000000009 | intrakavitäre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073609 | intratumorale Anwendung | 1.2.40.0.34.5.156:1707285 | BLEOMYCIN SULFAT | 1.2.40.0.34.5.221:100000085140 | BLEOMYCIN SULFATE | active | 10 | mg | 1.2.40.0.34.5.221:100000085140 | BLEOMYCIN SULFATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:125225002 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0084899 | BLEOMYCIN PLV DFL 15000IE | Bleomycin "Baxter" 15 000 I.E. - Durchstechflasche | 1.2.40.0.34.4.17:14829 | GA - zugelassen | Baxter Healthcare GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01DC01 | Bleomycin | 1.2.40.0.10.1.4.3.4.3.4:900000000009 | intrakavitäre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073609 | intratumorale Anwendung | 1.2.40.0.34.5.156:1707285 | BLEOMYCIN SULFAT | 1.2.40.0.34.5.221:100000085140 | BLEOMYCIN SULFATE | active | 10 | mg | 1.2.40.0.34.5.221:100000085140 | BLEOMYCIN SULFATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:125225001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0086237 | CANESTEN LSG AEUSSERL ANW | Canesten Clotrimazol - Lösung zur äußerlichen Anwendung | 1.2.40.0.34.4.17:15396 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D01AC01 | Clotrimazol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709166 | CLOTRIMAZOL | 1.2.40.0.34.5.221:100000092074 | CLOTRIMAZOLE | active | 0.2 | g | 1.2.40.0.34.5.221:100000092074 | CLOTRIMAZOLE | 0.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:124522001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0086711 | CARBOSTESIN AMP 0,50% 5ML | Carbostesin 0,5% - Lösung zur parenteralen Anwendung | 1.2.40.0.34.4.17:14209 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01BB01 | Bupivacain | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:1708789 | BUPIVACAINHYDROCHLORID | 1.2.40.0.34.5.221:100000091291 | BUPIVACAINE HYDROCHLORIDE | active | 26.4 | mg | 1.2.40.0.34.5.221:100000091291 | BUPIVACAINE HYDROCHLORIDE | 26.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:124912001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0087024 | CATAPRESAN 0,15MG/ML AMP 1ML | Catapresan 0,15 mg/ml - Ampullen | 1.2.40.0.34.4.17:13873 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C02AC01 | Clonidin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | 1.2.40.0.34.5.156:1708541 | CLONIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090325 | CLONIDINE HYDROCHLORIDE | active | 0.15 | mg | 1.2.40.0.34.5.221:100000090325 | CLONIDINE HYDROCHLORIDE | 0.15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:128189001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0087076 | CATHEJELL DIPH/CHX TB 100G | Cathejell Diphenhydramin 1 % / Chlorhexidin 0,05 % Gel (in Tuben) | 1.2.40.0.34.4.17:16076 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:N01BX | Andere Lokalanästhetika | 1.2.40.0.10.1.4.3.4.3.4:100000073638 | Anwendung in der Harnröhre | | | | | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 1 | g | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073880 | Gel zur Anwendung in der Harnröhre | true | human | 1.2.40.0.34.4.26:127178001 | 1.2.40.0.34.5.156:1709371 | CHLORHEXIDIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDINE DIHYDROCHLORIDE | active | 0.05 | g | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDINE DIHYDROCHLORIDE | 0.05 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0087886 | CEREBROLYSIN AMP 10ML | Cerebrolysin - parenterale Lösung | 1.2.40.0.34.4.17:1-21380 | GA - zugelassen | EVER Neuro Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N07X | Andere Mittel für das Nervensystem | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1710680 | PEPTIDE | 1.2.40.0.34.5.221:100000124442 | PEPTIDES | active | 2152 | mg | 1.2.40.0.34.5.221:100000124442 | PEPTIDES | 2152 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000116188 | Solution for injection/concentrate for solution for infusion | true | human | 1.2.40.0.34.4.26:934071008 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0088012 | CEVITOL KTBL 500MG | Cevitol 500 mg - Kautabletten | 1.2.40.0.34.4.17:15155 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A11GA01 | Ascorbinsäure (Vitamin C) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073684 | Kautablette | false | human | 1.2.40.0.34.4.26:124169001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0093065 | DESFERAL TRSTAMP 500MG | Desferal 500 mg - Trockenstechampullen | 1.2.40.0.34.4.17:12656 | GA - zugelassen | Novartis Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V03AC01 | Deferoxamin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | 1.2.40.0.34.5.156:1708452 | DEFEROXAMIN MESILAT | 1.2.40.0.34.5.221:100000090084 | DEFEROXAMINE MESILATE | active | 500 | mg | 1.2.40.0.34.5.221:100000090084 | DEFEROXAMINE MESILATE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:924680001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0093473 | DIAMOX TRSTAMP 500MG | Diamox 500 mg - Durchstechflaschen mit Pulver zur Herstellung einer Injektionslösung | 1.2.40.0.34.4.17:9684 | GA - zugelassen | Amdipharm Limited | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:S01EC01 | Acetazolamid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709499 | ACETAZOLAMID | 1.2.40.0.34.5.221:100000092652 | ACETAZOLAMIDE | active | 500 | mg | 1.2.40.0.34.5.221:100000092652 | ACETAZOLAMIDE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:920656001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0093616 | DIBENZYRAN KPS 10MG | Dibenzyran 10 mg Kapseln | 1.2.40.0.34.4.17:14842 | GA - zugelassen | Aristo Pharma GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AX02 | Phenoxybenzamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707348 | PHENOXYBENZAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000085275 | PHENOXYBENZAMINE HYDROCHLORIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000085275 | PHENOXYBENZAMINE HYDROCHLORIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:123020002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0094886 | DIPIDOLOR 7,5MG/ML AMP 2ML | Dipidolor 7,5 mg/ml Injektionslösung | 1.2.40.0.34.4.17:15315 | GA - zugelassen | Piramal Critical Care B.V. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N02AC03 | Piritramid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | 1.2.40.0.34.5.156:1707671 | PIRITRAMID | 1.2.40.0.34.5.221:100000086577 | PIRITRAMIDE | active | 15 | mg | 1.2.40.0.34.5.221:100000086577 | PIRITRAMIDE | 15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:127459001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0094975 | DIPRODERM CR | Diproderm - Creme | 1.2.40.0.34.4.17:15576 | GA - zugelassen | Organon Healthcare GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.0192 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.0192 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:120307002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0094998 | DIPRODERM SLB | Diproderm - Salbe | 1.2.40.0.34.4.17:15575 | GA - zugelassen | Organon Healthcare GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.0192 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.0192 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:120648003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0095822 | DOMINAL FTBL FTE 80MG | Dominal forte 80 mg - Filmtabletten | 1.2.40.0.34.4.17:10557 | GA - zugelassen | Viatris Austria GmbH | true | true | 250 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N05AX07 | Prothipendyl | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707282 | PROTHIPENDYLHYDROCHLORID | 1.2.40.0.34.5.221:100000085134 | PROTHIPENDYL HYDROCHLORIDE | active | 80 | mg | 1.2.40.0.34.5.221:100000085134 | PROTHIPENDYL HYDROCHLORIDE | 80 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:127202002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0097896 | ENDOXAN TRSTAMP 500MG | Endoxan "Baxter" 500 mg - Trockenstechampulle | 1.2.40.0.34.4.17:13546 | GA - zugelassen | Baxter Healthcare GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:L01AA01 | Cyclophosphamid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708517 | CYCLOPHOSPHAMID | 1.2.40.0.34.5.221:100000090277 | CYCLOPHOSPHAMIDE | active | 534.5 | mg | 1.2.40.0.34.5.221:100000090277 | CYCLOPHOSPHAMIDE | 534.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:127576001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0098720 | ERYTHROCIN-LACT TRSUB 1G | Erythrocin - Lactobionat 1,0 g - Trockensubstanz zur Infusionsbereitung | 1.2.40.0.34.4.17:9741 | GA - zugelassen | Amdipharm Limited | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01FA01 | Erythromycin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709363 | ERYTHROMYCIN | 1.2.40.0.34.5.221:100000092382 | ERYTHROMYCIN | active | 1 | g | 1.2.40.0.34.5.221:100000092382 | ERYTHROMYCIN | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:129428001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0099205 | ETIBI TBL 500MG | Etibi 500 mg - Tabletten | 1.2.40.0.34.4.17:15213 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J04AK02 | Ethambutol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707794 | ETHAMBUTOL DIHYDROCHLORID | 1.2.40.0.34.5.221:100000087279 | ETHAMBUTOL DIHYDROCHLORIDE | active | 500 | mg | 1.2.40.0.34.5.221:100000087279 | ETHAMBUTOL DIHYDROCHLORIDE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:126908001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0101296 | FLOXAPEN KPS 500MG | Floxapen 500 mg Kapseln | 1.2.40.0.34.4.17:15542 | GA - aufgehoben | Actavis Group PTC ehf. | false | false | 16 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CF05 | Flucloxacillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707729 | NATRIUM FLUCLOXACILLINAT | 1.2.40.0.34.5.221:100000086971 | FLUCLOXACILLIN SODIUM | active | 544 | mg | 1.2.40.0.34.5.221:100000086971 | FLUCLOXACILLIN SODIUM | 544 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:127658001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0101623 | FORTECORTIN AMP 4MG 1ML | Fortecortin 4 mg - Ampullen | 1.2.40.0.34.4.17:11742 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB02 | Dexamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | 1.2.40.0.34.5.156:1708635 | DEXAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | active | 4.37 | mg | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | 4.37 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:121095001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000075248 | Infiltration | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0102752 | GASTROGRAFIN ROENTGENKONTR. | Gastrografin Röntgenkontrastmittel zur oralen und rektalen Anwendung | 1.2.40.0.34.4.17:11920 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08AA01 | Amidotrizoesäure | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | 1.2.40.0.34.5.156:7447044 | AMIDOTRIZOESÄURE DIHYDRAT | 1.2.40.0.34.5.221:100000076674 | AMIDOTRIZOIC ACID DIHYDRATE | active | 63240 | mg | 1.2.40.0.34.5.221:100000076674 | AMIDOTRIZOIC ACID DIHYDRATE | 63240 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073917 | Lösung zur gastrointestinalen Anwendung | true | human | 1.2.40.0.34.4.26:124615001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0103668 | GLUCAGEN HYPOK.PLV+LSM1MG/ML | GlucaGen HypoKit 1 mg/ml - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | 1.2.40.0.34.4.17:1-24626 | GA - zugelassen | Novo Nordisk Pharma GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H04AA01 | Glucagon | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1707777 | GLUCAGON HYDROCHLORID | 1.2.40.0.34.5.221:100000087239 | GLUCAGON HYDROCHLORIDE | active | | | 1.2.40.0.34.5.221:100000087239 | GLUCAGON HYDROCHLORIDE | | | 1.2.40.0.10.1.4.3.4.3.5:100000073868 | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:946198001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0105006 | GYNODIAN DEP FSPR 1ML | Gynodian Depot - Fertigspritze | 1.2.40.0.34.4.17:15426 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:G03EA03 | Prasteron und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708616 | ESTRADIOL VALERAT | 1.2.40.0.34.5.221:100000090493 | ESTRADIOL VALERATE | active | 4 | mg | 1.2.40.0.34.5.221:100000090493 | ESTRADIOL VALERATE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:125730002 | 1.2.40.0.34.5.156:1707427 | PRASTERON ENANTAT | 1.2.40.0.34.5.221:100000085481 | PRASTERONE ENANTATE | active | 200 | mg | 1.2.40.0.34.5.221:100000085481 | PRASTERONE ENANTATE | 200 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0105762 | HEPAMERZ IKONZ AMP 10ML | Hepa-Merz 5 g / 10 ml Infusionslösungs-Konzentrat | 1.2.40.0.34.4.17:14964 | GA - zugelassen | Merz Pharma Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A05BA | Lebertherapie | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1706357 | ORNITHIN ASPARTAT | 1.2.40.0.34.5.221:100000080065 | ORNITHINE ASPARTATE | active | 5 | g | 1.2.40.0.34.5.221:100000080065 | ORNITHINE ASPARTATE | 5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:127847001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0106460 | HIRUDOID GEL BP10X40 | Hirudoid Gel | 1.2.40.0.34.4.17:14830 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | false | 400 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA01 | Heparinoide | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705406 | MUCOPOLYSACCHARIDPOLYSCHWEFELSÄUREESTER | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | active | 0.12 | g | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | 0.12 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:921777002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0106477 | HIRUDOID GEL BP10X100 | Hirudoid Gel | 1.2.40.0.34.4.17:14830 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | false | 1000 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA01 | Heparinoide | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705406 | MUCOPOLYSACCHARIDPOLYSCHWEFELSÄUREESTER | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | active | 0.3 | g | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:921777001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0106483 | HIRUDOID SLB BP10X40 | Hirudoid - Salbe | 1.2.40.0.34.4.17:8527 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | false | 400 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA01 | Heparinoide | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705406 | MUCOPOLYSACCHARIDPOLYSCHWEFELSÄUREESTER | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | active | 0.12 | g | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | 0.12 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:121004002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0106508 | HIRUDOID SLB BP10X100 | Hirudoid - Salbe | 1.2.40.0.34.4.17:8527 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | false | 1000 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA01 | Heparinoide | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705406 | MUCOPOLYSACCHARIDPOLYSCHWEFELSÄUREESTER | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | active | 0.3 | g | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:121004001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0107979 | HUMANALBUMIN OCT IFL 20% | Humanalbumin Octapharma 200 g/l Infusionslösung | 1.2.40.0.34.4.17:2-00273 | GA - zugelassen | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | true | false | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05AA01 | Albumin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708146 | HUMANALBUMIN | 1.2.40.0.34.5.221:100000124192 | ALBUMIN (HUMAN) | active | 9600 | mg | 1.2.40.0.34.5.221:100000124192 | ALBUMIN (HUMAN) | 9600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:945961002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0108424 | ICHTHO BAD | Ichtho - Bad | 1.2.40.0.34.4.17:12368 | GA - zugelassen | Ichthyol-Gesellschaft Cordes, Hermanni & Co. (GmbH & Co.) KG | true | true | 1000 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M02AX | Andere topische Mittel gegen Gelenk- und Muskelschmerzen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073568 | Badebehandlung | | | 1.2.40.0.34.5.156:1709356 | ICHTHAMMOLUM | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | active | 880 | g | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | 880 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073711 | Badezusatz | false | human | 1.2.40.0.34.4.26:120434001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073762 | Konzentrat zur Herstellung eines Tauchbades, Emulsion | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0109613 | INSTILLAGEL ESPR 6ML | Instillagel - Einmalspritze | 1.2.40.0.34.4.17:15097 | GA - zugelassen | Farco-Pharma GmbH | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:N01BB52 | Lidocain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073638 | Anwendung in der Harnröhre | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | | | 1.2.40.0.34.5.156:1708657 | LIDOCAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | active | 0.12 | g | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | 0.12 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:127455002 | 1.2.40.0.34.5.156:1708713 | CHLORHEXIDINDIGLUCONAT | 1.2.40.0.34.5.221:100000091036 | CHLORHEXIDINE GLUCONATE | active | 0.003 | g | 1.2.40.0.34.5.221:100000091036 | CHLORHEXIDINE GLUCONATE | 0.003 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0109636 | INSTILLAGEL ESPR 6ML | Instillagel - Einmalspritze | 1.2.40.0.34.4.17:15097 | GA - zugelassen | Farco-Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:N01BB52 | Lidocain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073638 | Anwendung in der Harnröhre | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | | | 1.2.40.0.34.5.156:1708657 | LIDOCAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | active | 0.12 | g | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | 0.12 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:127455004 | 1.2.40.0.34.5.156:1708713 | CHLORHEXIDINDIGLUCONAT | 1.2.40.0.34.5.221:100000091036 | CHLORHEXIDINE GLUCONATE | active | 0.003 | g | 1.2.40.0.34.5.221:100000091036 | CHLORHEXIDINE GLUCONATE | 0.003 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0109642 | INSTILLAGEL ESPR 11ML | Instillagel - Einmalspritze | 1.2.40.0.34.4.17:15097 | GA - zugelassen | Farco-Pharma GmbH | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:N01BB52 | Lidocain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073638 | Anwendung in der Harnröhre | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | | | 1.2.40.0.34.5.156:1708657 | LIDOCAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | active | 0.22 | g | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | 0.22 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:127455001 | 1.2.40.0.34.5.156:1708713 | CHLORHEXIDINDIGLUCONAT | 1.2.40.0.34.5.221:100000091036 | CHLORHEXIDINE GLUCONATE | active | 0.0055 | g | 1.2.40.0.34.5.221:100000091036 | CHLORHEXIDINE GLUCONATE | 0.0055 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0109659 | INSTILLAGEL ESPR 11ML | Instillagel - Einmalspritze | 1.2.40.0.34.4.17:15097 | GA - zugelassen | Farco-Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:N01BB52 | Lidocain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073638 | Anwendung in der Harnröhre | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | | | 1.2.40.0.34.5.156:1708657 | LIDOCAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | active | 0.22 | g | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | 0.22 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:127455003 | 1.2.40.0.34.5.156:1708713 | CHLORHEXIDINDIGLUCONAT | 1.2.40.0.34.5.221:100000091036 | CHLORHEXIDINE GLUCONATE | active | 0.0055 | g | 1.2.40.0.34.5.221:100000091036 | CHLORHEXIDINE GLUCONATE | 0.0055 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0110438 | IROMIN TBL | Iromin - Tabletten | 1.2.40.0.34.4.17:6200 | GA - aufgehoben | Dr. A. & L. Schmidgall GmbH & Co. KG | false | false | 600 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BA15 | Carbasalat calcium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706552 | CARBASALAT CALCIUM | 1.2.40.0.34.5.221:100000081316 | CARBASALATE CALCIUM | active | 500 | mg | 1.2.40.0.34.5.221:100000081316 | CARBASALATE CALCIUM | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:128878004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0115950 | LUDIOMIL AMP 5ML | Ludiomil - Ampullen | 1.2.40.0.34.4.17:15242 | GA - aufgehoben | Amdipharm Limited | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N06AA21 | Maprotilin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707376 | MAPROTILIN MESILAT | 1.2.40.0.34.5.221:100000085389 | MAPROTILINE MESYLATE | active | 25 | mg | 1.2.40.0.34.5.221:100000085389 | MAPROTILINE MESYLATE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:122641001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0116004 | LUDIOMIL FTBL 50MG | Ludiomil 50 mg - Filmtabletten | 1.2.40.0.34.4.17:15241 | GA - zugelassen | Amdipharm Limited | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AA21 | Maprotilin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709373 | MAPROTILIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092398 | MAPROTILINE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000092398 | MAPROTILINE HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:121192001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0116429 | LYSTHENON IJLSG 0,1G/5ML BP | Lysthenon 0,1 g/5 ml - Injektionslösung | 1.2.40.0.34.4.17:8594 | GA - zugelassen | Takeda Austria GmbH | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M03AB01 | Suxamethonium | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708396 | SUXAMETHONIUM CHLORID | 1.2.40.0.34.5.221:100000089877 | SUXAMETHONIUM CHLORIDE | active | 110 | mg | 1.2.40.0.34.5.221:100000089877 | SUXAMETHONIUM CHLORIDE | 110 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:125913002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0116671 | MAGN GLUC-G.L.AMP 10ML | Magnesium Gluconicum G.L. 1000 mg Ampullen | 1.2.40.0.34.4.17:7333 | GA - zugelassen | G.L. Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A12CC03 | Magnesiumgluconat | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705587 | MAGNESIUM DIGLUCONAT | 1.2.40.0.34.5.221:100000076821 | MAGNESIUM GLUCONATE | active | 1000 | mg | 1.2.40.0.34.5.221:100000076821 | MAGNESIUM GLUCONATE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:125346001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0118173 | MICROPAQUE ROENTG. FL | Micropaque 1 g/ml Suspension zur oralen oder rektalen Anwendung | 1.2.40.0.34.4.17:15623 | GA - zugelassen | Guerbet | true | false | 2000 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08BA01 | Bariumsulfat mit Suspensionsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | 1.2.40.0.34.5.156:1708374 | BARIUMSULFAT | 1.2.40.0.34.5.221:100000089788 | BARIUM SULFATE | active | 2000 | g | 1.2.40.0.34.5.221:100000089788 | BARIUM SULFATE | 2000 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074025 | Suspension zum Einnehmen/Rektalsuspension | true | human | 1.2.40.0.34.4.26:123790001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0118322 | MINIDIAB TBL 5MG | Minidiab 5 mg - Tabletten | 1.2.40.0.34.4.17:15529 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BB07 | Glipizid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708545 | GLIPIZID | 1.2.40.0.34.5.221:100000090337 | GLIPIZIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000090337 | GLIPIZIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129670002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0118339 | MINIDIAB TBL 5MG | Minidiab 5 mg - Tabletten | 1.2.40.0.34.4.17:15529 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 120 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BB07 | Glipizid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708545 | GLIPIZID | 1.2.40.0.34.5.221:100000090337 | GLIPIZIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000090337 | GLIPIZIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129670001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0119273 | MUTAFLOR KPS | Mutaflor Kapseln | 1.2.40.0.34.4.17:1-24345 | GA - zugelassen | Ardeypharm GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07FA | Mikrobielle Antidiarrhoika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706089 | ESCHERICHIA COLI | 1.2.40.0.34.5.221:100000078956 | ESCHERICHIA COLI | active | | | 1.2.40.0.34.5.221:100000078956 | ESCHERICHIA COLI | | | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:929637002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0119296 | MUTAFLOR KPS | Mutaflor Kapseln | 1.2.40.0.34.4.17:1-24345 | GA - zugelassen | Ardeypharm GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07FA | Mikrobielle Antidiarrhoika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706089 | ESCHERICHIA COLI | 1.2.40.0.34.5.221:100000078956 | ESCHERICHIA COLI | active | | | 1.2.40.0.34.5.221:100000078956 | ESCHERICHIA COLI | | | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:929637001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0119304 | MUTAFLOR KPS MTE | Mutaflor mite Kapseln | 1.2.40.0.34.4.17:1-24346 | GA - zugelassen | Ardeypharm GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A16A | Andere Mittel für das alimentäre System und den Stoffwechsel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706089 | ESCHERICHIA COLI | 1.2.40.0.34.5.221:100000078956 | ESCHERICHIA COLI | active | | | 1.2.40.0.34.5.221:100000078956 | ESCHERICHIA COLI | | | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:929636001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0121732 | NITROLINGUAL PUSPRAY 0,4MG | Nitrolingual 0,4 mg - Pumpspray | 1.2.40.0.34.4.17:14908 | GA - zugelassen | G. Pohl-Boskamp GmbH & Co. KG | true | true | 13.2 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C01DA02 | Glyceroltrinitrat | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | | | 1.2.40.0.34.5.156:1707860 | GLYCEROLTRINITRAT | 1.2.40.0.34.5.221:100000087614 | GLYCERYL TRINITRATE | active | 80 | mg | 1.2.40.0.34.5.221:100000087614 | GLYCERYL TRINITRATE | 80 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073693 | Sublingualspray | true | human | 1.2.40.0.34.4.26:121770001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0122281 | NOVALGIN FTBL | Novalgin Filmtabletten | 1.2.40.0.34.4.17:3192 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BB02 | Metamizol-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708977 | METAMIZOL NATRIUM | 1.2.40.0.34.5.221:100000091714 | METAMIZOLE SODIUM | active | 500 | mg | 1.2.40.0.34.5.221:100000091714 | METAMIZOLE SODIUM | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122948006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0125894 | PASTA COOL | Pasta Cool | 1.2.40.0.34.4.17:15164 | GA - zugelassen | Apomedica Pharmazeutische Produkte Ges.m.b.H. | true | false | 200 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707968 | PINI PUMILIONIS AETHEROLEUM | 1.2.40.0.34.5.221:100000088075 | PINI PUMILIONIS AETHEROLEUM | active | | | 1.2.40.0.34.5.221:100000088075 | PINI PUMILIONIS AETHEROLEUM | | | 1.2.40.0.10.1.4.3.4.3.5:100000073727 | Paste zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLSÄURE | active | | | 1.2.40.0.34.5.221:100000090038 | SALICYLSÄURE | | | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN NATRIUM | active | | | 1.2.40.0.34.5.221:100000090150 | HEPARIN NATRIUM | | | 2.16.840.1.113883.6.73:B01AB | Heparingruppe | | | | | 1.2.40.0.34.5.156:1706021 | ROSMARINI AETHEROLEUM | 1.2.40.0.34.5.221:100000078648 | ROSMARINI AETHEROLEUM | active | | | 1.2.40.0.34.5.221:100000078648 | ROSMARINI AETHEROLEUM | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0128415 | PK-MERZ PLIFL 500ML | PK - Merz Schoeller 0,4 mg/ml Infusionslösung | 1.2.40.0.34.4.17:15234 | GA - zugelassen | Merz Pharma Austria GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N04BB01 | Amantadin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709202 | AMANTADIN SULFAT | 1.2.40.0.34.5.221:100000092128 | AMANTADINE SULFATE | active | 200 | mg | 1.2.40.0.34.5.221:100000092128 | AMANTADINE SULFATE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:123768003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0132196 | REFOBACIN AMP 10MG 2ML 5X5 | Refobacin 10 mg - Ampullen | 1.2.40.0.34.4.17:14374 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 33.4 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 23.560961 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:120305002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0132204 | REFOBACIN AMP 40MG 1ML 5X5 | Refobacin 40 mg - Ampullen | 1.2.40.0.34.4.17:13548 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 66.7 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 47.051381 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:127740003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0132641 | RESONIUM-A PLV | Resonium A Pulver | 1.2.40.0.34.4.17:15583 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 450 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:V03AE01 | Polystyrolsulfonat | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | 1.2.40.0.34.5.156:1708571 | NATRIUMPOLYSTYROLSULFONAT | 1.2.40.0.34.5.221:100000090395 | SODIUM POLYSTYRENE SULPHONATE | active | 449.7 | g | 1.2.40.0.34.5.221:100000090395 | SODIUM POLYSTYRENE SULPHONATE | 449.7 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074034 | Pulver zur Herstellung einer Suspension zum Einnehmen/Rektalsuspension | true | human | 1.2.40.0.34.4.26:120024002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0132948 | RETARPEN TRSTAMP 2,4MEGA | Retarpen 2,4 Mio. I.E. - Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension | 1.2.40.0.34.4.17:13637 | GA - zugelassen | Sandoz GmbH | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:J01CE08 | Benzylpenicillin-Benzathin | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708624 | BENZATHIN BENZYLPENICILLIN | 1.2.40.0.34.5.221:100000090509 | BENZATHIN BENZYLPENICILLIN | active | | | 1.2.40.0.34.5.221:100000090509 | BENZATHIN BENZYLPENICILLIN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073869 | Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0133534 | RIFOCIN AMP 500MG I.V. | Rifocin intravenös 500 mg - Ampullen | 1.2.40.0.34.4.17:12827 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J04AB03 | Rifamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | 1.2.40.0.34.5.156:1708776 | RIFAMYCIN NATRIUM | 1.2.40.0.34.5.221:100000091241 | RIFAMYCIN SODIUM | active | | | 1.2.40.0.34.5.221:100000091241 | RIFAMYCIN SODIUM | | | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:128338002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0134893 | SAB-SIMPLEX TR | Sab Simplex - Tropfen | 1.2.40.0.34.4.17:13455 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A03AX13 | Silikone | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708384 | SIMETICON | 1.2.40.0.34.5.221:100000089833 | SIMETICONE | active | 2.07564 | g | 1.2.40.0.34.5.221:100000089833 | SIMETICONE | 2.07564 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073647 | Emulsion zum Einnehmen | false | human | 1.2.40.0.34.4.26:121552001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0136194 | SCOTTOPECT GEL | Scottopect - Gelee | 1.2.40.0.34.4.17:736262 | GA - registriert | Orifarm Healthcare A/S | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:R05X | Andere Kombinationspräparate gegen Erkältungskrankheiten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | 300 | g | 1.2.40.0.34.5.221:100000091364 | MENTHOL | 300 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:958424001 | 1.2.40.0.34.5.156:1709094 | TEREBINTHINAE AETHEROLEUM | 1.2.40.0.34.5.221:100000091958 | TURPENTINE OIL | active | 600 | g | 1.2.40.0.34.5.221:100000091958 | TURPENTINE OIL | 600 | g | 1.2.40.0.34.5.156:1706333 | EUCALYPTI AETHEROLEUM | 1.2.40.0.34.5.221:100000091979 | EUCALYPTUS OIL | active | 300 | g | 1.2.40.0.34.5.221:100000091979 | EUCALYPTUS OIL | 300 | g | | | | | | | 1.2.40.0.34.5.156:1708766 | THYMI TYPO THYMOLO AETHEROLEUM | 1.2.40.0.34.5.221:100000091153 | ESSENTIAL OIL - THYMUS VULGARIS | active | 200 | g | 1.2.40.0.34.5.221:100000091153 | ESSENTIAL OIL - THYMUS VULGARIS | 200 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0137319 | SOLCOSERYL GEL 20% | Solcoseryl Gel | 1.2.40.0.34.4.17:11672 | GA - zugelassen | Viatris Austria GmbH | true | false | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D03AX | Andere Wundbehandlungsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1710184 | DEPROTEINISIERTES HAEMODERIVAT AUS KÄLBERBLUT | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | active | 16.6 | g | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | 16.6 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:920856001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0137408 | SOLU-CELESTAN AMP 4MG/1ML | Solu - Celestan - 4 mg/ml injektionslösung | 1.2.40.0.34.4.17:15185 | GA - zugelassen | Organon Healthcare GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073597 | intraläsionale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073595 | intradermale Anwendung | 1.2.40.0.34.5.156:1708451 | BETAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | active | 5.3 | mg | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | 5.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:121339002 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073623 | periartikuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073589 | intrabursale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0137437 | SOLU-DACORTIN PLV+LSM 250MG | Solu - Dacortin 250 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung oder Infusionslösung | 1.2.40.0.34.4.17:15085 | GA - zugelassen | Merck Ges.m.b.H. | true | false | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709059 | NATRIUM PREDNISOLON SUCCINAT | 1.2.40.0.34.5.221:100000091910 | PREDNISOLONE SODIUM SUCCINATE | active | 250 | mg | 1.2.40.0.34.5.221:100000091910 | PREDNISOLONE SODIUM SUCCINATE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:125955002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0140190 | SYMBIOFLOR E.COLI TR | Symbioflor E. coli - Tropfen zum Einnehmen, Suspension | 1.2.40.0.34.4.17:1-23846 | GA - zugelassen | SymbioPharm GmbH | true | true | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L03AX | Andere Zytokine und Immunmodulatoren | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706089 | ESCHERICHIA COLI | 1.2.40.0.34.5.221:100000078956 | ESCHERICHIA COLI | active | | | 1.2.40.0.34.5.221:100000078956 | ESCHERICHIA COLI | | | 1.2.40.0.10.1.4.3.4.3.5:100000073643 | Tropfen zum Einnehmen, Suspension | false | human | 1.2.40.0.34.4.26:929747001 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:A07FA | Mikrobielle Antidiarrhoika | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0140592 | SYNTOCINON AMP 5IE 1ML | Syntocinon 5 I.E. Lösung zur Injektion | 1.2.40.0.34.4.17:10424 | GA - zugelassen | Alfasigma S.p.A. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H01BB02 | Oxytocin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709372 | OXYTOCIN | 1.2.40.0.34.5.221:100000092397 | OXYTOCIN | active | 5 | IU | 1.2.40.0.34.5.221:100000092397 | OXYTOCIN | 5 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:122977002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073857 | Konzentrat zur Herstellung einer Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0140600 | SYNTOCINON AMP 5IE 1ML | Syntocinon 5 I.E. Lösung zur Injektion | 1.2.40.0.34.4.17:10424 | GA - zugelassen | Alfasigma S.p.A. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H01BB02 | Oxytocin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709372 | OXYTOCIN | 1.2.40.0.34.5.221:100000092397 | OXYTOCIN | active | 5 | IU | 1.2.40.0.34.5.221:100000092397 | OXYTOCIN | 5 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:122977003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073857 | Konzentrat zur Herstellung einer Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0143952 | TIROLER STEINOEL HAUSSLB | Tiroler Steinöl - Haussalbe | 1.2.40.0.34.4.17:7430 | GA - zugelassen | Tiroler Steinölwerke Albrecht GmbH & Co. KG | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:900000000007 | Tiegel (NE) | 2.16.840.1.113883.6.73:D08AX | Andere Antiseptika und Desinfektionsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1711917 | SCHIEFERÖLE | 1.2.40.0.34.5.221:100000175806 | SCHIEFERÖLE | active | 10 | g | 1.2.40.0.34.5.221:100000175806 | SCHIEFERÖLE | 10 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:122624001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0146927 | ULTRACORTENOL AU-SLB | Ultracortenol 5 mg/g Augensalbe | 1.2.40.0.34.4.17:10318 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 5 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:S01BA04 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709473 | PREDNISOLON PIVALAT | 1.2.40.0.34.5.221:100000092615 | PREDNISOLONE PIVALATE | active | 25 | mg | 1.2.40.0.34.5.221:100000092615 | PREDNISOLONE PIVALATE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073772 | Augensalbe | true | human | 1.2.40.0.34.4.26:129320001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0146933 | ULTRACORTENOL AU-TR | Ultracortenol 0,5 % - Augentropfen | 1.2.40.0.34.4.17:10319 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073512 | Tropfbehältnis | 2.16.840.1.113883.6.73:S01BA04 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1708481 | PREDNISOLON ACETAT | 1.2.40.0.34.5.221:100000090168 | PREDNISOLONE ACETATE | active | 0.025 | g | 1.2.40.0.34.5.221:100000090168 | PREDNISOLONE ACETATE | 0.025 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073760 | Augentropfensuspension | true | human | 1.2.40.0.34.4.26:122705001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0147507 | URBASON SOL TRAMP 250MG +LSM | Urbason solubile 250 mg Trockenampullen mit Lösungsmittel | 1.2.40.0.34.4.17:15040 | GA - zugelassen | Fidia Farmaceutici S.p.A. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB04 | Methylprednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708630 | NATRIUM METHYLPREDNISOLON SUCCINAT | 1.2.40.0.34.5.221:100000090523 | METHYLPREDNISOLONE SODIUM SUCCINATE | active | 331.48 | mg | 1.2.40.0.34.5.221:100000090523 | METHYLPREDNISOLONE SODIUM SUCCINATE | 331.48 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:122775001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0147513 | URBASON TBL 40MG | Urbason 40 mg Tabletten | 1.2.40.0.34.4.17:12208 | GA - zugelassen | Fidia Farmaceutici S.p.A. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB04 | Methylprednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709015 | METHYLPREDNISOLON | 1.2.40.0.34.5.221:100000091803 | METHYLPREDNISOLONE | active | 40 | mg | 1.2.40.0.34.5.221:100000091803 | METHYLPREDNISOLONE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120952002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0149239 | VELBE TRSUB TRSTAMP 10MG | Velbe 10 mg Trockensubstanz zur Injektionsbereitung | 1.2.40.0.34.4.17:12269 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:L01CA01 | Vinblastin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707919 | VINBLASTIN SULFAT | 1.2.40.0.34.5.221:100000087899 | VINBLASTINE SULFATE | active | 10 | mg | 1.2.40.0.34.5.221:100000087899 | VINBLASTINE SULFATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073866 | Pulver zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:128819001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0151348 | VOLON-A HAFTSLB | Volon A - Haftsalbe | 1.2.40.0.34.4.17:13218 | GA - zugelassen | Dermapharm GmbH | true | true | 10 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:A01AC01 | Triamcinolon | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | | | 1.2.40.0.34.5.156:1708563 | TRIAMCINOLON ACETONID | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000116131 | Salbe zur Anwendung in der Mundhöhle | true | human | 1.2.40.0.34.4.26:128291001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0151489 | VOLTAREN FTBL 25MG | Voltaren 25 mg - Filmtabletten | 1.2.40.0.34.4.17:1-15554 | GA - aufgehoben | Novartis Pharma GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 25 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122195003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0151934 | XYLOCAIN AMP 2% 5ML | Xylocain 2 % - Ampullen | 1.2.40.0.34.4.17:16722 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01BB02 | Lidocain | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073572 | epidurale Anwendung | 1.2.40.0.34.5.156:1708657 | LIDOCAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | active | 106.65 | mg | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | 106.65 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:124876001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0152069 | XYLONEURAL AMP 5ML | Xyloneural - Ampullen | 1.2.40.0.34.4.17:14379 | GA - zugelassen | Gebro Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01BB02 | Lidocain | 1.2.40.0.10.1.4.3.4.3.4:100000073595 | intradermale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073624 | perineurale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000003 | perivasale Anwendung | 1.2.40.0.34.5.156:7211713 | LIDOCAIN HYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | active | 53.3 | mg | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | 53.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:126687002 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073623 | periartikuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075554 | submuköse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0152075 | XYLONEURAL DFL 50ML | Xyloneural - Durchstechflasche | 1.2.40.0.34.4.17:14380 | GA - zugelassen | Gebro Pharma GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:N01BB02 | Lidocain | 1.2.40.0.10.1.4.3.4.3.4:100000073595 | intradermale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073624 | perineurale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073623 | periartikuläre Anwendung | 1.2.40.0.34.5.156:7211713 | LIDOCAIN HYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | active | 533 | mg | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | 533 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:126686001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000075554 | submuköse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0153264 | ESTRADURIN TRSTAMP 80MG +LSM | Estradurin 80 mg - Trockenstechampulle mit Lösungsmittel | 1.2.40.0.34.4.17:15704 | GA - aufgehoben | Pharmanovia A/S | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:L02AA02 | Polyestradiolphosphat | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1707425 | POLYESTRADIOL PHOSPHAT | 1.2.40.0.34.5.221:100000085476 | POLYESTRADIOL PHOSPHATE | active | 80 | mg | 1.2.40.0.34.5.221:100000085476 | POLYESTRADIOL PHOSPHATE | 80 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073868 | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:122285001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0153270 | ESTRADURIN TRSTAMP 80MG +LSM | Estradurin 80 mg - Trockenstechampulle mit Lösungsmittel | 1.2.40.0.34.4.17:15704 | GA - aufgehoben | Pharmanovia A/S | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:L02AA02 | Polyestradiolphosphat | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1707425 | POLYESTRADIOL PHOSPHAT | 1.2.40.0.34.5.221:100000085476 | POLYESTRADIOL PHOSPHATE | active | 80 | mg | 1.2.40.0.34.5.221:100000085476 | POLYESTRADIOL PHOSPHATE | 80 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073868 | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:122285002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0154039 | DEPAKINE TR 300MG/ML | Depakine 300 mg/ml Tropfen | 1.2.40.0.34.4.17:15699 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N03AG01 | Valproinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708859 | NATRIUM VALPROAT | 1.2.40.0.34.5.221:100000091448 | SODIUM VALPROATE | active | 18 | g | 1.2.40.0.34.5.221:100000091448 | SODIUM VALPROATE | 18 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | true | human | 1.2.40.0.34.4.26:120567001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0154140 | PARACODIN TR | Paracodin - Tropfen | 1.2.40.0.34.4.17:8202 | GA - zugelassen | Teofarma S.r.l. | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05DA | Opium-Alkaloide und Derivate | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707836 | DIHYDROCODEIN THIOCYANAT | 1.2.40.0.34.5.221:100000087506 | DIHYDROCODEINE THIOCYANATE | active | 0.3 | g | 1.2.40.0.34.5.221:100000087506 | DIHYDROCODEINE THIOCYANATE | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:121781002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0154157 | RIFOLDIN DRG 450MG | Rifoldin 450 mg Dragees | 1.2.40.0.34.4.17:15692 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J04AB02 | Rifampicin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706447 | RIFAMPICIN | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | active | 450 | mg | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | 450 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:120870001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0154163 | RIFOLDIN DRG 600MG | Rifoldin 600 mg Dragees | 1.2.40.0.34.4.17:15693 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:J04AB02 | Rifampicin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706447 | RIFAMPICIN | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | active | 600 | mg | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:120871002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0154594 | DIBENZYRAN KPS 10MG | Dibenzyran 10 mg Kapseln | 1.2.40.0.34.4.17:14842 | GA - zugelassen | Aristo Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AX02 | Phenoxybenzamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707348 | PHENOXYBENZAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000085275 | PHENOXYBENZAMINE HYDROCHLORIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000085275 | PHENOXYBENZAMINE HYDROCHLORIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:123020001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0154737 | SULTANOL SFT | Sultanol - Saft | 1.2.40.0.34.4.17:15723 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 150 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R03CC02 | Salbutamol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708649 | SALBUTAMOLSULFAT | 1.2.40.0.34.5.221:100000090564 | SALBUTAMOL SULFATE | active | 72 | mg | 1.2.40.0.34.5.221:100000090564 | SALBUTAMOL SULFATE | 72 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:121866001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0155406 | ETIBI IKONZ AMP 500MG/5ML | Etibi 500 mg - Ampullen | 1.2.40.0.34.4.17:15737 | GA - zugelassen | G.L. Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J04AK02 | Ethambutol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707794 | ETHAMBUTOL DIHYDROCHLORID | 1.2.40.0.34.5.221:100000087279 | ETHAMBUTOL DIHYDROCHLORIDE | active | 500 | mg | 1.2.40.0.34.5.221:100000087279 | ETHAMBUTOL DIHYDROCHLORIDE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:121381001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0155777 | VOLON-A 80MG SPRAMP | Volon A 80 mg - Kristallsuspension - Spritzampulle | 1.2.40.0.34.4.17:15735 | GA - zugelassen | Dermapharm GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB08 | Triamcinolon | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708563 | TRIAMCINOLON ACETONID | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | active | 80 | mg | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | 80 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:121675001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0157718 | DIPRODERM LSG DERM | Diproderm - dermatologische Lösung | 1.2.40.0.34.4.17:15753 | GA - zugelassen | Organon Healthcare GmbH | true | true | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.0192 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.0192 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:121926001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0159516 | PANTELMIN TBL | Pantelmin 100 mg - Tabletten | 1.2.40.0.34.4.17:15800 | GA - zugelassen | Janssen-Cilag Pharma GmbH | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:P02CA01 | Mebendazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709157 | MEBENDAZOL | 1.2.40.0.34.5.221:100000092064 | MEBENDAZOLE | active | 100 | mg | 1.2.40.0.34.5.221:100000092064 | MEBENDAZOLE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122532001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0159574 | DAUNOBLASTIN TRSTAMP 20MG | Daunoblastin 20 mg Pulver zur Herstellung einer Infusions- oder Injektionslösung | 1.2.40.0.34.4.17:15778 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:L01DB02 | Daunorubicin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709216 | DAUNORUBICIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092148 | DAUNORUBICIN HYDROCHLORID | active | | | 1.2.40.0.34.5.221:100000092148 | DAUNORUBICIN HYDROCHLORID | | | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0159769 | TETAGAM P FSPR | Tetagam P - Fertigspritze | 1.2.40.0.34.4.17:2-00118 | GA - zugelassen | CSL Behring GmbH | true | true | 1 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:J06BB02 | Tetanus-Immunglobulin | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1705771 | IMMUNGLOBULIN | 1.2.40.0.34.5.221:100000077660 | IMMUNGLOBULIN | active | 170 | | 1.2.40.0.34.5.221:100000077660 | IMMUNGLOBULIN | 170 | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:928931001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0162820 | STARTONYL IJLSG 125MG/ML 2ML | Startonyl 125 mg/ml Injektions-/Infusionslösung | 1.2.40.0.34.4.17:15808 | GA - zugelassen | Chiesi Pharmaceuticals GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:N06BX06 | Citicolin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709490 | CITICOLIN NATRIUM | 1.2.40.0.34.5.221:100000092641 | CITICOLIN NATRIUM | active | | | 1.2.40.0.34.5.221:100000092641 | CITICOLIN NATRIUM | | | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0169644 | KCL RET SLOW-K DRG 600MG | KCl retard Slow-K 600 mg - Dragees | 1.2.40.0.34.4.17:15766 | GA - zugelassen | Gebro Pharma GmbH | true | true | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A12BA01 | Kaliumchlorid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 600 | mg | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:121100001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0171428 | ALDACTONE HARTKPS 100MG | Aldactone 100 mg - Hartkapseln | 1.2.40.0.34.4.17:15857 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03DA01 | Spironolacton | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 100 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:122280001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0171434 | ALDACTONE HARTKPS 100MG | Aldactone 100 mg - Hartkapseln | 1.2.40.0.34.4.17:15857 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03DA01 | Spironolacton | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 100 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:122280002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0171486 | CONVULEX LSG 300MG/ML | Convulex 300 mg/ml - Lösung zum Einnehmen | 1.2.40.0.34.4.17:15864 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N03AG01 | Valproinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708859 | NATRIUM VALPROAT | 1.2.40.0.34.5.221:100000091448 | SODIUM VALPROATE | active | 30 | g | 1.2.40.0.34.5.221:100000091448 | SODIUM VALPROATE | 30 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:123344001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0171931 | LASIX KONZ Z INF 250MG 25ML | Lasix 250 mg Konzentrat zur Herstellung einer Infusionslösung | 1.2.40.0.34.4.17:15861 | GA - zugelassen | Sanofi-Aventis GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C03CA01 | Furosemid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707308 | NATRIUM FUROSEMID | 1.2.40.0.34.5.221:100000085198 | FUROSEMIDE SODIUM | active | 266.6 | mg | 1.2.40.0.34.5.221:100000085198 | FUROSEMIDE SODIUM | 266.6 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:120685002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0171948 | LASIX TBL 500MG | Lasix 500 mg Tabletten | 1.2.40.0.34.4.17:15860 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03CA01 | Furosemid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 500 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120686001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0175946 | NA BICARB FRE 8,4% GFL 100ML | Natriumbicarbonat "Fresenius" 8,4 % - Konzentrat zur Infusionsbereitung | 1.2.40.0.34.4.17:13324 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05XA02 | Natriumbicarbonat | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1706182 | NATRIUMHYDROGENCARBONAT | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | active | 8400 | mg | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | 8400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:121067001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0176621 | OXSORALEN KPS 10MG | Oxsoralen 10 mg - Kapseln | 1.2.40.0.34.4.17:15892 | GA - zugelassen | G.L. Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:D05BA02 | Methoxsalen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709454 | METHOXSALEN | 1.2.40.0.34.5.221:100000092592 | METHOXSALEN | active | 10 | mg | 1.2.40.0.34.5.221:100000092592 | METHOXSALEN | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | true | human | 1.2.40.0.34.4.26:123853001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0177394 | ASTONIN-H TBL | Astonin - H - Tabletten | 1.2.40.0.34.4.17:15789 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073530 | Mehrdosenbehältnis | 2.16.840.1.113883.6.73:H02AA02 | Fludrocortison | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706461 | FLUDROCORTISON | 1.2.40.0.34.5.221:100000080700 | FLUDROCORTISONE | active | 0.1 | mg | 1.2.40.0.34.5.221:100000080700 | FLUDROCORTISONE | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120303001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0177477 | LAXBENE RTP SUPP | Laxbene ratiopharm - Zäpfchen | 1.2.40.0.34.4.17:15897 | GA - zugelassen | Teva B.V. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A06AB02 | Bisacodyl | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709088 | BISACODYL | 1.2.40.0.34.5.221:100000091949 | BISACODYL | active | 0.01 | g | 1.2.40.0.34.5.221:100000091949 | BISACODYL | 0.01 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:123745001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0178465 | ANXIOLIT RET KPS 30MG | Anxiolit retard 30 mg - Kapseln | 1.2.40.0.34.4.17:15916 | GA - aufgehoben | G.L. Pharma GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA04 | Oxazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709067 | OXAZEPAM | 1.2.40.0.34.5.221:100000091921 | OXAZEPAM | active | 30 | mg | 1.2.40.0.34.5.221:100000091921 | OXAZEPAM | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073663 | Hartkapsel mit veränderter Wirkstofffreisetzung | true | human | 1.2.40.0.34.4.26:123390001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0178531 | ERGOMED TR | Ergomed - Tropfen | 1.2.40.0.34.4.17:15917 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C04AE01 | Ergoloidmesylat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706283 | DIHYDROERGOCORNIN METHANSULFONAT | 1.2.40.0.34.5.221:100000079764 | DIHYDROERGOCORNINE MESILATE | active | 0.495 | g | 1.2.40.0.34.5.221:100000079764 | DIHYDROERGOCORNINE MESILATE | 0.495 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:122219001 | 1.2.40.0.34.5.156:1706142 | DIHYDROERGOCRYPTIN METHANSULFONAT | 1.2.40.0.34.5.221:100000079201 | DIHYDROERGOCRYPTINE MESILATE | active | 0.495 | g | 1.2.40.0.34.5.221:100000079201 | DIHYDROERGOCRYPTINE MESILATE | 0.495 | g | 1.2.40.0.34.5.156:1708734 | DIHYDROERGOCRISTIN METHANSULFONAT | 1.2.40.0.34.5.221:100000091063 | DIHYDROERGOCRISTINE MESILATE | active | 0.495 | g | 1.2.40.0.34.5.221:100000091063 | DIHYDROERGOCRISTINE MESILATE | 0.495 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0178548 | ERGOMED TR | Ergomed - Tropfen | 1.2.40.0.34.4.17:15917 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C04AE01 | Ergoloidmesylat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706283 | DIHYDROERGOCORNIN METHANSULFONAT | 1.2.40.0.34.5.221:100000079764 | DIHYDROERGOCORNINE MESILATE | active | 1.65 | g | 1.2.40.0.34.5.221:100000079764 | DIHYDROERGOCORNINE MESILATE | 1.65 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:122219002 | 1.2.40.0.34.5.156:1706142 | DIHYDROERGOCRYPTIN METHANSULFONAT | 1.2.40.0.34.5.221:100000079201 | DIHYDROERGOCRYPTINE MESILATE | active | 1.65 | g | 1.2.40.0.34.5.221:100000079201 | DIHYDROERGOCRYPTINE MESILATE | 1.65 | g | 1.2.40.0.34.5.156:1708734 | DIHYDROERGOCRISTIN METHANSULFONAT | 1.2.40.0.34.5.221:100000091063 | DIHYDROERGOCRISTINE MESILATE | active | 1.65 | g | 1.2.40.0.34.5.221:100000091063 | DIHYDROERGOCRISTINE MESILATE | 1.65 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0178873 | UROSIN TBL 300MG | Urosin 300 mg - Tabletten | 1.2.40.0.34.4.17:15928 | GA - zugelassen | Teofarma S.r.l. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M04AA01 | Allopurinol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709057 | ALLOPURINOL | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | active | 300 | mg | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123983001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0178904 | VOLTAREN IJLSG AMP 75MG/3ML | Voltaren 75 mg/3 ml - Injektionslösung | 1.2.40.0.34.4.17:1-15915 | GA - zugelassen | Novartis Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 75 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:100000005740 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0178910 | VOLTAREN IJLSG AMP 75MG/3ML | Voltaren 75 mg/3 ml - Injektionslösung | 1.2.40.0.34.4.17:1-15915 | GA - zugelassen | Novartis Pharma GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 75 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:100000005741 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0182136 | AUREOCORT SLB | Aureocort 1 mg/g + 30 mg/g Salbe | 1.2.40.0.34.4.17:13273 | GA - zugelassen | Dermapharm GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07CB01 | Triamcinolon und Antibiotika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707146 | CHLORTETRACYCLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000084806 | CHLORTETRACYCLINE HYDROCHLORIDE | active | 0.9 | g | 1.2.40.0.34.5.221:100000092152 | CHLORTETRACYCLINE | 0.836326 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:124942001 | 1.2.40.0.34.5.156:1708563 | TRIAMCINOLON ACETONID | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | active | 0.03 | g | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | 0.03 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0182225 | DIPROGENTA CR | Diprogenta - Creme | 1.2.40.0.34.4.17:15937 | GA - zugelassen | Organon Healthcare GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07CC01 | Betamethason und Antibiotika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.0192 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.0192 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:122973002 | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 0.051 | g | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 0.035976 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0182260 | DIPROGENTA SLB | Diprogenta - Salbe | 1.2.40.0.34.4.17:15936 | GA - zugelassen | Organon Healthcare GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07CC01 | Betamethason und Antibiotika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.0192 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.0192 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:122974002 | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 0.051 | g | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 0.035976 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0182490 | RIVOTRIL TBL 2MG | Rivotril 2 mg - Tabletten | 1.2.40.0.34.4.17:15944 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N03AE01 | Clonazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707067 | CLONAZEPAM | 1.2.40.0.34.5.221:100000084528 | CLONAZEPAM | active | 2 | mg | 1.2.40.0.34.5.221:100000084528 | CLONAZEPAM | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:121687001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0185873 | EPANUTIN IJLSG 250MG/5ML | Epanutin 250 mg/5 ml - Injektionslösung | 1.2.40.0.34.4.17:15958 | GA - zugelassen | Viatris Austria GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:N03AB02 | Phenytoin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708422 | PHENYTOIN NATRIUM | 1.2.40.0.34.5.221:100000089972 | PHENYTOIN SODIUM | active | 250 | mg | 1.2.40.0.34.5.221:100000089972 | PHENYTOIN SODIUM | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:122080001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0186111 | REPARIL GEL | Reparil-Gel | 1.2.40.0.34.4.17:14243 | GA - zugelassen | Viatris Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708722 | AESCIN | 1.2.40.0.34.5.221:100000091047 | ESCIN | active | 1 | g | 1.2.40.0.34.5.221:100000091047 | ESCIN | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:123762001 | 1.2.40.0.34.5.156:1706241 | DIETHYLAMINSALICYLAT | 1.2.40.0.34.5.221:100000079574 | DIETHYLAMINE SALICYLATE | active | 5 | g | 1.2.40.0.34.5.221:100000079574 | DIETHYLAMINE SALICYLATE | 5 | g | | | | | | | | | | | | 2.16.840.1.113883.6.73:C05CX | Andere kapillarstabilisierende Mittel | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0187719 | ANTIBIOPHILUS HKPS | Antibiophilus - Hartkapseln | 1.2.40.0.34.4.17:1-23448 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A07FA01 | Milchsäurebildner | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710410 | LACTOBACILLUS CASEI | 1.2.40.0.34.5.221:900000000641 | LACTOBACILLUS CASEI | active | 200000000 | CFU | 1.2.40.0.34.5.221:900000000641 | LACTOBACILLUS CASEI | 200000000 | CFU | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | false | human | 1.2.40.0.34.4.26:929798003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0187866 | PSYCHOPAX TR | Psychopax Tropfen | 1.2.40.0.34.4.17:15968 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 20 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N05BA01 | Diazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709349 | DIAZEPAM | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | active | 250 | mg | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:124279001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0188498 | DERMOVATE CR | Dermovate - Creme | 1.2.40.0.34.4.17:15911 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | false | 25 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:D07AD01 | Clobetasol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708885 | CLOBETASOL PROPIONAT | 1.2.40.0.34.5.221:100000091516 | CLOBETASOL PROPIONAT | active | | | 1.2.40.0.34.5.221:100000091516 | CLOBETASOL PROPIONAT | | | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0188506 | DERMOVATE CR | Dermovate - Creme | 1.2.40.0.34.4.17:15911 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AD01 | Clobetasol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708885 | CLOBETASOL PROPIONAT | 1.2.40.0.34.5.221:100000091516 | CLOBETASOL PROPIONATE | active | 0.05 | g | 1.2.40.0.34.5.221:100000091516 | CLOBETASOL PROPIONATE | 0.05 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:120818001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0188512 | DERMOVATE SLB | Dermovate - Salbe | 1.2.40.0.34.4.17:15910 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | false | 25 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AD01 | Clobetasol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708885 | CLOBETASOL PROPIONAT | 1.2.40.0.34.5.221:100000091516 | CLOBETASOL PROPIONATE | active | 0.0125 | g | 1.2.40.0.34.5.221:100000091516 | CLOBETASOL PROPIONATE | 0.0125 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:122830002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0188529 | DERMOVATE SLB | Dermovate - Salbe | 1.2.40.0.34.4.17:15910 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AD01 | Clobetasol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708885 | CLOBETASOL PROPIONAT | 1.2.40.0.34.5.221:100000091516 | CLOBETASOL PROPIONATE | active | 0.05 | g | 1.2.40.0.34.5.221:100000091516 | CLOBETASOL PROPIONATE | 0.05 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:122830001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0188647 | BETAISODONA LSG STAND. | Betaisodona Lösung standardisiert | 1.2.40.0.34.4.17:15973 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | true | 500 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D08AG02 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073573 | zum Auftragen auf die Wunde | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | active | 50 | g | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | 50 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:122143006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0188653 | BETAISODONA LSG STAND. | Betaisodona Lösung standardisiert | 1.2.40.0.34.4.17:15973 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | true | 1000 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D08AG02 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073573 | zum Auftragen auf die Wunde | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | active | 100 | g | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | 100 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:122143004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0188699 | BUERLECITHIN DRG | Buerlecithin plus Vitamine Dragees | 1.2.40.0.34.4.17:HERB-00043 | GA - aufgehoben | Takeda Pharma Ges.m.b.H. | false | false | 72 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:A13A | Tonika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 0.3 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 0.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:956773002 | 1.2.40.0.34.5.156:1705659 | LECITHIN | 1.2.40.0.34.5.221:100000077103 | LECITHIN | active | 750 | mg | 1.2.40.0.34.5.221:100000077103 | LECITHIN | 750 | mg | 1.2.40.0.34.5.156:1708612 | CALCIUM PANTOTHENAT | 1.2.40.0.34.5.221:100000090485 | CALCIUM PANTOTHENATE | active | 0.8 | mg | 1.2.40.0.34.5.221:100000090485 | CALCIUM PANTOTHENATE | 0.8 | mg | | | | | | | 1.2.40.0.34.5.156:1706334 | ALPHA-TOCOPHEROLACETAT | 1.2.40.0.34.5.221:100000079921 | ALPHATOCOPHEROL ACETATE | active | 5.5 | mg | 1.2.40.0.34.5.221:100000079921 | ALPHATOCOPHEROL ACETATE | 5.5 | mg | 1.2.40.0.34.5.156:1708142 | RIBOFLAVIN | 1.2.40.0.34.5.221:100000089010 | RIBOFLAVIN | active | 0.3 | mg | 1.2.40.0.34.5.221:100000089010 | RIBOFLAVIN | 0.3 | mg | 1.2.40.0.34.5.156:1709249 | THIAMIN NITRAT | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | active | 0.544 | mg | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | 0.544 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0188713 | ESTRACYT KPS 140MG | Estracyt 140 mg Kapseln | 1.2.40.0.34.4.17:15971 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L01XX11 | Estramustin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707799 | DINATRIUM ESTRAMUSTIN PHOSPHAT | 1.2.40.0.34.5.221:100000087294 | ESTRAMUSTINE PHOSPHATE SODIUM | active | 156.7 | mg | 1.2.40.0.34.5.221:100000087294 | ESTRAMUSTINE PHOSPHATE SODIUM | 156.7 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:121542002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0188788 | LIDOCORIT AMP 2% 10ML | Lidocorit 2 % - Ampullen | 1.2.40.0.34.4.17:15967 | GA - zugelassen | Gebro Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C01BB01 | Lidocain | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:7211713 | LIDOCAIN HYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | active | 213.3 | mg | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | 213.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:121478001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0189799 | BRIETAL TRSTAMP 500MG | Brietal 500 mg - Trockenstechampulle | 1.2.40.0.34.4.17:15983 | GA - zugelassen | Hikma Farmaceutica (Portugal) S.A. | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:N05CA15 | Methohexital | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707991 | METHOHEXITAL NATRIUM | 1.2.40.0.34.5.221:100000088254 | METHOHEXITAL SODIUM | active | 500 | mg | 1.2.40.0.34.5.221:100000088254 | METHOHEXITAL SODIUM | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:123669001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0189983 | INDERAL FTBL 40MG | Inderal 40 mg - Filmtabletten | 1.2.40.0.34.4.17:13295 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AA05 | Propranolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708790 | PROPRANOLOL HYDROCHLORID | 1.2.40.0.34.5.221:100000091292 | PROPRANOLOL HYDROCHLORIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000091292 | PROPRANOLOL HYDROCHLORIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124650001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0190093 | PETINIMID KPS 250MG | Petinimid 250mg - Kapseln | 1.2.40.0.34.4.17:12017 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AD01 | Ethosuximid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709576 | ETHOSUXIMID | 1.2.40.0.34.5.221:100000092816 | ETHOSUXIMIDE | active | 250 | mg | 1.2.40.0.34.5.221:100000092816 | ETHOSUXIMIDE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | true | human | 1.2.40.0.34.4.26:125272001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0190199 | QUANTALAN ZUFR PLV | Quantalan zuckerfrei - Pulver | 1.2.40.0.34.4.17:15992 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:C10AC01 | Colestyramin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707944 | COLESTYRAMIN | 1.2.40.0.34.5.221:100000087979 | COLESTYRAMINE | active | 4.4 | g | 1.2.40.0.34.5.221:100000087979 | COLESTYRAMINE | 4.4 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:123164001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0191885 | COLDOPHTHAL AU-TR | Coldophthal - Augentropfen | 1.2.40.0.34.4.17:16003 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01GA01 | Naphazolin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1708567 | NAPHAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | active | 2 | mg | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:124786001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0192175 | SAROTEN RET KPS 50MG | Saroten Retard 50 mg - Kapseln | 1.2.40.0.34.4.17:15984 | GA - aufgehoben | Lundbeck Austria GmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N06AA09 | Amitriptylin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708532 | AMITRIPTYLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090311 | AMITRIPTYLINE HYDROCHLORIDE | active | 56.55 | mg | 1.2.40.0.34.5.221:100000090311 | AMITRIPTYLINE HYDROCHLORIDE | 56.55 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:123952002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0193074 | REFOBACIN AMP 120MG 2ML | Refobacin 120 mg - Ampullen | 1.2.40.0.34.4.17:16022 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 200 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 141.0836 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:121482001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0193105 | RIFOLDIN +INH DRG 300MG | Rifoldin 300 mg mit INH Dragees | 1.2.40.0.34.4.17:16028 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J04AM02 | Rifampicin und Isoniazid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709527 | ISONIAZID | 1.2.40.0.34.5.221:100000092732 | ISONIAZID | active | 150 | mg | 1.2.40.0.34.5.221:100000092732 | ISONIAZID | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:122513001 | 1.2.40.0.34.5.156:1706447 | RIFAMPICIN | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | active | 300 | mg | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | 300 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0193111 | SIALIN-SIGMA LSG | Sialin Sigma - Lösung | 1.2.40.0.34.4.17:16011 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A01AD11 | Verschiedene | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | | | 1.2.40.0.34.5.156:1707753 | CARMELLOSE NATRIUM | 1.2.40.0.34.5.221:100000087080 | CARMELLOSE SODIUM | active | 500 | mg | 1.2.40.0.34.5.221:100000087080 | CARMELLOSE SODIUM | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073676 | Spray zur Anwendung in der Mundhöhle | false | human | 1.2.40.0.34.4.26:123896001 | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 120 | mg | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 120 | mg | 1.2.40.0.34.5.156:7395955 | CALCIUMCHLORID DIHYDRAT | 1.2.40.0.34.5.221:100000090106 | CALCIUM CHLORIDE DIHYDRATE | active | 14.77 | mg | 1.2.40.0.34.5.221:100000090106 | CALCIUM CHLORIDE DIHYDRATE | 14.77 | mg | | | | | | | 1.2.40.0.34.5.156:1707667 | KALIUMMONOHYDROGENPHOSPHAT | 1.2.40.0.34.5.221:100000086553 | DIPOTASSIUM PHOSPHATE | active | 35 | mg | 1.2.40.0.34.5.221:100000086553 | DIPOTASSIUM PHOSPHATE | 35 | mg | 1.2.40.0.34.5.156:7395962 | MAGNESIUMCHLORID HEXAHYDRAT | 1.2.40.0.34.5.221:100000091409 | MAGNESIUM CHLORIDE HEXAHYDRATE | active | 6.4 | mg | 1.2.40.0.34.5.221:100000091409 | MAGNESIUM CHLORIDE HEXAHYDRATE | 6.4 | mg | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 85 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 85 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0193186 | IMUREK FTBL | Imurek - 50 mg Filmtabletten | 1.2.40.0.34.4.17:13362 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:L04AX01 | Azathioprin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708875 | AZATHIOPRIN | 1.2.40.0.34.5.221:100000091475 | AZATHIOPRINE | active | 50 | mg | 1.2.40.0.34.5.221:100000091475 | AZATHIOPRINE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122419002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0193447 | GYNO-PEVARYL VAG-CR 10MG/G | Gyno-Pevaryl 10 mg/g Vaginalcreme | 1.2.40.0.34.4.17:16031 | GA - aufgehoben | Karo Healthcare AB | false | false | 78 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:G01AF05 | Econazol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | 1.2.40.0.34.5.156:1709603 | ECONAZOL NITRAT | 1.2.40.0.34.5.221:100000092986 | ECONAZOLE NITRATE | active | 780 | mg | 1.2.40.0.34.5.221:100000092986 | ECONAZOLE NITRATE | 780 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073811 | Vaginalcreme | true | human | 1.2.40.0.34.4.26:121326001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0193507 | LUDIOMIL FTBL 75MG | Ludiomil 75 mg - Filmtabletten | 1.2.40.0.34.4.17:16036 | GA - zugelassen | Amdipharm Limited | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AA21 | Maprotilin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709373 | MAPROTILIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092398 | MAPROTILINE HYDROCHLORIDE | active | 75 | mg | 1.2.40.0.34.5.221:100000092398 | MAPROTILINE HYDROCHLORIDE | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:121150002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0193513 | LUDIOMIL FTBL 75MG | Ludiomil 75 mg - Filmtabletten | 1.2.40.0.34.4.17:16036 | GA - zugelassen | Amdipharm Limited | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AA21 | Maprotilin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709373 | MAPROTILIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092398 | MAPROTILINE HYDROCHLORIDE | active | 75 | mg | 1.2.40.0.34.5.221:100000092398 | MAPROTILINE HYDROCHLORIDE | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:121150001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0193559 | PEVARYL CR | Pevaryl 10 mg/g Creme | 1.2.40.0.34.4.17:16032 | GA - zugelassen | Trimb Healthcare AB | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D01AC03 | Econazol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709603 | ECONAZOL NITRAT | 1.2.40.0.34.5.221:100000092986 | ECONAZOLE NITRATE | active | 300 | mg | 1.2.40.0.34.5.221:100000092986 | ECONAZOLE NITRATE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | false | human | 1.2.40.0.34.4.26:120360001 | 1.2.40.0.34.5.156:1708587 | BENZOESÄURE | 1.2.40.0.34.5.221:100000090433 | BENZOIC ACID | active | 60 | mg | 1.2.40.0.34.5.221:100000090433 | BENZOIC ACID | 60 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0193938 | CONVULEX KPS 300MG | Convulex 300 mg - Kapseln | 1.2.40.0.34.4.17:16057 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AG01 | Valproinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708579 | VALPROINSÄURE | 1.2.40.0.34.5.221:100000090423 | VALPROIC ACID | active | 300 | mg | 1.2.40.0.34.5.221:100000090423 | VALPROIC ACID | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073661 | magensaftresistente Weichkapsel | true | human | 1.2.40.0.34.4.26:124039001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0193944 | CONVULEX KPS 150MG | Convulex 150 mg - Kapseln | 1.2.40.0.34.4.17:16058 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AG01 | Valproinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708579 | VALPROINSÄURE | 1.2.40.0.34.5.221:100000090423 | VALPROIC ACID | active | 150 | mg | 1.2.40.0.34.5.221:100000090423 | VALPROIC ACID | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073661 | magensaftresistente Weichkapsel | true | human | 1.2.40.0.34.4.26:124038001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0193967 | DALACIN C PHOS AMP 300MG/2ML | Dalacin C Phosphat 300 mg/2 ml - Ampulle | 1.2.40.0.34.4.17:1-16059 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01FF01 | Clindamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708641 | CLINDAMYCIN PHOSPHAT | 1.2.40.0.34.5.221:100000090555 | CLINDAMYCIN PHOSPHATE | active | 356.45 | mg | 1.2.40.0.34.5.221:100000090555 | CLINDAMYCIN PHOSPHATE | 356.45 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:125035001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0193973 | DALACIN C PHOS AMP 600MG/4ML | Dalacin C Phosphat 600 mg/4 ml - Ampulle | 1.2.40.0.34.4.17:1-16060 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01FF01 | Clindamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708641 | CLINDAMYCIN PHOSPHAT | 1.2.40.0.34.5.221:100000090555 | CLINDAMYCIN PHOSPHATE | active | 712.91 | mg | 1.2.40.0.34.5.221:100000090555 | CLINDAMYCIN PHOSPHATE | 712.91 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:127007001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0193996 | DALACIN C PHOS AMP 900MG/6ML | Dalacin C Phosphat 900 mg/6 ml - Ampulle | 1.2.40.0.34.4.17:1-16061 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01FF01 | Clindamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708641 | CLINDAMYCIN PHOSPHAT | 1.2.40.0.34.5.221:100000090555 | CLINDAMYCIN PHOSPHATE | active | 1069.36 | mg | 1.2.40.0.34.5.221:100000090555 | CLINDAMYCIN PHOSPHATE | 1069.36 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:127008001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0194116 | MAXI-KALZ BRTBL 500MG | Maxi - Kalz 500 mg - Brausetabletten | 1.2.40.0.34.4.17:15997 | GA - zugelassen | Viatris Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:A12AA04 | Calciumcarbonat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708886 | CALCIUMCARBONAT | 1.2.40.0.34.5.221:100000091518 | CALCIUM CARBONATE | active | 1250 | mg | 1.2.40.0.34.5.221:100000091518 | CALCIUM CARBONATE | 1250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073681 | Brausetablette | true | human | 1.2.40.0.34.4.26:124014001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0194122 | MAXI-KALZ BRTBL 1000MG | Maxi - Kalz 1000 mg - Brausetabletten | 1.2.40.0.34.4.17:15996 | GA - zugelassen | Viatris Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:A12AA04 | Calciumcarbonat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708886 | CALCIUMCARBONAT | 1.2.40.0.34.5.221:100000091518 | CALCIUM CARBONATE | active | 2500 | mg | 1.2.40.0.34.5.221:100000091518 | CALCIUM CARBONATE | 2500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073681 | Brausetablette | true | human | 1.2.40.0.34.4.26:124017001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0195245 | BISOLVON LSG | Bisolvon - Lösung | 1.2.40.0.34.4.17:1-13241 | GA - aufgehoben | Opella Healthcare Austria GmbH | false | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CB02 | Bromhexin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709064 | BROMHEXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091917 | BROMHEXINE HYDROCHLORIDE | active | 0.2 | g | 1.2.40.0.34.5.221:100000091917 | BROMHEXINE HYDROCHLORIDE | 0.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:127185001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0195423 | KEFLEX FTBL 1000MG | Keflex 1000 mg Filmtabletten | 1.2.40.0.34.4.17:16085 | GA - zugelassen | Arcana Arzneimittel GmbH | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01DB01 | Cefalexin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7034728 | CEFALEXIN MONOHYDRAT | 1.2.40.0.34.5.221:100000092402 | CEFALEXIN MONOHYDRATE | active | 1052 | mg | 1.2.40.0.34.5.221:100000091359 | CEFALEXIN | 1000.149024 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:123305001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0196322 | FENISTIL GEL | Fenistil - Gel | 1.2.40.0.34.4.17:16084 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | false | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:D04AA13 | Dimetinden | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707840 | DIMETINDEN MALEAT | 1.2.40.0.34.5.221:100000087512 | DIMETINDEN MALEAT | active | | | 1.2.40.0.34.5.221:100000087512 | DIMETINDEN MALEAT | | | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0198338 | BETAISODONA WUNDGEL TG | Betadona Wund - Gel | 1.2.40.0.34.4.17:15974 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | false | 250 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:D08AG02 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073573 | zum Auftragen auf die Wunde | | | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDON-IOD | active | | | 1.2.40.0.34.5.221:100000091677 | POVIDON-IOD | | | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0202270 | DALACIN C KPS 150MG | Dalacin C 150 mg - Kapseln | 1.2.40.0.34.4.17:1-16138 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 16 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01FF01 | Clindamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708638 | CLINDAMYCIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090552 | CLINDAMYCIN HYDROCHLORIDE | active | 177.515 | mg | 1.2.40.0.34.5.221:100000084276 | CLINDAMYCIN | 163.48883 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:125033001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0202318 | EUTHYROX TBL 75MCG | Euthyrox 75 Mikrogramm Tabletten | 1.2.40.0.34.4.17:1-24160 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA01 | Levothyroxin-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.075 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.075 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:945250002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0202324 | EUTHYROX TBL 75MCG | Euthyrox 75 Mikrogramm Tabletten | 1.2.40.0.34.4.17:1-24160 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA01 | Levothyroxin-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.075 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.075 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:945250001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0202330 | GICHTEX RET KPS 250MG | Gichtex Retard 250 mg - Kapseln | 1.2.40.0.34.4.17:16146 | GA - zugelassen | G.L. Pharma GmbH | true | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M04AA01 | Allopurinol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709057 | ALLOPURINOL | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | active | 250 | mg | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073663 | Hartkapsel mit veränderter Wirkstofffreisetzung | true | human | 1.2.40.0.34.4.26:124736001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0202353 | GLURENORM TBL | Glurenorm 30 mg - Tabletten | 1.2.40.0.34.4.17:16103 | GA - zugelassen | Boehringer Ingelheim RCV GmbH & Co KG | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BB08 | Gliquidon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709552 | GLIQUIDON | 1.2.40.0.34.5.221:100000092780 | GLIQUIDONE | active | 30 | mg | 1.2.40.0.34.5.221:100000092780 | GLIQUIDONE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124341002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0202376 | GLURENORM TBL | Glurenorm 30 mg - Tabletten | 1.2.40.0.34.4.17:16103 | GA - zugelassen | Boehringer Ingelheim RCV GmbH & Co KG | true | true | 120 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BB08 | Gliquidon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709552 | GLIQUIDON | 1.2.40.0.34.5.221:100000092780 | GLIQUIDONE | active | 30 | mg | 1.2.40.0.34.5.221:100000092780 | GLIQUIDONE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124341001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0202471 | LEGALON KPS 70MG | Legalon 70 mg - Kapseln | 1.2.40.0.34.4.17:16139 | GA - zugelassen | Viatris Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A05BA03 | Silymarin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710766 | SILYBI MARIANI FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000001000 | SILYBI MARIANI FRUCTUS (EXTRACT) | active | 86.5 | mg | 1.2.40.0.34.5.221:900000001000 | SILYBI MARIANI FRUCTUS (EXTRACT) | 86.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:127187002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0202488 | LEGALON KPS 70MG | Legalon 70 mg - Kapseln | 1.2.40.0.34.4.17:16139 | GA - zugelassen | Viatris Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A05BA03 | Silymarin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710766 | SILYBI MARIANI FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000001000 | SILYBI MARIANI FRUCTUS (EXTRACT) | active | 86.5 | mg | 1.2.40.0.34.5.221:900000001000 | SILYBI MARIANI FRUCTUS (EXTRACT) | 86.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:127187001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0202531 | OSPEXIN FTBL 500MG | Ospexin 500 mg - Filmtabletten | 1.2.40.0.34.4.17:16134 | GA - zugelassen | Sandoz GmbH | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01DB01 | Cefalexin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708819 | CEFALEXIN | 1.2.40.0.34.5.221:100000091359 | CEFALEXIN | active | 526 | mg | 1.2.40.0.34.5.221:100000091359 | CEFALEXIN | 526 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124742002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0202554 | OSPEXIN FTBL 1000MG | Ospexin 1000 mg - Filmtabletten | 1.2.40.0.34.4.17:16135 | GA - zugelassen | Sandoz GmbH | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01DB01 | Cefalexin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708819 | CEFALEXIN | 1.2.40.0.34.5.221:100000091359 | CEFALEXIN | active | 1052 | mg | 1.2.40.0.34.5.221:100000091359 | CEFALEXIN | 1052 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124743002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0202577 | OSPEXIN GRAN OR SUS 250MG | Ospexin 250 mg/5 ml - Granulat für orale Suspension | 1.2.40.0.34.4.17:16132 | GA - zugelassen | Sandoz GmbH | true | true | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01DB01 | Cefalexin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7034728 | CEFALEXIN MONOHYDRAT | 1.2.40.0.34.5.221:100000092402 | CEFALEXIN MONOHYDRATE | active | 3154.68 | mg | 1.2.40.0.34.5.221:100000091359 | CEFALEXIN | 2999.192132 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073650 | Granulat zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:124672001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0204659 | INFLORAN KPS | Infloran - Kapseln | 1.2.40.0.34.4.17:1-23208 | GA - aufgehoben | Laboratorio Farmaceutico S.I.T. - Specialita' Igienico Terapeutiche S.r.l. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:A07FA | Mikrobielle Antidiarrhoika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705652 | LACTOBACILLUS ACIDOPHILUS | 1.2.40.0.34.5.221:100000077069 | LACTOBACILLUS ACIDOPHILUS | active | 1000000000 | U | 1.2.40.0.34.5.221:100000077069 | LACTOBACILLUS ACIDOPHILUS | 1000000000 | U | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | false | human | 1.2.40.0.34.4.26:929851001 | 1.2.40.0.34.5.156:1709740 | BIFIDOBACTERIUM | 1.2.40.0.34.5.221:100000124509 | BIFIDOBACTERIUM | active | 1000000000 | U | 1.2.40.0.34.5.221:100000124509 | BIFIDOBACTERIUM | 1000000000 | U | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0204808 | SALI-ALDOPUR DRG | Sali - Aldopur - Dragees | 1.2.40.0.34.4.17:16110 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C03EA13 | Bendroflumethiazid und Kalium sparende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709542 | BENDROFLUMETHIAZID | 1.2.40.0.34.5.221:100000092763 | BENDROFLUMETHIAZIDE | active | 2.5 | mg | 1.2.40.0.34.5.221:100000092763 | BENDROFLUMETHIAZIDE | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:123858001 | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 50 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0204814 | SALI-ALDOPUR DRG | Sali - Aldopur - Dragees | 1.2.40.0.34.4.17:16110 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C03EA13 | Bendroflumethiazid und Kalium sparende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709542 | BENDROFLUMETHIAZID | 1.2.40.0.34.5.221:100000092763 | BENDROFLUMETHIAZIDE | active | 2.5 | mg | 1.2.40.0.34.5.221:100000092763 | BENDROFLUMETHIAZIDE | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:123858002 | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 50 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0204895 | THROMBOPHOB-S GEL | Thrombophob - S Gel | 1.2.40.0.34.4.17:16093 | GA - zugelassen | Nordmark Pharma GmbH | true | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA03 | Heparin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 7.24 | g | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 7.24 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:125360001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0207267 | ACERBINE SLB | Acerbine Salbe | 1.2.40.0.34.4.17:16169 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | false | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D03AX | Andere Wundbehandlungsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 0.0133 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 0.0133 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:121989001 | 1.2.40.0.34.5.156:1709003 | ÄPFELSÄURE | 1.2.40.0.34.5.221:100000091777 | MALIC ACID | active | 0.7 | g | 1.2.40.0.34.5.221:100000091777 | MALIC ACID | 0.7 | g | 1.2.40.0.34.5.156:1708587 | BENZOESÄURE | 1.2.40.0.34.5.221:100000090433 | BENZOIC ACID | active | 0.05 | g | 1.2.40.0.34.5.221:100000090433 | BENZOIC ACID | 0.05 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0207304 | BELOC TBL 50MG | Beloc 50 mg - Tabletten | 1.2.40.0.34.4.17:16170 | GA - zugelassen | Recordati Ireland Limited | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122504002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0207310 | BELOC TBL 50MG | Beloc 50 mg - Tabletten | 1.2.40.0.34.4.17:16170 | GA - zugelassen | Recordati Ireland Limited | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122504001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0207327 | BELOC TBL 100MG | Beloc 100 mg - Tabletten | 1.2.40.0.34.4.17:16171 | GA - zugelassen | Recordati Ireland Limited | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122505001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0207333 | BELOC TBL 100MG | Beloc 100 mg - Tabletten | 1.2.40.0.34.4.17:16171 | GA - zugelassen | Recordati Ireland Limited | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122505002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0225118 | CUTASEPT DESINFEKT.FARBLOS | Cutasept - Desinfektionslösung farblos | 1.2.40.0.34.4.17:1-31780 | GA - zugelassen | Bode Chemie GmbH | true | true | 250 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D08AX53 | Propanol, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709170 | BENZALKONIUMCHLORID | 1.2.40.0.34.5.221:100000092079 | BENZALKONIUM CHLORIDE | active | 0.0625 | g | 1.2.40.0.34.5.221:100000092079 | BENZALKONIUM CHLORIDE | 0.0625 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:956625002 | 1.2.40.0.34.5.156:1705751 | 2-PROPANOL | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | active | 157.5 | g | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | 157.5 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0391779 | DANTROLEN I.V.PLV 20MG | Dantrolen i.v. 20 mg Pulver zur Herstellung einer Injektions-/Infusionslösung | 1.2.40.0.34.4.17:17709 | GA - zugelassen | Norgine B.V. | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:M03CA01 | Dantrolen | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:9054892 | DANTROLEN NATRIUM HEMIHEPTAHYDRAT | 1.2.40.0.34.5.221:100000126026 | DANTROLENE SODIUM, HEMIHEPTAHYDRATE | active | 20 | mg | 1.2.40.0.34.5.221:100000126026 | DANTROLENE SODIUM, HEMIHEPTAHYDRATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:922040001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0391791 | DANTROLEN I.V.PLV 20MG | Dantrolen i.v. 20 mg Pulver zur Herstellung einer Injektions-/Infusionslösung | 1.2.40.0.34.4.17:17709 | GA - zugelassen | Norgine B.V. | true | true | 36 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:M03CA01 | Dantrolen | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:9054892 | DANTROLEN NATRIUM HEMIHEPTAHYDRAT | 1.2.40.0.34.5.221:100000126026 | DANTROLENE SODIUM, HEMIHEPTAHYDRATE | active | 20 | mg | 1.2.40.0.34.5.221:100000126026 | DANTROLENE SODIUM, HEMIHEPTAHYDRATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:922040002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0395777 | BRAUNOL DESINF.LSG 1000ML | Braunol 7,5 % Lösung zur Anwendung auf der Haut | 1.2.40.0.34.4.17:17468 | GA - zugelassen | B. Braun Melsungen AG | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D08AG02 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | active | 75 | g | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | 75 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:128838003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0437984 | BELOC AMP 5MG 5ML | Beloc 5 mg - Ampullen | 1.2.40.0.34.4.17:17371 | GA - zugelassen | Recordati Ireland Limited | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 5 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:127230001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0438009 | CANDIO-HERMAL SOFT PST | Candio - Hermal soft - Paste | 1.2.40.0.34.4.17:16579 | GA - zugelassen | Almirall Hermal GmbH | true | true | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D01AA01 | Nystatin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708425 | NYSTATIN | 1.2.40.0.34.5.221:100000089986 | NYSTATIN | active | 0.4 | g | 1.2.40.0.34.5.221:100000089986 | NYSTATIN | 0.4 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073727 | Paste zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:123302002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0438274 | CIMETIDIN GEN FTBL 400MG | Cimetidin Genericon 400 mg Filmtabletten | 1.2.40.0.34.4.17:17360 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA01 | Cimetidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709561 | CIMETIDIN | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | active | 400 | mg | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:921843001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0438386 | CIMETIDIN GEN FTBL 400MG | Cimetidin Genericon 400 mg Filmtabletten | 1.2.40.0.34.4.17:17360 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA01 | Cimetidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709561 | CIMETIDIN | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | active | 400 | mg | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:921843002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0438392 | COLDAN AU-TR | Coldan - Augentropfen | 1.2.40.0.34.4.17:17355 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01GA01 | Naphazolin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1708567 | NAPHAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:922717001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0438400 | COLDISTAN AU-TR | Coldistan Augentropfen | 1.2.40.0.34.4.17:17356 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01GA51 | Naphazolin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1708567 | NAPHAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:922716001 | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 10 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0438682 | HARMOMED DRG FTE | Harmomed forte - Dragees | 1.2.40.0.34.4.17:17362 | GA - aufgehoben | Kwizda Pharma GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N06AA | Nichtselektive Monoamin-Wiederaufnahmehemmer | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709349 | DIAZEPAM | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | active | 5 | mg | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:920911001 | 1.2.40.0.34.5.156:1709076 | DOSULEPIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091934 | DOSULEPIN HYDROCHLORIDE | active | 28 | mg | 1.2.40.0.34.5.221:100000091934 | DOSULEPIN HYDROCHLORIDE | 28 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0438707 | HARMOMED DRG FTE | Harmomed forte - Dragees | 1.2.40.0.34.4.17:17362 | GA - aufgehoben | Kwizda Pharma GmbH | false | false | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N06AA | Nichtselektive Monoamin-Wiederaufnahmehemmer | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709349 | DIAZEPAM | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | active | 5 | mg | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:920911002 | 1.2.40.0.34.5.156:1709076 | DOSULEPIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091934 | DOSULEPIN HYDROCHLORIDE | active | 28 | mg | 1.2.40.0.34.5.221:100000091934 | DOSULEPIN HYDROCHLORIDE | 28 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0440093 | MOTRIM TBL 100MG | Motrim 100 mg - Tabletten | 1.2.40.0.34.4.17:17343 | GA - zugelassen | G.L. Pharma GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01EA01 | Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | 100 | mg | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922119001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0440325 | MOTRIM TBL 200MG | Motrim 200 mg - Tabletten | 1.2.40.0.34.4.17:17344 | GA - zugelassen | G.L. Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01EA01 | Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | 200 | mg | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922120001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0440331 | MOTRIM TBL 200MG | Motrim 200 mg - Tabletten | 1.2.40.0.34.4.17:17344 | GA - zugelassen | G.L. Pharma GmbH | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01EA01 | Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | 200 | mg | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922120002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0440644 | RIFOLDIN PLV+LSM INF600MG BP | Rifoldin 600 mg Trockensubstanz zur Infusionsbereitung mit Lösungsmittel | 1.2.40.0.34.4.17:17370 | GA - zugelassen | Sanofi-Aventis GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J04AB02 | Rifampicin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1706447 | RIFAMPICIN | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | active | 600 | mg | 1.2.40.0.34.5.221:100000080561 | RIFAMPICIN | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073860 | Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:129032002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0440940 | UMPREL TBL 2,5MG | Umprel 2,5 mg - Tabletten | 1.2.40.0.34.4.17:17357 | GA - aufgehoben | MEDA Pharma GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N04BC01 | Bromocriptin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708574 | BROMOCRIPTIN MESILAT | 1.2.40.0.34.5.221:100000090410 | BROMOCRIPTINE MESILATE | active | 2.87 | mg | 1.2.40.0.34.5.221:100000090410 | BROMOCRIPTINE MESILATE | 2.87 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923452002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0442637 | NERISONA CR | Nerisona - Creme | 1.2.40.0.34.4.17:16179 | GA - zugelassen | LEO PHARMA A/S | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC06 | Diflucortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 0.015 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 0.015 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:121026001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0442643 | NERISONA CR | Nerisona - Creme | 1.2.40.0.34.4.17:16179 | GA - zugelassen | LEO PHARMA A/S | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC06 | Diflucortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 0.03 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 0.03 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:121026002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0442666 | NERISONA FSLB | Nerisona - Fettsalbe | 1.2.40.0.34.4.17:16180 | GA - zugelassen | LEO PHARMA A/S | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC06 | Diflucortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 0.015 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 0.015 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:121024001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0442672 | NERISONA FSLB | Nerisona - Fettsalbe | 1.2.40.0.34.4.17:16180 | GA - zugelassen | LEO PHARMA A/S | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC06 | Diflucortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 0.03 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 0.03 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:121024002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0442689 | NERISONA SLB | Nerisona - Salbe | 1.2.40.0.34.4.17:16181 | GA - zugelassen | LEO PHARMA A/S | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC06 | Diflucortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 0.015 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 0.015 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:121025001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0442695 | NERISONA SLB | Nerisona - Salbe | 1.2.40.0.34.4.17:16181 | GA - zugelassen | LEO PHARMA A/S | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC06 | Diflucortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 0.03 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 0.03 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:121025002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0452127 | ANTABUS TBL LSL | Antabus 400 mg lösliche Tabletten | 1.2.40.0.34.4.17:11605 | GA - aufgehoben | Actavis Group PTC ehf. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:N07BB01 | Disulfiram | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706656 | DISULFIRAM | 1.2.40.0.34.5.221:100000081855 | DISULFIRAM | active | 400 | mg | 1.2.40.0.34.5.221:100000081855 | DISULFIRAM | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073369 | Tablette zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:126193001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0452216 | DALACIN C GRAN 75MG/5ML | Dalacin C 75 mg/5 ml - Granulat für orale Lösung | 1.2.40.0.34.4.17:1-16190 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 80 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01FF01 | Clindamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709193 | CLINDAMYCIN PALMITAT HYDROCHLORID | 1.2.40.0.34.5.221:100000092112 | CLINDAMYCIN PALMITATE HYDROCHLORIDE | active | 2032 | mg | 1.2.40.0.34.5.221:100000092112 | CLINDAMYCIN PALMITATE HYDROCHLORIDE | 2032 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073365 | Granulat zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:125034001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0452311 | REFOBACIN AMP 80MG 2ML 5X5 | Refobacin 80 mg - Ampullen | 1.2.40.0.34.4.17:14375 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 133.3 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 94.032219 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:123029004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0453701 | EUSAPRIM TBL FTE | Eusaprim forte - Tabletten | 1.2.40.0.34.4.17:16213 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01EE01 | Sulfamethoxazol und Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | 160 | mg | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | 160 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:125658001 | 1.2.40.0.34.5.156:1709475 | SULFAMETHOXAZOL | 1.2.40.0.34.5.221:100000092618 | SULFAMETHOXAZOLE | active | 800 | mg | 1.2.40.0.34.5.221:100000092618 | SULFAMETHOXAZOLE | 800 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0453888 | LEXOTANIL ROCH TBL 3MG | Lexotanil 3 mg - Tabletten | 1.2.40.0.34.4.17:16224 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA08 | Bromazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709428 | BROMAZEPAM | 1.2.40.0.34.5.221:100000092554 | BROMAZEPAM | active | 3 | mg | 1.2.40.0.34.5.221:100000092554 | BROMAZEPAM | 3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124391001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0453894 | LEXOTANIL TBL 3MG | Lexotanil 3 mg - Tabletten | 1.2.40.0.34.4.17:16224 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA08 | Bromazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709428 | BROMAZEPAM | 1.2.40.0.34.5.221:100000092554 | BROMAZEPAM | active | 3 | mg | 1.2.40.0.34.5.221:100000092554 | BROMAZEPAM | 3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124391002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0453919 | LEXOTANIL ROCH TBL 6MG | Lexotanil "Roche" 6 mg - Tabletten | 1.2.40.0.34.4.17:16225 | GA - aufgehoben | Roche Austria GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA08 | Bromazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709428 | BROMAZEPAM | 1.2.40.0.34.5.221:100000092554 | BROMAZEPAM | active | 6 | mg | 1.2.40.0.34.5.221:100000092554 | BROMAZEPAM | 6 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124392001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0454008 | PARLODEL TBL 2,5MG | Parlodel 2,5 mg - Tabletten | 1.2.40.0.34.4.17:16192 | GA - aufgehoben | MEDA Pharma GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:G02CB01 | Bromocriptin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708574 | BROMOCRIPTIN MESILAT | 1.2.40.0.34.5.221:100000090410 | BROMOCRIPTINE MESILATE | active | 2.87 | mg | 1.2.40.0.34.5.221:100000090410 | BROMOCRIPTINE MESILATE | 2.87 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123091003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0454014 | PARLODEL TBL 2,5MG | Parlodel 2,5 mg - Tabletten | 1.2.40.0.34.4.17:16192 | GA - aufgehoben | MEDA Pharma GmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:G02CB01 | Bromocriptin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708574 | BROMOCRIPTIN MESILAT | 1.2.40.0.34.5.221:100000090410 | BROMOCRIPTINE MESILATE | active | 2.87 | mg | 1.2.40.0.34.5.221:100000090410 | BROMOCRIPTINE MESILATE | 2.87 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123091001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0455404 | AKTIFERRIN SFT | Aktiferrin - Saft | 1.2.40.0.34.4.17:16197 | GA - aufgehoben | Teva B.V. | false | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B03AE10 | Verschiedene Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705968 | EISEN(II)-SULFAT | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | active | 3.42 | g | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | 3.42 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073652 | Sirup | true | human | 1.2.40.0.34.4.26:124739001 | 1.2.40.0.34.5.156:1707010 | SERIN | 1.2.40.0.34.5.221:100000084137 | SERINE | active | 2.58 | g | 1.2.40.0.34.5.221:100000084137 | SERINE | 2.58 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0455410 | AKTIFERRIN TR | Aktiferrin - Tropfen | 1.2.40.0.34.4.17:16198 | GA - aufgehoben | Teva B.V. | false | false | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B03AE10 | Verschiedene Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705968 | EISEN(II)-SULFAT | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | active | 1.416 | g | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | 1.416 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | true | human | 1.2.40.0.34.4.26:124738001 | 1.2.40.0.34.5.156:1707010 | SERIN | 1.2.40.0.34.5.221:100000084137 | SERINE | active | 1.068 | g | 1.2.40.0.34.5.221:100000084137 | SERINE | 1.068 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0455663 | DIAMOX TBL 250MG | Diamox 250 mg - Tabletten | 1.2.40.0.34.4.17:8366 | GA - zugelassen | Amdipharm Limited | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:S01EC01 | Acetazolamid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709499 | ACETAZOLAMID | 1.2.40.0.34.5.221:100000092652 | ACETAZOLAMIDE | active | 250 | mg | 1.2.40.0.34.5.221:100000092652 | ACETAZOLAMIDE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120128002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0455700 | DOLOMENTHONEURIN GEL | Dolo - Menthoneurin - Gel | 1.2.40.0.34.4.17:15765 | GA - aufgehoben | Takeda Pharma Ges.m.b.H. | false | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:7255602 | LEVOMENTHOL | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | active | 80 | mg | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | 80 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:121394003 | 1.2.40.0.34.5.156:1706241 | DIETHYLAMINSALICYLAT | 1.2.40.0.34.5.221:100000079574 | DIETHYLAMINE SALICYLATE | active | 4000 | mg | 1.2.40.0.34.5.221:100000079574 | DIETHYLAMINE SALICYLATE | 4000 | mg | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 16 | mg | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 16 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0455752 | ECHNATOL DRG | Echnatol - Dragees | 1.2.40.0.34.4.17:11769 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AE03 | Cyclizin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707941 | CYCLIZIN HYDROCHLORID | 1.2.40.0.34.5.221:100000087968 | CYCLIZINE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000087968 | CYCLIZINE HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:124617002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0455893 | ISOPTIN DRG 40MG | Isoptin 40 mg - Dragees | 1.2.40.0.34.4.17:1-12540 | GA - zugelassen | Viatris Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:122676001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0455901 | ISOPTIN DRG 40MG | Isoptin 40 mg - Dragees | 1.2.40.0.34.4.17:1-12540 | GA - zugelassen | Viatris Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:122676002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0456220 | REPARIL DRG 20MG | Reparil 20 mg - Dragees | 1.2.40.0.34.4.17:12947 | GA - zugelassen | Viatris Austria GmbH | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C05CX | Andere kapillarstabilisierende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7249184 | AESCIN WASSERLÖSLICH (ALPHA) | 1.2.40.0.34.5.221:100000130090 | AESCIN WATER SOLUBLE (ALPHA) | active | 20 | mg | 1.2.40.0.34.5.221:100000130090 | AESCIN WATER SOLUBLE (ALPHA) | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:128346003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0456303 | SOLU-MEDROL TRSTAMP 1000MG | Solu - Medrol 1000 mg - Trockenstechampulle mit Lösungsmittel | 1.2.40.0.34.4.17:16218 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H02AB04 | Methylprednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708835 | METHYLPREDNISOLONHYDROGENSUCCINAT | 1.2.40.0.34.5.221:100000091386 | METHYLPREDNISOLONE HYDROGEN SUCCINATE | active | 1267.1 | mg | 1.2.40.0.34.5.221:100000091386 | METHYLPREDNISOLONE HYDROGEN SUCCINATE | 1267.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:120013002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0457633 | CODIPERTUSSIN HU-SFT | Codipertussin 230 mg/100 ml Hustensaft | 1.2.40.0.34.4.17:16229 | GA - aufgehoben | Astellas Pharma Ges.m.b.H. | false | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05DA04 | Codein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7431272 | CODEINPHOSPHAT HEMIHYDRAT | 1.2.40.0.34.5.221:100000090188 | CODEINE PHOSPHATE HEMIHYDRATE | active | 31.2 | g | 1.2.40.0.34.5.221:100000090188 | CODEINE PHOSPHATE HEMIHYDRATE | 31.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:121262001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0458207 | CEVITOL AMP 1000MG/5ML | Cevitol 1000 mg - Ampullen | 1.2.40.0.34.4.17:6528 | GA - zugelassen | G.L. Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A11GA01 | Ascorbinsäure (Vitamin C) | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 1000 | mg | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:128357002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0458213 | RIVOTRIL TBL 0,5MG | Rivotril 0,5 mg - Tabletten | 1.2.40.0.34.4.17:15943 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N03AE01 | Clonazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707067 | CLONAZEPAM | 1.2.40.0.34.5.221:100000084528 | CLONAZEPAM | active | 0.5 | mg | 1.2.40.0.34.5.221:100000084528 | CLONAZEPAM | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:121686001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0458578 | APREDNISLON TBL 5MG | Aprednislon 5 mg - Tabletten | 1.2.40.0.34.4.17:11258 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 5 | mg | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122762001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0458584 | APREDNISLON TBL 5MG | Aprednislon 5 mg - Tabletten | 1.2.40.0.34.4.17:11258 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 5 | mg | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122762003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0458590 | BRUFEN FTBL 400MG | Brufen 400 mg - Filmtabletten | 1.2.40.0.34.4.17:16233 | GA - zugelassen | Viatris Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 400 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124287001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0458609 | BRUFEN FTBL 400MG | Brufen 400 mg - Filmtabletten | 1.2.40.0.34.4.17:16233 | GA - zugelassen | Viatris Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 400 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124287002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0458638 | DYTIDE-H TBL | Dytide H - Tabletten | 1.2.40.0.34.4.17:1-13944 | GA - zugelassen | Dermapharm GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03EA01 | Hydrochlorothiazid und Kalium sparende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709440 | TRIAMTEREN | 1.2.40.0.34.5.221:100000092570 | TRIAMTERENE | active | 50 | mg | 1.2.40.0.34.5.221:100000092570 | TRIAMTERENE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124609001 | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 25 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0458644 | INSIDON DRG | Insidon - Dragees | 1.2.40.0.34.4.17:12034 | GA - zugelassen | Laboratoires Juvise Pharmaceuticals | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AA05 | Opipramol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709364 | OPIPRAMOL DIHYDROCHLORID | 1.2.40.0.34.5.221:100000092384 | OPIPRAMOL HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000092384 | OPIPRAMOL HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:125715001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0458704 | TRAVEL-GUM KAUGU DRG 20MG | Travelgum 20 mg - Kaugummi-Dragees | 1.2.40.0.34.4.17:16238 | GA - zugelassen | Viatris Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AA02 | Diphenhydramin | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | | | 1.2.40.0.34.5.156:1709065 | DIMENHYDRINAT | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | active | 20 | mg | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073669 | wirkstoffhaltiges Kaugummi | true | human | 1.2.40.0.34.4.26:125214001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0460049 | ADRIBLASTIN TRSTAMP 50MG+LSM | Adriblastin 50 mg Trockenstechampulle | 1.2.40.0.34.4.17:16751 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 2 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01DB01 | Doxorubicin | 1.2.40.0.10.1.4.3.4.3.4:100000073612 | intravesikale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | 1.2.40.0.34.5.156:1708421 | DOXORUBICIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089971 | DOXORUBICIN HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000089971 | DOXORUBICIN HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073866 | Pulver zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:125872002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0461250 | BRICANYL AMP 0,5MG 1ML | Bricanyl 0,5 mg - Ampullen | 1.2.40.0.34.4.17:16126 | GA - zugelassen | Astrazeneca Österreich GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:R03AC03 | Terbutalin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1707142 | TERBUTALINSULFAT | 1.2.40.0.34.5.221:100000084794 | TERBUTALINE SULFATE | active | 0.5 | mg | 1.2.40.0.34.5.221:100000084794 | TERBUTALINE SULFATE | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:121582001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0461310 | PREDNISOLON NYC TBL 5MG | Prednisolon "Nycomed" 5 mg - Tabletten | 1.2.40.0.34.4.17:11046 | GA - zugelassen | Takeda Austria GmbH | true | true | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 5 | mg | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:127113003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0479899 | NERISONA CR | Nerisona - Creme | 1.2.40.0.34.4.17:16179 | GA - zugelassen | LEO PHARMA A/S | true | true | 300 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:900000000007 | Tiegel (NE) | 2.16.840.1.113883.6.73:D07AC06 | Diflucortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 0.3 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:121026003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0479913 | NERISONA SLB | Nerisona - Salbe | 1.2.40.0.34.4.17:16181 | GA - zugelassen | LEO PHARMA A/S | true | true | 300 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:D07AC06 | Diflucortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 0.3 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:121025003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0480626 | UMPREL TBL 2,5MG | Umprel 2,5 mg - Tabletten | 1.2.40.0.34.4.17:17357 | GA - aufgehoben | MEDA Pharma GmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N04BC01 | Bromocriptin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708574 | BROMOCRIPTIN MESILAT | 1.2.40.0.34.5.221:100000090410 | BROMOCRIPTINE MESILATE | active | 2.87 | mg | 1.2.40.0.34.5.221:100000090410 | BROMOCRIPTINE MESILATE | 2.87 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923452001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0481755 | BIKLIN STAMP 250MG 2ML | Biklin 250 mg - Stechampullen | 1.2.40.0.34.4.17:16299 | GA - aufgehoben | Bristol-Myers Squibb Ges.m.b.H. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01GB06 | Amikacin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709396 | AMIKACIN | 1.2.40.0.34.5.221:100000092483 | AMIKACIN | active | 250 | mg | 1.2.40.0.34.5.221:100000092483 | AMIKACIN | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:122887002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0481778 | BIKLIN STAMP 500MG 2ML | Biklin 500 mg - Stechampullen | 1.2.40.0.34.4.17:16300 | GA - aufgehoben | Bristol-Myers Squibb Ges.m.b.H. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01GB06 | Amikacin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709396 | AMIKACIN | 1.2.40.0.34.5.221:100000092483 | AMIKACIN | active | 500 | mg | 1.2.40.0.34.5.221:100000092483 | AMIKACIN | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:122886002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0486296 | HYDERGIN TBL 2MG | Hydergin 2 mg - Tabletten | 1.2.40.0.34.4.17:16244 | GA - aufgehoben | Alfasigma S.p.A. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AE01 | Ergoloidmesylat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706283 | DIHYDROERGOCORNIN METHANSULFONAT | 1.2.40.0.34.5.221:100000079764 | DIHYDROERGOCORNINE MESILATE | active | 0.667 | mg | 1.2.40.0.34.5.221:100000079764 | DIHYDROERGOCORNINE MESILATE | 0.667 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123740001 | 1.2.40.0.34.5.156:1706142 | DIHYDROERGOCRYPTIN METHANSULFONAT | 1.2.40.0.34.5.221:100000079201 | DIHYDROERGOCRYPTINE MESILATE | active | 0.667 | mg | 1.2.40.0.34.5.221:100000079201 | DIHYDROERGOCRYPTINE MESILATE | 0.667 | mg | 1.2.40.0.34.5.156:1708734 | DIHYDROERGOCRISTIN METHANSULFONAT | 1.2.40.0.34.5.221:100000091063 | DIHYDROERGOCRISTINE MESILATE | active | 0.667 | mg | 1.2.40.0.34.5.221:100000091063 | DIHYDROERGOCRISTINE MESILATE | 0.667 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0486304 | HYDERGIN TBL 2MG | Hydergin 2 mg - Tabletten | 1.2.40.0.34.4.17:16244 | GA - aufgehoben | Alfasigma S.p.A. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AE01 | Ergoloidmesylat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706283 | DIHYDROERGOCORNIN METHANSULFONAT | 1.2.40.0.34.5.221:100000079764 | DIHYDROERGOCORNINE MESILATE | active | 0.667 | mg | 1.2.40.0.34.5.221:100000079764 | DIHYDROERGOCORNINE MESILATE | 0.667 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123740002 | 1.2.40.0.34.5.156:1706142 | DIHYDROERGOCRYPTIN METHANSULFONAT | 1.2.40.0.34.5.221:100000079201 | DIHYDROERGOCRYPTINE MESILATE | active | 0.667 | mg | 1.2.40.0.34.5.221:100000079201 | DIHYDROERGOCRYPTINE MESILATE | 0.667 | mg | 1.2.40.0.34.5.156:1708734 | DIHYDROERGOCRISTIN METHANSULFONAT | 1.2.40.0.34.5.221:100000091063 | DIHYDROERGOCRISTINE MESILATE | active | 0.667 | mg | 1.2.40.0.34.5.221:100000091063 | DIHYDROERGOCRISTINE MESILATE | 0.667 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0486356 | NERIFORTE FSLB | Neriforte - Fettsalbe | 1.2.40.0.34.4.17:16297 | GA - aufgehoben | LEO PHARMA A/S | false | false | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC06 | Diflucortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 4.5 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 4.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:126913002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0486362 | NERIFORTE FSLB | Neriforte - Fettsalbe | 1.2.40.0.34.4.17:16297 | GA - aufgehoben | LEO PHARMA A/S | false | false | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC06 | Diflucortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 9 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 9 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:126913004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0486379 | NERIFORTE FSLB | Neriforte - Fettsalbe | 1.2.40.0.34.4.17:16297 | GA - aufgehoben | LEO PHARMA A/S | false | false | 300 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:900000000007 | Tiegel (NE) | 2.16.840.1.113883.6.73:D07AC06 | Diflucortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 90 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 90 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:126913005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0486385 | NERIFORTE SLB | Neriforte - Salbe | 1.2.40.0.34.4.17:16298 | GA - zugelassen | LEO PHARMA A/S | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC06 | Diflucortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 0.045 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 0.045 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:126912001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0486391 | NERIFORTE SLB | Neriforte - Salbe | 1.2.40.0.34.4.17:16298 | GA - zugelassen | LEO PHARMA A/S | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC06 | Diflucortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 0.09 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 0.09 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:126912002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0486416 | NERIFORTE SLB | Neriforte - Salbe | 1.2.40.0.34.4.17:16298 | GA - zugelassen | LEO PHARMA A/S | true | true | 300 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:900000000007 | Tiegel (NE) | 2.16.840.1.113883.6.73:D07AC06 | Diflucortolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 0.9 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 0.9 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:126912003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0489372 | OTRIVIN NA-GEL 0,1% | Otrivin 0,1 % - Nasengel | 1.2.40.0.34.4.17:16306 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 10 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:R01AA07 | Xylometazolin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1709513 | XYLOMETAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092670 | XYLOMETAZOLINE HYDROCHLORIDE | active | 0.01 | g | 1.2.40.0.34.5.221:100000092670 | XYLOMETAZOLINE HYDROCHLORIDE | 0.01 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073793 | Nasengel | true | human | 1.2.40.0.34.4.26:123071001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0489863 | ANXIOLIT RET KPS 30MG | Anxiolit retard 30 mg - Kapseln | 1.2.40.0.34.4.17:15916 | GA - aufgehoben | G.L. Pharma GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA04 | Oxazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709067 | OXAZEPAM | 1.2.40.0.34.5.221:100000091921 | OXAZEPAM | active | 30 | mg | 1.2.40.0.34.5.221:100000091921 | OXAZEPAM | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073663 | Hartkapsel mit veränderter Wirkstofffreisetzung | true | human | 1.2.40.0.34.4.26:123390002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0489917 | ATROPIN SULF NYC 0,5MG/1ML | Atropinum sulfuricum "Nycomed" 0,5 mg - Ampullen | 1.2.40.0.34.4.17:3087 | GA - zugelassen | Takeda Austria GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A03BA01 | Atropin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | 1.2.40.0.34.5.156:1707319 | ATROPINSULFAT | 1.2.40.0.34.5.221:100000085224 | ATROPINE SULPHATE | active | 0.5 | mg | 1.2.40.0.34.5.221:100000085224 | ATROPINE SULPHATE | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:128780002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0489952 | BANEOCIN PDR | Baneocin - Puder | 1.2.40.0.34.4.17:9451 | GA - zugelassen | Sandoz GmbH | true | true | 10 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:D06AX | Andere Antibiotika zur topischen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708440 | NEOMYCIN SULFAT | 1.2.40.0.34.5.221:100000090029 | NEOMYCIN SULFATE | active | 0.07463 | g | 1.2.40.0.34.5.221:100000090456 | NEOMYCIN | 0.00011 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073733 | Pulver zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:120104002 | 1.2.40.0.34.5.156:1708583 | ZINK BACITRACIN | 1.2.40.0.34.5.221:100000090427 | BACITRACIN ZINC | active | 0.04167 | g | 1.2.40.0.34.5.221:100000090427 | BACITRACIN ZINC | 0.04167 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0490151 | CYKLOKAPRON 100MG/ML AMP 5ML | Cyklokapron 100 mg/ml Injektionslösung/Infusionslösung | 1.2.40.0.34.4.17:13085 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B02AA02 | Tranexamsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708717 | TRANEXAMSÄURE | 1.2.40.0.34.5.221:100000091040 | TRANEXAMIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000091040 | TRANEXAMIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:120392005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0490168 | DELTA-HAEDENSA SUPP | Delta - Hädensa - Zäpfchen | 1.2.40.0.34.4.17:14327 | GA - aufgehoben | Merz Pharma Austria GmbH | false | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:C05AA04 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | | | 1.2.40.0.34.5.221:100000091364 | MENTHOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1708775 | NATRIUM PREDNISOLON M-SULFOBENZOAT | 1.2.40.0.34.5.221:100000091240 | NATRIUM PREDNISOLON M-SULFOBENZOAT | active | | | 1.2.40.0.34.5.221:100000091240 | NATRIUM PREDNISOLON M-SULFOBENZOAT | | | 1.2.40.0.34.5.156:1709854 | 5-CHLORCARVACROL | 1.2.40.0.34.5.221:100000080071 | 5-CHLORCARVACROL | active | | | 1.2.40.0.34.5.221:100000080071 | 5-CHLORCARVACROL | | | | | | | | | 1.2.40.0.34.5.156:1709356 | ICHTHAMMOLUM | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOLUM | active | | | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOLUM | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0490234 | DIBONDRIN LIQU | Dibondrin liquid | 1.2.40.0.34.4.17:11361 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R06AA02 | Diphenhydramin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 0.2 | g | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 0.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:127527001 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:N05CM | Andere Hypnotika und Sedativa | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0490369 | ECHNATOL-B6 DRG | Echnatol B 6 - Dragees | 1.2.40.0.34.4.17:14970 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AE53 | Cyclizin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:124616002 | 1.2.40.0.34.5.156:1710165 | CYCLIZIN DIHYDROCHLORID | 1.2.40.0.34.5.221:900000000396 | CYCLIZIN DIHYDROCHLORID | active | 50 | mg | 1.2.40.0.34.5.221:900000000396 | CYCLIZIN DIHYDROCHLORID | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0490398 | EFFORTIL AMP 0,01G 1ML | Effortil - Ampullen | 1.2.40.0.34.4.17:8336 | GA - zugelassen | N.V. Serb S.A. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C01CA01 | Etilefrin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | 1.2.40.0.34.5.156:1707831 | ETILEFRIN HYDROCHLORID | 1.2.40.0.34.5.221:100000087496 | ETILEFRINE HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000087496 | ETILEFRINE HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:121344001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0490441 | ESSENTIALE KPS FTE | Essentiale forte - Kapseln | 1.2.40.0.34.4.17:15587 | GA - zugelassen | Opella Healthcare Austria GmbH | true | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A05BA | Lebertherapie | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710631 | PHOSPHOLIPIDE AUS SOJABOHNEN | 1.2.40.0.34.5.221:100000156707 | SOYBEAN PHOSPHOLIPIDS | active | 300 | mg | 1.2.40.0.34.5.221:100000156707 | SOYBEAN PHOSPHOLIPIDS | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:120239002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0490464 | ETRAT GEL | Etrat - Gel | 1.2.40.0.34.4.17:15399 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA53 | Heparin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | 20 | g | 1.2.40.0.34.5.221:100000091364 | MENTHOL | 20 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:128732002 | 1.2.40.0.34.5.156:1709283 | HYDROXYETHYLSALICYLAT | 1.2.40.0.34.5.221:100000092263 | HYDROXYETHYL SALICYLATE | active | 200 | g | 1.2.40.0.34.5.221:100000092263 | HYDROXYETHYL SALICYLATE | 200 | g | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 1.44 | g | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 1.44 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0490470 | EUCARBON TBL | Eucarbon Tabletten | 1.2.40.0.34.4.17:735895 | GA - registriert | F. Trenka Chem.-Pharm. Fabrik GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A06AB | Kontaktlaxanzien | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712648 | RHEI RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000004221 | RHEI RADIX (EXTRACT) | active | 13.75 | mg | 1.2.40.0.34.5.221:900000004221 | RHEI RADIX (EXTRACT) | 13.75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:7321600003 | 1.2.40.0.34.5.156:7091649 | HOLZKOHLE | 1.2.40.0.34.5.221:900000004484 | WOOD CHARCOAL | active | 180 | mg | 1.2.40.0.34.5.221:900000004484 | WOOD CHARCOAL | 180 | mg | 1.2.40.0.34.5.156:1708673 | SENNAE FOLIUM | 1.2.40.0.34.5.221:100000090680 | SENNAE FOLIUM | active | 105 | mg | 1.2.40.0.34.5.221:100000090680 | SENNAE FOLIUM | 105 | mg | | | | | | | 1.2.40.0.34.5.156:1708592 | SCHWEFEL | 1.2.40.0.34.5.221:100000090444 | SULFUR | active | 50 | mg | 1.2.40.0.34.5.221:100000090444 | SULFUR | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0490636 | HAEDENSA SUPP | Hädensa Zäpfchen | 1.2.40.0.34.4.17:10746 | GA - zugelassen | Merz Pharma Austria GmbH | true | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:C05AX03 | Andere Hämorrhoidenmittel, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | | | 1.2.40.0.34.5.221:100000091364 | MENTHOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | false | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1709854 | 5-CHLORCARVACROL | 1.2.40.0.34.5.221:100000080071 | 5-CHLORCARVACROL | active | | | 1.2.40.0.34.5.221:100000080071 | 5-CHLORCARVACROL | | | 1.2.40.0.34.5.156:1709356 | ICHTHAMMOLUM | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOLUM | active | | | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOLUM | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0490642 | HALDOL TBL 1MG | Haldol 1 mg - Tabletten | 1.2.40.0.34.4.17:14106 | GA - zugelassen | Essential Pharma Limited | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AD01 | Haloperidol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709494 | HALOPERIDOL | 1.2.40.0.34.5.221:100000092645 | HALOPERIDOL | active | 1 | mg | 1.2.40.0.34.5.221:100000092645 | HALOPERIDOL | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123703001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0490748 | INDOCID KPS 25MG | Indocid 25 mg Kapseln | 1.2.40.0.34.4.17:12789 | GA - zugelassen | H.A.C. Pharma | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB01 | Indometacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709537 | INDOMETACIN | 1.2.40.0.34.5.221:100000092758 | INDOMETACIN | active | 25 | mg | 1.2.40.0.34.5.221:100000092758 | INDOMETACIN | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:124779002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0491618 | ROWALIND EINREIBUNG | Rowalind - Einreibung | 1.2.40.0.34.4.17:11882 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M02AX10 | Verschiedene | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | | | 1.2.40.0.34.5.221:100000091364 | MENTHOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:128435002 | 1.2.40.0.34.5.156:1705788 | AMMONIAK | 1.2.40.0.34.5.221:100000077712 | AMMONIA | active | | | 1.2.40.0.34.5.221:100000077712 | AMMONIA | | | 1.2.40.0.34.5.156:1708914 | AMMONIUMCHLORID | 1.2.40.0.34.5.221:100000091581 | AMMONIUM CHLORIDE | active | | | 1.2.40.0.34.5.221:100000091581 | AMMONIUM CHLORIDE | | | | | | | | | 1.2.40.0.34.5.156:1706341 | NICOTINALDEHYD | 1.2.40.0.34.5.221:100000079971 | NICOTINALDEHYDE | active | | | 1.2.40.0.34.5.221:100000079971 | NICOTINALDEHYDE | | | 1.2.40.0.34.5.156:1709036 | RACEMISCHER CAMPHER | 1.2.40.0.34.5.221:100000091848 | CAMPHOR, RACEMIC | active | | | 1.2.40.0.34.5.221:100000091848 | CAMPHOR, RACEMIC | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0492173 | VOLTAREN SUPP 100MG | Voltaren 100 mg - Zäpfchen für Erwachsene | 1.2.40.0.34.4.17:1-16308 | GA - zugelassen | Novartis Pharma GmbH | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:125597001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0495237 | TROMMCARDIN IFL 250ML | Trommcardin Infusionsflasche | 1.2.40.0.34.4.17:16187 | GA - aufgehoben | Jacoby GM Pharma GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A12CC05 | Magnesiumaspartat | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705588 | MAGNESIUM HYDROGENASPARTAT | 1.2.40.0.34.5.221:100000076822 | MAGNESIUM HYDROGEN ASPARTATE | active | 10 | mg | 1.2.40.0.34.5.221:100000076822 | MAGNESIUM HYDROGEN ASPARTATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:125329002 | 1.2.40.0.34.5.156:1706196 | KALIUM HYDROGENASPARTAT | 1.2.40.0.34.5.221:100000079418 | POTASSIUM HYDROGEN ASPARTATE | active | 10 | mg | 1.2.40.0.34.5.221:100000079418 | POTASSIUM HYDROGEN ASPARTATE | 10 | mg | | | | | | | | | | | | 2.16.840.1.113883.6.73:A12BA | Kalium | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0495243 | TROMMCARDIN-K-120 IFL | Trommcardin K 120 - Infusionsflasche | 1.2.40.0.34.4.17:16188 | GA - zugelassen | Jacoby GM Pharma GmbH | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A12CC05 | Magnesiumaspartat | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705588 | MAGNESIUM HYDROGENASPARTAT | 1.2.40.0.34.5.221:100000076822 | MAGNESIUM HYDROGEN ASPARTATE | active | 2.7 | g | 1.2.40.0.34.5.221:100000076822 | MAGNESIUM HYDROGEN ASPARTATE | 2.7 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:125328002 | 1.2.40.0.34.5.156:1706196 | KALIUM HYDROGENASPARTAT | 1.2.40.0.34.5.221:100000079418 | POTASSIUM HYDROGEN ASPARTATE | active | 5.405 | g | 1.2.40.0.34.5.221:100000079418 | POTASSIUM HYDROGEN ASPARTATE | 5.405 | g | | | | | | | | | | | | 2.16.840.1.113883.6.73:A12BA | Kalium | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0497874 | ASPIRIN C BRTBL | Aspirin + C Brausetabletten | 1.2.40.0.34.4.17:14079 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:A11GB | Ascorbinsäure (Vitamin C), Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 0.24 | g | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 0.24 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073681 | Brausetablette | true | human | 1.2.40.0.34.4.26:100000013233 | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 0.4 | g | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 0.4 | g | | | | | | | | | | | | 2.16.840.1.113883.6.73:N02BA01 | Acetylsalicylsäure | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0498767 | ZOVIRAX AU-SLB 3% | Zovirax 3% - Augensalbe | 1.2.40.0.34.4.17:1-18042 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 4.5 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:S01AD03 | Aciclovir | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709572 | ACICLOVIR | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | active | 3 | g | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | 3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073772 | Augensalbe | true | human | 1.2.40.0.34.4.26:921642001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0501222 | LIDAPRIM FTBL FTE | Lidaprim forte Filmtabletten | 1.2.40.0.34.4.17:16362 | GA - zugelassen | Rokitan GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:J01EE03 | Sulfametrol und Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | | | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | | | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1706887 | SULFAMETROL | 1.2.40.0.34.5.221:100000083272 | SULFAMETROL | active | | | 1.2.40.0.34.5.221:100000083272 | SULFAMETROL | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0501239 | LIDAPRIM FTBL FTE | Lidaprim forte Filmtabletten | 1.2.40.0.34.4.17:16362 | GA - zugelassen | Rokitan GmbH | true | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:J01EE03 | Sulfametrol und Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | | | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | | | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1706887 | SULFAMETROL | 1.2.40.0.34.5.221:100000083272 | SULFAMETROL | active | | | 1.2.40.0.34.5.221:100000083272 | SULFAMETROL | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0501386 | THIOGUANIN ASPEN TBL | Thioguanin "Aspen" 40 mg Tabletten | 1.2.40.0.34.4.17:16354 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L01BB03 | Tioguanin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705688 | TIOGUANIN | 1.2.40.0.34.5.221:100000077212 | TIOGUANINE | active | 40 | mg | 1.2.40.0.34.5.221:100000077212 | TIOGUANINE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120687001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0502078 | BEKUNIS TASSENF TEE | Bekunis tassenfertiger Tee | 1.2.40.0.34.4.17:11787 | GA - aufgehoben | Roha Arzneimittel GmbH | false | false | 150 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A06AB06 | Sennoside | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712673 | SENNAE FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000004287 | SENNAE FRUCTUS (AUSZUG) | active | 2850 | g | 1.2.40.0.34.5.221:900000004287 | SENNAE FRUCTUS (AUSZUG) | 2850 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073364 | Pulver zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:121531001 | 1.2.40.0.34.5.156:1712654 | SENNAE FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000004235 | SENNAE FOLIUM (EXTRACT) | active | 150 | g | 1.2.40.0.34.5.221:900000004235 | SENNAE FOLIUM (EXTRACT) | 150 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0502090 | BEPANTHEN CR | Bepanthen - Creme | 1.2.40.0.34.4.17:17233 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D03AX03 | Dexpanthenol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709167 | DEXPANTHENOL | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | active | 1.5 | g | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | 1.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | false | human | 1.2.40.0.34.4.26:920592003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0502196 | FARLUTAL DEP STAMP 500MG | Farlutal Depot 500 mg Stechampullen | 1.2.40.0.34.4.17:17391 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:L02AB02 | Medroxyprogesteron | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708932 | MEDROXYPROGESTERON ACETAT | 1.2.40.0.34.5.221:100000091612 | MEDROXYPROGESTERONE ACETATE | active | 1500 | mg | 1.2.40.0.34.5.221:100000091612 | MEDROXYPROGESTERONE ACETATE | 1500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:129021001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0506567 | SOLU-DACORTIN PLV+LSM 1G | Solu-Dacortin 1 g - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung oder Infusionslösung | 1.2.40.0.34.4.17:16416 | GA - zugelassen | Merck Ges.m.b.H. | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709059 | NATRIUM PREDNISOLON SUCCINAT | 1.2.40.0.34.5.221:100000091910 | PREDNISOLONE SODIUM SUCCINATE | active | 1 | g | 1.2.40.0.34.5.221:100000091910 | PREDNISOLONE SODIUM SUCCINATE | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:123069001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0507897 | ANAFRANIL DRG 25MG | Anafranil 25 mg - Dragees | 1.2.40.0.34.4.17:14192 | GA - zugelassen | pharmaand GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AA04 | Clomipramin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708620 | CLOMIPRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090503 | CLOMIPRAMIN HYDROCHLORID | active | 25 | mg | 1.2.40.0.34.5.221:100000090503 | CLOMIPRAMIN HYDROCHLORID | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:123473001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0507928 | CATAPRESAN TBL 0,15MG | Catapresan 0,15 mg - Tabletten | 1.2.40.0.34.4.17:13874 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C02AC01 | Clonidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708541 | CLONIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090325 | CLONIDINE HYDROCHLORIDE | active | 0.15 | mg | 1.2.40.0.34.5.221:100000090325 | CLONIDINE HYDROCHLORIDE | 0.15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:128191002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0507986 | FENISTIL DRG 1MG | Fenistil 1 mg - Dragees | 1.2.40.0.34.4.17:12146 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AB03 | Dimetinden | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707840 | DIMETINDEN MALEAT | 1.2.40.0.34.5.221:100000087512 | DIMETINDENE MALEATE | active | 1 | mg | 1.2.40.0.34.5.221:100000087512 | DIMETINDENE MALEATE | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:120511001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0508141 | RESYL TR +COD | Resyl mit Codein - Tropfen | 1.2.40.0.34.4.17:15049 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05FA02 | Opium-Derivate und Expektoranzien | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7431272 | CODEINPHOSPHAT HEMIHYDRAT | 1.2.40.0.34.5.221:100000090188 | CODEINE PHOSPHATE HEMIHYDRATE | active | 0.15 | g | 1.2.40.0.34.5.221:100000090188 | CODEINE PHOSPHATE HEMIHYDRATE | 0.15 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:129505002 | 1.2.40.0.34.5.156:1708576 | GUAIFENESIN | 1.2.40.0.34.5.221:100000090413 | GUAIFENESIN | active | 1.5 | g | 1.2.40.0.34.5.221:100000090413 | GUAIFENESIN | 1.5 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0508158 | RESYL TR +COD | Resyl mit Codein - Tropfen | 1.2.40.0.34.4.17:15049 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05FA02 | Opium-Derivate und Expektoranzien | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7431272 | CODEINPHOSPHAT HEMIHYDRAT | 1.2.40.0.34.5.221:100000090188 | CODEINE PHOSPHATE HEMIHYDRATE | active | 0.3 | g | 1.2.40.0.34.5.221:100000090188 | CODEINE PHOSPHATE HEMIHYDRATE | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:129505001 | 1.2.40.0.34.5.156:1708576 | GUAIFENESIN | 1.2.40.0.34.5.221:100000090413 | GUAIFENESIN | active | 3 | g | 1.2.40.0.34.5.221:100000090413 | GUAIFENESIN | 3 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0508276 | TENORMIN FTBL 100MG | Tenormin 100 mg - Filmtabletten | 1.2.40.0.34.4.17:16377 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124805001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0508282 | TENORMIN FTBL 100MG | Tenormin 100 mg - Filmtabletten | 1.2.40.0.34.4.17:16377 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124805002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0508448 | VOLTAREN SUPP 50MG | Voltaren 50 mg - Zäpfchen für Erwachsene | 1.2.40.0.34.4.17:1-15868 | GA - zugelassen | Novartis Pharma GmbH | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:122515001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0509465 | DOGMATIL TBL 200MG | Dogmatil 200 mg Tabletten | 1.2.40.0.34.4.17:16374 | GA - zugelassen | neuraxpharm Arzneimittel GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AL01 | Sulpirid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708729 | SULPIRID | 1.2.40.0.34.5.221:100000091056 | SULPIRIDE | active | 200 | mg | 1.2.40.0.34.5.221:100000091056 | SULPIRIDE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123788001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0509471 | DOGMATIL TBL 200MG | Dogmatil 200 mg Tabletten | 1.2.40.0.34.4.17:16374 | GA - zugelassen | neuraxpharm Arzneimittel GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AL01 | Sulpirid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708729 | SULPIRID | 1.2.40.0.34.5.221:100000091056 | SULPIRIDE | active | 200 | mg | 1.2.40.0.34.5.221:100000091056 | SULPIRIDE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123788002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0509577 | URBASON SOL PLV+LSM 1000MG | Urbason solubile 1000 mg Trockenstechampulle mit Lösungsmittel | 1.2.40.0.34.4.17:16419 | GA - zugelassen | Fidia Farmaceutici S.p.A. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H02AB04 | Methylprednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708630 | NATRIUM METHYLPREDNISOLON SUCCINAT | 1.2.40.0.34.5.221:100000090523 | METHYLPREDNISOLONE SODIUM SUCCINATE | active | 1325.92 | mg | 1.2.40.0.34.5.221:100000090523 | METHYLPREDNISOLONE SODIUM SUCCINATE | 1325.92 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:122685001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0510876 | UROSIN TBL 100MG | Urosin 100 mg - Tabletten | 1.2.40.0.34.4.17:15358 | GA - zugelassen | Teofarma S.r.l. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M04AA01 | Allopurinol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709057 | ALLOPURINOL | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129390002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0514986 | FSME-IMMUN FSPR 0,5ML NAD F | FSME-Immun 0,5 ml Erwachsene Injektionssuspension in einer Fertigspritze | 1.2.40.0.34.4.17:2-00174 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:J07BA01 | FSME, inaktiviert, ganzes Virus | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1708403 | FRÜHSOMMER-MENINGOENCEPHALITIS-VIRUS | 1.2.40.0.34.5.221:100000089915 | TICK-BORNE ENCEPHALITIS VIRUS | active | 2 | | 1.2.40.0.34.5.221:100000089915 | TICK-BORNE ENCEPHALITIS VIRUS | 2 | | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:929592001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0515738 | FSME-IMMUN FSPR 0,5ML NAD F | FSME-Immun 0,5 ml Erwachsene Injektionssuspension in einer Fertigspritze | 1.2.40.0.34.4.17:2-00174 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:J07BA01 | FSME, inaktiviert, ganzes Virus | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1708403 | FRÜHSOMMER-MENINGOENCEPHALITIS-VIRUS | 1.2.40.0.34.5.221:100000089915 | TICK-BORNE ENCEPHALITIS VIRUS | active | 2 | | 1.2.40.0.34.5.221:100000089915 | TICK-BORNE ENCEPHALITIS VIRUS | 2 | | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:929592003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0515767 | HALDOL 5MG/ML AMP 1ML | Haldol 5 mg/ml Injektionslösung | 1.2.40.0.34.4.17:11813 | GA - zugelassen | Essential Pharma Limited | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05AD01 | Haloperidol | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1709494 | HALOPERIDOL | 1.2.40.0.34.5.221:100000092645 | HALOPERIDOL | active | 5 | mg | 1.2.40.0.34.5.221:100000092645 | HALOPERIDOL | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:123705001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0515974 | VOLON-A 40MG SPRAMP | Volon A 40 mg - Kristallsuspension - Spritzampulle | 1.2.40.0.34.4.17:16439 | GA - zugelassen | Dermapharm GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB08 | Triamcinolon | 1.2.40.0.10.1.4.3.4.3.4:900000000002 | subläsionale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | 1.2.40.0.34.5.156:1708563 | TRIAMCINOLON ACETONID | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:126027001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0518228 | TRAMAL AMP 50MG 1ML | Tramal 50 mg - Ampullen | 1.2.40.0.34.4.17:17692 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N02AX02 | Tramadol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | 1.2.40.0.34.5.156:1709643 | TRAMADOLHYDROCHLORID | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:126747001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0519038 | BETAISODONA VAG-SUPP | Betaisodona Vaginal - Suppositorien | 1.2.40.0.34.4.17:16474 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | false | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:G01AX11 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | active | 200 | mg | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073815 | Vaginalzäpfchen | true | human | 1.2.40.0.34.4.26:128744001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0519541 | AKINETON RET FTBL 4MG | Akineton 4 mg - Retardtabletten | 1.2.40.0.34.4.17:15197 | GA - zugelassen | Desma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N04AA02 | Biperiden | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708527 | BIPERIDEN HYDROCHLORID | 1.2.40.0.34.5.221:100000090297 | BIPERIDEN HYDROCHLORIDE | active | 4 | mg | 1.2.40.0.34.5.221:100000090297 | BIPERIDEN HYDROCHLORIDE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:122123001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0519630 | BETNESOL BRTBL | Betnesol - Brausetabletten | 1.2.40.0.34.4.17:12867 | GA - zugelassen | Alfasigma S.p.A. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708451 | BETAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | active | 0.671 | mg | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | 0.671 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073681 | Brausetablette | true | human | 1.2.40.0.34.4.26:122813002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0519647 | BETNOVATE CRIN LSG | Betnovate - Crinale Lösung | 1.2.40.0.34.4.17:14435 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | false | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709477 | BETAMETHASONVALERAT | 1.2.40.0.34.5.221:100000092622 | BETAMETHASONE VALERATE | active | 0.0183 | g | 1.2.40.0.34.5.221:100000092622 | BETAMETHASONE VALERATE | 0.0183 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:120397002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0519742 | CELESTAN BIPHASE AMP 1ML | Celestan biphase 5,7 mg/ml Injektionssuspension | 1.2.40.0.34.4.17:14257 | GA - zugelassen | Organon Healthcare GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073597 | intraläsionale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000007 | intratendineale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073595 | intradermale Anwendung | 1.2.40.0.34.5.156:1708451 | BETAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | active | 3.945 | mg | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | 3.945 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:120680002 | 1.2.40.0.34.5.156:1707190 | BETAMETHASON ACETAT | 1.2.40.0.34.5.221:100000084907 | BETAMETHASONE ACETATE | active | 3 | mg | 1.2.40.0.34.5.221:100000084907 | BETAMETHASONE ACETATE | 3 | mg | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073623 | periartikuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073589 | intrabursale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0519794 | DELTA-HAEDENSA SLB | Delta - Hädensa - Salbe | 1.2.40.0.34.4.17:14326 | GA - aufgehoben | Merz Pharma Austria GmbH | false | false | 10 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05AA04 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | 2.5 | g | 1.2.40.0.34.5.221:100000091364 | MENTHOL | 2.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:121286001 | 1.2.40.0.34.5.156:1708775 | NATRIUM PREDNISOLON M-SULFOBENZOAT | 1.2.40.0.34.5.221:100000091240 | PREDNISOLONE METASULFOBENZOATE SODIUM | active | 0.2355 | g | 1.2.40.0.34.5.221:100000091240 | PREDNISOLONE METASULFOBENZOATE SODIUM | 0.2355 | g | 1.2.40.0.34.5.156:1709854 | 5-CHLORCARVACROL | 1.2.40.0.34.5.221:100000080071 | 5-CHLORCARVACROL | active | 0.01 | g | 1.2.40.0.34.5.221:100000080071 | 5-CHLORCARVACROL | 0.01 | g | | | | | | | 1.2.40.0.34.5.156:1709356 | ICHTHAMMOLUM | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | active | 0.2 | g | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | 0.2 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0519825 | DIGIMERCK TBL 0,1MG | Digimerck 0,1 mg - Tabletten | 1.2.40.0.34.4.17:1-18969 | GA - zugelassen | Merck Ges.m.b.H. | true | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01AA04 | Digitoxin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709550 | DIGITOXIN | 1.2.40.0.34.5.221:100000092778 | DIGITOXIN | active | 0.1 | mg | 1.2.40.0.34.5.221:100000092778 | DIGITOXIN | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:121428002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0519831 | DIPRODERM LSG DERM | Diproderm - dermatologische Lösung | 1.2.40.0.34.4.17:15753 | GA - zugelassen | Organon Healthcare GmbH | true | false | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.0096 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.0096 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:121926002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0520024 | INDERAL FTBL 10MG | Inderal 10 mg - Filmtabletten | 1.2.40.0.34.4.17:13294 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AA05 | Propranolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708790 | PROPRANOLOL HYDROCHLORID | 1.2.40.0.34.5.221:100000091292 | PROPRANOLOL HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000091292 | PROPRANOLOL HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:120862001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0520030 | INDERAL FTBL 40MG | Inderal 40 mg - Filmtabletten | 1.2.40.0.34.4.17:13295 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AA05 | Propranolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708790 | PROPRANOLOL HYDROCHLORID | 1.2.40.0.34.5.221:100000091292 | PROPRANOLOL HYDROCHLORIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000091292 | PROPRANOLOL HYDROCHLORIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124650002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0520171 | MOBILAT GEL | Mobilat - Gel | 1.2.40.0.34.4.17:15208 | GA - aufgehoben | STADA Arzneimittel Gesellschaft m.b.H. | false | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705406 | MUCOPOLYSACCHARIDPOLYSCHWEFELSÄUREESTER | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | active | 8 | g | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | 8 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:129784002 | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 80 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 80 | g | 1.2.40.0.34.5.156:1712635 | NEBENNIERE(EXTRAKT) | 1.2.40.0.34.5.221:900000004182 | ADRENAL GLAND EXTRACT | active | 40 | g | 1.2.40.0.34.5.221:900000004182 | ADRENAL GLAND EXTRACT | 40 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0520188 | MOBILAT SLB | Mobilat - Salbe | 1.2.40.0.34.4.17:12033 | GA - aufgehoben | STADA Arzneimittel Gesellschaft m.b.H. | false | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705406 | MUCOPOLYSACCHARIDPOLYSCHWEFELSÄUREESTER | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | active | 8 | g | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | 8 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:129783002 | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 80 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 80 | g | 1.2.40.0.34.5.156:1712635 | NEBENNIERE(EXTRAKT) | 1.2.40.0.34.5.221:900000004182 | ADRENAL GLAND EXTRACT | active | 40 | g | 1.2.40.0.34.5.221:900000004182 | ADRENAL GLAND EXTRACT | 40 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0520194 | MOBILISIN SLB | Mobilisin - Salbe | 1.2.40.0.34.4.17:15361 | GA - aufgehoben | STADA Arzneimittel Gesellschaft m.b.H. | false | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA | Nichtsteroidale Antiphlogistika zur topischen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1706458 | FLUFENAMINSÄURE | 1.2.40.0.34.5.221:100000080681 | FLUFENAMIC ACID | active | 3 | g | 1.2.40.0.34.5.221:100000080681 | FLUFENAMIC ACID | 3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:129782001 | 1.2.40.0.34.5.156:1705406 | MUCOPOLYSACCHARIDPOLYSCHWEFELSÄUREESTER | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | active | 0.2 | g | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | 0.2 | g | 1.2.40.0.34.5.156:1709283 | HYDROXYETHYLSALICYLAT | 1.2.40.0.34.5.221:100000092263 | HYDROXYETHYL SALICYLATE | active | 2.64 | g | 1.2.40.0.34.5.221:100000092263 | HYDROXYETHYL SALICYLATE | 2.64 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0520219 | MYSTECLIN OVULA | Mysteclin - Ovula | 1.2.40.0.34.4.17:14509 | GA - aufgehoben | Dermapharm GmbH | false | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G01AA | Antibiotika | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1706799 | TETRACYCLIN | 1.2.40.0.34.5.221:100000082736 | TETRACYCLINE | active | 104 | mg | 1.2.40.0.34.5.221:100000082736 | TETRACYCLINE | 104 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073824 | Vaginaltablette | true | human | 1.2.40.0.34.4.26:127734001 | 1.2.40.0.34.5.156:1709185 | AMPHOTERICIN B | 1.2.40.0.34.5.221:100000092100 | AMPHOTERICIN B | active | 50 | mg | 1.2.40.0.34.5.221:100000092100 | AMPHOTERICIN B | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0520260 | OVESTIN TBL 1MG | Ovestin 1 mg - Tabletten | 1.2.40.0.34.4.17:10382 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03CA04 | Estriol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709511 | ESTRIOL | 1.2.40.0.34.5.221:100000092668 | ESTRIOL | active | 1 | mg | 1.2.40.0.34.5.221:100000092668 | ESTRIOL | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123397001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0520343 | PK-MERZ FTBL | PK - Merz - Schoeller 100 mg Filmtabletten | 1.2.40.0.34.4.17:15018 | GA - zugelassen | Merz Pharma Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N04BB01 | Amantadin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709202 | AMANTADIN SULFAT | 1.2.40.0.34.5.221:100000092128 | AMANTADINE SULFATE | active | 100 | mg | 1.2.40.0.34.5.221:100000092128 | AMANTADINE SULFATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:129849001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0520550 | SOLU-CELESTAN AMP 1ML | Solu - Celestan - 4 mg/ml injektionslösung | 1.2.40.0.34.4.17:15185 | GA - zugelassen | Organon Healthcare GmbH | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073597 | intraläsionale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073595 | intradermale Anwendung | 1.2.40.0.34.5.156:1708451 | BETAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | active | 5.3 | mg | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | 5.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:121339001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073623 | periartikuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073589 | intrabursale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0520946 | VOLTAREN FTBL 50MG | Voltaren 50 mg - Filmtabletten | 1.2.40.0.34.4.17:1-16506 | GA - zugelassen | Novartis Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:127550004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0520952 | VOLTAREN FTBL 50MG | Voltaren 50 mg - Filmtabletten | 1.2.40.0.34.4.17:1-16506 | GA - zugelassen | Novartis Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:127550005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0522709 | DIPROPHOS SUS AMP 1ML | Diprophos 1 ml - Suspension zur Injektion | 1.2.40.0.34.4.17:16460 | GA - zugelassen | Organon Healthcare GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073597 | intraläsionale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000007 | intratendineale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073595 | intradermale Anwendung | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 6.43 | mg | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 6.43 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:123163001 | 1.2.40.0.34.5.156:1708451 | BETAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | active | 2.63 | mg | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | 2.63 | mg | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000002 | subläsionale Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073623 | periartikuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073589 | intrabursale Anwendung | | | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0522715 | DIPROPHOS SUS AMP 1ML | Diprophos 1 ml - Suspension zur Injektion | 1.2.40.0.34.4.17:16460 | GA - zugelassen | Organon Healthcare GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073597 | intraläsionale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000007 | intratendineale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073595 | intradermale Anwendung | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 6.43 | mg | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 6.43 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:123163002 | 1.2.40.0.34.5.156:1708451 | BETAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | active | 2.63 | mg | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | 2.63 | mg | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000002 | subläsionale Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073623 | periartikuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073589 | intrabursale Anwendung | | | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0522744 | DIPROSALIC SLB | Diprosalic - Salbe | 1.2.40.0.34.4.17:16443 | GA - zugelassen | Organon Healthcare GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07XC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.0192 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.0192 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:122292002 | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 0.9 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 0.9 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0523548 | ACTOVEGIN HNP IFL 20% | Actovegin „Nycomed“ 20% - Infusionslösung | 1.2.40.0.34.4.17:2-00014 | GA - aufgehoben | Takeda Austria GmbH | false | false | 250 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B06AB | Andere Hämprodukte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1710184 | DEPROTEINISIERTES HAEMODERIVAT AUS KÄLBERBLUT | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | active | 50 | ml | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | 50 | ml | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126539001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0523560 | ACTOVEGIN HNP IFL 10% | Actovegin „Nycomed“ 10% - Infusionslösung | 1.2.40.0.34.4.17:2-00012 | GA - aufgehoben | Takeda Austria GmbH | false | false | 250 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B06AB | Andere Hämprodukte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1710184 | DEPROTEINISIERTES HAEMODERIVAT AUS KÄLBERBLUT | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | active | 25 | ml | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | 25 | ml | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126537001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0523577 | BETASERC TBL 8MG | Betaserc 8 mg - Tabletten | 1.2.40.0.34.4.17:14785 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N07CA01 | Betahistin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708429 | BETAHISTIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000089998 | BETAHISTINE DIHYDROCHLORIDE | active | 8 | mg | 1.2.40.0.34.5.221:100000089998 | BETAHISTINE DIHYDROCHLORIDE | 8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:126634001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0523608 | DIPROSALIC LSG DERM | Diprosalic - dermatologische Lösung | 1.2.40.0.34.4.17:16500 | GA - zugelassen | Organon Healthcare GmbH | true | false | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D07XC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.00896 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.00896 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:127689003 | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 0.28 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 0.28 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0523614 | DIPROSALIC LSG DERM | Diprosalic - dermatologische Lösung | 1.2.40.0.34.4.17:16500 | GA - zugelassen | Organon Healthcare GmbH | true | true | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D07XC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.01792 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.01792 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:127689002 | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 0.56 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 0.56 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0523703 | TIMOPTIC AU-TR 0,25% | Timoptic 0,25 % - Augentropfen | 1.2.40.0.34.4.17:16514 | GA - aufgehoben | n.a. | false | false | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:S01ED01 | Timolol | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1708442 | TIMOLOLMALEAT | 1.2.40.0.34.5.221:100000090033 | TIMOLOL MALEATE | active | 342 | mg | 1.2.40.0.34.5.221:100000090033 | TIMOLOL MALEATE | 342 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:129310001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0523726 | TIMOPTIC AU-TR 0,50% | Timoptic 0,5 % - Augentropfen | 1.2.40.0.34.4.17:16515 | GA - zugelassen | Santen Oy | true | true | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073512 | Tropfbehältnis | 2.16.840.1.113883.6.73:S01ED01 | Timolol | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1708442 | TIMOLOLMALEAT | 1.2.40.0.34.5.221:100000090033 | TIMOLOL MALEATE | active | 34.15 | mg | 1.2.40.0.34.5.221:100000090033 | TIMOLOL MALEATE | 34.15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:129309001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0523732 | TRENTAL FTBL 400MG | Trental 400 mg Filmtabletten | 1.2.40.0.34.4.17:16480 | GA - zugelassen | neuraxpharm Arzneimittel GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 400 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074010 | Modified-release film-coated tablet | true | human | 1.2.40.0.34.4.26:124331001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0523749 | TRENTAL FTBL 400MG | Trental 400 mg Filmtabletten | 1.2.40.0.34.4.17:16480 | GA - zugelassen | neuraxpharm Arzneimittel GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 400 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074010 | Modified-release film-coated tablet | true | human | 1.2.40.0.34.4.26:124331002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0523844 | RHEUMON GEL | Rheumon - Gel | 1.2.40.0.34.4.17:1-16487 | GA - zugelassen | Viatris Austria GmbH | true | true | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA06 | Etofenamat | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709468 | ETOFENAMAT | 1.2.40.0.34.5.221:100000092609 | ETOFENAMATE | active | 2 | g | 1.2.40.0.34.5.221:100000092609 | ETOFENAMATE | 2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:125767003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0525553 | ACTOVEGIN AMP 80MG | Actovegin 80 mg - Injektionslösung | 1.2.40.0.34.4.17:2-00017 | GA - zugelassen | Takeda Austria GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B06AB | Andere Hämprodukte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1710184 | DEPROTEINISIERTES HAEMODERIVAT AUS KÄLBERBLUT | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | active | 160 | mg | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | 160 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:126534001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0525582 | ACTOVEGIN AMP 200MG | Actovegin 200 mg - Injektionslösung | 1.2.40.0.34.4.17:2-00016 | GA - zugelassen | Takeda Austria GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B06AB | Andere Hämprodukte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1710184 | DEPROTEINISIERTES HAEMODERIVAT AUS KÄLBERBLUT | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | active | 1000 | mg | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:126535001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0525607 | ACTOVEGIN AMP 400MG | Actovegin 400 mg - Injektionslösung | 1.2.40.0.34.4.17:2-00015 | GA - zugelassen | Takeda Austria GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B06AB | Andere Hämprodukte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1710184 | DEPROTEINISIERTES HAEMODERIVAT AUS KÄLBERBLUT | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | active | 4000 | mg | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | 4000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:126536001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0525636 | AKTIFERRIN CP KPS | Aktiferrin compositum - Kapseln | 1.2.40.0.34.4.17:16524 | GA - aufgehoben | Teva B.V. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B03AD01 | Eisen-Aminosäure-Komplex | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707468 | FOLSÄURE | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | active | 0.605 | mg | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | 0.605 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | true | human | 1.2.40.0.34.4.26:128038002 | 1.2.40.0.34.5.156:1705968 | EISEN(II)-SULFAT | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | active | 104.267 | mg | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | 104.267 | mg | 1.2.40.0.34.5.156:1707010 | SERIN | 1.2.40.0.34.5.221:100000084137 | SERINE | active | 129 | mg | 1.2.40.0.34.5.221:100000084137 | SERINE | 129 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0525642 | AKTIFERRIN CP KPS | Aktiferrin compositum - Kapseln | 1.2.40.0.34.4.17:16524 | GA - aufgehoben | Teva B.V. | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B03AD01 | Eisen-Aminosäure-Komplex | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707468 | FOLSÄURE | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | active | 0.605 | mg | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | 0.605 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | true | human | 1.2.40.0.34.4.26:128038001 | 1.2.40.0.34.5.156:1705968 | EISEN(II)-SULFAT | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | active | 104.267 | mg | 1.2.40.0.34.5.221:100000078474 | FERROUS SULFATE | 104.267 | mg | 1.2.40.0.34.5.156:1707010 | SERIN | 1.2.40.0.34.5.221:100000084137 | SERINE | active | 129 | mg | 1.2.40.0.34.5.221:100000084137 | SERINE | 129 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0528480 | DEQUONAL LSG Z. GURGELN | Dequonal - Lösung | 1.2.40.0.34.4.17:16932 | GA - zugelassen | Chemische Fabrik Kreussler & Co. GmbH | true | true | 200 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A01AB11 | Verschiedene | 1.2.40.0.10.1.4.3.4.3.4:100000073578 | Anwendung am Zahnfleisch | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | 1.2.40.0.10.1.4.3.4.3.4:100000073621 | zur Anwendung im Mund- und Rachenraum | 1.2.40.0.34.5.156:1708738 | DEQUALINIUM CHLORID | 1.2.40.0.34.5.221:100000091069 | DEQUALINIUM CHLORIDE | active | 0.03 | g | 1.2.40.0.34.5.221:100000091069 | DEQUALINIUM CHLORIDE | 0.03 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073678 | Lösung zur Anwendung am Zahnfleisch | false | human | 1.2.40.0.34.4.26:126499001 | 1.2.40.0.34.5.156:1709170 | BENZALKONIUMCHLORID | 1.2.40.0.34.5.221:100000092079 | BENZALKONIUM CHLORIDE | active | 0.07 | g | 1.2.40.0.34.5.221:100000092079 | BENZALKONIUM CHLORIDE | 0.07 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073676 | Spray zur Anwendung in der Mundhöhle | 1.2.40.0.10.1.4.3.4.3.5:100000073673 | Gurgellösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0528528 | ALDACTONE SALT KPS FTE | Aldactone - Saltucin forte - Hartkapseln | 1.2.40.0.34.4.17:16478 | GA - zugelassen | Herbrand PharmaChemicals GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03EA14 | Butizid und Kalium sparende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 100 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:126633001 | 1.2.40.0.34.5.156:1708065 | BUTIZID | 1.2.40.0.34.5.221:100000088634 | BUTIZIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000088634 | BUTIZIDE | 10 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0530293 | CYKLOKAPRON FTBL | Cyklokapron 500 mg - Filmtabletten | 1.2.40.0.34.4.17:13086 | GA - zugelassen | Viatris Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:900000000009 | Behältnis (NE) | 2.16.840.1.113883.6.73:B02AA02 | Tranexamsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708717 | TRANEXAMSÄURE | 1.2.40.0.34.5.221:100000091040 | TRANEXAMIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000091040 | TRANEXAMIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124357003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0530436 | LOESFERRON BRTBL FTE | Lösferron forte - Brausetabletten | 1.2.40.0.34.4.17:16100 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:B03AA03 | Eisen(II)gluconat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 100 | mg | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073681 | Brausetablette | true | human | 1.2.40.0.34.4.26:122765001 | 1.2.40.0.34.5.156:1708841 | EISEN(II)-GLUCONAT | 1.2.40.0.34.5.221:100000091403 | FERROUS GLUCONATE | active | 695 | mg | 1.2.40.0.34.5.221:100000091403 | FERROUS GLUCONATE | 695 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0530519 | RESYL TR | Grippostad Guaifenesin 100 mg/ml Hustentropfen zum Einnehmen | 1.2.40.0.34.4.17:4916 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | false | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:R05CA03 | Guaifenesin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708576 | GUAIFENESIN | 1.2.40.0.34.5.221:100000090413 | GUAIFENESIN | active | | | 1.2.40.0.34.5.221:100000090413 | GUAIFENESIN | | | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0532955 | BURINEX LEO TBL 1MG | Burinex 1 mg - Tabletten | 1.2.40.0.34.4.17:16540 | GA - zugelassen | Karo Healthcare AB | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03CA02 | Bumetanid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708037 | BUMETANID | 1.2.40.0.34.5.221:100000088443 | BUMETANIDE | active | 1 | mg | 1.2.40.0.34.5.221:100000088443 | BUMETANIDE | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122749003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533021 | DYTIDE-H TBL | Dytide H - Tabletten | 1.2.40.0.34.4.17:1-13944 | GA - zugelassen | Dermapharm GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03EA01 | Hydrochlorothiazid und Kalium sparende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709440 | TRIAMTEREN | 1.2.40.0.34.5.221:100000092570 | TRIAMTERENE | active | 50 | mg | 1.2.40.0.34.5.221:100000092570 | TRIAMTERENE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124609002 | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 25 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533067 | HARMOMED DRG | Harmomed - Dragees | 1.2.40.0.34.4.17:16541 | GA - aufgehoben | Kwizda Pharma GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N06AA | Nichtselektive Monoamin-Wiederaufnahmehemmer | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709349 | DIAZEPAM | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | active | 2.5 | mg | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:124050002 | 1.2.40.0.34.5.156:1709076 | DOSULEPIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091934 | DOSULEPIN HYDROCHLORIDE | active | 14 | mg | 1.2.40.0.34.5.221:100000091934 | DOSULEPIN HYDROCHLORIDE | 14 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533185 | LUDIOMIL FTBL 25MG | Ludiomil 25 mg - Filmtabletten | 1.2.40.0.34.4.17:15240 | GA - zugelassen | Amdipharm Limited | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AA21 | Maprotilin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709373 | MAPROTILIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092398 | MAPROTILINE HYDROCHLORIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000092398 | MAPROTILINE HYDROCHLORIDE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:121193002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533191 | LUDIOMIL FTBL 25MG | Ludiomil 25 mg - Filmtabletten | 1.2.40.0.34.4.17:15240 | GA - zugelassen | Amdipharm Limited | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AA21 | Maprotilin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709373 | MAPROTILIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092398 | MAPROTILINE HYDROCHLORIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000092398 | MAPROTILINE HYDROCHLORIDE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:121193001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533216 | LUDIOMIL FTBL 50MG | Ludiomil 50 mg - Filmtabletten | 1.2.40.0.34.4.17:15241 | GA - zugelassen | Amdipharm Limited | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AA21 | Maprotilin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709373 | MAPROTILIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092398 | MAPROTILINE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000092398 | MAPROTILINE HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:121192002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533222 | MADOPAR KPS 50/12,5MG | Madopar 50 mg/12,5 mg - Kapseln | 1.2.40.0.34.4.17:16549 | GA - zugelassen | Roche Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N04BA02 | Levodopa und Decarboxylasehemmer | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708901 | BENSERAZID HYDROCHLORID | 1.2.40.0.34.5.221:100000091558 | BENSERAZIDE HYDROCHLORIDE | active | 14.25 | mg | 1.2.40.0.34.5.221:100000091558 | BENSERAZIDE HYDROCHLORIDE | 14.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:128279002 | 1.2.40.0.34.5.156:1707406 | LEVODOPA | 1.2.40.0.34.5.221:100000085446 | LEVODOPA | active | 50 | mg | 1.2.40.0.34.5.221:100000085446 | LEVODOPA | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533239 | MADOPAR KPS 50/12,5MG | Madopar 50 mg/12,5 mg - Kapseln | 1.2.40.0.34.4.17:16549 | GA - zugelassen | Roche Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N04BA02 | Levodopa und Decarboxylasehemmer | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708901 | BENSERAZID HYDROCHLORID | 1.2.40.0.34.5.221:100000091558 | BENSERAZIDE HYDROCHLORIDE | active | 14.25 | mg | 1.2.40.0.34.5.221:100000091558 | BENSERAZIDE HYDROCHLORIDE | 14.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:128279001 | 1.2.40.0.34.5.156:1707406 | LEVODOPA | 1.2.40.0.34.5.221:100000085446 | LEVODOPA | active | 50 | mg | 1.2.40.0.34.5.221:100000085446 | LEVODOPA | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533245 | MARCOUMAR TBL 3MG | Marcoumar - Tabletten | 1.2.40.0.34.4.17:8096 | GA - zugelassen | Viatris Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B01AA04 | Phenprocoumon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706733 | PHENPROCOUMON | 1.2.40.0.34.5.221:100000082261 | PHENPROCOUMON | active | 3 | mg | 1.2.40.0.34.5.221:100000082261 | PHENPROCOUMON | 3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:920189002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533280 | MULTODRIN SLB | Multodrin - Salbe | 1.2.40.0.34.4.17:13232 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07XB05 | Dexamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709464 | DEXAMETHASON | 1.2.40.0.34.5.221:100000092605 | DEXAMETHASONE | active | 0.03 | g | 1.2.40.0.34.5.221:100000092605 | DEXAMETHASONE | 0.03 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:127201002 | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 0.45 | g | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 0.45 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533357 | PARKEMED FTBL 500MG | Parkemed 500 mg - Filmtabletten | 1.2.40.0.34.4.17:16288 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AG01 | Mefenaminsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708971 | MEFENAMINSÄURE | 1.2.40.0.34.5.221:100000091703 | MEFENAMIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000091703 | MEFENAMIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124752002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533363 | PARKEMED FTBL 500MG | Parkemed 500 mg - Filmtabletten | 1.2.40.0.34.4.17:16288 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AG01 | Mefenaminsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708971 | MEFENAMINSÄURE | 1.2.40.0.34.5.221:100000091703 | MEFENAMIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000091703 | MEFENAMIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124752003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533386 | PARKEMED KPS 250MG | Parkemed 250 mg - Kapseln | 1.2.40.0.34.4.17:12949 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AG01 | Mefenaminsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708971 | MEFENAMINSÄURE | 1.2.40.0.34.5.221:100000091703 | MEFENAMIC ACID | active | 250 | mg | 1.2.40.0.34.5.221:100000091703 | MEFENAMIC ACID | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:120622002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533392 | PARKEMED KPS 250MG | Parkemed 250 mg - Kapseln | 1.2.40.0.34.4.17:12949 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AG01 | Mefenaminsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708971 | MEFENAMINSÄURE | 1.2.40.0.34.5.221:100000091703 | MEFENAMIC ACID | active | 250 | mg | 1.2.40.0.34.5.221:100000091703 | MEFENAMIC ACID | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:120622003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533423 | SINTROM TBL 4MG | Sintrom 4 mg Tabletten | 1.2.40.0.34.4.17:9828 | GA - zugelassen | Merus Labs Luxco II S.à.r.l. | true | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B01AA07 | Acenocoumarol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708846 | ACENOCUMAROL | 1.2.40.0.34.5.221:100000091427 | ACENOCUMAROL | active | 4 | mg | 1.2.40.0.34.5.221:100000091427 | ACENOCUMAROL | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:125935002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0533446 | SINTROM TBL 4MG | Sintrom 4 mg Tabletten | 1.2.40.0.34.4.17:9828 | GA - zugelassen | Merus Labs Luxco II S.à.r.l. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B01AA07 | Acenocoumarol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708846 | ACENOCUMAROL | 1.2.40.0.34.5.221:100000091427 | ACENOCUMAROL | active | 4 | mg | 1.2.40.0.34.5.221:100000091427 | ACENOCUMAROL | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:125935001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0535652 | PARLODEL TBL 2,5MG | Parlodel 2,5 mg - Tabletten | 1.2.40.0.34.4.17:16192 | GA - aufgehoben | MEDA Pharma GmbH | false | false | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:G02CB01 | Bromocriptin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708574 | BROMOCRIPTIN MESILAT | 1.2.40.0.34.5.221:100000090410 | BROMOCRIPTINE MESILATE | active | 2.87 | mg | 1.2.40.0.34.5.221:100000090410 | BROMOCRIPTINE MESILATE | 2.87 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123091002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0540920 | ANDRODIANE TBL 3X15 | Andro - Diane 10 mg - Tabletten | 1.2.40.0.34.4.17:17400 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 45 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:G03HA01 | Cyproteron | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708539 | CYPROTERON ACETAT | 1.2.40.0.34.5.221:100000090321 | CYPROTERONE ACETATE | active | 10 | mg | 1.2.40.0.34.5.221:100000090321 | CYPROTERONE ACETATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:128635001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0545308 | BETAISODONA FLUESSIGSF. | Betadona Flüssigseife | 1.2.40.0.34.4.17:16615 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | false | 120 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:D08AG02 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDON-IOD | active | | | 1.2.40.0.34.5.221:100000091677 | POVIDON-IOD | | | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0545314 | BETAISODONA FLUESSIGSF. | Betadona Flüssigseife | 1.2.40.0.34.4.17:16615 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | false | 500 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:D08AG02 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDON-IOD | active | | | 1.2.40.0.34.5.221:100000091677 | POVIDON-IOD | | | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0545372 | ETRAT GEL | Etrat - Gel | 1.2.40.0.34.4.17:15399 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA53 | Heparin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | 50 | g | 1.2.40.0.34.5.221:100000091364 | MENTHOL | 50 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:128732001 | 1.2.40.0.34.5.156:1709283 | HYDROXYETHYLSALICYLAT | 1.2.40.0.34.5.221:100000092263 | HYDROXYETHYL SALICYLATE | active | 500 | g | 1.2.40.0.34.5.221:100000092263 | HYDROXYETHYL SALICYLATE | 500 | g | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 3.6 | g | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 3.6 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0547129 | ANAFRANIL DRG 25MG | Anafranil 25 mg - Dragees | 1.2.40.0.34.4.17:14192 | GA - zugelassen | pharmaand GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AA04 | Clomipramin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708620 | CLOMIPRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090503 | CLOMIPRAMIN HYDROCHLORID | active | 25 | mg | 1.2.40.0.34.5.221:100000090503 | CLOMIPRAMIN HYDROCHLORID | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:123473002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0547141 | APIHEPAR KPS | Apihepar - Kapseln | 1.2.40.0.34.4.17:1-16644 | GA - aufgehoben | Viatris Austria GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:A05BA03 | Silymarin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710766 | SILYBI MARIANI FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000001000 | SILYBI MARIANI FRUCTUS (EXTRACT) | active | | mg | 1.2.40.0.34.5.221:900000001000 | SILYBI MARIANI FRUCTUS (EXTRACT) | | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:124421002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0547158 | APIHEPAR KPS | Apihepar - Kapseln | 1.2.40.0.34.4.17:1-16644 | GA - aufgehoben | Viatris Austria GmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:A05BA03 | Silymarin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710766 | SILYBI MARIANI FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000001000 | SILYBI MARIANI FRUCTUS (EXTRACT) | active | | mg | 1.2.40.0.34.5.221:900000001000 | SILYBI MARIANI FRUCTUS (EXTRACT) | | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:124421001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0547299 | FERRETAB KPS | Ferretab - Kapseln | 1.2.40.0.34.4.17:16638 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B03AA02 | Eisen(II)fumarat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 20 | mg | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:126098002 | 1.2.40.0.34.5.156:1708593 | EISEN(II)-FUMARAT | 1.2.40.0.34.5.221:100000090445 | FERROUS FUMARATE | active | 50.7 | mg | 1.2.40.0.34.5.221:100000090445 | FERROUS FUMARATE | 50.7 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0547307 | FERRETAB KPS | Ferretab - Kapseln | 1.2.40.0.34.4.17:16638 | GA - zugelassen | G.L. Pharma GmbH | true | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B03AA02 | Eisen(II)fumarat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 20 | mg | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:126098001 | 1.2.40.0.34.5.156:1708593 | EISEN(II)-FUMARAT | 1.2.40.0.34.5.221:100000090445 | FERROUS FUMARATE | active | 50.7 | mg | 1.2.40.0.34.5.221:100000090445 | FERROUS FUMARATE | 50.7 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0547460 | OSPEN- 750 SFT | Ospen 750 - Saft | 1.2.40.0.34.4.17:16263 | GA - zugelassen | Sandoz GmbH | true | true | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707357 | PHENOXYMETHYLPENICILLIN BENZATHIN | 1.2.40.0.34.5.221:100000085294 | PHENOXYMETHYLPENICILLIN BENZATHINE | active | 8.1816 | g | 1.2.40.0.34.5.221:100000085294 | PHENOXYMETHYLPENICILLIN BENZATHINE | 8.1816 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:122200001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0549163 | JUMEX TBL | Jumex 5 mg - Tabletten | 1.2.40.0.34.4.17:17396 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N04BD01 | Selegilin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708715 | SELEGILIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091038 | SELEGILINE HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000091038 | SELEGILINE HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921569001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0550580 | BEKUNIS KR.TEE | Bekunis - Kräutertee | 1.2.40.0.34.4.17:13426 | GA - aufgehoben | Roha Arzneimittel GmbH | false | false | 175 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A06AB06 | Sennoside | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708673 | SENNAE FOLIUM | 1.2.40.0.34.5.221:100000090680 | SENNAE FOLIUM | active | 4375 | g | 1.2.40.0.34.5.221:100000090680 | SENNAE FOLIUM | 4375 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073370 | Arzneitee | true | human | 1.2.40.0.34.4.26:121105001 | 1.2.40.0.34.5.156:1712672 | SENNAE FRUCTUS | 1.2.40.0.34.5.221:900000004286 | SENNAE FRUCTUS | active | 13125 | g | 1.2.40.0.34.5.221:900000004286 | SENNAE FRUCTUS | 13125 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0551881 | HARMOMED DRG | Harmomed - Dragees | 1.2.40.0.34.4.17:16541 | GA - aufgehoben | Kwizda Pharma GmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N06AA | Nichtselektive Monoamin-Wiederaufnahmehemmer | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709349 | DIAZEPAM | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | active | 2.5 | mg | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:124050001 | 1.2.40.0.34.5.156:1709076 | DOSULEPIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091934 | DOSULEPIN HYDROCHLORIDE | active | 14 | mg | 1.2.40.0.34.5.221:100000091934 | DOSULEPIN HYDROCHLORIDE | 14 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0552018 | ZADITEN SIR KIND | Zaditen - Sirup für Kinder | 1.2.40.0.34.4.17:16660 | GA - aufgehoben | Alfasigma S.p.A. | false | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R06AX17 | Ketotifen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709246 | KETOTIFEN HYDROGENFUMARAT | 1.2.40.0.34.5.221:100000092186 | KETOTIFEN HYDROGEN FUMARATE | active | 0.028 | g | 1.2.40.0.34.5.221:100000092186 | KETOTIFEN HYDROGEN FUMARATE | 0.028 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073652 | Sirup | true | human | 1.2.40.0.34.4.26:129902001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0553696 | CEREBROLYSIN AMP 5ML | Cerebrolysin - parenterale Lösung | 1.2.40.0.34.4.17:1-21380 | GA - zugelassen | EVER Neuro Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N07X | Andere Mittel für das Nervensystem | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1710680 | PEPTIDE | 1.2.40.0.34.5.221:100000124442 | PEPTIDES | active | 1076 | mg | 1.2.40.0.34.5.221:100000124442 | PEPTIDES | 1076 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000116188 | Solution for injection/concentrate for solution for infusion | true | human | 1.2.40.0.34.4.26:934071011 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0554201 | MAGN VERLA FTBL | Magnesium Verla Filmtabletten | 1.2.40.0.34.4.17:13116 | GA - zugelassen | Kwizda Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A12CC30 | Magnesium (verschiedene Salze in Kombination) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710459 | MAGNESIUM DI(HYDROGENGLUTAMAT) | 1.2.40.0.34.5.221:100000086158 | MAGNESIUM DI(HYDROGENGLUTAMATE) | active | 165.4 | mg | 1.2.40.0.34.5.221:100000086158 | MAGNESIUM DI(HYDROGENGLUTAMATE) | 165.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:126290001 | 1.2.40.0.34.5.156:1708780 | MAGNESIUMCITRAT | 1.2.40.0.34.5.221:100000091252 | MAGNESIUM CITRATE | active | 436.8 | mg | 1.2.40.0.34.5.221:100000091252 | MAGNESIUM CITRATE | 436.8 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0559061 | GYNO-PEVARYL VAG-SUPP 150MG | Gyno-Pevaryl 150 mg - Vaginalzäpfchen | 1.2.40.0.34.4.17:16688 | GA - zugelassen | Karo Healthcare AB | true | true | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G01AF05 | Econazol | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1709603 | ECONAZOL NITRAT | 1.2.40.0.34.5.221:100000092986 | ECONAZOLE NITRATE | active | 150 | mg | 1.2.40.0.34.5.221:100000092986 | ECONAZOLE NITRATE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073815 | Vaginalzäpfchen | true | human | 1.2.40.0.34.4.26:124068001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0559285 | ULTRACAIN DNT ZAMP 1,7ML | Ultracain Dental Zylinderampullen | 1.2.40.0.34.4.17:16587 | GA - zugelassen | Septodont GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01BB58 | Articain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | 1.2.40.0.10.1.4.3.4.3.4:100000075554 | submuköse Anwendung | | | 1.2.40.0.34.5.156:1709361 | EPINEPHRIN | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | active | 0.0085 | mg | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | 0.0085 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:123068001 | 1.2.40.0.34.5.156:1708361 | ARTICAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089667 | ARTICAINE HYDROCHLORIDE | active | 68 | mg | 1.2.40.0.34.5.221:100000089667 | ARTICAINE HYDROCHLORIDE | 68 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0559291 | ULTRACAIN DNT ZAMP FTE 1,7ML | Ultracain Dental forte Zylinderampullen | 1.2.40.0.34.4.17:16588 | GA - zugelassen | Septodont GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01BB58 | Articain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | 1.2.40.0.10.1.4.3.4.3.4:100000075554 | submuköse Anwendung | | | 1.2.40.0.34.5.156:1709361 | EPINEPHRIN | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | active | 0.017 | mg | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | 0.017 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:123067001 | 1.2.40.0.34.5.156:1708361 | ARTICAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089667 | ARTICAINE HYDROCHLORIDE | active | 68 | mg | 1.2.40.0.34.5.221:100000089667 | ARTICAINE HYDROCHLORIDE | 68 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0564843 | DEXAMETHASON NYC AMP 4MG 5X5 | Dexamethason "Nycomed" 4 mg - Ampulle | 1.2.40.0.34.4.17:12755 | GA - aufgehoben | Takeda Austria GmbH | false | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB02 | Dexamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709464 | DEXAMETHASON | 1.2.40.0.34.5.221:100000092605 | DEXAMETHASONE | active | 4 | mg | 1.2.40.0.34.5.221:100000092605 | DEXAMETHASONE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920722003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0564889 | DIBENZYRAN KPS 5MG | Dibenzyran 5 mg Kapseln | 1.2.40.0.34.4.17:16736 | GA - aufgehoben | Aristo Pharma GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AX02 | Phenoxybenzamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707348 | PHENOXYBENZAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000085275 | PHENOXYBENZAMINE HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000085275 | PHENOXYBENZAMINE HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:120314002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0564895 | DIBENZYRAN KPS 5MG | Dibenzyran 5 mg Kapseln | 1.2.40.0.34.4.17:16736 | GA - aufgehoben | Aristo Pharma GmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AX02 | Phenoxybenzamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707348 | PHENOXYBENZAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000085275 | PHENOXYBENZAMINE HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000085275 | PHENOXYBENZAMINE HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:120314001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0564978 | GEWACALM TBL 2MG | Gewacalm 2 mg - Tabletten | 1.2.40.0.34.4.17:16754 | GA - zugelassen | Takeda Austria GmbH | true | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N05BA01 | Diazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709349 | DIAZEPAM | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | active | 2 | mg | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124595004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0564984 | GEWACALM TBL 2MG | Gewacalm 2 mg - Tabletten | 1.2.40.0.34.4.17:16754 | GA - zugelassen | Takeda Austria GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N05BA01 | Diazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709349 | DIAZEPAM | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | active | 2 | mg | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124595003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0564990 | GEWACALM TBL 5MG | Gewacalm 5 mg - Tabletten | 1.2.40.0.34.4.17:16755 | GA - zugelassen | Takeda Austria GmbH | true | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA01 | Diazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709349 | DIAZEPAM | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | active | 5 | mg | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124596001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0565009 | GEWACALM TBL 5MG | Gewacalm 5 mg - Tabletten | 1.2.40.0.34.4.17:16755 | GA - zugelassen | Takeda Austria GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA01 | Diazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709349 | DIAZEPAM | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | active | 5 | mg | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124596002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0565015 | GEWACALM TBL 10MG | Gewacalm 10 mg - Tabletten | 1.2.40.0.34.4.17:16756 | GA - zugelassen | Takeda Austria GmbH | true | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA01 | Diazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709349 | DIAZEPAM | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | active | 10 | mg | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124597001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0565021 | GEWACALM TBL 10MG | Gewacalm 10 mg - Tabletten | 1.2.40.0.34.4.17:16756 | GA - zugelassen | Takeda Austria GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA01 | Diazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709349 | DIAZEPAM | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | active | 10 | mg | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124597002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0570714 | INDOCID RET KPS 75MG | Indocid retard 75 mg Kapseln | 1.2.40.0.34.4.17:16728 | GA - zugelassen | H.A.C. Pharma | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB01 | Indometacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709537 | INDOMETACIN | 1.2.40.0.34.5.221:100000092758 | INDOMETACIN | active | 75 | mg | 1.2.40.0.34.5.221:100000092758 | INDOMETACIN | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073663 | Hartkapsel mit veränderter Wirkstofffreisetzung | true | human | 1.2.40.0.34.4.26:129522001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0570720 | INDOCID RET KPS 75MG | Indocid retard 75 mg Kapseln | 1.2.40.0.34.4.17:16728 | GA - zugelassen | H.A.C. Pharma | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB01 | Indometacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709537 | INDOMETACIN | 1.2.40.0.34.5.221:100000092758 | INDOMETACIN | active | 75 | mg | 1.2.40.0.34.5.221:100000092758 | INDOMETACIN | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073663 | Hartkapsel mit veränderter Wirkstofffreisetzung | true | human | 1.2.40.0.34.4.26:129522002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0574994 | FELDEN KPS 10MG | Felden 10 mg - Kapseln | 1.2.40.0.34.4.17:16690 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M01AC01 | Piroxicam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709404 | PIROXICAM | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | active | 10 | mg | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:129403002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0575019 | FELDEN KPS 10MG | Felden 10 mg - Kapseln | 1.2.40.0.34.4.17:16690 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M01AC01 | Piroxicam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709404 | PIROXICAM | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | active | 10 | mg | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:129403003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0575605 | SAROTEN FTBL 25MG | Saroten 25 mg - Filmtabletten | 1.2.40.0.34.4.17:11735 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N06AA09 | Amitriptylin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708532 | AMITRIPTYLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090311 | AMITRIPTYLINE HYDROCHLORIDE | active | 28.28 | mg | 1.2.40.0.34.5.221:100000090311 | AMITRIPTYLINE HYDROCHLORIDE | 28.28 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122960003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0589228 | DIHYDERGOT TBL 2,5MG | Dihydergot 2,5 mg - Tabletten | 1.2.40.0.34.4.17:1-16750 | GA - zugelassen | Amdipharm Limited | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02CA01 | Dihydroergotamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708652 | DIHYDROERGOTAMIN MESILAT | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | active | 2.5 | mg | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:128520001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0589234 | DIHYDERGOT TBL 2,5MG | Dihydergot 2,5 mg - Tabletten | 1.2.40.0.34.4.17:1-16750 | GA - zugelassen | Amdipharm Limited | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02CA01 | Dihydroergotamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708652 | DIHYDROERGOTAMIN MESILAT | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | active | 2.5 | mg | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:128520002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0593767 | ROCALTROL KPS 0,25MCG | Rocaltrol 0,25 Mikrogramm - Kapseln | 1.2.40.0.34.4.17:16767 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A11CC04 | Calcitriol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709558 | CALCITRIOL | 1.2.40.0.34.5.221:100000092790 | CALCITRIOL | active | 0.25 | µg | 1.2.40.0.34.5.221:100000092790 | CALCITRIOL | 0.25 | µg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:129796002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0593773 | ROCALTROL KPS 0,25MCG | Rocaltrol 0,25 Mikrogramm - Kapseln | 1.2.40.0.34.4.17:16767 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A11CC04 | Calcitriol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709558 | CALCITRIOL | 1.2.40.0.34.5.221:100000092790 | CALCITRIOL | active | 0.25 | µg | 1.2.40.0.34.5.221:100000092790 | CALCITRIOL | 0.25 | µg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:129796001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0593796 | ROCALTROL KPS 0,5MCG | Rocaltrol 0,5 Mikrogramm - Kapseln | 1.2.40.0.34.4.17:16768 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A11CC04 | Calcitriol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709558 | CALCITRIOL | 1.2.40.0.34.5.221:100000092790 | CALCITRIOL | active | 0.5 | µg | 1.2.40.0.34.5.221:100000092790 | CALCITRIOL | 0.5 | µg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:129797002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0593804 | ROCALTROL KPS 0,5MCG | Rocaltrol 0,5 Mikrogramm - Kapseln | 1.2.40.0.34.4.17:16768 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A11CC04 | Calcitriol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709558 | CALCITRIOL | 1.2.40.0.34.5.221:100000092790 | CALCITRIOL | active | 0.5 | µg | 1.2.40.0.34.5.221:100000092790 | CALCITRIOL | 0.5 | µg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:129797001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0594152 | CYCLOPENTOLAT AU-TR 1% | Cyclopentolat 1% "Thilo" - Augentropfen | 1.2.40.0.34.4.17:17352 | GA - aufgehoben | Alcon Ophthalmika GmbH | false | false | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01FA04 | Cyclopentolat | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709381 | CYCLOPENTOLAT HYDROCHLORID | 1.2.40.0.34.5.221:100000092411 | CYCLOPENTOLATE HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000092411 | CYCLOPENTOLATE HYDROCHLORIDE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:920377001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0595016 | HYPNOMIDATE AMP 2MG/ML 10ML | Hypnomidate 2 mg/ml Injektionslösung | 1.2.40.0.34.4.17:16817 | GA - zugelassen | Piramal Critical Care B.V. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01AX07 | Etomidate | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1706699 | ETOMIDAT | 1.2.40.0.34.5.221:100000082107 | ETOMIDATE | active | 0.02 | g | 1.2.40.0.34.5.221:100000082107 | ETOMIDATE | 0.02 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:128689001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0595507 | SAROTEN RET KPS 25MG | Saroten Retard 25 mg - Kapseln | 1.2.40.0.34.4.17:15089 | GA - aufgehoben | Lundbeck Austria GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N06AA09 | Amitriptylin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708532 | AMITRIPTYLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090311 | AMITRIPTYLINE HYDROCHLORIDE | active | 28.28 | mg | 1.2.40.0.34.5.221:100000090311 | AMITRIPTYLINE HYDROCHLORIDE | 28.28 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:122994003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0595513 | SAROTEN RET KPS 50MG | Saroten Retard 50 mg - Kapseln | 1.2.40.0.34.4.17:15984 | GA - aufgehoben | Lundbeck Austria GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N06AA09 | Amitriptylin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708532 | AMITRIPTYLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090311 | AMITRIPTYLINE HYDROCHLORIDE | active | 56.55 | mg | 1.2.40.0.34.5.221:100000090311 | AMITRIPTYLINE HYDROCHLORIDE | 56.55 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:123952003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0596932 | DERMOVATE CRIN LSG | Dermovate Crinale - Lösung | 1.2.40.0.34.4.17:16784 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | false | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D07AD01 | Clobetasol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708885 | CLOBETASOL PROPIONAT | 1.2.40.0.34.5.221:100000091516 | CLOBETASOL PROPIONATE | active | 0.75 | g | 1.2.40.0.34.5.221:100000091516 | CLOBETASOL PROPIONATE | 0.75 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:124118002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0596949 | DERMOVATE CRIN LSG | Dermovate Crinale - Lösung | 1.2.40.0.34.4.17:16784 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D07AD01 | Clobetasol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708885 | CLOBETASOL PROPIONAT | 1.2.40.0.34.5.221:100000091516 | CLOBETASOL PROPIONATE | active | 1.5 | g | 1.2.40.0.34.5.221:100000091516 | CLOBETASOL PROPIONATE | 1.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:124118001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0597015 | MAGN VERLA GRAN 5G | Magnesium "Verla" Granulat | 1.2.40.0.34.4.17:16776 | GA - zugelassen | Kwizda Pharma GmbH | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:A12CC05 | Magnesiumaspartat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:12094892 | MAGNESIUMASPARTAT DIHYDRAT | 1.2.40.0.34.5.221:900000005195 | MAGNESIUMASPARTATE DIHYDRATE | active | 1622.18 | mg | 1.2.40.0.34.5.221:900000005195 | MAGNESIUMASPARTATE DIHYDRATE | 1622.18 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073365 | Granulat zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:126289001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0597021 | MAGN VERLA GRAN 5G | Magnesium "Verla" Granulat | 1.2.40.0.34.4.17:16776 | GA - zugelassen | Kwizda Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:A12CC05 | Magnesiumaspartat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:12094892 | MAGNESIUMASPARTAT DIHYDRAT | 1.2.40.0.34.5.221:900000005195 | MAGNESIUMASPARTATE DIHYDRATE | active | 1622.18 | mg | 1.2.40.0.34.5.221:900000005195 | MAGNESIUMASPARTATE DIHYDRATE | 1622.18 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073365 | Granulat zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:126289002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0597185 | DOXIUM KPS 500MG | Doxium 500 mg - Hartkapseln | 1.2.40.0.34.4.17:1-16812 | GA - zugelassen | Vifor Pharma Österreich GmbH | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C05BX01 | Calciumdobesilat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708913 | CALCIUM DOBESILAT | 1.2.40.0.34.5.221:100000091580 | CALCIUM DOBESILATE | active | 500 | mg | 1.2.40.0.34.5.221:100000091580 | CALCIUM DOBESILATE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:125124002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0609043 | DESITIN SLB | Desitin - Salbe | 1.2.40.0.34.4.17:2111 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 50 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D03AA | Lebertransalben | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708243 | ZINKOXID | 1.2.40.0.34.5.221:100000089333 | ZINC OXIDE | active | 1500 | g | 1.2.40.0.34.5.221:100000089333 | ZINC OXIDE | 1500 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:124935001 | 1.2.40.0.34.5.156:1708881 | JECORIS ASELLI OLEUM | 1.2.40.0.34.5.221:100000091501 | COD-LIVER OIL | active | 650 | g | 1.2.40.0.34.5.221:100000091501 | COD-LIVER OIL | 650 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0609095 | HUMATIN PULVIS 1G | Humatin - Pulvis | 1.2.40.0.34.4.17:16830 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A07AA06 | Paromomycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707441 | PAROMOMYCIN SULFAT | 1.2.40.0.34.5.221:100000085520 | PAROMOMYCIN SULFATE | active | 1.428 | g | 1.2.40.0.34.5.221:100000082818 | PAROMOMYCIN | 0.001428 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073364 | Pulver zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:129621001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0609155 | TONSILLOL GURGELLSG | Tonsillol - Gurgellösung | 1.2.40.0.34.4.17:16818 | GA - zugelassen | Teva B.V. | true | true | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R02AA02 | Dequalinium | 1.2.40.0.10.1.4.3.4.3.4:100000073578 | Anwendung am Zahnfleisch | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | 1.2.40.0.10.1.4.3.4.3.4:100000073621 | zur Anwendung im Mund- und Rachenraum | 1.2.40.0.34.5.156:1708738 | DEQUALINIUM CHLORID | 1.2.40.0.34.5.221:100000091069 | DEQUALINIUM CHLORIDE | active | 0.006 | g | 1.2.40.0.34.5.221:100000091069 | DEQUALINIUM CHLORIDE | 0.006 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073678 | Lösung zur Anwendung am Zahnfleisch | false | human | 1.2.40.0.34.4.26:121984002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073691 | Lösung zur Anwendung in der Mundhöhle | 1.2.40.0.10.1.4.3.4.3.5:100000073673 | Gurgellösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0614392 | ALDOMETIL FTBL 500MG | Aldometil 500 mg Filmtabletten | 1.2.40.0.34.4.17:16873 | GA - zugelassen | H.A.C. Pharma | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C02AB01 | Methyldopa (linksdrehend) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7875825 | METHYLDOPA SESQUIHYDRAT | 1.2.40.0.34.5.221:100000089793 | METHYLDOPA SESQUIHYDRATE | active | 566 | mg | 1.2.40.0.34.5.221:100000089793 | METHYLDOPA SESQUIHYDRATE | 566 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:128042002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0614400 | ALDOMETIL FTBL 500MG | Aldometil 500 mg Filmtabletten | 1.2.40.0.34.4.17:16873 | GA - zugelassen | H.A.C. Pharma | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C02AB01 | Methyldopa (linksdrehend) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7875825 | METHYLDOPA SESQUIHYDRAT | 1.2.40.0.34.5.221:100000089793 | METHYLDOPA SESQUIHYDRATE | active | 566 | mg | 1.2.40.0.34.5.221:100000089793 | METHYLDOPA SESQUIHYDRATE | 566 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:128042001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0614601 | DIPROPHOS SUS AMP 2ML | Diprophos 2 ml - Suspension zur Injektion | 1.2.40.0.34.4.17:16848 | GA - zugelassen | Organon Healthcare GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073597 | intraläsionale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000007 | intratendineale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073595 | intradermale Anwendung | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 12.86 | mg | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 12.86 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:920445001 | 1.2.40.0.34.5.156:1708451 | BETAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | active | 5.26 | mg | 1.2.40.0.34.5.221:100000090082 | BETAMETHASONE SODIUM PHOSPHATE | 5.26 | mg | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:900000000002 | subläsionale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073623 | periartikuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073589 | intrabursale Anwendung | | | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0614647 | EMOVATE CR | Emovate - Creme | 1.2.40.0.34.4.17:16854 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AB01 | Clobetason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709553 | CLOBETASON BUTYRAT | 1.2.40.0.34.5.221:100000092781 | CLOBETASONE BUTYRATE | active | 0.0075 | g | 1.2.40.0.34.5.221:100000092781 | CLOBETASONE BUTYRATE | 0.0075 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:127242001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0614653 | EMOVATE CR | Emovate - Creme | 1.2.40.0.34.4.17:16854 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AB01 | Clobetason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709553 | CLOBETASON BUTYRAT | 1.2.40.0.34.5.221:100000092781 | CLOBETASONE BUTYRATE | active | 0.015 | g | 1.2.40.0.34.5.221:100000092781 | CLOBETASONE BUTYRATE | 0.015 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:127242002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0614682 | EMOVATE SLB | Emovate - Salbe | 1.2.40.0.34.4.17:16855 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AB01 | Clobetason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709553 | CLOBETASON BUTYRAT | 1.2.40.0.34.5.221:100000092781 | CLOBETASONE BUTYRATE | active | 0.05 | g | 1.2.40.0.34.5.221:100000092781 | CLOBETASONE BUTYRATE | 0.05 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:127241002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0614854 | TEGRETOL TBL 400MG | Tegretol 400 mg - Tabletten | 1.2.40.0.34.4.17:1-16866 | GA - zugelassen | Novartis Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AF01 | Carbamazepin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709201 | CARBAMAZEPIN | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | active | 400 | mg | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129090002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0614860 | TEGRETOL TBL 400MG | Tegretol 400 mg - Tabletten | 1.2.40.0.34.4.17:1-16866 | GA - zugelassen | Novartis Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AF01 | Carbamazepin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709201 | CARBAMAZEPIN | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | active | 400 | mg | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129090001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0614877 | TENORMIN FTBL 50MG | Tenormin 50 mg - Filmtabletten | 1.2.40.0.34.4.17:16376 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 50 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124804001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0614883 | TENORMIN FTBL 50MG | Tenormin 50 mg - Filmtabletten | 1.2.40.0.34.4.17:16376 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 50 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124804002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0614943 | VOLTAREN RET FTBL 100MG | Voltaren retard 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-16856 | GA - zugelassen | Novartis Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:129507002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0614966 | VOLTAREN RET FTBL 100MG | Voltaren retard 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-16856 | GA - zugelassen | Novartis Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:129507003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0618579 | DOGMATIL KPS 50MG | Dogmatil 50 mg Kapseln | 1.2.40.0.34.4.17:16835 | GA - zugelassen | neuraxpharm Arzneimittel GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AL01 | Sulpirid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708729 | SULPIRID | 1.2.40.0.34.5.221:100000091056 | SULPIRIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000091056 | SULPIRIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:123786002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0618585 | FRISIUM TBL 10MG | Frisium 10 mg Tabletten | 1.2.40.0.34.4.17:16842 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA09 | Clobazam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707038 | CLOBAZAM | 1.2.40.0.34.5.221:100000084299 | CLOBAZAM | active | 10 | mg | 1.2.40.0.34.5.221:100000084299 | CLOBAZAM | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:128108001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0620234 | SULTANOL INHAL LSG | Sultanol - Inhalationslösung | 1.2.40.0.34.4.17:16878 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R03CC02 | Salbutamol | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1708649 | SALBUTAMOLSULFAT | 1.2.40.0.34.5.221:100000090564 | SALBUTAMOL SULFATE | active | 0.06 | g | 1.2.40.0.34.5.221:100000090564 | SALBUTAMOL SULFATE | 0.06 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073911 | Verneblungslösung | true | human | 1.2.40.0.34.4.26:128067001 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:R03AC02 | Salbutamol | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0622078 | CALCITONIN ESSP 100IE AMP1ML | Calcitonin Essential Pharma 100 I.E./ml Injektions-/Infusionslösung | 1.2.40.0.34.4.17:16880 | GA - zugelassen | Essential Pharma (M) Limited | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H05BA01 | Calcitonin (Lachs, synthetisch) | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1707161 | CALCITONIN | 1.2.40.0.34.5.221:100000084845 | CALCITONIN | active | 100 | U | 1.2.40.0.34.5.221:100000084845 | CALCITONIN | 100 | U | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:123791003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0622084 | CONTRACTUBEX GEL | Contractubex Gel | 1.2.40.0.34.4.17:13883 | GA - zugelassen | Merz Pharma Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D03AX | Andere Wundbehandlungsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1712596 | ALLII CEPAE BULBUS (AUSZUG) | 1.2.40.0.34.5.221:900000004017 | ALLII CEPAE BULBUS (EXTRACT) | active | 200 | g | 1.2.40.0.34.5.221:900000004017 | ALLII CEPAE BULBUS (EXTRACT) | 200 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:124075002 | 1.2.40.0.34.5.156:1705858 | ALLANTOIN | 1.2.40.0.34.5.221:100000078014 | ALLANTOIN | active | 20 | g | 1.2.40.0.34.5.221:100000078014 | ALLANTOIN | 20 | g | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 100000 | IU | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 100000 | IU | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0622115 | FENISTIL GEL | Fenistil - Gel | 1.2.40.0.34.4.17:16084 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 50 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D04AA13 | Dimetinden | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707840 | DIMETINDEN MALEAT | 1.2.40.0.34.5.221:100000087512 | DIMETINDENE MALEATE | active | 5 | g | 1.2.40.0.34.5.221:100000087512 | DIMETINDENE MALEATE | 5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:120494001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0622492 | MOTILIUM SUPP 30MG | Motilium 30 mg - Zäpfchen | 1.2.40.0.34.4.17:17457 | GA - aufgehoben | Janssen-Cilag Pharma GmbH | false | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A03FA03 | Domperidon | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709278 | DOMPERIDON | 1.2.40.0.34.5.221:100000092257 | DOMPERIDONE | active | 30 | mg | 1.2.40.0.34.5.221:100000092257 | DOMPERIDONE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:129146001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0626107 | CANDIO-HERMAL SOFT PST | Candio - Hermal soft - Paste | 1.2.40.0.34.4.17:16579 | GA - zugelassen | Almirall Hermal GmbH | true | false | 50 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D01AA01 | Nystatin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708425 | NYSTATIN | 1.2.40.0.34.5.221:100000089986 | NYSTATIN | active | 1 | g | 1.2.40.0.34.5.221:100000089986 | NYSTATIN | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073727 | Paste zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:123302001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0626308 | SELSUN MED SH. | Selsun medizinisches Shampoo | 1.2.40.0.34.4.17:9214 | GA - aufgehoben | Opella Healthcare Austria GmbH | false | false | 120 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D11AC03 | Selen-haltige Verbindungen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1706169 | SELENDISULFID | 1.2.40.0.34.5.221:100000079291 | SELENIUM DISULPHIDE | active | 300 | g | 1.2.40.0.34.5.221:100000079291 | SELENIUM DISULPHIDE | 300 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073715 | Shampoo | false | human | 1.2.40.0.34.4.26:124855001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0628773 | PRONTOBARIO HD 340G | Prontobario HD - Magenkontrastmittel hochkonzentriert, 334,74 g, Pulver zur Herstellung einer Suspension zum Einnehmen | 1.2.40.0.34.4.17:16906 | GA - zugelassen | Bracco Österreich GmbH | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08BA01 | Bariumsulfat mit Suspensionsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708374 | BARIUMSULFAT | 1.2.40.0.34.5.221:100000089788 | BARIUM SULFATE | active | 334.74 | g | 1.2.40.0.34.5.221:100000089788 | BARIUM SULFATE | 334.74 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:920606001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0632289 | OSPEN- 750 SFT | Ospen 750 - Saft | 1.2.40.0.34.4.17:16263 | GA - zugelassen | Sandoz GmbH | true | true | 150 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707357 | PHENOXYMETHYLPENICILLIN BENZATHIN | 1.2.40.0.34.5.221:100000085294 | PHENOXYMETHYLPENICILLIN BENZATHINE | active | 20.454 | g | 1.2.40.0.34.5.221:100000085294 | PHENOXYMETHYLPENICILLIN BENZATHINE | 20.454 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:122200002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0632295 | POTABA GLENW PLV 3G | Potaba-Glenwood Pulver 3 g | 1.2.40.0.34.4.17:16927 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:D11AX23 | Kalium Aminobenzoat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706135 | KALIUM 4-AMINOBENZOAT | 1.2.40.0.34.5.221:100000079169 | POTASSIUM AMINOBENZOATE | active | 3 | g | 1.2.40.0.34.5.221:100000079169 | POTASSIUM AMINOBENZOATE | 3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073364 | Pulver zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:129408001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0632361 | TENORETIC FTBL | Tenoretic - Filmtabletten | 1.2.40.0.34.4.17:16896 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07CB03 | Atenolol und andere Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709446 | CHLORTALIDON | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | active | 25 | mg | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:920099001 | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0632378 | TENORETIC FTBL | Tenoretic - Filmtabletten | 1.2.40.0.34.4.17:16896 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07CB03 | Atenolol und andere Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709446 | CHLORTALIDON | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | active | 25 | mg | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:920099002 | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0632384 | TRAVOCORT CR | Travocort - Creme | 1.2.40.0.34.4.17:16909 | GA - zugelassen | LEO PHARMA A/S | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D01AC20 | Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708488 | ISOCONAZOL NITRAT | 1.2.40.0.34.5.221:100000090187 | ISOCONAZOLE NITRATE | active | 0.15 | g | 1.2.40.0.34.5.221:100000090187 | ISOCONAZOLE NITRATE | 0.15 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:920727001 | 1.2.40.0.34.5.156:1709563 | DIFLUCORTOLON VALERAT | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | active | 0.015 | g | 1.2.40.0.34.5.221:100000092797 | DIFLUCORTOLONE VALERATE | 0.015 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0632390 | TRAVOGEN CR | Travogen - Creme | 1.2.40.0.34.4.17:1-16910 | GA - zugelassen | LEO PHARMA A/S | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D01AC05 | Isoconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708488 | ISOCONAZOL NITRAT | 1.2.40.0.34.5.221:100000090187 | ISOCONAZOLE NITRATE | active | 0.3 | g | 1.2.40.0.34.5.221:100000090187 | ISOCONAZOLE NITRATE | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | false | human | 1.2.40.0.34.4.26:128376001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0633024 | ESTROFEM FTBL 2MG | Estrofem 2 mg - Filmtabletten | 1.2.40.0.34.4.17:16889 | GA - zugelassen | Novo Nordisk Pharma GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000116195 | Kalenderpackung | 2.16.840.1.113883.6.73:G03CA03 | Estradiol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708991 | ESTRADIOL | 1.2.40.0.34.5.221:100000091739 | ESTRADIOL | active | 2.07 | mg | 1.2.40.0.34.5.221:100000091739 | ESTRADIOL | 2.07 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124497001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0633099 | GEWACALM AMP 10MG 2ML | Gewacalm 10 mg - Ampullen | 1.2.40.0.34.4.17:16907 | GA - zugelassen | Takeda Austria GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05BA01 | Diazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709349 | DIAZEPAM | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | active | 10 | mg | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:124814001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0633107 | GEWACALM AMP 10MG 2ML BP10X5 | Gewacalm 10 mg - Ampullen | 1.2.40.0.34.4.17:16907 | GA - zugelassen | Takeda Austria GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05BA01 | Diazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709349 | DIAZEPAM | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | active | 10 | mg | 1.2.40.0.34.5.221:100000092362 | DIAZEPAM | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:124814002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0633202 | PREDNISOLON NYC TBL 25MG | Prednisolon "Nycomed" 25 mg - Tabletten | 1.2.40.0.34.4.17:16904 | GA - zugelassen | Takeda Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 50 | mg | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124478001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0633219 | PREDNISOLON NYC TBL 25MG | Prednisolon "Nycomed" 25 mg - Tabletten | 1.2.40.0.34.4.17:16904 | GA - zugelassen | Takeda Austria GmbH | true | true | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 50 | mg | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124478003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0633225 | PREDNISOLON NYC TBL 25MG | Prednisolon "Nycomed" 25 mg - Tabletten | 1.2.40.0.34.4.17:16904 | GA - zugelassen | Takeda Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 25 | mg | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124478002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0633308 | TAVIPEC KPS | Tavipec - Kapseln | 1.2.40.0.34.4.17:10571 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R05CB | Mukolytika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710425 | LAVANDULAE LATIFOLIAE AETHEROLEUM | 1.2.40.0.34.5.221:900000000656 | LAVANDULAE LATIFOLIAE AETHEROLEUM | active | 150 | mg | 1.2.40.0.34.5.221:900000000656 | LAVANDULAE LATIFOLIAE AETHEROLEUM | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | false | human | 1.2.40.0.34.4.26:124706001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0633314 | TRISEQUENS FTBL | Trisequens - Filmtabletten | 1.2.40.0.34.4.17:16893 | GA - zugelassen | Novo Nordisk Pharma GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000116195 | Kalenderpackung | 2.16.840.1.113883.6.73:G03FB05 | Norethisteron und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709617 | NORETHISTERON ACETAT | 1.2.40.0.34.5.221:100000093036 | NORETHISTERONE ACETATE | active | 1 | mg | 1.2.40.0.34.5.221:100000093036 | NORETHISTERONE ACETATE | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124500001 | 1.2.40.0.34.5.156:1708991 | ESTRADIOL | 1.2.40.0.34.5.221:100000091739 | ESTRADIOL | active | 5.17 | mg | 1.2.40.0.34.5.221:100000091739 | ESTRADIOL | 5.17 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0637737 | ANAEROBEX IFL 0,5% 100ML | Anaerobex 0,5% - Infusionsflasche | 1.2.40.0.34.4.17:16847 | GA - zugelassen | G.L. Pharma GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01XD01 | Metronidazol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708522 | METRONIDAZOL | 1.2.40.0.34.5.221:100000090285 | METRONIDAZOLE | active | 500 | mg | 1.2.40.0.34.5.221:100000090285 | METRONIDAZOLE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:920467001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0637743 | CECLOR GRAN 250MG/5ML | Ceclor 250 mg/ 5 ml - Granulat für orale Suspension | 1.2.40.0.34.4.17:16884 | GA - zugelassen | Arcana Arzneimittel GmbH | true | true | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01DC04 | Cefaclor | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709388 | CEFACLOR MONOHYDRAT | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRATE | active | 3138 | mg | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRATE | 3138 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:128821003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0637826 | FLOXAPEN TRSTAMP 1G | Floxapen 1 g Trockenstechampullen | 1.2.40.0.34.4.17:16914 | GA - zugelassen | Actavis Group PTC ehf. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01CF05 | Flucloxacillin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1707729 | NATRIUM FLUCLOXACILLINAT | 1.2.40.0.34.5.221:100000086971 | FLUCLOXACILLIN SODIUM | active | 1115.2 | mg | 1.2.40.0.34.5.221:100000086971 | FLUCLOXACILLIN SODIUM | 1115.2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:128954001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0637861 | HOLOXAN TRSUB DFL 1G | Holoxan 1 g - Trockensubstanz zur Injektionsbereitung | 1.2.40.0.34.4.17:16940 | GA - zugelassen | Baxter Healthcare GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01AA06 | Ifosfamid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1706950 | IFOSFAMID | 1.2.40.0.34.5.221:100000083681 | IFOSFAMIDE | active | 1000 | mg | 1.2.40.0.34.5.221:100000083681 | IFOSFAMIDE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:126281001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0637884 | HOLOXAN TRSUB DFL 2G | Holoxan 2 g - Trockensubstanz zur Injektionsbereitung | 1.2.40.0.34.4.17:16941 | GA - zugelassen | Baxter Healthcare GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01AA06 | Ifosfamid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1706950 | IFOSFAMID | 1.2.40.0.34.5.221:100000083681 | IFOSFAMIDE | active | 2000 | mg | 1.2.40.0.34.5.221:100000083681 | IFOSFAMIDE | 2000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:920120001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0640515 | MONTANA HAUSTR | MONTANA HAUSTROPFEN Flüssigkeit zum Einnehmen | 1.2.40.0.34.4.17:738049 | GA - registriert | Pharmonta Dr. Fischer GmbH | true | true | 200 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A15 | Appetit stimulierende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709272 | MENTHAE PIPERITAE AETHEROLEUM | 1.2.40.0.34.5.221:100000092241 | PEPPERMINT OIL | active | | | 1.2.40.0.34.5.221:100000092241 | PEPPERMINT OIL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073645 | Flüssigkeit zum Einnehmen | true | human | 1.2.40.0.34.4.26:958261004 | 1.2.40.0.34.5.156:1712632 | LUPULI FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000004166 | LUPULI FLOS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000004166 | LUPULI FLOS (EXTRACT) | | | 1.2.40.0.34.5.156:1709970 | AURANTII AMARI EPICARPIUM ET MESOCARPIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000201 | AURANTII AMARI EPICARPIUM ET MESOCARPIUM (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000201 | AURANTII AMARI EPICARPIUM ET MESOCARPIUM (EXTRACT) | | | | | | | | | 1.2.40.0.34.5.156:1710066 | CARVI FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000000297 | CARVI FRUCTUS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000297 | CARVI FRUCTUS (EXTRACT) | | | 1.2.40.0.34.5.156:1710112 | CINNAMOMI CORTEX (AUSZUG) | 1.2.40.0.34.5.221:900000000343 | CINNAMOMI CORTEX (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000343 | CINNAMOMI CORTEX (EXTRACT) | | | 1.2.40.0.34.5.156:1710301 | GENTIANAE RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000000532 | GENTIANAE RADIX (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000532 | GENTIANAE RADIX (EXTRACT) | | | | | | | 1.2.40.0.34.5.156:1710813 | TARAXACI RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000001048 | TARAXACI RADIX (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000001048 | TARAXACI RADIX (EXTRACT) | | | 1.2.40.0.34.5.156:1712761 | MISCHEXTRAKT | 1.2.40.0.34.5.221:900000004454 | MIXED EXTRACT | active | 200 | ml | 1.2.40.0.34.5.221:900000004454 | MIXED EXTRACT | 200 | ml | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0643086 | CECLOR GRAN 125MG/5ML | Ceclor 125 mg/5ml - Granulat für orale Suspension | 1.2.40.0.34.4.17:16963 | GA - zugelassen | Arcana Arzneimittel GmbH | true | true | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01DC04 | Cefaclor | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709388 | CEFACLOR MONOHYDRAT | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRATE | active | 1569 | mg | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRATE | 1569 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:128820003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0643382 | SEPTOPAL-KETTE Z.IMPL. 10KUG | Septopal - Kette zur Implantation | 1.2.40.0.34.4.17:16971 | GA - aufgehoben | Zimmer Biomet Austria GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000075249 | zur Implantation | | | | | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 7.5 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 5.290635 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073875 | Kette zur Implantation | true | human | 1.2.40.0.34.4.26:128086001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0643399 | SEPTOPAL-KETTE Z.IMPL. 10KUG | Septopal - Kette zur Implantation | 1.2.40.0.34.4.17:16971 | GA - aufgehoben | Zimmer Biomet Austria GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000075249 | zur Implantation | | | | | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 7.5 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 5.290635 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073875 | Kette zur Implantation | true | human | 1.2.40.0.34.4.26:128086004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0643407 | SEPTOPAL-KETTE Z.IMPL. 30KUG | Septopal - Kette zur Implantation | 1.2.40.0.34.4.17:16971 | GA - aufgehoben | Zimmer Biomet Austria GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000075249 | zur Implantation | | | | | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 7.5 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 5.290635 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073875 | Kette zur Implantation | true | human | 1.2.40.0.34.4.26:128086002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0643413 | SEPTOPAL-KETTE Z.IMPL. 30KUG | Septopal - Kette zur Implantation | 1.2.40.0.34.4.17:16971 | GA - aufgehoben | Zimmer Biomet Austria GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000075249 | zur Implantation | | | | | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 7.5 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 5.290635 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073875 | Kette zur Implantation | true | human | 1.2.40.0.34.4.26:128086005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0643436 | SEPTOPAL-KETTE Z.IMPL. 60KUG | Septopal - Kette zur Implantation | 1.2.40.0.34.4.17:16971 | GA - aufgehoben | Zimmer Biomet Austria GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000075249 | zur Implantation | | | | | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 7.5 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 5.290635 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073875 | Kette zur Implantation | true | human | 1.2.40.0.34.4.26:128086003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0651683 | FENTANYL PIR AMP 0,1MG 2ML | Fentanyl - Piramal 0,1 mg - Ampullen | 1.2.40.0.34.4.17:17049 | GA - zugelassen | Piramal Critical Care B.V. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01AH01 | Fentanyl | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709212 | FENTANYLCITRAT | 1.2.40.0.34.5.221:100000092142 | FENTANYL CITRATE | active | 0.157 | mg | 1.2.40.0.34.5.221:100000092142 | FENTANYL CITRATE | 0.157 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:126631001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0651743 | MINIRIN LSG Z.INTRANAS.ANW. | Minirin - Lösung zur intranasalen Anwendung | 1.2.40.0.34.4.17:15400 | GA - aufgehoben | Ferring Arzneimittel Ges.m.b.H. | false | false | 2.5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:H01BA02 | Desmopressin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1707893 | DESMOPRESSIN ACETAT | 1.2.40.0.34.5.221:100000087773 | DESMOPRESSIN ACETATE | active | 10 | mg | 1.2.40.0.34.5.221:100000087773 | DESMOPRESSIN ACETATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073794 | Nasentropfen, Lösung | true | human | 1.2.40.0.34.4.26:120815001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0651915 | URSOFALK KPS 250MG | Ursofalk 250 mg - Kapseln | 1.2.40.0.34.4.17:17053 | GA - zugelassen | Dr. Falk Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A05AA02 | Ursodeoxycholsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709189 | URSODEOXYCHOLSÄURE | 1.2.40.0.34.5.221:100000092107 | URSODEOXYCHOLIC ACID | active | 250 | mg | 1.2.40.0.34.5.221:100000092107 | URSODEOXYCHOLIC ACID | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:920022001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0658509 | APREDNISLON TBL 25MG | Aprednislon 25 mg - Tabletten | 1.2.40.0.34.4.17:12106 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 25 | mg | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123024002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0658515 | CANESTEN VAG-TBL 0,5G | Canesten Clotrimazol 0,5 g - 1 Vaginaltablette | 1.2.40.0.34.4.17:17070 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G01AF02 | Clotrimazol | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1709166 | CLOTRIMAZOL | 1.2.40.0.34.5.221:100000092074 | CLOTRIMAZOLE | active | 500 | mg | 1.2.40.0.34.5.221:100000092074 | CLOTRIMAZOLE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073824 | Vaginaltablette | true | human | 1.2.40.0.34.4.26:921117001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0658550 | CONVULEX KPS 500MG | Convulex 500 mg - Kapseln | 1.2.40.0.34.4.17:17044 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AG01 | Valproinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708579 | VALPROINSÄURE | 1.2.40.0.34.5.221:100000090423 | VALPROIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000090423 | VALPROIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073661 | magensaftresistente Weichkapsel | true | human | 1.2.40.0.34.4.26:920466001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0658633 | FELDEN KPS 20MG | Felden 20 mg - Kapseln | 1.2.40.0.34.4.17:17048 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M01AC01 | Piroxicam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709404 | PIROXICAM | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | active | 20 | mg | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:129405002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0659012 | TENORETIC FTBL MTE | Tenoretic mite - Filmtabletten | 1.2.40.0.34.4.17:17075 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07CB03 | Atenolol und andere Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709446 | CHLORTALIDON | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | 12.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:921103001 | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 50 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0659029 | TENORETIC FTBL MTE | Tenoretic mite - Filmtabletten | 1.2.40.0.34.4.17:17075 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07CB03 | Atenolol und andere Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709446 | CHLORTALIDON | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | 12.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:921103002 | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 50 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0661871 | CEVITOL AMP 500MG/2ML | Cevitol 500 mg - Ampullen | 1.2.40.0.34.4.17:14308 | GA - zugelassen | G.L. Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A11GA01 | Ascorbinsäure (Vitamin C) | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:123537002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0662008 | MULTIVIT-B AMP 2ML | Multivit - B - Ampullen | 1.2.40.0.34.4.17:8433 | GA - zugelassen | G.L. Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A11EA | Vitamin-B-Komplex, rein | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 2.3 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 2.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:125778002 | 1.2.40.0.34.5.156:1709251 | NICOTINAMID | 1.2.40.0.34.5.221:100000092193 | NICOTINAMIDE | active | 27.5 | mg | 1.2.40.0.34.5.221:100000092193 | NICOTINAMIDE | 27.5 | mg | 1.2.40.0.34.5.156:1708752 | THIAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | active | 6.2 | mg | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | 6.2 | mg | | | | | | | 1.2.40.0.34.5.156:1709167 | DEXPANTHENOL | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | active | 2 | mg | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | 2 | mg | 1.2.40.0.34.5.156:1708147 | NATRIUM RIBOFLAVINPHOSPHAT | 1.2.40.0.34.5.221:100000089026 | RIBOFLAVIN SODIUM PHOSPHATE | active | 1.2 | mg | 1.2.40.0.34.5.221:100000089026 | RIBOFLAVIN SODIUM PHOSPHATE | 1.2 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0662020 | MULTIVIT-B AMP FTE 2ML | Multivit - B - forte - Ampullen | 1.2.40.0.34.4.17:8301 | GA - zugelassen | G.L. Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A11EA | Vitamin-B-Komplex, rein | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 4.6 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 4.6 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:128963002 | 1.2.40.0.34.5.156:1709251 | NICOTINAMID | 1.2.40.0.34.5.221:100000092193 | NICOTINAMIDE | active | 110 | mg | 1.2.40.0.34.5.221:100000092193 | NICOTINAMIDE | 110 | mg | 1.2.40.0.34.5.156:1708752 | THIAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | active | 12.4 | mg | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | 12.4 | mg | | | | | | | 1.2.40.0.34.5.156:1709167 | DEXPANTHENOL | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | active | 6 | mg | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | 6 | mg | 1.2.40.0.34.5.156:1708147 | NATRIUM RIBOFLAVINPHOSPHAT | 1.2.40.0.34.5.221:100000089026 | RIBOFLAVIN SODIUM PHOSPHATE | active | 4.8 | mg | 1.2.40.0.34.5.221:100000089026 | RIBOFLAVIN SODIUM PHOSPHATE | 4.8 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0662103 | TRANDATE AMP 100MG 20ML | Trandate 100 mg - Ampullen | 1.2.40.0.34.4.17:17082 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C07AG01 | Labetalol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708382 | LABETALOL HYDROCHLORID | 1.2.40.0.34.5.221:100000089827 | LABETALOL HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000089827 | LABETALOL HYDROCHLORIDE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:920588001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0665751 | PROSTIN-E2 KONZ AMP 0,75MG | Prostin E2 0,75 mg/0,75 ml - Konzentrat zur Infusionsbereitung | 1.2.40.0.34.4.17:17093 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:G02AD02 | Dinoproston | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709260 | DINOPROSTON | 1.2.40.0.34.5.221:100000092220 | DINOPROSTONE | active | 0.75 | mg | 1.2.40.0.34.5.221:100000092220 | DINOPROSTONE | 0.75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:129318001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0665768 | PROSTIN-E2 KONZ AMP 5MG | Prostin E2 5 mg/0,5 ml - Konzentrat zur Infusionsbereitung | 1.2.40.0.34.4.17:17094 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:G02AD02 | Dinoproston | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709260 | DINOPROSTON | 1.2.40.0.34.5.221:100000092220 | DINOPROSTONE | active | 5 | mg | 1.2.40.0.34.5.221:100000092220 | DINOPROSTONE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:129319001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0665780 | SOLCOSERYL AMP 212,5MG/5ML | Solcoseryl 212,5 mg/ 5 ml - Ampulle | 1.2.40.0.34.4.17:10252 | GA - aufgehoben | MEDA Pharma GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B06AB | Andere Hämprodukte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1710184 | DEPROTEINISIERTES HAEMODERIVAT AUS KÄLBERBLUT | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | active | 212.5 | mg | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | 212.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:120179004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0669424 | ENDOXAN DRG 50MG | Endoxan "Baxter" 50 mg - Dragees | 1.2.40.0.34.4.17:10824 | GA - zugelassen | Baxter Healthcare GmbH | true | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:L01AA01 | Cyclophosphamid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708517 | CYCLOPHOSPHAMID | 1.2.40.0.34.5.221:100000090277 | CYCLOPHOSPHAMIDE | active | 53.5 | mg | 1.2.40.0.34.5.221:100000090277 | CYCLOPHOSPHAMIDE | 53.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:125770001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0678707 | CONVULEX SIR 50MG/ML KIND | Convulex 50 mg/ml - Sirup für Kinder | 1.2.40.0.34.4.17:17127 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N03AG01 | Valproinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708579 | VALPROINSÄURE | 1.2.40.0.34.5.221:100000090423 | VALPROIC ACID | active | 4.338 | g | 1.2.40.0.34.5.221:100000090423 | VALPROIC ACID | 4.338 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073652 | Sirup | true | human | 1.2.40.0.34.4.26:129978001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0678854 | EUSAPRIM SUS OR KIND | Eusaprim orale Suspension für Kinder | 1.2.40.0.34.4.17:14631 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01EE01 | Sulfamethoxazol und Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | 800 | mg | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | 800 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:122417001 | 1.2.40.0.34.5.156:1709475 | SULFAMETHOXAZOL | 1.2.40.0.34.5.221:100000092618 | SULFAMETHOXAZOLE | active | 4000 | mg | 1.2.40.0.34.5.221:100000092618 | SULFAMETHOXAZOLE | 4000 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0678908 | FRISIUM TBL 10MG | Frisium 10 mg Tabletten | 1.2.40.0.34.4.17:16842 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA09 | Clobazam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707038 | CLOBAZAM | 1.2.40.0.34.5.221:100000084299 | CLOBAZAM | active | 10 | mg | 1.2.40.0.34.5.221:100000084299 | CLOBAZAM | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:128108002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0678943 | LASILACTON KPS 20/ 50MG | Lasilacton 20 mg/50 mg Kapseln | 1.2.40.0.34.4.17:17055 | GA - zugelassen | Sanofi-Aventis GmbH | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03EB01 | Furosemid und Kalium sparende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:129998001 | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 50 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0678966 | LASILACTON KPS 20/ 50MG | Lasilacton 20 mg/50 mg Kapseln | 1.2.40.0.34.4.17:17055 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03EB01 | Furosemid und Kalium sparende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:129998002 | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 50 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0678972 | LASILACTON KPS 20/100MG | Lasilacton 20 mg/100 mg Kapseln | 1.2.40.0.34.4.17:17056 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03EB01 | Furosemid und Kalium sparende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:129999001 | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 100 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0679345 | TOLVON FTBL 30MG | Tolvon 30 mg - Filmtabletten | 1.2.40.0.34.4.17:17054 | GA - zugelassen | Organon Healthcare GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AX03 | Mianserin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708463 | MIANSERIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090114 | MIANSERIN HYDROCHLORIDE | active | 30 | mg | 1.2.40.0.34.5.221:100000090114 | MIANSERIN HYDROCHLORIDE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:920994002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0690677 | ANDROCUR DEP AMP 3ML | Androcur Depot 300 mg - Injektionslösung | 1.2.40.0.34.4.17:17157 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:G03HA01 | Cyproteron | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708539 | CYPROTERON ACETAT | 1.2.40.0.34.5.221:100000090321 | CYPROTERONE ACETATE | active | 300 | mg | 1.2.40.0.34.5.221:100000090321 | CYPROTERONE ACETATE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:127555001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0694008 | ANTIBIOPHILUS PLV | Antibiophilus - Pulver zum Einnehmen | 1.2.40.0.34.4.17:1-23449 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:A07FA01 | Milchsäurebildner | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710410 | LACTOBACILLUS CASEI | 1.2.40.0.34.5.221:900000000641 | LACTOBACILLUS CASEI | active | 225000000 | CFU | 1.2.40.0.34.5.221:900000000641 | LACTOBACILLUS CASEI | 225000000 | CFU | 1.2.40.0.10.1.4.3.4.3.5:100000073655 | Pulver zum Einnehmen | false | human | 1.2.40.0.34.4.26:929782002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0694066 | CEFOBID TRSTAMP 2G BP5X1 | Cefobid 2 g - Trockenstechampullen | 1.2.40.0.34.4.17:17173 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01DD12 | Cefoperazon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709479 | CEFOPERAZON NATRIUM | 1.2.40.0.34.5.221:100000092626 | CEFOPERAZONE SODIUM | active | 2.223 | g | 1.2.40.0.34.5.221:100000092626 | CEFOPERAZONE SODIUM | 2.223 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:921254002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0694161 | NICORETTE CLASSIC KAUGU 2MG | Nicorette Classic 2 mg - Kaugummi zur Raucherentwöhnung | 1.2.40.0.34.4.17:17167 | GA - zugelassen | Johnson & Johnson Ges.m.b.H. | true | true | 105 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N07BA01 | Nicotin | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | | | 1.2.40.0.34.5.156:1708144 | NICOTINRESINAT | 1.2.40.0.34.5.221:100000089016 | NICOTINE RESINATE | active | 10 | mg | 1.2.40.0.34.5.221:100000089016 | NICOTINE RESINATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073669 | wirkstoffhaltiges Kaugummi | false | human | 1.2.40.0.34.4.26:920761001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0694178 | NICORETTE CLASSIC KAUGU 4MG | Nicorette Classic 4 mg - Kaugummi zur Raucherentwöhnung | 1.2.40.0.34.4.17:17168 | GA - zugelassen | Johnson & Johnson Ges.m.b.H. | true | true | 105 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N07BA01 | Nicotin | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | | | 1.2.40.0.34.5.156:1708144 | NICOTINRESINAT | 1.2.40.0.34.5.221:100000089016 | NICOTINE RESINATE | active | 20 | mg | 1.2.40.0.34.5.221:100000089016 | NICOTINE RESINATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073669 | wirkstoffhaltiges Kaugummi | false | human | 1.2.40.0.34.4.26:920762001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0694267 | THOMAPYRIN TBL | Thomapyrin - Tabletten | 1.2.40.0.34.4.17:1-17100 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BE51 | Paracetamol, Kombinationen exkl. Psycholeptika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921096001 | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | 400 | mg | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | 400 | mg | 1.2.40.0.34.5.156:1708366 | COFFEIN | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | active | 100 | mg | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | 100 | mg | 2.16.840.1.113883.6.73:N02BA51 | Acetylsalicylsäure, Kombinationen exkl. Psycholeptika | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0705775 | BURONIL FTBL 50MG | Buronil 50 mg - Filmtabletten | 1.2.40.0.34.4.17:17209 | GA - zugelassen | Medilink A/S | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:N05AD03 | Melperon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709160 | MELPERON HYDROCHLORID | 1.2.40.0.34.5.221:100000092068 | MELPERONE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000092068 | MELPERONE HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:127340003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0705781 | BURONIL FTBL 50MG | Buronil 50 mg - Filmtabletten | 1.2.40.0.34.4.17:17209 | GA - zugelassen | Medilink A/S | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:N05AD03 | Melperon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709160 | MELPERON HYDROCHLORID | 1.2.40.0.34.5.221:100000092068 | MELPERONE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000092068 | MELPERONE HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:127340002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0705947 | FORTECORTIN AMP 40MG 5ML | Fortecortin 40 mg - Ampulle | 1.2.40.0.34.4.17:1-17215 | GA - zugelassen | Merck Ges.m.b.H. | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB02 | Dexamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708635 | DEXAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | active | 43.72 | mg | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | 43.72 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920157001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0705953 | FORTECORTIN AMP 100MG 10ML | Fortecortin 100 mg - Ampulle | 1.2.40.0.34.4.17:1-17216 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB02 | Dexamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708635 | DEXAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | active | 1093 | mg | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | 1093 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920158001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0706148 | MYCOSTATIN ZINKOXID PST | Mycostatin - Zinkoxid - Paste | 1.2.40.0.34.4.17:17154 | GA - zugelassen | Dermapharm GmbH | true | true | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D01AA01 | Nystatin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708243 | ZINKOXID | 1.2.40.0.34.5.221:100000089333 | ZINC OXIDE | active | 4000 | mg | 1.2.40.0.34.5.221:100000089333 | ZINC OXIDE | 4000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073727 | Paste zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:128969001 | 1.2.40.0.34.5.156:1708425 | NYSTATIN | 1.2.40.0.34.5.221:100000089986 | NYSTATIN | active | 2000000 | IU | 1.2.40.0.34.5.221:100000089986 | NYSTATIN | 2000000 | IU | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0706160 | PRONTOBARIO COLON | Prontobario Colon - Dickdarmkontrastmittel | 1.2.40.0.34.4.17:17198 | GA - zugelassen | Bracco Österreich GmbH | true | true | 397 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:V08BA01 | Bariumsulfat mit Suspensionsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1708374 | BARIUMSULFAT | 1.2.40.0.34.5.221:100000089788 | BARIUM SULFATE | active | 383.020836 | g | 1.2.40.0.34.5.221:100000089788 | BARIUM SULFATE | 383.020836 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073832 | Pulver zur Herstellung einer Rektalsuspension | true | human | 1.2.40.0.34.4.26:920605001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0706906 | GLANDOSANE SYNTH SPEICH.AER | Glandosane synthetischer Speichel - Aerosol | 1.2.40.0.34.4.17:16749 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | false | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073553 | Spraydose | 2.16.840.1.113883.6.73:A01AD11 | Verschiedene | 1.2.40.0.10.1.4.3.4.3.4:100000073621 | zur Anwendung im Mund- und Rachenraum | | | | | 1.2.40.0.34.5.156:1707753 | CARMELLOSE NATRIUM | 1.2.40.0.34.5.221:100000087080 | CARMELLOSE SODIUM | active | 0.5075 | g | 1.2.40.0.34.5.221:100000087080 | CARMELLOSE SODIUM | 0.5075 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073676 | Spray zur Anwendung in der Mundhöhle | true | human | 1.2.40.0.34.4.26:125014001 | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 0.0609 | g | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 0.0609 | g | 1.2.40.0.34.5.156:1709535 | CALCIUMCHLORID | 1.2.40.0.34.5.221:100000092755 | CALCIUM CHLORIDE | active | 0.0074 | g | 1.2.40.0.34.5.221:100000092755 | CALCIUM CHLORIDE | 0.0074 | g | | | | | | | 1.2.40.0.34.5.156:1707667 | KALIUMMONOHYDROGENPHOSPHAT | 1.2.40.0.34.5.221:100000086553 | DIPOTASSIUM PHOSPHATE | active | 0.0174 | g | 1.2.40.0.34.5.221:100000086553 | DIPOTASSIUM PHOSPHATE | 0.0174 | g | 1.2.40.0.34.5.156:1709182 | SORBITOL | 1.2.40.0.34.5.221:100000092096 | SORBITOL (E420) | active | 1.5225 | g | 1.2.40.0.34.5.221:100000092096 | SORBITOL (E420) | 1.5225 | g | 1.2.40.0.34.5.156:1708460 | MAGNESIUMCHLORID | 1.2.40.0.34.5.221:100000090109 | MAGNESIUM CHLORIDE | active | 0.0026 | g | 1.2.40.0.34.5.221:100000090109 | MAGNESIUM CHLORIDE | 0.0026 | g | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 0.0428 | g | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 0.0428 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0709342 | ACERBINE LSG PUSPRAY | Acerbine Lösung | 1.2.40.0.34.4.17:15124 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | false | 80 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D03AX | Andere Wundbehandlungsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 0.0328 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 0.0328 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:128065001 | 1.2.40.0.34.5.156:1708587 | BENZOESÄURE | 1.2.40.0.34.5.221:100000090433 | BENZOIC ACID | active | 0.1232 | g | 1.2.40.0.34.5.221:100000090433 | BENZOIC ACID | 0.1232 | g | 1.2.40.0.34.5.156:1709003 | ÄPFELSÄURE | 1.2.40.0.34.5.221:100000091777 | MALIC ACID | active | 1.722 | g | 1.2.40.0.34.5.221:100000091777 | MALIC ACID | 1.722 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0709514 | XYLOCAIN DFL 1% 50ML | Xylocain 1 % - Durchstechflasche | 1.2.40.0.34.4.17:16720 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:N01BB02 | Lidocain | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073572 | epidurale Anwendung | 1.2.40.0.34.5.156:1708657 | LIDOCAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | active | 500 | mg | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:124874001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0709520 | XYLOCAIN DFL 2% 50ML | Xylocain 2 % - Durchstechflasche | 1.2.40.0.34.4.17:16721 | GA - aufgehoben | Aspen Pharma Trading Limited | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:N01BB02 | Lidocain | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073572 | epidurale Anwendung | 1.2.40.0.34.5.156:1708657 | LIDOCAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | active | 1000 | mg | 1.2.40.0.34.5.221:100000090580 | LIDOCAINE HYDROCHLORIDE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:124875001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0713958 | CHLORHEXAMED FLUID 0,1% | Chlorhexamed Fluid 0,1 % | 1.2.40.0.34.4.17:16916 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 200 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A01AB03 | Chlorhexidin | 1.2.40.0.10.1.4.3.4.3.4:100000073567 | dentale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073578 | Anwendung am Zahnfleisch | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | 1.2.40.0.34.5.156:1708713 | CHLORHEXIDINDIGLUCONAT | 1.2.40.0.34.5.221:100000091036 | CHLORHEXIDINE GLUCONATE | active | 0.2 | g | 1.2.40.0.34.5.221:100000091036 | CHLORHEXIDINE GLUCONATE | 0.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073678 | Lösung zur Anwendung am Zahnfleisch | false | human | 1.2.40.0.34.4.26:126033001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073621 | zur Anwendung im Mund- und Rachenraum | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073691 | Lösung zur Anwendung in der Mundhöhle | 1.2.40.0.10.1.4.3.4.3.5:100000073673 | Gurgellösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0713987 | FOLSAN TBL 5MG | Folsan 5 mg - Tabletten | 1.2.40.0.34.4.17:17266 | GA - zugelassen | Teofarma S.r.l. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B03BB01 | Folsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707468 | FOLSÄURE | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | active | 5 | mg | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129647001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0715472 | TRAMAL KPS 50MG | Tramal 50 mg Kapseln | 1.2.40.0.34.4.17:17688 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:N02AX02 | Tramadol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709643 | TRAMADOLHYDROCHLORID | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:921064001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0715489 | TRAMAL TR | Tramal Tropfen | 1.2.40.0.34.4.17:17689 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N02AX01 | Tilidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709643 | TRAMADOLHYDROCHLORID | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | active | 1 | g | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | true | human | 1.2.40.0.34.4.26:921062003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0721461 | BETAISODONA LSG STAND. | Betaisodona Lösung standardisiert | 1.2.40.0.34.4.17:15973 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | true | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D08AG02 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073573 | zum Auftragen auf die Wunde | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | active | 1.5 | g | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | 1.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:122143009 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0721478 | BETAISODONA LSG STAND. | Betaisodona Lösung standardisiert | 1.2.40.0.34.4.17:15973 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D08AG02 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073573 | zum Auftragen auf die Wunde | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | active | 10 | g | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | 10 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:122143005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0721998 | ISOMONAT TBL 20MG | Isomonat 20 mg - Tabletten | 1.2.40.0.34.4.17:17206 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01DA14 | Isosorbidmononitrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708568 | ISOSORBIDMONONITRAT | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | active | 20 | mg | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921141001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0722006 | ISOMONAT TBL 20MG | Isomonat 20 mg - Tabletten | 1.2.40.0.34.4.17:17206 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01DA14 | Isosorbidmononitrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708568 | ISOSORBIDMONONITRAT | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | active | 20 | mg | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921141002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0722035 | JOPAMIRO 200MG J/ML AMP 10ML | Jopamiro 200 mg J/ml - Ampullen | 1.2.40.0.34.4.17:17300 | GA - aufgehoben | Bracco Österreich GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 4080 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 4080 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920602001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0722041 | JOPAMIRO 300MG J/ML AMP 10ML | Jopamiro 300 mg J/ml - Ampullen | 1.2.40.0.34.4.17:17301 | GA - aufgehoben | Bracco Österreich GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 6120 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 6120 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920603002 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0722064 | JOPAMIRO 300MG J/ML DFL 50ML | Jopamiro 300 mg J/ml - Stechampullen | 1.2.40.0.34.4.17:17302 | GA - zugelassen | Bracco Österreich GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 30600 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 30600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920664011 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0722087 | JOPAMIRO 370MG J/ML DFL 50ML | Jopamiro 370 mg J/ml - Stechampullen | 1.2.40.0.34.4.17:17304 | GA - zugelassen | Bracco Österreich GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 37750 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 37750 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920665008 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0722101 | MYCOSTATIN SLB | Mycostatin - Salbe | 1.2.40.0.34.4.17:10691 | GA - zugelassen | Dermapharm GmbH | true | true | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D01AA01 | Nystatin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708425 | NYSTATIN | 1.2.40.0.34.5.221:100000089986 | NYSTATIN | active | 2000000 | IU | 1.2.40.0.34.5.221:100000089986 | NYSTATIN | 2000000 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:129209001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0722130 | NEUROTOP TBL 200MG | Neurotop 200 mg - Tabletten | 1.2.40.0.34.4.17:1-17282 | GA - zugelassen | G.L. Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AF01 | Carbamazepin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709201 | CARBAMAZEPIN | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | active | 200 | mg | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:127616002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0722147 | NEUROTOP TBL 200MG | Neurotop 200 mg - Tabletten | 1.2.40.0.34.4.17:1-17282 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AF01 | Carbamazepin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709201 | CARBAMAZEPIN | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | active | 200 | mg | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:127616001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0722153 | NOCTAMID TBL | Noctamid - Tabletten | 1.2.40.0.34.4.17:17186 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05CD06 | Lormetazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709107 | LORMETAZEPAM | 1.2.40.0.34.5.221:100000091985 | LORMETAZEPAM | active | 1 | mg | 1.2.40.0.34.5.221:100000091985 | LORMETAZEPAM | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:920271001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0722242 | PROXEN FTBL 500MG | Proxen 500 mg - Filmtabletten | 1.2.40.0.34.4.17:17231 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE02 | Naproxen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708562 | NAPROXEN | 1.2.40.0.34.5.221:100000090383 | NAPROXEN | active | 500 | mg | 1.2.40.0.34.5.221:100000090383 | NAPROXEN | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:921076003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0722325 | TOLVON FTBL 30MG | Tolvon 30 mg - Filmtabletten | 1.2.40.0.34.4.17:17054 | GA - zugelassen | Organon Healthcare GmbH | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AX03 | Mianserin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708463 | MIANSERIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090114 | MIANSERIN HYDROCHLORIDE | active | 30 | mg | 1.2.40.0.34.5.221:100000090114 | MIANSERIN HYDROCHLORIDE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:920994001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0722377 | VOLON-A CR | Volon A - Creme antibiotikafrei | 1.2.40.0.34.4.17:17192 | GA - zugelassen | Dermapharm GmbH | true | true | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AB09 | Triamcinolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708563 | TRIAMCINOLON ACETONID | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:125794001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0722414 | VOLON-A SLB | Volon A - Salbe antibiotikafrei | 1.2.40.0.34.4.17:17193 | GA - zugelassen | Dermapharm GmbH | true | true | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AB09 | Triamcinolon | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708563 | TRIAMCINOLON ACETONID | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000090386 | TRIAMCINOLONE ACETONIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:126414002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0724181 | ISOZID H FARBLOS BP10X500ML | Isozid - H farblos - alkoholische Lösung zur Hautdesinfektion | 1.2.40.0.34.4.17:1-20414 | GA - zugelassen | Gebro Pharma GmbH | true | true | 5000 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D08AX53 | Propanol, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1706076 | 1-PROPANOL | 1.2.40.0.34.5.221:100000078877 | PROPANOL | active | 140.75 | g | 1.2.40.0.34.5.221:100000078877 | PROPANOL | 140.75 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:931805004 | 1.2.40.0.34.5.156:1709419 | HEXETIDIN | 1.2.40.0.34.5.221:100000092531 | HEXETIDINE | active | 0.5 | g | 1.2.40.0.34.5.221:100000092531 | HEXETIDINE | 0.5 | g | 1.2.40.0.34.5.156:1705751 | 2-PROPANOL | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | active | 157 | g | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | 157 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0724778 | FLAMMAZINE CR | Flammazine - Creme | 1.2.40.0.34.4.17:17189 | GA - zugelassen | Alliance Pharma (Ireland) Limited | true | true | 500 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073523 | Weithalsgefäss | 2.16.840.1.113883.6.73:D06BA01 | Sulfadiazin-Silber | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708127 | SULFADIAZIN SILBER | 1.2.40.0.34.5.221:100000088916 | SULFADIAZINE SILVER | active | 5 | g | 1.2.40.0.34.5.221:100000088916 | SULFADIAZINE SILVER | 5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:121486002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0725200 | SOLUVIT TRSUB INF TRSTAMP | Soluvit - Trockensubstanz zur Infusionsbereitung | 1.2.40.0.34.4.17:1-19573 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B05XC | Vitamine | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | 0.005 | mg | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | 0.005 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:128165001 | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 4.9 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 4.9 | mg | 1.2.40.0.34.5.156:1707468 | FOLSÄURE | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | active | 0.4 | mg | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | 0.4 | mg | | | | | | | 1.2.40.0.34.5.156:1709557 | BIOTIN | 1.2.40.0.34.5.221:100000092789 | BIOTIN | active | 0.06 | mg | 1.2.40.0.34.5.221:100000092789 | BIOTIN | 0.06 | mg | 1.2.40.0.34.5.156:1709251 | NICOTINAMID | 1.2.40.0.34.5.221:100000092193 | NICOTINAMIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000092193 | NICOTINAMIDE | 40 | mg | 1.2.40.0.34.5.156:1707439 | NATRIUM PANTOTHENAT | 1.2.40.0.34.5.221:100000085517 | PANTOTHENATE SODIUM | active | 16.5 | mg | 1.2.40.0.34.5.221:100000085517 | PANTOTHENATE SODIUM | 16.5 | mg | | | | | 1.2.40.0.34.5.156:1709249 | THIAMIN NITRAT | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | active | 3.1 | mg | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | 3.1 | mg | 1.2.40.0.34.5.156:1708147 | NATRIUM RIBOFLAVINPHOSPHAT | 1.2.40.0.34.5.221:100000089026 | RIBOFLAVIN SODIUM PHOSPHATE | active | 4.9 | mg | 1.2.40.0.34.5.221:100000089026 | RIBOFLAVIN SODIUM PHOSPHATE | 4.9 | mg | | | | | 1.2.40.0.34.5.156:1708858 | NATRIUM ASCORBAT | 1.2.40.0.34.5.221:100000091447 | SODIUM ASCORBATE | active | 1.2.40.0.34.5.221:100000091447 | SODIUM ASCORBATE | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 113 | mg | 113 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0726398 | ADALAT RET FTBL 20MG | Adalat retard 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-17404 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C08CA05 | Nifedipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708560 | NIFEDIPIN | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | active | 20 | mg | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:921693001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0726406 | ADALAT RET FTBL 20MG | Adalat retard 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-17404 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C08CA05 | Nifedipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708560 | NIFEDIPIN | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | active | 20 | mg | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:921693002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0726429 | ANTEPAN AMP 200MCG 1ML | Antepan 200 µg - Ampullen | 1.2.40.0.34.4.17:17290 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:V04CJ02 | Protirelin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709250 | PROTIRELIN | 1.2.40.0.34.5.221:100000092191 | PROTIRELIN | active | 0.2 | mg | 1.2.40.0.34.5.221:100000092191 | PROTIRELIN | 0.2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:126645003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0726530 | EBRANTIL AMP 25MG 5ML | Ebrantil 25 mg - Ampullen | 1.2.40.0.34.4.17:17382 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C02CA06 | Urapidil | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707461 | URAPIDIL HYDROCHLORID | 1.2.40.0.34.5.221:100000085608 | URAPIDIL HYDROCHLORIDE | active | 27.35 | mg | 1.2.40.0.34.5.221:100000085608 | URAPIDIL HYDROCHLORIDE | 27.35 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921210002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0726553 | EBRANTIL AMP 50MG 10ML | Ebrantil 50 mg - Ampullen | 1.2.40.0.34.4.17:17380 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C02CA06 | Urapidil | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707461 | URAPIDIL HYDROCHLORID | 1.2.40.0.34.5.221:100000085608 | URAPIDIL HYDROCHLORIDE | active | 54.7 | mg | 1.2.40.0.34.5.221:100000085608 | URAPIDIL HYDROCHLORIDE | 54.7 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921209002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0726582 | EBRANTIL RET KPS 30MG | Ebrantil retard 30 mg - Kapseln | 1.2.40.0.34.4.17:1-17381 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:C02CA06 | Urapidil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705541 | URAPIDIL | 1.2.40.0.34.5.221:100000076662 | URAPIDIL | active | 30 | mg | 1.2.40.0.34.5.221:100000076662 | URAPIDIL | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:921543001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0727529 | MADOPAR TBL 200/50MG | Madopar 200 mg/50 mg - Tabletten | 1.2.40.0.34.4.17:17235 | GA - zugelassen | Roche Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N04BA02 | Levodopa und Decarboxylasehemmer | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708901 | BENSERAZID HYDROCHLORID | 1.2.40.0.34.5.221:100000091558 | BENSERAZIDE HYDROCHLORIDE | active | 57 | mg | 1.2.40.0.34.5.221:100000091558 | BENSERAZIDE HYDROCHLORIDE | 57 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921349002 | 1.2.40.0.34.5.156:1707406 | LEVODOPA | 1.2.40.0.34.5.221:100000085446 | LEVODOPA | active | 200 | mg | 1.2.40.0.34.5.221:100000085446 | LEVODOPA | 200 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0727535 | MADOPAR TBL 200/50MG | Madopar 200 mg/50 mg - Tabletten | 1.2.40.0.34.4.17:17235 | GA - zugelassen | Roche Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N04BA02 | Levodopa und Decarboxylasehemmer | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708901 | BENSERAZID HYDROCHLORID | 1.2.40.0.34.5.221:100000091558 | BENSERAZIDE HYDROCHLORIDE | active | 57 | mg | 1.2.40.0.34.5.221:100000091558 | BENSERAZIDE HYDROCHLORIDE | 57 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921349001 | 1.2.40.0.34.5.156:1707406 | LEVODOPA | 1.2.40.0.34.5.221:100000085446 | LEVODOPA | active | 200 | mg | 1.2.40.0.34.5.221:100000085446 | LEVODOPA | 200 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0727558 | EBETREXAT KONZ 100MG/ML 10ML | Ebetrexat 100 mg/ml - Konzentrat zur Infusionsbereitung | 1.2.40.0.34.4.17:1-20290 | GA - zugelassen | Ebewe Pharma Ges.m.b.H. Nfg.KG | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01BA01 | Methotrexat | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | 1.2.40.0.34.5.156:1708507 | METHOTREXAT | 1.2.40.0.34.5.221:100000090250 | METHOTREXATE | active | 1000 | mg | 1.2.40.0.34.5.221:100000090250 | METHOTREXATE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:931206001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0727593 | MOTILIUM FTBL 10MG | Motilium 10 mg - Filmtabletten | 1.2.40.0.34.4.17:17412 | GA - zugelassen | Johnson & Johnson Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A03FA03 | Domperidon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709278 | DOMPERIDON | 1.2.40.0.34.5.221:100000092257 | DOMPERIDONE | active | 10 | mg | 1.2.40.0.34.5.221:100000092257 | DOMPERIDONE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:129144001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0727601 | MOTILIUM FTBL 10MG | Motilium 10 mg - Filmtabletten | 1.2.40.0.34.4.17:17412 | GA - zugelassen | Johnson & Johnson Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A03FA03 | Domperidon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709278 | DOMPERIDON | 1.2.40.0.34.5.221:100000092257 | DOMPERIDONE | active | 10 | mg | 1.2.40.0.34.5.221:100000092257 | DOMPERIDONE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:129144002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0727653 | MUCOSOLVAN LSG | Mucosolvan Schleimlöser 7,5 mg/1 ml Lösung | 1.2.40.0.34.4.17:1-17346 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CB06 | Ambroxol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 0.75 | g | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 0.75 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:921269001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073835 | Lösung für einen Vernebler | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0727676 | MUCOSOLVAN SFT 15MG/5ML | Mucosolvan Kinder 15 mg / 5 ml Saft | 1.2.40.0.34.4.17:1-17347 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CB06 | Ambroxol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 0.3 | g | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:921272001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0727802 | RHEUMESSER AMP 3ML | Rheumesser 3 ml - Ampullen | 1.2.40.0.34.4.17:17397 | GA - zugelassen | G.L. Pharma GmbH | true | true | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M01BA | Antiphlogistika/Antirheumatika in Kombination mit Corticosteroiden | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1709464 | DEXAMETHASON | 1.2.40.0.34.5.221:100000092605 | DEXAMETHASONE | active | 3.5 | mg | 1.2.40.0.34.5.221:100000092605 | DEXAMETHASONE | 3.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:925876002 | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | 2.5 | mg | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | 2.5 | mg | 1.2.40.0.34.5.156:1708976 | LIDOCAIN | 1.2.40.0.34.5.221:100000091713 | LIDOCAINE | active | 5 | mg | 1.2.40.0.34.5.221:100000091713 | LIDOCAINE | 5 | mg | | | | | | | 1.2.40.0.34.5.156:1707971 | 2-(2-CARBAMOYLPHENOXY)ESSIGSÄURE | 1.2.40.0.34.5.221:100000088109 | SALAMIDACETIC ACID | active | 150 | mg | 1.2.40.0.34.5.221:100000088109 | SALAMIDACETIC ACID | 150 | mg | 1.2.40.0.34.5.156:1706821 | KEBUZON | 1.2.40.0.34.5.221:100000082866 | KEBUZONE | active | 450 | mg | 1.2.40.0.34.5.221:100000082866 | KEBUZONE | 450 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0729451 | CHINA-OEL TR | China-Oel Tropfen | 1.2.40.0.34.4.17:735159 | GA - registriert | Dermapharm GmbH | true | true | 25 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M02AX | Andere topische Mittel gegen Gelenk- und Muskelschmerzen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | 1.2.40.0.34.5.156:1709272 | MENTHAE PIPERITAE AETHEROLEUM | 1.2.40.0.34.5.221:100000092241 | PEPPERMINT OIL | active | 25 | g | 1.2.40.0.34.5.221:100000092241 | PEPPERMINT OIL | 25 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073854 | Flüssigkeit zur Herstellung eines Dampfs zur Inhalation | true | human | 1.2.40.0.34.4.26:956360002 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:R05X | Andere Kombinationspräparate gegen Erkältungskrankheiten | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073717 | Flüssigkeit zur Anwendung auf der Haut | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0735724 | SANDIMMUN IKONZ AMP 50MG/1ML | Sandimmun 50 mg/ml - Konzentrat zur Infusionsbereitung | 1.2.40.0.34.4.17:17896 | GA - zugelassen | Novartis Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:L04AD01 | Ciclosporin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709199 | CICLOSPORIN | 1.2.40.0.34.5.221:100000092121 | CICLOSPORIN | active | 50 | mg | 1.2.40.0.34.5.221:100000092121 | CICLOSPORIN | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:924058001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0738071 | SOLCOSERYL AU-GEL | Solcoseryl-Augen-Gel | 1.2.40.0.34.4.17:17428 | GA - aufgehoben | MEDA Pharma GmbH | false | false | 5 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:S01XA | Andere Ophthalmika | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1710184 | DEPROTEINISIERTES HAEMODERIVAT AUS KÄLBERBLUT | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | active | 4.15 | g | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | 4.15 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073758 | Augengel | true | human | 1.2.40.0.34.4.26:922065001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0738088 | SOLU-VOLON A AMP 40MG | Solu - Volon A 40 mg - Ampulle | 1.2.40.0.34.4.17:17429 | GA - zugelassen | Dermapharm GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB08 | Triamcinolon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707098 | TRIAMCINOLON ACETONID DIKALIUMPHOSPHAT | 1.2.40.0.34.5.221:100000084660 | TRIAMCINOLONE ACETONIDE DIPOTASSIUM PHOSPHATE | active | 54.4 | mg | 1.2.40.0.34.5.221:100000084660 | TRIAMCINOLONE ACETONIDE DIPOTASSIUM PHOSPHATE | 54.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:129353001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0742345 | CALCIUM FOLINAT EBE KPS 15MG | Calciumfolinat Ebewe 15 mg - Kapseln | 1.2.40.0.34.4.17:17442 | GA - zugelassen | Ebewe Pharma Ges.m.b.H. Nfg.KG | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:V03AF03 | Calciumfolinat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708520 | CALCIUM FOLINAT | 1.2.40.0.34.5.221:100000090280 | CALCIUM FOLINATE | active | 19.06 | mg | 1.2.40.0.34.5.221:100000090280 | CALCIUM FOLINATE | 19.06 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:921503002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0742428 | FAKTOR VII TAK PLV+LSM 600IE | Faktor VII "Takeda" 600 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | 1.2.40.0.34.4.17:2-00299 | GA - zugelassen | Takeda Manufacturing Austria AG | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B02BD05 | Gerinnungsfaktor VII | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708168 | GERINNUNGSFAKTOR VII | 1.2.40.0.34.5.221:100000089092 | HUMAN COAGULATION FACTOR VII | active | 600 | IU | 1.2.40.0.34.5.221:100000089092 | HUMAN COAGULATION FACTOR VII | 600 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073868 | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:929473001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073545 | Druckbehältnis | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0742658 | PROTHROMPLEX TOTAL DFL 600IE | Prothromplex TOTAL 600 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | 1.2.40.0.34.4.17:2-00312 | GA - zugelassen | Takeda Manufacturing Austria AG | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B02BD01 | Gerinnungsfaktoren IX, II, VII und X in Kombination | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708168 | GERINNUNGSFAKTOR VII | 1.2.40.0.34.5.221:100000089092 | HUMAN COAGULATION FACTOR VII | active | 500 | IU | 1.2.40.0.34.5.221:100000089092 | HUMAN COAGULATION FACTOR VII | 500 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073868 | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:929647001 | 1.2.40.0.34.5.156:1708166 | GERINNUNGSFAKTOR IX | 1.2.40.0.34.5.221:100000089087 | HUMAN COAGULATION FACTOR IX | active | 600 | IU | 1.2.40.0.34.5.221:100000089087 | HUMAN COAGULATION FACTOR IX | 600 | IU | 1.2.40.0.34.5.156:1708176 | GERINNUNGSFAKTOR X | 1.2.40.0.34.5.221:100000089113 | FACTOR X | active | 600 | IU | 1.2.40.0.34.5.221:100000089113 | FACTOR X | 600 | IU | | | | | | | 1.2.40.0.34.5.156:1709118 | PROTEIN C | 1.2.40.0.34.5.221:100000092007 | PROTEIN C | active | 400 | IU | 1.2.40.0.34.5.221:100000092007 | PROTEIN C | 400 | IU | 1.2.40.0.34.5.156:1708173 | GERINNUNGSFAKTOR II | 1.2.40.0.34.5.221:100000089109 | HUMAN COAGULATION FACTOR II | active | 450 | IU | 1.2.40.0.34.5.221:100000089109 | HUMAN COAGULATION FACTOR II | 450 | IU | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0743190 | ISOZID H FARBLOS | Isozid - H farblos - alkoholische Lösung zur Hautdesinfektion | 1.2.40.0.34.4.17:1-20414 | GA - zugelassen | Gebro Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D08AX53 | Propanol, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1706076 | 1-PROPANOL | 1.2.40.0.34.5.221:100000078877 | PROPANOL | active | 28.15 | g | 1.2.40.0.34.5.221:100000078877 | PROPANOL | 28.15 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:931805001 | 1.2.40.0.34.5.156:1709419 | HEXETIDIN | 1.2.40.0.34.5.221:100000092531 | HEXETIDINE | active | 0.1 | g | 1.2.40.0.34.5.221:100000092531 | HEXETIDINE | 0.1 | g | 1.2.40.0.34.5.156:1705751 | 2-PROPANOL | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | active | 31.4 | g | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | 31.4 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0743209 | ISOZID H FARBLOS | Isozid - H farblos - alkoholische Lösung zur Hautdesinfektion | 1.2.40.0.34.4.17:1-20414 | GA - zugelassen | Gebro Pharma GmbH | true | true | 500 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D08AX53 | Propanol, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1706076 | 1-PROPANOL | 1.2.40.0.34.5.221:100000078877 | PROPANOL | active | 140.75 | g | 1.2.40.0.34.5.221:100000078877 | PROPANOL | 140.75 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:931805003 | 1.2.40.0.34.5.156:1709419 | HEXETIDIN | 1.2.40.0.34.5.221:100000092531 | HEXETIDINE | active | 0.5 | g | 1.2.40.0.34.5.221:100000092531 | HEXETIDINE | 0.5 | g | 1.2.40.0.34.5.156:1705751 | 2-PROPANOL | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | active | 157 | g | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | 157 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0750787 | SEDACORON TBL 200MG | Sedacoron 200 mg - Tabletten | 1.2.40.0.34.4.17:1-18028 | GA - zugelassen | Ebewe Pharma Ges.m.b.H. Nfg.KG | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01BD01 | Amiodaron | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709586 | AMIODARON HYDROCHLORID | 1.2.40.0.34.5.221:100000092847 | AMIODARONE HYDROCHLORIDE | active | 200 | mg | 1.2.40.0.34.5.221:100000092847 | AMIODARONE HYDROCHLORIDE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922978001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0751700 | BERODUALIN INHAL LSG | Berodualin - Inhalationslösung | 1.2.40.0.34.4.17:17452 | GA - zugelassen | Boehringer Ingelheim RCV GmbH & Co KG | true | true | 20 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R03AL01 | Fenoterol und Ipratropium bromid | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1708016 | FENOTEROL HYDROBROMID | 1.2.40.0.34.5.221:100000088371 | FENOTEROL HYDROBROMIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000088371 | FENOTEROL HYDROBROMIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073911 | Verneblungslösung | true | human | 1.2.40.0.34.4.26:921999001 | 1.2.40.0.34.5.156:1709469 | IPRATROPIUM BROMID | 1.2.40.0.34.5.221:100000092610 | IPRATROPIUM BROMIDE | active | 5.22 | mg | 1.2.40.0.34.5.221:100000092610 | IPRATROPIUM BROMIDE | 5.22 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0751723 | COLOFAC DRG 135MG | Colofac 135 mg - Dragees | 1.2.40.0.34.4.17:17445 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A03AA04 | Mebeverin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707595 | MEBEVERIN HYDROCHLORID | 1.2.40.0.34.5.221:100000086181 | MEBEVERINE HYDROCHLORIDE | active | 135 | mg | 1.2.40.0.34.5.221:100000086181 | MEBEVERINE HYDROCHLORIDE | 135 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:920432001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0751858 | DOEDERLEIN-MED VAG-KPS | Döderlein Med - Vaginalkapseln | 1.2.40.0.34.4.17:1-23623 | GA - zugelassen | Heilpflanzenwohl GmbH | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:G01AX | Andere Antiinfektiva und Antiseptika | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1710411 | LACTOBACILLUS GASSERI | 1.2.40.0.34.5.221:900000000642 | LACTOBACILLUS GASSERI | active | 20 | mg | 1.2.40.0.34.5.221:900000000642 | LACTOBACILLUS GASSERI | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073823 | Hartkapsel zur vaginalen Anwendung | false | human | 1.2.40.0.34.4.26:929633001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0752817 | JOPAMIRO 300MG J/ML DFL 50ML | Jopamiro 300 mg J/ml - Stechampullen | 1.2.40.0.34.4.17:17302 | GA - zugelassen | Bracco Österreich GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 30600 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 30600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920664005 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0752823 | LASIX RET KPS 30MG | Lasix retard 30 mg Kapseln | 1.2.40.0.34.4.17:17113 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03CA01 | Furosemid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 30 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:129624001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0752970 | PYRAFAT TBL 500MG | Pyrafat - Tabletten | 1.2.40.0.34.4.17:17448 | GA - zugelassen | Esteve Pharmaceuticals GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J04AK01 | Pyrazinamid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706476 | PYRAZINAMID | 1.2.40.0.34.5.221:100000080846 | PYRAZINAMIDE | active | 500 | mg | 1.2.40.0.34.5.221:100000080846 | PYRAZINAMIDE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921573003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0752993 | RHEUTROP KPS | Rheutrop - Kapseln | 1.2.40.0.34.4.17:1-17447 | GA - zugelassen | Viatris Austria GmbH | true | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB11 | Acemetacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707925 | ACEMETACIN | 1.2.40.0.34.5.221:100000087912 | ACEMETACIN | active | 60 | mg | 1.2.40.0.34.5.221:100000087912 | ACEMETACIN | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:922117002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0753001 | RHEUTROP KPS | Rheutrop - Kapseln | 1.2.40.0.34.4.17:1-17447 | GA - zugelassen | Viatris Austria GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB11 | Acemetacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707925 | ACEMETACIN | 1.2.40.0.34.5.221:100000087912 | ACEMETACIN | active | 60 | mg | 1.2.40.0.34.5.221:100000087912 | ACEMETACIN | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:922117003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0753171 | VIBRAMYCIN TBL LSB 100MG | Vibramycin 100 mg - lösbare Tabletten | 1.2.40.0.34.4.17:1-17395 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01AA02 | Doxycyclin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709256 | DOXYCYCLIN | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | active | 106.04 | mg | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | 106.04 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073654 | Tablette zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:920796002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0753188 | VIBRAMYCIN TBL LSB 100MG | Vibramycin 100 mg - lösbare Tabletten | 1.2.40.0.34.4.17:1-17395 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01AA02 | Doxycyclin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709256 | DOXYCYCLIN | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | active | 106.04 | mg | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | 106.04 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073654 | Tablette zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:920796001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0753521 | ISOZID H FARBLOS | Isozid - H farblos - alkoholische Lösung zur Hautdesinfektion | 1.2.40.0.34.4.17:1-20414 | GA - zugelassen | Gebro Pharma GmbH | true | false | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D08AX53 | Propanol, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1706076 | 1-PROPANOL | 1.2.40.0.34.5.221:100000078877 | PROPANOL | active | 4.2225 | g | 1.2.40.0.34.5.221:100000078877 | PROPANOL | 4.2225 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:931805002 | 1.2.40.0.34.5.156:1709419 | HEXETIDIN | 1.2.40.0.34.5.221:100000092531 | HEXETIDINE | active | 0.015 | g | 1.2.40.0.34.5.221:100000092531 | HEXETIDINE | 0.015 | g | 1.2.40.0.34.5.156:1705751 | 2-PROPANOL | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | active | 4.71 | g | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | 4.71 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0754153 | FEIBA 25E./ML PLV +LSM 500E | Feiba 25 E./ml Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | 1.2.40.0.34.4.17:2-00294 | GA - zugelassen | Takeda Manufacturing Austria AG | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B02BD03 | Faktor-VIII-Inhibitor bypass Aktivität | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708257 | FAKTOR VIII-INHIBITOR-BYPASSING-AKTIVITÄT | 1.2.40.0.34.5.221:100000089386 | FACTOR VIII INHIBITOR BYPASSING FRACTION | active | 500 | U | 1.2.40.0.34.5.221:100000089386 | FACTOR VIII INHIBITOR BYPASSING FRACTION | 500 | U | 1.2.40.0.10.1.4.3.4.3.5:100000073860 | Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:928548001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0754176 | FEIBA 50E/ML PLV+LSM 1000E | Feiba 50 E./ml Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | 1.2.40.0.34.4.17:2-00295 | GA - zugelassen | Takeda Manufacturing Austria AG | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B02BD03 | Faktor-VIII-Inhibitor bypass Aktivität | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708257 | FAKTOR VIII-INHIBITOR-BYPASSING-AKTIVITÄT | 1.2.40.0.34.5.221:100000089386 | FACTOR VIII INHIBITOR BYPASSING FRACTION | active | 1000 | U | 1.2.40.0.34.5.221:100000089386 | FACTOR VIII INHIBITOR BYPASSING FRACTION | 1000 | U | 1.2.40.0.10.1.4.3.4.3.5:100000073860 | Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:928547003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0760283 | ALDACTONE INJ AMP 200MG/10ML | Aldactone 200 mg/ 10 ml Injektionslösung | 1.2.40.0.34.4.17:16120 | GA - zugelassen | Esteve Pharmaceuticals GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C03DA02 | Kaliumcanrenoat | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1706610 | CANRENOINSÄURE | 1.2.40.0.34.5.221:100000081603 | CANRENOIC ACID | active | 180.6 | mg | 1.2.40.0.34.5.221:100000081603 | CANRENOIC ACID | 180.6 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:125219001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0760780 | HALDOL DECAN.AMP 50MG/ML 1ML | Haldol Decanoat 50 mg/ml Injektionslösung | 1.2.40.0.34.4.17:17459 | GA - zugelassen | Essential Pharma Limited | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05AD01 | Haloperidol | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1707517 | HALOPERIDOL DECANOAT | 1.2.40.0.34.5.221:100000085826 | HALOPERIDOL DECANOATE | active | 70.52 | mg | 1.2.40.0.34.5.221:100000085826 | HALOPERIDOL DECANOATE | 70.52 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920954002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0760805 | HALDOL DECAN.AMP 50MG/ML 3ML | Haldol Decanoat 50 mg/ml Injektionslösung | 1.2.40.0.34.4.17:17459 | GA - zugelassen | Essential Pharma Limited | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05AD01 | Haloperidol | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1707517 | HALOPERIDOL DECANOAT | 1.2.40.0.34.5.221:100000085826 | HALOPERIDOL DECANOATE | active | 211.56 | mg | 1.2.40.0.34.5.221:100000085826 | HALOPERIDOL DECANOATE | 211.56 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920954003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0760900 | JOPAMIRO 300MG J/ML DFL100ML | Jopamiro 300 mg J/ml - Stechampullen | 1.2.40.0.34.4.17:17302 | GA - zugelassen | Bracco Österreich GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 61200 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 61200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920664008 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0760917 | JOPAMIRO 370MG J/ML AMP 20ML | Jopamiro 370 mg J/ml - Ampullen | 1.2.40.0.34.4.17:17303 | GA - aufgehoben | Bracco Österreich GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 15100 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 15100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920604002 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0760923 | JOPAMIRO 370MG J/ML DFL100ML | Jopamiro 370 mg J/ml - Stechampullen | 1.2.40.0.34.4.17:17304 | GA - zugelassen | Bracco Österreich GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 75500 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 75500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920665006 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0766067 | SPERTI PREPARATION H SUPP | Sperti Preparation H Hämorrhoidalzäpfchen | 1.2.40.0.34.4.17:12945 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:C05AX03 | Andere Hämorrhoidenmittel, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1710245 | HEFE (AUSZUG) | 1.2.40.0.34.5.221:900000000476 | FAEX MEDICINALIS (EXTRACT) | active | 0.023 | g | 1.2.40.0.34.5.221:900000000476 | FAEX MEDICINALIS (EXTRACT) | 0.023 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | false | human | 1.2.40.0.34.4.26:122902001 | 1.2.40.0.34.5.156:1705973 | FISCHLEBERÖL | 1.2.40.0.34.5.221:100000078497 | FISH LIVER OIL | active | 0.069 | g | 1.2.40.0.34.5.221:100000078497 | FISH LIVER OIL | 0.069 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0769031 | WOBENZYM DRG | Wobenzym magensaftresistente Tabletten | 1.2.40.0.34.4.17:17712 | GA - zugelassen | MUCOS Pharma GmbH & Co. KG | true | false | 200 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:M09AB52 | Trypsin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707180 | CHYMOTRYPSIN | 1.2.40.0.34.5.221:100000084879 | CHYMOTRYPSIN | active | | | 1.2.40.0.34.5.221:100000084879 | CHYMOTRYPSIN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073667 | magensaftresistente Tablette | true | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1707997 | BROMELAIN | 1.2.40.0.34.5.221:100000088272 | BROMELAIN | active | | | 1.2.40.0.34.5.221:100000088272 | BROMELAIN | | | 1.2.40.0.34.5.156:1706048 | TRYPSIN | 1.2.40.0.34.5.221:100000078784 | TRYPSIN | active | | | 1.2.40.0.34.5.221:100000078784 | TRYPSIN | | | | | | | | | 1.2.40.0.34.5.156:1706275 | PANKREAS(EXTRAKT) | 1.2.40.0.34.5.221:100000079736 | PANKREAS(EXTRAKT) | active | | | 1.2.40.0.34.5.221:100000079736 | PANKREAS(EXTRAKT) | | | 1.2.40.0.34.5.156:1706278 | PAPAYOTIN | 1.2.40.0.34.5.221:100000079740 | PAPAYOTIN | active | | | 1.2.40.0.34.5.221:100000079740 | PAPAYOTIN | | | 1.2.40.0.34.5.156:11181545 | RUTOSID TRIHYDRAT | 1.2.40.0.34.5.221:100000115324 | RUTOSID TRIHYDRAT | active | | | 1.2.40.0.34.5.221:100000115324 | RUTOSID TRIHYDRAT | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0769410 | FORANE INHAL NARKOTIK | Forane - Inhalationsnarkotikum | 1.2.40.0.34.4.17:17651 | GA - aufgehoben | Abbvie GmbH | false | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N01AB06 | Isofluran | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1708948 | ISOFLURAN | 1.2.40.0.34.5.221:100000091651 | ISOFLURANE | active | 100 | ml | 1.2.40.0.34.5.221:100000091651 | ISOFLURANE | 100 | ml | 1.2.40.0.10.1.4.3.4.3.5:100000073854 | Flüssigkeit zur Herstellung eines Dampfs zur Inhalation | true | human | 1.2.40.0.34.4.26:921920001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0773179 | BEZALIP RET FTBL 400MG | Bezalip retard 400 mg - Filmtabletten | 1.2.40.0.34.4.17:17805 | GA - zugelassen | Actavis Group PTC ehf. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C10AB02 | Bezafibrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707528 | BEZAFIBRAT | 1.2.40.0.34.5.221:100000085894 | BEZAFIBRATE | active | 400 | mg | 1.2.40.0.34.5.221:100000085894 | BEZAFIBRATE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:922654001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0773311 | CISORDINOL FTBL 2MG | Cisordinol 2 mg - Filmtabletten | 1.2.40.0.34.4.17:17532 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N05AF05 | Zuclopenthixol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710904 | ZUCLOPENTHIXOL DIHYDROCHLORID | 1.2.40.0.34.5.221:100000085645 | ZUCLOPENTHIXOL DIHYDROCHLORIDE | active | 2.36 | mg | 1.2.40.0.34.5.221:100000085645 | ZUCLOPENTHIXOL DIHYDROCHLORIDE | 2.36 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922797002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0773334 | CISORDINOL FTBL 10MG | Cisordinol 10 mg - Filmtabletten | 1.2.40.0.34.4.17:17533 | GA - zugelassen | Lundbeck Austria GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N05AF05 | Zuclopenthixol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710904 | ZUCLOPENTHIXOL DIHYDROCHLORID | 1.2.40.0.34.5.221:100000085645 | ZUCLOPENTHIXOL DIHYDROCHLORIDE | active | 11.8 | mg | 1.2.40.0.34.5.221:100000085645 | ZUCLOPENTHIXOL DIHYDROCHLORIDE | 11.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922814002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0773340 | CISORDINOL FTBL 10MG | Cisordinol 10 mg - Filmtabletten | 1.2.40.0.34.4.17:17533 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N05AF05 | Zuclopenthixol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710904 | ZUCLOPENTHIXOL DIHYDROCHLORID | 1.2.40.0.34.5.221:100000085645 | ZUCLOPENTHIXOL DIHYDROCHLORIDE | active | 11.8 | mg | 1.2.40.0.34.5.221:100000085645 | ZUCLOPENTHIXOL DIHYDROCHLORIDE | 11.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922814001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0773357 | CISORDINOL FTBL 25MG | Cisordinol 25 mg - Filmtabletten | 1.2.40.0.34.4.17:17534 | GA - zugelassen | Lundbeck Austria GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N05AF05 | Zuclopenthixol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710904 | ZUCLOPENTHIXOL DIHYDROCHLORID | 1.2.40.0.34.5.221:100000085645 | ZUCLOPENTHIXOL DIHYDROCHLORIDE | active | 29.5 | mg | 1.2.40.0.34.5.221:100000085645 | ZUCLOPENTHIXOL DIHYDROCHLORIDE | 29.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922794003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0773363 | CISORDINOL FTBL 25MG | Cisordinol 25 mg - Filmtabletten | 1.2.40.0.34.4.17:17534 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N05AF05 | Zuclopenthixol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710904 | ZUCLOPENTHIXOL DIHYDROCHLORID | 1.2.40.0.34.5.221:100000085645 | ZUCLOPENTHIXOL DIHYDROCHLORIDE | active | 29.5 | mg | 1.2.40.0.34.5.221:100000085645 | ZUCLOPENTHIXOL DIHYDROCHLORIDE | 29.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922794002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0773423 | CISORDINOL DEP AMP 200MG | Cisordinol Depot 200 mg - Ampullen | 1.2.40.0.34.4.17:15952 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05AF05 | Zuclopenthixol | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1707515 | ZUCLOPENTHIXOL DECANOAT | 1.2.40.0.34.5.221:100000085821 | ZUCLOPENTHIXOL DECANOATE | active | 200 | mg | 1.2.40.0.34.5.221:100000085821 | ZUCLOPENTHIXOL DECANOATE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:123338001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0773446 | CISORDINOL DEP AMP 200MG | Cisordinol Depot 200 mg - Ampullen | 1.2.40.0.34.4.17:15952 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05AF05 | Zuclopenthixol | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1707515 | ZUCLOPENTHIXOL DECANOAT | 1.2.40.0.34.5.221:100000085821 | ZUCLOPENTHIXOL DECANOATE | active | 200 | mg | 1.2.40.0.34.5.221:100000085821 | ZUCLOPENTHIXOL DECANOATE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:123338002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0773676 | HALCION TBL 0,25MG | Halcion 0,25 mg - Tabletten | 1.2.40.0.34.4.17:1-17546 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05CD05 | Triazolam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709413 | TRIAZOLAM | 1.2.40.0.34.5.221:100000092518 | TRIAZOLAM | active | 0.25 | mg | 1.2.40.0.34.5.221:100000092518 | TRIAZOLAM | 0.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:127780001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0773883 | MERESASUL KPS 50MG | Meresasul 50 mg - Kapseln | 1.2.40.0.34.4.17:17247 | GA - aufgehoben | SANOVA Pharma GesmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N05AL01 | Sulpirid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708729 | SULPIRID | 1.2.40.0.34.5.221:100000091056 | SULPIRIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000091056 | SULPIRIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:124799002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0773908 | MERESASUL KPS 50MG | Meresasul 50 mg - Kapseln | 1.2.40.0.34.4.17:17247 | GA - aufgehoben | SANOVA Pharma GesmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N05AL01 | Sulpirid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708729 | SULPIRID | 1.2.40.0.34.5.221:100000091056 | SULPIRIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000091056 | SULPIRIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:124799001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0773937 | ONCOVIN INJ DFL 1MG/1ML | Oncovin 1 mg Injektionslösung | 1.2.40.0.34.4.17:17579 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:L01CA02 | Vincristin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708821 | VINCRISTIN SULFAT | 1.2.40.0.34.5.221:100000091361 | VINCRISTINE SULFATE | active | 1 | mg | 1.2.40.0.34.5.221:100000091361 | VINCRISTINE SULFATE | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:922587001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0773989 | OSPAMOX FTBL 500MG | Ospamox 500 mg - Filmtabletten | 1.2.40.0.34.4.17:17659 | GA - zugelassen | Sandoz GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CA04 | Amoxicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708923 | AMOXICILLIN | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | active | 574 | mg | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 574 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922421001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0774003 | OSPAMOX FTBL 750MG | Ospamox 750 mg - Filmtabletten | 1.2.40.0.34.4.17:17657 | GA - zugelassen | Sandoz GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CA04 | Amoxicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708923 | AMOXICILLIN | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | active | 861.1 | mg | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 861.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922420001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0774026 | OSPAMOX FTBL 1000MG | Ospamox 1000 mg - Filmtabletten | 1.2.40.0.34.4.17:17653 | GA - zugelassen | Sandoz GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CA04 | Amoxicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708923 | AMOXICILLIN | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | active | 1148 | mg | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 1148 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922419001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0774233 | ROWALIND EINREIBUNG | Rowalind - Einreibung | 1.2.40.0.34.4.17:11882 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M02AX10 | Verschiedene | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | | | 1.2.40.0.34.5.221:100000091364 | MENTHOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:128435001 | 1.2.40.0.34.5.156:1705788 | AMMONIAK | 1.2.40.0.34.5.221:100000077712 | AMMONIA | active | | | 1.2.40.0.34.5.221:100000077712 | AMMONIA | | | 1.2.40.0.34.5.156:1708914 | AMMONIUMCHLORID | 1.2.40.0.34.5.221:100000091581 | AMMONIUM CHLORIDE | active | | | 1.2.40.0.34.5.221:100000091581 | AMMONIUM CHLORIDE | | | | | | | | | 1.2.40.0.34.5.156:1709036 | RACEMISCHER CAMPHER | 1.2.40.0.34.5.221:100000091848 | CAMPHOR, RACEMIC | active | | | 1.2.40.0.34.5.221:100000091848 | CAMPHOR, RACEMIC | | | 1.2.40.0.34.5.156:1706341 | NICOTINALDEHYD | 1.2.40.0.34.5.221:100000079971 | NICOTINALDEHYDE | active | | | 1.2.40.0.34.5.221:100000079971 | NICOTINALDEHYDE | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0774285 | SANAXIN FTBL 500MG | Sanaxin 500 mg - Filmtabletten | 1.2.40.0.34.4.17:17287 | GA - aufgehoben | Sandoz GmbH | false | false | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01DB01 | Cefalexin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7034728 | CEFALEXIN MONOHYDRAT | 1.2.40.0.34.5.221:100000092402 | CEFALEXIN MONOHYDRATE | active | 526 | mg | 1.2.40.0.34.5.221:100000091359 | CEFALEXIN | 500.074512 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:129823001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0774291 | SANAXIN FTBL 1000MG | Sanaxin 1000 mg - Filmtabletten | 1.2.40.0.34.4.17:17288 | GA - aufgehoben | Sandoz GmbH | false | false | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01DB01 | Cefalexin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7034728 | CEFALEXIN MONOHYDRAT | 1.2.40.0.34.5.221:100000092402 | CEFALEXIN MONOHYDRATE | active | 1052 | mg | 1.2.40.0.34.5.221:100000091359 | CEFALEXIN | 1000.149024 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:129751001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0774457 | WOBENZYM DRG | Wobenzym magensaftresistente Tabletten | 1.2.40.0.34.4.17:17712 | GA - zugelassen | MUCOS Pharma GmbH & Co. KG | true | false | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:M09AB52 | Trypsin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707180 | CHYMOTRYPSIN | 1.2.40.0.34.5.221:100000084879 | CHYMOTRYPSIN | active | | | 1.2.40.0.34.5.221:100000084879 | CHYMOTRYPSIN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073667 | magensaftresistente Tablette | true | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1707997 | BROMELAIN | 1.2.40.0.34.5.221:100000088272 | BROMELAIN | active | | | 1.2.40.0.34.5.221:100000088272 | BROMELAIN | | | 1.2.40.0.34.5.156:1706048 | TRYPSIN | 1.2.40.0.34.5.221:100000078784 | TRYPSIN | active | | | 1.2.40.0.34.5.221:100000078784 | TRYPSIN | | | | | | | | | 1.2.40.0.34.5.156:1706275 | PANKREAS(EXTRAKT) | 1.2.40.0.34.5.221:100000079736 | PANKREAS(EXTRAKT) | active | | | 1.2.40.0.34.5.221:100000079736 | PANKREAS(EXTRAKT) | | | 1.2.40.0.34.5.156:1706278 | PAPAYOTIN | 1.2.40.0.34.5.221:100000079740 | PAPAYOTIN | active | | | 1.2.40.0.34.5.221:100000079740 | PAPAYOTIN | | | 1.2.40.0.34.5.156:11181545 | RUTOSID TRIHYDRAT | 1.2.40.0.34.5.221:100000115324 | RUTOSID TRIHYDRAT | active | | | 1.2.40.0.34.5.221:100000115324 | RUTOSID TRIHYDRAT | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0774463 | WOBENZYM DRG | Wobenzym magensaftresistente Tabletten | 1.2.40.0.34.4.17:17712 | GA - zugelassen | MUCOS Pharma GmbH & Co. KG | true | false | 800 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:M09AB52 | Trypsin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707180 | CHYMOTRYPSIN | 1.2.40.0.34.5.221:100000084879 | CHYMOTRYPSIN | active | | | 1.2.40.0.34.5.221:100000084879 | CHYMOTRYPSIN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073667 | magensaftresistente Tablette | true | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1707997 | BROMELAIN | 1.2.40.0.34.5.221:100000088272 | BROMELAIN | active | | | 1.2.40.0.34.5.221:100000088272 | BROMELAIN | | | 1.2.40.0.34.5.156:1706048 | TRYPSIN | 1.2.40.0.34.5.221:100000078784 | TRYPSIN | active | | | 1.2.40.0.34.5.221:100000078784 | TRYPSIN | | | | | | | | | 1.2.40.0.34.5.156:1706275 | PANKREAS(EXTRAKT) | 1.2.40.0.34.5.221:100000079736 | PANKREAS(EXTRAKT) | active | | | 1.2.40.0.34.5.221:100000079736 | PANKREAS(EXTRAKT) | | | 1.2.40.0.34.5.156:1706278 | PAPAYOTIN | 1.2.40.0.34.5.221:100000079740 | PAPAYOTIN | active | | | 1.2.40.0.34.5.221:100000079740 | PAPAYOTIN | | | 1.2.40.0.34.5.156:11181545 | RUTOSID TRIHYDRAT | 1.2.40.0.34.5.221:100000115324 | RUTOSID TRIHYDRAT | active | | | 1.2.40.0.34.5.221:100000115324 | RUTOSID TRIHYDRAT | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0774523 | KREON KPS 10.000 E | Kreon 10.000 Einheiten - Kapseln | 1.2.40.0.34.4.17:17836 | GA - zugelassen | Viatris Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A09AA02 | Multienzyme (Lipase, Protease etc.) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706275 | PANKREAS(EXTRAKT) | 1.2.40.0.34.5.221:100000079736 | PANCREAS EXTRACT | active | 150 | mg | 1.2.40.0.34.5.221:100000079736 | PANCREAS EXTRACT | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:923632003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0774546 | KREON KPS 10.000 E | Kreon 10.000 Einheiten - Kapseln | 1.2.40.0.34.4.17:17836 | GA - zugelassen | Viatris Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A09AA02 | Multienzyme (Lipase, Protease etc.) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706275 | PANKREAS(EXTRAKT) | 1.2.40.0.34.5.221:100000079736 | PANCREAS EXTRACT | active | 150 | mg | 1.2.40.0.34.5.221:100000079736 | PANCREAS EXTRACT | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:923632004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0774552 | KREON KPS 10.000 E BP10X50 | Kreon 10.000 Einheiten - Kapseln | 1.2.40.0.34.4.17:17836 | GA - zugelassen | Viatris Austria GmbH | true | true | 500 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A09AA02 | Multienzyme (Lipase, Protease etc.) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706275 | PANKREAS(EXTRAKT) | 1.2.40.0.34.5.221:100000079736 | PANCREAS EXTRACT | active | 150 | mg | 1.2.40.0.34.5.221:100000079736 | PANCREAS EXTRACT | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:923632001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0777562 | EBETREXAT KONZ 100MG/ML 50ML | Ebetrexat 100 mg/ml - Konzentrat zur Infusionsbereitung | 1.2.40.0.34.4.17:1-20290 | GA - zugelassen | Ebewe Pharma Ges.m.b.H. Nfg.KG | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01BA01 | Methotrexat | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | 1.2.40.0.34.5.156:1708507 | METHOTREXAT | 1.2.40.0.34.5.221:100000090250 | METHOTREXATE | active | 5000 | mg | 1.2.40.0.34.5.221:100000090250 | METHOTREXATE | 5000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:931206003 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0777591 | NALADOR TRAMP 500MCG | Nalador 0,5 mg Pulver zur Herstellung einer Infusionslösung | 1.2.40.0.34.4.17:1-17577 | GA - zugelassen | Teofarma S.r.l. | true | false | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:G02AD05 | Sulproston | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709462 | SULPROSTON | 1.2.40.0.34.5.221:100000092603 | SULPROSTONE | active | 0.5 | mg | 1.2.40.0.34.5.221:100000092603 | SULPROSTONE | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:921122001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0781753 | DIGIMERCK TBL 0,07MG | Digimerck 0,07 mg - Tabletten | 1.2.40.0.34.4.17:17642 | GA - zugelassen | Merck Ges.m.b.H. | true | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01AA04 | Digitoxin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709550 | DIGITOXIN | 1.2.40.0.34.5.221:100000092778 | DIGITOXIN | active | 0.07 | mg | 1.2.40.0.34.5.221:100000092778 | DIGITOXIN | 0.07 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921189001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0781776 | DIGIMERCK TBL 0,07MG | Digimerck 0,07 mg - Tabletten | 1.2.40.0.34.4.17:17642 | GA - zugelassen | Merck Ges.m.b.H. | true | false | 84 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01AA04 | Digitoxin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709550 | DIGITOXIN | 1.2.40.0.34.5.221:100000092778 | DIGITOXIN | active | 0.07 | mg | 1.2.40.0.34.5.221:100000092778 | DIGITOXIN | 0.07 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921189002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0781799 | DOGMATIL KPS 50MG | Dogmatil 50 mg Kapseln | 1.2.40.0.34.4.17:16835 | GA - zugelassen | neuraxpharm Arzneimittel GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AL01 | Sulpirid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708729 | SULPIRID | 1.2.40.0.34.5.221:100000091056 | SULPIRIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000091056 | SULPIRIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:123786001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0781865 | GYNIPRAL AMP 10MCG/2ML BP5X5 | Gynipral 10 µg/2 ml - Ampullen | 1.2.40.0.34.4.17:17687 | GA - zugelassen | Takeda Austria GmbH | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:G02CA | Sympathomimetika, Wehen hemmend | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707699 | HEXOPRENALIN SULFAT | 1.2.40.0.34.5.221:100000086703 | HEXOPRENALINE SULFATE | active | 0.01 | mg | 1.2.40.0.34.5.221:100000086703 | HEXOPRENALINE SULFATE | 0.01 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921266002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0781888 | GYNIPRAL KONZ AMP 25MCG 5X5 | Gynipral 25 µg - Konzentrat zur Infusionsbereitung | 1.2.40.0.34.4.17:17686 | GA - zugelassen | Takeda Austria GmbH | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:G02CA | Sympathomimetika, Wehen hemmend | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707699 | HEXOPRENALIN SULFAT | 1.2.40.0.34.5.221:100000086703 | HEXOPRENALINE SULFATE | active | 0.025 | mg | 1.2.40.0.34.5.221:100000086703 | HEXOPRENALINE SULFATE | 0.025 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:921265002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0781919 | KRYPTOCUR SPRLSG 0,2MG | Kryptocur 0,2 mg/0,1 ml - nasale Sprühlösung | 1.2.40.0.34.4.17:17612 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 2 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:H01CA01 | Gonadorelin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1708373 | GONADORELIN ACETAT | 1.2.40.0.34.5.221:100000089787 | GONADORELIN ACETATE | active | 0.21 | mg | 1.2.40.0.34.5.221:100000089787 | GONADORELIN ACETATE | 0.21 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073796 | Nasenspray, Lösung | true | human | 1.2.40.0.34.4.26:922029001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0785900 | ZOVIRAX FTBL 200MG | Zovirax 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18043 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J05AB01 | Aciclovir | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709572 | ACICLOVIR | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | active | 200 | mg | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922818001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0786360 | ELDISIN TRSTAMP 5MG | Eldisin 5 mg Trockenstechampulle | 1.2.40.0.34.4.17:17578 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01CA03 | Vindesin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707911 | VINDESIN SULFAT | 1.2.40.0.34.5.221:100000087883 | VINDESINE SULFATE | active | 5 | mg | 1.2.40.0.34.5.221:100000087883 | VINDESINE SULFATE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073866 | Pulver zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:920390001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0786762 | VENOBENE SLB | Venobene - Salbe | 1.2.40.0.34.4.17:17942 | GA - zugelassen | Teva B.V. | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA53 | Heparin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709167 | DEXPANTHENOL | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | active | 500 | g | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | 500 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:920567001 | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 3000000 | IU | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 3000000 | IU | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0787218 | TRAMAL AMP 100MG 2ML | Tramal 100 mg - Ampullen | 1.2.40.0.34.4.17:17690 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N02AX02 | Tramadol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | 1.2.40.0.34.5.156:1709643 | TRAMADOLHYDROCHLORID | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921063001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0788407 | TEMGESIC SUBLING TBL 0,2MG | Temgesic 0,2 mg Sublingualtabletten | 1.2.40.0.34.4.17:17877 | GA - zugelassen | Eumedica Pharmaceuticals GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AE01 | Buprenorphin | 1.2.40.0.10.1.4.3.4.3.4:100000073634 | sublinguale Anwendung | | | | | 1.2.40.0.34.5.156:1709132 | BUPRENORPHIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092032 | BUPRENORPHINE HYDROCHLORIDE | active | 0.216 | mg | 1.2.40.0.34.5.221:100000092032 | BUPRENORPHINE HYDROCHLORIDE | 0.216 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073698 | Sublingualtablette | true | human | 1.2.40.0.34.4.26:921428001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0791964 | BETAISODONA VAG-SUPP | Betaisodona Vaginal - Suppositorien | 1.2.40.0.34.4.17:16474 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:G01AX11 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | active | 200 | mg | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073815 | Vaginalzäpfchen | true | human | 1.2.40.0.34.4.26:128744002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0792018 | COLDISTAN NA-TR +NEBULIS. | Coldistan Nasentropfen | 1.2.40.0.34.4.17:7506 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AB02 | Naphazolin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1708567 | NAPHAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073796 | Nasenspray, Lösung | true | human | 1.2.40.0.34.4.26:127392002 | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 10 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073794 | Nasentropfen, Lösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0792082 | DIPROFORTE SLB | Diproforte - Salbe | 1.2.40.0.34.4.17:17868 | GA - zugelassen | Organon Healthcare GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.0192 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.0192 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:921944002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0792188 | FELDEN KPS 20MG | Felden 20 mg - Kapseln | 1.2.40.0.34.4.17:17048 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M01AC01 | Piroxicam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709404 | PIROXICAM | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | active | 20 | mg | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:129405003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0792219 | HALDOL TBL 10MG | Haldol 10 mg - Tabletten | 1.2.40.0.34.4.17:17543 | GA - zugelassen | Essential Pharma Limited | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AD01 | Haloperidol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709494 | HALOPERIDOL | 1.2.40.0.34.5.221:100000092645 | HALOPERIDOL | active | 10 | mg | 1.2.40.0.34.5.221:100000092645 | HALOPERIDOL | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:127179002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0792225 | HALDOL TBL 10MG | Haldol 10 mg - Tabletten | 1.2.40.0.34.4.17:17543 | GA - zugelassen | Essential Pharma Limited | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AD01 | Haloperidol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709494 | HALOPERIDOL | 1.2.40.0.34.5.221:100000092645 | HALOPERIDOL | active | 10 | mg | 1.2.40.0.34.5.221:100000092645 | HALOPERIDOL | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:127179001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0792515 | DICLOFENAC SAN FTBL 50MG | Diclofenac Sandoz 50 mg - Filmtabletten | 1.2.40.0.34.4.17:1-17996 | GA - zugelassen | Sandoz GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:921524001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0792521 | DICLOFENAC SAN FTBL 50MG | Diclofenac Sandoz 50 mg - Filmtabletten | 1.2.40.0.34.4.17:1-17996 | GA - zugelassen | Sandoz GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:921524002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0792544 | DICLOFENAC SAN RET FTBL 100 | Diclofenac Sandoz retard 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-17997 | GA - zugelassen | Sandoz GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:921525001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0792550 | DICLOFENAC SAN RET FTBL 100 | Diclofenac Sandoz retard 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-17997 | GA - zugelassen | Sandoz GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:921525002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0792745 | SOTACOR TBL 160MG | Sotacor 160 mg - Tabletten | 1.2.40.0.34.4.17:17797 | GA - aufgehoben | Bristol-Myers Squibb Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AA07 | Sotalol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708828 | SOTALOL HYDROCHLORID | 1.2.40.0.34.5.221:100000091374 | SOTALOL HYDROCHLORIDE | active | 160 | mg | 1.2.40.0.34.5.221:100000091374 | SOTALOL HYDROCHLORIDE | 160 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:126582003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0792828 | UNIFYL RET TBL 400MG | Unifyl retard 400 mg Tabletten | 1.2.40.0.34.4.17:1-17835 | GA - aufgehoben | Mundipharma Ges.m.b.H. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 400 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:922802001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0792834 | UNIFYL RET TBL 400MG | Unifyl retard 400 mg Tabletten | 1.2.40.0.34.4.17:1-17835 | GA - aufgehoben | Mundipharma Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 400 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:922802002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0798854 | BETAISODONA MUND-ANTISEPT | Betadona Mund - Antiseptikum | 1.2.40.0.34.4.17:17220 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | false | 120 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:R02AA15 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073621 | zur Anwendung im Mund- und Rachenraum | | | | | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDON-IOD | active | | | 1.2.40.0.34.5.221:100000091677 | POVIDON-IOD | | | 1.2.40.0.10.1.4.3.4.3.5:100000073691 | Lösung zur Anwendung in der Mundhöhle | false | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073673 | Gurgellösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0798860 | CARBO MEDICIN SANOVA TBL | Carbo medicinalis "Sanova" - Tabletten | 1.2.40.0.34.4.17:8426 | GA - zugelassen | SANOVA Pharma GesmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07BA01 | Medizinische Kohle | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708634 | AKTIVKOHLE | 1.2.40.0.34.5.221:100000090961 | CHARCOAL ACTIVATED | active | 250 | mg | 1.2.40.0.34.5.221:100000090961 | CHARCOAL ACTIVATED | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122698003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0799090 | XYLANAEST PURUM DFL 1% 50ML | Xylanaest purum 1% - Durchstechflaschen | 1.2.40.0.34.4.17:15695 | GA - zugelassen | Gebro Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:N01BB02 | Lidocain | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:7211713 | LIDOCAIN HYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | active | 533 | mg | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | 533 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:121657001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0799109 | XYLANAEST PURUM DFL 2% 50ML | Xylanaest purum 2% - Durchstechflaschen | 1.2.40.0.34.4.17:15696 | GA - zugelassen | Gebro Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:N01BB02 | Lidocain | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:7211713 | LIDOCAIN HYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | active | 1066.5 | mg | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | 1066.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:121632001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0802917 | AUGMENTIN FTBL 500/125MG | Augmentin 500 mg/125 mg Filmtabletten | 1.2.40.0.34.4.17:1-17839 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CR02 | Amoxicillin und Enzym-Inhibitoren | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708923 | AMOXICILLIN | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | active | 574 | mg | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 574 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:921684012 | 1.2.40.0.34.5.156:1709625 | KALIUMCLAVULANAT | 1.2.40.0.34.5.221:100000093061 | POTASSIUM CLAVULANATE | active | 148.9 | mg | 1.2.40.0.34.5.221:100000093061 | POTASSIUM CLAVULANATE | 148.9 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0803035 | SINUPRET TR | Sinupret Tropfen | 1.2.40.0.34.4.17:17736 | GA - zugelassen | Bionorica SE | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CB10 | Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710724 | SAMBUCI FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000000958 | SAMBUCI FLOS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000958 | SAMBUCI FLOS (EXTRACT) | | | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | false | human | 1.2.40.0.34.4.26:124517001 | 1.2.40.0.34.5.156:1710671 | PRIMULAE FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000000904 | PRIMULAE FLOS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000904 | PRIMULAE FLOS (EXTRACT) | | | 1.2.40.0.34.5.156:1710301 | GENTIANAE RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000000532 | GENTIANAE RADIX (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000532 | GENTIANAE RADIX (EXTRACT) | | | | | | | | | 1.2.40.0.34.5.156:1710718 | RUMICIS ACETOSAE HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000000952 | RUMICIS ACETOSAE HERBA (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000952 | RUMICIS ACETOSAE HERBA (EXTRACT) | | | 1.2.40.0.34.5.156:1712668 | VERBENAE HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000004278 | VERBENAE HERBA (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000004278 | VERBENAE HERBA (EXTRACT) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0806364 | VEPESID KPS | Vepesid - Weichkapseln | 1.2.40.0.34.4.17:17994 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L01CB01 | Etoposid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706695 | ETOPOSID | 1.2.40.0.34.5.221:100000082091 | ETOPOSIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000082091 | ETOPOSIDE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | true | human | 1.2.40.0.34.4.26:920804004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0806387 | XYLANAEST EPIN.DFL 0,5% 50ML | Xylanaest 0,5 % mit Epinephrin 1 : 200.000 - Durchstechflaschen | 1.2.40.0.34.4.17:17909 | GA - zugelassen | Gebro Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:N01BB52 | Lidocain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:1709361 | EPINEPHRIN | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | active | 0.25 | mg | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | 0.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:126605001 | 1.2.40.0.34.5.156:7211713 | LIDOCAIN HYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | active | 266 | mg | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | 266 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0806393 | XYLANAEST EPIN.DFL 1% 50ML | Xylanaest 1 % mit Epinephrin 1 : 200.000 - Durchstechflaschen | 1.2.40.0.34.4.17:17908 | GA - zugelassen | Gebro Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:N01BB52 | Lidocain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:1709361 | EPINEPHRIN | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | active | 0.25 | mg | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | 0.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:122265002 | 1.2.40.0.34.5.156:7211713 | LIDOCAIN HYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | active | 533 | mg | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | 533 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0806401 | XYLANAEST EPIN.DFL 2% 50ML | Xylanaest 2 % mit Epinephrin 1 : 200.000 - Durchstechflaschen | 1.2.40.0.34.4.17:17975 | GA - zugelassen | Gebro Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:N01BB52 | Lidocain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:1709361 | EPINEPHRIN | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | active | 0.25 | mg | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | 0.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:922995001 | 1.2.40.0.34.5.156:7211713 | LIDOCAIN HYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | active | 1066.5 | mg | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | 1066.5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0806418 | XYLANAEST PURUM AMP 2% 2ML | Xylanaest purum 2% - Ampullen | 1.2.40.0.34.4.17:17792 | GA - zugelassen | Gebro Pharma GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01BB02 | Lidocain | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:7211713 | LIDOCAIN HYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | active | 42.66 | mg | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | 42.66 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:124669001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0806424 | XYLANAEST PURUM AMP 2% 5ML | Xylanaest purum 2% - Ampullen | 1.2.40.0.34.4.17:17792 | GA - zugelassen | Gebro Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01BB02 | Lidocain | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:7211713 | LIDOCAIN HYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | active | 106.65 | mg | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | 106.65 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:124669003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0809776 | BETAISODONA VAG-GEL | Betaisodona Vaginal - Gel | 1.2.40.0.34.4.17:16473 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | true | 50 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:G01AX11 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | active | 5 | g | 1.2.40.0.34.5.221:100000091677 | POVIDONE, IODINATED | 5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073799 | Vaginalgel | true | human | 1.2.40.0.34.4.26:122130001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0809842 | DAKTARIN GEL OR 2% | Daktarin 2% - orales Gel | 1.2.40.0.34.4.17:17956 | GA - zugelassen | Johnson & Johnson Ges.m.b.H. | true | true | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:A01AB09 | Miconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | | | 1.2.40.0.34.5.156:1708558 | MICONAZOL | 1.2.40.0.34.5.221:100000090369 | MICONAZOLE | active | 800 | mg | 1.2.40.0.34.5.221:100000090369 | MICONAZOLE | 800 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073695 | Gel zur Anwendung in der Mundhöhle | true | human | 1.2.40.0.34.4.26:920449001 | 1.2.40.0.34.5.156:1705992 | POLYSORBAT 20 | 1.2.40.0.34.5.221:100000078537 | POLYSORBATE 20 | active | 86 | mg | 1.2.40.0.34.5.221:100000078537 | POLYSORBATE 20 | 86 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0809960 | ICHTHALGAN CR FTE | Ichthalgan forte - Creme | 1.2.40.0.34.4.17:15342 | GA - aufgehoben | Ichthyol-Gesellschaft Cordes, Hermanni & Co. (GmbH & Co.) KG | false | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:M02AX | Andere topische Mittel gegen Gelenk- und Muskelschmerzen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705770 | NATRIUM SULFOBITUMINOSUM | 1.2.40.0.34.5.221:100000077657 | ICHTHAMMOL SODIUM | active | 4 | g | 1.2.40.0.34.5.221:100000077657 | ICHTHAMMOL SODIUM | 4 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | false | human | 1.2.40.0.34.4.26:923912001 | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 30000 | IU | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 30000 | IU | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0810147 | MAALOX OR SUS 10ML | Maalox - orale Suspension | 1.2.40.0.34.4.17:17837 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:A02AD01 | Einfache Salzkombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708069 | ALUMINIUMHYDROXID | 1.2.40.0.34.5.221:100000088685 | ALGELDRATE | active | 7.5 | g | 1.2.40.0.34.5.221:100000088685 | ALGELDRATE | 7.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:921730001 | 1.2.40.0.34.5.156:1708457 | MAGNESIUMHYDROXID | 1.2.40.0.34.5.221:100000090104 | MAGNESIUM HYDROXIDE | active | 2 | g | 1.2.40.0.34.5.221:100000090104 | MAGNESIUM HYDROXIDE | 2 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0810153 | MAALOX OR SUS 10ML | Maalox - orale Suspension | 1.2.40.0.34.4.17:17837 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:A02AD01 | Einfache Salzkombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708069 | ALUMINIUMHYDROXID | 1.2.40.0.34.5.221:100000088685 | ALGELDRATE | active | 7.5 | g | 1.2.40.0.34.5.221:100000088685 | ALGELDRATE | 7.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:921730002 | 1.2.40.0.34.5.156:1708457 | MAGNESIUMHYDROXID | 1.2.40.0.34.5.221:100000090104 | MAGNESIUM HYDROXIDE | active | 2 | g | 1.2.40.0.34.5.221:100000090104 | MAGNESIUM HYDROXIDE | 2 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0810176 | MUNDIDOL RET FTBL 10MG | Mundidol retard 10 mg Filmtabletten | 1.2.40.0.34.4.17:1-18003 | GA - zugelassen | Mundipharma Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705405 | MORPHINSULFAT | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | active | 10 | mg | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:923312001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0810236 | PENTAGLOBIN 50G/L ILSG DFL | Pentaglobin 50 g/l Infusionslösung | 1.2.40.0.34.4.17:2-00365 | GA - zugelassen | Biotest Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J06BA02 | Immunglobuline, normal human, zur intravasalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705771 | IMMUNGLOBULIN | 1.2.40.0.34.5.221:100000077660 | IMMUNGLOBULIN | active | 475 | mg | 1.2.40.0.34.5.221:100000077660 | IMMUNGLOBULIN | 475 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:929714001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0810265 | PENTAGLOBIN 50G/L ILSG DFL | Pentaglobin 50 g/l Infusionslösung | 1.2.40.0.34.4.17:2-00365 | GA - zugelassen | Biotest Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J06BA02 | Immunglobuline, normal human, zur intravasalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705771 | IMMUNGLOBULIN | 1.2.40.0.34.5.221:100000077660 | IMMUNGLOBULIN | active | 4750 | mg | 1.2.40.0.34.5.221:100000077660 | IMMUNGLOBULIN | 4750 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:929714002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0813708 | DELPRAL AMP 2ML | Delpral Ampullen | 1.2.40.0.34.4.17:17801 | GA - zugelassen | neuraxpharm Arzneimittel GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05AL03 | Tiaprid | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708763 | TIAPRID HYDROCHLORID | 1.2.40.0.34.5.221:100000091110 | TIAPRIDE HYDROCHLORIDE | active | 111.1 | mg | 1.2.40.0.34.5.221:100000091110 | TIAPRIDE HYDROCHLORIDE | 111.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:123416001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0813714 | DELPRAL TBL | Delpral 100 mg Tabletten | 1.2.40.0.34.4.17:17800 | GA - zugelassen | neuraxpharm Arzneimittel GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AL03 | Tiaprid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708763 | TIAPRID HYDROCHLORID | 1.2.40.0.34.5.221:100000091110 | TIAPRIDE HYDROCHLORIDE | active | 111.1 | mg | 1.2.40.0.34.5.221:100000091110 | TIAPRIDE HYDROCHLORIDE | 111.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124401001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0813996 | MARVELON TBL | Marvelon - Tabletten | 1.2.40.0.34.4.17:1-18002 | GA - zugelassen | Organon Healthcare GmbH | true | false | 21 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AA09 | Desogestrel und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.03 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.03 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922138001 | 1.2.40.0.34.5.156:1706864 | DESOGESTREL | 1.2.40.0.34.5.221:100000083191 | DESOGESTREL | active | 0.15 | mg | 1.2.40.0.34.5.221:100000083191 | DESOGESTREL | 0.15 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0814004 | MARVELON TBL 3X21 | Marvelon - Tabletten | 1.2.40.0.34.4.17:1-18002 | GA - zugelassen | Organon Healthcare GmbH | true | true | 63 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AA09 | Desogestrel und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.03 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.03 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922138002 | 1.2.40.0.34.5.156:1706864 | DESOGESTREL | 1.2.40.0.34.5.221:100000083191 | DESOGESTREL | active | 0.15 | mg | 1.2.40.0.34.5.221:100000083191 | DESOGESTREL | 0.15 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0814033 | THEOSPIREX RET FTBL 300MG | Theospirex retard 300 mg - Filmtabletten | 1.2.40.0.34.4.17:17818 | GA - zugelassen | Gebro Pharma GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 300 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:922070001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0814056 | THEOSPIREX RET FTBL 300MG | Theospirex retard 300 mg - Filmtabletten | 1.2.40.0.34.4.17:17818 | GA - zugelassen | Gebro Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 300 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:922070002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0814062 | TROSYD CR 1% | Trosyd 1% - Creme | 1.2.40.0.34.4.17:17889 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D01AC07 | Tioconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705687 | TIOCONAZOL | 1.2.40.0.34.5.221:100000077210 | TIOCONAZOLE | active | 0.3 | g | 1.2.40.0.34.5.221:100000077210 | TIOCONAZOLE | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | false | human | 1.2.40.0.34.4.26:921383001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0825456 | CODIPERTUSSIN KONZ TR | Codipertussin 697 mg/100 ml Konzentrat - Tropfen | 1.2.40.0.34.4.17:17832 | GA - aufgehoben | Astellas Pharma Ges.m.b.H. | false | false | 33 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05DA04 | Codein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7431272 | CODEINPHOSPHAT HEMIHYDRAT | 1.2.40.0.34.5.221:100000090188 | CODEINE PHOSPHATE HEMIHYDRATE | active | 31.218 | g | 1.2.40.0.34.5.221:100000090188 | CODEINE PHOSPHATE HEMIHYDRATE | 31.218 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:920244001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0825462 | DUPHASTON FTBL 10MG | Duphaston 10 mg - Filmtabletten | 1.2.40.0.34.4.17:1-15953 | GA - zugelassen | Theramex Ireland Limited | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03DB01 | Dydrogesteron | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706440 | DYDROGESTERON | 1.2.40.0.34.5.221:100000080500 | DYDROGESTERONE | active | 10 | mg | 1.2.40.0.34.5.221:100000080500 | DYDROGESTERONE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122397002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0825485 | HOFCOMANT FTBL | Hofcomant - Filmtabletten | 1.2.40.0.34.4.17:1-18013 | GA - aufgehoben | Merz Pharma Austria GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N04BB01 | Amantadin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709202 | AMANTADIN SULFAT | 1.2.40.0.34.5.221:100000092128 | AMANTADINE SULFATE | active | 100 | mg | 1.2.40.0.34.5.221:100000092128 | AMANTADINE SULFATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:924694002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0825516 | HOFCOMANT PLIFL 500ML | Hofcomant - Plastikinfusionsflaschen | 1.2.40.0.34.4.17:1-18012 | GA - aufgehoben | Merz Pharma Austria GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N04BB01 | Amantadin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709202 | AMANTADIN SULFAT | 1.2.40.0.34.5.221:100000092128 | AMANTADINE SULFATE | active | 0.4 | mg | 1.2.40.0.34.5.221:100000092128 | AMANTADINE SULFATE | 0.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:924695002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0825522 | HOFCOMANT PLIFL 500ML | Hofcomant - Plastikinfusionsflaschen | 1.2.40.0.34.4.17:1-18012 | GA - aufgehoben | Merz Pharma Austria GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N04BB01 | Amantadin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709202 | AMANTADIN SULFAT | 1.2.40.0.34.5.221:100000092128 | AMANTADINE SULFATE | active | 0.4 | mg | 1.2.40.0.34.5.221:100000092128 | AMANTADINE SULFATE | 0.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:924695004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0834225 | ANTICHOLIUM AMP 5ML | Anticholium Ampullen | 1.2.40.0.34.4.17:1-21271 | GA - zugelassen | Dr. Franz Köhler Chemie GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AB19 | Physostigmin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1706210 | PHYSOSTIGMINSALICYLAT | 1.2.40.0.34.5.221:100000079464 | PHYSOSTIGMINE SALICYLATE | active | 0 | mg | 1.2.40.0.34.5.221:100000079464 | PHYSOSTIGMINE SALICYLATE | 0 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:928441003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0841900 | DARMOL ABFUEHRSCHOKOLADE | Darmol - Täfelchen | 1.2.40.0.34.4.17:1-18007 | GA - zugelassen | Dr. A. & L. Schmidgall GmbH & Co. KG | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:A06AB06 | Sennoside | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712654 | SENNAE FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000004235 | SENNAE FOLIUM (EXTRACT) | active | 96 | mg | 1.2.40.0.34.5.221:900000004235 | SENNAE FOLIUM (EXTRACT) | 96 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073684 | Kautablette | true | human | 1.2.40.0.34.4.26:129798002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0841917 | DARMOL ABFUEHRSCHOKOLADE | Darmol - Täfelchen | 1.2.40.0.34.4.17:1-18007 | GA - zugelassen | Dr. A. & L. Schmidgall GmbH & Co. KG | true | true | 16 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:A06AB06 | Sennoside | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712654 | SENNAE FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000004235 | SENNAE FOLIUM (EXTRACT) | active | 96 | mg | 1.2.40.0.34.5.221:900000004235 | SENNAE FOLIUM (EXTRACT) | 96 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073684 | Kautablette | true | human | 1.2.40.0.34.4.26:129798001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0842012 | LOMUSOL AU-TR | Lomusol Augentropfen | 1.2.40.0.34.4.17:1-18032 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01GX01 | Cromoglicinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709682 | DINATRIUM CROMOGLICAT | 1.2.40.0.34.5.221:100000115606 | DISODIUM CROMOGLYCATE | active | 0.2 | g | 1.2.40.0.34.5.221:100000115606 | DISODIUM CROMOGLYCATE | 0.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:923582001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0842029 | LOMUSOL NA-SPRAY | Lomusol - Nasenspray | 1.2.40.0.34.4.17:1-18031 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 20 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AC01 | Cromoglicinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1709682 | DINATRIUM CROMOGLICAT | 1.2.40.0.34.5.221:100000115606 | DISODIUM CROMOGLYCATE | active | 400 | mg | 1.2.40.0.34.5.221:100000115606 | DISODIUM CROMOGLYCATE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073796 | Nasenspray, Lösung | true | human | 1.2.40.0.34.4.26:923583001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0842124 | VIBROCIL NA-TR | Vibrocil Nasentropfen | 1.2.40.0.34.4.17:1-18035 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AB01 | Phenylephrin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1707993 | PHENYLEPHRIN | 1.2.40.0.34.5.221:100000088260 | PHENYLEPHRINE | active | 0.0375 | g | 1.2.40.0.34.5.221:100000088260 | PHENYLEPHRINE | 0.0375 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073794 | Nasentropfen, Lösung | true | human | 1.2.40.0.34.4.26:123682001 | 1.2.40.0.34.5.156:1707840 | DIMETINDEN MALEAT | 1.2.40.0.34.5.221:100000087512 | DIMETINDENE MALEATE | active | 0.00375 | g | 1.2.40.0.34.5.221:100000087512 | DIMETINDENE MALEATE | 0.00375 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0843371 | NOVALGIN AMP 1,0G 2ML BP | Novalgin 1,0 g Ampullen | 1.2.40.0.34.4.17:3191 | GA - zugelassen | Opella Healthcare Austria GmbH | true | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N02BB02 | Metamizol-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708977 | METAMIZOL NATRIUM | 1.2.40.0.34.5.221:100000091714 | METAMIZOLE SODIUM | active | 1 | g | 1.2.40.0.34.5.221:100000091714 | METAMIZOLE SODIUM | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:127861001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0851117 | ANAEROBEX IFL 0,5% 300ML | Anaerobex 0,5% - Infusionsflasche | 1.2.40.0.34.4.17:16847 | GA - zugelassen | G.L. Pharma GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01XD01 | Metronidazol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708522 | METRONIDAZOL | 1.2.40.0.34.5.221:100000090285 | METRONIDAZOLE | active | 1500 | mg | 1.2.40.0.34.5.221:100000090285 | METRONIDAZOLE | 1500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:920467002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0851241 | IROMIN TBL | Iromin - Tabletten | 1.2.40.0.34.4.17:6200 | GA - aufgehoben | Dr. A. & L. Schmidgall GmbH & Co. KG | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BA15 | Carbasalat calcium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706552 | CARBASALAT CALCIUM | 1.2.40.0.34.5.221:100000081316 | CARBASALATE CALCIUM | active | 500 | mg | 1.2.40.0.34.5.221:100000081316 | CARBASALATE CALCIUM | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:128878003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0851264 | JOPAMIRO 300MG J/ML AMP 10ML | Jopamiro 300 mg J/ml - Ampullen | 1.2.40.0.34.4.17:17301 | GA - aufgehoben | Bracco Österreich GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 6120 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 6120 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920603001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0851270 | JOPAMIRO 300MG J/ML DFL100ML | Jopamiro 300 mg J/ml - Stechampullen | 1.2.40.0.34.4.17:17302 | GA - zugelassen | Bracco Österreich GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 61200 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 61200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920664002 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0851287 | JOPAMIRO 370MG J/ML DFL 50ML | Jopamiro 370 mg J/ml - Stechampullen | 1.2.40.0.34.4.17:17304 | GA - zugelassen | Bracco Österreich GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 37750 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 37750 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920665003 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0851293 | JOPAMIRO 370MG J/ML DFL100ML | Jopamiro 370 mg J/ml - Stechampullen | 1.2.40.0.34.4.17:17304 | GA - zugelassen | Bracco Österreich GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 75500 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 75500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920665001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0851318 | JOSALID FTBL 500MG | Josalid 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18019 | GA - aufgehoben | Sandoz GmbH | false | false | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01FA07 | Josamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706310 | JOSAMYCIN | 1.2.40.0.34.5.221:100000079852 | JOSAMYCIN | active | 0.5 | g | 1.2.40.0.34.5.221:100000079852 | JOSAMYCIN | 0.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922528001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0851376 | NEUROTOP TBL 400MG | Neurotop 400 mg - Tabletten | 1.2.40.0.34.4.17:1-18026 | GA - zugelassen | G.L. Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AF01 | Carbamazepin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709201 | CARBAMAZEPIN | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | active | 400 | mg | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922815002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0851382 | NEUROTOP TBL 400MG | Neurotop 400 mg - Tabletten | 1.2.40.0.34.4.17:1-18026 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AF01 | Carbamazepin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709201 | CARBAMAZEPIN | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | active | 400 | mg | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922815001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0851465 | SALAZOPYRIN SUPP 500MG | Salazopyrin 500 mg - Suppositorien | 1.2.40.0.34.4.17:1-14452 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:A07EC01 | Sulfasalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1708908 | SULFASALAZIN | 1.2.40.0.34.5.221:100000091572 | SULFASALAZINE | active | 535 | mg | 1.2.40.0.34.5.221:100000091572 | SULFASALAZINE | 535 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:128769001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0851519 | SELEXID FTBL | Selexid 200 mg Filmtabletten | 1.2.40.0.34.4.17:1-17644 | GA - zugelassen | Karo Healthcare AB | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CA08 | Pivmecillinam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708822 | PIVMECILLINAM HYDROCHLORID | 1.2.40.0.34.5.221:100000091362 | PIVMECILLINAM HYDROCHLORIDE | active | 200 | mg | 1.2.40.0.34.5.221:100000091362 | PIVMECILLINAM HYDROCHLORIDE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:129540001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0851548 | TRENTAL AMP 100MG 5ML | Trental 100 mg Ampullen | 1.2.40.0.34.4.17:15371 | GA - zugelassen | neuraxpharm Arzneimittel GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 100 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:122239002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0851560 | TRENTAL AMP 300MG 15ML | Trental 300 mg Ampullen | 1.2.40.0.34.4.17:17972 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 200 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:927066001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0851608 | ZOVIRAX TRSUB INF DFL 250MG | Zovirax 250 mg - Trockensubstanz zur Infusionsbereitung | 1.2.40.0.34.4.17:1-18044 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J05AB01 | Aciclovir | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709572 | ACICLOVIR | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | active | 250 | mg | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:922250001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0857568 | NIMOTOP FTBL 30MG | Nimotop 30 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18040 | GA - zugelassen | Laboratoire X.O | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08CA06 | Nimodipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709291 | NIMODIPIN | 1.2.40.0.34.5.221:100000092273 | NIMODIPINE | active | 30 | mg | 1.2.40.0.34.5.221:100000092273 | NIMODIPINE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:923653001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0863936 | SELUKOS MED SH. | Selukos - medizinisches Shampoon | 1.2.40.0.34.4.17:17570 | GA - aufgehoben | Viatris Austria GmbH | false | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D11AC03 | Selen-haltige Verbindungen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1706169 | SELENDISULFID | 1.2.40.0.34.5.221:100000079291 | SELENIUM DISULPHIDE | active | 2.5 | g | 1.2.40.0.34.5.221:100000079291 | SELENIUM DISULPHIDE | 2.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073715 | Shampoo | false | human | 1.2.40.0.34.4.26:126317001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0865042 | COLIFOAM REKSCHAUM | Colifoam - Rektalschaum | 1.2.40.0.34.4.17:1-18460 | GA - aufgehoben | Viatris Austria GmbH | false | false | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:A07EA02 | Hydrocortison | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709281 | HYDROCORTISON ACETAT | 1.2.40.0.34.5.221:100000092260 | HYDROCORTISONE ACETATE | active | 10 | g | 1.2.40.0.34.5.221:100000092260 | HYDROCORTISONE ACETATE | 10 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073820 | Rektalschaum | true | human | 1.2.40.0.34.4.26:920509001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0865450 | NIMOTOP IFL 10MG 50ML | Nimotop 10 mg - Infusionsflasche | 1.2.40.0.34.4.17:1-18039 | GA - zugelassen | Laboratoire X.O | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C08CA06 | Nimodipin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709291 | NIMODIPIN | 1.2.40.0.34.5.221:100000092273 | NIMODIPINE | active | 10 | mg | 1.2.40.0.34.5.221:100000092273 | NIMODIPINE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:923655002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0865622 | LASIX AMP 40MG 4ML | Lasix 40 mg/4 ml Ampullen | 1.2.40.0.34.4.17:17822 | GA - zugelassen | Sanofi-Aventis GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C03CA01 | Furosemid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1707308 | NATRIUM FUROSEMID | 1.2.40.0.34.5.221:100000085198 | FUROSEMIDE SODIUM | active | 42.656 | mg | 1.2.40.0.34.5.221:100000085198 | FUROSEMIDE SODIUM | 42.656 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:922196001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0871522 | DAKTARIN LSG DERM 2% | Daktarin 2% - dermatologische Lösung | 1.2.40.0.34.4.17:1-18057 | GA - aufgehoben | Johnson & Johnson Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D01AC02 | Miconazol | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:1708558 | MICONAZOL | 1.2.40.0.34.5.221:100000090369 | MICONAZOLE | active | 600 | mg | 1.2.40.0.34.5.221:100000090369 | MICONAZOLE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073742 | wirkstoffhaltiger Nagellack | false | human | 1.2.40.0.34.4.26:920448001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0871686 | CUTASEPT DESINFEKT.GEFAERBT | Cutasept - Desinfektionslösung gefärbt | 1.2.40.0.34.4.17:1-31781 | GA - zugelassen | Bode Chemie GmbH | true | true | 1 | 2.16.840.1.113883.6.8:L | Liter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D08AX53 | Propanol, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709170 | BENZALKONIUMCHLORID | 1.2.40.0.34.5.221:100000092079 | BENZALKONIUM CHLORIDE | active | 0.25 | g | 1.2.40.0.34.5.221:100000092079 | BENZALKONIUM CHLORIDE | 0.25 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:956626001 | 1.2.40.0.34.5.156:1705751 | 2-PROPANOL | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | active | 630 | g | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | 630 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0872450 | ZOVIRAX CR 5% | Zovirax 5 % - Creme | 1.2.40.0.34.4.17:1-18064 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 2 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D06BB03 | Aciclovir | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709572 | ACICLOVIR | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | active | 0.1 | g | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | 0.1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:924628002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0875023 | ZOVIRAX CR 5% | Zovirax 5 % - Creme | 1.2.40.0.34.4.17:1-18064 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D06BB03 | Aciclovir | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709572 | ACICLOVIR | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | active | 0.5 | g | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | 0.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:924628001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0877878 | ERGOVASAN RET KPS 2,5MG | Ergovasan 2,5 mg retard - Kapseln | 1.2.40.0.34.4.17:1-18079 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N02CA01 | Dihydroergotamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708652 | DIHYDROERGOTAMIN MESILAT | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | active | 2.5 | mg | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:922312001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0877884 | ERGOVASAN RET KPS 2,5MG | Ergovasan 2,5 mg retard - Kapseln | 1.2.40.0.34.4.17:1-18079 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N02CA01 | Dihydroergotamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708652 | DIHYDROERGOTAMIN MESILAT | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | active | 2.5 | mg | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:922312002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0877996 | URBASON SOL TRAMP 16MG +LSM | Urbason solubile 16 mg Trockenampullen mit Lösungsmittel | 1.2.40.0.34.4.17:11404 | GA - zugelassen | Fidia Farmaceutici S.p.A. | true | false | 15 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB04 | Methylprednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708630 | NATRIUM METHYLPREDNISOLON SUCCINAT | 1.2.40.0.34.5.221:100000090523 | METHYLPREDNISOLONE SODIUM SUCCINATE | active | 20.92 | mg | 1.2.40.0.34.5.221:100000090523 | METHYLPREDNISOLONE SODIUM SUCCINATE | 20.92 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:920991003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0878004 | URBASON SOL TRAMP 32MG +LSM | Urbason solubile 32 mg Trockenampullen mit Lösungsmittel | 1.2.40.0.34.4.17:11405 | GA - zugelassen | Fidia Farmaceutici S.p.A. | true | false | 15 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB04 | Methylprednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708630 | NATRIUM METHYLPREDNISOLON SUCCINAT | 1.2.40.0.34.5.221:100000090523 | METHYLPREDNISOLONE SODIUM SUCCINATE | active | 41.85 | mg | 1.2.40.0.34.5.221:100000090523 | METHYLPREDNISOLONE SODIUM SUCCINATE | 41.85 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:920992003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0886452 | ROBINUL 0,2MG AMP 1ML | Robinul 0,2 mg - Ampullen | 1.2.40.0.34.4.17:1-18081 | GA - zugelassen | Esteve Pharmaceuticals GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A03AB02 | Glycopyrronium | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1707026 | GLYCOPYRRONIUMBROMID | 1.2.40.0.34.5.221:100000084232 | GLYCOPYRRONIUM BROMIDE | active | 0.2 | mg | 1.2.40.0.34.5.221:100000084232 | GLYCOPYRRONIUM BROMIDE | 0.2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921834002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0892607 | PROTAGENT AU-TR | Protagent - Augentropfen | 1.2.40.0.34.4.17:1-18088 | GA - aufgehoben | Alcon Ophthalmika GmbH | false | false | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01XA20 | Künstliche Tränen und andere indifferente Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709362 | POVIDON | 1.2.40.0.34.5.221:100000092381 | POVIDONE | active | 20 | g | 1.2.40.0.34.5.221:100000092381 | POVIDONE | 20 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | false | human | 1.2.40.0.34.4.26:926929001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0894405 | KYBERNIN P PLV+LSM 500IE | Kybernin P 500 I.E./1000 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung | 1.2.40.0.34.4.17:2-00052 | GA - zugelassen | CSL Behring GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B01AB02 | Antithrombin III | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708172 | ANTITHROMBIN III | 1.2.40.0.34.5.221:100000089108 | ANTITHROMBIN III | active | 400 | IU | 1.2.40.0.34.5.221:100000089108 | ANTITHROMBIN III | 400 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:928357002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0894411 | KYBERNIN P PLV+LSM 1000IE | Kybernin P 500 I.E./1000 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung | 1.2.40.0.34.4.17:2-00052 | GA - zugelassen | CSL Behring GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B01AB02 | Antithrombin III | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708172 | ANTITHROMBIN III | 1.2.40.0.34.5.221:100000089108 | ANTITHROMBIN III | active | 800 | IU | 1.2.40.0.34.5.221:100000089108 | ANTITHROMBIN III | 800 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:928357001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0897852 | IROCOPHAN TBL | Irocophan - Tabletten | 1.2.40.0.34.4.17:1-18063 | GA - aufgehoben | Dr. A. & L. Schmidgall GmbH & Co. KG | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BE51 | Paracetamol, Kombinationen exkl. Psycholeptika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | 200 | mg | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922068001 | 1.2.40.0.34.5.156:1708366 | COFFEIN | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | active | 46 | mg | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | 46 | mg | 1.2.40.0.34.5.156:1706552 | CARBASALAT CALCIUM | 1.2.40.0.34.5.221:100000081316 | CARBASALATE CALCIUM | active | 250 | mg | 1.2.40.0.34.5.221:100000081316 | CARBASALATE CALCIUM | 250 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0897869 | IROCOPHAN TBL | Irocophan - Tabletten | 1.2.40.0.34.4.17:1-18063 | GA - aufgehoben | Dr. A. & L. Schmidgall GmbH & Co. KG | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BE51 | Paracetamol, Kombinationen exkl. Psycholeptika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | 200 | mg | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922068002 | 1.2.40.0.34.5.156:1708366 | COFFEIN | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | active | 46 | mg | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | 46 | mg | 1.2.40.0.34.5.156:1706552 | CARBASALAT CALCIUM | 1.2.40.0.34.5.221:100000081316 | CARBASALATE CALCIUM | active | 250 | mg | 1.2.40.0.34.5.221:100000081316 | CARBASALATE CALCIUM | 250 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0898610 | ERGOVASAN RET KPS 5MG | Ergovasan 5 mg retard - Kapseln | 1.2.40.0.34.4.17:1-18080 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N02CA01 | Dihydroergotamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708652 | DIHYDROERGOTAMIN MESILAT | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | active | 5 | mg | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:921761001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0898627 | ERGOVASAN RET KPS 5MG | Ergovasan 5 mg retard - Kapseln | 1.2.40.0.34.4.17:1-18080 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N02CA01 | Dihydroergotamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708652 | DIHYDROERGOTAMIN MESILAT | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | active | 5 | mg | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:921761002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0903386 | CATHEJELL DIPH/CHX SPR 12,5G | Cathejell Diphenhydramin 1 % / Chlorhexidin 0,05 % - Gel (sterile Einmalabgabeform) | 1.2.40.0.34.4.17:1-09414 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:900000000006 | Applikationssystem (NE) | 2.16.840.1.113883.6.73:N01BX | Andere Lokalanästhetika | 1.2.40.0.10.1.4.3.4.3.4:100000073638 | Anwendung in der Harnröhre | | | | | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 0.125 | g | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 0.125 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073880 | Gel zur Anwendung in der Harnröhre | true | human | 1.2.40.0.34.4.26:126321003 | 1.2.40.0.34.5.156:1709371 | CHLORHEXIDIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDINE DIHYDROCHLORIDE | active | 0.00625 | g | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDINE DIHYDROCHLORIDE | 0.00625 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0903392 | CATHEJELL DIPH/CHX SPR 12,5G | Cathejell Diphenhydramin 1 % / Chlorhexidin 0,05 % - Gel (sterile Einmalabgabeform) | 1.2.40.0.34.4.17:1-09414 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:900000000006 | Applikationssystem (NE) | 2.16.840.1.113883.6.73:N01BX | Andere Lokalanästhetika | 1.2.40.0.10.1.4.3.4.3.4:100000073638 | Anwendung in der Harnröhre | | | | | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 0.125 | g | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 0.125 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073880 | Gel zur Anwendung in der Harnröhre | true | human | 1.2.40.0.34.4.26:126321001 | 1.2.40.0.34.5.156:1709371 | CHLORHEXIDIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDINE DIHYDROCHLORIDE | active | 0.00625 | g | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDINE DIHYDROCHLORIDE | 0.00625 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0903423 | ISCADOR-Q AMP SER 0/1ML | Iscador Qu Injektionslösung | 1.2.40.0.34.4.17:10670 | GA - zugelassen | Iscador AG | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 111.11 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 111.11 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921812002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0909986 | FLAMMAZINE CR | Flammazine - Creme | 1.2.40.0.34.4.17:17189 | GA - zugelassen | Alliance Pharma (Ireland) Limited | true | true | 50 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D06BA01 | Sulfadiazin-Silber | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708127 | SULFADIAZIN SILBER | 1.2.40.0.34.5.221:100000088916 | SULFADIAZINE SILVER | active | 0.5 | g | 1.2.40.0.34.5.221:100000088916 | SULFADIAZINE SILVER | 0.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:121486001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0910021 | ISCADOR-M AMP SER 0/1ML | Iscador M Injektionslösung | 1.2.40.0.34.4.17:10669 | GA - zugelassen | Iscador AG | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 111.11 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 111.11 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921811002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0910162 | TALCID KTBL | Talcid - Kautabletten | 1.2.40.0.34.4.17:17898 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02AD04 | Hydrotalcit | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | | | 1.2.40.0.34.5.156:1705780 | ALUMINIUMHYDROXID X MAGNESIUMCARBONAT | 1.2.40.0.34.5.221:100000077696 | ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE | active | 500 | mg | 1.2.40.0.34.5.221:100000077696 | ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073684 | Kautablette | true | human | 1.2.40.0.34.4.26:129328001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0910179 | TALCID KTBL | Talcid - Kautabletten | 1.2.40.0.34.4.17:17898 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02AD04 | Hydrotalcit | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | | | 1.2.40.0.34.5.156:1705780 | ALUMINIUMHYDROXID X MAGNESIUMCARBONAT | 1.2.40.0.34.5.221:100000077696 | ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE | active | 500 | mg | 1.2.40.0.34.5.221:100000077696 | ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073684 | Kautablette | true | human | 1.2.40.0.34.4.26:129328002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0916549 | COLPERMIN KPS | Colpermin 187 mg - magensaftresistente Hartkapseln | 1.2.40.0.34.4.17:1-18090 | GA - aufgehoben | Tillotts Pharma AB | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A16AX | Sonstige Mittel für das alimentäre System und den Stoffwechsel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712671 | AETHEROLEUM MENTHAE | 1.2.40.0.34.5.221:900000004284 | AETHEROLEUM MENTHAE | active | 187 | mg | 1.2.40.0.34.5.221:900000004284 | AETHEROLEUM MENTHAE | 187 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073376 | magensaftresistente Hartkapsel | true | human | 1.2.40.0.34.4.26:922803003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0916555 | ELMEX DENT LSG | Elmex - Dentallösung | 1.2.40.0.34.4.17:1-18094 | GA - aufgehoben | Gebro Pharma GmbH | false | false | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A01AA03 | Olaflur | 1.2.40.0.10.1.4.3.4.3.4:100000073567 | dentale Anwendung | | | | | 1.2.40.0.34.5.156:1706892 | OLAFLUR | 1.2.40.0.34.5.221:100000083292 | OLAFLUR | active | 12.126 | g | 1.2.40.0.34.5.221:100000083292 | OLAFLUR | 12.126 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073723 | Dentallösung | true | human | 1.2.40.0.34.4.26:120157001 | 1.2.40.0.34.5.156:1706915 | DECTAFLUR | 1.2.40.0.34.5.221:100000083475 | DECTAFLUR | active | 1.15 | g | 1.2.40.0.34.5.221:100000083475 | DECTAFLUR | 1.15 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0916561 | ELMEX ZAHNGEL | elmex Zahngel | 1.2.40.0.34.4.17:1-18093 | GA - zugelassen | CP Gaba GmbH | true | true | 25 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:A01AA51 | Natriumfluorid, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073567 | dentale Anwendung | | | | | 1.2.40.0.34.5.156:1706892 | OLAFLUR | 1.2.40.0.34.5.221:100000083292 | OLAFLUR | active | 0.758 | g | 1.2.40.0.34.5.221:100000083292 | OLAFLUR | 0.758 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073705 | Dentalgel | false | human | 1.2.40.0.34.4.26:120158001 | 1.2.40.0.34.5.156:1708898 | NATRIUMFLUORID | 1.2.40.0.34.5.221:100000091554 | SODIUM FLUORIDE | active | 0.5525 | g | 1.2.40.0.34.5.221:100000091554 | SODIUM FLUORIDE | 0.5525 | g | 1.2.40.0.34.5.156:1706915 | DECTAFLUR | 1.2.40.0.34.5.221:100000083475 | DECTAFLUR | active | 0.07175 | g | 1.2.40.0.34.5.221:100000083475 | DECTAFLUR | 0.07175 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0916584 | FORTUM TRSTAMP 1G | Fortum 1 g Pulver zur Herstellung einer Injektionslösung | 1.2.40.0.34.4.17:1-18139 | GA - zugelassen | Sandoz GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01DD02 | Ceftazidim | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709482 | CEFTAZIDIM | 1.2.40.0.34.5.221:100000092630 | CEFTAZIDIME | active | 1.182 | g | 1.2.40.0.34.5.221:100000092630 | CEFTAZIDIME | 1.182 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073866 | Pulver zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:927143002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0916609 | FORTUM PLV IJ/ILSG DFL 2G | Fortum 2 g Pulver zur Herstellung einer Injektions- oder Infusionslösung | 1.2.40.0.34.4.17:1-18140 | GA - zugelassen | Sandoz GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01DD02 | Ceftazidim | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709482 | CEFTAZIDIM | 1.2.40.0.34.5.221:100000092630 | CEFTAZIDIME | active | 2.364 | g | 1.2.40.0.34.5.221:100000092630 | CEFTAZIDIME | 2.364 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:927144002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0916621 | MEXALEN SIR 200MG/5ML | Mexaratio 200 mg/5 ml - Sirup | 1.2.40.0.34.4.17:1-18100 | GA - zugelassen | Teva B.V. | true | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:N02BE01 | Paracetamol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | | | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073652 | Sirup | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0916638 | MEXALEN SUPP 125MG | Mexaratio 125 mg - Zäpfchen | 1.2.40.0.34.4.17:1-18097 | GA - zugelassen | Teva B.V. | true | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:N02BE01 | Paracetamol | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | | | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0916644 | MEXALEN SUPP 250MG | Mexaratio 250 mg - Zäpfchen | 1.2.40.0.34.4.17:1-18098 | GA - zugelassen | Teva B.V. | true | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:N02BE01 | Paracetamol | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | | | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0916650 | MEXALEN SUPP 500MG | Mexaratio 500 mg - Zäpfchen | 1.2.40.0.34.4.17:1-18096 | GA - zugelassen | Teva B.V. | true | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:N02BE01 | Paracetamol | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | | | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0916667 | MEXALEN TBL 500MG | Mexalen 500 mg - Tabletten | 1.2.40.0.34.4.17:1-18099 | GA - zugelassen | Teva B.V. | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BE01 | Paracetamol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | 500 | mg | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927033001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0921154 | AUGMENTIN I.V.PLV ILSG 550MG | Augmentin 500 mg/50 mg Pulver zur Herstellung einer Injektions-/Infusionslösung | 1.2.40.0.34.4.17:1-18137 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01CR02 | Amoxicillin und Enzym-Inhibitoren | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708462 | NATRIUM AMOXICILLINAT | 1.2.40.0.34.5.221:100000090113 | AMOXICILLIN SODIUM | active | 530.1 | mg | 1.2.40.0.34.5.221:100000090113 | AMOXICILLIN SODIUM | 530.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:927007003 | 1.2.40.0.34.5.156:1709625 | KALIUMCLAVULANAT | 1.2.40.0.34.5.221:100000093061 | POTASSIUM CLAVULANATE | active | 59.56 | mg | 1.2.40.0.34.5.221:100000093061 | POTASSIUM CLAVULANATE | 59.56 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0921160 | AUGMENTIN I.V.PLV ILSG 1,1G | Augmentin 1.000 mg/100 mg Pulver zur Herstellung einer Injektions-/Infusionslösung | 1.2.40.0.34.4.17:1-18135 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01CR02 | Amoxicillin und Enzym-Inhibitoren | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708462 | NATRIUM AMOXICILLINAT | 1.2.40.0.34.5.221:100000090113 | AMOXICILLIN SODIUM | active | 1060 | mg | 1.2.40.0.34.5.221:100000090113 | AMOXICILLIN SODIUM | 1060 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:927006003 | 1.2.40.0.34.5.156:1709625 | KALIUMCLAVULANAT | 1.2.40.0.34.5.221:100000093061 | POTASSIUM CLAVULANATE | active | 119.12 | mg | 1.2.40.0.34.5.221:100000093061 | POTASSIUM CLAVULANATE | 119.12 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0921183 | AUGMENTIN I.V.PLV IFL 2,2G | Augmentin 2.000 mg/200 mg Pulver zur Herstellung einer Infusionslösung | 1.2.40.0.34.4.17:1-18136 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01CR02 | Amoxicillin und Enzym-Inhibitoren | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708462 | NATRIUM AMOXICILLINAT | 1.2.40.0.34.5.221:100000090113 | AMOXICILLIN SODIUM | active | 2120 | mg | 1.2.40.0.34.5.221:100000090113 | AMOXICILLIN SODIUM | 2120 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:927004003 | 1.2.40.0.34.5.156:1709625 | KALIUMCLAVULANAT | 1.2.40.0.34.5.221:100000093061 | POTASSIUM CLAVULANATE | active | 238.25 | mg | 1.2.40.0.34.5.221:100000093061 | POTASSIUM CLAVULANATE | 238.25 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0921220 | BIOFLAIR KPS | Bioflair - Kapseln | 1.2.40.0.34.4.17:2-00143 | GA - zugelassen | SANOVA Pharma GesmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A07FA | Mikrobielle Antidiarrhoika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:103092443 | ENTEROCOCCUS LACTIS SF68 | 1.2.40.0.34.5.221:100000133395 | ENTEROCOCCUS LACTIS SF68 | active | 5.7 | mg | 1.2.40.0.34.5.221:100000133395 | ENTEROCOCCUS LACTIS SF68 | 5.7 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | false | human | 1.2.40.0.34.4.26:929680002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0921289 | GLUCOBENE TBL 1,75MG | Glucobene 1,75 mg - Tabletten | 1.2.40.0.34.4.17:1-18105 | GA - aufgehoben | ratiopharm Arzneimittel Vertriebs GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BB01 | Glibenclamid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706430 | GLIBENCLAMID | 1.2.40.0.34.5.221:100000080403 | GLIBENCLAMIDE | active | 1.75 | mg | 1.2.40.0.34.5.221:100000080403 | GLIBENCLAMIDE | 1.75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923518002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0921295 | GLUCOBENE TBL 1,75MG | Glucobene 1,75 mg - Tabletten | 1.2.40.0.34.4.17:1-18105 | GA - aufgehoben | ratiopharm Arzneimittel Vertriebs GmbH | false | false | 120 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BB01 | Glibenclamid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706430 | GLIBENCLAMID | 1.2.40.0.34.5.221:100000080403 | GLIBENCLAMIDE | active | 1.75 | mg | 1.2.40.0.34.5.221:100000080403 | GLIBENCLAMIDE | 1.75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923518001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0921303 | GLUCOBENE TBL 3,5MG | Glucobene 3,5 mg - Tabletten | 1.2.40.0.34.4.17:1-18106 | GA - aufgehoben | ratiopharm Arzneimittel Vertriebs GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BB01 | Glibenclamid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706430 | GLIBENCLAMID | 1.2.40.0.34.5.221:100000080403 | GLIBENCLAMIDE | active | 3.5 | mg | 1.2.40.0.34.5.221:100000080403 | GLIBENCLAMIDE | 3.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923519002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0921326 | GLUCOBENE TBL 3,5MG | Glucobene 3,5 mg - Tabletten | 1.2.40.0.34.4.17:1-18106 | GA - aufgehoben | ratiopharm Arzneimittel Vertriebs GmbH | false | false | 120 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BB01 | Glibenclamid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706430 | GLIBENCLAMID | 1.2.40.0.34.5.221:100000080403 | GLIBENCLAMIDE | active | 3.5 | mg | 1.2.40.0.34.5.221:100000080403 | GLIBENCLAMIDE | 3.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923519001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0921384 | LONITEN TBL 5MG | Loniten 5 mg Tabletten | 1.2.40.0.34.4.17:1-18118 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C02DC01 | Minoxidil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708556 | MINOXIDIL | 1.2.40.0.34.5.221:100000090366 | MINOXIDIL | active | 5 | mg | 1.2.40.0.34.5.221:100000090366 | MINOXIDIL | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:920700001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0928624 | COLOFAC DRG 135MG | Colofac 135 mg - Dragees | 1.2.40.0.34.4.17:17445 | GA - zugelassen | Viatris Austria GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A03AA04 | Mebeverin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707595 | MEBEVERIN HYDROCHLORID | 1.2.40.0.34.5.221:100000086181 | MEBEVERINE HYDROCHLORIDE | active | 135 | mg | 1.2.40.0.34.5.221:100000086181 | MEBEVERINE HYDROCHLORIDE | 135 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:920432002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0928676 | IROCOPHAN TBL BP5X30 | Irocophan - Tabletten | 1.2.40.0.34.4.17:1-18063 | GA - aufgehoben | Dr. A. & L. Schmidgall GmbH & Co. KG | false | false | 150 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BE51 | Paracetamol, Kombinationen exkl. Psycholeptika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | 200 | mg | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922068003 | 1.2.40.0.34.5.156:1708366 | COFFEIN | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | active | 46 | mg | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | 46 | mg | 1.2.40.0.34.5.156:1706552 | CARBASALAT CALCIUM | 1.2.40.0.34.5.221:100000081316 | CARBASALATE CALCIUM | active | 250 | mg | 1.2.40.0.34.5.221:100000081316 | CARBASALATE CALCIUM | 250 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0942966 | BRUFEN FTBL 600MG | Brufen 600 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18151 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 600 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922778001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0942972 | BRUFEN FTBL 600MG | Brufen 600 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18151 | GA - zugelassen | Viatris Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 600 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922778002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0944149 | ANAFRANIL RET FTBL 75MG | Anafranil retard 75 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18159 | GA - zugelassen | pharmaand GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AA04 | Clomipramin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708620 | CLOMIPRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090503 | CLOMIPRAMIN HYDROCHLORID | active | 75 | mg | 1.2.40.0.34.5.221:100000090503 | CLOMIPRAMIN HYDROCHLORID | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922284001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0944296 | DUAN TBL | Duan - Tabletten | 1.2.40.0.34.4.17:1-18211 | GA - aufgehoben | M.C.M. Klosterfrau Healthcare GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BE71 | Paracetamol, Kombinationen mit Psycholeptika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 250 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123244001 | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | 250 | mg | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | 250 | mg | 1.2.40.0.34.5.156:1708366 | COFFEIN | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | active | 25 | mg | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | 25 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0944379 | GYNO-PEVARYL VAG-SUPP DEP | Gyno-Pevaryl Depot 150 mg - Vaginalzäpfchen | 1.2.40.0.34.4.17:1-18167 | GA - zugelassen | Karo Healthcare AB | true | false | 2 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G01AF05 | Econazol | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1709603 | ECONAZOL NITRAT | 1.2.40.0.34.5.221:100000092986 | ECONAZOLE NITRATE | active | 150 | mg | 1.2.40.0.34.5.221:100000092986 | ECONAZOLE NITRATE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073815 | Vaginalzäpfchen | true | human | 1.2.40.0.34.4.26:924603001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0944385 | HAEMOCOMPLETTAN P PLV 1G | Haemocomplettan P 1g/2g Pulver zur Herstellung einer Injektions-/Infusionslösung | 1.2.40.0.34.4.17:2-00136 | GA - zugelassen | CSL Behring GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B02BB01 | Fibrinogen, human | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708666 | FIBRINOGEN | 1.2.40.0.34.5.221:100000090630 | HUMAN FIBRINOGEN | active | 900 | mg | 1.2.40.0.34.5.221:100000090630 | HUMAN FIBRINOGEN | 900 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:929395001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0944712 | PROXEN FTBL 500MG | Proxen 500 mg - Filmtabletten | 1.2.40.0.34.4.17:17231 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE02 | Naproxen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708562 | NAPROXEN | 1.2.40.0.34.5.221:100000090383 | NAPROXEN | active | 500 | mg | 1.2.40.0.34.5.221:100000090383 | NAPROXEN | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:921076002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0944801 | ULSAL FTBL 150MG | Ulsal 150 mg - Filmtabletten | 1.2.40.0.34.4.17:1-17368 | GA - aufgehoben | Gebro Pharma GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA02 | Ranitidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708596 | RANITIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | active | 168 | mg | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | 168 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922198001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0944818 | ULSAL FTBL 150MG | Ulsal 150 mg - Filmtabletten | 1.2.40.0.34.4.17:1-17368 | GA - aufgehoben | Gebro Pharma GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA02 | Ranitidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708596 | RANITIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | active | 168 | mg | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | 168 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922198002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0944876 | ZANTAC FTBL 150MG | Zantac 150 mg - Filmtabletten | 1.2.40.0.34.4.17:1-17373 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA02 | Ranitidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708596 | RANITIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | active | 168 | mg | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | 168 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:921933002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0944882 | ZANTAC FTBL 150MG | Zantac 150 mg - Filmtabletten | 1.2.40.0.34.4.17:1-17373 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA02 | Ranitidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708596 | RANITIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | active | 168 | mg | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | 168 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:921933001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0948851 | PANTOGAR KPS | Pantogar - Kapseln | 1.2.40.0.34.4.17:1-18177 | GA - zugelassen | Merz Pharma Austria GmbH | true | true | 90 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:D11AX | Andere Dermatika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708612 | CALCIUM PANTOTHENAT | 1.2.40.0.34.5.221:100000090485 | CALCIUM PANTOTHENATE | active | 60 | mg | 1.2.40.0.34.5.221:100000090485 | CALCIUM PANTOTHENATE | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | false | human | 1.2.40.0.34.4.26:123867003 | 1.2.40.0.34.5.156:1708749 | CYSTIN | 1.2.40.0.34.5.221:100000091082 | CYSTINE | active | 220 | mg | 1.2.40.0.34.5.221:100000091082 | CYSTINE | 220 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0955696 | MOLSIDOLAT TBL 4MG | Molsidolat 4 mg Tabletten | 1.2.40.0.34.4.17:1-18224 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01DX12 | Molsidomin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709069 | MOLSIDOMIN | 1.2.40.0.34.5.221:100000091923 | MOLSIDOMINE | active | 4 | mg | 1.2.40.0.34.5.221:100000091923 | MOLSIDOMINE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923005001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0955704 | MOLSIDOLAT TBL 4MG | Molsidolat 4 mg Tabletten | 1.2.40.0.34.4.17:1-18224 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01DX12 | Molsidomin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709069 | MOLSIDOMIN | 1.2.40.0.34.5.221:100000091923 | MOLSIDOMINE | active | 4 | mg | 1.2.40.0.34.5.221:100000091923 | MOLSIDOMINE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923005002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0955710 | PRONERV AMP 2ML | Neuromultivit - Ampullen | 1.2.40.0.34.4.17:1-18025 | GA - zugelassen | G.L. Pharma GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A11DB | Vitamin-B1 in Kombination mit Vitamin-B6 und/oder Vitamin-B12 | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | 1 | mg | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923907001 | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 100 | mg | 1.2.40.0.34.5.156:1708752 | THIAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | active | 110 | mg | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | 110 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0955727 | PRONERV KPS | Pronerv - Kapseln | 1.2.40.0.34.4.17:1-18087 | GA - zugelassen | G.L. Pharma GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A11DB | Vitamin-B1 in Kombination mit Vitamin-B6 und/oder Vitamin-B12 | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | 0.5 | mg | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:923908001 | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 200 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 200 | mg | 1.2.40.0.34.5.156:1709249 | THIAMIN NITRAT | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | active | 110 | mg | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | 110 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0955733 | PRONERV KPS | Pronerv - Kapseln | 1.2.40.0.34.4.17:1-18087 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A11DB | Vitamin-B1 in Kombination mit Vitamin-B6 und/oder Vitamin-B12 | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | 0.5 | mg | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:923908002 | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 200 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 200 | mg | 1.2.40.0.34.5.156:1709249 | THIAMIN NITRAT | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | active | 110 | mg | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | 110 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0955756 | RENITEC TBL 5MG | Renitec 5 mg Tabletten | 1.2.40.0.34.4.17:1-18172 | GA - zugelassen | Organon Healthcare GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA02 | Enalapril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708809 | ENALAPRIL MALEAT | 1.2.40.0.34.5.221:100000091343 | ENALAPRIL MALEATE | active | 5 | mg | 1.2.40.0.34.5.221:100000091343 | ENALAPRIL MALEATE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:926994005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0955762 | RENITEC TBL 10MG | Renitec 10 mg Tabletten | 1.2.40.0.34.4.17:1-18173 | GA - zugelassen | Organon Healthcare GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA02 | Enalapril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708809 | ENALAPRIL MALEAT | 1.2.40.0.34.5.221:100000091343 | ENALAPRIL MALEATE | active | 10 | mg | 1.2.40.0.34.5.221:100000091343 | ENALAPRIL MALEATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:926992002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0955779 | RENITEC TBL 20MG | Renitec 20 mg Tabletten | 1.2.40.0.34.4.17:1-18174 | GA - zugelassen | Organon Healthcare GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA02 | Enalapril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708809 | ENALAPRIL MALEAT | 1.2.40.0.34.5.221:100000091343 | ENALAPRIL MALEATE | active | 20 | mg | 1.2.40.0.34.5.221:100000091343 | ENALAPRIL MALEATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:926993005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0960912 | TARIVID FTBL 200MG | Tarivid 200 mg Filmtabletten | 1.2.40.0.34.4.17:1-18215 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:J01MA01 | Ofloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709310 | OFLOXACIN | 1.2.40.0.34.5.221:100000092309 | OFLOXACIN | active | 200 | mg | 1.2.40.0.34.5.221:100000092309 | OFLOXACIN | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927139001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0960929 | TARIVID FTBL 200MG | Tarivid 200 mg Filmtabletten | 1.2.40.0.34.4.17:1-18215 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:J01MA01 | Ofloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709310 | OFLOXACIN | 1.2.40.0.34.5.221:100000092309 | OFLOXACIN | active | 200 | mg | 1.2.40.0.34.5.221:100000092309 | OFLOXACIN | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927139002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0960935 | TRACRIUM AMP 25MG 2,5ML | Tracrium 25 mg - Ampullen | 1.2.40.0.34.4.17:1-18232 | GA - aufgehoben | Aspen Pharma Trading Limited | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M03AC04 | Atracurium | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707312 | ATRACURIUM BESILAT | 1.2.40.0.34.5.221:100000085206 | ATRACURIUM BESILATE | active | 25 | mg | 1.2.40.0.34.5.221:100000085206 | ATRACURIUM BESILATE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:923567001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0960941 | TRACRIUM AMP 50MG 5ML | Tracrium 50 mg - Ampullen | 1.2.40.0.34.4.17:1-18233 | GA - aufgehoben | Aspen Pharma Trading Limited | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M03AC04 | Atracurium | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707312 | ATRACURIUM BESILAT | 1.2.40.0.34.5.221:100000085206 | ATRACURIUM BESILATE | active | 50 | mg | 1.2.40.0.34.5.221:100000085206 | ATRACURIUM BESILATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:922673001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967038 | CLAVERSAL FTBL 250MG | Claversal 250 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18368 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:A07EC02 | Mesalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709091 | MESALAZIN | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | active | 250 | mg | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927210001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967156 | BRONCHO-VAXOM KPS 3,5MG | Broncho - Vaxom 3,5 mg - Kapseln für Kinder | 1.2.40.0.34.4.17:2-00002 | GA - zugelassen | Omedicamed Unipessoal Lda. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R07AX | Andere Mittel für den Respirationstrakt | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712678 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:900000004292 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | active | | | 1.2.40.0.34.5.221:900000004292 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | | | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927137001 | 1.2.40.0.34.5.156:1712677 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:900000004291 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | active | | | 1.2.40.0.34.5.221:900000004291 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | | | 1.2.40.0.34.5.156:1710518 | MORAXELLA (BRANHAMELLA) | 1.2.40.0.34.5.221:900000000751 | MORAXELLA (BRANHAMELLA) | active | | | 1.2.40.0.34.5.221:900000000751 | MORAXELLA (BRANHAMELLA) | | | | | | | | | 1.2.40.0.34.5.156:1712657 | STAPHYLOCOCCUS SPEC. | 1.2.40.0.34.5.221:900000004248 | STAPHYLOCOCCUS SPEC. | active | | | 1.2.40.0.34.5.221:900000004248 | STAPHYLOCOCCUS SPEC. | | | 1.2.40.0.34.5.156:1705651 | KLEBSIELLA | 1.2.40.0.34.5.221:100000077067 | KLEBSIELLA PNEUMONIAE | active | | | 1.2.40.0.34.5.221:100000077067 | KLEBSIELLA PNEUMONIAE | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967162 | BRONCHO-VAXOM KPS 3,5MG | Broncho - Vaxom 3,5 mg - Kapseln für Kinder | 1.2.40.0.34.4.17:2-00002 | GA - zugelassen | Omedicamed Unipessoal Lda. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R07AX | Andere Mittel für den Respirationstrakt | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712678 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:900000004292 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | active | | | 1.2.40.0.34.5.221:900000004292 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | | | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927137002 | 1.2.40.0.34.5.156:1712677 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:900000004291 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | active | | | 1.2.40.0.34.5.221:900000004291 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | | | 1.2.40.0.34.5.156:1710518 | MORAXELLA (BRANHAMELLA) | 1.2.40.0.34.5.221:900000000751 | MORAXELLA (BRANHAMELLA) | active | | | 1.2.40.0.34.5.221:900000000751 | MORAXELLA (BRANHAMELLA) | | | | | | | | | 1.2.40.0.34.5.156:1712657 | STAPHYLOCOCCUS SPEC. | 1.2.40.0.34.5.221:900000004248 | STAPHYLOCOCCUS SPEC. | active | | | 1.2.40.0.34.5.221:900000004248 | STAPHYLOCOCCUS SPEC. | | | 1.2.40.0.34.5.156:1705651 | KLEBSIELLA | 1.2.40.0.34.5.221:100000077067 | KLEBSIELLA PNEUMONIAE | active | | | 1.2.40.0.34.5.221:100000077067 | KLEBSIELLA PNEUMONIAE | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967179 | BRONCHO-VAXOM KPS 7MG | Broncho - Vaxom 7 mg - Kapseln für Erwachsene | 1.2.40.0.34.4.17:2-00001 | GA - zugelassen | Omedicamed Unipessoal Lda. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R07AX | Andere Mittel für den Respirationstrakt | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712678 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:900000004292 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | active | | | 1.2.40.0.34.5.221:900000004292 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | | | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927136001 | 1.2.40.0.34.5.156:1712677 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:900000004291 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | active | | | 1.2.40.0.34.5.221:900000004291 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | | | 1.2.40.0.34.5.156:1710518 | MORAXELLA (BRANHAMELLA) | 1.2.40.0.34.5.221:900000000751 | MORAXELLA (BRANHAMELLA) | active | | | 1.2.40.0.34.5.221:900000000751 | MORAXELLA (BRANHAMELLA) | | | | | | | | | 1.2.40.0.34.5.156:1712657 | STAPHYLOCOCCUS SPEC. | 1.2.40.0.34.5.221:900000004248 | STAPHYLOCOCCUS SPEC. | active | | | 1.2.40.0.34.5.221:900000004248 | STAPHYLOCOCCUS SPEC. | | | 1.2.40.0.34.5.156:1705651 | KLEBSIELLA | 1.2.40.0.34.5.221:100000077067 | KLEBSIELLA PNEUMONIAE | active | | | 1.2.40.0.34.5.221:100000077067 | KLEBSIELLA PNEUMONIAE | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967185 | BRONCHO-VAXOM KPS 7MG | Broncho - Vaxom 7 mg - Kapseln für Erwachsene | 1.2.40.0.34.4.17:2-00001 | GA - zugelassen | Omedicamed Unipessoal Lda. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R07AX | Andere Mittel für den Respirationstrakt | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712678 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:900000004292 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | active | | | 1.2.40.0.34.5.221:900000004292 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | | | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927136002 | 1.2.40.0.34.5.156:1712677 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:900000004291 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | active | | | 1.2.40.0.34.5.221:900000004291 | STREPTOCOCCUS SPEC. /ENTEROCOCCUS (AUSZUG, PRODUKTE) | | | 1.2.40.0.34.5.156:1710518 | MORAXELLA (BRANHAMELLA) | 1.2.40.0.34.5.221:900000000751 | MORAXELLA (BRANHAMELLA) | active | | | 1.2.40.0.34.5.221:900000000751 | MORAXELLA (BRANHAMELLA) | | | | | | | | | 1.2.40.0.34.5.156:1712657 | STAPHYLOCOCCUS SPEC. | 1.2.40.0.34.5.221:900000004248 | STAPHYLOCOCCUS SPEC. | active | | | 1.2.40.0.34.5.221:900000004248 | STAPHYLOCOCCUS SPEC. | | | 1.2.40.0.34.5.156:1705651 | KLEBSIELLA | 1.2.40.0.34.5.221:100000077067 | KLEBSIELLA PNEUMONIAE | active | | | 1.2.40.0.34.5.221:100000077067 | KLEBSIELLA PNEUMONIAE | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967191 | CANESTEN CR | Canesten Clotrimazol - Creme | 1.2.40.0.34.4.17:15397 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D01AC01 | Clotrimazol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709166 | CLOTRIMAZOL | 1.2.40.0.34.5.221:100000092074 | CLOTRIMAZOLE | active | 0.3 | g | 1.2.40.0.34.5.221:100000092074 | CLOTRIMAZOLE | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | false | human | 1.2.40.0.34.4.26:126524001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967216 | COMBANTRIN KTBL 250MG | Combantrin 250 mg Kautabletten | 1.2.40.0.34.4.17:14824 | GA - zugelassen | INFECTOPHARM Arzneimittel und Consilium GmbH | true | true | 4 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:P02CC01 | Pyrantel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708155 | PYRANTEL EMBONAT | 1.2.40.0.34.5.221:100000089059 | PYRANTEL EMBONATE | active | 720 | mg | 1.2.40.0.34.5.221:100000089059 | PYRANTEL EMBONATE | 720 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073684 | Kautablette | true | human | 1.2.40.0.34.4.26:121158001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967274 | GENTAMICIN SAN AMP 40MG | Gentamicin Sandoz 40 mg - Ampullen | 1.2.40.0.34.4.17:1-18859 | GA - aufgehoben | Sandoz GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 312 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 220.090416 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927799001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967297 | GENTAMICIN SAN AMP 80MG | Gentamicin Sandoz 80 mg - Ampullen | 1.2.40.0.34.4.17:1-18856 | GA - aufgehoben | Sandoz GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 124.8 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 88.036166 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:927801002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967417 | NOLVADEX FTBL 20MG | Nolvadex 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18179 | GA - zugelassen | Astrazeneca Österreich GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:L02BA01 | Tamoxifen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708489 | TAMOXIFENCITRAT | 1.2.40.0.34.5.221:100000090201 | TAMOXIFEN CITRATE | active | 30.4 | mg | 1.2.40.0.34.5.221:100000090201 | TAMOXIFEN CITRATE | 30.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922521001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967423 | RAPIFEN AMP 1MG 2ML | Rapifen 1 mg - Ampullen | 1.2.40.0.34.4.17:1-18255 | GA - zugelassen | Piramal Critical Care B.V. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01AH02 | Alfentanil | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708580 | ALFENTANIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090424 | ALFENTANIL HYDROCHLORIDE | active | 1.088 | mg | 1.2.40.0.34.5.221:100000090424 | ALFENTANIL HYDROCHLORIDE | 1.088 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923553001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967452 | RETROVIR KPS 100MG | Retrovir 100 mg - Kapseln | 1.2.40.0.34.4.17:1-18276 | GA - aufgehoben | Viiv Healthcare B.V. | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J05AF01 | Zidovudin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707951 | ZIDOVUDIN | 1.2.40.0.34.5.221:100000088002 | ZIDOVUDINE | active | 100 | mg | 1.2.40.0.34.5.221:100000088002 | ZIDOVUDINE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927514003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967481 | SIRDALUD TBL 2MG | Sirdalud 2 mg - Tabletten | 1.2.40.0.34.4.17:1-18197 | GA - zugelassen | Sandoz GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M03BX02 | Tizanidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709012 | TIZANIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091800 | TIZANIDINE HYDROCHLORIDE | active | 2.288 | mg | 1.2.40.0.34.5.221:100000091800 | TIZANIDINE HYDROCHLORIDE | 2.288 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922157001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967506 | SIRDALUD TBL 4MG | Sirdalud 4 mg - Tabletten | 1.2.40.0.34.4.17:1-18196 | GA - zugelassen | Sandoz GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M03BX02 | Tizanidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709012 | TIZANIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091800 | TIZANIDINE HYDROCHLORIDE | active | 4.576 | mg | 1.2.40.0.34.5.221:100000091800 | TIZANIDINE HYDROCHLORIDE | 4.576 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922158001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967512 | SIRDALUD TBL 4MG | Sirdalud 4 mg - Tabletten | 1.2.40.0.34.4.17:1-18196 | GA - zugelassen | Sandoz GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M03BX02 | Tizanidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709012 | TIZANIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091800 | TIZANIDINE HYDROCHLORIDE | active | 4.576 | mg | 1.2.40.0.34.5.221:100000091800 | TIZANIDINE HYDROCHLORIDE | 4.576 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922158002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967558 | SUPREFACT DFL 1MG/ML | Suprefact 1 mg/ml Durchstechflasche | 1.2.40.0.34.4.17:1-18261 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 2 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L02AE01 | Buserelin | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1707155 | BUSERELIN ACETAT | 1.2.40.0.34.5.221:100000084837 | BUSERELIN ACETATE | active | 5.775 | mg | 1.2.40.0.34.5.221:100000084837 | BUSERELIN ACETATE | 5.775 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927115003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967570 | UNIFYL RET TBL 200MG | Unifyl retard 200 mg Tabletten | 1.2.40.0.34.4.17:1-18171 | GA - aufgehoben | Mundipharma Ges.m.b.H. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 200 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927043001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0967587 | UNIFYL RET TBL 200MG | Unifyl retard 200 mg Tabletten | 1.2.40.0.34.4.17:1-18171 | GA - aufgehoben | Mundipharma Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 200 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927043002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0981340 | ACTILYSE PLV +LSM DFL 50MG | Actilyse - Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung | 1.2.40.0.34.4.17:1-24717 | GA - zugelassen | Boehringer Ingelheim RCV GmbH & Co KG | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B01AD02 | Alteplase | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708405 | ALTEPLASE | 1.2.40.0.34.5.221:100000089921 | ALTEPLASE | active | 50 | mg | 1.2.40.0.34.5.221:100000089921 | ALTEPLASE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:945076003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0981386 | CIPROXIN FTBL 250MG | Ciproxin 250 mg Filmtabletten | 1.2.40.0.34.4.17:1-18295 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01MA02 | Ciprofloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708891 | CIPROFLOXACINHYDROCHLORID | 1.2.40.0.34.5.221:100000091536 | CIPROFLOXACIN HYDROCHLORIDE | active | 291 | mg | 1.2.40.0.34.5.221:100000091536 | CIPROFLOXACIN HYDROCHLORIDE | 291 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927318001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0981392 | CIPROXIN FTBL 250MG | Ciproxin 250 mg Filmtabletten | 1.2.40.0.34.4.17:1-18295 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01MA02 | Ciprofloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708891 | CIPROFLOXACINHYDROCHLORID | 1.2.40.0.34.5.221:100000091536 | CIPROFLOXACIN HYDROCHLORIDE | active | 291 | mg | 1.2.40.0.34.5.221:100000091536 | CIPROFLOXACIN HYDROCHLORIDE | 291 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927318007 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0981417 | CIPROXIN FTBL 500MG | Ciproxin 500 mg Filmtabletten | 1.2.40.0.34.4.17:1-18296 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01MA02 | Ciprofloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708891 | CIPROFLOXACINHYDROCHLORID | 1.2.40.0.34.5.221:100000091536 | CIPROFLOXACIN HYDROCHLORIDE | active | 582 | mg | 1.2.40.0.34.5.221:100000091536 | CIPROFLOXACIN HYDROCHLORIDE | 582 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927319001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0981423 | CIPROXIN FTBL 500MG | Ciproxin 500 mg Filmtabletten | 1.2.40.0.34.4.17:1-18296 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01MA02 | Ciprofloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708891 | CIPROFLOXACINHYDROCHLORID | 1.2.40.0.34.5.221:100000091536 | CIPROFLOXACIN HYDROCHLORIDE | active | 582 | mg | 1.2.40.0.34.5.221:100000091536 | CIPROFLOXACIN HYDROCHLORIDE | 582 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927319007 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0981481 | CIPROXIN IFL 100MG 50ML BP | Ciproxin 100 mg/50 ml Infusionslösung | 1.2.40.0.34.4.17:1-18293 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01MA02 | Ciprofloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709192 | CIPROFLOXACIN | 1.2.40.0.34.5.221:100000092110 | CIPROFLOXACIN | active | 2 | mg | 1.2.40.0.34.5.221:100000092110 | CIPROFLOXACIN | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927322002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0981558 | MUCOSPAS SFT | Mucospas - Saft | 1.2.40.0.34.4.17:1-18236 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CB10 | Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708459 | CLENBUTEROL HYDROCHLORID | 1.2.40.0.34.5.221:100000090108 | CLENBUTEROL HYDROCHLORIDE | active | 0.0001 | g | 1.2.40.0.34.5.221:100000090108 | CLENBUTEROL HYDROCHLORIDE | 0.0001 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:927026001 | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 0.15 | g | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 0.15 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0981564 | MUCOSPAS TBL | Mucospas - Tabletten | 1.2.40.0.34.4.17:1-18235 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R05CB10 | Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708459 | CLENBUTEROL HYDROCHLORID | 1.2.40.0.34.5.221:100000090108 | CLENBUTEROL HYDROCHLORIDE | active | 0.02 | mg | 1.2.40.0.34.5.221:100000090108 | CLENBUTEROL HYDROCHLORIDE | 0.02 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927025001 | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 30 | mg | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 30 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0985740 | ASCORBISAL TBL | Ascorbisal - Tabletten | 1.2.40.0.34.4.17:6696 | GA - zugelassen | G.L. Pharma GmbH | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BA51 | Acetylsalicylsäure, Kombinationen exkl. Psycholeptika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 20 | mg | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:120526001 | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 500 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0985786 | CAPOZIDE TBL FTE | Capozide forte Tabletten | 1.2.40.0.34.4.17:1-18153 | GA - aufgehoben | Bristol-Myers Squibb Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09BA01 | Captopril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709431 | CAPTOPRIL | 1.2.40.0.34.5.221:100000092557 | CAPTOPRIL | active | 50 | mg | 1.2.40.0.34.5.221:100000092557 | CAPTOPRIL | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927106006 | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 25 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0985906 | FELDEN LSB TBL 20MG | Felden 20 mg - Tabletten zur Herstellung einer Suspension zum Einnehmen | 1.2.40.0.34.4.17:1-18280 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M01AC01 | Piroxicam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709404 | PIROXICAM | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | active | 20 | mg | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073654 | Tablette zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:927011002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0985912 | FELDEN LSB TBL 20MG | Felden 20 mg - Tabletten zur Herstellung einer Suspension zum Einnehmen | 1.2.40.0.34.4.17:1-18280 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M01AC01 | Piroxicam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709404 | PIROXICAM | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | active | 20 | mg | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073654 | Tablette zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:927011003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0985993 | ISOPTIN RET FTBL 120MG | Isoptin retard 120 mg - Filmtabletten | 1.2.40.0.34.4.17:1-16150 | GA - zugelassen | Viatris Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 120 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 120 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:123980001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0986001 | ISOPTIN RET FTBL 120MG | Isoptin retard 120 mg - Filmtabletten | 1.2.40.0.34.4.17:1-16150 | GA - zugelassen | Viatris Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 120 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 120 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:123980002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0986018 | JOPAMIRO 300MG STAMP 70ML | Jopamiro 300 mg J/ml - Stechampullen | 1.2.40.0.34.4.17:17302 | GA - zugelassen | Bracco Österreich GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 45900 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 45900 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920664012 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0986024 | JOPAMIRO 370MG J/ML DFL 70ML | Jopamiro 370 mg J/ml - Stechampullen | 1.2.40.0.34.4.17:17304 | GA - zugelassen | Bracco Österreich GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 52850 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 52850 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920665009 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0986136 | SOLCOSERYL DENT ADHAESIV PST | Solcoseryl 2,125 mg/g + 10 mg/g Dentalpaste | 1.2.40.0.34.4.17:2-00003 | GA - zugelassen | Viatris Austria GmbH | true | false | 5 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:A01AD11 | Verschiedene | 1.2.40.0.10.1.4.3.4.3.4:100000073578 | Anwendung am Zahnfleisch | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | 1.2.40.0.34.5.156:1710184 | DEPROTEINISIERTES HAEMODERIVAT AUS KÄLBERBLUT | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | active | 1.06 | g | 1.2.40.0.34.5.221:900000000415 | DEPROTEINIZED HEMODERIVATIVE OF CALF BLOOD | 1.06 | g | 1.2.40.0.10.1.4.3.4.3.5:900000000034 | Dentalpaste (alt) | true | human | 1.2.40.0.34.4.26:922030001 | 1.2.40.0.34.5.156:9786300 | LAUROMACROGOL 400 | 1.2.40.0.34.5.221:100000086663 | LAUROMACROGOL 400 | active | 5 | g | 1.2.40.0.34.5.221:100000086663 | LAUROMACROGOL 400 | 5 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0986142 | TAUROLIN CHIR.SPLSG 0,5% | Taurolin (Taurolidin "Geistlich") 0,5% - chirurgische Spüllösung | 1.2.40.0.34.4.17:1-18259 | GA - aufgehoben | Chemomedica GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:B05CA05 | Taurolidin | 1.2.40.0.10.1.4.3.4.3.4:100000073604 | intraperitoneale Anwendung | | | | | 1.2.40.0.34.5.156:1706756 | TAUROLIDIN | 1.2.40.0.34.5.221:100000082427 | TAUROLIDINE | active | 5 | mg | 1.2.40.0.34.5.221:100000082427 | TAUROLIDINE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073924 | Spüllösung | true | human | 1.2.40.0.34.4.26:921715001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0986159 | TAUROLIN INSTILL 2% 100ML | Taurolin (Taurolidin "Geistlich") 2% - Instillationslösung | 1.2.40.0.34.4.17:1-18260 | GA - aufgehoben | Chemomedica GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B05CA05 | Taurolidin | 1.2.40.0.10.1.4.3.4.3.4:100000073604 | intraperitoneale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | | | 1.2.40.0.34.5.156:1706756 | TAUROLIDIN | 1.2.40.0.34.5.221:100000082427 | TAUROLIDINE | active | 20 | g | 1.2.40.0.34.5.221:100000082427 | TAUROLIDINE | 20 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074040 | Lösung zur intraperitonealen Anwendung | true | human | 1.2.40.0.34.4.26:921716001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0986165 | TAUROLIN INSTILL 2% 250ML | Taurolin (Taurolidin "Geistlich") 2% - Instillationslösung | 1.2.40.0.34.4.17:1-18260 | GA - aufgehoben | Chemomedica GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B05CA05 | Taurolidin | 1.2.40.0.10.1.4.3.4.3.4:100000073604 | intraperitoneale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | | | 1.2.40.0.34.5.156:1706756 | TAUROLIDIN | 1.2.40.0.34.5.221:100000082427 | TAUROLIDINE | active | 20 | g | 1.2.40.0.34.5.221:100000082427 | TAUROLIDINE | 20 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074040 | Lösung zur intraperitonealen Anwendung | true | human | 1.2.40.0.34.4.26:921716002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0986188 | YAL-KLIS FLASCHE 67,5ML | Yal - Klistier | 1.2.40.0.34.4.17:1-18252 | GA - aufgehoben | Jacoby GM Pharma GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A06AD | Osmotisch wirkende Laxanzien | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709123 | DOCUSAT NATRIUM | 1.2.40.0.34.5.221:100000092012 | DOCUSATE SODIUM | active | 0.01 | g | 1.2.40.0.34.5.221:100000092012 | DOCUSATE SODIUM | 0.01 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073829 | Rektallösung | true | human | 1.2.40.0.34.4.26:922935001 | 1.2.40.0.34.5.156:1709182 | SORBITOL | 1.2.40.0.34.5.221:100000092096 | SORBITOL (E420) | active | 13.4 | g | 1.2.40.0.34.5.221:100000092096 | SORBITOL (E420) | 13.4 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0990534 | AZACTAM TRSTAMP 1G BP10X1 | Azactam 1 g - Trockenstechampulle | 1.2.40.0.34.4.17:1-18328 | GA - zugelassen | Bristol-Myers Squibb Ges.m.b.H. | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:J01DF01 | Aztreonam | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708922 | AZTREONAM | 1.2.40.0.34.5.221:100000091595 | AZTREONAM | active | | | 1.2.40.0.34.5.221:100000091595 | AZTREONAM | | | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0990557 | AZACTAM TRSTAMP 2G BP10X1 | Azactam 2 g - Trockenstechampulle | 1.2.40.0.34.4.17:1-18329 | GA - zugelassen | Bristol-Myers Squibb Ges.m.b.H. | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:J01DF01 | Aztreonam | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708922 | AZTREONAM | 1.2.40.0.34.5.221:100000091595 | AZTREONAM | active | | | 1.2.40.0.34.5.221:100000091595 | AZTREONAM | | | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0990592 | BENOXINAT LSG 1% | Benoxinat 1% - Lösung zur Anästhesie in der Oto-Rhino-Laryngologie | 1.2.40.0.34.4.17:8074 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01HA02 | Oxybuprocain | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073564 | Anwendung am Ohr | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1707436 | OXYBUPROCAIN HYDROCHLORID | 1.2.40.0.34.5.221:100000085509 | OXYBUPROCAINE HYDROCHLORIDE | active | 0.1 | g | 1.2.40.0.34.5.221:100000085509 | OXYBUPROCAINE HYDROCHLORIDE | 0.1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073752 | Lösung zum Auftropfen | true | human | 1.2.40.0.34.4.26:122041001 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:N01BA | Ester der Aminobenzoesäure | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | 1.2.40.0.10.1.4.3.4.3.4:100000073621 | zur Anwendung im Mund- und Rachenraum | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073570 | Anwendung in den Nebenhöhlen | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0990646 | DIANE MTE DRG | Diane mite - Dragees | 1.2.40.0.34.4.17:1-18338 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 21 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03HB01 | Cyproteron und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.035 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.035 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:927401001 | 1.2.40.0.34.5.156:1708539 | CYPROTERON ACETAT | 1.2.40.0.34.5.221:100000090321 | CYPROTERONE ACETATE | active | 2 | mg | 1.2.40.0.34.5.221:100000090321 | CYPROTERONE ACETATE | 2 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0990652 | DIANE MTE DRG 3X21 | Diane mite - Dragees | 1.2.40.0.34.4.17:1-18338 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 63 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03HB01 | Cyproteron und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.035 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.035 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:927401002 | 1.2.40.0.34.5.156:1708539 | CYPROTERON ACETAT | 1.2.40.0.34.5.221:100000090321 | CYPROTERONE ACETATE | active | 2 | mg | 1.2.40.0.34.5.221:100000090321 | CYPROTERONE ACETATE | 2 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0990706 | LANITOP TBL 0,1MG | Lanitop 0,1 mg - Tabletten | 1.2.40.0.34.4.17:14953 | GA - zugelassen | Esteve Pharmaceuticals GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01AA08 | Metildigoxin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708866 | METILDIGOXIN | 1.2.40.0.34.5.221:100000091460 | METILDIGOXIN | active | 0.1 | mg | 1.2.40.0.34.5.221:100000091460 | METILDIGOXIN | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:125018002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0990712 | LANITOP TBL 0,1MG | Lanitop 0,1 mg - Tabletten | 1.2.40.0.34.4.17:14953 | GA - zugelassen | Esteve Pharmaceuticals GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01AA08 | Metildigoxin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708866 | METILDIGOXIN | 1.2.40.0.34.5.221:100000091460 | METILDIGOXIN | active | 0.1 | mg | 1.2.40.0.34.5.221:100000091460 | METILDIGOXIN | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:125018001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
0990735 | MUCOSOLVAN RET KPS 75MG | Mucosolvan 1x täglich 75 mg - Retardkapseln | 1.2.40.0.34.4.17:1-18234 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R05CB06 | Ambroxol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 75 | mg | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:923566002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1015765 | ACNE PLUS CR WIDMER | Acne Plus - Creme Widmer | 1.2.40.0.34.4.17:1-18281 | GA - zugelassen | Louis Widmer GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D10AE51 | Benzoylperoxid, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709041 | MICONAZOL NITRAT | 1.2.40.0.34.5.221:100000091859 | MICONAZOLE NITRATE | active | 0.6 | g | 1.2.40.0.34.5.221:100000091859 | MICONAZOLE NITRATE | 0.6 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:921415001 | 1.2.40.0.34.5.156:1707256 | BENZOYLPEROXID | 1.2.40.0.34.5.221:100000085061 | BENZOYL PEROXIDE | active | 1.5 | g | 1.2.40.0.34.5.221:100000085061 | BENZOYL PEROXIDE | 1.5 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1015883 | CISORDINOL ACU AMP 50MG/1ML | Cisordinol Acutard 50 mg - Ampullen | 1.2.40.0.34.4.17:1-18331 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05AF05 | Zuclopenthixol | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708003 | ZUCLOPENTHIXOL ACETAT | 1.2.40.0.34.5.221:100000088298 | ZUCLOPENTHIXOL ACETATE | active | 50 | mg | 1.2.40.0.34.5.221:100000088298 | ZUCLOPENTHIXOL ACETATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927369002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1015972 | EXODERIL CR 1% | Exoderil 1% - Creme | 1.2.40.0.34.4.17:1-17911 | GA - zugelassen | Sandoz GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D01AE22 | Naftifin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707486 | NAFTIFIN HYDROCHLORID | 1.2.40.0.34.5.221:100000085708 | NAFTIFINE HYDROCHLORIDE | active | 0.3 | g | 1.2.40.0.34.5.221:100000085708 | NAFTIFINE HYDROCHLORIDE | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:922066001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1016061 | LANITOP TBL 0,15MG | Lanitop 0,15 mg - Tabletten | 1.2.40.0.34.4.17:1-18222 | GA - aufgehoben | Esteve Pharmaceuticals GmbH | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01AA08 | Metildigoxin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708866 | METILDIGOXIN | 1.2.40.0.34.5.221:100000091460 | METILDIGOXIN | active | 0.15 | mg | 1.2.40.0.34.5.221:100000091460 | METILDIGOXIN | 0.15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922313001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1016078 | LANITOP TBL 0,15MG | Lanitop 0,15 mg - Tabletten | 1.2.40.0.34.4.17:1-18222 | GA - aufgehoben | Esteve Pharmaceuticals GmbH | false | false | 84 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01AA08 | Metildigoxin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708866 | METILDIGOXIN | 1.2.40.0.34.5.221:100000091460 | METILDIGOXIN | active | 0.15 | mg | 1.2.40.0.34.5.221:100000091460 | METILDIGOXIN | 0.15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922313002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1016138 | NOZINAN FTBL 25MG | Nozinan 25 mg - Filmtabletten | 1.2.40.0.34.4.17:10816 | GA - zugelassen | G.L. Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AA02 | Levomepromazin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709544 | LEVOMEPROMAZIN HYDROGENMALEAT | 1.2.40.0.34.5.221:100000092766 | LEVOMEPROMAZINE HYDROGENMALEATE | active | 33.83 | mg | 1.2.40.0.34.5.221:100000092766 | LEVOMEPROMAZINE HYDROGENMALEATE | 33.83 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:925915002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1016144 | NOZINAN FTBL 25MG | Nozinan 25 mg - Filmtabletten | 1.2.40.0.34.4.17:10816 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AA02 | Levomepromazin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709544 | LEVOMEPROMAZIN HYDROGENMALEAT | 1.2.40.0.34.5.221:100000092766 | LEVOMEPROMAZINE HYDROGENMALEATE | active | 33.83 | mg | 1.2.40.0.34.5.221:100000092766 | LEVOMEPROMAZINE HYDROGENMALEATE | 33.83 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:925915001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1016150 | NOZINAN FTBL 100MG | Nozinan 100 mg - Filmtabletten | 1.2.40.0.34.4.17:13131 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AA02 | Levomepromazin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709544 | LEVOMEPROMAZIN HYDROGENMALEAT | 1.2.40.0.34.5.221:100000092766 | LEVOMEPROMAZINE HYDROGENMALEATE | active | 135.34 | mg | 1.2.40.0.34.5.221:100000092766 | LEVOMEPROMAZINE HYDROGENMALEATE | 135.34 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922027001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1016167 | OVESTIN OVULA | Ovestin - Ovula | 1.2.40.0.34.4.17:1-18286 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 15 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03CA04 | Estriol | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1709511 | ESTRIOL | 1.2.40.0.34.5.221:100000092668 | ESTRIOL | active | 0.5 | mg | 1.2.40.0.34.5.221:100000092668 | ESTRIOL | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073815 | Vaginalzäpfchen | true | human | 1.2.40.0.34.4.26:924795001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1016210 | TARDYFERON FOL RETARDTBL | Tardyferon Fol Retardtabletten | 1.2.40.0.34.4.17:16520 | GA - zugelassen | Pierre Fabre Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B03AD03 | Eisen(II)sulfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707468 | FOLSÄURE | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | active | 0.35 | mg | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | 0.35 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:126126002 | 1.2.40.0.34.5.156:7409854 | EISEN(II)-SULFAT, GETROCKNETES | 1.2.40.0.34.5.221:100000163619 | FERROUS SULFATE, DRIED | active | 247.25 | mg | 1.2.40.0.34.5.221:100000163619 | FERROUS SULFATE, DRIED | 247.25 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1018367 | CLAVERSAL SUPP 500MG | Claversal 500 mg - Zäpfchen | 1.2.40.0.34.4.17:1-18371 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 15 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:A07EC02 | Mesalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709091 | MESALAZIN | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | active | 500 | mg | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:927211001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1018396 | CLAVERSAL SUPP 250MG | Claversal 250 mg - Zäpfchen | 1.2.40.0.34.4.17:1-18370 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 15 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:A07EC02 | Mesalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709091 | MESALAZIN | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | active | 0.25 | g | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | 0.25 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:927212001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1021317 | PROFENID KPS 50MG | Profenid 50 mg Kapseln | 1.2.40.0.34.4.17:15652 | GA - zugelassen | Sanofi-Aventis GmbH | true | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE03 | Ketoprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708999 | KETOPROFEN | 1.2.40.0.34.5.221:100000091768 | KETOPROFEN | active | 50 | mg | 1.2.40.0.34.5.221:100000091768 | KETOPROFEN | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:120645001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1023322 | ANEXATE INJ AMP 0,5MG/5ML | Anexate 0,5 mg - Injektionslösung | 1.2.40.0.34.4.17:1-18341 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AB25 | Flumazenil | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1706462 | FLUMAZENIL | 1.2.40.0.34.5.221:100000080704 | FLUMAZENIL | active | 0.5 | mg | 1.2.40.0.34.5.221:100000080704 | FLUMAZENIL | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927535001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1023339 | ANEXATE INJ AMP 1MG/10ML | Anexate 1 mg - Injektionslösung | 1.2.40.0.34.4.17:1-18342 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AB25 | Flumazenil | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1706462 | FLUMAZENIL | 1.2.40.0.34.5.221:100000080704 | FLUMAZENIL | active | 1 | mg | 1.2.40.0.34.5.221:100000080704 | FLUMAZENIL | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927536001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1023368 | DEFLAMAT AMP 75MG/3ML | Deflamat 75 mg - Ampullen | 1.2.40.0.34.4.17:1-18303 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 75 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:927292001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1023397 | DEFLAMAT KPS 50MG | Deflamat 50 mg - Kapseln | 1.2.40.0.34.4.17:1-18302 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927289002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1023405 | DEFLAMAT KPS 50MG | Deflamat 50 mg - Kapseln | 1.2.40.0.34.4.17:1-18302 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927289003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1023428 | DEFLAMAT SUPP 100MG | Deflamat 100 mg - Suppositorien | 1.2.40.0.34.4.17:1-18306 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:927291001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1023434 | DEFLAMAT RET KPS 100MG | Deflamat retard 100 mg - Kapseln | 1.2.40.0.34.4.17:1-18305 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:927155001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1023440 | DEFLAMAT RET KPS 100MG | Deflamat retard 100 mg - Kapseln | 1.2.40.0.34.4.17:1-18305 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:927155002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1023552 | RHEUMON GEL | Rheumon - Gel | 1.2.40.0.34.4.17:1-16487 | GA - zugelassen | Viatris Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA06 | Etofenamat | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709468 | ETOFENAMAT | 1.2.40.0.34.5.221:100000092609 | ETOFENAMATE | active | 5 | g | 1.2.40.0.34.5.221:100000092609 | ETOFENAMATE | 5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:125767001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1023569 | TRAUMON GEL | Traumon - Gel | 1.2.40.0.34.4.17:1-18380 | GA - zugelassen | Viatris Austria GmbH | true | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA06 | Etofenamat | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709468 | ETOFENAMAT | 1.2.40.0.34.5.221:100000092609 | ETOFENAMATE | active | 4 | g | 1.2.40.0.34.5.221:100000092609 | ETOFENAMATE | 4 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:927381002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1023575 | TRAUMON GEL | Traumon - Gel | 1.2.40.0.34.4.17:1-18380 | GA - zugelassen | Viatris Austria GmbH | true | false | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA06 | Etofenamat | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709468 | ETOFENAMAT | 1.2.40.0.34.5.221:100000092609 | ETOFENAMATE | active | 10 | g | 1.2.40.0.34.5.221:100000092609 | ETOFENAMATE | 10 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:927381001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1023581 | TUSSIMONT HU-SFT THYMIAN+SEN | TUSSIMONT HUSTENSAFT mit Thymian und Senegawurzel | 1.2.40.0.34.4.17:736772 | GA - registriert | Pharmonta Dr. Fischer GmbH | true | true | 180 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05X | Andere Kombinationspräparate gegen Erkältungskrankheiten | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710651 | POLYGALAE RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000000884 | POLYGALAE RADIX (EXTRACT) | active | 540 | g | 1.2.40.0.34.5.221:900000000884 | POLYGALAE RADIX (EXTRACT) | 540 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073645 | Flüssigkeit zum Einnehmen | false | human | 1.2.40.0.34.4.26:958576002 | 1.2.40.0.34.5.156:1710828 | THYMI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001063 | THYMI HERBA (EXTRACT) | active | 1800 | g | 1.2.40.0.34.5.221:900000001063 | THYMI HERBA (EXTRACT) | 1800 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1025858 | HELIXOR-A AMP EX 1MG 1ML | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013012 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1025864 | HELIXOR-A AMP EX 1MG 1ML | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1025870 | HELIXOR-A AMP EX 5MG 1ML | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013016 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1025887 | HELIXOR-A AMP EX 5MG 1ML | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013009 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1025893 | HELIXOR-A AMP EX 10MG 1ML | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013013 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1025901 | HELIXOR-A AMP EX 10MG 1ML | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1025918 | HELIXOR-A AMP EX 20MG 1ML | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013014 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1025924 | HELIXOR-A AMP EX 20MG 1ML | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013007 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1025930 | HELIXOR-A AMP EX 30MG 1ML | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013015 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1025947 | HELIXOR-A AMP EX 30MG 1ML | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013008 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1025953 | HELIXOR-A AMP EX 50MG 1ML | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013017 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1025976 | HELIXOR-A AMP EX 50MG 1ML | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013010 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1025982 | HELIXOR-A AMP EX 100MG 2ML | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013018 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1025999 | HELIXOR-A AMP EX 100MG 2ML | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013011 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026007 | HELIXOR-A AMP SERIENP.1 | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026013 | HELIXOR-A AMP SERIENP.2 | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026036 | HELIXOR-A AMP SERIENP.3 | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026042 | HELIXOR-A AMP SERIENP.4 | Helixor A (Abietis) - Ampullen | 1.2.40.0.34.4.17:1-18311 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921013004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026059 | HELIXOR-M AMP EX 1MG 1ML | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620012 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026065 | HELIXOR-M AMP EX 1MG 1ML | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026071 | HELIXOR-M AMP EX 5MG 1ML | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620016 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026088 | HELIXOR-M AMP EX 5MG 1ML | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620009 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026094 | HELIXOR-M AMP EX 10MG 1ML | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620013 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026102 | HELIXOR-M AMP EX 10MG 1ML | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026119 | HELIXOR-M AMP EX 20MG 1ML | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620014 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026125 | HELIXOR-M AMP EX 20MG 1ML | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620007 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026131 | HELIXOR-M AMP EX 30MG 1ML | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620015 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026148 | HELIXOR-M AMP EX 30MG 1ML | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620008 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026154 | HELIXOR-M AMP EX 50MG 1ML | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620017 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026160 | HELIXOR-M AMP EX 50MG 1ML | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620010 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026177 | HELIXOR-M AMP EX 100MG 2ML | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620018 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026183 | HELIXOR-M AMP EX 100MG 2ML | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620011 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026208 | HELIXOR-M AMP SERIENP.1 | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026214 | HELIXOR-M AMP SERIENP.2 | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026220 | HELIXOR-M AMP SERIENP.3 | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026237 | HELIXOR-M AMP SERIENP.4 | Helixor M (Mali) - Ampullen | 1.2.40.0.34.4.17:1-18310 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923620004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026243 | HELIXOR-P AMP EX 1MG 1ML | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629012 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026266 | HELIXOR-P AMP EX 1MG 1ML | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026272 | HELIXOR-P AMP EX 5MG 1ML | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629016 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026289 | HELIXOR-P AMP EX 5MG 1ML | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629009 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026295 | HELIXOR-P AMP EX 10MG 1ML | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629013 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026303 | HELIXOR-P AMP EX 10MG 1ML | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026326 | HELIXOR-P AMP EX 20MG 1ML | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629014 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026332 | HELIXOR-P AMP EX 20MG 1ML | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629007 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026349 | HELIXOR-P AMP EX 30MG 1ML | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629015 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026355 | HELIXOR-P AMP EX 30MG 1ML | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629008 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026361 | HELIXOR-P AMP EX 50MG 1ML | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629017 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026378 | HELIXOR-P AMP EX 50MG 1ML | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629010 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026384 | HELIXOR-P AMP EX 100MG 2ML | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629018 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026390 | HELIXOR-P AMP EX 100MG 2ML | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629011 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026409 | HELIXOR-P AMP SERIENP.1 | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026415 | HELIXOR-P AMP SERIENP.2 | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026421 | HELIXOR-P AMP SERIENP.3 | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1026438 | HELIXOR-P AMP SERIENP.4 | Helixor P (Pini) - Ampullen | 1.2.40.0.34.4.17:1-18312 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AX | Andere therapeutische Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1710885 | VISCI ALBI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | active | 4307.44 | mg | 1.2.40.0.34.5.221:900000001120 | VISCI ALBI HERBA (EXTRACT) | 4307.44 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923629004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1032321 | VOLTAREN EMULGEL-GEL | Voltaren Emulgel - Gel | 1.2.40.0.34.4.17:1-18355 | GA - zugelassen | Novartis Pharma GmbH | true | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA15 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | 1.2.40.0.34.5.156:1708742 | DICLOFENAC DIETHYLAMIN | 1.2.40.0.34.5.221:100000091074 | DICLOFENAC DIETHYLAMINE | active | 0.464 | g | 1.2.40.0.34.5.221:100000091074 | DICLOFENAC DIETHYLAMINE | 0.464 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:927434003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1033616 | JOPAMIRO 300MG STAMP 70ML | Jopamiro 300 mg J/ml - Stechampullen | 1.2.40.0.34.4.17:17302 | GA - zugelassen | Bracco Österreich GmbH | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | | | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1033622 | JOPAMIRO 370MG J/ML DFL 70ML | Jopamiro 370 mg J/ml - Stechampullen | 1.2.40.0.34.4.17:17304 | GA - zugelassen | Bracco Österreich GmbH | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 52850 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 52850 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920665005 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1033680 | RIDAURA FTBL | Ridaura - Filmtabletten | 1.2.40.0.34.4.17:17790 | GA - aufgehoben | Mercury Pharmaceuticals Limited | false | false | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:M01CB03 | Auranofin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707687 | AURANOFIN | 1.2.40.0.34.5.221:100000086659 | AURANOFIN | active | 3 | mg | 1.2.40.0.34.5.221:100000086659 | AURANOFIN | 3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:921968002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1040651 | CUROCEF TRSTAMP 1500MG BP5X1 | Curocef 1500 mg Pulver zur Herstellung einer Injektions- oder Infusionslösung | 1.2.40.0.34.4.17:16569 | GA - zugelassen | Sandoz GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01DC02 | Cefuroxim | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708850 | CEFUROXIM-NATRIUM | 1.2.40.0.34.5.221:100000091436 | CEFUROXIME SODIUM | active | 1578 | mg | 1.2.40.0.34.5.221:100000091436 | CEFUROXIME SODIUM | 1578 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:128827002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1040674 | CUROCEF TRSUB 1500MG BP5X1 | Curocef 1500 mg Pulver zur Herstellung einer Infusionslösung in einer Einzelampulle | 1.2.40.0.34.4.17:16570 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01DC02 | Cefuroxim | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708850 | CEFUROXIM-NATRIUM | 1.2.40.0.34.5.221:100000091436 | CEFUROXIME SODIUM | active | 1578 | mg | 1.2.40.0.34.5.221:100000091436 | CEFUROXIME SODIUM | 1578 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:128818002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1040792 | MINPROG IKONZ AMP 500MCG/1ML | Minprog 500 Mikrogramm - Konzentrat zur Herstellung einer Infusionslösung | 1.2.40.0.34.4.17:1-18290 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C01EA01 | Alprostadil | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709309 | ALPROSTADIL | 1.2.40.0.34.5.221:100000092306 | ALPROSTADIL | active | 0.5 | mg | 1.2.40.0.34.5.221:100000092306 | ALPROSTADIL | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:923659001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1040800 | MUNDIDOL RET FTBL 60MG | Mundidol retard 60 mg Filmtabletten | 1.2.40.0.34.4.17:1-18375 | GA - zugelassen | Mundipharma Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705405 | MORPHINSULFAT | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | active | 60 | mg | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927264001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1040817 | MUNDIDOL RET FTBL 60MG | Mundidol retard 60 mg Filmtabletten | 1.2.40.0.34.4.17:1-18375 | GA - zugelassen | Mundipharma Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705405 | MORPHINSULFAT | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | active | 60 | mg | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927264002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1040823 | MUNDIDOL RET FTBL 100MG | Mundidol retard 100 mg Filmtabletten | 1.2.40.0.34.4.17:1-18376 | GA - zugelassen | Mundipharma Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705405 | MORPHINSULFAT | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | active | 100 | mg | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927265001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1040846 | MUNDIDOL RET FTBL 100MG | Mundidol retard 100 mg Filmtabletten | 1.2.40.0.34.4.17:1-18376 | GA - zugelassen | Mundipharma Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705405 | MORPHINSULFAT | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | active | 100 | mg | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927265002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1040941 | TEGRETOL RET FTBL 200MG | Tegretol retard 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18357 | GA - zugelassen | Novartis Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AF01 | Carbamazepin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709201 | CARBAMAZEPIN | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | active | 200 | mg | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927417001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1040958 | TEGRETOL RET FTBL 400MG | Tegretol retard 400 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18356 | GA - zugelassen | Novartis Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AF01 | Carbamazepin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709201 | CARBAMAZEPIN | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | active | 400 | mg | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927418001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1041001 | VENOBENE SLB | Venobene - Salbe | 1.2.40.0.34.4.17:17942 | GA - zugelassen | Teva B.V. | true | true | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA53 | Heparin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709167 | DEXPANTHENOL | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | active | 200 | g | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | 200 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:920567003 | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 1200000 | IU | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 1200000 | IU | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1041024 | VOLTAREN EMULGEL-GEL | Voltaren Emulgel - Gel | 1.2.40.0.34.4.17:1-18355 | GA - zugelassen | Novartis Pharma GmbH | true | false | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA15 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | 1.2.40.0.34.5.156:1708742 | DICLOFENAC DIETHYLAMIN | 1.2.40.0.34.5.221:100000091074 | DICLOFENAC DIETHYLAMINE | active | 1.16 | g | 1.2.40.0.34.5.221:100000091074 | DICLOFENAC DIETHYLAMINE | 1.16 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:927434001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1041030 | ZINTONA KPS | Zintona Kapseln | 1.2.40.0.34.4.17:1-18282 | GA - zugelassen | Herbalist & Doc Gesundheitsgesellschaft mbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A04AD | Andere Antiemetika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705907 | ZINGIBERIS RHIZOMA | 1.2.40.0.34.5.221:100000078163 | GINGER | active | 250 | mg | 1.2.40.0.34.5.221:100000078163 | GINGER | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | false | human | 1.2.40.0.34.4.26:927118001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1041047 | ZINTONA KPS | Zintona Kapseln | 1.2.40.0.34.4.17:1-18282 | GA - zugelassen | Herbalist & Doc Gesundheitsgesellschaft mbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A04AD | Andere Antiemetika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705907 | ZINGIBERIS RHIZOMA | 1.2.40.0.34.5.221:100000078163 | GINGER | active | 250 | mg | 1.2.40.0.34.5.221:100000078163 | GINGER | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | false | human | 1.2.40.0.34.4.26:927118002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1042710 | MERESASUL TBL 200MG | Meresasul 200 mg - Tabletten | 1.2.40.0.34.4.17:17249 | GA - aufgehoben | SANOVA Pharma GesmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AL01 | Sulpirid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708729 | SULPIRID | 1.2.40.0.34.5.221:100000091056 | SULPIRIDE | active | 200 | mg | 1.2.40.0.34.5.221:100000091056 | SULPIRIDE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:124803002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1044620 | MONOKET RET KPS 50MG | Monoket retard 50 mg - Kapseln | 1.2.40.0.34.4.17:1-18270 | GA - zugelassen | Merus Labs Luxco II S.à.r.l. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01DA14 | Isosorbidmononitrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708568 | ISOSORBIDMONONITRAT | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:927267002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1046487 | GYNOVIN DRG | Gynovin - Dragees | 1.2.40.0.34.4.17:1-18412 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | false | 21 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AA10 | Gestoden und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.03 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.03 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:927351001 | 1.2.40.0.34.5.156:1709341 | GESTODEN | 1.2.40.0.34.5.221:100000092348 | GESTODENE | active | 0.075 | mg | 1.2.40.0.34.5.221:100000092348 | GESTODENE | 0.075 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1046493 | GYNOVIN DRG 3X21 | Gynovin - Dragees | 1.2.40.0.34.4.17:1-18412 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | false | 63 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AA10 | Gestoden und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.03 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.03 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:927351002 | 1.2.40.0.34.5.156:1709341 | GESTODEN | 1.2.40.0.34.5.221:100000092348 | GESTODENE | active | 0.075 | mg | 1.2.40.0.34.5.221:100000092348 | GESTODENE | 0.075 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1046547 | MINULET DRG | Minulet - Dragees 75 Mikrogramm/30 Mikrogramm überzogene Tabletten | 1.2.40.0.34.4.17:1-18411 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 21 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AA10 | Gestoden und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.03 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.03 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:927352002 | 1.2.40.0.34.5.156:1709341 | GESTODEN | 1.2.40.0.34.5.221:100000092348 | GESTODENE | active | 0.075 | mg | 1.2.40.0.34.5.221:100000092348 | GESTODENE | 0.075 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1046553 | MINULET DRG 3X21 | Minulet - Dragees 75 Mikrogramm/30 Mikrogramm überzogene Tabletten | 1.2.40.0.34.4.17:1-18411 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 63 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AA10 | Gestoden und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.03 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.03 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:927352001 | 1.2.40.0.34.5.156:1709341 | GESTODEN | 1.2.40.0.34.5.221:100000092348 | GESTODENE | active | 0.075 | mg | 1.2.40.0.34.5.221:100000092348 | GESTODENE | 0.075 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1051614 | ACTILYSE PLV +LSM DFL 20MG | Actilyse - Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung | 1.2.40.0.34.4.17:1-24717 | GA - zugelassen | Boehringer Ingelheim RCV GmbH & Co KG | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B01AD02 | Alteplase | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708405 | ALTEPLASE | 1.2.40.0.34.5.221:100000089921 | ALTEPLASE | active | 20 | mg | 1.2.40.0.34.5.221:100000089921 | ALTEPLASE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:945076002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1051732 | THOMAPYRIN TBL | Thomapyrin - Tabletten | 1.2.40.0.34.4.17:1-17100 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BE51 | Paracetamol, Kombinationen exkl. Psycholeptika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921096002 | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | 400 | mg | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | 400 | mg | 1.2.40.0.34.5.156:1708366 | COFFEIN | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | active | 100 | mg | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | 100 | mg | 2.16.840.1.113883.6.73:N02BA51 | Acetylsalicylsäure, Kombinationen exkl. Psycholeptika | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1059484 | CLAVERSAL FTBL 500MG | Claversal 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18369 | GA - zugelassen | Merck Ges.m.b.H. | true | false | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07EC02 | Mesalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709091 | MESALAZIN | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | active | 500 | mg | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927435002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1059490 | CLAVERSAL FTBL 500MG | Claversal 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18369 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07EC02 | Mesalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709091 | MESALAZIN | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | active | 500 | mg | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927435001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1059544 | DUAN TBL | Duan - Tabletten | 1.2.40.0.34.4.17:1-18211 | GA - aufgehoben | M.C.M. Klosterfrau Healthcare GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BE71 | Paracetamol, Kombinationen mit Psycholeptika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 250 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123244003 | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | 250 | mg | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | 250 | mg | 1.2.40.0.34.5.156:1708366 | COFFEIN | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | active | 25 | mg | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | 25 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1059567 | ESTROFEM FTBL 2MG 3X28 | Estrofem 2 mg - Filmtabletten | 1.2.40.0.34.4.17:16889 | GA - zugelassen | Novo Nordisk Pharma GmbH | true | true | 84 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000116195 | Kalenderpackung | 2.16.840.1.113883.6.73:G03CA03 | Estradiol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708991 | ESTRADIOL | 1.2.40.0.34.5.221:100000091739 | ESTRADIOL | active | 2.07 | mg | 1.2.40.0.34.5.221:100000091739 | ESTRADIOL | 2.07 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:124497002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1059596 | GINSANA (GINSENG) KPS 100MG | Ginsana Kapseln | 1.2.40.0.34.4.17:737535 | GA - registriert | SANOVA Pharma GesmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A13A | Tonika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706030 | GINSENG RADIX (AUSZUG) | 1.2.40.0.34.5.221:100000078688 | EXTRACTUM GINSENG | active | 30 | mg | 1.2.40.0.34.5.221:100000078688 | EXTRACTUM GINSENG | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | true | human | 1.2.40.0.34.4.26:7525733002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1059610 | GINSANA (GINSENG) TON | Ginsana (Ginseng-Extrakt G 115) 140 mg/ 15 ml - Tonikum | 1.2.40.0.34.4.17:737537 | GA - aufgehoben | SANOVA Pharma GesmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A13A | Tonika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706030 | GINSENG RADIX (AUSZUG) | 1.2.40.0.34.5.221:100000078688 | EXTRACTUM GINSENG | active | 10500 | mg | 1.2.40.0.34.5.221:100000078688 | EXTRACTUM GINSENG | 10500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:7525718002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1059627 | GINSANA (GINSENG) TON | Ginsana (Ginseng-Extrakt G 115) 140 mg/ 15 ml - Tonikum | 1.2.40.0.34.4.17:737537 | GA - aufgehoben | SANOVA Pharma GesmbH | false | false | 2 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A13A | Tonika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706030 | GINSENG RADIX (AUSZUG) | 1.2.40.0.34.5.221:100000078688 | EXTRACTUM GINSENG | active | 21000 | mg | 1.2.40.0.34.5.221:100000078688 | EXTRACTUM GINSENG | 21000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:7525718001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1059745 | TEGRETOL OR SUS | Tegretol - orale Suspension | 1.2.40.0.34.4.17:1-18374 | GA - zugelassen | Novartis Pharma GmbH | true | true | 250 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N03AF01 | Carbamazepin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709201 | CARBAMAZEPIN | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | active | 5 | g | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | 5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:927494001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1061676 | RHINOPERD NA-TR | Rhinoperd - Nasentropfen | 1.2.40.0.34.4.17:6368 | GA - zugelassen | AGEPHA Pharma s.r.o | true | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AA08 | Naphazolin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1708567 | NAPHAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | active | 0.1 | g | 1.2.40.0.34.5.221:100000090391 | NAPHAZOLINE HYDROCHLORIDE | 0.1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073794 | Nasentropfen, Lösung | true | human | 1.2.40.0.34.4.26:922238002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1064539 | RHEUMON CR | Rheumon - Creme | 1.2.40.0.34.4.17:1-18381 | GA - aufgehoben | Viatris Austria GmbH | false | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA06 | Etofenamat | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709468 | ETOFENAMAT | 1.2.40.0.34.5.221:100000092609 | ETOFENAMATE | active | 5 | g | 1.2.40.0.34.5.221:100000092609 | ETOFENAMATE | 5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:927382001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1064545 | RHEUMON DEP AMP 2ML | Rheumon - Depot - Ampullen | 1.2.40.0.34.4.17:1-18420 | GA - zugelassen | Viatris Austria GmbH | true | false | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M01A | Nichtsteroidale antiphlogistika und Antirheumatika | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1709468 | ETOFENAMAT | 1.2.40.0.34.5.221:100000092609 | ETOFENAMATE | active | 1000 | mg | 1.2.40.0.34.5.221:100000092609 | ETOFENAMATE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927380002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1073455 | CALC FRE AMP 10ML | Calcium "Fresenius" - Ampullen | 1.2.40.0.34.4.17:1-18323 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A12AA20 | Calcium (verschiedene Salze in Kombination) | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708126 | CALCIUMGLUCONAT | 1.2.40.0.34.5.221:100000088912 | CALCIUM GLUCONATE | active | 0.95 | g | 1.2.40.0.34.5.221:100000088912 | CALCIUM GLUCONATE | 0.95 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:127682001 | 1.2.40.0.34.5.156:1706612 | CALCIUM SACCHARAT | 1.2.40.0.34.5.221:100000081613 | CALCIUM SACCHARATE | active | 0.036 | g | 1.2.40.0.34.5.221:100000081613 | CALCIUM SACCHARATE | 0.036 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1073604 | GEVILON FTBL 450MG | Gevilon 450 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18410 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C10AB04 | Gemfibrozil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709492 | GEMFIBROZIL | 1.2.40.0.34.5.221:100000092643 | GEMFIBROZIL | active | 450 | mg | 1.2.40.0.34.5.221:100000092643 | GEMFIBROZIL | 450 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927022003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1073610 | GEVILON FTBL 450MG | Gevilon 450 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18410 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C10AB04 | Gemfibrozil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709492 | GEMFIBROZIL | 1.2.40.0.34.5.221:100000092643 | GEMFIBROZIL | active | 450 | mg | 1.2.40.0.34.5.221:100000092643 | GEMFIBROZIL | 450 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927022001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1073768 | ZOVIRAX FTBL 400MG | Zovirax 400 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18445 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J05AB01 | Aciclovir | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709572 | ACICLOVIR | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | active | 400 | mg | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927518001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1076502 | VAXIGRIP FSPR M.KANUELE | VAXIGRIP Injektionssupension in einer Fertigspritze | 1.2.40.0.34.4.17:2-00215 | GA - aufgehoben | Sanofi Vaccines | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:J07BB02 | Influenza, gereinigtes Antigen | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1708839 | INFLUENZAVIRUS (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:100000091392 | IMMUNOSERA FOR HUMAN USE, ANIMAL | active | | | 1.2.40.0.34.5.221:100000091392 | IMMUNOSERA FOR HUMAN USE, ANIMAL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:942778001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1078524 | ALLOPURINOL GEN RET TBL300MG | Allopurinol Genericon retard 300 mg Tabletten | 1.2.40.0.34.4.17:17208 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M04AA01 | Allopurinol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709057 | ALLOPURINOL | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | active | 300 | mg | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:122690001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1078530 | ASS GEN TBL 500MG | ASS Genericon 500 mg Tabletten | 1.2.40.0.34.4.17:6432 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BA01 | Acetylsalicylsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923071001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1078582 | CHLORAMPH AGE AU-SLB | Chloramphenicol "Agepha" 1 % - Augensalbe | 1.2.40.0.34.4.17:11592 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 5 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:S01AA01 | Chloramphenicol | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709547 | CHLORAMPHENICOL | 1.2.40.0.34.5.221:100000092772 | CHLORAMPHENICOL | active | 0.05 | g | 1.2.40.0.34.5.221:100000092772 | CHLORAMPHENICOL | 0.05 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073772 | Augensalbe | true | human | 1.2.40.0.34.4.26:122105001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1078613 | EBRANTIL RET KPS 60MG | Ebrantil retard 60 mg - Kapseln | 1.2.40.0.34.4.17:1-18449 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:C02CA06 | Urapidil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705541 | URAPIDIL | 1.2.40.0.34.5.221:100000076662 | URAPIDIL | active | 60 | mg | 1.2.40.0.34.5.221:100000076662 | URAPIDIL | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:927379001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1078814 | KEFAZIM TRSTAMP 500MG | Kefazim 500 mg Trockenstechampulle | 1.2.40.0.34.4.17:1-18436 | GA - aufgehoben | Astro-Pharma Vertrieb Und Handel Von Pharmazeutischen Produkten GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01DD02 | Ceftazidim | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709482 | CEFTAZIDIM | 1.2.40.0.34.5.221:100000092630 | CEFTAZIDIME | active | 641 | mg | 1.2.40.0.34.5.221:100000092630 | CEFTAZIDIME | 641 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:927310001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1078843 | KEFAZIM TRSTAMP 2G | Kefazim 2 g Trockenstechampulle | 1.2.40.0.34.4.17:1-18435 | GA - aufgehoben | Astro-Pharma Vertrieb Und Handel Von Pharmazeutischen Produkten GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01DD02 | Ceftazidim | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709482 | CEFTAZIDIM | 1.2.40.0.34.5.221:100000092630 | CEFTAZIDIME | active | 2.447 | g | 1.2.40.0.34.5.221:100000092630 | CEFTAZIDIME | 2.447 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:927336001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1078955 | NEUROTOP RET TBL 300MG | Neurotop retard 300 mg - Tabletten | 1.2.40.0.34.4.17:1-18147 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AF01 | Carbamazepin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709201 | CARBAMAZEPIN | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | active | 300 | mg | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927176001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1078961 | NEUROTOP RET TBL 600MG | Neurotop retard 600 mg - Tabletten | 1.2.40.0.34.4.17:1-18146 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AF01 | Carbamazepin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709201 | CARBAMAZEPIN | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | active | 600 | mg | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927175001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1079021 | SANDOVAC FSPR 0,5ML | Sandovac Injektionssuspension in einer Fertigspritze | 1.2.40.0.34.4.17:2-00235 | GA - aufgehoben | Seqirus S.r.l. | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:J07BB02 | Influenza, gereinigtes Antigen | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1708839 | INFLUENZAVIRUS (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:100000091392 | IMMUNOSERA FOR HUMAN USE, ANIMAL | active | | | 1.2.40.0.34.5.221:100000091392 | IMMUNOSERA FOR HUMAN USE, ANIMAL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:943596001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1079050 | SIBELIUM TBL 10MG | Sibelium 10 mg - Tabletten | 1.2.40.0.34.4.17:1-18443 | GA - zugelassen | Janssen-Cilag Pharma GmbH | true | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N07C | Antivertiginosa | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708088 | FLUNARIZIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000088767 | FLUNARIZINE DIHYDROCHLORIDE | active | 11.78 | mg | 1.2.40.0.34.5.221:100000088767 | FLUNARIZINE DIHYDROCHLORIDE | 11.78 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927283001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1083910 | BAYPRESS TBL 20MG | Baypress 20 mg - Tabletten | 1.2.40.0.34.4.17:1-18430 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08CA08 | Nitrendipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708497 | NITRENDIPIN | 1.2.40.0.34.5.221:100000090223 | NITRENDIPINE | active | 20 | mg | 1.2.40.0.34.5.221:100000090223 | NITRENDIPINE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927301001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1084128 | DUSODRIL RET FTBL 100MG | Dusodril retard 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-15617 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C04AX21 | Naftidrofuryl | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709274 | NAFTIDROFURYL HYDROGENOXALAT | 1.2.40.0.34.5.221:100000092248 | NAFTIDROFURYL HYDROGEN OXALATE | active | 100 | mg | 1.2.40.0.34.5.221:100000092248 | NAFTIDROFURYL HYDROGEN OXALATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:123286001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1084134 | DUSODRIL RET FTBL 100MG | Dusodril retard 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-15617 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C04AX21 | Naftidrofuryl | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709274 | NAFTIDROFURYL HYDROGENOXALAT | 1.2.40.0.34.5.221:100000092248 | NAFTIDROFURYL HYDROGEN OXALATE | active | 100 | mg | 1.2.40.0.34.5.221:100000092248 | NAFTIDROFURYL HYDROGEN OXALATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:123286002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1084275 | PEN-G-NA TRSTAMP 1MEGA IE | Penicillin G-Natrium Sandoz 1 Mega IE - Trockenstechampulle | 1.2.40.0.34.4.17:12785 | GA - zugelassen | Sandoz GmbH | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01CE01 | Benzylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708931 | BENZYLPENICILLIN NATRIUM | 1.2.40.0.34.5.221:100000091609 | BENZYLPENICILLIN SODIUM | active | 0.599 | g | 1.2.40.0.34.5.221:100000091070 | BENZYLPENICILLIN | 0.562055 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:123574001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1084281 | PEN-G-NA TRSTAMP 5MEGA IE | Penicillin G-Natrium Sandoz 5 Mega IE - Trockenstechampulle | 1.2.40.0.34.4.17:12786 | GA - zugelassen | Sandoz GmbH | true | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01CE01 | Benzylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708931 | BENZYLPENICILLIN NATRIUM | 1.2.40.0.34.5.221:100000091609 | BENZYLPENICILLIN SODIUM | active | 2.994 | g | 1.2.40.0.34.5.221:100000091070 | BENZYLPENICILLIN | 2.809339 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:123573003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1084298 | PEN-G-NA TRSTAMP 10MEGA IE | Penicillin G-Natrium Sandoz 10 Mega IE - Trockenstechampulle | 1.2.40.0.34.4.17:12787 | GA - zugelassen | Sandoz GmbH | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01CE01 | Benzylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708931 | BENZYLPENICILLIN NATRIUM | 1.2.40.0.34.5.221:100000091609 | BENZYLPENICILLIN SODIUM | active | 5.988 | g | 1.2.40.0.34.5.221:100000091070 | BENZYLPENICILLIN | 5.618678 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:123572002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1084306 | PEN-G-NA TRSTAMP 10MEGA IE | Penicillin G-Natrium Sandoz 10 Mega IE - Trockenstechampulle | 1.2.40.0.34.4.17:12787 | GA - zugelassen | Sandoz GmbH | true | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01CE01 | Benzylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708931 | BENZYLPENICILLIN NATRIUM | 1.2.40.0.34.5.221:100000091609 | BENZYLPENICILLIN SODIUM | active | 5.988 | g | 1.2.40.0.34.5.221:100000091070 | BENZYLPENICILLIN | 5.618678 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:123572003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1084312 | PEN-G-NA TRSUB INF 10MEGA IE | Penicillin G-Natrium Sandoz 10 Mega IE - Trockensubstanz zur Infusionsbereitung | 1.2.40.0.34.4.17:15886 | GA - zugelassen | Sandoz GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01CE01 | Benzylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708931 | BENZYLPENICILLIN NATRIUM | 1.2.40.0.34.5.221:100000091609 | BENZYLPENICILLIN SODIUM | active | 5.988 | g | 1.2.40.0.34.5.221:100000091070 | BENZYLPENICILLIN | 5.618678 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:121198001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1089605 | SULTANOL AMP 1ML | Sultanol - Ampullen | 1.2.40.0.34.4.17:17574 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:R03CC02 | Salbutamol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | 1.2.40.0.34.5.156:1708649 | SALBUTAMOLSULFAT | 1.2.40.0.34.5.221:100000090564 | SALBUTAMOL SULFATE | active | 0.6 | mg | 1.2.40.0.34.5.221:100000090564 | SALBUTAMOL SULFATE | 0.6 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920774001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1091275 | HALSET LTBL | Halset - Lutschtabletten | 1.2.40.0.34.4.17:1-18515 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 24 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R02AA06 | Cetylpyridinium | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | | | 1.2.40.0.34.5.156:1708345 | CETYLPYRIDINIUMCHLORID | 1.2.40.0.34.5.221:100000089624 | CETYLPYRIDINIUM CHLORIDE | active | 1.5 | mg | 1.2.40.0.34.5.221:100000089624 | CETYLPYRIDINIUM CHLORIDE | 1.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073703 | Lutschtablette | false | human | 1.2.40.0.34.4.26:927505001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099271 | ABFUEHRTEE ST.SEVERIN | Abführtee St. Severin | 1.2.40.0.34.4.17:9674 | GA - zugelassen | Gall & Reidlinger OHG | true | true | 70 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:A06AB56 | Sennoside, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712672 | SENNAE FRUCTUS | 1.2.40.0.34.5.221:900000004286 | SENNAE FRUCTUS | active | 2845.5 | g | 1.2.40.0.34.5.221:900000004286 | SENNAE FRUCTUS | 2845.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073370 | Arzneitee | true | human | 1.2.40.0.34.4.26:922981001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099294 | BLASENTEE ST.SEVERIN | Blasentee St. Severin | 1.2.40.0.34.4.17:9938 | GA - aufgehoben | Gall & Reidlinger OHG | false | false | 70 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:G04BX | Andere Urologika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705615 | BETULAE FOLIUM | 1.2.40.0.34.5.221:100000076915 | BETULAE FOLIUM | active | | | 1.2.40.0.34.5.221:100000076915 | BETULAE FOLIUM | | | 1.2.40.0.10.1.4.3.4.3.5:100000073370 | Arzneitee | false | human | 1.2.40.0.34.4.26:922982001 | 1.2.40.0.34.5.156:1705378 | EQUISETI HERBA | 1.2.40.0.34.5.221:100000076118 | EQUISETUM STEM | active | | | 1.2.40.0.34.5.221:100000076118 | EQUISETUM STEM | | | 1.2.40.0.34.5.156:1710047 | CALLUNAE HERBA | 1.2.40.0.34.5.221:900000000278 | CALLUNAE HERBA | active | | | 1.2.40.0.34.5.221:900000000278 | CALLUNAE HERBA | | | | | | | | | 1.2.40.0.34.5.156:1710334 | HERNIARIAE HERBA | 1.2.40.0.34.5.221:900000000565 | HERNIARIAE HERBA | active | | | 1.2.40.0.34.5.221:900000000565 | HERNIARIAE HERBA | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099302 | ENTSCHLACKUNGSTEE ST.SEVERIN | Entschlackender Abführtee St. Severin | 1.2.40.0.34.4.17:9939 | GA - zugelassen | Gall & Reidlinger OHG | true | true | 70 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A06AB | Kontaktlaxanzien | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705376 | SAMBUCI FLOS | 1.2.40.0.34.5.221:100000076110 | SAMBUCI FLOS | active | 18.75 | g | 1.2.40.0.34.5.221:100000076110 | SAMBUCI FLOS | 18.75 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073370 | Arzneitee | true | human | 1.2.40.0.34.4.26:922983001 | 1.2.40.0.34.5.156:1705378 | EQUISETI HERBA | 1.2.40.0.34.5.221:100000076118 | EQUISETUM STEM | active | 25 | g | 1.2.40.0.34.5.221:100000076118 | EQUISETUM STEM | 25 | g | 1.2.40.0.34.5.156:1712672 | SENNAE FRUCTUS | 1.2.40.0.34.5.221:900000004286 | SENNAE FRUCTUS | active | 33.8 | g | 1.2.40.0.34.5.221:900000004286 | SENNAE FRUCTUS | 33.8 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099319 | BRUST/HU-TEE ST.SEVERIN | Brust- und Hustentee St. Severin | 1.2.40.0.34.4.17:12097 | GA - aufgehoben | Gall & Reidlinger OHG | false | false | 70 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:R05X | Andere Kombinationspräparate gegen Erkältungskrankheiten | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709703 | HELENII RHIZOMA | 1.2.40.0.34.5.221:100000115914 | HELENII RHIZOMA | active | 20 | g | 1.2.40.0.34.5.221:100000115914 | HELENII RHIZOMA | 20 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073370 | Arzneitee | false | human | 1.2.40.0.34.4.26:922990002 | 1.2.40.0.34.5.156:1710069 | CASTANEAE FOLIUM | 1.2.40.0.34.5.221:900000000300 | CASTANEAE FOLIUM | active | 25 | g | 1.2.40.0.34.5.221:900000000300 | CASTANEAE FOLIUM | 25 | g | 1.2.40.0.34.5.156:1708672 | THYMI HERBA | 1.2.40.0.34.5.221:100000090678 | THYMI HERBA | active | 17.5 | g | 1.2.40.0.34.5.221:100000090678 | THYMI HERBA | 17.5 | g | | | | | | | 1.2.40.0.34.5.156:1710864 | VERBASCI FOLIUM | 1.2.40.0.34.5.221:900000001099 | VERBASCI FOLIUM | active | 17.5 | g | 1.2.40.0.34.5.221:900000001099 | VERBASCI FOLIUM | 17.5 | g | 1.2.40.0.34.5.156:1708669 | PLANTAGINIS LANCEOLATAE FOLIUM | 1.2.40.0.34.5.221:100000090650 | PLANTAGINIS LANCEOLATAE FOLIUM | active | 20 | g | 1.2.40.0.34.5.221:100000090650 | PLANTAGINIS LANCEOLATAE FOLIUM | 20 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099325 | DICLOFENAC GEN FTBL 50MG | Diclofenac Genericon 50 mg Filmtabletten | 1.2.40.0.34.4.17:1-18512 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927657004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099331 | DICLOFENAC GEN FTBL 50MG | Diclofenac Genericon 50 mg Filmtabletten | 1.2.40.0.34.4.17:1-18512 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927657005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099354 | DICLOFENAC GEN RET FTBL 100 | Diclofenac Genericon retard 100 mg Filmtabletten | 1.2.40.0.34.4.17:1-18513 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927658004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099360 | DICLOFENAC GEN RET FTBL 100 | Diclofenac Genericon retard 100 mg Filmtabletten | 1.2.40.0.34.4.17:1-18513 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927658005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099437 | DUSODRIL RET FTBL 200MG | Dusodril retard 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18407 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C04AX21 | Naftidrofuryl | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709274 | NAFTIDROFURYL HYDROGENOXALAT | 1.2.40.0.34.5.221:100000092248 | NAFTIDROFURYL HYDROGEN OXALATE | active | 200 | mg | 1.2.40.0.34.5.221:100000092248 | NAFTIDROFURYL HYDROGEN OXALATE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927361001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099443 | DUSODRIL RET FTBL 200MG | Dusodril retard 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18407 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C04AX21 | Naftidrofuryl | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709274 | NAFTIDROFURYL HYDROGENOXALAT | 1.2.40.0.34.5.221:100000092248 | NAFTIDROFURYL HYDROGEN OXALATE | active | 200 | mg | 1.2.40.0.34.5.221:100000092248 | NAFTIDROFURYL HYDROGEN OXALATE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927361002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099532 | GRIPPETEE ST.SEVERIN | Grippetee St. Severin | 1.2.40.0.34.4.17:10054 | GA - aufgehoben | Gall & Reidlinger OHG | false | false | 70 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:R05X | Andere Kombinationspräparate gegen Erkältungskrankheiten | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708696 | TILIAE FLOS | 1.2.40.0.34.5.221:100000090843 | TILIAE FLOS | active | 20 | g | 1.2.40.0.34.5.221:100000090843 | TILIAE FLOS | 20 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073370 | Arzneitee | false | human | 1.2.40.0.34.4.26:922984002 | 1.2.40.0.34.5.156:1705376 | SAMBUCI FLOS | 1.2.40.0.34.5.221:100000076110 | SAMBUCI FLOS | active | 40 | g | 1.2.40.0.34.5.221:100000076110 | SAMBUCI FLOS | 40 | g | 1.2.40.0.34.5.156:1708669 | PLANTAGINIS LANCEOLATAE FOLIUM | 1.2.40.0.34.5.221:100000090650 | PLANTAGINIS LANCEOLATAE FOLIUM | active | 40 | g | 1.2.40.0.34.5.221:100000090650 | PLANTAGINIS LANCEOLATAE FOLIUM | 40 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099555 | JOSALID FTBL 750MG | Josalid 750 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18487 | GA - aufgehoben | Sandoz GmbH | false | false | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01FA07 | Josamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706310 | JOSAMYCIN | 1.2.40.0.34.5.221:100000079852 | JOSAMYCIN | active | 750 | mg | 1.2.40.0.34.5.221:100000079852 | JOSAMYCIN | 750 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927637001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099561 | JOSALID SFT KIND 250MG/5ML | Josalid 250 mg/5 ml - Saft für Kinder | 1.2.40.0.34.4.17:1-18485 | GA - aufgehoben | Sandoz GmbH | false | false | 80 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01FA07 | Josamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707191 | JOSAMYCIN PROPIONAT | 1.2.40.0.34.5.221:100000084908 | JOSAMYCIN PROPIONATE | active | 21624 | mg | 1.2.40.0.34.5.221:100000084908 | JOSAMYCIN PROPIONATE | 21624 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:927387001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099578 | JOSALID SFT KIND 375MG/5ML | Josalid 375 mg/5 ml - Saft für Kinder | 1.2.40.0.34.4.17:1-18488 | GA - aufgehoben | Sandoz GmbH | false | false | 80 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01FA07 | Josamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707191 | JOSAMYCIN PROPIONAT | 1.2.40.0.34.5.221:100000084908 | JOSAMYCIN PROPIONATE | active | 32432 | mg | 1.2.40.0.34.5.221:100000084908 | JOSAMYCIN PROPIONATE | 32432 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:927638002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099704 | FUNGORAL CR 2% | Fungoral 2 % - Creme | 1.2.40.0.34.4.17:1-18474 | GA - zugelassen | Karo Healthcare AB | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D01AC08 | Ketoconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709169 | KETOCONAZOL | 1.2.40.0.34.5.221:100000092078 | KETOCONAZOLE | active | 0.6 | g | 1.2.40.0.34.5.221:100000092078 | KETOCONAZOLE | 0.6 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:128860002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1099762 | ROSALGIN 0,1% VAG-LSG | Rosalgin - 0,1% Vaginallösung | 1.2.40.0.34.4.17:1-18486 | GA - zugelassen | Angelini Pharma Österreich GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:G02CC03 | Benzydamin | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1708966 | BENZYDAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091695 | BENZYDAMINE HYDROCHLORIDE | active | 140 | mg | 1.2.40.0.34.5.221:100000091695 | BENZYDAMINE HYDROCHLORIDE | 140 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073813 | Vaginallösung | true | human | 1.2.40.0.34.4.26:923733003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1106700 | DALACIN LSG Z AEUSSERL ANW | Dalacin - Lösung zur äußerlichen Anwendung | 1.2.40.0.34.4.17:1-18361 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D10AF01 | Clindamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708641 | CLINDAMYCIN PHOSPHAT | 1.2.40.0.34.5.221:100000090555 | CLINDAMYCIN PHOSPHATE | active | 1.276 | g | 1.2.40.0.34.5.221:100000090555 | CLINDAMYCIN PHOSPHATE | 1.276 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:922825001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1106717 | DORMICUM AMP 5MG/1ML | Dormicum 5 mg/1 ml - Injektionslösung | 1.2.40.0.34.4.17:1-18520 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05CD08 | Midazolam | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1706453 | MIDAZOLAM | 1.2.40.0.34.5.221:100000080626 | MIDAZOLAM | active | 5 | mg | 1.2.40.0.34.5.221:100000080626 | MIDAZOLAM | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927307002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | 1.2.40.0.10.1.4.3.4.3.5:100000073829 | Rektallösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1106746 | PROSTIN-E2 VAG-TBL 3MG | Prostin E2 3 mg - Vaginaltabletten | 1.2.40.0.34.4.17:1-18362 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 4 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G02AD02 | Dinoproston | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1709260 | DINOPROSTON | 1.2.40.0.34.5.221:100000092220 | DINOPROSTONE | active | 3 | mg | 1.2.40.0.34.5.221:100000092220 | DINOPROSTONE | 3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073824 | Vaginaltablette | true | human | 1.2.40.0.34.4.26:927201001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1111003 | GALLEN-U.LEBERTEE ST.SEVERIN | Gallen- und Lebertee St. Severin | 1.2.40.0.34.4.17:11640 | GA - aufgehoben | Gall & Reidlinger OHG | false | false | 70 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A05AX | Andere Mittel zur Gallentherapie | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708693 | MENTHAE PIPERITAE FOLIUM | 1.2.40.0.34.5.221:100000090817 | MENTHAE PIPERITAE FOLIUM | active | 13.3 | g | 1.2.40.0.34.5.221:100000090817 | MENTHAE PIPERITAE FOLIUM | 13.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073370 | Arzneitee | false | human | 1.2.40.0.34.4.26:123182002 | 1.2.40.0.34.5.156:1709649 | MILLEFOLII HERBA | 1.2.40.0.34.5.221:100000093312 | ACHILLEA MILLEFOLIUM L. HERBA | active | 23.3 | g | 1.2.40.0.34.5.221:100000093312 | ACHILLEA MILLEFOLIUM L. HERBA | 23.3 | g | 1.2.40.0.34.5.156:1705538 | AGRIMONIAE HERBA | 1.2.40.0.34.5.221:100000076649 | AGRIMONY | active | 23.4 | g | 1.2.40.0.34.5.221:100000076649 | AGRIMONY | 23.4 | g | | | | | | | 1.2.40.0.34.5.156:1710475 | MARRUBII HERBA | 1.2.40.0.34.5.221:900000000708 | MARRUBII HERBA | active | 16.7 | g | 1.2.40.0.34.5.221:900000000708 | MARRUBII HERBA | 16.7 | g | 1.2.40.0.34.5.156:1710812 | TARAXACI HERBA | 1.2.40.0.34.5.221:900000001047 | TARAXACI HERBA | active | 23.3 | g | 1.2.40.0.34.5.221:900000001047 | TARAXACI HERBA | 23.3 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1111049 | MAGENTEE ST.SEVERIN | Magentee St.Severin | 1.2.40.0.34.4.17:10075 | GA - aufgehoben | Gall & Reidlinger OHG | false | false | 70 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A15 | Appetit stimulierende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706161 | ABSINTHII HERBA | 1.2.40.0.34.5.221:100000079273 | WORMWOOD | active | 15 | g | 1.2.40.0.34.5.221:100000079273 | WORMWOOD | 15 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073370 | Arzneitee | false | human | 1.2.40.0.34.4.26:922985002 | 1.2.40.0.34.5.156:1705464 | CENTAURII HERBA | 1.2.40.0.34.5.221:100000076417 | CENTAURY | active | 15 | g | 1.2.40.0.34.5.221:100000076417 | CENTAURY | 15 | g | 1.2.40.0.34.5.156:1710810 | TARAXACI FOLIUM | 1.2.40.0.34.5.221:900000001045 | TARAXACI FOLIUM | active | 25 | g | 1.2.40.0.34.5.221:900000001045 | TARAXACI FOLIUM | 25 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1111121 | TRATUL AMP 90MG 3ML | Tratul 90 mg - Ampullen | 1.2.40.0.34.4.17:17603 | GA - zugelassen | G.L. Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1710178 | DEANOL DICLOFENACAT | 1.2.40.0.34.5.221:100000140773 | DICLOFENAC DEANOL | active | 90 | mg | 1.2.40.0.34.5.221:100000140773 | DICLOFENAC DEANOL | 90 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920598001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1111138 | TRATUL KPS 50MG | Tratul 50 mg Kapseln | 1.2.40.0.34.4.17:17607 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709564 | DICLOFENAC | 1.2.40.0.34.5.221:100000092798 | DICLOFENAC | active | 50 | mg | 1.2.40.0.34.5.221:100000092798 | DICLOFENAC | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | true | human | 1.2.40.0.34.4.26:920404002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1111150 | TRATUL SUPP 60MG | Tratul 60 mg - Suppositorien | 1.2.40.0.34.4.17:17604 | GA - aufgehoben | G.L. Pharma GmbH | false | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1710178 | DEANOL DICLOFENACAT | 1.2.40.0.34.5.221:100000140773 | DICLOFENAC DEANOL | active | 60 | mg | 1.2.40.0.34.5.221:100000140773 | DICLOFENAC DEANOL | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:920600001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1111167 | TRATUL SUPP 120MG | Tratul 120 mg - Suppositorien | 1.2.40.0.34.4.17:17605 | GA - aufgehoben | G.L. Pharma GmbH | false | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1710178 | DEANOL DICLOFENACAT | 1.2.40.0.34.5.221:100000140773 | DICLOFENAC DEANOL | active | 120 | mg | 1.2.40.0.34.5.221:100000140773 | DICLOFENAC DEANOL | 120 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:920601001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1111173 | ULTRAVIST 240MG J/ML IFL 50 | Ultravist 240 mg J/ml - Injektionslösung | 1.2.40.0.34.4.17:1-18551 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08AB05 | Iopromid | 1.2.40.0.10.1.4.3.4.3.4:100000073598 | intralymphatische Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.34.5.156:1709106 | IOPROMID | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | active | 24936 | mg | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | 24936 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:927376003 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073590 | intracardiale Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1111210 | ULTRAVIST 300MG J/ML IFL 50 | Ultravist 300 mg J/ml - Infusionsflaschen | 1.2.40.0.34.4.17:1-18546 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08AB05 | Iopromid | 1.2.40.0.10.1.4.3.4.3.4:100000073598 | intralymphatische Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1709106 | IOPROMID | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | active | 31170 | mg | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | 31170 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927375010 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073590 | intracardiale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1111227 | ULTRAVIST 300MG/ML IFL 75ML | Ultravist 300 mg J/ml - Infusionsflaschen | 1.2.40.0.34.4.17:1-18546 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08AB05 | Iopromid | 1.2.40.0.10.1.4.3.4.3.4:100000073598 | intralymphatische Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1709106 | IOPROMID | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | active | 46755 | mg | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | 46755 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927375011 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073590 | intracardiale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1111256 | ULTRAVIST 300MG J/ML IFL 100 | Ultravist 300 mg J/ml - Infusionsflaschen | 1.2.40.0.34.4.17:1-18546 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08AB05 | Iopromid | 1.2.40.0.10.1.4.3.4.3.4:100000073598 | intralymphatische Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1709106 | IOPROMID | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | active | 62340 | mg | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | 62340 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927375008 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073590 | intracardiale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1111262 | ULTRAVIST 370MG J/ML IFL 50 | Ultravist 370 mg J/ml - Infusionsflaschen | 1.2.40.0.34.4.17:1-18548 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08AB05 | Iopromid | 1.2.40.0.10.1.4.3.4.3.4:100000073598 | intralymphatische Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1709106 | IOPROMID | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | active | 38443 | mg | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | 38443 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927373004 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073590 | intracardiale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1111279 | ULTRAVIST 370MG J/ML IFL 100 | Ultravist 370 mg J/ml - Infusionsflaschen | 1.2.40.0.34.4.17:1-18548 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08AB05 | Iopromid | 1.2.40.0.10.1.4.3.4.3.4:100000073598 | intralymphatische Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1709106 | IOPROMID | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | active | 76886 | mg | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | 76886 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927373002 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073590 | intracardiale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1111285 | ULTRAVIST 370MG J/ML IFL 200 | Ultravist 370 mg J/ml - Infusionsflaschen | 1.2.40.0.34.4.17:1-18548 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08AB05 | Iopromid | 1.2.40.0.10.1.4.3.4.3.4:100000073598 | intralymphatische Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1709106 | IOPROMID | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | active | 153772 | mg | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | 153772 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927373003 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073590 | intracardiale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1111322 | WECHSELTEE ST.SEVERIN | Wechseltee St. Severin | 1.2.40.0.34.4.17:11942 | GA - aufgehoben | Gall & Reidlinger OHG | false | false | 70 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N05CX | Hypnotika und Sedativa in Kombination, exkl. Barbiturate | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708694 | MELISSAE FOLIUM | 1.2.40.0.34.5.221:100000090819 | MELISSAE FOLIUM | active | 8.5 | g | 1.2.40.0.34.5.221:100000090819 | MELISSAE FOLIUM | 8.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073370 | Arzneitee | true | human | 1.2.40.0.34.4.26:922989002 | 1.2.40.0.34.5.156:1708710 | LUPULI FLOS | 1.2.40.0.34.5.221:100000090996 | LUPULI FLOS | active | 8.5 | g | 1.2.40.0.34.5.221:100000090996 | LUPULI FLOS | 8.5 | g | 1.2.40.0.34.5.156:1710884 | VISCI ALBI HERBA | 1.2.40.0.34.5.221:900000001119 | VISCI ALBI HERBA | active | 11 | g | 1.2.40.0.34.5.221:900000001119 | VISCI ALBI HERBA | 11 | g | | | | | | | 1.2.40.0.34.5.156:1708769 | VALERIANAE RADIX | 1.2.40.0.34.5.221:100000091186 | VALERIANAE RADIX | active | 27.5 | g | 1.2.40.0.34.5.221:100000091186 | VALERIANAE RADIX | 27.5 | g | 1.2.40.0.34.5.156:1709648 | CRATAEGI FOLIUM CUM FLORE | 1.2.40.0.34.5.221:100000093308 | CRATAEGI FOLIUM CUM FLORE | active | 11 | g | 1.2.40.0.34.5.221:100000093308 | CRATAEGI FOLIUM CUM FLORE | 11 | g | 1.2.40.0.34.5.156:1708685 | PASSIFLORAE HERBA | 1.2.40.0.34.5.221:100000090759 | PASSIFLORAE HERBA | active | 6 | g | 1.2.40.0.34.5.221:100000090759 | PASSIFLORAE HERBA | 6 | g | | | | | 1.2.40.0.34.5.156:1708698 | HYPERICI HERBA | 1.2.40.0.34.5.221:100000090863 | HYPERICI HERBA | active | 27.5 | g | 1.2.40.0.34.5.221:100000090863 | HYPERICI HERBA | 27.5 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1114065 | FORTECORTIN SPRAMP 40MG/5ML | Fortecortin Inject 40 mg - Spritzampulle | 1.2.40.0.34.4.17:1-18431 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H02AB02 | Dexamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708635 | DEXAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | active | 43.72 | mg | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | 43.72 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921759001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1114071 | FORTECORTIN SPRAMP100MG/10ML | Fortecortin Inject 100 mg - Spritzampulle | 1.2.40.0.34.4.17:1-18432 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H02AB02 | Dexamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708635 | DEXAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | active | 109.3 | mg | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | 109.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:921760001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1115679 | DITROPAN TBL | Ditropan Tabletten | 1.2.40.0.34.4.17:1-18728 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G04BD04 | Oxybutynin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709235 | OXYBUTYNIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092169 | OXYBUTYNIN HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000092169 | OXYBUTYNIN HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927343003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1117230 | ENDOXAN TRSTAMP 1G | Endoxan "Baxter" 1 g - Trockenstechampulle | 1.2.40.0.34.4.17:17948 | GA - zugelassen | Baxter Healthcare GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:L01AA01 | Cyclophosphamid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708517 | CYCLOPHOSPHAMID | 1.2.40.0.34.5.221:100000090277 | CYCLOPHOSPHAMIDE | active | 1069 | mg | 1.2.40.0.34.5.221:100000090277 | CYCLOPHOSPHAMIDE | 1069 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:124071002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1117307 | LENDORM TBL | Lendorm 0,25 mg - Tabletten | 1.2.40.0.34.4.17:1-18220 | GA - zugelassen | Boehringer Ingelheim RCV GmbH & Co KG | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05CD09 | Brotizolam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707524 | BROTIZOLAM | 1.2.40.0.34.5.221:100000085858 | BROTIZOLAM | active | 0.25 | mg | 1.2.40.0.34.5.221:100000085858 | BROTIZOLAM | 0.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922177001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1117313 | MAGNEVIST IJLSG 0,5STAMP 20 | Magnevist 0,5 mmol/ml - Injektionslösung | 1.2.40.0.34.4.17:1-18577 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V08CA01 | Gadopentetsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1710278 | GADOLINIUMOXID | 1.2.40.0.34.5.221:100000128280 | GADOLINIUM OXIDE | active | 90.625 | mg | 1.2.40.0.34.5.221:100000128280 | GADOLINIUM OXIDE | 90.625 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927667010 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1118330 | ZYLORIC TBL 300MG | Zyloric 300 mg - Tabletten | 1.2.40.0.34.4.17:15555 | GA - aufgehoben | Aspen Pharma Trading Limited | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M04AA01 | Allopurinol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709057 | ALLOPURINOL | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | active | 300 | mg | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122430001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1118347 | ZYLORIC TBL 300MG | Zyloric 300 mg - Tabletten | 1.2.40.0.34.4.17:15555 | GA - aufgehoben | Aspen Pharma Trading Limited | false | false | 90 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M04AA01 | Allopurinol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709057 | ALLOPURINOL | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | active | 300 | mg | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122430002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1121533 | MAGNESIOCARD AMP I.V. 10ML | Magnesiocard i.v. - Ampullen | 1.2.40.0.34.4.17:1-18609 | GA - zugelassen | Kwizda Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A12CC05 | Magnesiumaspartat | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705578 | MAGNESIUM ASPARTAT HYDROCHLORID TRIHYDRAT | 1.2.40.0.34.5.221:100000076799 | MAGNESIUM ASPARTATE HYDROCHLORIDE | active | 737.6 | mg | 1.2.40.0.34.5.221:100000076799 | MAGNESIUM ASPARTATE HYDROCHLORIDE | 737.6 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:129735001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1121622 | NIEREN TEE ST.SEVERIN | Nierentee St. Severin | 1.2.40.0.34.4.17:10239 | GA - aufgehoben | Gall & Reidlinger OHG | false | false | 70 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:G04BX | Andere Urologika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706173 | ONONIDIS RADIX | 1.2.40.0.34.5.221:100000079305 | RESTHARROW ROOT | active | 25 | g | 1.2.40.0.34.5.221:100000079305 | RESTHARROW ROOT | 25 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073370 | Arzneitee | false | human | 1.2.40.0.34.4.26:922986002 | 1.2.40.0.34.5.156:1708368 | KALIUMACETAT | 1.2.40.0.34.5.221:100000089697 | POTASSIUM ACETATE | active | 12.5 | g | 1.2.40.0.34.5.221:100000089697 | POTASSIUM ACETATE | 12.5 | g | 1.2.40.0.34.5.156:1705378 | EQUISETI HERBA | 1.2.40.0.34.5.221:100000076118 | EQUISETUM STEM | active | 25 | g | 1.2.40.0.34.5.221:100000076118 | EQUISETUM STEM | 25 | g | | | | | | | 1.2.40.0.34.5.156:1708683 | POLYGONI HERBA | 1.2.40.0.34.5.221:100000090756 | POLYGONI HERBA | active | 37.5 | g | 1.2.40.0.34.5.221:100000090756 | POLYGONI HERBA | 37.5 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1125726 | NOZINAN TR 4% | Nozinan 4 % - Tropfen | 1.2.40.0.34.4.17:13132 | GA - zugelassen | G.L. Pharma GmbH | true | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N05AA02 | Levomepromazin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708648 | LEVOMEPROMAZIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090562 | LEVOMEPROMAZINE HYDROCHLORIDE | active | 4.4444 | g | 1.2.40.0.34.5.221:100000090562 | LEVOMEPROMAZINE HYDROCHLORIDE | 4.4444 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | true | human | 1.2.40.0.34.4.26:126683001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1125732 | RULIDE FTBL 150MG | Rulide 150 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18581 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:J01FA06 | Roxithromycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709172 | ROXITHROMYCIN | 1.2.40.0.34.5.221:100000092081 | ROXITHROMYCIN | active | 150 | mg | 1.2.40.0.34.5.221:100000092081 | ROXITHROMYCIN | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927558001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1125761 | UNASYN TRSTAMP 1,5G BP | Unasyn 1,5 g - Trockenstechampullen | 1.2.40.0.34.4.17:1-18599 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01CR01 | Ampicillin und Enzym-Inhibitoren | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708424 | AMPICILLIN NATRIUM | 1.2.40.0.34.5.221:100000089974 | AMPICILLIN SODIUM | active | 1064 | mg | 1.2.40.0.34.5.221:100000092323 | AMPICILLIN | 1001.029288 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:927609002 | 1.2.40.0.34.5.156:1708438 | SULBACTAM NATRIUM | 1.2.40.0.34.5.221:100000090027 | SULBACTAM SODIUM | active | 547 | mg | 1.2.40.0.34.5.221:100000090027 | SULBACTAM SODIUM | 547 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1125778 | UNASYN TRSTAMP 3G BP | Unasyn 3 g - Trockenstechampullen | 1.2.40.0.34.4.17:1-18596 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01CR01 | Ampicillin und Enzym-Inhibitoren | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708424 | AMPICILLIN NATRIUM | 1.2.40.0.34.5.221:100000089974 | AMPICILLIN SODIUM | active | 2.128 | g | 1.2.40.0.34.5.221:100000092323 | AMPICILLIN | 2.002059 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:927610002 | 1.2.40.0.34.5.156:1708438 | SULBACTAM NATRIUM | 1.2.40.0.34.5.221:100000090027 | SULBACTAM SODIUM | active | 1.094 | g | 1.2.40.0.34.5.221:100000090027 | SULBACTAM SODIUM | 1.094 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1125784 | UNASYN TRSUB IFL 3G BP5X1 | Unasyn 3 g - Trockensubstanz zur Infusionsbereitung | 1.2.40.0.34.4.17:1-18597 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01CR01 | Ampicillin und Enzym-Inhibitoren | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708424 | AMPICILLIN NATRIUM | 1.2.40.0.34.5.221:100000089974 | AMPICILLIN SODIUM | active | 2.128 | g | 1.2.40.0.34.5.221:100000092323 | AMPICILLIN | 2.002059 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:927611002 | 1.2.40.0.34.5.156:1708438 | SULBACTAM NATRIUM | 1.2.40.0.34.5.221:100000090027 | SULBACTAM SODIUM | active | 1.094 | g | 1.2.40.0.34.5.221:100000090027 | SULBACTAM SODIUM | 1.094 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1127151 | LOVENOX FSPR 2000IE/0,2ML | LOVENOX 2.000 IE (20 mg)/0,2 ml Injektionslösung in einer Fertigspritze | 1.2.40.0.34.4.17:1-18663 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:B01AB05 | Enoxaparin | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1708477 | ENOXAPARIN NATRIUM | 1.2.40.0.34.5.221:100000090152 | ENOXAPARIN SODIUM | active | 20 | mg | 1.2.40.0.34.5.221:100000090152 | ENOXAPARIN SODIUM | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927580001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1127168 | LOVENOX FSPR 4000IE/0,4ML | LOVENOX 4.000 IE (40 mg)/0,4 ml Injektionslösung in einer Fertigspritze | 1.2.40.0.34.4.17:1-18662 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:B01AB05 | Enoxaparin | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1708477 | ENOXAPARIN NATRIUM | 1.2.40.0.34.5.221:100000090152 | ENOXAPARIN SODIUM | active | 40 | mg | 1.2.40.0.34.5.221:100000090152 | ENOXAPARIN SODIUM | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927581001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1128794 | ISOPTIN RR RET FTBL 240MG | Isoptin RR retard 240 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18441 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 240 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 240 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927277001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1129977 | ADALAT 2-PHAS FTBL 20MG | Adalat 2-Phasen 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18561 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C08CA05 | Nifedipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708560 | NIFEDIPIN | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | active | 20 | mg | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927308001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1129983 | ADALAT 2-PHAS FTBL 20MG | Adalat 2-Phasen 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18561 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C08CA05 | Nifedipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708560 | NIFEDIPIN | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | active | 20 | mg | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927308002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1130012 | BAYPRESS TBL 10MG | Baypress 10 mg - Tabletten | 1.2.40.0.34.4.17:1-18429 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08CA08 | Nitrendipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708497 | NITRENDIPIN | 1.2.40.0.34.5.221:100000090223 | NITRENDIPINE | active | 10 | mg | 1.2.40.0.34.5.221:100000090223 | NITRENDIPINE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927300001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1130035 | CONCOR FTBL 5MG | Concor 5 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18587 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB07 | Bisoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709671 | BISOPROLOL HEMIFUMARAT | 1.2.40.0.34.5.221:100000115415 | BISOPROLOL HEMIFUMARATE | active | 5 | mg | 1.2.40.0.34.5.221:100000115415 | BISOPROLOL HEMIFUMARATE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927183001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1130041 | CONCOR FTBL 5MG | Concor 5 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18587 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB07 | Bisoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709671 | BISOPROLOL HEMIFUMARAT | 1.2.40.0.34.5.221:100000115415 | BISOPROLOL HEMIFUMARATE | active | 5 | mg | 1.2.40.0.34.5.221:100000115415 | BISOPROLOL HEMIFUMARATE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927183002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1130058 | CONCOR FTBL 10MG | Concor 10 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18586 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB07 | Bisoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709671 | BISOPROLOL HEMIFUMARAT | 1.2.40.0.34.5.221:100000115415 | BISOPROLOL HEMIFUMARATE | active | 10 | mg | 1.2.40.0.34.5.221:100000115415 | BISOPROLOL HEMIFUMARATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927184001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1130064 | CONCOR FTBL 10MG | Concor 10 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18586 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB07 | Bisoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709671 | BISOPROLOL HEMIFUMARAT | 1.2.40.0.34.5.221:100000115415 | BISOPROLOL HEMIFUMARATE | active | 10 | mg | 1.2.40.0.34.5.221:100000115415 | BISOPROLOL HEMIFUMARATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927184002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1130130 | EXODERIL DERM LSG 1% | Exoderil 1% - dermatologische Lösung | 1.2.40.0.34.4.17:1-18517 | GA - zugelassen | Sandoz GmbH | true | true | 20 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D01AE22 | Naftifin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707486 | NAFTIFIN HYDROCHLORID | 1.2.40.0.34.5.221:100000085708 | NAFTIFINE HYDROCHLORIDE | active | 0.2 | g | 1.2.40.0.34.5.221:100000085708 | NAFTIFINE HYDROCHLORIDE | 0.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:927479001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1130302 | NIFTEN KPS | Niften - Kapseln | 1.2.40.0.34.4.17:1-18626 | GA - aufgehoben | Astrazeneca Österreich GmbH | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C07FB03 | Atenolol und andere Antihypertonika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 50 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927821001 | 1.2.40.0.34.5.156:1708560 | NIFEDIPIN | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | active | 20 | mg | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | 20 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1130319 | NOZINAN TR 4% | Nozinan 4 % - Tropfen | 1.2.40.0.34.4.17:13132 | GA - zugelassen | G.L. Pharma GmbH | true | false | 20 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N05AA02 | Levomepromazin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708648 | LEVOMEPROMAZIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090562 | LEVOMEPROMAZINE HYDROCHLORIDE | active | 0.88888 | g | 1.2.40.0.34.5.221:100000090562 | LEVOMEPROMAZINE HYDROCHLORIDE | 0.88888 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | true | human | 1.2.40.0.34.4.26:126683002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1130414 | TRATUL KPS 50MG | Tratul 50 mg Kapseln | 1.2.40.0.34.4.17:17607 | GA - zugelassen | G.L. Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709564 | DICLOFENAC | 1.2.40.0.34.5.221:100000092798 | DICLOFENAC | active | 50 | mg | 1.2.40.0.34.5.221:100000092798 | DICLOFENAC | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | true | human | 1.2.40.0.34.4.26:920404003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1130897 | CUTASEPT DESINFEKT.FARBLOS | Cutasept - Desinfektionslösung farblos | 1.2.40.0.34.4.17:1-31780 | GA - zugelassen | Bode Chemie GmbH | true | true | 1 | 2.16.840.1.113883.6.8:L | Liter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D08AX53 | Propanol, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709170 | BENZALKONIUMCHLORID | 1.2.40.0.34.5.221:100000092079 | BENZALKONIUM CHLORIDE | active | 0.25 | g | 1.2.40.0.34.5.221:100000092079 | BENZALKONIUM CHLORIDE | 0.25 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:956625001 | 1.2.40.0.34.5.156:1705751 | 2-PROPANOL | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | active | 630 | g | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | 630 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1138120 | ULSAL FTBL 300MG | Ulsal 300 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18559 | GA - aufgehoben | Gebro Pharma GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA02 | Ranitidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708596 | RANITIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | active | 336 | mg | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | 336 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927625001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1138137 | ULSAL FTBL 300MG | Ulsal 300 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18559 | GA - aufgehoben | Gebro Pharma GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA02 | Ranitidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708596 | RANITIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | active | 336 | mg | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | 336 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927625002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1138835 | FLUCTINE KPS 20MG | Fluctine 20 mg - Kapseln | 1.2.40.0.34.4.17:1-18570 | GA - zugelassen | Eli Lilly Ges.m.b.H. | true | true | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AB03 | Fluoxetin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708899 | FLUOXETIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091555 | FLUOXETINE HYDROCHLORIDE | active | 22.36 | mg | 1.2.40.0.34.5.221:100000091555 | FLUOXETINE HYDROCHLORIDE | 22.36 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927207003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1138841 | FLUCTINE KPS 20MG | Fluctine 20 mg - Kapseln | 1.2.40.0.34.4.17:1-18570 | GA - zugelassen | Eli Lilly Ges.m.b.H. | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AB03 | Fluoxetin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708899 | FLUOXETIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091555 | FLUOXETINE HYDROCHLORIDE | active | 22.36 | mg | 1.2.40.0.34.5.221:100000091555 | FLUOXETINE HYDROCHLORIDE | 22.36 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927207006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1140186 | MITOMYCIN-C TRSTAMP 10MG | Mitomycin C "Kyowa" 10 mg - Trockenstechampullen | 1.2.40.0.34.4.17:1-18408 | GA - aufgehoben | Ebewe Pharma Ges.m.b.H. Nfg.KG | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:L01DC03 | Mitomycin | 1.2.40.0.10.1.4.3.4.3.4:900000000009 | intrakavitäre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | 1.2.40.0.34.5.156:1706493 | MITOMYCIN | 1.2.40.0.34.5.221:100000080898 | MITOMYCIN | active | 10 | mg | 1.2.40.0.34.5.221:100000080898 | MITOMYCIN | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:922497002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1141010 | ZOVIRAX FTBL 800MG | Zovirax 800 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18619 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | false | 35 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J05AB01 | Aciclovir | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709572 | ACICLOVIR | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | active | 800 | mg | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | 800 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927847001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1141056 | ACIMETHIN FTBL | Acimethin - Filmtabletten | 1.2.40.0.34.4.17:1-18611 | GA - zugelassen | Viatris Austria GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:V03AB26 | Methionin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709383 | METHIONIN | 1.2.40.0.34.5.221:100000092414 | METHIONINE | active | 500 | mg | 1.2.40.0.34.5.221:100000092414 | METHIONINE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927394002 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:G04BA | Harn ansäuernde Mittel | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1141122 | FRAGMIN AMP 10000IE/1ML | Fragmin 10.000 IE/1 ml - Ampullen | 1.2.40.0.34.4.17:1-18732 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B01AB04 | Dalteparin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1708792 | DALTEPARIN NATRIUM | 1.2.40.0.34.5.221:100000091301 | DALTEPARIN SODIUM | active | 10000 | IU | 1.2.40.0.34.5.221:100000091301 | DALTEPARIN SODIUM | 10000 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927676001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1141139 | FRAGMIN STAMP 10000IE/4ML | Fragmin 10.000 IE/4 ml - Stechampullen | 1.2.40.0.34.4.17:1-18734 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B01AB04 | Dalteparin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708792 | DALTEPARIN NATRIUM | 1.2.40.0.34.5.221:100000091301 | DALTEPARIN SODIUM | active | 10000 | IU | 1.2.40.0.34.5.221:100000091301 | DALTEPARIN SODIUM | 10000 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927675001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1141168 | NERVENTEE ST.SEVERIN | Nerventee St. Severin | 1.2.40.0.34.4.17:10249 | GA - aufgehoben | Gall & Reidlinger OHG | false | false | 70 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N05CX | Hypnotika und Sedativa in Kombination, exkl. Barbiturate | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708710 | LUPULI FLOS | 1.2.40.0.34.5.221:100000090996 | LUPULI FLOS | active | 7.5 | g | 1.2.40.0.34.5.221:100000090996 | LUPULI FLOS | 7.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073370 | Arzneitee | true | human | 1.2.40.0.34.4.26:922987002 | 1.2.40.0.34.5.156:1708769 | VALERIANAE RADIX | 1.2.40.0.34.5.221:100000091186 | VALERIANAE RADIX | active | 25 | g | 1.2.40.0.34.5.221:100000091186 | VALERIANAE RADIX | 25 | g | 1.2.40.0.34.5.156:1710047 | CALLUNAE HERBA | 1.2.40.0.34.5.221:900000000278 | CALLUNAE HERBA | active | 20 | g | 1.2.40.0.34.5.221:900000000278 | CALLUNAE HERBA | 20 | g | | | | | | | 1.2.40.0.34.5.156:1710491 | MENTHAE PIPERITAE HERBA | 1.2.40.0.34.5.221:900000000724 | MENTHAE PIPERITAE HERBA | active | 25 | g | 1.2.40.0.34.5.221:900000000724 | MENTHAE PIPERITAE HERBA | 25 | g | 1.2.40.0.34.5.156:1708698 | HYPERICI HERBA | 1.2.40.0.34.5.221:100000090863 | HYPERICI HERBA | active | 17.5 | g | 1.2.40.0.34.5.221:100000090863 | HYPERICI HERBA | 17.5 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1144741 | KELOSOFT NARBENSLB | Kelosoft - Narbensalbe | 1.2.40.0.34.4.17:735897 | GA - registriert | Guterrat Gesundheitsprodukte GmbH & Co. KG | true | true | 10 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D11AX | Andere Dermatika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1710360 | HYOSCYAMI FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000591 | HYOSCYAMI FOLIUM (EXTRACT) | active | 500 | g | 1.2.40.0.34.5.221:900000000591 | HYOSCYAMI FOLIUM (EXTRACT) | 500 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:958393001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1144758 | KELOSOFT NARBENSLB | Kelosoft - Narbensalbe | 1.2.40.0.34.4.17:735897 | GA - registriert | Guterrat Gesundheitsprodukte GmbH & Co. KG | true | true | 25 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D11AX | Andere Dermatika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1710360 | HYOSCYAMI FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000591 | HYOSCYAMI FOLIUM (EXTRACT) | active | 1250 | g | 1.2.40.0.34.5.221:900000000591 | HYOSCYAMI FOLIUM (EXTRACT) | 1250 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:958393002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1144764 | DHE RTP KPS 2,5MG | DHE "ratiopharm" 2,5 mg - Kapseln | 1.2.40.0.34.4.17:1-18564 | GA - aufgehoben | ratiopharm Arzneimittel Vertriebs GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02CA01 | Dihydroergotamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708652 | DIHYDROERGOTAMIN MESILAT | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | active | 2.5 | mg | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:924620001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1144770 | DHE RTP KPS 2,5MG | DHE "ratiopharm" 2,5 mg - Kapseln | 1.2.40.0.34.4.17:1-18564 | GA - aufgehoben | ratiopharm Arzneimittel Vertriebs GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02CA01 | Dihydroergotamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708652 | DIHYDROERGOTAMIN MESILAT | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | active | 2.5 | mg | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:924620002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1144818 | AMOXILAN KPS 500MG | Amoxilan 500 mg - Kapseln | 1.2.40.0.34.4.17:1-18622 | GA - aufgehoben | G.L. Pharma GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CA04 | Amoxicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708923 | AMOXICILLIN | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | active | 573.8 | mg | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 573.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927031001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1144824 | AMOXILAN KPS 500MG | Amoxilan 500 mg - Kapseln | 1.2.40.0.34.4.17:1-18622 | GA - aufgehoben | G.L. Pharma GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CA04 | Amoxicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708923 | AMOXICILLIN | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | active | 573.8 | mg | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 573.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927031002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1144830 | AMOXILAN TBL 1000MG | Amoxilan 1000 mg - Tabletten | 1.2.40.0.34.4.17:1-18386 | GA - zugelassen | G.L. Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CA04 | Amoxicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7033709 | AMOXICILLIN TRIHYDRAT | 1.2.40.0.34.5.221:100000092629 | AMOXICILLIN TRIHYDRATE | active | 1147.6 | mg | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 999.721412 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922901001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1144847 | BETAISODONA WUNDGEL | Betadona Wund - Gel | 1.2.40.0.34.4.17:15974 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | false | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:D08AG02 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073573 | zum Auftragen auf die Wunde | | | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDON-IOD | active | | | 1.2.40.0.34.5.221:100000091677 | POVIDON-IOD | | | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1144853 | BETAISODONA WUNDGEL | Betadona Wund - Gel | 1.2.40.0.34.4.17:15974 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | false | 90 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:D08AG02 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073573 | zum Auftragen auf die Wunde | | | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDON-IOD | active | | | 1.2.40.0.34.5.221:100000091677 | POVIDON-IOD | | | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1144876 | BETAISODONA WUNDGEL TB | Betadona Wund - Gel | 1.2.40.0.34.4.17:15974 | GA - zugelassen | Taw Pharma (Ireland) Limited | true | false | 250 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:D08AG02 | Povidon-Iod | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073573 | zum Auftragen auf die Wunde | | | 1.2.40.0.34.5.156:1708959 | POVIDON-IOD | 1.2.40.0.34.5.221:100000091677 | POVIDON-IOD | active | | | 1.2.40.0.34.5.221:100000091677 | POVIDON-IOD | | | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1144965 | AMOXICILLIN RTP FTBL 1000MG | Amoxicillin "ratiopharm" 1000 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18385 | GA - zugelassen | Teva B.V. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CA04 | Amoxicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7033709 | AMOXICILLIN TRIHYDRAT | 1.2.40.0.34.5.221:100000092629 | AMOXICILLIN TRIHYDRATE | active | 1148 | mg | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 1000.069868 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:925235001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1145114 | MERCILON TBL | Mercilon - Tabletten | 1.2.40.0.34.4.17:1-18576 | GA - zugelassen | Organon Healthcare GmbH | true | false | 21 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AA09 | Desogestrel und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.02 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.02 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927732001 | 1.2.40.0.34.5.156:1706864 | DESOGESTREL | 1.2.40.0.34.5.221:100000083191 | DESOGESTREL | active | 0.15 | mg | 1.2.40.0.34.5.221:100000083191 | DESOGESTREL | 0.15 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1145120 | MERCILON TBL 3X21 | Mercilon - Tabletten | 1.2.40.0.34.4.17:1-18576 | GA - zugelassen | Organon Healthcare GmbH | true | true | 63 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AA09 | Desogestrel und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.02 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.02 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927732002 | 1.2.40.0.34.5.156:1706864 | DESOGESTREL | 1.2.40.0.34.5.221:100000083191 | DESOGESTREL | active | 0.15 | mg | 1.2.40.0.34.5.221:100000083191 | DESOGESTREL | 0.15 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1145203 | ROHYPNOL FTBL 1MG | Rohypnol 1 mg - Filmtabletten | 1.2.40.0.34.4.17:17743 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05CD03 | Flunitrazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709505 | FLUNITRAZEPAM | 1.2.40.0.34.5.221:100000092658 | FLUNITRAZEPAM | active | 1 | mg | 1.2.40.0.34.5.221:100000092658 | FLUNITRAZEPAM | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:920643001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1145261 | SUPRESSIN TBL 2MG | Supressin 2 mg Tabletten | 1.2.40.0.34.4.17:1-18589 | GA - zugelassen | Viatris Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C02CA04 | Doxazosin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708426 | DOXAZOSIN MESILAT | 1.2.40.0.34.5.221:100000089988 | DOXAZOSIN MESILATE | active | 2.43 | mg | 1.2.40.0.34.5.221:100000089988 | DOXAZOSIN MESILATE | 2.43 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927329001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1145278 | SUPRESSIN TBL 2MG | Supressin 2 mg Tabletten | 1.2.40.0.34.4.17:1-18589 | GA - zugelassen | Viatris Austria GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C02CA04 | Doxazosin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708426 | DOXAZOSIN MESILAT | 1.2.40.0.34.5.221:100000089988 | DOXAZOSIN MESILATE | active | 2.43 | mg | 1.2.40.0.34.5.221:100000089988 | DOXAZOSIN MESILATE | 2.43 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927329002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1145284 | SUPRESSIN TBL 4MG | Supressin 4 mg Tabletten | 1.2.40.0.34.4.17:1-18588 | GA - zugelassen | Viatris Austria GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C02CA04 | Doxazosin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708426 | DOXAZOSIN MESILAT | 1.2.40.0.34.5.221:100000089988 | DOXAZOSIN MESILATE | active | 4.85 | mg | 1.2.40.0.34.5.221:100000089988 | DOXAZOSIN MESILATE | 4.85 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927330001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1145290 | TRICHEX FTBL 500MG | Trichex 500 mg - Filmtabletten | 1.2.40.0.34.4.17:15562 | GA - aufgehoben | G.L. Pharma GmbH | false | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01XD01 | Metronidazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708522 | METRONIDAZOL | 1.2.40.0.34.5.221:100000090285 | METRONIDAZOLE | active | 500 | mg | 1.2.40.0.34.5.221:100000090285 | METRONIDAZOLE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129287001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1145321 | ZANTAC FTBL 300MG | Zantac 300 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18558 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:A02BA02 | Ranitidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708596 | RANITIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | active | 336 | mg | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | 336 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927624001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1145338 | ZANTAC FTBL 300MG | Zantac 300 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18558 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:A02BA02 | Ranitidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708596 | RANITIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | active | 336 | mg | 1.2.40.0.34.5.221:100000090451 | RANITIDINE HYDROCHLORIDE | 336 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927624002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1149247 | DECAPEPTYL DEP RET MIKROKPS | Decapeptyl Depot - Retardmikrokapseln und Suspensionsmittel in Einmalspritzen | 1.2.40.0.34.4.17:1-18914 | GA - zugelassen | Ferring Arzneimittel Ges.m.b.H. | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:L02AE04 | Triptorelin | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1708622 | TRIPTORELIN ACETAT | 1.2.40.0.34.5.221:100000090505 | TRIPTORELIN ACETATE | active | 4.12 | mg | 1.2.40.0.34.5.221:100000090505 | TRIPTORELIN ACETATE | 4.12 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073869 | Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension | true | human | 1.2.40.0.34.4.26:927571001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1151787 | TARGOCID TRSTAMP 200MG SP5X5 | Targocid 200 mg - Trockenstechampullen mit Lösungsmittel | 1.2.40.0.34.4.17:1-19652 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01XA02 | Teicoplanin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1707381 | TEICOPLANIN | 1.2.40.0.34.5.221:100000085403 | TEICOPLANIN | active | 200 | mg | 1.2.40.0.34.5.221:100000085403 | TEICOPLANIN | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:929237001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073366 | Pulver und Lösungsmittel zur Herstellung einer Lösung zum Einnehmen | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1151793 | TARGOCID TRSTAMP 400MG SP5X5 | Targocid 400 mg - Trockenstechampullen mit Lösungsmittel | 1.2.40.0.34.4.17:1-19653 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01XA02 | Teicoplanin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1707381 | TEICOPLANIN | 1.2.40.0.34.5.221:100000085403 | TEICOPLANIN | active | 400 | mg | 1.2.40.0.34.5.221:100000085403 | TEICOPLANIN | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:929238001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073366 | Pulver und Lösungsmittel zur Herstellung einer Lösung zum Einnehmen | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1152203 | EMGECARD FTBL 2,5MMOL | Emgecard 2,5 mmol - Filmtabletten | 1.2.40.0.34.4.17:1-18610 | GA - zugelassen | Kwizda Pharma GmbH | true | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A12CC | Magnesium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705578 | MAGNESIUM ASPARTAT HYDROCHLORID TRIHYDRAT | 1.2.40.0.34.5.221:100000076799 | MAGNESIUM ASPARTATE HYDROCHLORIDE | active | 614.8 | mg | 1.2.40.0.34.5.221:100000076799 | MAGNESIUM ASPARTATE HYDROCHLORIDE | 614.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:129740002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1152278 | LOVENOX AMP 100MG | LOVENOX 10.000 IE (100 mg)/1 ml Injektionslösung in einer Ampulle | 1.2.40.0.34.4.17:1-18753 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B01AB05 | Enoxaparin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | 1.2.40.0.34.5.156:1708477 | ENOXAPARIN NATRIUM | 1.2.40.0.34.5.221:100000090152 | ENOXAPARIN SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000090152 | ENOXAPARIN SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927582001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1152338 | NEOTIGASON KPS 10MG | Neotigason 10 mg Kapseln | 1.2.40.0.34.4.17:1-18708 | GA - aufgehoben | Actavis Group PTC ehf. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:D05BB02 | Acitretin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707078 | ACITRETIN | 1.2.40.0.34.5.221:100000084604 | ACITRETIN | active | 10 | mg | 1.2.40.0.34.5.221:100000084604 | ACITRETIN | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927990002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1152344 | NEOTIGASON KPS 10MG | Neotigason 10 mg Kapseln | 1.2.40.0.34.4.17:1-18708 | GA - aufgehoben | Actavis Group PTC ehf. | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:D05BB02 | Acitretin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707078 | ACITRETIN | 1.2.40.0.34.5.221:100000084604 | ACITRETIN | active | 10 | mg | 1.2.40.0.34.5.221:100000084604 | ACITRETIN | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927990001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1152350 | NEOTIGASON KPS 25MG | Neotigason 25 mg Kapseln | 1.2.40.0.34.4.17:1-18709 | GA - aufgehoben | Actavis Group PTC ehf. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:D05BB02 | Acitretin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707078 | ACITRETIN | 1.2.40.0.34.5.221:100000084604 | ACITRETIN | active | 25 | mg | 1.2.40.0.34.5.221:100000084604 | ACITRETIN | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927991002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1152367 | NEOTIGASON KPS 25MG | Neotigason 25 mg Kapseln | 1.2.40.0.34.4.17:1-18709 | GA - aufgehoben | Actavis Group PTC ehf. | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:D05BB02 | Acitretin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707078 | ACITRETIN | 1.2.40.0.34.5.221:100000084604 | ACITRETIN | active | 25 | mg | 1.2.40.0.34.5.221:100000084604 | ACITRETIN | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927991001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1152373 | RETROVIR KPS 250MG | Retrovir 250 mg - Kapseln | 1.2.40.0.34.4.17:1-18277 | GA - aufgehoben | Viiv Healthcare B.V. | false | false | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J05AF01 | Zidovudin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707951 | ZIDOVUDIN | 1.2.40.0.34.5.221:100000088002 | ZIDOVUDINE | active | 250 | mg | 1.2.40.0.34.5.221:100000088002 | ZIDOVUDINE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927513001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1161432 | DITROPAN TBL | Ditropan Tabletten | 1.2.40.0.34.4.17:1-18728 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G04BD04 | Oxybutynin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709235 | OXYBUTYNIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092169 | OXYBUTYNIN HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000092169 | OXYBUTYNIN HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927343002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1161515 | JOPAMIRO 200MG J/ML IFL 50ML | Jopamiro 200 mg J/ml - Infusionsflasche | 1.2.40.0.34.4.17:17608 | GA - zugelassen | Bracco Österreich GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 20400 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 20400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920666005 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1161521 | JOPAMIRO 200MG J/ML IFL 50ML | Jopamiro 200 mg J/ml - Infusionsflasche | 1.2.40.0.34.4.17:17608 | GA - zugelassen | Bracco Österreich GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 20400 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 20400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920666009 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1161538 | JOPAMIRO 200MG J/ML IFL100ML | Jopamiro 200 mg J/ml - Infusionsflasche | 1.2.40.0.34.4.17:17608 | GA - zugelassen | Bracco Österreich GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 40800 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 40800 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920666007 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1161544 | KONAKION MMIZ AMP 10MG/1ML | Konakion 10 mg/1 ml Mischmizellenlösung - Ampullen | 1.2.40.0.34.4.17:1-18712 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B02BA01 | Phytomenadion | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | 1.2.40.0.34.5.156:1709068 | PHYTOMENADION | 1.2.40.0.34.5.221:100000091922 | PHYTOMENADIONE | active | 10 | mg | 1.2.40.0.34.5.221:100000091922 | PHYTOMENADIONE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:927660001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1161685 | TRATUL RET FTBL 100MG | Tratul retard 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18204 | GA - zugelassen | G.L. Pharma GmbH | true | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927141001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1166783 | ESTRACYT TRSTAMP 300MG | Estracyt 300 mg Trockenstechampullen mit Lösungsmittel | 1.2.40.0.34.4.17:14881 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:L01XX11 | Estramustin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709336 | ESTRAMUSTIN PHOSPHAT | 1.2.40.0.34.5.221:100000092342 | ESTRAMUSTINE PHOSPHATE | active | 300 | mg | 1.2.40.0.34.5.221:100000092342 | ESTRAMUSTINE PHOSPHATE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073868 | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:125057001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1166843 | LEGALON KPS 140MG | Legalon 140 mg - Kapseln | 1.2.40.0.34.4.17:1-18656 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A05BA03 | Silymarin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710766 | SILYBI MARIANI FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000001000 | SILYBI MARIANI FRUCTUS (EXTRACT) | active | 173 | mg | 1.2.40.0.34.5.221:900000001000 | SILYBI MARIANI FRUCTUS (EXTRACT) | 173 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:922967001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1166866 | LOVENOX FSPR 2000IE/0,2ML | LOVENOX 2.000 IE (20 mg)/0,2 ml Injektionslösung in einer Fertigspritze | 1.2.40.0.34.4.17:1-18663 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:B01AB05 | Enoxaparin | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1708477 | ENOXAPARIN NATRIUM | 1.2.40.0.34.5.221:100000090152 | ENOXAPARIN SODIUM | active | 20 | mg | 1.2.40.0.34.5.221:100000090152 | ENOXAPARIN SODIUM | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927580009 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1166955 | NEUROFENAC KPS | Neurofenac - Kapseln | 1.2.40.0.34.4.17:1-18584 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB55 | Diclofenac, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927771003 | 1.2.40.0.34.5.156:1709249 | THIAMIN NITRAT | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | 50 | mg | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1166961 | NEUROFENAC KPS | Neurofenac - Kapseln | 1.2.40.0.34.4.17:1-18584 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB55 | Diclofenac, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927771004 | 1.2.40.0.34.5.156:1709249 | THIAMIN NITRAT | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | 50 | mg | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1167009 | RHEUTROP RET KPS | Rheutrop retard - Kapseln | 1.2.40.0.34.4.17:1-18567 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB11 | Acemetacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707925 | ACEMETACIN | 1.2.40.0.34.5.221:100000087912 | ACEMETACIN | active | 90 | mg | 1.2.40.0.34.5.221:100000087912 | ACEMETACIN | 90 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:927512001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1167015 | RHEUTROP RET KPS | Rheutrop retard - Kapseln | 1.2.40.0.34.4.17:1-18567 | GA - zugelassen | Viatris Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB11 | Acemetacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707925 | ACEMETACIN | 1.2.40.0.34.5.221:100000087912 | ACEMETACIN | active | 90 | mg | 1.2.40.0.34.5.221:100000087912 | ACEMETACIN | 90 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:927512002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1167073 | TUSSIMONT HU-SFT THYMIAN+SEN | TUSSIMONT HUSTENSAFT mit Thymian und Senegawurzel | 1.2.40.0.34.4.17:736772 | GA - registriert | Pharmonta Dr. Fischer GmbH | true | true | 120 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05X | Andere Kombinationspräparate gegen Erkältungskrankheiten | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710651 | POLYGALAE RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000000884 | POLYGALAE RADIX (EXTRACT) | active | 360 | g | 1.2.40.0.34.5.221:900000000884 | POLYGALAE RADIX (EXTRACT) | 360 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073645 | Flüssigkeit zum Einnehmen | false | human | 1.2.40.0.34.4.26:958576001 | 1.2.40.0.34.5.156:1710828 | THYMI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001063 | THYMI HERBA (EXTRACT) | active | 1200 | g | 1.2.40.0.34.5.221:900000001063 | THYMI HERBA (EXTRACT) | 1200 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1167133 | UNASYN FTBL | Unasyn - Filmtabletten | 1.2.40.0.34.4.17:1-18707 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CR04 | Sultamicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707260 | SULTAMICILLINTOSILAT-DIHYDRAT | 1.2.40.0.34.5.221:100000151757 | SULTAMICILLIN TOSYLATE DIHYDRATE | active | 520.8 | mg | 1.2.40.0.34.5.221:100000151757 | SULTAMICILLIN TOSYLATE DIHYDRATE | 520.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927678001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1172602 | TARGOCID TRSTAMP 100MG SP5X5 | Targocid 100 mg - Trockenstechampullen mit Lösungsmittel | 1.2.40.0.34.4.17:1-19651 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01XA02 | Teicoplanin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1707381 | TEICOPLANIN | 1.2.40.0.34.5.221:100000085403 | TEICOPLANIN | active | 100 | mg | 1.2.40.0.34.5.221:100000085403 | TEICOPLANIN | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:929236001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073366 | Pulver und Lösungsmittel zur Herstellung einer Lösung zum Einnehmen | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1174363 | ASTHMATEE EF-EM-ES | Asthmatee EF - EM - ES | 1.2.40.0.34.4.17:11884 | GA - aufgehoben | Gall & Reidlinger OHG | false | false | 70 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:R03 | Mittel bei obstruktiven Atemwegserkrankungen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709703 | HELENII RHIZOMA | 1.2.40.0.34.5.221:100000115914 | HELENII RHIZOMA | active | | | 1.2.40.0.34.5.221:100000115914 | HELENII RHIZOMA | | | 1.2.40.0.10.1.4.3.4.3.5:100000073370 | Arzneitee | true | human | 1.2.40.0.34.4.26:922988002 | 1.2.40.0.34.5.156:1705547 | ARNICAE FLOS | 1.2.40.0.34.5.221:100000076681 | ARNICA FLOWER | active | | | 1.2.40.0.34.5.221:100000076681 | ARNICA FLOWER | | | 1.2.40.0.34.5.156:1705552 | ANISI FRUCTUS | 1.2.40.0.34.5.221:100000076696 | ANISI FRUCTUS | active | | | 1.2.40.0.34.5.221:100000076696 | ANISI FRUCTUS | | | | | | | | | 1.2.40.0.34.5.156:1710475 | MARRUBII HERBA | 1.2.40.0.34.5.221:900000000708 | MARRUBII HERBA | active | | | 1.2.40.0.34.5.221:900000000708 | MARRUBII HERBA | | | 1.2.40.0.34.5.156:1710588 | ORIGANI HERBA | 1.2.40.0.34.5.221:900000000821 | ORIGANI HERBA | active | | | 1.2.40.0.34.5.221:900000000821 | ORIGANI HERBA | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1176818 | ZOLADEX DP IMP SPRAMP 3,6MG | Zoladex Depot 3,6 mg - Implantat | 1.2.40.0.34.4.17:1-18860 | GA - zugelassen | Astrazeneca Österreich GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:L02AE03 | Goserelin | 1.2.40.0.10.1.4.3.4.3.4:100000075249 | zur Implantation | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1707689 | GOSERELIN ACETAT | 1.2.40.0.34.5.221:100000086673 | GOSERELIN ACETATE | active | 3.8 | mg | 1.2.40.0.34.5.221:100000086673 | GOSERELIN ACETATE | 3.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073874 | Implantat | true | human | 1.2.40.0.34.4.26:927579001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1178421 | NORMOLYT LSL PLV KIND | Normolyt für Kinder - lösliches Pulver | 1.2.40.0.34.4.17:1-18775 | GA - zugelassen | Gebro Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:A07CA | Elektrolyte zur oralen Rehydrierung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 0.3 | g | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073364 | Pulver zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:129937001 | 1.2.40.0.34.5.156:1709025 | NATRIUMCITRAT | 1.2.40.0.34.5.221:100000091827 | SODIUM CITRATE | active | 0.59 | g | 1.2.40.0.34.5.221:100000091827 | SODIUM CITRATE | 0.59 | g | 1.2.40.0.34.5.156:1705910 | GLUCOSE | 1.2.40.0.34.5.221:100000078171 | GLUCOSE | active | 4 | g | 1.2.40.0.34.5.221:100000078171 | GLUCOSE | 4 | g | | | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 0.35 | g | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 0.35 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1181185 | ERYTHROCIN FTBL 500MG | Erythrocin 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18764 | GA - zugelassen | Amdipharm Limited | true | false | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01FA01 | Erythromycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708636 | ERYTHROMYCINETHYLSUCCINAT | 1.2.40.0.34.5.221:100000090545 | ERYTHROMYCIN ETHYLSUCCINATE | active | 635.3 | mg | 1.2.40.0.34.5.221:100000090545 | ERYTHROMYCIN ETHYLSUCCINATE | 635.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927413001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1181222 | MICRO-KAL RET KPS | Micro - Kalium retard - Kapseln | 1.2.40.0.34.4.17:1-18711 | GA - zugelassen | G.L. Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A12BA01 | Kaliumchlorid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 600 | mg | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:126430001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1181274 | PARACETAMOL GEN TBL 500MG | Paracetamol Genericon 500 mg Tabletten | 1.2.40.0.34.4.17:1-18726 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BE01 | Paracetamol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | 500 | mg | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927760002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1181280 | PARACETAMOL GEN TBL 500MG | Paracetamol Genericon 500 mg Tabletten | 1.2.40.0.34.4.17:1-18726 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BE01 | Paracetamol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | 500 | mg | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927760001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1181535 | TIMOLOL-SANTEN AU-TR 0,25% | Timolol Santen 0,25 % - Augentropfen | 1.2.40.0.34.4.17:1-18760 | GA - aufgehoben | CROMA-PHARMA GmbH | false | false | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:S01ED01 | Timolol | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1708442 | TIMOLOLMALEAT | 1.2.40.0.34.5.221:100000090033 | TIMOLOL MALEATE | active | 342 | mg | 1.2.40.0.34.5.221:100000090033 | TIMOLOL MALEATE | 342 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:927314001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1181541 | TIMOLOL-SANTEN AU-TR 0,5% | Timolol Santen 0,5 % - Augentropfen | 1.2.40.0.34.4.17:1-18761 | GA - aufgehoben | CROMA-PHARMA GmbH | false | false | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:S01ED01 | Timolol | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1708442 | TIMOLOLMALEAT | 1.2.40.0.34.5.221:100000090033 | TIMOLOL MALEATE | active | 684 | mg | 1.2.40.0.34.5.221:100000090033 | TIMOLOL MALEATE | 684 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:927313001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1186662 | DORMICUM AMP 5MG/5ML | DORMICUM "Roche" 5 mg/5 ml - Injektionslösung | 1.2.40.0.34.4.17:1-18809 | GA - aufgehoben | Roche Austria GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05CD08 | Midazolam | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1706453 | MIDAZOLAM | 1.2.40.0.34.5.221:100000080626 | MIDAZOLAM | active | 5 | mg | 1.2.40.0.34.5.221:100000080626 | MIDAZOLAM | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:928629002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | 1.2.40.0.10.1.4.3.4.3.5:100000073829 | Rektallösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1190959 | UNIFYL RET TBL 300MG | Unifyl retard 300 mg Tabletten | 1.2.40.0.34.4.17:1-18815 | GA - aufgehoben | Mundipharma Ges.m.b.H. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 300 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927909001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1190965 | UNIFYL RET TBL 300MG | Unifyl retard 300 mg Tabletten | 1.2.40.0.34.4.17:1-18815 | GA - aufgehoben | Mundipharma Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 300 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927909002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1190971 | UNIFYL RET TBL 600MG | Unifyl retard 600 mg Tabletten | 1.2.40.0.34.4.17:1-18818 | GA - aufgehoben | Mundipharma Ges.m.b.H. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 600 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927886001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1190988 | UNIFYL RET TBL 600MG | Unifyl retard 600 mg Tabletten | 1.2.40.0.34.4.17:1-18818 | GA - aufgehoben | Mundipharma Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 600 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927886002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1192266 | LUTRELEF PLV+LSM INJ 3,2MG | Lutrelef 3,2 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | 1.2.40.0.34.4.17:1-18947 | GA - zugelassen | Ferring Arzneimittel Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H01CA01 | Gonadorelin | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1708373 | GONADORELIN ACETAT | 1.2.40.0.34.5.221:100000089787 | GONADORELIN ACETATE | active | 3.2 | mg | 1.2.40.0.34.5.221:100000089787 | GONADORELIN ACETATE | 3.2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073868 | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:927889001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1192326 | SERMION FTBL 30MG | Sermion 30 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18913 | GA - zugelassen | Upjohn EESV | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AE02 | Nicergolin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709127 | NICERGOLIN | 1.2.40.0.34.5.221:100000092017 | NICERGOLINE | active | 30 | mg | 1.2.40.0.34.5.221:100000092017 | NICERGOLINE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928647001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1192349 | ULCOGANT OR SUS 1G/5ML | Ulcogant 1 g/5 ml - orale Suspension | 1.2.40.0.34.4.17:1-18789 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 250 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A02BX02 | Sucralfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708896 | SUCRALFAT | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | active | 1000 | mg | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:927910001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1198984 | DICLOFENAC GEN AMP 75MG 3ML | Diclofenac Genericon 75 mg Ampullen | 1.2.40.0.34.4.17:1-18918 | GA - aufgehoben | Genericon Pharma Ges.m.b.H. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 75 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:928594001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1198990 | DICLOFENAC GEN GEL 1% | Diclofenac Genericon 1 % Gel | 1.2.40.0.34.4.17:1-18916 | GA - aufgehoben | Genericon Pharma Ges.m.b.H. | false | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA15 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 1 | g | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:928593001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1199021 | DIFLUCAN ILSG 2MG/ML 100MG | Diflucan 2 mg/ml Infusionslösung | 1.2.40.0.34.4.17:1-18900 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J02AC01 | Fluconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709504 | FLUCONAZOL | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | active | 100 | mg | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:928830007 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1199038 | DIFLUCAN ILSG 2MG/ML 200MG | Diflucan 2 mg/ml Infusionslösung | 1.2.40.0.34.4.17:1-18900 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J02AC01 | Fluconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709504 | FLUCONAZOL | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | active | 200 | mg | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:928830001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1199044 | DIFLUCAN ILSG 2MG/ML 400MG | Diflucan 2 mg/ml Infusionslösung | 1.2.40.0.34.4.17:1-18900 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J02AC01 | Fluconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709504 | FLUCONAZOL | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | active | 400 | mg | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:928830003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1199110 | FUNGATA KPS 150MG | Fungata 150 mg - Kapsel | 1.2.40.0.34.4.17:1-18837 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J02AC01 | Fluconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709504 | FLUCONAZOL | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | active | 150 | mg | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927981001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1199297 | TEBOFORTAN FTBL 40MG | Tebofortan 40 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18674 | GA - zugelassen | Dr. Willmar Schwabe GmbH & Co. KG | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AX | Andere periphere Vasodilatatoren | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705908 | GINKGONIS FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:100000078164 | GINKGO BILOBA EXTRACT | active | 40 | mg | 1.2.40.0.34.5.221:100000078164 | GINKGO BILOBA EXTRACT | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927304001 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:N06DX02 | Ginkgo biloba | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1199305 | TEBOFORTAN FTBL 40MG | Tebofortan 40 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18674 | GA - zugelassen | Dr. Willmar Schwabe GmbH & Co. KG | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AX | Andere periphere Vasodilatatoren | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705908 | GINKGONIS FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:100000078164 | GINKGO BILOBA EXTRACT | active | 40 | mg | 1.2.40.0.34.5.221:100000078164 | GINKGO BILOBA EXTRACT | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927304002 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:N06DX02 | Ginkgo biloba | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1199340 | ULCOGANT OR SUS 1G/5ML BTL | Ulcogant 1 g/5 ml - orale Suspension | 1.2.40.0.34.4.17:1-18789 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:A02BX02 | Sucralfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708896 | SUCRALFAT | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | active | 1000 | mg | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:927910002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1199357 | ULCOGANT OR SUS 1G/5ML BTL | Ulcogant 1 g/5 ml - orale Suspension | 1.2.40.0.34.4.17:1-18789 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:A02BX02 | Sucralfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708896 | SUCRALFAT | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | active | 1000 | mg | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:927910003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1199363 | ZOROXIN AU-TR | Zoroxin - Augentropfen | 1.2.40.0.34.4.17:1-18831 | GA - zugelassen | Laboratoires Thea | true | true | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01AE02 | Norfloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1708743 | NORFLOXACIN | 1.2.40.0.34.5.221:100000091076 | NORFLOXACIN | active | 15 | mg | 1.2.40.0.34.5.221:100000091076 | NORFLOXACIN | 15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:928628001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1199423 | GASTROMIRO ROENTGENMTL 50ML | Gastromiro - nichtionisches Röntgenkontrastmittel - enterale Lösung | 1.2.40.0.34.4.17:1-18981 | GA - zugelassen | Bracco Österreich GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 61.24 | g | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 61.24 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073917 | Lösung zur gastrointestinalen Anwendung | true | human | 1.2.40.0.34.4.26:928635004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1199452 | GASTROMIRO ROENTGENMTL 100ML | Gastromiro - nichtionisches Röntgenkontrastmittel - enterale Lösung | 1.2.40.0.34.4.17:1-18981 | GA - zugelassen | Bracco Österreich GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 30.62 | g | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 30.62 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073917 | Lösung zur gastrointestinalen Anwendung | true | human | 1.2.40.0.34.4.26:928635003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1203900 | DIFLUCAN KPS 50MG | Diflucan 50 mg - Kapseln | 1.2.40.0.34.4.17:1-18838 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J02AC01 | Fluconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709504 | FLUCONAZOL | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | active | 50 | mg | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927980033 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1203917 | DIFLUCAN KPS 100MG | Diflucan 100 mg - Kapseln | 1.2.40.0.34.4.17:1-18836 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J02AC01 | Fluconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709504 | FLUCONAZOL | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | active | 100 | mg | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:928827033 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1203923 | DIFLUCAN KPS 200MG | Diflucan 200 mg - Kapseln | 1.2.40.0.34.4.17:1-18835 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J02AC01 | Fluconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709504 | FLUCONAZOL | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | active | 200 | mg | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:928825001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1203969 | FARLUTAL TBL 500MG | Farlutal 500 mg Tabletten | 1.2.40.0.34.4.17:1-18903 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L02AB02 | Medroxyprogesteron | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708932 | MEDROXYPROGESTERON ACETAT | 1.2.40.0.34.5.221:100000091612 | MEDROXYPROGESTERONE ACETATE | active | 500 | mg | 1.2.40.0.34.5.221:100000091612 | MEDROXYPROGESTERONE ACETATE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927532001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1203981 | MAGNEVIST IJLSG 0,5STAMP 15 | Magnevist 0,5 mmol/ml - Injektionslösung | 1.2.40.0.34.4.17:1-18577 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V08CA01 | Gadopentetsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1710278 | GADOLINIUMOXID | 1.2.40.0.34.5.221:100000128280 | GADOLINIUM OXIDE | active | 90.625 | mg | 1.2.40.0.34.5.221:100000128280 | GADOLINIUM OXIDE | 90.625 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927667009 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1203998 | PREPIDIL GEL Z.INTRAZERV.ANW | Prepidil - Gel zur intrazervikalen Anwendung | 1.2.40.0.34.4.17:1-18931 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 3 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:900000000002 | Injektionsset (NE) | 2.16.840.1.113883.6.73:G02AD02 | Dinoproston | 1.2.40.0.10.1.4.3.4.3.4:100000073593 | intrazervikale Anwendung | | | | | 1.2.40.0.34.5.156:1709260 | DINOPROSTON | 1.2.40.0.34.5.221:100000092220 | DINOPROSTONE | active | 0.5 | mg | 1.2.40.0.34.5.221:100000092220 | DINOPROSTONE | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073903 | Gel zur endozervikalen Anwendung | true | human | 1.2.40.0.34.4.26:927669001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1204058 | STANDACILLIN TRSTAMP 2G BP | Standacillin 2 g – Pulver zur Herstellung einer Injektions-/Infusionslösung | 1.2.40.0.34.4.17:17201 | GA - zugelassen | Sandoz GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:J01CA01 | Ampicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708424 | AMPICILLIN NATRIUM | 1.2.40.0.34.5.221:100000089974 | AMPICILLIN NATRIUM | active | | | 1.2.40.0.34.5.221:100000089974 | AMPICILLIN NATRIUM | | | 1.2.40.0.10.1.4.3.4.3.5:100000116186 | Pulver zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1204064 | UBISTESIN ZYLAMP 1,7ML | Ubistesin 40 mg/ml + 5 Mikrogramm/ml - Injektionslösung | 1.2.40.0.34.4.17:1-18993 | GA - zugelassen | Pierrel S.p.A. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073503 | Patrone | 2.16.840.1.113883.6.73:N01BB58 | Articain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073567 | dentale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | 1.2.40.0.34.5.156:1707678 | ARTICAIN | 1.2.40.0.34.5.221:100000086625 | ARTICAINE | active | 60.282 | mg | 1.2.40.0.34.5.221:100000086625 | ARTICAINE | 60.282 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927988001 | 1.2.40.0.34.5.156:1709361 | EPINEPHRIN | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | active | 0.0085 | mg | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | 0.0085 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1204070 | UBISTESIN ZYLAMP FTE 1,7ML | Ubistesin forte 40 mg/ml + 10 Mikrogramm/ml - Injektionslösung | 1.2.40.0.34.4.17:1-18992 | GA - zugelassen | Pierrel S.p.A. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073503 | Patrone | 2.16.840.1.113883.6.73:N01BB58 | Articain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073567 | dentale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | 1.2.40.0.34.5.156:1707678 | ARTICAIN | 1.2.40.0.34.5.221:100000086625 | ARTICAINE | active | 60.282 | mg | 1.2.40.0.34.5.221:100000086625 | ARTICAINE | 60.282 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927987001 | 1.2.40.0.34.5.156:1709361 | EPINEPHRIN | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | active | 0.017 | mg | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | 0.017 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1204710 | STANDACILLIN TRSTAMP 1G BP | Standacillin 1 g – Pulver zur Herstellung einer Injektions-/Infusionslösung | 1.2.40.0.34.4.17:17200 | GA - zugelassen | Sandoz GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:J01CA01 | Ampicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708424 | AMPICILLIN NATRIUM | 1.2.40.0.34.5.221:100000089974 | AMPICILLIN NATRIUM | active | | | 1.2.40.0.34.5.221:100000089974 | AMPICILLIN NATRIUM | | | 1.2.40.0.10.1.4.3.4.3.5:100000116186 | Pulver zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1212514 | ADALAT IFL 5MG 50ML | Adalat 5 mg - Infusionsflasche | 1.2.40.0.34.4.17:1-19035 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:C08CA05 | Nifedipin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708560 | NIFEDIPIN | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | active | 0.1 | mg | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927816001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1219226 | VICARD TBL 1MG | Vicard 1 mg - Tabletten | 1.2.40.0.34.4.17:1-18683 | GA - zugelassen | Amdipharm Limited | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G04CA03 | Terazosin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:10242403 | TERAZOSINHYDROCHLORID DIHYDRAT | 1.2.40.0.34.5.221:100000086021 | TERAZOSIN HYDROCHLORIDE DIHYDRATE | active | 1.187 | mg | 1.2.40.0.34.5.221:100000086021 | TERAZOSIN HYDROCHLORIDE DIHYDRATE | 1.187 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927193001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1224144 | GLUCOPHAGE FTBL 500MG | Glucophage 500 mg - Filmtabletten | 1.2.40.0.34.4.17:11834 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BA02 | Metformin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708825 | METFORMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | active | 500 | mg | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:127584016 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1224150 | GLUCOPHAGE FTBL 500MG | Glucophage 500 mg - Filmtabletten | 1.2.40.0.34.4.17:11834 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 200 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BA02 | Metformin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708825 | METFORMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | active | 500 | mg | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:127584010 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1229124 | GLUCOPHAGE FTBL 850MG | Glucophage 850 mg - Filmtabletten | 1.2.40.0.34.4.17:14190 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BA02 | Metformin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708825 | METFORMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | active | 850 | mg | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | 850 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:127542011 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1229130 | GLUCOPHAGE FTBL 850MG | Glucophage 850 mg - Filmtabletten | 1.2.40.0.34.4.17:14190 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BA02 | Metformin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708825 | METFORMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | active | 850 | mg | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | 850 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:127542002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1230417 | METHOTREXAT LED DFL 25MG/1ML | Methotrexat "Lederle" 25 mg - Stechampulle | 1.2.40.0.34.4.17:17626 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01BA01 | Methotrexat | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1708507 | METHOTREXAT | 1.2.40.0.34.5.221:100000090250 | METHOTREXATE | active | 25 | mg | 1.2.40.0.34.5.221:100000090250 | METHOTREXATE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:922402001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1232333 | MUNDIDOL RET FTBL 10MG | Mundidol retard 10 mg Filmtabletten | 1.2.40.0.34.4.17:1-18003 | GA - zugelassen | Mundipharma Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705405 | MORPHINSULFAT | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | active | 10 | mg | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:923312002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1232379 | VI-DE3 TR | Vi - De 3 - Tropfen | 1.2.40.0.34.4.17:8192 | GA - zugelassen | Wabosan Arzneimittelvertriebs GmbH | true | false | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A11CC05 | Colecalciferol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709523 | COLECALCIFEROL | 1.2.40.0.34.5.221:100000092724 | COLECALCIFEROL | active | 6 | mg | 1.2.40.0.34.5.221:100000092724 | COLECALCIFEROL | 6 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:100000013100 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1240628 | CRATAEGUTT TR | Crataegutt - Tropfen | 1.2.40.0.34.4.17:9789 | GA - aufgehoben | Austroplant-Arzneimittel GmbH | false | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C01EB | Andere Herzmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710151 | CRATAEGI FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000000382 | CRATAEGI FRUCTUS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000382 | CRATAEGI FRUCTUS (EXTRACT) | | | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | false | human | 1.2.40.0.34.4.26:125495002 | 1.2.40.0.34.5.156:1710150 | CRATAEGI FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000381 | CRATAEGI FOLIUM (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000381 | CRATAEGI FOLIUM (EXTRACT) | | | 1.2.40.0.34.5.156:1710153 | CRATAEGI OXYACANTHAE FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000000384 | CRATAEGI OXYACANTHAE FLOS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000384 | CRATAEGI OXYACANTHAE FLOS (EXTRACT) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1240640 | DEFLAMAT DRS KPS 75MG | Deflamat DRS 75 mg - Kapseln | 1.2.40.0.34.4.17:1-18990 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 75 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073663 | Hartkapsel mit veränderter Wirkstofffreisetzung | true | human | 1.2.40.0.34.4.26:927892001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1240657 | DEFLAMAT DRS KPS 75MG | Deflamat DRS 75 mg - Kapseln | 1.2.40.0.34.4.17:1-18990 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 75 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073663 | Hartkapsel mit veränderter Wirkstofffreisetzung | true | human | 1.2.40.0.34.4.26:927892002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1240663 | ERGOTOP FTBL 20MG | Ergotop 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18938 | GA - aufgehoben | Kwizda Pharma GmbH | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AE02 | Nicergolin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709127 | NICERGOLIN | 1.2.40.0.34.5.221:100000092017 | NICERGOLINE | active | 20 | mg | 1.2.40.0.34.5.221:100000092017 | NICERGOLINE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928340002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1240829 | MUNDIDOL RET FTBL 30MG | Mundidol retard 30 mg Filmtabletten | 1.2.40.0.34.4.17:1-18004 | GA - zugelassen | Mundipharma Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705405 | MORPHINSULFAT | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | active | 30 | mg | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:923350001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1240835 | MUNDIDOL RET FTBL 30MG | Mundidol retard 30 mg Filmtabletten | 1.2.40.0.34.4.17:1-18004 | GA - zugelassen | Mundipharma Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705405 | MORPHINSULFAT | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | active | 30 | mg | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:923350002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1242722 | CODIDOL RET FTBL 60MG | Codidol retard 60 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19119 | GA - zugelassen | Ennogen Healthcare (Europe) Limited | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA08 | Dihydrocodein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705856 | DIHYDROCODEIN BITARTRAT | 1.2.40.0.34.5.221:100000078009 | DIHYDROCODEINE TARTRATE | active | 60 | mg | 1.2.40.0.34.5.221:100000078009 | DIHYDROCODEINE TARTRATE | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927807002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1242739 | CODIDOL RET FTBL 60MG | Codidol retard 60 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19119 | GA - zugelassen | Ennogen Healthcare (Europe) Limited | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA08 | Dihydrocodein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705856 | DIHYDROCODEIN BITARTRAT | 1.2.40.0.34.5.221:100000078009 | DIHYDROCODEINE TARTRATE | active | 60 | mg | 1.2.40.0.34.5.221:100000078009 | DIHYDROCODEINE TARTRATE | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927807001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1242745 | CODIDOL RET FTBL 90MG | Codidol retard 90 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19121 | GA - zugelassen | Ennogen Healthcare (Europe) Limited | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA08 | Dihydrocodein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705856 | DIHYDROCODEIN BITARTRAT | 1.2.40.0.34.5.221:100000078009 | DIHYDROCODEINE TARTRATE | active | 90 | mg | 1.2.40.0.34.5.221:100000078009 | DIHYDROCODEINE TARTRATE | 90 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:929015002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1242751 | CODIDOL RET FTBL 90MG | Codidol retard 90 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19121 | GA - zugelassen | Ennogen Healthcare (Europe) Limited | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA08 | Dihydrocodein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705856 | DIHYDROCODEIN BITARTRAT | 1.2.40.0.34.5.221:100000078009 | DIHYDROCODEINE TARTRATE | active | 90 | mg | 1.2.40.0.34.5.221:100000078009 | DIHYDROCODEINE TARTRATE | 90 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:929015001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1242768 | CODIDOL RET FTBL 120MG | Codidol retard 120 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19120 | GA - zugelassen | Ennogen Healthcare (Europe) Limited | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA08 | Dihydrocodein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705856 | DIHYDROCODEIN BITARTRAT | 1.2.40.0.34.5.221:100000078009 | DIHYDROCODEINE TARTRATE | active | 120 | mg | 1.2.40.0.34.5.221:100000078009 | DIHYDROCODEINE TARTRATE | 120 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:929016002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1242774 | CODIDOL RET FTBL 120MG | Codidol retard 120 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19120 | GA - zugelassen | Ennogen Healthcare (Europe) Limited | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA08 | Dihydrocodein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705856 | DIHYDROCODEIN BITARTRAT | 1.2.40.0.34.5.221:100000078009 | DIHYDROCODEINE TARTRATE | active | 120 | mg | 1.2.40.0.34.5.221:100000078009 | DIHYDROCODEINE TARTRATE | 120 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:929016001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1242780 | CONDYLOX LSG 0,5% | Condylox 0,5% - Lösung zur Anwendung auf der Haut | 1.2.40.0.34.4.17:1-18963 | GA - zugelassen | Takeda Austria GmbH | true | true | 3.5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D06BB04 | Podophyllotoxin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708757 | PODOPHYLLOTOXIN | 1.2.40.0.34.5.221:100000091097 | PODOPHYLLOTOXIN | active | 17.5 | mg | 1.2.40.0.34.5.221:100000091097 | PODOPHYLLOTOXIN | 17.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:928359001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1242828 | ECHNATOL-B6 DRG | Echnatol B 6 - Dragees | 1.2.40.0.34.4.17:14970 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AE53 | Cyclizin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:124616001 | 1.2.40.0.34.5.156:1710165 | CYCLIZIN DIHYDROCHLORID | 1.2.40.0.34.5.221:900000000396 | CYCLIZIN DIHYDROCHLORID | active | 50 | mg | 1.2.40.0.34.5.221:900000000396 | CYCLIZIN DIHYDROCHLORID | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1242863 | KLIOGEST FTBL | Kliogest 2 mg/1mg Filmtabletten | 1.2.40.0.34.4.17:1-19017 | GA - zugelassen | Novo Nordisk Pharma GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000116195 | Kalenderpackung | 2.16.840.1.113883.6.73:G03FA01 | Norethisteron und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709617 | NORETHISTERON ACETAT | 1.2.40.0.34.5.221:100000093036 | NORETHISTERONE ACETATE | active | 1 | mg | 1.2.40.0.34.5.221:100000093036 | NORETHISTERONE ACETATE | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928460001 | 1.2.40.0.34.5.156:1708991 | ESTRADIOL | 1.2.40.0.34.5.221:100000091739 | ESTRADIOL | active | 2.07 | mg | 1.2.40.0.34.5.221:100000091739 | ESTRADIOL | 2.07 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1242923 | SQUAMASOL GEL | Squamasol - Gel | 1.2.40.0.34.4.17:1-19042 | GA - zugelassen | Ichthyol-Gesellschaft Cordes, Hermanni & Co. (GmbH & Co.) KG | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D11AF | Warzenmittel und Keratolytika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 10 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 10 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:927556001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1246861 | FLOXAL AU-TR 3MG/ML | Floxal - 3 mg/ml Augentropfen, Lösung | 1.2.40.0.34.4.17:1-19054 | GA - zugelassen | Dr. Gerhard Mann chem.-pharm. Fabrik GmbH | true | true | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01AE01 | Ofloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709310 | OFLOXACIN | 1.2.40.0.34.5.221:100000092309 | OFLOXACIN | active | 15 | mg | 1.2.40.0.34.5.221:100000092309 | OFLOXACIN | 15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:928577001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250130 | OLICARDIN RET KPS 40MG | Olicardin retard 40 mg - Kapseln | 1.2.40.0.34.4.17:1-18979 | GA - aufgehoben | Medicopharm GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01DA14 | Isosorbidmononitrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708568 | ISOSORBIDMONONITRAT | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | active | 40 | mg | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:927281001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250153 | OLICARDIN RET KPS 60MG | Olicardin retard 60 mg - Kapseln | 1.2.40.0.34.4.17:1-18976 | GA - aufgehoben | Medicopharm GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01DA14 | Isosorbidmononitrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708568 | ISOSORBIDMONONITRAT | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | active | 60 | mg | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:927282001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250325 | FELDEN AMP 20MG 1ML | Felden 20 mg - Ampullen | 1.2.40.0.34.4.17:1-18967 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M01AC01 | Piroxicam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709404 | PIROXICAM | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | active | 20 | mg | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:928360001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250331 | FELDEN GEL | Felden 0,5% - Gel | 1.2.40.0.34.4.17:1-18971 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA07 | Piroxicam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709404 | PIROXICAM | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | active | 0.2 | g | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | 0.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:927721001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250348 | XYLOCAIN PUSPRAY 10% | Xylocain 10 % - Pumpspray | 1.2.40.0.34.4.17:12979 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N01BB02 | Lidocain | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | 1.2.40.0.34.5.156:1708976 | LIDOCAIN | 1.2.40.0.34.5.221:100000091713 | LIDOCAINE | active | 500 | mg | 1.2.40.0.34.5.221:100000091713 | LIDOCAINE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073729 | Spray zur Anwendung auf der Haut, Lösung | true | human | 1.2.40.0.34.4.26:121576001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250354 | HYPREN KPS 1,25MG | Hypren 1,25 mg - Kapseln | 1.2.40.0.34.4.17:1-18883 | GA - aufgehoben | Astrazeneca Österreich GmbH | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C09AA05 | Ramipril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709271 | RAMIPRIL | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | active | 1.25 | mg | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | 1.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927878001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250360 | HYPREN KPS 2,5MG | Hypren 2,5 mg - Kapseln | 1.2.40.0.34.4.17:1-18884 | GA - aufgehoben | Astrazeneca Österreich GmbH | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C09AA05 | Ramipril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709271 | RAMIPRIL | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | active | 2.5 | mg | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927879001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250377 | HYPREN KPS 5MG | Hypren 5 mg - Kapseln | 1.2.40.0.34.4.17:1-18886 | GA - aufgehoben | Astrazeneca Österreich GmbH | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C09AA05 | Ramipril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709271 | RAMIPRIL | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | active | 5 | mg | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927880001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250408 | ATACAND TBL 4MG | Atacand 4 mg - Tabletten | 1.2.40.0.34.4.17:1-22287 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09CA06 | Candesartan | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708890 | CANDESARTAN CILEXETIL | 1.2.40.0.34.5.221:100000091533 | CANDESARTAN CILEXETIL | active | 4 | mg | 1.2.40.0.34.5.221:100000091533 | CANDESARTAN CILEXETIL | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:942334008 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250420 | SELOKEN RET-FTBL 47,5MG | Seloken retard 47,5 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18928 | GA - zugelassen | Recordati Ireland Limited | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708826 | METOPROLOL SUCCINAT | 1.2.40.0.34.5.221:100000091368 | METOPROLOL SUCCINATE | active | 47.5 | mg | 1.2.40.0.34.5.221:100000091368 | METOPROLOL SUCCINATE | 47.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927812004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250437 | SELOKEN RET-FTBL 95MG | Seloken retard 95 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18930 | GA - zugelassen | Recordati Ireland Limited | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708826 | METOPROLOL SUCCINAT | 1.2.40.0.34.5.221:100000091368 | METOPROLOL SUCCINATE | active | 95 | mg | 1.2.40.0.34.5.221:100000091368 | METOPROLOL SUCCINATE | 95 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927811001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250443 | SELOKEN RET-FTBL PLUS | Seloken retard plus - Filmtabletten | 1.2.40.0.34.4.17:1-20077 | GA - aufgehoben | SANOVA Pharma GesmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07BB02 | Metoprolol und Thiazide | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 12.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:930592001 | 1.2.40.0.34.5.156:1708826 | METOPROLOL SUCCINAT | 1.2.40.0.34.5.221:100000091368 | METOPROLOL SUCCINATE | active | 95 | mg | 1.2.40.0.34.5.221:100000091368 | METOPROLOL SUCCINATE | 95 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250466 | BRICANYL TURBOHALER PLV 0,5 | Bricanyl Turbohaler 0,5 mg pro Dosis Pulver zur Inhalation | 1.2.40.0.34.4.17:1-19028 | GA - aufgehoben | Astrazeneca Österreich GmbH | false | false | 200 | 2.16.840.1.113883.6.8:{Hub} | Hub/Hübe | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073530 | Mehrdosenbehältnis | 2.16.840.1.113883.6.73:R03AC03 | Terbutalin | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1707142 | TERBUTALINSULFAT | 1.2.40.0.34.5.221:100000084794 | TERBUTALINE SULFATE | active | 49.9 | mg | 1.2.40.0.34.5.221:100000084794 | TERBUTALINE SULFATE | 49.9 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073839 | Pulver zur Inhalation | true | human | 1.2.40.0.34.4.26:927837002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250495 | ATACAND TBL 8MG | Atacand 8 mg - Tabletten | 1.2.40.0.34.4.17:1-22288 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09CA06 | Candesartan | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708890 | CANDESARTAN CILEXETIL | 1.2.40.0.34.5.221:100000091533 | CANDESARTAN CILEXETIL | active | 8 | mg | 1.2.40.0.34.5.221:100000091533 | CANDESARTAN CILEXETIL | 8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:942335008 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250503 | ATACAND TBL 16MG | Atacand 16 mg - Tabletten | 1.2.40.0.34.4.17:1-22289 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09CA06 | Candesartan | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708890 | CANDESARTAN CILEXETIL | 1.2.40.0.34.5.221:100000091533 | CANDESARTAN CILEXETIL | active | 16 | mg | 1.2.40.0.34.5.221:100000091533 | CANDESARTAN CILEXETIL | 16 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:942336008 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250532 | PULMICORT SUS INH 0,5MG/2ML | Pulmicort 0,5 mg - Suspension zur Inhalation | 1.2.40.0.34.4.17:1-20318 | GA - zugelassen | Astrazeneca Österreich GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073550 | Einzeldosisbehältnis | 2.16.840.1.113883.6.73:R03BA02 | Budesonid | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1708795 | BUDESONID | 1.2.40.0.34.5.221:100000091309 | BUDESONIDE | active | 0.5 | mg | 1.2.40.0.34.5.221:100000091309 | BUDESONIDE | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073846 | Suspension für einen Vernebler | true | human | 1.2.40.0.34.4.26:929146001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250555 | PULMICORT SUS INH 1MG/2ML | Pulmicort 1 mg - Suspension zur Inhalation | 1.2.40.0.34.4.17:1-20319 | GA - zugelassen | Astrazeneca Österreich GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073550 | Einzeldosisbehältnis | 2.16.840.1.113883.6.73:R03BA02 | Budesonid | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1708795 | BUDESONID | 1.2.40.0.34.5.221:100000091309 | BUDESONIDE | active | 1 | mg | 1.2.40.0.34.5.221:100000091309 | BUDESONIDE | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073846 | Suspension für einen Vernebler | true | human | 1.2.40.0.34.4.26:929148001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250704 | CEC-HEX FTBL 500MG | Cec Sandoz 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-22300 | GA - aufgehoben | Sandoz GmbH | false | false | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:J01DC04 | Cefaclor | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709388 | CEFACLOR MONOHYDRAT | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRAT | active | | | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRAT | | | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250710 | CEC-HEX TRSFT 125MG | Cec Sandoz 125 mg/5 ml - Trockensaft | 1.2.40.0.34.4.17:1-22465 | GA - aufgehoben | Sandoz GmbH | false | false | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:J01DC04 | Cefaclor | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709388 | CEFACLOR MONOHYDRAT | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRAT | active | | | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRAT | | | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250779 | CEC-HEX TRSFT FTE 250MG | Cec Sandoz forte 250 mg/5 ml - Trockensaft | 1.2.40.0.34.4.17:1-22466 | GA - aufgehoben | Sandoz GmbH | false | false | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:J01DC04 | Cefaclor | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709388 | CEFACLOR MONOHYDRAT | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRAT | active | | | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRAT | | | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250785 | PENTOHEXAL RET TBL 600MG | Pentohexal retard 600 mg - Tabletten | 1.2.40.0.34.4.17:1-22292 | GA - aufgehoben | Hexal Pharma GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 600 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:935802001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250791 | PENTOHEXAL RET TBL 600MG | Pentohexal retard 600 mg - Tabletten | 1.2.40.0.34.4.17:1-22292 | GA - aufgehoben | Hexal Pharma GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 600 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:935802002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250905 | THEOSPIREX AMP 10ML | Theospirex - Ampullen | 1.2.40.0.34.4.17:1-18867 | GA - zugelassen | Gebro Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 200 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:928476002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250911 | THEOSPIREX RET FTBL 150MG | Theospirex retard 150 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18941 | GA - zugelassen | Gebro Pharma GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 150 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:922071001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1250928 | THEOSPIREX RET FTBL 150MG | Theospirex retard 150 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18941 | GA - zugelassen | Gebro Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 150 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:922071002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1251129 | VIBROCIL NA-SPRAY | Vibrocil Nasenspray | 1.2.40.0.34.4.17:1-19041 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 20 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AB01 | Phenylephrin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1707993 | PHENYLEPHRIN | 1.2.40.0.34.5.221:100000088260 | PHENYLEPHRINE | active | 0.05 | g | 1.2.40.0.34.5.221:100000088260 | PHENYLEPHRINE | 0.05 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073796 | Nasenspray, Lösung | true | human | 1.2.40.0.34.4.26:927763002 | 1.2.40.0.34.5.156:1707840 | DIMETINDEN MALEAT | 1.2.40.0.34.5.221:100000087512 | DIMETINDENE MALEATE | active | 0.005 | g | 1.2.40.0.34.5.221:100000087512 | DIMETINDENE MALEATE | 0.005 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1251247 | ATENOLOL GEN FTBL 50MG | Atenolol Genericon 50 mg Filmtabletten | 1.2.40.0.34.4.17:1-18998 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 50 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927930001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1251253 | ATENOLOL GEN FTBL 50MG | Atenolol Genericon 50 mg Filmtabletten | 1.2.40.0.34.4.17:1-18998 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 50 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927930002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1251276 | ATENOLOL GEN FTBL 100MG | Atenolol Genericon 100 mg Filmtabletten | 1.2.40.0.34.4.17:1-19000 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927929001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1251282 | ATENOLOL GEN FTBL 100MG | Atenolol Genericon 100 mg Filmtabletten | 1.2.40.0.34.4.17:1-19000 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927929002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1251313 | AURORIX FTBL 150MG | Aurorix 150 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18878 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N06AG02 | Moclobemid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709401 | MOCLOBEMID | 1.2.40.0.34.5.221:100000092489 | MOCLOBEMIDE | active | 150 | mg | 1.2.40.0.34.5.221:100000092489 | MOCLOBEMIDE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928715002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1251336 | AURORIX FTBL 150MG | Aurorix 150 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18878 | GA - zugelassen | Viatris Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N06AG02 | Moclobemid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709401 | MOCLOBEMID | 1.2.40.0.34.5.221:100000092489 | MOCLOBEMIDE | active | 150 | mg | 1.2.40.0.34.5.221:100000092489 | MOCLOBEMIDE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928715001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1251419 | DALACIN C KPS 300MG | Dalacin C 300 mg - Kapseln | 1.2.40.0.34.4.17:1-18937 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 16 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01FF01 | Clindamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708638 | CLINDAMYCIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090552 | CLINDAMYCIN HYDROCHLORIDE | active | 355.03 | mg | 1.2.40.0.34.5.221:100000084276 | CLINDAMYCIN | 326.97766 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:929010002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1251448 | DOLOMENTHONEURIN GEL | Dolo - Menthoneurin - Gel | 1.2.40.0.34.4.17:15765 | GA - aufgehoben | Takeda Pharma Ges.m.b.H. | false | false | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:7255602 | LEVOMENTHOL | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | active | 200 | mg | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:121394001 | 1.2.40.0.34.5.156:1706241 | DIETHYLAMINSALICYLAT | 1.2.40.0.34.5.221:100000079574 | DIETHYLAMINE SALICYLATE | active | 10000 | mg | 1.2.40.0.34.5.221:100000079574 | DIETHYLAMINE SALICYLATE | 10000 | mg | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 40 | mg | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 40 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1251483 | FUROSEMID GEN TBL 40MG | Furosemid Genericon 40 mg Tabletten | 1.2.40.0.34.4.17:1-18995 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03CA01 | Furosemid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927752001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1251508 | FUROSEMID GEN TBL 40MG | Furosemid Genericon 40 mg Tabletten | 1.2.40.0.34.4.17:1-18995 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03CA01 | Furosemid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927752002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1251649 | GYNOFLOR VAG-TBL | Gynoflor - Vaginaltabletten | 1.2.40.0.34.4.17:2-00039 | GA - zugelassen | Richter Gedeon Plc. | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G01AX | Andere Antiinfektiva und Antiseptika | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1709511 | ESTRIOL | 1.2.40.0.34.5.221:100000092668 | ESTRIOL | active | 0.03 | mg | 1.2.40.0.34.5.221:100000092668 | ESTRIOL | 0.03 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073824 | Vaginaltablette | true | human | 1.2.40.0.34.4.26:927986002 | 1.2.40.0.34.5.156:1705652 | LACTOBACILLUS ACIDOPHILUS | 1.2.40.0.34.5.221:100000077069 | LACTOBACILLUS ACIDOPHILUS | active | 50 | mg | 1.2.40.0.34.5.221:100000077069 | LACTOBACILLUS ACIDOPHILUS | 50 | mg | | | | | | | | | | | | 2.16.840.1.113883.6.73:G03CC06 | Estriol | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1251916 | MOVIFLEX GEL | Moviflex - Gel | 1.2.40.0.34.4.17:1-18508 | GA - aufgehoben | STADA Arzneimittel Gesellschaft m.b.H. | false | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708484 | PHENYLEPHRINHYDROCHLORID | 1.2.40.0.34.5.221:100000090176 | PHENYLEPHRINE HYDROCHLORIDE | active | 0.5 | g | 1.2.40.0.34.5.221:100000090176 | PHENYLEPHRINE HYDROCHLORIDE | 0.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:920810001 | 1.2.40.0.34.5.156:1705406 | MUCOPOLYSACCHARIDPOLYSCHWEFELSÄUREESTER | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | active | 0.2 | g | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | 0.2 | g | 1.2.40.0.34.5.156:1709283 | HYDROXYETHYLSALICYLAT | 1.2.40.0.34.5.221:100000092263 | HYDROXYETHYL SALICYLATE | active | 6.65 | g | 1.2.40.0.34.5.221:100000092263 | HYDROXYETHYL SALICYLATE | 6.65 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252100 | SUPRECUR NAS.SPRLSG 0,15MG | Suprecur 0,15 mg - nasale Sprühlösung | 1.2.40.0.34.4.17:1-18846 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 2 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L02AE01 | Buserelin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1707155 | BUSERELIN ACETAT | 1.2.40.0.34.5.221:100000084837 | BUSERELIN ACETATE | active | 15.75 | mg | 1.2.40.0.34.5.221:100000084837 | BUSERELIN ACETATE | 15.75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073796 | Nasenspray, Lösung | true | human | 1.2.40.0.34.4.26:927628002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252206 | VIBRAMYCIN TBL LSB 50MG | Vibramycin 50 mg - lösbare Tabletten | 1.2.40.0.34.4.17:1-18778 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01AA02 | Doxycyclin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709256 | DOXYCYCLIN | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | active | 53.02 | mg | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | 53.02 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073654 | Tablette zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:927912001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252212 | XANOR TBL 0,5MG | Xanor 0,5 mg - Tabletten | 1.2.40.0.34.4.17:1-18639 | GA - zugelassen | Upjohn EESV | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA12 | Alprazolam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709058 | ALPRAZOLAM | 1.2.40.0.34.5.221:100000091908 | ALPRAZOLAM | active | 0.5 | mg | 1.2.40.0.34.5.221:100000091908 | ALPRAZOLAM | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:920861002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252229 | XANOR TBL 0,5MG | Xanor 0,5 mg - Tabletten | 1.2.40.0.34.4.17:1-18639 | GA - zugelassen | Upjohn EESV | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA12 | Alprazolam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709058 | ALPRAZOLAM | 1.2.40.0.34.5.221:100000091908 | ALPRAZOLAM | active | 0.5 | mg | 1.2.40.0.34.5.221:100000091908 | ALPRAZOLAM | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:920861001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252235 | XANOR TBL 1MG | Xanor 1 mg - Tabletten | 1.2.40.0.34.4.17:1-18638 | GA - zugelassen | Upjohn EESV | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA12 | Alprazolam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709058 | ALPRAZOLAM | 1.2.40.0.34.5.221:100000091908 | ALPRAZOLAM | active | 1 | mg | 1.2.40.0.34.5.221:100000091908 | ALPRAZOLAM | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:920862001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252241 | XANOR TBL 1MG | Xanor 1 mg - Tabletten | 1.2.40.0.34.4.17:1-18638 | GA - zugelassen | Upjohn EESV | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA12 | Alprazolam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709058 | ALPRAZOLAM | 1.2.40.0.34.5.221:100000091908 | ALPRAZOLAM | active | 1 | mg | 1.2.40.0.34.5.221:100000091908 | ALPRAZOLAM | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:920862002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252324 | IMPORTAL PLV 10G | Importal - Pulver | 1.2.40.0.34.4.17:1-18983 | GA - aufgehoben | Angelini Pharma Österreich GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:A06AD12 | Lactitol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708951 | LACTITOL, E-966 | 1.2.40.0.34.5.221:100000091655 | LACTITOL | active | 10 | g | 1.2.40.0.34.5.221:100000091655 | LACTITOL | 10 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073655 | Pulver zum Einnehmen | true | human | 1.2.40.0.34.4.26:927764003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252614 | BETASERC TBL 16MG | Betaserc 16 mg - Tabletten | 1.2.40.0.34.4.17:1-19125 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N07CA01 | Betahistin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708429 | BETAHISTIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000089998 | BETAHISTINE DIHYDROCHLORIDE | active | 16 | mg | 1.2.40.0.34.5.221:100000089998 | BETAHISTINE DIHYDROCHLORIDE | 16 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927469002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252620 | BETASERC TBL 16MG | Betaserc 16 mg - Tabletten | 1.2.40.0.34.4.17:1-19125 | GA - zugelassen | Viatris Austria GmbH | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N07CA01 | Betahistin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708429 | BETAHISTIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000089998 | BETAHISTINE DIHYDROCHLORIDE | active | 16 | mg | 1.2.40.0.34.5.221:100000089998 | BETAHISTINE DIHYDROCHLORIDE | 16 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927469003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252666 | TUSSIMONT HU-TR | Tussimont Hustentropfen mit Thymian und Spitzwegerich | 1.2.40.0.34.4.17:HERB-00115 | GA - registriert | Pharmonta Dr. Fischer GmbH | true | true | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CA | Expektoranzien | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712642 | PLANTAGINIS LANCEOLATAE FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000004203 | PLANTAGINIS LANCEOLATAE FOLIUM (EXTRACT) | active | 2500 | g | 1.2.40.0.34.5.221:900000004203 | PLANTAGINIS LANCEOLATAE FOLIUM (EXTRACT) | 2500 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | false | human | 1.2.40.0.34.4.26:956755001 | 1.2.40.0.34.5.156:1710828 | THYMI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001063 | THYMI HERBA (EXTRACT) | active | 2500 | g | 1.2.40.0.34.5.221:900000001063 | THYMI HERBA (EXTRACT) | 2500 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252672 | SALOFALK MSR TBL 500MG | Salofalk 500 mg magensaftresistente Tabletten | 1.2.40.0.34.4.17:1-19004 | GA - zugelassen | Dr. Falk Pharma GmbH | true | true | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07EC02 | Mesalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709091 | MESALAZIN | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | active | 500 | mg | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928881002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252689 | SALOFALK MSR TBL 500MG | Salofalk 500 mg magensaftresistente Tabletten | 1.2.40.0.34.4.17:1-19004 | GA - zugelassen | Dr. Falk Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07EC02 | Mesalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709091 | MESALAZIN | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | active | 500 | mg | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928881001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252703 | SALOFALK SUPP 500MG | Salofalk 500 mg Zäpfchen | 1.2.40.0.34.4.17:1-19005 | GA - zugelassen | Dr. Falk Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07EC02 | Mesalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709091 | MESALAZIN | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | active | 500 | mg | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:928880001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252726 | SALOFALK SUPP 500MG | Salofalk 500 mg Zäpfchen | 1.2.40.0.34.4.17:1-19005 | GA - zugelassen | Dr. Falk Pharma GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07EC02 | Mesalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709091 | MESALAZIN | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | active | 500 | mg | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:928880002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252749 | SALOFALK KLYSMEN 4G/60G BP | Salofalk 4 g - Klysmen | 1.2.40.0.34.4.17:1-19003 | GA - zugelassen | Dr. Falk Pharma GmbH | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A07EC02 | Mesalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709091 | MESALAZIN | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | active | 4 | g | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | 4 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073830 | Rektalsuspension | true | human | 1.2.40.0.34.4.26:928379001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252821 | COFFO-SELT BRTBL | Coffo - Selt - Brausetabletten | 1.2.40.0.34.4.17:9315 | GA - aufgehoben | APONOVA-PHARMA HandelsgesmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N06BC01 | Coffein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:10443255 | COFFEIN, WASSERFREI | 1.2.40.0.34.5.221:100000089650 | CAFFEINE, ANHYDROUS | active | 75 | mg | 1.2.40.0.34.5.221:100000089650 | CAFFEINE, ANHYDROUS | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123154001 | 1.2.40.0.34.5.156:1707313 | PHENAZON | 1.2.40.0.34.5.221:100000085208 | PHENAZONE | active | 500 | mg | 1.2.40.0.34.5.221:100000085208 | PHENAZONE | 500 | mg | | | | | | | | | | | | 2.16.840.1.113883.6.73:N02BB01 | Phenazon | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252838 | COFFO-SELT BRTBL | Coffo - Selt - Brausetabletten | 1.2.40.0.34.4.17:9315 | GA - aufgehoben | APONOVA-PHARMA HandelsgesmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N06BC01 | Coffein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:10443255 | COFFEIN, WASSERFREI | 1.2.40.0.34.5.221:100000089650 | CAFFEINE, ANHYDROUS | active | 75 | mg | 1.2.40.0.34.5.221:100000089650 | CAFFEINE, ANHYDROUS | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123154002 | 1.2.40.0.34.5.156:1707313 | PHENAZON | 1.2.40.0.34.5.221:100000085208 | PHENAZONE | active | 500 | mg | 1.2.40.0.34.5.221:100000085208 | PHENAZONE | 500 | mg | | | | | | | | | | | | 2.16.840.1.113883.6.73:N02BB01 | Phenazon | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252844 | COFFO-SELT BRTBL | Coffo - Selt - Brausetabletten | 1.2.40.0.34.4.17:9315 | GA - aufgehoben | APONOVA-PHARMA HandelsgesmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N06BC01 | Coffein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:10443255 | COFFEIN, WASSERFREI | 1.2.40.0.34.5.221:100000089650 | CAFFEINE, ANHYDROUS | active | 75 | mg | 1.2.40.0.34.5.221:100000089650 | CAFFEINE, ANHYDROUS | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123154003 | 1.2.40.0.34.5.156:1707313 | PHENAZON | 1.2.40.0.34.5.221:100000085208 | PHENAZONE | active | 500 | mg | 1.2.40.0.34.5.221:100000085208 | PHENAZONE | 500 | mg | | | | | | | | | | | | 2.16.840.1.113883.6.73:N02BB01 | Phenazon | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252985 | SANDOSTATIN AMP 50MCG/1ML | Sandostatin 50 Mikrogramm/ml Injektions-/Infusionslösung | 1.2.40.0.34.4.17:1-19101 | GA - zugelassen | Novartis Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H01CB02 | Octreotid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1709407 | OCTREOTID | 1.2.40.0.34.5.221:100000092509 | OCTREOTIDE | active | 0.05 | mg | 1.2.40.0.34.5.221:100000092509 | OCTREOTIDE | 0.05 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:927914001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1252991 | SANDOSTATIN AMP 500MCG/1ML | Sandostatin 500 Mikrogramm/ml Injektions-/Infusionslösung | 1.2.40.0.34.4.17:1-19100 | GA - zugelassen | Novartis Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H01CB02 | Octreotid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1709407 | OCTREOTID | 1.2.40.0.34.5.221:100000092509 | OCTREOTIDE | active | 0.5 | mg | 1.2.40.0.34.5.221:100000092509 | OCTREOTIDE | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:927891009 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253016 | SANDOSTATIN AMP 100MCG/1ML | Sandostatin 100 Mikrogramm/ml Injektions-/Infusionslösung | 1.2.40.0.34.4.17:1-19099 | GA - zugelassen | Novartis Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H01CB02 | Octreotid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1709407 | OCTREOTID | 1.2.40.0.34.5.221:100000092509 | OCTREOTIDE | active | 0.1 | mg | 1.2.40.0.34.5.221:100000092509 | OCTREOTIDE | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:927913009 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253022 | SANDOSTATIN IJLSG 1000MCG | Sandostatin 1000 Mikrogramm/5 ml Injektions-/Infusionslösung | 1.2.40.0.34.4.17:1-19108 | GA - aufgehoben | Novartis Pharma GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H01CB02 | Octreotid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1709407 | OCTREOTID | 1.2.40.0.34.5.221:100000092509 | OCTREOTIDE | active | 0.2 | mg | 1.2.40.0.34.5.221:100000092509 | OCTREOTIDE | 0.2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:927915001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253068 | UMPREL KPS 5MG | Umprel 5 mg - Kapseln | 1.2.40.0.34.4.17:1-18744 | GA - aufgehoben | MEDA Pharma GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N04BC01 | Bromocriptin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708574 | BROMOCRIPTIN MESILAT | 1.2.40.0.34.5.221:100000090410 | BROMOCRIPTINE MESILATE | active | 5.735 | mg | 1.2.40.0.34.5.221:100000090410 | BROMOCRIPTINE MESILATE | 5.735 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:924615002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253080 | ACEMIN TBL 5MG | Acemin 5 mg - Tabletten | 1.2.40.0.34.4.17:1-19014 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA03 | Lisinopril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709062 | LISINOPRIL | 1.2.40.0.34.5.221:100000091915 | LISINOPRIL | active | 5.45 | mg | 1.2.40.0.34.5.221:100000091915 | LISINOPRIL | 5.45 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927710019 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253097 | ACEMIN TBL 10MG | Acemin 10 mg - Tabletten | 1.2.40.0.34.4.17:1-19013 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA03 | Lisinopril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709062 | LISINOPRIL | 1.2.40.0.34.5.221:100000091915 | LISINOPRIL | active | 10.89 | mg | 1.2.40.0.34.5.221:100000091915 | LISINOPRIL | 10.89 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927711013 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253105 | ACEMIN TBL 20MG | Acemin 20 mg - Tabletten | 1.2.40.0.34.4.17:1-19015 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA03 | Lisinopril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709062 | LISINOPRIL | 1.2.40.0.34.5.221:100000091915 | LISINOPRIL | active | 21.78 | mg | 1.2.40.0.34.5.221:100000091915 | LISINOPRIL | 21.78 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927712019 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253111 | ACECOMB TBL | Acecomb - Tabletten | 1.2.40.0.34.4.17:1-19510 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09BA03 | Lisinopril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709062 | LISINOPRIL | 1.2.40.0.34.5.221:100000091915 | LISINOPRIL | active | 21.8 | mg | 1.2.40.0.34.5.221:100000091915 | LISINOPRIL | 21.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928537001 | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 25 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253140 | LEPONEX TBL 100MG | Leponex 100 mg - Tabletten | 1.2.40.0.34.4.17:14255 | GA - zugelassen | Viatris Healthcare Limited | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05AH02 | Clozapin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709562 | CLOZAPIN | 1.2.40.0.34.5.221:100000092795 | CLOZAPINE | active | 100 | mg | 1.2.40.0.34.5.221:100000092795 | CLOZAPINE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122035040 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253157 | FERRETAB CP KPS | Ferretab comp. - Kapseln | 1.2.40.0.34.4.17:1-19058 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B03AD02 | Eisen(II)fumarat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707468 | FOLSÄURE | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | active | 0.5 | mg | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:928416002 | 1.2.40.0.34.5.156:1708593 | EISEN(II)-FUMARAT | 1.2.40.0.34.5.221:100000090445 | FERROUS FUMARATE | active | 50.7 | mg | 1.2.40.0.34.5.221:100000090445 | FERROUS FUMARATE | 50.7 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253163 | FERRETAB CP KPS | Ferretab comp. - Kapseln | 1.2.40.0.34.4.17:1-19058 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B03AD02 | Eisen(II)fumarat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707468 | FOLSÄURE | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | active | 0.5 | mg | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:928416001 | 1.2.40.0.34.5.156:1708593 | EISEN(II)-FUMARAT | 1.2.40.0.34.5.221:100000090445 | FERROUS FUMARATE | active | 50.7 | mg | 1.2.40.0.34.5.221:100000090445 | FERROUS FUMARATE | 50.7 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253200 | FINALGON SLB | Finalgon - Salbe | 1.2.40.0.34.4.17:7488 | GA - zugelassen | Zentiva k.s. | true | true | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AX10 | Verschiedene | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707019 | NICOBOXIL | 1.2.40.0.34.5.221:100000084188 | NICOBOXIL | active | 0 | g | 1.2.40.0.34.5.221:100000084188 | NICOBOXIL | 0 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:921727001 | 1.2.40.0.34.5.156:1706934 | NONIVAMID | 1.2.40.0.34.5.221:100000083590 | NONIVAMIDE | active | 0 | g | 1.2.40.0.34.5.221:100000083590 | NONIVAMIDE | 0 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253223 | CATHEJELL LIDOC/CHX SPR12,5G | Cathejell comp 17,31 mg/g / 0,5 mg/g Gel | 1.2.40.0.34.4.17:1-19198 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:N01BB52 | Lidocain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073638 | Anwendung in der Harnröhre | 1.2.40.0.10.1.4.3.4.3.4:100000073571 | endotracheopulmonale Anwendung | | | 1.2.40.0.34.5.156:1708976 | LIDOCAIN | 1.2.40.0.34.5.221:100000091713 | LIDOCAIN | active | | | 1.2.40.0.34.5.221:100000091713 | LIDOCAIN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1709371 | CHLORHEXIDIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDIN DIHYDROCHLORID | active | | | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDIN DIHYDROCHLORID | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253246 | CATHEJELL LIDOC/CHX SPR 8,5G | Cathejell comp 17,31 mg/g / 0,5 mg/g Gel | 1.2.40.0.34.4.17:1-19198 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:N01BB52 | Lidocain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073638 | Anwendung in der Harnröhre | 1.2.40.0.10.1.4.3.4.3.4:100000073571 | endotracheopulmonale Anwendung | | | 1.2.40.0.34.5.156:1708976 | LIDOCAIN | 1.2.40.0.34.5.221:100000091713 | LIDOCAIN | active | | | 1.2.40.0.34.5.221:100000091713 | LIDOCAIN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1709371 | CHLORHEXIDIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDIN DIHYDROCHLORID | active | | | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDIN DIHYDROCHLORID | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253252 | CATHEJELL LIDOC/CHX SPR12,5G | Cathejell comp 17,31 mg/g / 0,5 mg/g Gel | 1.2.40.0.34.4.17:1-19198 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:N01BB52 | Lidocain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073638 | Anwendung in der Harnröhre | 1.2.40.0.10.1.4.3.4.3.4:100000073571 | endotracheopulmonale Anwendung | | | 1.2.40.0.34.5.156:1708976 | LIDOCAIN | 1.2.40.0.34.5.221:100000091713 | LIDOCAIN | active | | | 1.2.40.0.34.5.221:100000091713 | LIDOCAIN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1709371 | CHLORHEXIDIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDIN DIHYDROCHLORID | active | | | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDIN DIHYDROCHLORID | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253269 | TEBOFORTAN TR 4% | Tebofortan 4 % - Tropfen | 1.2.40.0.34.4.17:1-18671 | GA - zugelassen | Dr. Willmar Schwabe GmbH & Co. KG | true | true | 20 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C04AX | Andere periphere Vasodilatatoren | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705908 | GINKGONIS FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:100000078164 | GINKGO BILOBA EXTRACT | active | 80 | g | 1.2.40.0.34.5.221:100000078164 | GINKGO BILOBA EXTRACT | 80 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:927305001 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:N06DX02 | Ginkgo biloba | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253275 | TEBOFORTAN TR 4% | Tebofortan 4 % - Tropfen | 1.2.40.0.34.4.17:1-18671 | GA - zugelassen | Dr. Willmar Schwabe GmbH & Co. KG | true | true | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:C04AX | Andere periphere Vasodilatatoren | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705908 | GINKGONIS FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:100000078164 | GINKGO BILOBA EXTRACT | active | 200 | g | 1.2.40.0.34.5.221:100000078164 | GINKGO BILOBA EXTRACT | 200 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:927305002 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:N06DX02 | Ginkgo biloba | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253298 | ANTEPAN NA-SPRAY 4,7ML | Antepan - Nasal - Spray | 1.2.40.0.34.4.17:1-19069 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:V04CJ02 | Protirelin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1709250 | PROTIRELIN | 1.2.40.0.34.5.221:100000092191 | PROTIRELIN | active | 1.11 | g | 1.2.40.0.34.5.221:100000092191 | PROTIRELIN | 1.11 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073796 | Nasenspray, Lösung | true | human | 1.2.40.0.34.4.26:927814001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253335 | BURINEX LEO AMP 2MG 4ML | Burinex 2 mg - Ampullen | 1.2.40.0.34.4.17:1-18702 | GA - zugelassen | Karo Healthcare AB | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C03CA02 | Bumetanid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708037 | BUMETANID | 1.2.40.0.34.5.221:100000088443 | BUMETANIDE | active | 2 | mg | 1.2.40.0.34.5.221:100000088443 | BUMETANIDE | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927598001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253364 | MAGNOSOLV GRAN BTL | Magnosolv - Granulat | 1.2.40.0.34.4.17:1-19002 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:A12CC30 | Magnesium (verschiedene Salze in Kombination) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709592 | LEICHTES BASISCHES MAGNESIUMCARBONAT | 1.2.40.0.34.5.221:100000092910 | MAGNESIUM CARBONATE LIGHT | active | 670 | mg | 1.2.40.0.34.5.221:100000092910 | MAGNESIUM CARBONATE LIGHT | 670 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073365 | Granulat zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:928640002 | 1.2.40.0.34.5.156:8023417 | MAGNESIUMOXID, LEICHTES | 1.2.40.0.34.5.221:100000092247 | MAGNESIUM OXIDE, LIGHT | active | 342 | mg | 1.2.40.0.34.5.221:100000092247 | MAGNESIUM OXIDE, LIGHT | 342 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253370 | SKINOREN CR | Skinoren 20 % - Creme | 1.2.40.0.34.4.17:1-18823 | GA - zugelassen | LEO PHARMA A/S | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D10AX03 | Azelainsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709079 | AZELAINSÄURE | 1.2.40.0.34.5.221:100000091937 | AZELAIC ACID | active | 6 | g | 1.2.40.0.34.5.221:100000091937 | AZELAIC ACID | 6 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:927961001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253401 | EBEFEN TBL 20MG | Ebefen 20 mg - Tabletten | 1.2.40.0.34.4.17:1-18833 | GA - zugelassen | Ebewe Pharma Ges.m.b.H. Nfg.KG | true | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:L02BA01 | Tamoxifen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708489 | TAMOXIFENCITRAT | 1.2.40.0.34.5.221:100000090201 | TAMOXIFEN CITRATE | active | 30.4 | mg | 1.2.40.0.34.5.221:100000090201 | TAMOXIFEN CITRATE | 30.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927702002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253418 | SELOKEN RET-FTBL 95MG | Seloken retard 95 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18930 | GA - zugelassen | Recordati Ireland Limited | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708826 | METOPROLOL SUCCINAT | 1.2.40.0.34.5.221:100000091368 | METOPROLOL SUCCINATE | active | 95 | mg | 1.2.40.0.34.5.221:100000091368 | METOPROLOL SUCCINATE | 95 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927811003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253430 | SELOKEN RET-FTBL PLUS | Seloken retard plus - Filmtabletten | 1.2.40.0.34.4.17:1-20077 | GA - aufgehoben | SANOVA Pharma GesmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07BB02 | Metoprolol und Thiazide | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 12.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:930592002 | 1.2.40.0.34.5.156:1708826 | METOPROLOL SUCCINAT | 1.2.40.0.34.5.221:100000091368 | METOPROLOL SUCCINATE | active | 95 | mg | 1.2.40.0.34.5.221:100000091368 | METOPROLOL SUCCINATE | 95 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253476 | AGIOCUR GRAN | Agiocur-Granulat | 1.2.40.0.34.4.17:1-18924 | GA - aufgehoben | Viatris Austria GmbH | false | false | 250 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A06AC01 | Ispaghula (Flohsamen) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707903 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | 1.2.40.0.34.5.221:100000087827 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | active | 550 | g | 1.2.40.0.34.5.221:100000087827 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | 550 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073372 | Granulat | true | human | 1.2.40.0.34.4.26:922092001 | 1.2.40.0.34.5.156:1706309 | PLANTAGINIS OVATAE SEMEN | 1.2.40.0.34.5.221:100000079851 | ISPAGHULA SEED | active | 16250 | g | 1.2.40.0.34.5.221:100000079851 | ISPAGHULA SEED | 16250 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253499 | TRICEF TRSFT 100MG/5ML 31,8G | Tricef 100 mg/5 ml - Trockensaft | 1.2.40.0.34.4.17:1-19111 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01DD08 | Cefixim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709484 | CEFIXIM | 1.2.40.0.34.5.221:100000092632 | CEFIXIME | active | 1343.04 | mg | 1.2.40.0.34.5.221:100000092632 | CEFIXIME | 1343.04 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:927950001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253660 | VOLTAREN RAPID DRG 50MG | Voltaren rapid 50 mg - Dragees | 1.2.40.0.34.4.17:1-19098 | GA - zugelassen | Novartis Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709354 | DICLOFENAC KALIUM | 1.2.40.0.34.5.221:100000092368 | DICLOFENAC POTASSIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092368 | DICLOFENAC POTASSIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:927962001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253677 | ZYRTEC FTBL 10MG | Zyrtec 10 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19030 | GA - zugelassen | UCB Pharma Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AE07 | Cetirizin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708870 | CETIRIZIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000091468 | CETIRIZINE DIHYDROCHLORIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000091468 | CETIRIZINE DIHYDROCHLORIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928378002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253683 | ZYRTEC FTBL 10MG | Zyrtec 10 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19030 | GA - zugelassen | UCB Pharma Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AE07 | Cetirizin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708870 | CETIRIZIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000091468 | CETIRIZINE DIHYDROCHLORIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000091468 | CETIRIZINE DIHYDROCHLORIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928378009 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253878 | CLARITYN TBL 10MG | Clarityn 10 mg - Tabletten | 1.2.40.0.34.4.17:1-19490 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AX13 | Loratadin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709242 | LORATADIN | 1.2.40.0.34.5.221:100000092179 | LORATADINE | active | 10 | mg | 1.2.40.0.34.5.221:100000092179 | LORATADINE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:929193001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1253884 | CLARITYN TBL 10MG | Clarityn 10 mg - Tabletten | 1.2.40.0.34.4.17:1-19490 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AX13 | Loratadin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709242 | LORATADIN | 1.2.40.0.34.5.221:100000092179 | LORATADINE | active | 10 | mg | 1.2.40.0.34.5.221:100000092179 | LORATADINE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:929193004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254139 | OLBETAM KPS | Olbetam - Kapseln | 1.2.40.0.34.4.17:1-19221 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C10AD06 | Acipimox | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709316 | ACIPIMOX | 1.2.40.0.34.5.221:100000092318 | ACIPIMOX | active | 250 | mg | 1.2.40.0.34.5.221:100000092318 | ACIPIMOX | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927825001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254145 | OLBETAM KPS | Olbetam - Kapseln | 1.2.40.0.34.4.17:1-19221 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C10AD06 | Acipimox | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709316 | ACIPIMOX | 1.2.40.0.34.5.221:100000092318 | ACIPIMOX | active | 250 | mg | 1.2.40.0.34.5.221:100000092318 | ACIPIMOX | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:927825002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254286 | BETOPTIC S AU-SUS | Betoptic S Augensuspension | 1.2.40.0.34.4.17:1-20898 | GA - zugelassen | Immedica Pharma AB | true | true | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01ED02 | Betaxolol | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709397 | BETAXOLOL HYDROCHLORID | 1.2.40.0.34.5.221:100000092485 | BETAXOLOL HYDROCHLORIDE | active | 14 | mg | 1.2.40.0.34.5.221:100000092485 | BETAXOLOL HYDROCHLORIDE | 14 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073760 | Augentropfensuspension | true | human | 1.2.40.0.34.4.26:931523001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254470 | TOBREX AU-TR | Tobrex Augentropfen | 1.2.40.0.34.4.17:1-19633 | GA - zugelassen | Novartis Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01AA12 | Tobramycin | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1708735 | TOBRAMYCIN | 1.2.40.0.34.5.221:100000091065 | TOBRAMYCIN | active | 15 | mg | 1.2.40.0.34.5.221:100000091065 | TOBRAMYCIN | 15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:927504001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254493 | NICOTINELL TRA PFL TTS 10 | Nicotinell TTS 10 (7 mg/24 h) transdermale Pflaster | 1.2.40.0.34.4.17:1-26670 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:N07BA01 | Nicotin | 1.2.40.0.10.1.4.3.4.3.4:100000073637 | transdermale Anwendung | | | | | 1.2.40.0.34.5.156:1706345 | NICOTIN | 1.2.40.0.34.5.221:100000079991 | NICOTINE | active | 17.5 | mg | 1.2.40.0.34.5.221:100000079991 | NICOTINE | 17.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073741 | transdermales Pflaster | false | human | 1.2.40.0.34.4.26:949725004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254518 | NICOTINELL TRA PFL TTS 10 | Nicotinell TTS 10 (7 mg/24 h) transdermale Pflaster | 1.2.40.0.34.4.17:1-26670 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:N07BA01 | Nicotin | 1.2.40.0.10.1.4.3.4.3.4:100000073637 | transdermale Anwendung | | | | | 1.2.40.0.34.5.156:1706345 | NICOTIN | 1.2.40.0.34.5.221:100000079991 | NICOTINE | active | 17.5 | mg | 1.2.40.0.34.5.221:100000079991 | NICOTINE | 17.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073741 | transdermales Pflaster | false | human | 1.2.40.0.34.4.26:949725003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254524 | NICOTINELL TRA PFL TTS 20 | Nicotinell TTS 20 (14 mg/24 h) transdermale Pflaster | 1.2.40.0.34.4.17:1-26672 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:N07BA01 | Nicotin | 1.2.40.0.10.1.4.3.4.3.4:100000073637 | transdermale Anwendung | | | | | 1.2.40.0.34.5.156:1706345 | NICOTIN | 1.2.40.0.34.5.221:100000079991 | NICOTINE | active | 35 | mg | 1.2.40.0.34.5.221:100000079991 | NICOTINE | 35 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073741 | transdermales Pflaster | false | human | 1.2.40.0.34.4.26:949726004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254547 | NICOTINELL TRA PFL TTS 20 | Nicotinell TTS 20 (14 mg/24 h) transdermale Pflaster | 1.2.40.0.34.4.17:1-26672 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:N07BA01 | Nicotin | 1.2.40.0.10.1.4.3.4.3.4:100000073637 | transdermale Anwendung | | | | | 1.2.40.0.34.5.156:1706345 | NICOTIN | 1.2.40.0.34.5.221:100000079991 | NICOTINE | active | 35 | mg | 1.2.40.0.34.5.221:100000079991 | NICOTINE | 35 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073741 | transdermales Pflaster | false | human | 1.2.40.0.34.4.26:949726003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254553 | NICOTINELL TRA PFL TTS 30 | Nicotinell TTS 30 (21 mg/24 h) transdermale Pflaster | 1.2.40.0.34.4.17:1-26673 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:N07BA01 | Nicotin | 1.2.40.0.10.1.4.3.4.3.4:100000073637 | transdermale Anwendung | | | | | 1.2.40.0.34.5.156:1706345 | NICOTIN | 1.2.40.0.34.5.221:100000079991 | NICOTINE | active | 52.5 | mg | 1.2.40.0.34.5.221:100000079991 | NICOTINE | 52.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073741 | transdermales Pflaster | false | human | 1.2.40.0.34.4.26:949727004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254582 | NICOTINELL TRA PFL TTS 30 | Nicotinell TTS 30 (21 mg/24 h) transdermale Pflaster | 1.2.40.0.34.4.17:1-26673 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:N07BA01 | Nicotin | 1.2.40.0.10.1.4.3.4.3.4:100000073637 | transdermale Anwendung | | | | | 1.2.40.0.34.5.156:1706345 | NICOTIN | 1.2.40.0.34.5.221:100000079991 | NICOTINE | active | 52.5 | mg | 1.2.40.0.34.5.221:100000079991 | NICOTINE | 52.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073741 | transdermales Pflaster | false | human | 1.2.40.0.34.4.26:949727003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254642 | ATENOLOL GEN CP FTBL | Atenolol Genericon comp. Filmtabletten | 1.2.40.0.34.4.17:1-19172 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07CB03 | Atenolol und andere Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709446 | CHLORTALIDON | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | active | 25 | mg | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927921001 | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254659 | ATENOLOL GEN CP FTBL | Atenolol Genericon comp. Filmtabletten | 1.2.40.0.34.4.17:1-19172 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07CB03 | Atenolol und andere Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709446 | CHLORTALIDON | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | active | 25 | mg | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927921002 | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254665 | ATENOLOL GEN CP MTE FTBL | Atenolol Genericon comp. mite Filmtabletten | 1.2.40.0.34.4.17:1-19170 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07CB03 | Atenolol und andere Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709446 | CHLORTALIDON | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | 12.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927919001 | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 50 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254671 | ATENOLOL GEN CP MTE FTBL | Atenolol Genericon comp. mite Filmtabletten | 1.2.40.0.34.4.17:1-19170 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07CB03 | Atenolol und andere Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709446 | CHLORTALIDON | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | 12.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927919002 | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 50 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254688 | VASONIT RET FTBL 600MG | Vasonit retard 600 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19165 | GA - zugelassen | G.L. Pharma GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 600 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927944001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254694 | VASONIT RET FTBL 600MG | Vasonit retard 600 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19165 | GA - zugelassen | G.L. Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 600 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927944002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254702 | XYLANAEST EPIN.AMP 1% 5ML | Xylanaest 1 % mit Epinephrin 1 : 200.000 - Ampullen | 1.2.40.0.34.4.17:1-19137 | GA - zugelassen | Gebro Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01BB52 | Lidocain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:1709361 | EPINEPHRIN | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | active | 0.025 | mg | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | 0.025 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:922993001 | 1.2.40.0.34.5.156:7211713 | LIDOCAIN HYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | active | 53.3 | mg | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | 53.3 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254719 | XYLANAEST EPIN.AMP 2% 5ML | Xylanaest 2 % mit Epinephrin 1:200.000 - Ampullen | 1.2.40.0.34.4.17:1-19138 | GA - zugelassen | Gebro Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N01BB52 | Lidocain, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:1709361 | EPINEPHRIN | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | active | 0.025 | mg | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | 0.025 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:923606001 | 1.2.40.0.34.5.156:7211713 | LIDOCAIN HYDROCHLORID MONOHYDRAT | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | active | 106.65 | mg | 1.2.40.0.34.5.221:100000090563 | LIDOCAINE HYDROCHLORIDE MONOHYDRATE | 106.65 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254748 | PENTOXI GEN RET FTBL 600MG | Pentoxi Genericon retard 600 mg Filmtabletten | 1.2.40.0.34.4.17:1-19164 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 600 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927945001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254754 | PENTOXI GEN RET FTBL 600MG | Pentoxi Genericon retard 600 mg Filmtabletten | 1.2.40.0.34.4.17:1-19164 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 600 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927945002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254820 | ERGOVASAN TR 2MG/ML | Ergovasan 2 mg/ml - Tropfen | 1.2.40.0.34.4.17:1-19270 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N02CA01 | Dihydroergotamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708652 | DIHYDROERGOTAMIN MESILAT | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | active | 0.2 | g | 1.2.40.0.34.5.221:100000090575 | DIHYDROERGOTAMINE MESILATE | 0.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:927480002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254837 | AMBROBENE INJ AMP 15MG/2ML | Ambrobene 15 mg - Ampullen | 1.2.40.0.34.4.17:1-19114 | GA - zugelassen | Teva B.V. | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:R05CB06 | Ambroxol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 15 | mg | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927898001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254843 | AMBROBENE LSG 7,5MG/ML | Ambrobene 7,5 mg/ml - Lösung | 1.2.40.0.34.4.17:1-19113 | GA - zugelassen | Teva B.V. | true | true | 40 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CB06 | Ambroxol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 300 | mg | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:927895002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073835 | Lösung für einen Vernebler | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254866 | AMBROBENE LSG 7,5MG/ML | Ambrobene 7,5 mg/ml - Lösung | 1.2.40.0.34.4.17:1-19113 | GA - zugelassen | Teva B.V. | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CB06 | Ambroxol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 750 | mg | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 750 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:927895001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073835 | Lösung für einen Vernebler | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254872 | AMBROBENE RET KPS 75MG | Ambrobene retard 75 mg - Kapseln | 1.2.40.0.34.4.17:1-19117 | GA - zugelassen | Teva B.V. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R05CB06 | Ambroxol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 75 | mg | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:927896001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254889 | AMBROBENE RET KPS 75MG | Ambrobene retard 75 mg - Kapseln | 1.2.40.0.34.4.17:1-19117 | GA - zugelassen | Teva B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R05CB06 | Ambroxol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 75 | mg | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:927896002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254895 | CYMEVENE PLV IKONZ DFL 500MG | Cymevene 500 mg - Trockensubstanz zur Infusionsbereitung | 1.2.40.0.34.4.17:1-19235 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J05AB06 | Ganciclovir | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708265 | GANCICLOVIR NATRIUM | 1.2.40.0.34.5.221:100000089399 | GANCICLOVIR SODIUM | active | 543 | mg | 1.2.40.0.34.5.221:100000089399 | GANCICLOVIR SODIUM | 543 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:928988001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254903 | MADOPAR CR KPS 100/25MG | Madopar CR 100 mg/25 mg - Kapseln | 1.2.40.0.34.4.17:1-19177 | GA - zugelassen | Roche Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N04BA02 | Levodopa und Decarboxylasehemmer | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708901 | BENSERAZID HYDROCHLORID | 1.2.40.0.34.5.221:100000091558 | BENSERAZIDE HYDROCHLORIDE | active | 28.5 | mg | 1.2.40.0.34.5.221:100000091558 | BENSERAZIDE HYDROCHLORIDE | 28.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:927979002 | 1.2.40.0.34.5.156:1707406 | LEVODOPA | 1.2.40.0.34.5.221:100000085446 | LEVODOPA | active | 100 | mg | 1.2.40.0.34.5.221:100000085446 | LEVODOPA | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254926 | MADOPAR CR KPS 100/25MG | Madopar CR 100 mg/25 mg - Kapseln | 1.2.40.0.34.4.17:1-19177 | GA - zugelassen | Roche Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N04BA02 | Levodopa und Decarboxylasehemmer | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708901 | BENSERAZID HYDROCHLORID | 1.2.40.0.34.5.221:100000091558 | BENSERAZIDE HYDROCHLORIDE | active | 28.5 | mg | 1.2.40.0.34.5.221:100000091558 | BENSERAZIDE HYDROCHLORIDE | 28.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:927979001 | 1.2.40.0.34.5.156:1707406 | LEVODOPA | 1.2.40.0.34.5.221:100000085446 | LEVODOPA | active | 100 | mg | 1.2.40.0.34.5.221:100000085446 | LEVODOPA | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254978 | PAEDAMIN IFL 100ML | Pädamin - Infusionslösung | 1.2.40.0.34.4.17:1-19217 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BA01 | Aminosäuren | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707674 | ARGININ | 1.2.40.0.34.5.221:100000086598 | ARGININE | active | 390 | mg | 1.2.40.0.34.5.221:100000086598 | ARGININE | 390 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:928815001 | 1.2.40.0.34.5.156:1709495 | HISTIDIN | 1.2.40.0.34.5.221:100000092646 | HISTIDINE | active | 425 | mg | 1.2.40.0.34.5.221:100000092646 | HISTIDINE | 425 | mg | 1.2.40.0.34.5.156:1706526 | PROLIN | 1.2.40.0.34.5.221:100000081124 | PROLINE | active | 695 | mg | 1.2.40.0.34.5.221:100000081124 | PROLINE | 695 | mg | | | | | | | 1.2.40.0.34.5.156:1706752 | TAURIN | 1.2.40.0.34.5.221:100000082407 | TAURINE | active | 75 | mg | 1.2.40.0.34.5.221:100000082407 | TAURINE | 75 | mg | 1.2.40.0.34.5.156:1706357 | ORNITHIN ASPARTAT | 1.2.40.0.34.5.221:100000080065 | ORNITHINE ASPARTATE | active | 301.4 | mg | 1.2.40.0.34.5.221:100000080065 | ORNITHINE ASPARTATE | 301.4 | mg | 1.2.40.0.34.5.156:1709352 | THREONIN | 1.2.40.0.34.5.221:100000092365 | THREONINE | active | 300 | mg | 1.2.40.0.34.5.221:100000092365 | THREONINE | 300 | mg | | | | | 1.2.40.0.34.5.156:1709383 | METHIONIN | 1.2.40.0.34.5.221:100000092414 | METHIONINE | active | 120 | mg | 1.2.40.0.34.5.221:100000092414 | METHIONINE | 120 | mg | 1.2.40.0.34.5.156:1709284 | LEUCIN | 1.2.40.0.34.5.221:100000092265 | LEUCINE | active | 640 | mg | 1.2.40.0.34.5.221:100000092265 | LEUCINE | 640 | mg | | | | | 1.2.40.0.34.5.156:1709282 | ACETYLCYSTEIN | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | active | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | 1.2.40.0.34.5.156:1707010 | SERIN | 1.2.40.0.34.5.221:100000084137 | SERINE | active | 1.2.40.0.34.5.221:100000084137 | SERINE | 1.2.40.0.34.5.156:1709070 | TRYPTOPHAN | 1.2.40.0.34.5.221:100000091926 | TRYPTOPHAN | active | 1.2.40.0.34.5.221:100000091926 | TRYPTOPHAN | 1.2.40.0.34.5.156:1709325 | ALANIN | 1.2.40.0.34.5.221:100000092328 | ALANINE | active | 1.2.40.0.34.5.221:100000092328 | ALANINE | 1.2.40.0.34.5.156:1709389 | VALIN | 1.2.40.0.34.5.221:100000092422 | VALINE | active | 1.2.40.0.34.5.221:100000092422 | VALINE | 1.2.40.0.34.5.156:1709099 | ISOLEUCIN | 1.2.40.0.34.5.221:100000091969 | ISOLEUCINE | active | 1.2.40.0.34.5.221:100000091969 | ISOLEUCINE | 1.2.40.0.34.5.156:1709035 | ASPARAGINSÄURE | 1.2.40.0.34.5.221:100000091847 | ASPARTIC ACID | active | 1.2.40.0.34.5.221:100000091847 | ASPARTIC ACID | 1.2.40.0.34.5.156:1710444 | LYSIN GLUTAMAT | 1.2.40.0.34.5.221:100000172792 | LYSINE L-GLUTAMATE | active | 1.2.40.0.34.5.221:100000172792 | LYSINE L-GLUTAMATE | 1.2.40.0.34.5.156:1708006 | N-ACETYLTYROSIN | 1.2.40.0.34.5.221:100000088304 | N-ACETYLTYROSINE | active | 1.2.40.0.34.5.221:100000088304 | N-ACETYLTYROSINE | 1.2.40.0.34.5.156:1709098 | GLYCIN | 1.2.40.0.34.5.221:100000091968 | GLYCINE | active | 1.2.40.0.34.5.221:100000091968 | GLYCINE | 1.2.40.0.34.5.156:1709225 | TYROSIN | 1.2.40.0.34.5.221:100000092159 | TYROSINE | active | 1.2.40.0.34.5.221:100000092159 | TYROSINE | 1.2.40.0.34.5.156:1709385 | PHENYLALANIN | 1.2.40.0.34.5.221:100000092416 | PHENYLALANINE | active | 1.2.40.0.34.5.221:100000092416 | PHENYLALANINE | 1.2.40.0.34.5.156:1709161 | GLUTAMINSÄURE | 1.2.40.0.34.5.221:100000092069 | GLUTAMIC ACID | active | 1.2.40.0.34.5.221:100000092069 | GLUTAMIC ACID | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 148 | mg | 148 | mg | 295 | mg | 295 | mg | 138 | mg | 138 | mg | 800 | mg | 800 | mg | 450 | mg | 450 | mg | 350 | mg | 350 | mg | 81 | mg | 81 | mg | 1126.5 | mg | 1126.5 | mg | 326 | mg | 326 | mg | 310 | mg | 310 | mg | 60 | mg | 60 | mg | 285 | mg | 285 | mg | 242 | mg | 242 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254984 | PAEDAMIN IFL 250ML | Pädamin - Infusionslösung | 1.2.40.0.34.4.17:1-19217 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BA01 | Aminosäuren | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707674 | ARGININ | 1.2.40.0.34.5.221:100000086598 | ARGININE | active | 975 | mg | 1.2.40.0.34.5.221:100000086598 | ARGININE | 975 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:928815002 | 1.2.40.0.34.5.156:1709495 | HISTIDIN | 1.2.40.0.34.5.221:100000092646 | HISTIDINE | active | 1062.5 | mg | 1.2.40.0.34.5.221:100000092646 | HISTIDINE | 1062.5 | mg | 1.2.40.0.34.5.156:1706526 | PROLIN | 1.2.40.0.34.5.221:100000081124 | PROLINE | active | 1737.5 | mg | 1.2.40.0.34.5.221:100000081124 | PROLINE | 1737.5 | mg | | | | | | | 1.2.40.0.34.5.156:1706752 | TAURIN | 1.2.40.0.34.5.221:100000082407 | TAURINE | active | 187.5 | mg | 1.2.40.0.34.5.221:100000082407 | TAURINE | 187.5 | mg | 1.2.40.0.34.5.156:1706357 | ORNITHIN ASPARTAT | 1.2.40.0.34.5.221:100000080065 | ORNITHINE ASPARTATE | active | 753.5 | mg | 1.2.40.0.34.5.221:100000080065 | ORNITHINE ASPARTATE | 753.5 | mg | 1.2.40.0.34.5.156:1709352 | THREONIN | 1.2.40.0.34.5.221:100000092365 | THREONINE | active | 750 | mg | 1.2.40.0.34.5.221:100000092365 | THREONINE | 750 | mg | | | | | 1.2.40.0.34.5.156:1709383 | METHIONIN | 1.2.40.0.34.5.221:100000092414 | METHIONINE | active | 300 | mg | 1.2.40.0.34.5.221:100000092414 | METHIONINE | 300 | mg | 1.2.40.0.34.5.156:1709284 | LEUCIN | 1.2.40.0.34.5.221:100000092265 | LEUCINE | active | 1600 | mg | 1.2.40.0.34.5.221:100000092265 | LEUCINE | 1600 | mg | | | | | 1.2.40.0.34.5.156:1709282 | ACETYLCYSTEIN | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | active | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | 1.2.40.0.34.5.156:1707010 | SERIN | 1.2.40.0.34.5.221:100000084137 | SERINE | active | 1.2.40.0.34.5.221:100000084137 | SERINE | 1.2.40.0.34.5.156:1709070 | TRYPTOPHAN | 1.2.40.0.34.5.221:100000091926 | TRYPTOPHAN | active | 1.2.40.0.34.5.221:100000091926 | TRYPTOPHAN | 1.2.40.0.34.5.156:1709389 | VALIN | 1.2.40.0.34.5.221:100000092422 | VALINE | active | 1.2.40.0.34.5.221:100000092422 | VALINE | 1.2.40.0.34.5.156:1709325 | ALANIN | 1.2.40.0.34.5.221:100000092328 | ALANINE | active | 1.2.40.0.34.5.221:100000092328 | ALANINE | 1.2.40.0.34.5.156:1708006 | N-ACETYLTYROSIN | 1.2.40.0.34.5.221:100000088304 | N-ACETYLTYROSINE | active | 1.2.40.0.34.5.221:100000088304 | N-ACETYLTYROSINE | 1.2.40.0.34.5.156:1709099 | ISOLEUCIN | 1.2.40.0.34.5.221:100000091969 | ISOLEUCINE | active | 1.2.40.0.34.5.221:100000091969 | ISOLEUCINE | 1.2.40.0.34.5.156:1709035 | ASPARAGINSÄURE | 1.2.40.0.34.5.221:100000091847 | ASPARTIC ACID | active | 1.2.40.0.34.5.221:100000091847 | ASPARTIC ACID | 1.2.40.0.34.5.156:1710444 | LYSIN GLUTAMAT | 1.2.40.0.34.5.221:100000172792 | LYSINE L-GLUTAMATE | active | 1.2.40.0.34.5.221:100000172792 | LYSINE L-GLUTAMATE | 1.2.40.0.34.5.156:1709098 | GLYCIN | 1.2.40.0.34.5.221:100000091968 | GLYCINE | active | 1.2.40.0.34.5.221:100000091968 | GLYCINE | 1.2.40.0.34.5.156:1709225 | TYROSIN | 1.2.40.0.34.5.221:100000092159 | TYROSINE | active | 1.2.40.0.34.5.221:100000092159 | TYROSINE | 1.2.40.0.34.5.156:1709385 | PHENYLALANIN | 1.2.40.0.34.5.221:100000092416 | PHENYLALANINE | active | 1.2.40.0.34.5.221:100000092416 | PHENYLALANINE | 1.2.40.0.34.5.156:1709161 | GLUTAMINSÄURE | 1.2.40.0.34.5.221:100000092069 | GLUTAMIC ACID | active | 1.2.40.0.34.5.221:100000092069 | GLUTAMIC ACID | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 370 | mg | 370 | mg | 737.5 | mg | 737.5 | mg | 345 | mg | 345 | mg | 1125 | mg | 1125 | mg | 2000 | mg | 2000 | mg | 815 | mg | 815 | mg | 875 | mg | 875 | mg | 202.5 | mg | 202.5 | mg | 2816.25 | mg | 2816.25 | mg | 775 | mg | 775 | mg | 150 | mg | 150 | mg | 712.5 | mg | 712.5 | mg | 605 | mg | 605 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1254990 | RIOPAN KAUTBL 800MG | Riopan 800 mg - Kautabletten | 1.2.40.0.34.4.17:1-19161 | GA - zugelassen | Takeda Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02AD02 | Magaldrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708537 | MAGALDRAT | 1.2.40.0.34.5.221:100000090318 | MAGALDRATE | active | 800 | mg | 1.2.40.0.34.5.221:100000090318 | MAGALDRATE | 800 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073684 | Kautablette | true | human | 1.2.40.0.34.4.26:928502002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255009 | RIOPAN KAUTBL 800MG | Riopan 800 mg - Kautabletten | 1.2.40.0.34.4.17:1-19161 | GA - zugelassen | Takeda Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02AD02 | Magaldrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708537 | MAGALDRAT | 1.2.40.0.34.5.221:100000090318 | MAGALDRATE | active | 800 | mg | 1.2.40.0.34.5.221:100000090318 | MAGALDRATE | 800 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073684 | Kautablette | true | human | 1.2.40.0.34.4.26:928502003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255067 | DOLGIT DRG 400MG | Dolgit 400 mg - Dragees | 1.2.40.0.34.4.17:1-19153 | GA - aufgehoben | Dolorgiet GmbH & Co. KG | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 400 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:928704002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255073 | DOLGIT DRG 400MG | Dolgit 400 mg - Dragees | 1.2.40.0.34.4.17:1-19153 | GA - aufgehoben | Dolorgiet GmbH & Co. KG | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 400 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:928704003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255096 | DOLGIT DRG 600MG | Dolgit 600 mg - Dragees | 1.2.40.0.34.4.17:1-19152 | GA - aufgehoben | Dolorgiet GmbH & Co. KG | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 600 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:928706002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255104 | DOLGIT DRG 600MG | Dolgit 600 mg - Dragees | 1.2.40.0.34.4.17:1-19152 | GA - aufgehoben | Dolorgiet GmbH & Co. KG | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 600 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:928706003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255110 | DOLGIT CR | Dolgit - Creme | 1.2.40.0.34.4.17:1-19151 | GA - zugelassen | Dolorgiet GmbH & Co. KG | true | true | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA13 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 2 | g | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:928569002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255127 | DOLGIT CR | Dolgit - Creme | 1.2.40.0.34.4.17:1-19151 | GA - zugelassen | Dolorgiet GmbH & Co. KG | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA13 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 5 | g | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:928569001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255156 | LEMOCIN LTBL | Lemocin - Lutschtabletten | 1.2.40.0.34.4.17:13263 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R02AB02 | Tyrothricin | 1.2.40.0.10.1.4.3.4.3.4:100000073621 | zur Anwendung im Mund- und Rachenraum | | | | | 1.2.40.0.34.5.156:1708976 | LIDOCAIN | 1.2.40.0.34.5.221:100000091713 | LIDOCAINE | active | 1 | mg | 1.2.40.0.34.5.221:100000091713 | LIDOCAINE | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073703 | Lutschtablette | false | human | 1.2.40.0.34.4.26:120106002 | 1.2.40.0.34.5.156:1706594 | CETRIMONIUM BROMID | 1.2.40.0.34.5.221:100000081536 | CETRIMONIUM BROMIDE | active | 2 | mg | 1.2.40.0.34.5.221:100000081536 | CETRIMONIUM BROMIDE | 2 | mg | 1.2.40.0.34.5.156:1709209 | TYROTHRICIN | 1.2.40.0.34.5.221:100000092138 | TYROTHRICIN | active | 4 | mg | 1.2.40.0.34.5.221:100000092138 | TYROTHRICIN | 4 | mg | 2.16.840.1.113883.6.73:R02AA17 | Cetrimonium | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:R02AD02 | Lidocain | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255185 | PROSPAN HU-TR | Prospan - Hustentropfen | 1.2.40.0.34.4.17:11754 | GA - zugelassen | Engelhard Arzneimittel GmbH & Co. KG | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CA | Expektoranzien | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | 1.2.40.0.34.5.156:1712622 | HEDERAE FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000004140 | HEDERAE FOLIUM (EXTRACT) | active | 200 | g | 1.2.40.0.34.5.221:900000004140 | HEDERAE FOLIUM (EXTRACT) | 200 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | false | human | 1.2.40.0.34.4.26:121930001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255191 | PROSTAVASIN TRSUB AMP 20MCG | Prostavasin 20 µg Trockensubstanz zur Infusionsbereitung | 1.2.40.0.34.4.17:1-19299 | GA - zugelassen | Amdipharm Limited | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C01EA01 | Alprostadil | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | 1.2.40.0.34.5.156:1709255 | ALPROSTADIL X ALFADEX | 1.2.40.0.34.5.221:100000092209 | ALPROSTADIL ALFADEX | active | 0.666 | mg | 1.2.40.0.34.5.221:100000092209 | ALPROSTADIL ALFADEX | 0.666 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:927488001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255340 | KLACID FTBL 250MG | Klacid 250 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19163 | GA - zugelassen | Viatris Austria GmbH | true | true | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01FA09 | Clarithromycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709351 | CLARITHROMYCIN | 1.2.40.0.34.5.221:100000092364 | CLARITHROMYCIN | active | 250 | mg | 1.2.40.0.34.5.221:100000092364 | CLARITHROMYCIN | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928690002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255446 | ASPIRIN TBL 500MG | Aspirin 500 mg Tabletten | 1.2.40.0.34.4.17:3155 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BA01 | Acetylsalicylsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129844002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255475 | DORMICUM AMP 50MG/10ML | DORMICUM "Roche" 50 mg/10 ml - Injektionslösung | 1.2.40.0.34.4.17:1-19197 | GA - aufgehoben | Roche Austria GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05CD08 | Midazolam | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1706453 | MIDAZOLAM | 1.2.40.0.34.5.221:100000080626 | MIDAZOLAM | active | 50 | mg | 1.2.40.0.34.5.221:100000080626 | MIDAZOLAM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:929507002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | 1.2.40.0.10.1.4.3.4.3.5:100000073829 | Rektallösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255498 | FUCIDIN SLB | Fucidin - Salbe | 1.2.40.0.34.4.17:13999 | GA - zugelassen | Leo Pharma GmbH | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D06AX01 | Fusidinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1706178 | NATRIUM FUSIDAT | 1.2.40.0.34.5.221:100000079317 | SODIUM FUSIDATE | active | 300 | mg | 1.2.40.0.34.5.221:100000079317 | SODIUM FUSIDATE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:121695001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255699 | VENDAL AMP 10MG/1ML | Vendal 10 mg - Ampullen | 1.2.40.0.34.4.17:36 | GA - zugelassen | G.L. Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073572 | epidurale Anwendung | 1.2.40.0.34.5.156:1708617 | MORPHINHYDROCHLORID | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:922835001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255736 | BEPANTHEN PLUS CR | Bepanthen plus Creme | 1.2.40.0.34.4.17:1-19149 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D03AX03 | Dexpanthenol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709167 | DEXPANTHENOL | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | active | 1.5 | g | 1.2.40.0.34.5.221:100000092075 | DEXPANTHENOL | 1.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | false | human | 1.2.40.0.34.4.26:928630001 | 1.2.40.0.34.5.156:1709371 | CHLORHEXIDIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDINE DIHYDROCHLORIDE | active | 0.15 | g | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDINE DIHYDROCHLORIDE | 0.15 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255825 | HUMAL BAD BTL 37G | Humal-Bad | 1.2.40.0.34.4.17:1-19319 | GA - aufgehoben | Bano Healthcare GmbH | false | false | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1710350 | HUMINSÄUREVERBINDUNG MIT SALICYLSÄURE | 1.2.40.0.34.5.221:900000000581 | HUMINSÄUREVERBINDUNG MIT SALICYLSÄURE | active | | | 1.2.40.0.34.5.221:900000000581 | HUMINSÄUREVERBINDUNG MIT SALICYLSÄURE | | | 1.2.40.0.10.1.4.3.4.3.5:100000073711 | Badezusatz | false | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLSÄURE | active | | | 1.2.40.0.34.5.221:100000090038 | SALICYLSÄURE | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255831 | HUMAL BAD BTL 37G | Humal-Bad | 1.2.40.0.34.4.17:1-19319 | GA - aufgehoben | Bano Healthcare GmbH | false | false | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1710350 | HUMINSÄUREVERBINDUNG MIT SALICYLSÄURE | 1.2.40.0.34.5.221:900000000581 | HUMIC ACID CONJUGATE WITH SALICYLIC ACID | active | 7 | g | 1.2.40.0.34.5.221:900000000581 | HUMIC ACID CONJUGATE WITH SALICYLIC ACID | 7 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073711 | Badezusatz | false | human | 1.2.40.0.34.4.26:928692001 | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 175 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 175 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255848 | LASIX RET KPS 60MG | Lasix retard 60 mg Kapseln | 1.2.40.0.34.4.17:1-22210 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03CA01 | Furosemid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 60 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:933682001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255854 | HUMAL TEILBAD BTL 12G | Humal-Teilbad | 1.2.40.0.34.4.17:1-19318 | GA - aufgehoben | Bano Healthcare GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1710350 | HUMINSÄUREVERBINDUNG MIT SALICYLSÄURE | 1.2.40.0.34.5.221:900000000581 | HUMIC ACID CONJUGATE WITH SALICYLIC ACID | active | 3.25 | g | 1.2.40.0.34.5.221:900000000581 | HUMIC ACID CONJUGATE WITH SALICYLIC ACID | 3.25 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073711 | Badezusatz | false | human | 1.2.40.0.34.4.26:928691001 | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 81.12 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 81.12 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1255966 | LOMAHERPAN FIEBERBLASENCR | Lomaherpan Fieberblasen-Creme | 1.2.40.0.34.4.17:1-19337 | GA - aufgehoben | INFECTOPHARM Arzneimittel und Consilium GmbH | false | false | 5 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D06BB | Antivirale Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1710487 | MELISSAE FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000720 | MELISSAE FOLIUM (EXTRACT) | active | 250 | mg | 1.2.40.0.34.5.221:900000000720 | MELISSAE FOLIUM (EXTRACT) | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | false | human | 1.2.40.0.34.4.26:927671001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256173 | ACCUPRO FTBL 5MG | Accupro 5 mg Filmtabletten | 1.2.40.0.34.4.17:1-19359 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA06 | Quinapril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708604 | QUINAPRIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090468 | QUINAPRIL HYDROCHLORIDE | active | 5.416 | mg | 1.2.40.0.34.5.221:100000090468 | QUINAPRIL HYDROCHLORIDE | 5.416 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928626001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256196 | ACCUPRO FTBL 10MG | Accupro 10 mg Filmtabletten | 1.2.40.0.34.4.17:1-19361 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA06 | Quinapril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708604 | QUINAPRIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090468 | QUINAPRIL HYDROCHLORIDE | active | 10.832 | mg | 1.2.40.0.34.5.221:100000090468 | QUINAPRIL HYDROCHLORIDE | 10.832 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928624001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256204 | ACCUPRO FTBL 20MG | Accupro 20 mg Filmtabletten | 1.2.40.0.34.4.17:1-19363 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA06 | Quinapril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708604 | QUINAPRIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090468 | QUINAPRIL HYDROCHLORIDE | active | 21.664 | mg | 1.2.40.0.34.5.221:100000090468 | QUINAPRIL HYDROCHLORIDE | 21.664 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928627001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256210 | NEUROMULTIVIT FTBL | Neuromultivit - Filmtabletten | 1.2.40.0.34.4.17:1-19222 | GA - zugelassen | G.L. Pharma GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A11DB | Vitamin-B1 in Kombination mit Vitamin-B6 und/oder Vitamin-B12 | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | 0.2 | mg | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | 0.2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927989001 | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 200 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 200 | mg | 1.2.40.0.34.5.156:1708752 | THIAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256411 | AMINOMEL NEPHRO IFL 250ML | Amino - Mel "nephro" - Infusionsflasche | 1.2.40.0.34.4.17:1-19271 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BA01 | Aminosäuren | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709495 | HISTIDIN | 1.2.40.0.34.5.221:100000092646 | HISTIDINE | active | 2450 | mg | 1.2.40.0.34.5.221:100000092646 | HISTIDINE | 2450 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:928916001 | 1.2.40.0.34.5.156:1707674 | ARGININ | 1.2.40.0.34.5.221:100000086598 | ARGININE | active | 2050 | mg | 1.2.40.0.34.5.221:100000086598 | ARGININE | 2050 | mg | 1.2.40.0.34.5.156:1706526 | PROLIN | 1.2.40.0.34.5.221:100000081124 | PROLINE | active | 750 | mg | 1.2.40.0.34.5.221:100000081124 | PROLINE | 750 | mg | | | | | | | 1.2.40.0.34.5.156:1708992 | LYSIN ACETAT | 1.2.40.0.34.5.221:100000091744 | LYSINE ACETATE | active | 4231.25 | mg | 1.2.40.0.34.5.221:100000091744 | LYSINE ACETATE | 4231.25 | mg | 1.2.40.0.34.5.156:1709352 | THREONIN | 1.2.40.0.34.5.221:100000092365 | THREONINE | active | 2050 | mg | 1.2.40.0.34.5.221:100000092365 | THREONINE | 2050 | mg | 1.2.40.0.34.5.156:1710311 | GLYCYLTYROSIN | 1.2.40.0.34.5.221:100000159327 | GLYCYL-L-TYROSINE | active | 908.25 | mg | 1.2.40.0.34.5.221:100000159327 | GLYCYL-L-TYROSINE | 908.25 | mg | | | | | 1.2.40.0.34.5.156:1709383 | METHIONIN | 1.2.40.0.34.5.221:100000092414 | METHIONINE | active | 500 | mg | 1.2.40.0.34.5.221:100000092414 | METHIONINE | 500 | mg | 1.2.40.0.34.5.156:1709284 | LEUCIN | 1.2.40.0.34.5.221:100000092265 | LEUCINE | active | 3200 | mg | 1.2.40.0.34.5.221:100000092265 | LEUCINE | 3200 | mg | | | | | 1.2.40.0.34.5.156:1709282 | ACETYLCYSTEIN | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | active | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | 1.2.40.0.34.5.156:1707010 | SERIN | 1.2.40.0.34.5.221:100000084137 | SERINE | active | 1.2.40.0.34.5.221:100000084137 | SERINE | 1.2.40.0.34.5.156:1709070 | TRYPTOPHAN | 1.2.40.0.34.5.221:100000091926 | TRYPTOPHAN | active | 1.2.40.0.34.5.221:100000091926 | TRYPTOPHAN | 1.2.40.0.34.5.156:1709325 | ALANIN | 1.2.40.0.34.5.221:100000092328 | ALANINE | active | 1.2.40.0.34.5.221:100000092328 | ALANINE | 1.2.40.0.34.5.156:1709389 | VALIN | 1.2.40.0.34.5.221:100000092422 | VALINE | active | 1.2.40.0.34.5.221:100000092422 | VALINE | 1.2.40.0.34.5.156:1709099 | ISOLEUCIN | 1.2.40.0.34.5.221:100000091969 | ISOLEUCINE | active | 1.2.40.0.34.5.221:100000091969 | ISOLEUCINE | 1.2.40.0.34.5.156:1709098 | GLYCIN | 1.2.40.0.34.5.221:100000091968 | GLYCINE | active | 1.2.40.0.34.5.221:100000091968 | GLYCINE | 1.2.40.0.34.5.156:1709385 | PHENYLALANIN | 1.2.40.0.34.5.221:100000092416 | PHENYLALANINE | active | 1.2.40.0.34.5.221:100000092416 | PHENYLALANINE | 1.2.40.0.34.5.156:1709225 | TYROSIN | 1.2.40.0.34.5.221:100000092159 | TYROSINE | active | 1.2.40.0.34.5.221:100000092159 | TYROSINE | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 135 | mg | 135 | mg | 1900 | mg | 1900 | mg | 750 | mg | 750 | mg | 1550 | mg | 1550 | mg | 2175 | mg | 2175 | mg | 1450 | mg | 1450 | mg | 1326.25 | mg | 1326.25 | mg | 875 | mg | 875 | mg | 150 | mg | 150 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256457 | FLUANXOL DEP AMP 100MG 1ML | Fluanxol Depot 100 mg - Ampullen | 1.2.40.0.34.4.17:1-19329 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05AF01 | Flupentixol | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708031 | FLUPENTIXOL DECANOAT | 1.2.40.0.34.5.221:100000088415 | FLUPENTIXOL DECANOATE | active | 100 | mg | 1.2.40.0.34.5.221:100000088415 | FLUPENTIXOL DECANOATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:129259001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256492 | SEROPRAM FTBL 20MG | Seropram 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19326 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AB04 | Citalopram | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708640 | CITALOPRAM HYDROBROMID | 1.2.40.0.34.5.221:100000090554 | CITALOPRAM HYDROBROMIDE | active | 24.98 | mg | 1.2.40.0.34.5.221:100000090554 | CITALOPRAM HYDROBROMIDE | 24.98 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928669002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256500 | SEROPRAM FTBL 20MG | Seropram 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19326 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AB04 | Citalopram | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708640 | CITALOPRAM HYDROBROMID | 1.2.40.0.34.5.221:100000090554 | CITALOPRAM HYDROBROMIDE | active | 24.98 | mg | 1.2.40.0.34.5.221:100000090554 | CITALOPRAM HYDROBROMIDE | 24.98 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928669003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256517 | TAVANIC IFL 500MG 100ML | Tavanic Infusionsflasche | 1.2.40.0.34.4.17:1-22321 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01MA12 | Levofloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708158 | LEVOFLOXACIN | 1.2.40.0.34.5.221:100000089067 | LEVOFLOXACIN | active | 512.46 | mg | 1.2.40.0.34.5.221:100000089067 | LEVOFLOXACIN | 512.46 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:942382001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256523 | SEROPRAM IKONZ 40MG/1ML | Seropram 40 mg - Konzentrat zur Infusionsbereitung | 1.2.40.0.34.4.17:1-19396 | GA - zugelassen | Lundbeck Austria GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N06AB04 | Citalopram | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708779 | CITALOPRAM HYDROCHLORID | 1.2.40.0.34.5.221:100000091251 | CITALOPRAM HYDROCHLORIDE | active | 44.48 | mg | 1.2.40.0.34.5.221:100000091251 | CITALOPRAM HYDROCHLORIDE | 44.48 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:928667001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256546 | AMBROBENE SFT 15MG/5ML | Ambrobene 15 mg/5 ml - Saft | 1.2.40.0.34.4.17:1-19116 | GA - zugelassen | Teva B.V. | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CB06 | Ambroxol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 0.3 | g | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:927894001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256552 | AMBROBENE TBL 30MG | Ambrobene 30 mg - Tabletten | 1.2.40.0.34.4.17:1-19115 | GA - zugelassen | Teva B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R05CB06 | Ambroxol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 30 | mg | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927897001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256569 | ATENOLAN CP FTBL | Atenolan comp. - Filmtabletten | 1.2.40.0.34.4.17:1-19181 | GA - zugelassen | G.L. Pharma GmbH | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07CB03 | Atenolol und andere Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709446 | CHLORTALIDON | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | active | 25 | mg | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927918001 | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256575 | ATENOLAN CP FTBL | Atenolan comp. - Filmtabletten | 1.2.40.0.34.4.17:1-19181 | GA - zugelassen | G.L. Pharma GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07CB03 | Atenolol und andere Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709446 | CHLORTALIDON | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | active | 25 | mg | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927918002 | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256598 | ATENOLAN CP MTE FTBL | Atenolan comp. mite - Filmtabletten | 1.2.40.0.34.4.17:1-19182 | GA - zugelassen | G.L. Pharma GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07CB03 | Atenolol und andere Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709446 | CHLORTALIDON | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000092578 | CHLORTALIDONE | 12.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927920001 | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 50 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256612 | CO-RENITEC TBL | Co - Renitec 20 mg/12,5 mg Tabletten | 1.2.40.0.34.4.17:1-19220 | GA - zugelassen | Organon Healthcare GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09BA02 | Enalapril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 12.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927978001 | 1.2.40.0.34.5.156:1708809 | ENALAPRIL MALEAT | 1.2.40.0.34.5.221:100000091343 | ENALAPRIL MALEATE | active | 20 | mg | 1.2.40.0.34.5.221:100000091343 | ENALAPRIL MALEATE | 20 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256718 | SOTACOR TBL 80MG | Sotacor 80 mg - Tabletten | 1.2.40.0.34.4.17:1-19064 | GA - aufgehoben | Bristol-Myers Squibb Ges.m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AA07 | Sotalol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708828 | SOTALOL HYDROCHLORID | 1.2.40.0.34.5.221:100000091374 | SOTALOL HYDROCHLORIDE | active | 80 | mg | 1.2.40.0.34.5.221:100000091374 | SOTALOL HYDROCHLORIDE | 80 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927917003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256776 | KLOST JAPAN MINZOEL | Japanisches Minzöl „Klosterfrau" | 1.2.40.0.34.4.17:737757 | GA - registriert | Divapharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A03 | Mittel bei funktionellen gastrointestinalen Störungen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | 1.2.40.0.34.5.156:1709658 | MENTHAE ARVENSIS AETHEROLEUM PARTIM MENTHOLUM DEPLETUM | 1.2.40.0.34.5.221:100000093427 | MINT OIL, PARTLY DEMENTHOLISED | active | 1000 | ml | 1.2.40.0.34.5.221:100000093427 | MINT OIL, PARTLY DEMENTHOLISED | 1000 | ml | 1.2.40.0.10.1.4.3.4.3.5:100000073854 | Flüssigkeit zur Herstellung eines Dampfs zur Inhalation | false | human | 1.2.40.0.34.4.26:958445001 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:R05 | Husten- und Erkältungspräparate | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073645 | Flüssigkeit zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.5:100000073717 | Flüssigkeit zur Anwendung auf der Haut | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:M02 | Topische Mittel gegen Gelenk- und Muskelschmerzen | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256948 | VITAWUND SLB | Vitawund 5,25 mg/g - Salbe | 1.2.40.0.34.4.17:1-19407 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D08AC02 | Chlorhexidin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708713 | CHLORHEXIDINDIGLUCONAT | 1.2.40.0.34.5.221:100000091036 | CHLORHEXIDINE GLUCONATE | active | 1050 | mg | 1.2.40.0.34.5.221:100000091036 | CHLORHEXIDINE GLUCONATE | 1050 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:929294002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1256954 | VITAWUND SLB | Vitawund 5,25 mg/g - Salbe | 1.2.40.0.34.4.17:1-19407 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D08AC02 | Chlorhexidin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708713 | CHLORHEXIDINDIGLUCONAT | 1.2.40.0.34.5.221:100000091036 | CHLORHEXIDINE GLUCONATE | active | 2625 | mg | 1.2.40.0.34.5.221:100000091036 | CHLORHEXIDINE GLUCONATE | 2625 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:929294001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257149 | PULMICORT TURBOH. 0,4/20MG | Pulmicort Turbohaler 0,4 mg - Dosier-Pulverinhalator | 1.2.40.0.34.4.17:1-19464 | GA - zugelassen | Astrazeneca Österreich GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073531 | Mehrdosenbehältnis mit gasfreiem Pumpsystem | 2.16.840.1.113883.6.73:R03BA02 | Budesonid | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1708795 | BUDESONID | 1.2.40.0.34.5.221:100000091309 | BUDESONIDE | active | 0.4 | mg | 1.2.40.0.34.5.221:100000091309 | BUDESONIDE | 0.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073839 | Pulver zur Inhalation | true | human | 1.2.40.0.34.4.26:929024001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257155 | TAVANIC FTBL 250MG | Tavanic 250 mg Filmtabletten | 1.2.40.0.34.4.17:1-22319 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01MA12 | Levofloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708158 | LEVOFLOXACIN | 1.2.40.0.34.5.221:100000089067 | LEVOFLOXACIN | active | 256.23 | mg | 1.2.40.0.34.5.221:100000089067 | LEVOFLOXACIN | 256.23 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:942381007 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257215 | HAEDENSA SUPP | Hädensa Zäpfchen | 1.2.40.0.34.4.17:10746 | GA - zugelassen | Merz Pharma Austria GmbH | true | false | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:C05AX03 | Andere Hämorrhoidenmittel, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1708824 | MENTHOL | 1.2.40.0.34.5.221:100000091364 | MENTHOL | active | | | 1.2.40.0.34.5.221:100000091364 | MENTHOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | false | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1709854 | 5-CHLORCARVACROL | 1.2.40.0.34.5.221:100000080071 | 5-CHLORCARVACROL | active | | | 1.2.40.0.34.5.221:100000080071 | 5-CHLORCARVACROL | | | 1.2.40.0.34.5.156:1709356 | ICHTHAMMOLUM | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOLUM | active | | | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOLUM | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257304 | CISORDINOL DEP AMP 500MG | Cisordinol Depot 500 mg - Ampullen | 1.2.40.0.34.4.17:1-19866 | GA - zugelassen | Lundbeck Austria GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05AF05 | Zuclopenthixol | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1707515 | ZUCLOPENTHIXOL DECANOAT | 1.2.40.0.34.5.221:100000085821 | ZUCLOPENTHIXOL DECANOATE | active | 500 | mg | 1.2.40.0.34.5.221:100000085821 | ZUCLOPENTHIXOL DECANOATE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:930189002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257327 | PREDNISOLON AGE TBL 5MG | Prednisolon "Agepha" 5 mg - Tabletten | 1.2.40.0.34.4.17:10596 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 5 | mg | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923954001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257333 | PREDNISOLON AGE TBL 5MG | Prednisolon "Agepha" 5 mg - Tabletten | 1.2.40.0.34.4.17:10596 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708887 | PREDNISOLON | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | active | 5 | mg | 1.2.40.0.34.5.221:100000091520 | PREDNISOLONE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923954004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257534 | TRICEF FTBL 200MG | Tricef 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19112 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01DD08 | Cefixim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709484 | CEFIXIM | 1.2.40.0.34.5.221:100000092632 | CEFIXIME | active | 223.84 | mg | 1.2.40.0.34.5.221:100000092632 | CEFIXIME | 223.84 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927949004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257592 | IMUKIN STAMP 0,5ML | IMUKIN 100 Mikrogramm/0,5 ml Injektionslösung | 1.2.40.0.34.4.17:1-19480 | GA - zugelassen | Clinigen Healthcare B.V. | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L03AB03 | Interferon-gamma | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1708289 | INTERFERON GAMMA | 1.2.40.0.34.5.221:100000089508 | INTERFERON GAMMA | active | 0.05 | mg | 1.2.40.0.34.5.221:100000089508 | INTERFERON GAMMA | 0.05 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:930010005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257681 | NEO CITRAN PLV ERW BTL | Neo Citran - Pulver für Erwachsene | 1.2.40.0.34.4.17:1-19371 | GA - zugelassen | Novartis Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:N02BE51 | Paracetamol, Kombinationen exkl. Psycholeptika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707562 | ASCORBINSÄURE | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | active | 50 | mg | 1.2.40.0.34.5.221:100000086036 | ASCORBIC ACID | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073364 | Pulver zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:928878001 | 1.2.40.0.34.5.156:1708484 | PHENYLEPHRINHYDROCHLORID | 1.2.40.0.34.5.221:100000090176 | PHENYLEPHRINE HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000090176 | PHENYLEPHRINE HYDROCHLORIDE | 10 | mg | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | 500 | mg | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | 500 | mg | | | | | | | 1.2.40.0.34.5.156:1708603 | PHENIRAMIN HYDROGENMALEAT | 1.2.40.0.34.5.221:100000090467 | PHENIRAMINE MALEATE | active | 20 | mg | 1.2.40.0.34.5.221:100000090467 | PHENIRAMINE MALEATE | 20 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257758 | TRIODENA DRG | Triodena - Dragees | 1.2.40.0.34.4.17:1-18522 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 21 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AB06 | Gestoden und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.1 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:927529001 | 1.2.40.0.34.5.156:1709341 | GESTODEN | 1.2.40.0.34.5.221:100000092348 | GESTODENE | active | 0.22 | mg | 1.2.40.0.34.5.221:100000092348 | GESTODENE | 0.22 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257764 | TRIODENA DRG 3X21 | Triodena - Dragees | 1.2.40.0.34.4.17:1-18522 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 63 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AB06 | Gestoden und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.1 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:927529002 | 1.2.40.0.34.5.156:1709341 | GESTODEN | 1.2.40.0.34.5.221:100000092348 | GESTODENE | active | 0.22 | mg | 1.2.40.0.34.5.221:100000092348 | GESTODENE | 0.22 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257770 | NEUROMULTIVIT FTBL | Neuromultivit - Filmtabletten | 1.2.40.0.34.4.17:1-19222 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A11DB | Vitamin-B1 in Kombination mit Vitamin-B6 und/oder Vitamin-B12 | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | 0.2 | mg | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | 0.2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927989002 | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 200 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 200 | mg | 1.2.40.0.34.5.156:1708752 | THIAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257787 | AMBROXOL GEN TBL 30MG | Ambroxol Genericon 30 mg Tabletten | 1.2.40.0.34.4.17:1-19330 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R05CB06 | Ambroxol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 30 | mg | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928822001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257818 | AMBROXOL GEN LSG | Ambroxol !+pharma 7,5 mg/ml Lösung | 1.2.40.0.34.4.17:1-19348 | GA - zugelassen | +pharma Arzneimittel gmbh | true | false | 40 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CB06 | Ambroxol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 0.298536 | g | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 0.298536 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:928816002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073835 | Lösung für einen Vernebler | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257824 | AMBROXOL GEN LSG | Ambroxol !+pharma 7,5 mg/ml Lösung | 1.2.40.0.34.4.17:1-19348 | GA - zugelassen | +pharma Arzneimittel gmbh | true | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CB06 | Ambroxol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 0.74634 | g | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 0.74634 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:928816001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073835 | Lösung für einen Vernebler | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257830 | AMBROXOL GEN SFT | Ambroxol Genericon Saft | 1.2.40.0.34.4.17:1-19349 | GA - aufgehoben | Genericon Pharma Ges.m.b.H. | false | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05CB06 | Ambroxol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708682 | AMBROXOL HYDROCHLORID | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | active | 0.26 | g | 1.2.40.0.34.5.221:100000090754 | AMBROXOL HYDROCHLORIDE | 0.26 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:928817001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257913 | SAIZEN PLV+LSM 1,33MG | Saizen 1,33 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | 1.2.40.0.34.4.17:1-18635 | GA - aufgehoben | Merck Ges.m.b.H. | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H01AC01 | Somatropin | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1708200 | SOMATROPIN | 1.2.40.0.34.5.221:100000089188 | SOMATROPIN | active | 1.33 | mg | 1.2.40.0.34.5.221:100000089188 | SOMATROPIN | 1.33 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073868 | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:927888002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1257965 | CAROTABEN KPS | Carotaben 25 mg - Kapseln | 1.2.40.0.34.4.17:1-19438 | GA - aufgehoben | Almirall Hermal GmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D02BB01 | Betacaroten | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709021 | BETA-CAROTIN | 1.2.40.0.34.5.221:100000091819 | BETACAROTENE | active | 25 | mg | 1.2.40.0.34.5.221:100000091819 | BETACAROTENE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:921012001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258054 | GLUCOBAY TBL 50MG | Glucobay 50 mg - Tabletten | 1.2.40.0.34.4.17:1-19232 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 120 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:A10BF01 | Acarbose | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709293 | ACARBOSE | 1.2.40.0.34.5.221:100000092276 | ACARBOSE | active | 50 | mg | 1.2.40.0.34.5.221:100000092276 | ACARBOSE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922211001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258060 | GLUCOBAY TBL 100MG | Glucobay 100 mg - Tabletten | 1.2.40.0.34.4.17:1-19233 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BF01 | Acarbose | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709293 | ACARBOSE | 1.2.40.0.34.5.221:100000092276 | ACARBOSE | active | 100 | mg | 1.2.40.0.34.5.221:100000092276 | ACARBOSE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922212002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258077 | GLUCOBAY TBL 100MG | Glucobay 100 mg - Tabletten | 1.2.40.0.34.4.17:1-19233 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 120 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BF01 | Acarbose | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709293 | ACARBOSE | 1.2.40.0.34.5.221:100000092276 | ACARBOSE | active | 100 | mg | 1.2.40.0.34.5.221:100000092276 | ACARBOSE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922212001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258083 | ANTIBIOPHILUS PLV | Antibiophilus - Pulver zum Einnehmen | 1.2.40.0.34.4.17:1-23449 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:A07FA01 | Milchsäurebildner | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710410 | LACTOBACILLUS CASEI | 1.2.40.0.34.5.221:900000000641 | LACTOBACILLUS CASEI | active | 225000000 | CFU | 1.2.40.0.34.5.221:900000000641 | LACTOBACILLUS CASEI | 225000000 | CFU | 1.2.40.0.10.1.4.3.4.3.5:100000073655 | Pulver zum Einnehmen | false | human | 1.2.40.0.34.4.26:929782001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258120 | INFLUVAC FSPR 0,5ML | Influvac - Injektionssuspension in einer Fertigspritze | 1.2.40.0.34.4.17:2-00216 | GA - aufgehoben | Viatris Austria GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:J07BB02 | Influenza, gereinigtes Antigen | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1708839 | INFLUENZAVIRUS (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:100000091392 | IMMUNOSERA FOR HUMAN USE, ANIMAL | active | | | 1.2.40.0.34.5.221:100000091392 | IMMUNOSERA FOR HUMAN USE, ANIMAL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:942663001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258137 | ATENOLAN FTBL 50MG | Atenolan 50 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18999 | GA - zugelassen | G.L. Pharma GmbH | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 50 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927928001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258143 | ATENOLAN FTBL 50MG | Atenolan 50 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18999 | GA - zugelassen | G.L. Pharma GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 50 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927928002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258166 | ATENOLAN FTBL 100MG | Atenolan 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19001 | GA - zugelassen | G.L. Pharma GmbH | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927927001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258172 | ATENOLAN FTBL 100MG | Atenolan 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19001 | GA - zugelassen | G.L. Pharma GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927927002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258189 | TENORMIN FTBL 25MG | Tenormin 25 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19636 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 25 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930286001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258195 | TENORMIN FTBL 25MG | Tenormin 25 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19636 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 25 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930286002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258278 | GILUDOP KONZ 10MG/ML 5ML | Giludop 10 mg/ml - Infusionskonzentrat | 1.2.40.0.34.4.17:15762 | GA - zugelassen | Pharmaselect International Beteiligungs GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C01CA04 | Dopamin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709122 | DOPAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092011 | DOPAMINE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000092011 | DOPAMINE HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:122312003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258350 | ELO-MEL BASIS+GL PLIFL 500ML | Elo-Mel basis mit Glucose - Infusionslösung | 1.2.40.0.34.4.17:1-19274 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB | Lösungen mit Wirkung auf den Elektrolythaushalt | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 932 | mg | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 932 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:928461002 | 1.2.40.0.34.5.156:1705986 | NATRIUMDIHYDROGENPHOSPHAT | 1.2.40.0.34.5.221:100000078524 | SODIUM DIHYDROGEN PHOSPHATE | active | 780 | mg | 1.2.40.0.34.5.221:100000078524 | SODIUM DIHYDROGEN PHOSPHATE | 780 | mg | 1.2.40.0.34.5.156:1705910 | GLUCOSE | 1.2.40.0.34.5.221:100000078171 | GLUCOSE | active | 27500 | mg | 1.2.40.0.34.5.221:100000078171 | GLUCOSE | 27500 | mg | | | | | | | 1.2.40.0.34.5.156:1708460 | MAGNESIUMCHLORID | 1.2.40.0.34.5.221:100000090109 | MAGNESIUM CHLORIDE | active | 254 | mg | 1.2.40.0.34.5.221:100000090109 | MAGNESIUM CHLORIDE | 254 | mg | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 1023 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 1023 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258373 | ELO-MEL ISOT PLIFL 500ML | Elo-Mel isoton - Infusionslösung | 1.2.40.0.34.4.17:1-19279 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707257 | NATRIUMACETAT | 1.2.40.0.34.5.221:100000085063 | SODIUM ACETATE | active | 3062 | mg | 1.2.40.0.34.5.221:100000085063 | SODIUM ACETATE | 3062 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:928469006 | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 186.5 | mg | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 186.5 | mg | 1.2.40.0.34.5.156:1709535 | CALCIUMCHLORID | 1.2.40.0.34.5.221:100000092755 | CALCIUM CHLORIDE | active | 184 | mg | 1.2.40.0.34.5.221:100000092755 | CALCIUM CHLORIDE | 184 | mg | | | | | | | 1.2.40.0.34.5.156:1708460 | MAGNESIUMCHLORID | 1.2.40.0.34.5.221:100000090109 | MAGNESIUM CHLORIDE | active | 152.5 | mg | 1.2.40.0.34.5.221:100000090109 | MAGNESIUM CHLORIDE | 152.5 | mg | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 2776 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 2776 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258456 | ELO-MEL SEMIT+GL PLIFL 500ML | Elo-Mel semiton mit Glucose - Infusionslösung | 1.2.40.0.34.4.17:1-19273 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB02 | Elektrolyte mit Kohlenhydraten | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 93 | mg | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 93 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:928464002 | 1.2.40.0.34.5.156:1709535 | CALCIUMCHLORID | 1.2.40.0.34.5.221:100000092755 | CALCIUM CHLORIDE | active | 92 | mg | 1.2.40.0.34.5.221:100000092755 | CALCIUM CHLORIDE | 92 | mg | 1.2.40.0.34.5.156:1705910 | GLUCOSE | 1.2.40.0.34.5.221:100000078171 | GLUCOSE | active | 27500 | mg | 1.2.40.0.34.5.221:100000078171 | GLUCOSE | 27500 | mg | | | | | | | 1.2.40.0.34.5.156:1708460 | MAGNESIUMCHLORID | 1.2.40.0.34.5.221:100000090109 | MAGNESIUM CHLORIDE | active | 76.5 | mg | 1.2.40.0.34.5.221:100000090109 | MAGNESIUM CHLORIDE | 76.5 | mg | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 2045.5 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 2045.5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258516 | L-CARNITIN FRE AMP 1G 5ML | L-Carnitin "Fresenius" 1 g - Ampullen | 1.2.40.0.34.4.17:1-19352 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A16AA01 | Levocarnitin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708540 | LEVOCARNITIN | 1.2.40.0.34.5.221:100000090324 | LEVOCARNITINE | active | 1 | g | 1.2.40.0.34.5.221:100000090324 | LEVOCARNITINE | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:927769001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258551 | MEXALEN SUPP 1000MG | Mexaratio 1000 mg - Zäpfchen | 1.2.40.0.34.4.17:1-19325 | GA - zugelassen | Teva B.V. | true | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:N02BE01 | Paracetamol | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | | | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258605 | NEUPOGEN STAMP 30MIO E/1ML | Neupogen 30 Mio E./1 ml - parenterale Lösung | 1.2.40.0.34.4.17:1-19412 | GA - aufgehoben | Amgen Europe B.V. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L03AA02 | Filgrastim | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1707399 | FILGRASTIM | 1.2.40.0.34.5.221:100000085436 | FILGRASTIM | active | 0.3 | mg | 1.2.40.0.34.5.221:100000085436 | FILGRASTIM | 0.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:929961002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258717 | COMBACTAM TRSTAMP 1G | Combactam 1 g - Trockenstechampullen | 1.2.40.0.34.4.17:1-19449 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01CG01 | Sulbactam | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708438 | SULBACTAM NATRIUM | 1.2.40.0.34.5.221:100000090027 | SULBACTAM SODIUM | active | 1.094 | g | 1.2.40.0.34.5.221:100000090027 | SULBACTAM SODIUM | 1.094 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:929326001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258723 | GUTTALAX TR | Guttalax - Tropfen | 1.2.40.0.34.4.17:17160 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A06AB08 | Natriumpicosulfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707244 | NATRIUM PICOSULFAT | 1.2.40.0.34.5.221:100000085034 | SODIUM PICOSULFATE | active | 112.5 | mg | 1.2.40.0.34.5.221:100000085034 | SODIUM PICOSULFATE | 112.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:124162002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258769 | ZAVEDOS TRSTAMP 5MG | Zavedos 5 mg Trockenstechampulle | 1.2.40.0.34.4.17:1-19483 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01DB06 | Idarubicin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708621 | IDARUBICIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090504 | IDARUBICIN HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000090504 | IDARUBICIN HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:928858001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258775 | ZAVEDOS TRSTAMP 10MG | Zavedos 10 mg Trockenstechampulle | 1.2.40.0.34.4.17:1-19481 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01DB06 | Idarubicin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708621 | IDARUBICIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090504 | IDARUBICIN HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000090504 | IDARUBICIN HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:928856001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258806 | OVESTIN CR | Ovestin - Creme | 1.2.40.0.34.4.17:17453 | GA - zugelassen | Aspen Pharma Trading Limited | true | false | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:G03CA04 | Estriol | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1709511 | ESTRIOL | 1.2.40.0.34.5.221:100000092668 | ESTRIOL | active | 30 | mg | 1.2.40.0.34.5.221:100000092668 | ESTRIOL | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073811 | Vaginalcreme | true | human | 1.2.40.0.34.4.26:129754001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258901 | NUROFEN DRG 200MG | Nurofen 200 mg - Dragees | 1.2.40.0.34.4.17:14712 | GA - zugelassen | Reckitt Benckiser Deutschland GmbH | true | true | 24 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 200 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:128752002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258982 | NORVASC TBL 5MG | Norvasc 5 mg Tabletten | 1.2.40.0.34.4.17:1-19247 | GA - zugelassen | Upjohn EESV | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08CA01 | Amlodipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708450 | AMLODIPIN BESILAT | 1.2.40.0.34.5.221:100000090079 | AMLODIPINE BESILATE | active | 6.944 | mg | 1.2.40.0.34.5.221:100000090079 | AMLODIPINE BESILATE | 6.944 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928497005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1258999 | PULMICORT TURBOH. 0,2/20MG | Pulmicort Turbohaler 0,2 mg - Dosier-Pulverinhalator | 1.2.40.0.34.4.17:1-19463 | GA - zugelassen | Astrazeneca Österreich GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073531 | Mehrdosenbehältnis mit gasfreiem Pumpsystem | 2.16.840.1.113883.6.73:R03BA02 | Budesonid | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1708795 | BUDESONID | 1.2.40.0.34.5.221:100000091309 | BUDESONIDE | active | 0.2 | mg | 1.2.40.0.34.5.221:100000091309 | BUDESONIDE | 0.2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073839 | Pulver zur Inhalation | true | human | 1.2.40.0.34.4.26:929023001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1259042 | SPIRONO GEN COMP TBL | Spirono Genericon comp. Tabletten | 1.2.40.0.34.4.17:1-19457 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03EB01 | Furosemid und Kalium sparende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928959001 | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 50 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1259059 | SPIRONO GEN COMP TBL | Spirono Genericon comp. Tabletten | 1.2.40.0.34.4.17:1-19457 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03EB01 | Furosemid und Kalium sparende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928959002 | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 50 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1259065 | SPIRONO GEN COMP FTE TBL | Spirono Genericon comp. forte Tabletten | 1.2.40.0.34.4.17:1-19458 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03EB01 | Furosemid und Kalium sparende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928958002 | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 100 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1259071 | SPIRONO GEN CP TBL FTE | Spirono Genericon comp. forte Tabletten | 1.2.40.0.34.4.17:1-19458 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03EB01 | Furosemid und Kalium sparende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928958001 | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 100 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 100 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1259935 | ILOMEDIN IKONZ 50MCG/0,5ML | Ilomedin 50 µg/0,5 ml - Infusionslösungskonzentrat | 1.2.40.0.34.4.17:1-19454 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B01AC11 | Iloprost | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707414 | ILOPROST | 1.2.40.0.34.5.221:100000085458 | ILOPROST | active | 0.025 | mg | 1.2.40.0.34.5.221:100000085458 | ILOPROST | 0.025 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:928438001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1260051 | INHIBACE FTBL 0,5MG | Inhibace 0,5 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19537 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA08 | Cilazapril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708956 | CILAZAPRIL | 1.2.40.0.34.5.221:100000091670 | CILAZAPRIL | active | 0.522 | mg | 1.2.40.0.34.5.221:100000091670 | CILAZAPRIL | 0.522 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928941006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1260068 | INHIBACE FTBL 2,5MG | Inhibace 2,5 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19531 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA08 | Cilazapril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708956 | CILAZAPRIL | 1.2.40.0.34.5.221:100000091670 | CILAZAPRIL | active | 2.61 | mg | 1.2.40.0.34.5.221:100000091670 | CILAZAPRIL | 2.61 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928942004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1260074 | INHIBACE FTBL 5MG | Inhibace 5 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19535 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09BA08 | Cilazapril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708956 | CILAZAPRIL | 1.2.40.0.34.5.221:100000091670 | CILAZAPRIL | active | 5.22 | mg | 1.2.40.0.34.5.221:100000091670 | CILAZAPRIL | 5.22 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928943004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1260111 | TAVANIC FTBL 500MG | Tavanic 500 mg Filmtabletten | 1.2.40.0.34.4.17:1-22320 | GA - zugelassen | Sanofi-Aventis GmbH | true | false | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01MA12 | Levofloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708158 | LEVOFLOXACIN | 1.2.40.0.34.5.221:100000089067 | LEVOFLOXACIN | active | 512.46 | mg | 1.2.40.0.34.5.221:100000089067 | LEVOFLOXACIN | 512.46 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:942383008 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1260140 | AKNEROXID GEL 5% | Akneroxid 5 % - Gel | 1.2.40.0.34.4.17:1-19508 | GA - aufgehoben | Almirall Hermal GmbH | false | false | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D10AE01 | Benzoylperoxid | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707256 | BENZOYLPEROXID | 1.2.40.0.34.5.221:100000085061 | BENZOYL PEROXIDE | active | 5 | g | 1.2.40.0.34.5.221:100000085061 | BENZOYL PEROXIDE | 5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:922344001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1260157 | AKNEROXID GEL 5% | Akneroxid 5 % - Gel | 1.2.40.0.34.4.17:1-19508 | GA - aufgehoben | Almirall Hermal GmbH | false | false | 50 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D10AE01 | Benzoylperoxid | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707256 | BENZOYLPEROXID | 1.2.40.0.34.5.221:100000085061 | BENZOYL PEROXIDE | active | 5 | g | 1.2.40.0.34.5.221:100000085061 | BENZOYL PEROXIDE | 5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:922344002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1260252 | THERMO-RHEUMON CR | Thermo - Rheumon - Creme | 1.2.40.0.34.4.17:1-19372 | GA - aufgehoben | Viatris Austria GmbH | false | false | 35 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA06 | Etofenamat | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709378 | BENZYLNICOTINAT | 1.2.40.0.34.5.221:100000092407 | BENZYL NICOTINATE | active | 1 | g | 1.2.40.0.34.5.221:100000092407 | BENZYL NICOTINATE | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:929086002 | 1.2.40.0.34.5.156:1709468 | ETOFENAMAT | 1.2.40.0.34.5.221:100000092609 | ETOFENAMATE | active | 5 | g | 1.2.40.0.34.5.221:100000092609 | ETOFENAMATE | 5 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1260335 | SABRIL FTBL 500MG | Sabril 500 mg Filmtabletten | 1.2.40.0.34.4.17:1-19486 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AG04 | Vigabatrin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706121 | VIGABATRIN | 1.2.40.0.34.5.221:100000079084 | VIGABATRIN | active | 500 | mg | 1.2.40.0.34.5.221:100000079084 | VIGABATRIN | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929032001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1260341 | ISOMONAT RET TBL 40MG | Isomonat retard 40 mg - Retardtabletten | 1.2.40.0.34.4.17:1-19479 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01DA14 | Isosorbidmononitrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708568 | ISOSORBIDMONONITRAT | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | active | 40 | mg | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:928367001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1260536 | FORTECORTIN TBL 4MG | Fortecortin 4 mg - Tabletten | 1.2.40.0.34.4.17:1-19393 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB02 | Dexamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709464 | DEXAMETHASON | 1.2.40.0.34.5.221:100000092605 | DEXAMETHASONE | active | 4 | mg | 1.2.40.0.34.5.221:100000092605 | DEXAMETHASONE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928846001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1260542 | FORTECORTIN TBL 4MG | Fortecortin 4 mg - Tabletten | 1.2.40.0.34.4.17:1-19393 | GA - zugelassen | Merck Ges.m.b.H. | true | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H02AB02 | Dexamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709464 | DEXAMETHASON | 1.2.40.0.34.5.221:100000092605 | DEXAMETHASONE | active | 4 | mg | 1.2.40.0.34.5.221:100000092605 | DEXAMETHASONE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928846002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1260571 | POLIO SALK MER FSPR 0,5ML | Polio Salk "Merieux" - Fertigspritze | 1.2.40.0.34.4.17:2-00068 | GA - zugelassen | Sanofi Winthrop Industrie | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:J07BF03 | Poliomyelitis, trivalent, inaktiviert, ganzes Virus | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1709005 | POLIOMYELITISVIRUS | 1.2.40.0.34.5.221:100000091781 | POLIOMYELITIS VACCINE | active | | | 1.2.40.0.34.5.221:100000091781 | POLIOMYELITIS VACCINE | | | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:929410001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1262311 | LARIAM TBL 250MG | Lariam 250 mg Tabletten | 1.2.40.0.34.4.17:1-18216 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:P01BC02 | Mefloquin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705498 | MEFLOQUIN HYDROCHLORID | 1.2.40.0.34.5.221:100000076533 | MEFLOQUINE HYDROCHLORIDE | active | 274.12 | mg | 1.2.40.0.34.5.221:100000076533 | MEFLOQUINE HYDROCHLORIDE | 274.12 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927312001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1262771 | BRONCHOSTOP HALS/MUNDSPRAY | Bronchostop Hals & Mundspray | 1.2.40.0.34.4.17:7-00175 | GA - aufgehoben | Kwizda Pharma GmbH | false | false | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A01AB | Antiinfektiva und Antiseptika zur oralen Lokalbehandlung | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | | | 1.2.40.0.34.5.156:1710828 | THYMI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001063 | THYMI HERBA (EXTRACT) | active | 0.32 | g | 1.2.40.0.34.5.221:900000001063 | THYMI HERBA (EXTRACT) | 0.32 | g | 1.2.40.0.10.1.4.3.4.3.5:900000000037 | nicht definiert | false | human | 1.2.40.0.34.4.26:930929002 | 1.2.40.0.34.5.156:1712652 | SALVIAE OFFICINALIS FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000004230 | SALVIAE OFFICINALIS FOLIUM (EXTRACT) | active | 0.32 | g | 1.2.40.0.34.5.221:900000004230 | SALVIAE OFFICINALIS FOLIUM (EXTRACT) | 0.32 | g | 1.2.40.0.34.5.156:1710490 | MENTHAE PIPERITAE FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000723 | MENTHAE PIPERITAE FOLIUM (EXTRACT) | active | 0.32 | g | 1.2.40.0.34.5.221:900000000723 | MENTHAE PIPERITAE FOLIUM (EXTRACT) | 0.32 | g | 2.16.840.1.113883.6.73:R02AA | Antiseptika | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1262966 | TOLVON FTBL 60MG | Tolvon 60 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19586 | GA - aufgehoben | Merck Sharp & Dohme Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AX03 | Mianserin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708463 | MIANSERIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090114 | MIANSERIN HYDROCHLORIDE | active | 60 | mg | 1.2.40.0.34.5.221:100000090114 | MIANSERIN HYDROCHLORIDE | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929090001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1262995 | NASIVIN SPRAY 0,05% | WICK Nasivin Classic 0,05 % - Spray | 1.2.40.0.34.4.17:12194 | GA - zugelassen | P&G Health Germany GmbH | true | false | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AA05 | Oxymetazolin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1708514 | OXYMETAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090269 | OXYMETAZOLINE HYDROCHLORIDE | active | 7.5 | mg | 1.2.40.0.34.5.221:100000090269 | OXYMETAZOLINE HYDROCHLORIDE | 7.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073796 | Nasenspray, Lösung | true | human | 1.2.40.0.34.4.26:123030002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263078 | SIRDALUD-MR KPS 6MG | Sirdalud MR 6 mg - Kapseln | 1.2.40.0.34.4.17:1-19584 | GA - zugelassen | Sandoz GmbH | true | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M03BX02 | Tizanidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709012 | TIZANIDIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091800 | TIZANIDINE HYDROCHLORIDE | active | 6.864 | mg | 1.2.40.0.34.5.221:100000091800 | TIZANIDINE HYDROCHLORIDE | 6.864 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073663 | Hartkapsel mit veränderter Wirkstofffreisetzung | true | human | 1.2.40.0.34.4.26:929181001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263090 | DILATREND TBL 25MG | Dilatrend 25 mg - Tabletten | 1.2.40.0.34.4.17:1-19553 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 56 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AG02 | Carvedilol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709445 | CARVEDILOL | 1.2.40.0.34.5.221:100000092577 | CARVEDILOL | active | 25 | mg | 1.2.40.0.34.5.221:100000092577 | CARVEDILOL | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928917002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263150 | CIMETIDIN GEN FTBL 800MG | Cimetidin Genericon 800 mg Filmtabletten | 1.2.40.0.34.4.17:1-19497 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA01 | Cimetidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709561 | CIMETIDIN | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | active | 800 | mg | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | 800 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929004001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263167 | CIMETIDIN GEN FTBL 800MG | Cimetidin Genericon 800 mg Filmtabletten | 1.2.40.0.34.4.17:1-19497 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA01 | Cimetidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709561 | CIMETIDIN | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | active | 800 | mg | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | 800 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929004002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263204 | IBUPROFEN GEN FTBL 400MG | Ibuprofen Genericon 400 mg Filmtabletten | 1.2.40.0.34.4.17:1-19430 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 400 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929072004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263210 | IBUPROFEN GEN FTBL 400MG | Ibuprofen Genericon 400 mg Filmtabletten | 1.2.40.0.34.4.17:1-19430 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 400 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929072005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263227 | IBUPROFEN GEN FTBL FTE 600MG | Ibuprofen Genericon 600 mg forte Filmtabletten | 1.2.40.0.34.4.17:1-19429 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 600 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929077004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263233 | IBUPROFEN GEN FTBL FTE 600MG | Ibuprofen Genericon 600 mg forte Filmtabletten | 1.2.40.0.34.4.17:1-19429 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 600 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929077005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263457 | DICLOBENE SUPP 50MG | Diclobene 50 mg - Zäpfchen | 1.2.40.0.34.4.17:1-19499 | GA - aufgehoben | Teva B.V. | false | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:929121001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263463 | DICLOBENE SUPP 100MG | Diclobene 100 mg - Zäpfchen | 1.2.40.0.34.4.17:1-19500 | GA - aufgehoben | Teva B.V. | false | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:929116001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263486 | DICLOBENE RET KPS 100MG | Diclobene retard 100 mg - Kapseln | 1.2.40.0.34.4.17:1-19567 | GA - zugelassen | Teva B.V. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:929120002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263492 | DICLOBENE RET KPS 100MG | Diclobene retard 100 mg - Kapseln | 1.2.40.0.34.4.17:1-19567 | GA - zugelassen | Teva B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:929120001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263500 | DICLOBENE GEL | Diclobene - Gel | 1.2.40.0.34.4.17:1-19551 | GA - zugelassen | Teva B.V. | true | true | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA15 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 0.4 | g | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 0.4 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:929280002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263517 | DICLOBENE GEL | Diclobene - Gel | 1.2.40.0.34.4.17:1-19551 | GA - zugelassen | Teva B.V. | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA15 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 1 | g | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:929280001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263523 | ACECOMB-MTE TBL | Acecomb mite - Tabletten | 1.2.40.0.34.4.17:1-19511 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09BA03 | Lisinopril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709062 | LISINOPRIL | 1.2.40.0.34.5.221:100000091915 | LISINOPRIL | active | 21.8 | mg | 1.2.40.0.34.5.221:100000091915 | LISINOPRIL | 21.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928538001 | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 12.5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263546 | NIFTEN KPS MTE | Niften mite - Kapseln | 1.2.40.0.34.4.17:1-20491 | GA - aufgehoben | Astrazeneca Österreich GmbH | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C07FB03 | Atenolol und andere Antihypertonika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708560 | NIFEDIPIN | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | active | 10 | mg | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:933438001 | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 25 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 25 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263581 | LECICARBON SUPP | Lecicarbon - Zäpfchen | 1.2.40.0.34.4.17:3437 | GA - zugelassen | C. Brady GmbH & Co. KG | true | true | 120 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:A06AX02 | Kohlendioxid-freisetzende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1708363 | KALIUMHYDROGENTARTRAT | 1.2.40.0.34.5.221:100000089671 | POTASSIUM HYDROGEN TARTRATE | active | 0.9 | g | 1.2.40.0.34.5.221:100000089671 | POTASSIUM HYDROGEN TARTRATE | 0.9 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | false | human | 1.2.40.0.34.4.26:128754002 | 1.2.40.0.34.5.156:1706182 | NATRIUMHYDROGENCARBONAT | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | active | 0.54 | g | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | 0.54 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263948 | ADVANTAN CR | Advantan 0,1 % - Creme | 1.2.40.0.34.4.17:1-19575 | GA - zugelassen | LEO PHARMA A/S | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC14 | Methylprednisolonaceponat | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709200 | METHYLPREDNISOLON ACEPONAT | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | active | 0.015 | g | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | 0.015 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:929404002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263954 | ADVANTAN CR | Advantan 0,1 % - Creme | 1.2.40.0.34.4.17:1-19575 | GA - zugelassen | LEO PHARMA A/S | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC14 | Methylprednisolonaceponat | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709200 | METHYLPREDNISOLON ACEPONAT | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | active | 0.03 | g | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | 0.03 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:929404003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263960 | ADVANTAN FSLB | Advantan 0,1 % - Fettsalbe | 1.2.40.0.34.4.17:1-19574 | GA - zugelassen | LEO PHARMA A/S | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC14 | Methylprednisolonaceponat | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709200 | METHYLPREDNISOLON ACEPONAT | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | active | 0.015 | g | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | 0.015 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:929405002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263977 | ADVANTAN FSLB | Advantan 0,1 % - Fettsalbe | 1.2.40.0.34.4.17:1-19574 | GA - zugelassen | LEO PHARMA A/S | true | false | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC14 | Methylprednisolonaceponat | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709200 | METHYLPREDNISOLON ACEPONAT | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | active | 0.03 | g | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | 0.03 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:929405003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1263983 | ADVANTAN SLB | Advantan 0,1 % - Salbe | 1.2.40.0.34.4.17:1-19576 | GA - zugelassen | LEO PHARMA A/S | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC14 | Methylprednisolonaceponat | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709200 | METHYLPREDNISOLON ACEPONAT | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | active | 0.015 | g | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | 0.015 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:929406002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1264008 | ADVANTAN SLB | Advantan 0,1 % - Salbe | 1.2.40.0.34.4.17:1-19576 | GA - zugelassen | LEO PHARMA A/S | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC14 | Methylprednisolonaceponat | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709200 | METHYLPREDNISOLON ACEPONAT | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | active | 0.03 | g | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | 0.03 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:929406003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1264014 | CLIMEN DRG | Climen - Dragees | 1.2.40.0.34.4.17:1-19753 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 21 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03HB01 | Cyproteron und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708616 | ESTRADIOL VALERAT | 1.2.40.0.34.5.221:100000090493 | ESTRADIOL VALERATE | active | 4 | mg | 1.2.40.0.34.5.221:100000090493 | ESTRADIOL VALERATE | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:930084001 | 1.2.40.0.34.5.156:1708539 | CYPROTERON ACETAT | 1.2.40.0.34.5.221:100000090321 | CYPROTERONE ACETATE | active | 1 | mg | 1.2.40.0.34.5.221:100000090321 | CYPROTERONE ACETATE | 1 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1264669 | PURSENNID DRG 12MG | Pursennid 12 mg - Dragees | 1.2.40.0.34.4.17:6989 | GA - aufgehoben | Haleon - Gebro Consumer Health GmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:A06AB06 | Sennoside | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705950 | CALCIUMSALZE DER SENNOSIDE A+B | 1.2.40.0.34.5.221:100000078410 | SENNOSIDE A+B CALCIUM | active | 20 | mg | 1.2.40.0.34.5.221:100000078410 | SENNOSIDE A+B CALCIUM | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:125891001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265025 | VERTIROSAN AMP 150MG 1ML | Vertirosan 150 mg - Ampullen | 1.2.40.0.34.4.17:9581 | GA - zugelassen | UMIP Limited | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:R06AA02 | Diphenhydramin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709065 | DIMENHYDRINAT | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | active | 150 | mg | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:128906001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265031 | PROLEUKIN TRSUB Z IBER | Proleukin 18 x 10 6 IE - Pulver zur Herstellung einer Injektions- oder Infusionslösung | 1.2.40.0.34.4.17:1-22475 | GA - zugelassen | Iovance Biotherapeutics B.V. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L03AC01 | Aldesleukin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1709124 | ALDESLEUKIN | 1.2.40.0.34.5.221:100000092013 | ALDESLEUKIN | active | 90000000 | IU | 1.2.40.0.34.5.221:100000092013 | ALDESLEUKIN | 90000000 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:942056001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265060 | JODTHYROX TBL | Jodthyrox - Tabletten | 1.2.40.0.34.4.17:1-19423 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA | Schilddrüsenhormone | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.1 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928925002 | 1.2.40.0.34.5.156:1708800 | KALIUMIODID | 1.2.40.0.34.5.221:100000091320 | POTASSIUM IODIDE | active | 0.131 | mg | 1.2.40.0.34.5.221:100000091320 | POTASSIUM IODIDE | 0.131 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265077 | JODTHYROX TBL | Jodthyrox - Tabletten | 1.2.40.0.34.4.17:1-19423 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA | Schilddrüsenhormone | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.1 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928925001 | 1.2.40.0.34.5.156:1708800 | KALIUMIODID | 1.2.40.0.34.5.221:100000091320 | POTASSIUM IODIDE | active | 0.131 | mg | 1.2.40.0.34.5.221:100000091320 | POTASSIUM IODIDE | 0.131 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265143 | BALNEUM-HERMAL-PLUS POLI. | Balneum Hermal Plus Polidocanol - Badezusatz | 1.2.40.0.34.4.17:1-19739 | GA - zugelassen | Almirall Hermal GmbH | true | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D11AX | Andere Dermatika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073568 | Badebehandlung | | | 1.2.40.0.34.5.156:1707369 | POLIDOCANOL | 1.2.40.0.34.5.221:100000085336 | POLIDOCANOL | active | 1500 | g | 1.2.40.0.34.5.221:100000085336 | POLIDOCANOL | 1500 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073711 | Badezusatz | false | human | 1.2.40.0.34.4.26:928957001 | 1.2.40.0.34.5.156:1705802 | SOJAÖL | 1.2.40.0.34.5.221:100000077798 | SOYA OIL | active | 8295 | g | 1.2.40.0.34.5.221:100000077798 | SOYA OIL | 8295 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265166 | BALNEUM-HERMAL-PLUS POLI. | Balneum Hermal Plus Polidocanol - Badezusatz | 1.2.40.0.34.4.17:1-19739 | GA - zugelassen | Almirall Hermal GmbH | true | false | 200 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D11AX | Andere Dermatika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073568 | Badebehandlung | | | 1.2.40.0.34.5.156:1705802 | SOJAÖL | 1.2.40.0.34.5.221:100000077798 | SOYA OIL | active | 16590 | g | 1.2.40.0.34.5.221:100000077798 | SOYA OIL | 16590 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073711 | Badezusatz | false | human | 1.2.40.0.34.4.26:928957004 | 1.2.40.0.34.5.156:1707369 | POLIDOCANOL | 1.2.40.0.34.5.221:100000085336 | POLIDOCANOL | active | 3000 | g | 1.2.40.0.34.5.221:100000085336 | POLIDOCANOL | 3000 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265255 | TROMMCARDIN IFL 250ML | Trommcardin Infusionsflasche | 1.2.40.0.34.4.17:16187 | GA - aufgehoben | Jacoby GM Pharma GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A12CC05 | Magnesiumaspartat | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705588 | MAGNESIUM HYDROGENASPARTAT | 1.2.40.0.34.5.221:100000076822 | MAGNESIUM HYDROGEN ASPARTATE | active | 10 | mg | 1.2.40.0.34.5.221:100000076822 | MAGNESIUM HYDROGEN ASPARTATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:125329001 | 1.2.40.0.34.5.156:1706196 | KALIUM HYDROGENASPARTAT | 1.2.40.0.34.5.221:100000079418 | POTASSIUM HYDROGEN ASPARTATE | active | 10 | mg | 1.2.40.0.34.5.221:100000079418 | POTASSIUM HYDROGEN ASPARTATE | 10 | mg | | | | | | | | | | | | 2.16.840.1.113883.6.73:A12BA | Kalium | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265261 | TROMMCARDIN-K 120 IFL | Trommcardin K 120 - Infusionsflasche | 1.2.40.0.34.4.17:16188 | GA - zugelassen | Jacoby GM Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A12CC05 | Magnesiumaspartat | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705588 | MAGNESIUM HYDROGENASPARTAT | 1.2.40.0.34.5.221:100000076822 | MAGNESIUM HYDROGEN ASPARTATE | active | 2.7 | g | 1.2.40.0.34.5.221:100000076822 | MAGNESIUM HYDROGEN ASPARTATE | 2.7 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:125328001 | 1.2.40.0.34.5.156:1706196 | KALIUM HYDROGENASPARTAT | 1.2.40.0.34.5.221:100000079418 | POTASSIUM HYDROGEN ASPARTATE | active | 5.405 | g | 1.2.40.0.34.5.221:100000079418 | POTASSIUM HYDROGEN ASPARTATE | 5.405 | g | | | | | | | | | | | | 2.16.840.1.113883.6.73:A12BA | Kalium | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265315 | DILATREND TBL 25MG | Dilatrend 25 mg - Tabletten | 1.2.40.0.34.4.17:1-19553 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AG02 | Carvedilol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709445 | CARVEDILOL | 1.2.40.0.34.5.221:100000092577 | CARVEDILOL | active | 25 | mg | 1.2.40.0.34.5.221:100000092577 | CARVEDILOL | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928917001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265344 | L-CARNITIN FRE OR LSG 10ML | L-Carnitin "Fresenius" - orale Lösung | 1.2.40.0.34.4.17:1-19350 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A16AA01 | Levocarnitin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708540 | LEVOCARNITIN | 1.2.40.0.34.5.221:100000090324 | LEVOCARNITINE | active | 1 | g | 1.2.40.0.34.5.221:100000090324 | LEVOCARNITINE | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:927739001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265433 | TARGOCID TRSTAMP 100MG | Targocid 100 mg - Trockenstechampullen mit Lösungsmittel | 1.2.40.0.34.4.17:1-19651 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01XA02 | Teicoplanin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1707381 | TEICOPLANIN | 1.2.40.0.34.5.221:100000085403 | TEICOPLANIN | active | 100 | mg | 1.2.40.0.34.5.221:100000085403 | TEICOPLANIN | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:929236002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073366 | Pulver und Lösungsmittel zur Herstellung einer Lösung zum Einnehmen | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265456 | TARGOCID TRSTAMP+LSM 200MG | Targocid 200 mg - Trockenstechampullen mit Lösungsmittel | 1.2.40.0.34.4.17:1-19652 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01XA02 | Teicoplanin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1707381 | TEICOPLANIN | 1.2.40.0.34.5.221:100000085403 | TEICOPLANIN | active | 200 | mg | 1.2.40.0.34.5.221:100000085403 | TEICOPLANIN | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:929237002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073366 | Pulver und Lösungsmittel zur Herstellung einer Lösung zum Einnehmen | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265462 | TARGOCID TRSTAMP+LSM 400MG | Targocid 400 mg - Trockenstechampullen mit Lösungsmittel | 1.2.40.0.34.4.17:1-19653 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01XA02 | Teicoplanin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1707381 | TEICOPLANIN | 1.2.40.0.34.5.221:100000085403 | TEICOPLANIN | active | 400 | mg | 1.2.40.0.34.5.221:100000085403 | TEICOPLANIN | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:929238002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073366 | Pulver und Lösungsmittel zur Herstellung einer Lösung zum Einnehmen | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265485 | ULCUSAN FTBL 20MG | Ulcusan 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19673 | GA - zugelassen | Kwizda Pharma GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA03 | Famotidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709350 | FAMOTIDIN | 1.2.40.0.34.5.221:100000092363 | FAMOTIDINE | active | 20 | mg | 1.2.40.0.34.5.221:100000092363 | FAMOTIDINE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928513001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265491 | ULCUSAN FTBL 20MG | Ulcusan 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19673 | GA - zugelassen | Kwizda Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA03 | Famotidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709350 | FAMOTIDIN | 1.2.40.0.34.5.221:100000092363 | FAMOTIDINE | active | 20 | mg | 1.2.40.0.34.5.221:100000092363 | FAMOTIDINE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928513002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265516 | ULCUSAN FTBL 40MG | Ulcusan 40 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19672 | GA - zugelassen | Kwizda Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA03 | Famotidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709350 | FAMOTIDIN | 1.2.40.0.34.5.221:100000092363 | FAMOTIDINE | active | 40 | mg | 1.2.40.0.34.5.221:100000092363 | FAMOTIDINE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928484001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265522 | ULCUSAN FTBL 40MG | Ulcusan 40 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19672 | GA - zugelassen | Kwizda Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA03 | Famotidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709350 | FAMOTIDIN | 1.2.40.0.34.5.221:100000092363 | FAMOTIDINE | active | 40 | mg | 1.2.40.0.34.5.221:100000092363 | FAMOTIDINE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928484002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265597 | INFLUVAC FSPR 0,5ML O.KANUEL | Influvac - Injektionssuspension in einer Fertigspritze | 1.2.40.0.34.4.17:2-00216 | GA - aufgehoben | Viatris Austria GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:J07BB02 | Influenza, gereinigtes Antigen | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1708839 | INFLUENZAVIRUS (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:100000091392 | IMMUNOSERA FOR HUMAN USE, ANIMAL | active | | | 1.2.40.0.34.5.221:100000091392 | IMMUNOSERA FOR HUMAN USE, ANIMAL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:942663003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265605 | PRODAFEM TBL 5MG | Prodafem 5 mg - Tabletten | 1.2.40.0.34.4.17:1-19462 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03DA02 | Medroxyprogesteron | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708932 | MEDROXYPROGESTERON ACETAT | 1.2.40.0.34.5.221:100000091612 | MEDROXYPROGESTERONE ACETATE | active | 5 | mg | 1.2.40.0.34.5.221:100000091612 | MEDROXYPROGESTERONE ACETATE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921653001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265611 | PRODAFEM TBL 10MG | Prodafem 10 mg - Tabletten | 1.2.40.0.34.4.17:1-19465 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03DA02 | Medroxyprogesteron | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708932 | MEDROXYPROGESTERON ACETAT | 1.2.40.0.34.5.221:100000091612 | MEDROXYPROGESTERONE ACETATE | active | 10 | mg | 1.2.40.0.34.5.221:100000091612 | MEDROXYPROGESTERONE ACETATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:923660001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265628 | SYSCOR FTBL 5MG | Syscor 5 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18701 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C08CA07 | Nisoldipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709402 | NISOLDIPIN | 1.2.40.0.34.5.221:100000092490 | NISOLDIPINE | active | 5 | mg | 1.2.40.0.34.5.221:100000092490 | NISOLDIPINE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927464001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265634 | SYSCOR FTBL 10MG | Syscor 10 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18700 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08CA07 | Nisoldipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709402 | NISOLDIPIN | 1.2.40.0.34.5.221:100000092490 | NISOLDIPINE | active | 10 | mg | 1.2.40.0.34.5.221:100000092490 | NISOLDIPINE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927465001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265640 | VERTIROSAN AMP 50MG 1ML | Vertirosan 50 mg - Ampullen | 1.2.40.0.34.4.17:9580 | GA - zugelassen | UMIP Limited | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:R06AA02 | Diphenhydramin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709065 | DIMENHYDRINAT | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | active | 50 | mg | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:128078001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265663 | DEDOLOR KPS DRS 100MG | Dedolor DRS 100 mg - Kapseln | 1.2.40.0.34.4.17:1-19764 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073663 | Hartkapsel mit veränderter Wirkstofffreisetzung | true | human | 1.2.40.0.34.4.26:930325001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265686 | DEDOLOR KPS DRS 100MG | Dedolor DRS 100 mg - Kapseln | 1.2.40.0.34.4.17:1-19764 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 100 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073663 | Hartkapsel mit veränderter Wirkstofffreisetzung | true | human | 1.2.40.0.34.4.26:930325002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265717 | ELOCON CR | Elocon - Creme | 1.2.40.0.34.4.17:1-19791 | GA - zugelassen | Organon Healthcare GmbH | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC13 | Mometason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709042 | MOMETASON FUROAT | 1.2.40.0.34.5.221:100000091860 | MOMETASONE FUROATE | active | 0.015 | g | 1.2.40.0.34.5.221:100000091860 | MOMETASONE FUROATE | 0.015 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:929918002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265723 | ELOCON CR | Elocon - Creme | 1.2.40.0.34.4.17:1-19791 | GA - zugelassen | Organon Healthcare GmbH | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC13 | Mometason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709042 | MOMETASON FUROAT | 1.2.40.0.34.5.221:100000091860 | MOMETASONE FUROATE | active | 0.1 | g | 1.2.40.0.34.5.221:100000091860 | MOMETASONE FUROATE | 0.1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:929918001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265746 | ELOCON SLB | Elocon - Salbe | 1.2.40.0.34.4.17:1-19792 | GA - zugelassen | Organon Healthcare GmbH | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC13 | Mometason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709042 | MOMETASON FUROAT | 1.2.40.0.34.5.221:100000091860 | MOMETASONE FUROATE | active | 0.015 | g | 1.2.40.0.34.5.221:100000091860 | MOMETASONE FUROATE | 0.015 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:929917002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265752 | ELOCON SLB | Elocon - Salbe | 1.2.40.0.34.4.17:1-19792 | GA - zugelassen | Organon Healthcare GmbH | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC13 | Mometason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709042 | MOMETASON FUROAT | 1.2.40.0.34.5.221:100000091860 | MOMETASONE FUROATE | active | 0.1 | g | 1.2.40.0.34.5.221:100000091860 | MOMETASONE FUROATE | 0.1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:929917001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265829 | PROSCAR FTBL 5MG | Proscar 5 mg Filmtabletten | 1.2.40.0.34.4.17:1-19689 | GA - zugelassen | Organon Healthcare GmbH | true | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:G04CB01 | Finasterid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709503 | FINASTERID | 1.2.40.0.34.5.221:100000092656 | FINASTERID | active | | | 1.2.40.0.34.5.221:100000092656 | FINASTERID | | | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265858 | ZOCORD FTBL 20MG | Zocord 20 mg Filmtabletten | 1.2.40.0.34.4.17:1-19502 | GA - zugelassen | Organon Healthcare GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C10AA01 | Simvastatin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709007 | SIMVASTATIN | 1.2.40.0.34.5.221:100000091786 | SIMVASTATIN | active | 20 | mg | 1.2.40.0.34.5.221:100000091786 | SIMVASTATIN | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928510016 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265982 | IMIGRAN FTBL 100MG | Imigran 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19777 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 2 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02CC01 | Sumatriptan | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705740 | SUMATRIPTAN SUCCINAT | 1.2.40.0.34.5.221:100000077527 | SUMATRIPTAN SUCCINATE | active | 140 | mg | 1.2.40.0.34.5.221:100000077527 | SUMATRIPTAN SUCCINATE | 140 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930225001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1265999 | IMIGRAN FTBL 100MG | Imigran 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19777 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02CC01 | Sumatriptan | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705740 | SUMATRIPTAN SUCCINAT | 1.2.40.0.34.5.221:100000077527 | SUMATRIPTAN SUCCINATE | active | 140 | mg | 1.2.40.0.34.5.221:100000077527 | SUMATRIPTAN SUCCINATE | 140 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930225002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266007 | IMIGRAN SAMP STPK 6MG/0,5ML | Imigran 6 mg/0,5 ml - Spritzampullen | 1.2.40.0.34.4.17:1-19773 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N02CC01 | Sumatriptan | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1705740 | SUMATRIPTAN SUCCINAT | 1.2.40.0.34.5.221:100000077527 | SUMATRIPTAN SUCCINATE | active | 8.4 | mg | 1.2.40.0.34.5.221:100000077527 | SUMATRIPTAN SUCCINATE | 8.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:930226002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266013 | IMIGRAN SAMP GXPEN 6MG/0,5ML | Imigran 6 mg/0,5 ml - Spritzampullen | 1.2.40.0.34.4.17:1-19773 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 2 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N02CC01 | Sumatriptan | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1705740 | SUMATRIPTAN SUCCINAT | 1.2.40.0.34.5.221:100000077527 | SUMATRIPTAN SUCCINATE | active | 8.4 | mg | 1.2.40.0.34.5.221:100000077527 | SUMATRIPTAN SUCCINATE | 8.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:930226001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266036 | SEREVENT ROTADISKS PLV 14X4D | Serevent Rotadisks - Pulver zur Trockeninhalation | 1.2.40.0.34.4.17:1-19934 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03AC12 | Salmeterol | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1708832 | SALMETEROL XINAFOAT | 1.2.40.0.34.5.221:100000091381 | SALMETEROL XINAFOATE | active | 0.072 | mg | 1.2.40.0.34.5.221:100000091381 | SALMETEROL XINAFOATE | 0.072 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073839 | Pulver zur Inhalation | true | human | 1.2.40.0.34.4.26:930025001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266059 | BETNOVATE CRIN LSG BP10X30 | Betnovate - Crinale Lösung | 1.2.40.0.34.4.17:14435 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 300 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709477 | BETAMETHASONVALERAT | 1.2.40.0.34.5.221:100000092622 | BETAMETHASONE VALERATE | active | 0.366 | g | 1.2.40.0.34.5.221:100000092622 | BETAMETHASONE VALERATE | 0.366 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:120397001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266065 | DIPRODERM CR | Diproderm - Creme | 1.2.40.0.34.4.17:15576 | GA - zugelassen | Organon Healthcare GmbH | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.0096 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.0096 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:120307001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266071 | DIPRODERM SLB | Diproderm - Salbe | 1.2.40.0.34.4.17:15575 | GA - zugelassen | Organon Healthcare GmbH | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.0096 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.0096 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:120648002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266088 | DIPROGENTA CR | Diprogenta - Creme | 1.2.40.0.34.4.17:15937 | GA - zugelassen | Organon Healthcare GmbH | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07CC01 | Betamethason und Antibiotika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.0096 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.0096 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:122973001 | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 0.0255 | g | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 0.017988 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266094 | DIPROGENTA SLB | Diprogenta - Salbe | 1.2.40.0.34.4.17:15936 | GA - zugelassen | Organon Healthcare GmbH | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07CC01 | Betamethason und Antibiotika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.0096 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.0096 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:122974001 | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 0.0255 | g | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 0.017988 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266102 | DIPROSALIC SLB | Diprosalic - Salbe | 1.2.40.0.34.4.17:16443 | GA - zugelassen | Organon Healthcare GmbH | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07XC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.0096 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.0096 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:122292001 | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 0.45 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 0.45 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266119 | DIPROFORTE SLB | Diproforte - Salbe | 1.2.40.0.34.4.17:17868 | GA - zugelassen | Organon Healthcare GmbH | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.0096 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.0096 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:921944001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266148 | DOXYCYCLIN GEN TBL LSL 100MG | Doxycyclin Genericon 100 mg lösliche Tabletten | 1.2.40.0.34.4.17:1-19706 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01AA02 | Doxycyclin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709256 | DOXYCYCLIN | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | active | 104.1 | mg | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | 104.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073369 | Tablette zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:929295002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266154 | DOXYCYCLIN GEN TBL LSL 100MG | Doxycyclin Genericon 100 mg lösliche Tabletten | 1.2.40.0.34.4.17:1-19706 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01AA02 | Doxycyclin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709256 | DOXYCYCLIN | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | active | 104.1 | mg | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | 104.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073369 | Tablette zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:929295001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266183 | BRONCHOSTOP HU-SFT | BRONCHOSTOP Hustensaft | 1.2.40.0.34.4.17:HERB-00086 | GA - registriert | Kwizda Pharma GmbH | true | true | 150 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073541 | Gießbehältnis | 2.16.840.1.113883.6.73:R05CA10 | Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710828 | THYMI HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000001063 | THYMI HERBA (EXTRACT) | active | 33.75 | g | 1.2.40.0.34.5.221:900000001063 | THYMI HERBA (EXTRACT) | 33.75 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | false | human | 1.2.40.0.34.4.26:955856001 | 1.2.40.0.34.5.156:1709897 | ALTHAEAE RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000000128 | ALTHAEAE RADIX (EXTRACT) | active | 28.825 | g | 1.2.40.0.34.5.221:900000000128 | ALTHAEAE RADIX (EXTRACT) | 28.825 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266214 | ELOCON DERM LSG | Elocon - dermatologische Lösung | 1.2.40.0.34.4.17:1-19790 | GA - zugelassen | Organon Healthcare GmbH | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D07AC13 | Mometason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709042 | MOMETASON FUROAT | 1.2.40.0.34.5.221:100000091860 | MOMETASONE FUROATE | active | 0.1 | g | 1.2.40.0.34.5.221:100000091860 | MOMETASONE FUROATE | 0.1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:929919001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266237 | BALNEUM-HERMAL BADEZUS. | Balneum Hermal - Badezusatz | 1.2.40.0.34.4.17:13643 | GA - zugelassen | Almirall Hermal GmbH | true | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D11AX | Andere Dermatika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073568 | Badebehandlung | | | 1.2.40.0.34.5.156:1705802 | SOJAÖL | 1.2.40.0.34.5.221:100000077798 | SOYA OIL | active | 8475 | g | 1.2.40.0.34.5.221:100000077798 | SOYA OIL | 8475 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073711 | Badezusatz | false | human | 1.2.40.0.34.4.26:120603001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266243 | BALNEUM-HERMAL BADEZUS. | Balneum Hermal - Badezusatz | 1.2.40.0.34.4.17:13643 | GA - zugelassen | Almirall Hermal GmbH | true | false | 200 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D11AX | Andere Dermatika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073568 | Badebehandlung | | | 1.2.40.0.34.5.156:1705802 | SOJAÖL | 1.2.40.0.34.5.221:100000077798 | SOYA OIL | active | 16950 | g | 1.2.40.0.34.5.221:100000077798 | SOYA OIL | 16950 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073711 | Badezusatz | false | human | 1.2.40.0.34.4.26:120603004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266272 | BALNEUM-HERMAL-F BADEZUS. | Balneum Hermal F - Badezusatz | 1.2.40.0.34.4.17:16838 | GA - zugelassen | Almirall Hermal GmbH | true | false | 200 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D11AX | Andere Dermatika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073568 | Badebehandlung | | | 1.2.40.0.34.5.156:1709286 | PARAFFIN, DÜNNFLÜSSIGES | 1.2.40.0.34.5.221:100000092267 | PARAFFIN, LIGHT LIQUID | active | 9400 | g | 1.2.40.0.34.5.221:100000092267 | PARAFFIN, LIGHT LIQUID | 9400 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073711 | Badezusatz | false | human | 1.2.40.0.34.4.26:126415002 | 1.2.40.0.34.5.156:1707127 | ARACHIDIS OLEUM RAFFINATUM | 1.2.40.0.34.5.221:100000084742 | PEANUT OIL | active | 9290 | g | 1.2.40.0.34.5.221:100000084742 | PEANUT OIL | 9290 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266289 | TRICEF FTBL 200MG | Tricef 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19112 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01DD08 | Cefixim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709484 | CEFIXIM | 1.2.40.0.34.5.221:100000092632 | CEFIXIME | active | 223.84 | mg | 1.2.40.0.34.5.221:100000092632 | CEFIXIME | 223.84 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927949002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266740 | IROCOPHAN TBL | Irocophan - Tabletten | 1.2.40.0.34.4.17:1-18063 | GA - aufgehoben | Dr. A. & L. Schmidgall GmbH & Co. KG | false | false | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BE51 | Paracetamol, Kombinationen exkl. Psycholeptika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | 200 | mg | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922068004 | 1.2.40.0.34.5.156:1708366 | COFFEIN | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | active | 46 | mg | 1.2.40.0.34.5.221:100000089693 | CAFFEINE | 46 | mg | 1.2.40.0.34.5.156:1706552 | CARBASALAT CALCIUM | 1.2.40.0.34.5.221:100000081316 | CARBASALATE CALCIUM | active | 250 | mg | 1.2.40.0.34.5.221:100000081316 | CARBASALATE CALCIUM | 250 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266786 | HYALGAN STAMP 20MG 2ML | Hyalgan 20 mg Stechampullen | 1.2.40.0.34.4.17:1-19646 | GA - zugelassen | Fidia Farmaceutici S.p.A. | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M09AX01 | Hyaluronsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708449 | NATRIUMHYALURONAT | 1.2.40.0.34.5.221:100000090076 | SODIUM HYALURONATE | active | 20 | mg | 1.2.40.0.34.5.221:100000090076 | SODIUM HYALURONATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:929300001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1266792 | HYALGAN SPRAMP 20MG 2ML | Hyalgan 20 mg Spritzampullen | 1.2.40.0.34.4.17:1-19647 | GA - zugelassen | Fidia Farmaceutici S.p.A. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M09AX01 | Hyaluronsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708449 | NATRIUMHYALURONAT | 1.2.40.0.34.5.221:100000090076 | SODIUM HYALURONATE | active | 20 | mg | 1.2.40.0.34.5.221:100000090076 | SODIUM HYALURONATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:929299001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1267320 | KYTRIL INJ AMP 3MG/3ML | Kytril 3 mg - Injektionslösung | 1.2.40.0.34.4.17:1-19775 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A04AA02 | Granisetron | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708599 | GRANISETRON HYDROCHLORID | 1.2.40.0.34.5.221:100000090454 | GRANISETRON HYDROCHLORIDE | active | 3.36 | mg | 1.2.40.0.34.5.221:100000090454 | GRANISETRON HYDROCHLORIDE | 3.36 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:929970001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1267343 | SEROXAT FTBL 20MG | Seroxat 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19931 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AB05 | Paroxetin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708417 | PAROXETINHYDROCHLORID | 1.2.40.0.34.5.221:100000089965 | PAROXETINE HYDROCHLORIDE | active | 22.8 | mg | 1.2.40.0.34.5.221:100000089965 | PAROXETINE HYDROCHLORIDE | 22.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929525003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1267366 | SEROXAT FTBL 20MG | Seroxat 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19931 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AB05 | Paroxetin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708417 | PAROXETINHYDROCHLORID | 1.2.40.0.34.5.221:100000089965 | PAROXETINE HYDROCHLORIDE | active | 22.8 | mg | 1.2.40.0.34.5.221:100000089965 | PAROXETINE HYDROCHLORIDE | 22.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929525006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1267372 | ZOVIRAX SFT 400MG/5ML | Zovirax 400 mg/5 ml - Saft | 1.2.40.0.34.4.17:1-19562 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J05AB01 | Aciclovir | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709572 | ACICLOVIR | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | active | 8000 | mg | 1.2.40.0.34.5.221:100000092808 | ACICLOVIR | 8000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:929190002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1267395 | DICLOSYL GEL | Diclosyl - Gel | 1.2.40.0.34.4.17:1-18915 | GA - aufgehoben | Pharmaselect Handels GmbH | false | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA15 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 1 | g | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:928595001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1267426 | EUSAPRIM TBL FTE | Eusaprim forte - Tabletten | 1.2.40.0.34.4.17:16213 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01EE01 | Sulfamethoxazol und Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | 160 | mg | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | 160 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:125658002 | 1.2.40.0.34.5.156:1709475 | SULFAMETHOXAZOL | 1.2.40.0.34.5.221:100000092618 | SULFAMETHOXAZOLE | active | 800 | mg | 1.2.40.0.34.5.221:100000092618 | SULFAMETHOXAZOLE | 800 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1267432 | ZYLORIC TBL 100MG | Zyloric 100 mg - Tabletten | 1.2.40.0.34.4.17:13512 | GA - aufgehoben | Aspen Pharma Trading Limited | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M04AA01 | Allopurinol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709057 | ALLOPURINOL | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:122429002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1267461 | ALLERGODIL NA-SPRAY | Allergodil - Nasenspray | 1.2.40.0.34.4.17:1-19772 | GA - zugelassen | Viatris Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AC03 | Azelastin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1708582 | AZELASTIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090426 | AZELASTINE HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000090426 | AZELASTINE HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073796 | Nasenspray, Lösung | true | human | 1.2.40.0.34.4.26:930570001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1267656 | GELOMYRTOL KPS 300MG | GeloMyrtol 300 mg - Kapseln | 1.2.40.0.34.4.17:17650 | GA - zugelassen | G. Pohl-Boskamp GmbH & Co. KG | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R05CA10 | Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709976 | AURANTII DULCIS AETHEROLEUM | 1.2.40.0.34.5.221:900000000207 | AURANTII DULCIS AETHEROLEUM | active | | | 1.2.40.0.34.5.221:900000000207 | AURANTII DULCIS AETHEROLEUM | | | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | false | human | 1.2.40.0.34.4.26:123181002 | 1.2.40.0.34.5.156:1706333 | EUCALYPTI AETHEROLEUM | 1.2.40.0.34.5.221:100000091979 | EUCALYPTUS OIL | active | | | 1.2.40.0.34.5.221:100000091979 | EUCALYPTUS OIL | | | 1.2.40.0.34.5.156:8332638 | MYRTI AETHEROLEUM | 1.2.40.0.34.5.221:900000004961 | MYRTI AETHEROLEUM | active | | | 1.2.40.0.34.5.221:900000004961 | MYRTI AETHEROLEUM | | | | | | | | | 1.2.40.0.34.5.156:1710434 | LIMONIS AETHEROLEUM | 1.2.40.0.34.5.221:900000000666 | LIMONIS AETHEROLEUM | active | | | 1.2.40.0.34.5.221:900000000666 | LIMONIS AETHEROLEUM | | | 1.2.40.0.34.5.156:1712761 | MISCHEXTRAKT | 1.2.40.0.34.5.221:900000004454 | MIXED EXTRACT | active | 300 | mg | 1.2.40.0.34.5.221:900000004454 | MIXED EXTRACT | 300 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1267685 | NICORETTE CLASSIC KAUGU 2MG | Nicorette Classic 2 mg - Kaugummi zur Raucherentwöhnung | 1.2.40.0.34.4.17:17167 | GA - zugelassen | Johnson & Johnson Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N07BA01 | Nicotin | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | | | 1.2.40.0.34.5.156:1708144 | NICOTINRESINAT | 1.2.40.0.34.5.221:100000089016 | NICOTINE RESINATE | active | 10 | mg | 1.2.40.0.34.5.221:100000089016 | NICOTINE RESINATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073669 | wirkstoffhaltiges Kaugummi | false | human | 1.2.40.0.34.4.26:920761003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1267834 | LAMISIL CR 1% | Lamisil 1 % - Creme | 1.2.40.0.34.4.17:1-19581 | GA - zugelassen | Karo Healthcare AB | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D01AE15 | Terbinafin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708665 | TERBINAFIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090624 | TERBINAFINE HYDROCHLORIDE | active | 0.15 | g | 1.2.40.0.34.5.221:100000090624 | TERBINAFINE HYDROCHLORIDE | 0.15 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | false | human | 1.2.40.0.34.4.26:930333001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1267857 | ZADITEN-SRO FTBL 2MG | Zaditen SRO 2 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19771 | GA - aufgehoben | Alfasigma S.p.A. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AX17 | Ketotifen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709246 | KETOTIFEN HYDROGENFUMARAT | 1.2.40.0.34.5.221:100000092186 | KETOTIFEN HYDROGEN FUMARATE | active | 2.75 | mg | 1.2.40.0.34.5.221:100000092186 | KETOTIFEN HYDROGEN FUMARATE | 2.75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073668 | Tablette mit veränderter Wirkstofffreisetzung | true | human | 1.2.40.0.34.4.26:929374001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268182 | NAVELBINE IKONZ 10MG/1ML | Navelbine 10 mg - Infusionskonzentrat | 1.2.40.0.34.4.17:1-20425 | GA - aufgehoben | Pierre Fabre Medicament | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:L01CA04 | Vinorelbin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707986 | VINORELBINTARTRAT | 1.2.40.0.34.5.221:100000088235 | VINORELBINE TARTRATE | active | 13.85 | mg | 1.2.40.0.34.5.221:100000088235 | VINORELBINE TARTRATE | 13.85 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:930918001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268259 | NAVELBINE IKONZ 50MG/5ML | Navelbine 50 mg - Infusionskonzentrat | 1.2.40.0.34.4.17:1-20428 | GA - aufgehoben | Pierre Fabre Medicament | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:L01CA04 | Vinorelbin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707986 | VINORELBINTARTRAT | 1.2.40.0.34.5.221:100000088235 | VINORELBINE TARTRATE | active | 69.25 | mg | 1.2.40.0.34.5.221:100000088235 | VINORELBINE TARTRATE | 69.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:930921001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268271 | ANDRIOL TESTOCAPS KPS | Andriol Testocaps 40 mg - Kapseln | 1.2.40.0.34.4.17:1-19756 | GA - aufgehoben | Merck Sharp & Dohme Ges.m.b.H. | false | false | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03BA03 | Testosteron | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708141 | TESTOSTERON UNDECENOAT | 1.2.40.0.34.5.221:100000089009 | TESTOSTERONE UNDECYLATE | active | 40 | mg | 1.2.40.0.34.5.221:100000089009 | TESTOSTERONE UNDECYLATE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:129377003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268302 | BEROTEC DOSAER 100MCG | Berotec 100 µg - Dosieraerosol | 1.2.40.0.34.4.17:1-20014 | GA - zugelassen | Boehringer Ingelheim RCV GmbH & Co KG | true | true | 14 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:R03AC04 | Fenoterol | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1708016 | FENOTEROL HYDROBROMID | 1.2.40.0.34.5.221:100000088371 | FENOTEROL HYDROBROMIDE | active | 26 | mg | 1.2.40.0.34.5.221:100000088371 | FENOTEROL HYDROBROMIDE | 26 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073848 | Druckgasinhalation, Lösung | true | human | 1.2.40.0.34.4.26:930940001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268325 | ATENATIV PLV+LSM 500IE | Atenativ 500 I.E. - Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung | 1.2.40.0.34.4.17:2-00080 | GA - zugelassen | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B01AB02 | Antithrombin III | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708172 | ANTITHROMBIN III | 1.2.40.0.34.5.221:100000089108 | ANTITHROMBIN III | active | 500 | IU | 1.2.40.0.34.5.221:100000089108 | ANTITHROMBIN III | 500 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:929306001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268331 | ATENATIV PLV+LSM 1000IE | Atenativ 1000 I.E. - Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung | 1.2.40.0.34.4.17:2-00081 | GA - zugelassen | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B01AB02 | Antithrombin III | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708172 | ANTITHROMBIN III | 1.2.40.0.34.5.221:100000089108 | ANTITHROMBIN III | active | 1000 | IU | 1.2.40.0.34.5.221:100000089108 | ANTITHROMBIN III | 1000 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:929308001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268420 | PURINOL TBL 100MG | Purinol 100 mg - Tabletten | 1.2.40.0.34.4.17:1-19725 | GA - zugelassen | Teva B.V. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M04AA01 | Allopurinol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709057 | ALLOPURINOL | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:929396002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268437 | PURINOL TBL 100MG | Purinol 100 mg - Tabletten | 1.2.40.0.34.4.17:1-19725 | GA - zugelassen | Teva B.V. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M04AA01 | Allopurinol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709057 | ALLOPURINOL | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:929396001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268443 | PURINOL TBL 300MG | Purinol 300 mg - Tabletten | 1.2.40.0.34.4.17:1-19726 | GA - zugelassen | Teva B.V. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M04AA01 | Allopurinol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709057 | ALLOPURINOL | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | active | 300 | mg | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:929397001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268466 | DICLOBENE AMP 75MG/2ML | Diclobene 75 mg - Ampullen | 1.2.40.0.34.4.17:1-19719 | GA - zugelassen | Teva B.V. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 75 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:926981001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268549 | TILADE DOSAER 112 STO. | Tilade Dosieraerosol | 1.2.40.0.34.4.17:1-19068 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073517 | Inhalator | 2.16.840.1.113883.6.73:R03BC03 | Nedocromil | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1705480 | NEDOCROMIL DINATRIUM | 1.2.40.0.34.5.221:100000076482 | NEDOCROMIL SODIUM | active | 2 | mg | 1.2.40.0.34.5.221:100000076482 | NEDOCROMIL SODIUM | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073838 | Druckgasinhalation, Suspension | true | human | 1.2.40.0.34.4.26:927530001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268561 | NORPROLAC TBL 0,075MG | Norprolac 0,075 mg - Tabletten | 1.2.40.0.34.4.17:1-20874 | GA - zugelassen | Ferring Arzneimittel Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G02CB04 | Quinagolid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708433 | QUINAGOLID HYDROCHLORID | 1.2.40.0.34.5.221:100000090012 | QUINAGOLIDE HYDROCHLORIDE | active | 0.082 | mg | 1.2.40.0.34.5.221:100000090012 | QUINAGOLIDE HYDROCHLORIDE | 0.082 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933696001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268696 | CISORDINOL DEP AMP 500MG | Cisordinol Depot 500 mg - Ampullen | 1.2.40.0.34.4.17:1-19866 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05AF05 | Zuclopenthixol | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1707515 | ZUCLOPENTHIXOL DECANOAT | 1.2.40.0.34.5.221:100000085821 | ZUCLOPENTHIXOL DECANOATE | active | 500 | mg | 1.2.40.0.34.5.221:100000085821 | ZUCLOPENTHIXOL DECANOATE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:930189001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268779 | SEROPRAM IKONZ 20MG/0,5ML | Seropram 20 mg - Konzentrat zur Infusionsbereitung | 1.2.40.0.34.4.17:1-19815 | GA - zugelassen | Lundbeck Austria GmbH | true | false | 2 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N06AB04 | Citalopram | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708779 | CITALOPRAM HYDROCHLORID | 1.2.40.0.34.5.221:100000091251 | CITALOPRAM HYDROCHLORIDE | active | 22.24 | mg | 1.2.40.0.34.5.221:100000091251 | CITALOPRAM HYDROCHLORIDE | 22.24 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:931844001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1268785 | HELOPANFLAT DRG | Helopanflat Dragees | 1.2.40.0.34.4.17:14200 | GA - zugelassen | Bano Healthcare GmbH | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:A09AA02 | Multienzyme (Lipase, Protease etc.) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708384 | SIMETICON | 1.2.40.0.34.5.221:100000089833 | SIMETICON | active | | | 1.2.40.0.34.5.221:100000089833 | SIMETICON | | | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | false | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1706275 | PANKREAS(EXTRAKT) | 1.2.40.0.34.5.221:100000079736 | PANKREAS(EXTRAKT) | active | | | 1.2.40.0.34.5.221:100000079736 | PANKREAS(EXTRAKT) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269425 | SEROPRAM IKONZ 20MG/0,5ML | Seropram 20 mg - Konzentrat zur Infusionsbereitung | 1.2.40.0.34.4.17:1-19815 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N06AB04 | Citalopram | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708779 | CITALOPRAM HYDROCHLORID | 1.2.40.0.34.5.221:100000091251 | CITALOPRAM HYDROCHLORIDE | active | 22.24 | mg | 1.2.40.0.34.5.221:100000091251 | CITALOPRAM HYDROCHLORIDE | 22.24 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:931844002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269431 | ISMN GEN TBL 20MG | ISMN Genericon 20 mg Tabletten | 1.2.40.0.34.4.17:1-19759 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01DA14 | Isosorbidmononitrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708568 | ISOSORBIDMONONITRAT | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | active | 20 | mg | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928517001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269448 | ISMN GEN TBL 20MG | ISMN Genericon 20 mg Tabletten | 1.2.40.0.34.4.17:1-19759 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01DA14 | Isosorbidmononitrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708568 | ISOSORBIDMONONITRAT | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | active | 20 | mg | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928517002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269454 | ISMN GEN TBL 40MG | ISMN Genericon 40 mg Tabletten | 1.2.40.0.34.4.17:1-19760 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01DA14 | Isosorbidmononitrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708568 | ISOSORBIDMONONITRAT | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | active | 40 | mg | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928580001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269460 | ISMN GEN TBL 40MG | ISMN Genericon 40 mg Tabletten | 1.2.40.0.34.4.17:1-19760 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01DA14 | Isosorbidmononitrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708568 | ISOSORBIDMONONITRAT | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | active | 40 | mg | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928580002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269520 | THROMBO ASS FTBL 50MG | Thrombo ASS 50 mg-Filmtabletten | 1.2.40.0.34.4.17:1-19829 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B01AC06 | Acetylsalicylsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 50 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073667 | magensaftresistente Tablette | true | human | 1.2.40.0.34.4.26:931514002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269537 | THROMBO ASS FTBL 50MG | Thrombo ASS 50 mg-Filmtabletten | 1.2.40.0.34.4.17:1-19829 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B01AC06 | Acetylsalicylsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 50 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073667 | magensaftresistente Tablette | true | human | 1.2.40.0.34.4.26:931514001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269543 | THROMBO ASS FTBL 100MG | Thrombo ASS 100 mg-Filmtabletten | 1.2.40.0.34.4.17:1-19830 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B01AC06 | Acetylsalicylsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 100 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073667 | magensaftresistente Tablette | true | human | 1.2.40.0.34.4.26:931515002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269566 | THROMBO ASS FTBL 100MG | Thrombo ASS 100 mg-Filmtabletten | 1.2.40.0.34.4.17:1-19830 | GA - zugelassen | G.L. Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B01AC06 | Acetylsalicylsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 100 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073667 | magensaftresistente Tablette | true | human | 1.2.40.0.34.4.26:931515001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269649 | AMOXICILLIN RTP FTBL 500MG | Amoxicillin "ratiopharm" 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19794 | GA - zugelassen | Teva B.V. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CA04 | Amoxicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7033709 | AMOXICILLIN TRIHYDRAT | 1.2.40.0.34.5.221:100000092629 | AMOXICILLIN TRIHYDRATE | active | 574 | mg | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 500.034934 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929933001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269655 | AMOXICILLIN RTP FTBL 500MG | Amoxicillin "ratiopharm" 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19794 | GA - zugelassen | Teva B.V. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CA04 | Amoxicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7033709 | AMOXICILLIN TRIHYDRAT | 1.2.40.0.34.5.221:100000092629 | AMOXICILLIN TRIHYDRATE | active | 574 | mg | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 500.034934 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929933002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269661 | AMOXICILLIN RTP 250MG/5ML | Amoxicillin "ratiopharm" 250 mg/5 ml - Trockensaft | 1.2.40.0.34.4.17:1-19793 | GA - aufgehoben | Teva B.V. | false | false | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01CA04 | Amoxicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708923 | AMOXICILLIN | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | active | 0.287 | g | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 0.287 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073650 | Granulat zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:929932002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269750 | MUCOBENE LSL PLV 600MG | Mucobene 600 mg - lösliches Pulver | 1.2.40.0.34.4.17:1-19799 | GA - zugelassen | Teva B.V. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:R05CB01 | Acetylcystein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709282 | ACETYLCYSTEIN | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | active | 600 | mg | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073365 | Granulat zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:927875001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269767 | MUCOBENE LSL PLV 600MG | Mucobene 600 mg - lösliches Pulver | 1.2.40.0.34.4.17:1-19799 | GA - zugelassen | Teva B.V. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:R05CB01 | Acetylcystein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709282 | ACETYLCYSTEIN | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | active | 600 | mg | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073365 | Granulat zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:927875002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269856 | VIBRAMYCIN TBL LSB 200MG | Vibramycin 200 mg - lösbare Tabletten | 1.2.40.0.34.4.17:1-19796 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01AA02 | Doxycyclin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709256 | DOXYCYCLIN | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | active | 212.08 | mg | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | 212.08 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073654 | Tablette zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:930023002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269862 | VIBRAMYCIN TBL LSB 200MG | Vibramycin 200 mg - lösbare Tabletten | 1.2.40.0.34.4.17:1-19796 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01AA02 | Doxycyclin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709256 | DOXYCYCLIN | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | active | 212.08 | mg | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | 212.08 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073654 | Tablette zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:930023001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1269968 | ONCOTICE DFL | OncoTice zur intravesikalen Instillation | 1.2.40.0.34.4.17:2-00074 | GA - zugelassen | Merck Sharp & Dohme Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L03AX03 | BCG-Impfstoff | 1.2.40.0.10.1.4.3.4.3.4:100000073612 | intravesikale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073638 | Anwendung in der Harnröhre | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.34.5.156:1709584 | MYCOBACTERIUM BOVIS | 1.2.40.0.34.5.221:100000092841 | MYCOBACTERIUM BOVIS | active | | | 1.2.40.0.34.5.221:100000092841 | MYCOBACTERIUM BOVIS | | | 1.2.40.0.10.1.4.3.4.3.5:100000074020 | Pulver zur Herstellung einer Suspension zur intravesikalen Anwendung | true | human | 1.2.40.0.34.4.26:928631001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1270150 | DALACIN C KPS 300MG BP10X16 | Dalacin C 300 mg - Kapseln | 1.2.40.0.34.4.17:1-18937 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 160 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01FF01 | Clindamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708638 | CLINDAMYCIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090552 | CLINDAMYCIN HYDROCHLORIDE | active | 355.03 | mg | 1.2.40.0.34.5.221:100000084276 | CLINDAMYCIN | 326.97766 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:929010001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1270345 | LUIFLEX SPRAY | Mobiflex 1 % Schmerzspray zur Anwendung auf der Haut, Lösung | 1.2.40.0.34.4.17:1-18955 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | false | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:M02AA23 | Indometacin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709537 | INDOMETACIN | 1.2.40.0.34.5.221:100000092758 | INDOMETACIN | active | | | 1.2.40.0.34.5.221:100000092758 | INDOMETACIN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073729 | Spray zur Anwendung auf der Haut, Lösung | false | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1270405 | HYALGAN STAMP 20MG 2ML BP5X1 | Hyalgan 20 mg Stechampullen | 1.2.40.0.34.4.17:1-19646 | GA - zugelassen | Fidia Farmaceutici S.p.A. | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M09AX01 | Hyaluronsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708449 | NATRIUMHYALURONAT | 1.2.40.0.34.5.221:100000090076 | SODIUM HYALURONATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090076 | SODIUM HYALURONATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:929300002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1270411 | HYALGAN SPRAMP 20MG 2ML | Hyalgan 20 mg Spritzampullen | 1.2.40.0.34.4.17:1-19647 | GA - zugelassen | Fidia Farmaceutici S.p.A. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M09AX01 | Hyaluronsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708449 | NATRIUMHYALURONAT | 1.2.40.0.34.5.221:100000090076 | SODIUM HYALURONATE | active | 20 | mg | 1.2.40.0.34.5.221:100000090076 | SODIUM HYALURONATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:929299002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1270428 | UROMITEXAN AMP 400MG 4ML | Uromitexan 400 mg - Ampullen | 1.2.40.0.34.4.17:17565 | GA - zugelassen | Baxter Healthcare GmbH | true | true | 15 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:V03AF01 | Mesna | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709400 | MESNA | 1.2.40.0.34.5.221:100000092488 | MESNA | active | 400 | mg | 1.2.40.0.34.5.221:100000092488 | MESNA | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:920504001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1270598 | FENISTIL AMP 4ML | Histakut 1 mg/ml Injektionslösung | 1.2.40.0.34.4.17:1-19861 | GA - zugelassen | Gebro Pharma GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:R06AB03 | Dimetinden | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707840 | DIMETINDEN MALEAT | 1.2.40.0.34.5.221:100000087512 | DIMETINDEN MALEAT | active | | | 1.2.40.0.34.5.221:100000087512 | DIMETINDEN MALEAT | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1270782 | AQUA BID FRE GLIFL 500ML | Aqua bidest. "Fresenius" - Lösungsmittel für Parenteralia | 1.2.40.0.34.4.17:16231 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V07AB | Lösungs- und Verdünnungsmittel, inkl. Spüllösungen | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705860 | WASSER FÜR INJEKTIONSZWECKE | 1.2.40.0.34.5.221:100000078023 | WATER FOR INJECTION | active | 500 | ml | 1.2.40.0.34.5.221:100000078023 | WATER FOR INJECTION | 500 | ml | 1.2.40.0.10.1.4.3.4.3.5:100000073881 | Lösungsmittel zur Herstellung von Parenteralia | true | human | 1.2.40.0.34.4.26:126047011 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1270799 | AQUA BID FRE GLIFL 1000ML | Aqua bidest. "Fresenius" - Lösungsmittel für Parenteralia | 1.2.40.0.34.4.17:16231 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V07AB | Lösungs- und Verdünnungsmittel, inkl. Spüllösungen | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705860 | WASSER FÜR INJEKTIONSZWECKE | 1.2.40.0.34.5.221:100000078023 | WATER FOR INJECTION | active | 1000 | ml | 1.2.40.0.34.5.221:100000078023 | WATER FOR INJECTION | 1000 | ml | 1.2.40.0.10.1.4.3.4.3.5:100000073881 | Lösungsmittel zur Herstellung von Parenteralia | true | human | 1.2.40.0.34.4.26:126047037 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1271126 | ELOZELL FTE IFL 250ML | Elozell "forte" - Infusionsflasche | 1.2.40.0.34.4.17:14667 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:7782183 | KALIUMHYDROGENASPARTAT HEMIHYDRAT | 1.2.40.0.34.5.221:100000143418 | POTASSIUM HYDROGEN ASPARTATE HEMIHYDRATE | active | 2162.5 | mg | 1.2.40.0.34.5.221:100000143418 | POTASSIUM HYDROGEN ASPARTATE HEMIHYDRATE | 2162.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:123197002 | 1.2.40.0.34.5.156:1705588 | MAGNESIUM HYDROGENASPARTAT | 1.2.40.0.34.5.221:100000076822 | MAGNESIUM HYDROGEN ASPARTATE | active | 2162.5 | mg | 1.2.40.0.34.5.221:100000076822 | MAGNESIUM HYDROGEN ASPARTATE | 2162.5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1271132 | ELOZELL SPEZ IFL 250ML | Elozell "spezial" - Infusionsflasche | 1.2.40.0.34.4.17:17294 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 1193 | mg | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 1193 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:128163002 | 1.2.40.0.34.5.156:7782183 | KALIUMHYDROGENASPARTAT HEMIHYDRAT | 1.2.40.0.34.5.221:100000143418 | POTASSIUM HYDROGEN ASPARTATE HEMIHYDRATE | active | 1441 | mg | 1.2.40.0.34.5.221:100000143418 | POTASSIUM HYDROGEN ASPARTATE HEMIHYDRATE | 1441 | mg | 1.2.40.0.34.5.156:1705588 | MAGNESIUM HYDROGENASPARTAT | 1.2.40.0.34.5.221:100000076822 | MAGNESIUM HYDROGEN ASPARTATE | active | 2163 | mg | 1.2.40.0.34.5.221:100000076822 | MAGNESIUM HYDROGEN ASPARTATE | 2163 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1271155 | GLUCOSE FRE 5% GLIFL 250ML | Glucose 5 % "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:16433 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BA03 | Kohlenhydrate | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705910 | GLUCOSE | 1.2.40.0.34.5.221:100000078171 | GLUCOSE | active | 13750 | mg | 1.2.40.0.34.5.221:100000078171 | GLUCOSE | 13750 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126045013 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1271161 | GLUCOSE FRE 5% GLIFL 500ML | Glucose 5 % "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:16433 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BA03 | Kohlenhydrate | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705910 | GLUCOSE | 1.2.40.0.34.5.221:100000078171 | GLUCOSE | active | 27500 | mg | 1.2.40.0.34.5.221:100000078171 | GLUCOSE | 27500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126045019 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1271215 | DOTAREM IJLSG FSPR 15ML | Dotarem - Injektionslösung | 1.2.40.0.34.4.17:1-21996 | GA - zugelassen | Guerbet | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:V08CA02 | Gadotersäure | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708389 | GADOTERSÄURE | 1.2.40.0.34.5.221:100000089855 | GADOTERIC ACID | active | 4189.8 | mg | 1.2.40.0.34.5.221:100000089855 | GADOTERIC ACID | 4189.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:938704007 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1271273 | GLUCOSE FRE 5% PLIFL 500ML | Glucose 5 % "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:16433 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BA03 | Kohlenhydrate | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705910 | GLUCOSE | 1.2.40.0.34.5.221:100000078171 | GLUCOSE | active | 27500 | mg | 1.2.40.0.34.5.221:100000078171 | GLUCOSE | 27500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126045020 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1271735 | LEBERINFUSION WABO IFL 500ML | Leberinfusion "Wabo" - Infusionsflasche | 1.2.40.0.34.4.17:14091 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A05BA | Lebertherapie | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707674 | ARGININ | 1.2.40.0.34.5.221:100000086598 | ARGININE | active | 10000 | mg | 1.2.40.0.34.5.221:100000086598 | ARGININE | 10000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:123471002 | 1.2.40.0.34.5.156:1709003 | ÄPFELSÄURE | 1.2.40.0.34.5.221:100000091777 | MALIC ACID | active | 10000 | mg | 1.2.40.0.34.5.221:100000091777 | MALIC ACID | 10000 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272025 | PERFLUX IFL 1000ML | Perflux - Infusionsflasche | 1.2.40.0.34.4.17:16083 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB02 | Elektrolyte mit Kohlenhydraten | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:7396038 | NATRIUMACETAT TRIHYDRAT | 1.2.40.0.34.5.221:100000089838 | SODIUM ACETATE TRIHYDRATE | active | 0.68 | g | 1.2.40.0.34.5.221:100000089838 | SODIUM ACETATE TRIHYDRATE | 0.68 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:123470001 | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 0.895 | g | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 0.895 | g | 1.2.40.0.34.5.156:7395955 | CALCIUMCHLORID DIHYDRAT | 1.2.40.0.34.5.221:100000090106 | CALCIUM CHLORIDE DIHYDRATE | active | 0.22 | g | 1.2.40.0.34.5.221:100000090106 | CALCIUM CHLORIDE DIHYDRATE | 0.22 | g | | | | | | | 1.2.40.0.34.5.156:7033513 | D-GLUCOSE 1-PHOSPHAT DINATRIUMSALZ TETRAHYDRAT | 1.2.40.0.34.5.221:100000138206 | D-GLUCOSE 1-PHOSPHATE DISODIUM SALT TETRAHYDRATE | active | 0.282 | g | 1.2.40.0.34.5.221:100000138206 | D-GLUCOSE 1-PHOSPHATE DISODIUM SALT TETRAHYDRATE | 0.282 | g | 1.2.40.0.34.5.156:7395962 | MAGNESIUMCHLORID HEXAHYDRAT | 1.2.40.0.34.5.221:100000091409 | MAGNESIUM CHLORIDE HEXAHYDRATE | active | 0.152 | g | 1.2.40.0.34.5.221:100000091409 | MAGNESIUM CHLORIDE HEXAHYDRATE | 0.152 | g | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 6.926 | g | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 6.926 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272114 | PHYS KOCHS.FRE GLIFL 500ML | Physiologische Kochsalzlösung "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:1-16417 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 4500 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 4500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126043033 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272120 | PHYS KOCHS.FRE GLIFL 1000ML | Physiologische Kochsalzlösung "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:1-16417 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 9000 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 9000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126043075 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272137 | PHYS KOCHS.FRE GLIFL 200/250 | Physiologische Kochsalzlösung "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:1-16417 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 1800 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 1800 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126043022 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272143 | PHYS KOCHS.FRE GLIFL 250/500 | Physiologische Kochsalzlösung "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:1-16417 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 2250 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 2250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126043028 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272166 | PHYS KOCHS.FRE PLIFL 500ML | Physiologische Kochsalzlösung "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:1-16417 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 4500 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 4500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126043034 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272189 | RESPICUR RET KPS 200MG | Respicur retard 200 mg - Kapseln | 1.2.40.0.34.4.17:1-19779 | GA - aufgehoben | Astrazeneca Österreich GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 200 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:930313001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272195 | RESPICUR RET KPS 200MG | Respicur retard 200 mg - Kapseln | 1.2.40.0.34.4.17:1-19779 | GA - aufgehoben | Astrazeneca Österreich GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 200 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:930313002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272203 | RESPICUR RET KPS 400MG | Respicur retard 400 mg - Kapseln | 1.2.40.0.34.4.17:1-19780 | GA - aufgehoben | Astrazeneca Österreich GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 400 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:930314001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272226 | RESPICUR RET KPS 400MG | Respicur retard 400 mg - Kapseln | 1.2.40.0.34.4.17:1-19780 | GA - aufgehoben | Astrazeneca Österreich GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03DA04 | Theophyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708878 | THEOPHYLLIN | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | active | 400 | mg | 1.2.40.0.34.5.221:100000091484 | THEOPHYLLINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:930314002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272284 | RINGER-LACT FRE IFL 500ML | Ringer - Lactat "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:16230 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 200 | mg | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126048012 | 1.2.40.0.34.5.156:1708455 | NATRIUMLACTAT | 1.2.40.0.34.5.221:100000090101 | SODIUM LACTATE | active | 3170 | mg | 1.2.40.0.34.5.221:100000090101 | SODIUM LACTATE | 3170 | mg | 1.2.40.0.34.5.156:1709535 | CALCIUMCHLORID | 1.2.40.0.34.5.221:100000092755 | CALCIUM CHLORIDE | active | 135 | mg | 1.2.40.0.34.5.221:100000092755 | CALCIUM CHLORIDE | 135 | mg | | | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 3000 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 3000 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272290 | RINGER-LACT FRE PLIFL 500 | Ringer - Lactat "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:16230 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 200 | mg | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126048011 | 1.2.40.0.34.5.156:1708455 | NATRIUMLACTAT | 1.2.40.0.34.5.221:100000090101 | SODIUM LACTATE | active | 3170 | mg | 1.2.40.0.34.5.221:100000090101 | SODIUM LACTATE | 3170 | mg | 1.2.40.0.34.5.156:1709535 | CALCIUMCHLORID | 1.2.40.0.34.5.221:100000092755 | CALCIUM CHLORIDE | active | 135 | mg | 1.2.40.0.34.5.221:100000092755 | CALCIUM CHLORIDE | 135 | mg | | | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 3000 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 3000 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272344 | RINGERLSG FRE IFL 500ML | Ringer - Lösung "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:17169 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 150 | mg | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:120579015 | 1.2.40.0.34.5.156:1709535 | CALCIUMCHLORID | 1.2.40.0.34.5.221:100000092755 | CALCIUM CHLORIDE | active | 165 | mg | 1.2.40.0.34.5.221:100000092755 | CALCIUM CHLORIDE | 165 | mg | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 4300 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 4300 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272350 | RINGERLSG FRE IFL 1000ML | Ringer - Lösung "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:17169 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 300 | mg | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:120579029 | 1.2.40.0.34.5.156:1709535 | CALCIUMCHLORID | 1.2.40.0.34.5.221:100000092755 | CALCIUM CHLORIDE | active | 330 | mg | 1.2.40.0.34.5.221:100000092755 | CALCIUM CHLORIDE | 330 | mg | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 8600 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 8600 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272781 | DOTAREM IJLSG FSPR 20ML | Dotarem - Injektionslösung | 1.2.40.0.34.4.17:1-21996 | GA - zugelassen | Guerbet | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:V08CA02 | Gadotersäure | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708389 | GADOTERSÄURE | 1.2.40.0.34.5.221:100000089855 | GADOTERIC ACID | active | 5586.4 | mg | 1.2.40.0.34.5.221:100000089855 | GADOTERIC ACID | 5586.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:938704008 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272835 | DOXYDYN FTBL 200MG | Doxydyn 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19925 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01AA02 | Doxycyclin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709488 | DOXYCYCLINHYCLAT | 1.2.40.0.34.5.221:100000092638 | DOXYCYCLINE HYCLATE | active | 230.8 | mg | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | 199.838642 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929922002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272841 | DOXYDYN FTBL 200MG | Doxydyn 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19925 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01AA02 | Doxycyclin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709488 | DOXYCYCLINHYCLAT | 1.2.40.0.34.5.221:100000092638 | DOXYCYCLINE HYCLATE | active | 230.8 | mg | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | 199.838642 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929922001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272864 | DOXYDERM FTBL 50MG | Doxyderm 50 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19924 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01AA02 | Doxycyclin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709488 | DOXYCYCLINHYCLAT | 1.2.40.0.34.5.221:100000092638 | DOXYCYCLINE HYCLATE | active | 57.7 | mg | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | 49.95966 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929923001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1272976 | CLARINASE RET TBL 5/120MG | Clarinase 5 mg/ 120 mg Retardtabletten | 1.2.40.0.34.4.17:1-19913 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R01BA52 | Pseudoephedrin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709659 | PSEUDOEPHEDRIN SULFAT | 1.2.40.0.34.5.221:100000093436 | PSEUDOEPHEDRINE SULPHATE | active | 120 | mg | 1.2.40.0.34.5.221:100000093436 | PSEUDOEPHEDRINE SULPHATE | 120 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:930155002 | 1.2.40.0.34.5.156:1709242 | LORATADIN | 1.2.40.0.34.5.221:100000092179 | LORATADINE | active | 5 | mg | 1.2.40.0.34.5.221:100000092179 | LORATADINE | 5 | mg | | | | | | | | | | | | 2.16.840.1.113883.6.73:R06AX13 | Loratadin | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273036 | PREPACOL KOMBI OR LSG +FTBL | Prepacol-Kombinationspackung (orale Lösung und Filmtabletten) zur Darmreinigung | 1.2.40.0.34.4.17:1-19960 | GA - aufgehoben | Guerbet | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A06AB52 | Bisacodyl, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705900 | NATRIUMMONOHYDROGENPHOSPHAT | 1.2.40.0.34.5.221:100000078141 | SODIUM PHOSPHATE DIBASIC | active | 7.217 | g | 1.2.40.0.34.5.221:100000078141 | SODIUM PHOSPHATE DIBASIC | 7.217 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:929660001 | 1.2.40.0.34.5.156:1709088 | BISACODYL | 1.2.40.0.34.5.221:100000091949 | BISACODYL | active | 5 | mg | 1.2.40.0.34.5.221:100000091949 | BISACODYL | 5 | mg | 1.2.40.0.34.5.156:1705986 | NATRIUMDIHYDROGENPHOSPHAT | 1.2.40.0.34.5.221:100000078524 | SODIUM DIHYDROGEN PHOSPHATE | active | 16.279 | g | 1.2.40.0.34.5.221:100000078524 | SODIUM DIHYDROGEN PHOSPHATE | 16.279 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273119 | DIFLUCAN KPS 150MG | Diflucan 150 mg - Kapseln | 1.2.40.0.34.4.17:1-19976 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 2 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J02AC01 | Fluconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709504 | FLUCONAZOL | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | active | 150 | mg | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:933703011 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273131 | DIABETEX FTBL 850MG | Diabetex 850 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19855 | GA - zugelassen | Germania Pharmazeutika Ges.m.b.H. | true | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BA02 | Metformin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708825 | METFORMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | active | 850 | mg | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | 850 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933454001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273220 | SEROPRAM FTBL 10MG | Seropram 10 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19871 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AB04 | Citalopram | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708640 | CITALOPRAM HYDROBROMID | 1.2.40.0.34.5.221:100000090554 | CITALOPRAM HYDROBROMIDE | active | 12.49 | mg | 1.2.40.0.34.5.221:100000090554 | CITALOPRAM HYDROBROMIDE | 12.49 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928668001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273237 | SEROPRAM FTBL 10MG | Seropram 10 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19871 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AB04 | Citalopram | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708640 | CITALOPRAM HYDROBROMID | 1.2.40.0.34.5.221:100000090554 | CITALOPRAM HYDROBROMIDE | active | 12.49 | mg | 1.2.40.0.34.5.221:100000090554 | CITALOPRAM HYDROBROMIDE | 12.49 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928668002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273384 | ZOFRAN ZYDIS TBL 4MG | Zofran Zydis 4 mg - Tabletten | 1.2.40.0.34.4.17:1-22512 | GA - zugelassen | Sandoz GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A04AA01 | Ondansetron | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709330 | ONDANSETRON | 1.2.40.0.34.5.221:100000092334 | ONDANSETRON | active | 4 | mg | 1.2.40.0.34.5.221:100000092334 | ONDANSETRON | 4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073682 | Lyophilisat zum Einnehmen | true | human | 1.2.40.0.34.4.26:942266001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273415 | ZOFRAN ZYDIS TBL 8MG | Zofran Zydis 8 mg - Tabletten | 1.2.40.0.34.4.17:1-22513 | GA - zugelassen | Sandoz GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A04AA01 | Ondansetron | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709330 | ONDANSETRON | 1.2.40.0.34.5.221:100000092334 | ONDANSETRON | active | 8 | mg | 1.2.40.0.34.5.221:100000092334 | ONDANSETRON | 8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073682 | Lyophilisat zum Einnehmen | true | human | 1.2.40.0.34.4.26:942265001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273510 | MIRANAX FTBL 550MG | Miranax 550 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19930 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE02 | Naproxen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709277 | NATRIUM NAPROXENAT | 1.2.40.0.34.5.221:100000092256 | NAPROXEN SODIUM | active | 550 | mg | 1.2.40.0.34.5.221:100000092256 | NAPROXEN SODIUM | 550 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930080003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273711 | VENDAL RET FTBL 10MG | Vendal retard 10 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19834 | GA - zugelassen | G.L. Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708617 | MORPHINHYDROCHLORID | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:931613001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273728 | VENDAL RET FTBL 10MG | Vendal retard 10 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19834 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708617 | MORPHINHYDROCHLORID | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:931613006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273734 | VENDAL RET FTBL 30MG | Vendal retard 30 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19837 | GA - zugelassen | G.L. Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708617 | MORPHINHYDROCHLORID | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | active | 30 | mg | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:931345001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273740 | VENDAL RET FTBL 30MG | Vendal retard 30 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19837 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708617 | MORPHINHYDROCHLORID | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | active | 30 | mg | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:931345006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273757 | VENDAL RET FTBL 60MG | Vendal retard 60 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19833 | GA - zugelassen | G.L. Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708617 | MORPHINHYDROCHLORID | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | active | 60 | mg | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:931347001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273763 | VENDAL RET FTBL 60MG | Vendal retard 60 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19833 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708617 | MORPHINHYDROCHLORID | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | active | 60 | mg | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:931347006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273786 | VENDAL RET FTBL 100MG | Vendal retard 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19835 | GA - zugelassen | G.L. Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708617 | MORPHINHYDROCHLORID | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:931346001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273792 | VENDAL RET FTBL 100MG | Vendal retard 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19835 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708617 | MORPHINHYDROCHLORID | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000090494 | MORPHINE HYDROCHLORIDE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:931346006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273800 | VENDAL RET FTBL 200MG | Vendal retard 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19836 | GA - zugelassen | G.L. Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:9412042 | MORPHINHYDROCHLORID TRIHYDRAT | 1.2.40.0.34.5.221:100000091614 | MORPHINE HYDROCHLORIDE TRIHYDRATE | active | 200 | mg | 1.2.40.0.34.5.221:100000091614 | MORPHINE HYDROCHLORIDE TRIHYDRATE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:931344001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273817 | VENDAL RET FTBL 200MG | Vendal retard 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19836 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:9412042 | MORPHINHYDROCHLORID TRIHYDRAT | 1.2.40.0.34.5.221:100000091614 | MORPHINE HYDROCHLORIDE TRIHYDRATE | active | 200 | mg | 1.2.40.0.34.5.221:100000091614 | MORPHINE HYDROCHLORIDE TRIHYDRATE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:931344006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273823 | BROMAZEPAM GEN FTBL 3MG | Bromazepam Genericon 3 mg Filmtabletten | 1.2.40.0.34.4.17:1-19858 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA08 | Bromazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709428 | BROMAZEPAM | 1.2.40.0.34.5.221:100000092554 | BROMAZEPAM | active | 3 | mg | 1.2.40.0.34.5.221:100000092554 | BROMAZEPAM | 3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930231001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273846 | BROMAZEPAM GEN FTBL 3MG | Bromazepam Genericon 3 mg Filmtabletten | 1.2.40.0.34.4.17:1-19858 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA08 | Bromazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709428 | BROMAZEPAM | 1.2.40.0.34.5.221:100000092554 | BROMAZEPAM | active | 3 | mg | 1.2.40.0.34.5.221:100000092554 | BROMAZEPAM | 3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930231002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273875 | DICLOFENAC GEN FTBL 50MG | Diclofenac Genericon 50 mg Filmtabletten | 1.2.40.0.34.4.17:1-18512 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:927657001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273881 | BROMAZEPAM GEN FTBL 6MG | Bromazepam Genericon 6 mg Filmtabletten | 1.2.40.0.34.4.17:1-19857 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA08 | Bromazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709428 | BROMAZEPAM | 1.2.40.0.34.5.221:100000092554 | BROMAZEPAM | active | 6 | mg | 1.2.40.0.34.5.221:100000092554 | BROMAZEPAM | 6 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930058001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1273898 | BROMAZEPAM GEN FTBL 6MG | Bromazepam Genericon 6 mg Filmtabletten | 1.2.40.0.34.4.17:1-19857 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05BA08 | Bromazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709428 | BROMAZEPAM | 1.2.40.0.34.5.221:100000092554 | BROMAZEPAM | active | 6 | mg | 1.2.40.0.34.5.221:100000092554 | BROMAZEPAM | 6 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930058002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1274018 | MICROPAQUE CT KONZ OR SUS | Micropaque CT 50 mg/ml Konzentrat für orale Suspension | 1.2.40.0.34.4.17:1-20434 | GA - zugelassen | Guerbet | true | false | 150 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08BA01 | Bariumsulfat mit Suspensionsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708374 | BARIUMSULFAT | 1.2.40.0.34.5.221:100000089788 | BARIUM SULFATE | active | 7.5 | g | 1.2.40.0.34.5.221:100000089788 | BARIUM SULFATE | 7.5 | g | 1.2.40.0.10.1.4.3.4.3.5:900000000008 | Konzentrat für eine orale / rektale Suspension | true | human | 1.2.40.0.34.4.26:929281001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1274343 | ZOFRAN FTBL 4MG | Zofran 4 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19341 | GA - zugelassen | Sandoz GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A04AA01 | Ondansetron | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709269 | ONDANSETRON HYDROCHLORID | 1.2.40.0.34.5.221:100000092237 | ONDANSETRON HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000092237 | ONDANSETRON HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928961001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1274366 | ZOFRAN FTBL 8MG | Zofran 8 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19343 | GA - zugelassen | Sandoz GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A04AA01 | Ondansetron | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709269 | ONDANSETRON HYDROCHLORID | 1.2.40.0.34.5.221:100000092237 | ONDANSETRON HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000092237 | ONDANSETRON HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928962001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1274395 | VICARD TBL 1MG | Vicard 1 mg - Tabletten | 1.2.40.0.34.4.17:1-18683 | GA - zugelassen | Amdipharm Limited | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G04CA03 | Terazosin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:10242403 | TERAZOSINHYDROCHLORID DIHYDRAT | 1.2.40.0.34.5.221:100000086021 | TERAZOSIN HYDROCHLORIDE DIHYDRATE | active | 1.187 | mg | 1.2.40.0.34.5.221:100000086021 | TERAZOSIN HYDROCHLORIDE DIHYDRATE | 1.187 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927193002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1274521 | BIOCEF FTBL 200MG | Prodoxsef 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20161 | GA - aufgehoben | Sandoz GmbH | false | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01DD13 | Cefpodoxim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708912 | CEFPODOXIM PROXETIL | 1.2.40.0.34.5.221:100000091579 | CEFPODOXIME PROXETIL | active | 260.8 | mg | 1.2.40.0.34.5.221:100000091579 | CEFPODOXIME PROXETIL | 260.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930926005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1274538 | BIOCEF FTBL 200MG | Prodoxsef 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20161 | GA - aufgehoben | Sandoz GmbH | false | false | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01DD13 | Cefpodoxim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708912 | CEFPODOXIM PROXETIL | 1.2.40.0.34.5.221:100000091579 | CEFPODOXIME PROXETIL | active | 260.8 | mg | 1.2.40.0.34.5.221:100000091579 | CEFPODOXIME PROXETIL | 260.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930926003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1274573 | METHOTREXAT LED TBL | Methotrexat "Lederle" 2,5 mg - Tabletten | 1.2.40.0.34.4.17:10496 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:L04AX03 | Methotrexat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708507 | METHOTREXAT | 1.2.40.0.34.5.221:100000090250 | METHOTREXATE | active | 2.5 | mg | 1.2.40.0.34.5.221:100000090250 | METHOTREXATE | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:125627002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1274604 | DECAPEPTYL FSPR 0,1MG 1ML | Decapeptyl 0,1 mg - Fertigspritzen | 1.2.40.0.34.4.17:1-22758 | GA - zugelassen | Ferring Arzneimittel Ges.m.b.H. | true | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:L02AE04 | Triptorelin | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1708622 | TRIPTORELIN ACETAT | 1.2.40.0.34.5.221:100000090505 | TRIPTORELIN ACETAT | active | | | 1.2.40.0.34.5.221:100000090505 | TRIPTORELIN ACETAT | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1274656 | SINEMET RET TBL | Sinemet retard - Tabletten | 1.2.40.0.34.4.17:1-19687 | GA - aufgehoben | Merck Sharp & Dohme Ges.m.b.H. | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:N04BA02 | Levodopa und Decarboxylasehemmer | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708535 | CARBIDOPA | 1.2.40.0.34.5.221:100000090314 | CARBIDOPA | active | 54 | mg | 1.2.40.0.34.5.221:100000090314 | CARBIDOPA | 54 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:928934001 | 1.2.40.0.34.5.156:1707406 | LEVODOPA | 1.2.40.0.34.5.221:100000085446 | LEVODOPA | active | 200 | mg | 1.2.40.0.34.5.221:100000085446 | LEVODOPA | 200 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1274662 | TOBRASIX AMP 160MG/2ML | Tobrasix 160 mg/2 ml Injektionslösung bzw. Konzentrat zur Herstellung einer Infusionslösung | 1.2.40.0.34.4.17:1-19875 | GA - zugelassen | INFECTOPHARM Arzneimittel und Consilium GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01GB01 | Tobramycin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708735 | TOBRAMYCIN | 1.2.40.0.34.5.221:100000091065 | TOBRAMYCIN | active | 160 | mg | 1.2.40.0.34.5.221:100000091065 | TOBRAMYCIN | 160 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000116188 | Solution for injection/concentrate for solution for infusion | true | human | 1.2.40.0.34.4.26:930462002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1274797 | GUTTALAX TR | Guttalax - Tropfen | 1.2.40.0.34.4.17:17160 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A06AB08 | Natriumpicosulfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707244 | NATRIUM PICOSULFAT | 1.2.40.0.34.5.221:100000085034 | SODIUM PICOSULFATE | active | 225 | mg | 1.2.40.0.34.5.221:100000085034 | SODIUM PICOSULFATE | 225 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:124162001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1274857 | CATHEJELL DIPH/CHX SPR 8,5G | Cathejell Diphenhydramin 1 % / Chlorhexidin 0,05 % - Gel (sterile Einmalabgabeform) | 1.2.40.0.34.4.17:1-09414 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:900000000006 | Applikationssystem (NE) | 2.16.840.1.113883.6.73:N01BX | Andere Lokalanästhetika | 1.2.40.0.10.1.4.3.4.3.4:100000073638 | Anwendung in der Harnröhre | | | | | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 0.085 | g | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 0.085 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073880 | Gel zur Anwendung in der Harnröhre | true | human | 1.2.40.0.34.4.26:126321002 | 1.2.40.0.34.5.156:1709371 | CHLORHEXIDIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDINE DIHYDROCHLORIDE | active | 0.00425 | g | 1.2.40.0.34.5.221:100000092395 | CHLORHEXIDINE DIHYDROCHLORIDE | 0.00425 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1275029 | HYDOFTAL AU-SLB 1,5% | Hydoftal 1,5 % - Augensalbe | 1.2.40.0.34.4.17:9842 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 5 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:S01CA03 | Hydrocortison und Antiinfektiva | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1708440 | NEOMYCIN SULFAT | 1.2.40.0.34.5.221:100000090029 | NEOMYCIN SULFATE | active | 0.025 | g | 1.2.40.0.34.5.221:100000090456 | NEOMYCIN | 0.000037 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073772 | Augensalbe | true | human | 1.2.40.0.34.4.26:120627002 | 1.2.40.0.34.5.156:1709281 | HYDROCORTISON ACETAT | 1.2.40.0.34.5.221:100000092260 | HYDROCORTISONE ACETATE | active | 0.0375 | g | 1.2.40.0.34.5.221:100000092260 | HYDROCORTISONE ACETATE | 0.0375 | g | 1.2.40.0.34.5.156:1709485 | HYDROCORTISON | 1.2.40.0.34.5.221:100000092635 | HYDROCORTISONE | active | 0.0375 | g | 1.2.40.0.34.5.221:100000092635 | HYDROCORTISONE | 0.0375 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1275070 | PHYS KOCHS.FRE GLIFL 100ML | Physiologische Kochsalzlösung "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:1-16417 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 900 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 900 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126043015 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1275087 | PHYS KOCHS.FRE GLIFL 100/250 | Physiologische Kochsalzlösung "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:1-16417 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 900 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 900 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126043017 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1275288 | DIFLUCAN TRSFT 10MG/ML | Diflucan 10 mg/ml Trockensaft | 1.2.40.0.34.4.17:1-19988 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 35 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J02AC01 | Fluconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709504 | FLUCONAZOL | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | active | 350 | mg | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | 350 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:930641002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1275294 | DIFLUCAN TRSFT 40MG/ML | Diflucan 40 mg/ml Trockensaft | 1.2.40.0.34.4.17:1-19991 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 35 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J02AC01 | Fluconazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709504 | FLUCONAZOL | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | active | 1400 | mg | 1.2.40.0.34.5.221:100000092657 | FLUCONAZOLE | 1400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:930642001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1275532 | KLACID GRAN OR SUS 125MG 1G | Klacid 125 mg/5 ml - Granulat für orale Suspension | 1.2.40.0.34.4.17:1-19911 | GA - zugelassen | Viatris Austria GmbH | true | true | 40 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01FA09 | Clarithromycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709351 | CLARITHROMYCIN | 1.2.40.0.34.5.221:100000092364 | CLARITHROMYCIN | active | 1 | g | 1.2.40.0.34.5.221:100000092364 | CLARITHROMYCIN | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073650 | Granulat zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:930367001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1275549 | KLACID GRAN OR SUS 125MG 2G | Klacid 125 mg/5 ml - Granulat für orale Suspension | 1.2.40.0.34.4.17:1-19911 | GA - zugelassen | Viatris Austria GmbH | true | true | 80 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01FA09 | Clarithromycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709351 | CLARITHROMYCIN | 1.2.40.0.34.5.221:100000092364 | CLARITHROMYCIN | active | 2 | g | 1.2.40.0.34.5.221:100000092364 | CLARITHROMYCIN | 2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073650 | Granulat zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:930367002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1275638 | ISMN GEN RET KPS 60MG | ISMN Genericon retard 60 mg Kapseln | 1.2.40.0.34.4.17:1-19922 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01DA14 | Isosorbidmononitrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708568 | ISOSORBIDMONONITRAT | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | active | 60 | mg | 1.2.40.0.34.5.221:100000090392 | ISOSORBIDE MONONITRATE | 60 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073663 | Hartkapsel mit veränderter Wirkstofffreisetzung | true | human | 1.2.40.0.34.4.26:930198001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1275673 | DEPAKINE CHR.RET FTBL 300MG | Depakine chrono retard 300 mg Filmtabletten | 1.2.40.0.34.4.17:1-19787 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073530 | Mehrdosenbehältnis | 2.16.840.1.113883.6.73:N03AG01 | Valproinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708579 | VALPROINSÄURE | 1.2.40.0.34.5.221:100000090423 | VALPROIC ACID | active | 87 | mg | 1.2.40.0.34.5.221:100000090423 | VALPROIC ACID | 87 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:928876001 | 1.2.40.0.34.5.156:1708859 | NATRIUM VALPROAT | 1.2.40.0.34.5.221:100000091448 | SODIUM VALPROATE | active | 199.8 | mg | 1.2.40.0.34.5.221:100000091448 | SODIUM VALPROATE | 199.8 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1275710 | DEPAKINE CHR.RET FTBL 500MG | Depakine chrono retard 500 mg Filmtabletten | 1.2.40.0.34.4.17:1-19786 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073530 | Mehrdosenbehältnis | 2.16.840.1.113883.6.73:N03AG01 | Valproinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708579 | VALPROINSÄURE | 1.2.40.0.34.5.221:100000090423 | VALPROIC ACID | active | 145 | mg | 1.2.40.0.34.5.221:100000090423 | VALPROIC ACID | 145 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:928875001 | 1.2.40.0.34.5.156:1708859 | NATRIUM VALPROAT | 1.2.40.0.34.5.221:100000091448 | SODIUM VALPROATE | active | 333 | mg | 1.2.40.0.34.5.221:100000091448 | SODIUM VALPROATE | 333 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1275822 | ADVANTAN CR | Advantan 0,1 % - Creme | 1.2.40.0.34.4.17:1-19575 | GA - zugelassen | LEO PHARMA A/S | true | true | 300 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:900000000007 | Tiegel (NE) | 2.16.840.1.113883.6.73:D07AC14 | Methylprednisolonaceponat | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709200 | METHYLPREDNISOLON ACEPONAT | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | active | 0.3 | g | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:929404001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1275839 | ADVANTAN SLB | Advantan 0,1 % - Salbe | 1.2.40.0.34.4.17:1-19576 | GA - zugelassen | LEO PHARMA A/S | true | true | 300 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:900000000007 | Tiegel (NE) | 2.16.840.1.113883.6.73:D07AC14 | Methylprednisolonaceponat | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709200 | METHYLPREDNISOLON ACEPONAT | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | active | 0.3 | g | 1.2.40.0.34.5.221:100000092126 | METHYLPREDNISOLONE ACEPONATE | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:929406001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1275934 | FLOLAN TRSUB +LSM 0,5MG | Flolan 0,5 mg - Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | 1.2.40.0.34.4.17:1-20059 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | false | 1 | 2.16.840.1.113883.6.8:{Packung} | Packung(en) | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B01AC09 | Epoprostenol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708807 | NATRIUM EPOPROSTENOLAT | 1.2.40.0.34.5.221:100000091340 | EPOPROSTENOL SODIUM | active | 0.531 | mg | 1.2.40.0.34.5.221:100000091340 | EPOPROSTENOL SODIUM | 0.531 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073860 | Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:930629002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276017 | PSORCUTAN SLB | Psorcutan - Salbe | 1.2.40.0.34.4.17:1-20045 | GA - zugelassen | Leo Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D05AX02 | Calcipotriol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:10305148 | CALCIPOTRIOL, WASSERFREI | 1.2.40.0.34.5.221:100000088915 | CALCIPOTRIOL, ANHYDROUS | active | 1500 | µg | 1.2.40.0.34.5.221:100000088915 | CALCIPOTRIOL, ANHYDROUS | 1500 | µg | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:931432001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276023 | PSORCUTAN SLB | Psorcutan - Salbe | 1.2.40.0.34.4.17:1-20045 | GA - zugelassen | Leo Pharma GmbH | true | false | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:D05AX02 | Calcipotriol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:10305148 | CALCIPOTRIOL, WASSERFREI | 1.2.40.0.34.5.221:100000088915 | CALCIPOTRIOL, WASSERFREI | active | | | 1.2.40.0.34.5.221:100000088915 | CALCIPOTRIOL, WASSERFREI | | | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276075 | KREON KPS 25.000 E | Kreon 25.000 Einheiten - Kapseln | 1.2.40.0.34.4.17:1-20005 | GA - zugelassen | Viatris Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A09AA02 | Multienzyme (Lipase, Protease etc.) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706275 | PANKREAS(EXTRAKT) | 1.2.40.0.34.5.221:100000079736 | PANCREAS EXTRACT | active | 300 | mg | 1.2.40.0.34.5.221:100000079736 | PANCREAS EXTRACT | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:930186004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276081 | KREON KPS 25.000 E BP10X50 | Kreon 25.000 Einheiten - Kapseln | 1.2.40.0.34.4.17:1-20005 | GA - zugelassen | Viatris Austria GmbH | true | true | 500 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A09AA02 | Multienzyme (Lipase, Protease etc.) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706275 | PANKREAS(EXTRAKT) | 1.2.40.0.34.5.221:100000079736 | PANCREAS EXTRACT | active | 300 | mg | 1.2.40.0.34.5.221:100000079736 | PANCREAS EXTRACT | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:930186001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276098 | ULCUSAN TRSTAMP +LSM | Ulcusan 20 mg Trockenstechampullen mit Lösungsmittel | 1.2.40.0.34.4.17:1-20056 | GA - aufgehoben | Kwizda Pharma GmbH | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A02BA03 | Famotidin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709350 | FAMOTIDIN | 1.2.40.0.34.5.221:100000092363 | FAMOTIDINE | active | 20 | mg | 1.2.40.0.34.5.221:100000092363 | FAMOTIDINE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073868 | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:929934001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276218 | PENTASA RET TBL 500MG | Pentasa retard 500 mg - Tabletten | 1.2.40.0.34.4.17:1-20047 | GA - zugelassen | Ferring Arzneimittel Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07EC02 | Mesalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709091 | MESALAZIN | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | active | 500 | mg | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:930813001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276230 | PENTASA SUPP 1G | Pentasa 1 g - Zäpfchen | 1.2.40.0.34.4.17:1-20055 | GA - zugelassen | Ferring Arzneimittel Ges.m.b.H. | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07EC02 | Mesalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709091 | MESALAZIN | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | active | 1000 | mg | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:930777002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276247 | PENTASA KLYSMA 1G/100ML | Pentasa 1 g - Klysma | 1.2.40.0.34.4.17:1-19907 | GA - zugelassen | Ferring Arzneimittel Ges.m.b.H. | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A07EC02 | Mesalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1709091 | MESALAZIN | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | active | 1000 | mg | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073830 | Rektalsuspension | true | human | 1.2.40.0.34.4.26:929100001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276394 | CANDIBENE CR 1% | Candibene 1 % - Creme | 1.2.40.0.34.4.17:1-19997 | GA - zugelassen | Teva B.V. | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D01AC01 | Clotrimazol | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709166 | CLOTRIMAZOL | 1.2.40.0.34.5.221:100000092074 | CLOTRIMAZOLE | active | 0.3 | g | 1.2.40.0.34.5.221:100000092074 | CLOTRIMAZOLE | 0.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:930394001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276419 | CANDIBENE VAG-TBL 100MG | Candibene 100 mg - Vaginaltabletten | 1.2.40.0.34.4.17:1-19999 | GA - zugelassen | Teva B.V. | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G01AF02 | Clotrimazol | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1709166 | CLOTRIMAZOL | 1.2.40.0.34.5.221:100000092074 | CLOTRIMAZOLE | active | 100 | mg | 1.2.40.0.34.5.221:100000092074 | CLOTRIMAZOLE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073824 | Vaginaltablette | true | human | 1.2.40.0.34.4.26:930392001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276425 | CANDIBENE VAG-TBL 200MG | Candibene 200 mg - Vaginaltabletten | 1.2.40.0.34.4.17:1-20000 | GA - zugelassen | Teva B.V. | true | true | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G01AF02 | Clotrimazol | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1709166 | CLOTRIMAZOL | 1.2.40.0.34.5.221:100000092074 | CLOTRIMAZOLE | active | 200 | mg | 1.2.40.0.34.5.221:100000092074 | CLOTRIMAZOLE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073824 | Vaginaltablette | true | human | 1.2.40.0.34.4.26:930393001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276431 | FURON TBL 40MG | Furon 40 mg - Tabletten | 1.2.40.0.34.4.17:1-20060 | GA - zugelassen | Teva B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03CA01 | Furosemid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930251001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276448 | MONTANA HAUSTR | MONTANA HAUSTROPFEN Flüssigkeit zum Einnehmen | 1.2.40.0.34.4.17:738049 | GA - registriert | Pharmonta Dr. Fischer GmbH | true | true | 500 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A15 | Appetit stimulierende Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709272 | MENTHAE PIPERITAE AETHEROLEUM | 1.2.40.0.34.5.221:100000092241 | PEPPERMINT OIL | active | | | 1.2.40.0.34.5.221:100000092241 | PEPPERMINT OIL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073645 | Flüssigkeit zum Einnehmen | true | human | 1.2.40.0.34.4.26:958261001 | 1.2.40.0.34.5.156:1712632 | LUPULI FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000004166 | LUPULI FLOS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000004166 | LUPULI FLOS (EXTRACT) | | | 1.2.40.0.34.5.156:1709970 | AURANTII AMARI EPICARPIUM ET MESOCARPIUM (AUSZUG) | 1.2.40.0.34.5.221:900000000201 | AURANTII AMARI EPICARPIUM ET MESOCARPIUM (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000201 | AURANTII AMARI EPICARPIUM ET MESOCARPIUM (EXTRACT) | | | | | | | | | 1.2.40.0.34.5.156:1710066 | CARVI FRUCTUS (AUSZUG) | 1.2.40.0.34.5.221:900000000297 | CARVI FRUCTUS (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000297 | CARVI FRUCTUS (EXTRACT) | | | 1.2.40.0.34.5.156:1710112 | CINNAMOMI CORTEX (AUSZUG) | 1.2.40.0.34.5.221:900000000343 | CINNAMOMI CORTEX (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000343 | CINNAMOMI CORTEX (EXTRACT) | | | 1.2.40.0.34.5.156:1710301 | GENTIANAE RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000000532 | GENTIANAE RADIX (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000000532 | GENTIANAE RADIX (EXTRACT) | | | | | | | 1.2.40.0.34.5.156:1710813 | TARAXACI RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000001048 | TARAXACI RADIX (EXTRACT) | active | | | 1.2.40.0.34.5.221:900000001048 | TARAXACI RADIX (EXTRACT) | | | 1.2.40.0.34.5.156:1712761 | MISCHEXTRAKT | 1.2.40.0.34.5.221:900000004454 | MIXED EXTRACT | active | 500 | ml | 1.2.40.0.34.5.221:900000004454 | MIXED EXTRACT | 500 | ml | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276454 | FURON TBL 40MG | Furon 40 mg - Tabletten | 1.2.40.0.34.4.17:1-20060 | GA - zugelassen | Teva B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03CA01 | Furosemid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930251002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276460 | FURON AMP 20MG 2ML | Furon 20 mg - Ampullen | 1.2.40.0.34.4.17:1-20066 | GA - zugelassen | Teva B.V. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C03CA01 | Furosemid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:930252001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276477 | FURON IKONZ AMP 250MG/25ML | Furon 250 mg - Konzentrat zur Infusionsbereitung | 1.2.40.0.34.4.17:1-20075 | GA - zugelassen | Teva B.V. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C03CA01 | Furosemid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 0.25 | g | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 0.25 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:930253001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276589 | PENBENE TRSFT 400T. IE | Penbene 400.000 I.E./5 ml - Trockensaft | 1.2.40.0.34.4.17:1-20035 | GA - aufgehoben | ratiopharm Arzneimittel Vertriebs GmbH | false | false | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708516 | PHENOXYMETHYLPENICILLIN-KALIUM | 1.2.40.0.34.5.221:100000090273 | PHENOXYMETHYLPENICILLIN POTASSIUM | active | 261.44 | mg | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | 235.806069 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073650 | Granulat zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:930266001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276595 | PENBENE TRSFT 400T. IE | Penbene 400.000 I.E./5 ml - Trockensaft | 1.2.40.0.34.4.17:1-20035 | GA - aufgehoben | ratiopharm Arzneimittel Vertriebs GmbH | false | false | 150 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708516 | PHENOXYMETHYLPENICILLIN-KALIUM | 1.2.40.0.34.5.221:100000090273 | PHENOXYMETHYLPENICILLIN POTASSIUM | active | 261.44 | mg | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | 235.806069 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073650 | Granulat zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:930266002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276603 | PENBENE FTBL 1MIO IE | Penbene 1 Mio. I.E. - Filmtabletten | 1.2.40.0.34.4.17:1-20037 | GA - zugelassen | Teva B.V. | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708516 | PHENOXYMETHYLPENICILLIN-KALIUM | 1.2.40.0.34.5.221:100000090273 | PHENOXYMETHYLPENICILLIN POTASSIUM | active | 654 | mg | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | 589.875954 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930278001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276626 | PENBENE FTBL 1MIO IE | Penbene 1 Mio. I.E. - Filmtabletten | 1.2.40.0.34.4.17:1-20037 | GA - zugelassen | Teva B.V. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708516 | PHENOXYMETHYLPENICILLIN-KALIUM | 1.2.40.0.34.5.221:100000090273 | PHENOXYMETHYLPENICILLIN POTASSIUM | active | 654 | mg | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | 589.875954 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930278002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276649 | PENTOMER AMP 300MG 15ML | Pentomer 300 mg - Ampullen | 1.2.40.0.34.4.17:1-19936 | GA - aufgehoben | Teva B.V. | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 300 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:929141001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276678 | REGAINE LSG 2% | Regaine 2 % - Lösung | 1.2.40.0.34.4.17:1-20070 | GA - zugelassen | Johnson & Johnson Ges.m.b.H. | true | true | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D11AX01 | Minoxidil | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708556 | MINOXIDIL | 1.2.40.0.34.5.221:100000090366 | MINOXIDIL | active | 1.2 | g | 1.2.40.0.34.5.221:100000090366 | MINOXIDIL | 1.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:927395003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276810 | ACCUZIDE FTBL | Accuzide Filmtabletten | 1.2.40.0.34.4.17:1-20206 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09BA06 | Quinapril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 12.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:931354001 | 1.2.40.0.34.5.156:1708604 | QUINAPRIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090468 | QUINAPRIL HYDROCHLORIDE | active | 10.832 | mg | 1.2.40.0.34.5.221:100000090468 | QUINAPRIL HYDROCHLORIDE | 10.832 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276827 | ACCUZIDE FTBL FTE | Accuzide forte Filmtabletten | 1.2.40.0.34.4.17:1-20208 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09BA06 | Quinapril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 12.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933997001 | 1.2.40.0.34.5.156:1708604 | QUINAPRIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090468 | QUINAPRIL HYDROCHLORIDE | active | 21.664 | mg | 1.2.40.0.34.5.221:100000090468 | QUINAPRIL HYDROCHLORIDE | 21.664 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276916 | GRACIAL TBL | Gracial - Tabletten | 1.2.40.0.34.4.17:1-20025 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 22 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AB05 | Desogestrel und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.07 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.07 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930106001 | 1.2.40.0.34.5.156:1706864 | DESOGESTREL | 1.2.40.0.34.5.221:100000083191 | DESOGESTREL | active | 0.15 | mg | 1.2.40.0.34.5.221:100000083191 | DESOGESTREL | 0.15 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276922 | GRACIAL TBL 3X22 | Gracial - Tabletten | 1.2.40.0.34.4.17:1-20025 | GA - zugelassen | Aspen Pharma Trading Limited | true | true | 66 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03AB05 | Desogestrel und Estrogen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708983 | ETHINYLESTRADIOL | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | active | 0.07 | mg | 1.2.40.0.34.5.221:100000091721 | ETHINYLESTRADIOL | 0.07 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930106002 | 1.2.40.0.34.5.156:1706864 | DESOGESTREL | 1.2.40.0.34.5.221:100000083191 | DESOGESTREL | active | 0.15 | mg | 1.2.40.0.34.5.221:100000083191 | DESOGESTREL | 0.15 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1276939 | ACT-HIB TRSTAMP +LSM | Act-HIB Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension | 1.2.40.0.34.4.17:2-00101 | GA - aufgehoben | Sanofi Vaccines | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J07AG01 | Haemophilus-influenzae B, gereinigtes Antigen konjugiert | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1712678 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:900000004292 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | active | 10 | µg | 1.2.40.0.34.5.221:900000004292 | HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE) | 10 | µg | 1.2.40.0.10.1.4.3.4.3.5:100000073869 | Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension | true | human | 1.2.40.0.34.4.26:931020001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277146 | MAGN VERLA FTBL | Magnesium Verla Filmtabletten | 1.2.40.0.34.4.17:13116 | GA - zugelassen | Kwizda Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A12CC30 | Magnesium (verschiedene Salze in Kombination) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1710459 | MAGNESIUM DI(HYDROGENGLUTAMAT) | 1.2.40.0.34.5.221:100000086158 | MAGNESIUM DI(HYDROGENGLUTAMATE) | active | 165.4 | mg | 1.2.40.0.34.5.221:100000086158 | MAGNESIUM DI(HYDROGENGLUTAMATE) | 165.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:126290002 | 1.2.40.0.34.5.156:1708780 | MAGNESIUMCITRAT | 1.2.40.0.34.5.221:100000091252 | MAGNESIUM CITRATE | active | 436.8 | mg | 1.2.40.0.34.5.221:100000091252 | MAGNESIUM CITRATE | 436.8 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277175 | BAMBEC TBL 10MG | Bambec 10 mg - Tabletten | 1.2.40.0.34.4.17:1-19970 | GA - zugelassen | Astrazeneca Österreich GmbH | true | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:R03CC12 | Bambuterol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709554 | BAMBUTEROL HYDROCHLORID | 1.2.40.0.34.5.221:100000092785 | BAMBUTEROL HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000092785 | BAMBUTEROL HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:929434003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277206 | CYPROSTOL TBL | Cyprostol - Tabletten | 1.2.40.0.34.4.17:1-19557 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BB01 | Misoprostol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709386 | MISOPROSTOL | 1.2.40.0.34.5.221:100000092418 | MISOPROSTOL | active | 0.2 | mg | 1.2.40.0.34.5.221:100000092418 | MISOPROSTOL | 0.2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:928584001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277301 | PROTAGENT EINM.AU-TR 0,4ML | Protagent - Einmalaugentropfen | 1.2.40.0.34.4.17:1-20437 | GA - aufgehoben | Alcon Ophthalmika GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073550 | Einzeldosisbehältnis | 2.16.840.1.113883.6.73:S01XA20 | Künstliche Tränen und andere indifferente Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709362 | POVIDON | 1.2.40.0.34.5.221:100000092381 | POVIDONE | active | 8 | mg | 1.2.40.0.34.5.221:100000092381 | POVIDONE | 8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | false | human | 1.2.40.0.34.4.26:932701001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277382 | SULMYCIN IMPL.SCHWAMM 5X 5 | Sulmycin Implant - Schwamm | 1.2.40.0.34.4.17:1-20152 | GA - zugelassen | N.V. Serb S.A. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075249 | zur Implantation | | | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 2.17 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 1.530757 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073874 | Implantat | true | human | 1.2.40.0.34.4.26:931352003 | 1.2.40.0.34.5.156:1705989 | KOLLAGEN | 1.2.40.0.34.5.221:100000078529 | COLLAGEN | active | 2.8 | mg | 1.2.40.0.34.5.221:100000078529 | COLLAGEN | 2.8 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277399 | SULMYCIN IMPL.SCHWAMM 10X10 | Sulmycin Implant - Schwamm | 1.2.40.0.34.4.17:1-20152 | GA - zugelassen | N.V. Serb S.A. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01GB03 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075249 | zur Implantation | | | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 2.17 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 1.530757 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073874 | Implantat | true | human | 1.2.40.0.34.4.26:931352001 | 1.2.40.0.34.5.156:1705989 | KOLLAGEN | 1.2.40.0.34.5.221:100000078529 | COLLAGEN | active | 2.8 | mg | 1.2.40.0.34.5.221:100000078529 | COLLAGEN | 2.8 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277548 | METOPROLOL GEN TBL 50MG | Metoprolol Genericon 50 mg Tabletten | 1.2.40.0.34.4.17:1-20052 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930904001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277554 | METOPROLOL GEN TBL 50MG | Metoprolol Genericon 50 mg Tabletten | 1.2.40.0.34.4.17:1-20052 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930904002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277560 | METOPROLOL GEN TBL 100MG | Metoprolol Genericon 100 mg Tabletten | 1.2.40.0.34.4.17:1-20053 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930901001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277577 | METOPROLOL GEN TBL 100MG | Metoprolol Genericon 100 mg Tabletten | 1.2.40.0.34.4.17:1-20053 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930901002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277732 | IBUTOP CR | Dolgit akut Schmerzcreme, 50 mg/g Creme | 1.2.40.0.34.4.17:1-20032 | GA - zugelassen | Dolorgiet GmbH & Co. KG | true | false | 50 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:M02AA13 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | | | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | false | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277749 | IBUTOP CR | Dolgit akut Schmerzcreme, 50 mg/g Creme | 1.2.40.0.34.4.17:1-20032 | GA - zugelassen | Dolorgiet GmbH & Co. KG | true | false | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:M02AA13 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | | | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | false | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277755 | COROTROP AMP 10MG 10ML | Corotrop 10 mg Ampullen | 1.2.40.0.34.4.17:1-20100 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C01CE02 | Milrinon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1706456 | MILRINON | 1.2.40.0.34.5.221:100000080655 | MILRINONE | active | 100 | mg | 1.2.40.0.34.5.221:100000080655 | MILRINONE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:929130001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277790 | SERACTIL FTBL 200MG | Seractil 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20001 | GA - zugelassen | Gebro Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:M01AE14 | Dexibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706866 | DEXIBUPROFEN | 1.2.40.0.34.5.221:100000083204 | DEXIBUPROFEN | active | | | 1.2.40.0.34.5.221:100000083204 | DEXIBUPROFEN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277809 | SERACTIL FTBL 200MG | Seractil 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20001 | GA - zugelassen | Gebro Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:M01AE14 | Dexibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706866 | DEXIBUPROFEN | 1.2.40.0.34.5.221:100000083204 | DEXIBUPROFEN | active | | | 1.2.40.0.34.5.221:100000083204 | DEXIBUPROFEN | | | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277815 | SERACTIL FTBL 300MG | Seractil 300 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20002 | GA - zugelassen | Gebro Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE14 | Dexibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706866 | DEXIBUPROFEN | 1.2.40.0.34.5.221:100000083204 | DEXIBUPROFEN | active | 300 | mg | 1.2.40.0.34.5.221:100000083204 | DEXIBUPROFEN | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930319004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277821 | SERACTIL FTBL 300MG | Seractil 300 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20002 | GA - zugelassen | Gebro Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE14 | Dexibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706866 | DEXIBUPROFEN | 1.2.40.0.34.5.221:100000083204 | DEXIBUPROFEN | active | 300 | mg | 1.2.40.0.34.5.221:100000083204 | DEXIBUPROFEN | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930319002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277838 | GENTAX AU-SLB | Gentax Augensalbe | 1.2.40.0.34.4.17:1-18881 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 5 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:S01AA11 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 0.025 | g | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 0.017635 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073772 | Augensalbe | true | human | 1.2.40.0.34.4.26:927795001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277844 | GENTAX AU-TR | Gentax - Augentropfen | 1.2.40.0.34.4.17:1-18880 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01AA11 | Gentamicin | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 0.0235 | g | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 0.016577 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:927805001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277896 | ARISTOCOR AMP 5ML | Aristocor 10 mg/ml - Injektionslösung | 1.2.40.0.34.4.17:1-20061 | GA - zugelassen | Viatris Austria GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:C01BC04 | Flecainid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708577 | FLECAINID ACETAT | 1.2.40.0.34.5.221:100000090415 | FLECAINID ACETAT | active | | | 1.2.40.0.34.5.221:100000090415 | FLECAINID ACETAT | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277904 | ARISTOCOR TBL 100MG | Aristocor 100 mg - Tabletten | 1.2.40.0.34.4.17:1-20057 | GA - zugelassen | Viatris Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01BC04 | Flecainid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708577 | FLECAINID ACETAT | 1.2.40.0.34.5.221:100000090415 | FLECAINIDE ACETATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090415 | FLECAINIDE ACETATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927645001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1277910 | ARISTOCOR TBL 100MG | Aristocor 100 mg - Tabletten | 1.2.40.0.34.4.17:1-20057 | GA - zugelassen | Viatris Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01BC04 | Flecainid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708577 | FLECAINID ACETAT | 1.2.40.0.34.5.221:100000090415 | FLECAINIDE ACETATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090415 | FLECAINIDE ACETATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927645002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1278039 | CEREMIN FTBL 40MG | Ceremin 40 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20124 | GA - zugelassen | Dr. Willmar Schwabe GmbH & Co. KG | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06DX02 | Ginkgo biloba | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705908 | GINKGONIS FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:100000078164 | GINKGO BILOBA EXTRACT | active | 40 | mg | 1.2.40.0.34.5.221:100000078164 | GINKGO BILOBA EXTRACT | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:931287002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1278074 | HOVA FTBL | Hova - Filmtabletten | 1.2.40.0.34.4.17:1-19906 | GA - zugelassen | Haleon - Gebro Consumer Health GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05CM | Andere Hypnotika und Sedativa | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712632 | LUPULI FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000004166 | LUPULI FLOS (EXTRACT) | active | 45.5 | mg | 1.2.40.0.34.5.221:900000004166 | LUPULI FLOS (EXTRACT) | 45.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | false | human | 1.2.40.0.34.4.26:930503002 | 1.2.40.0.34.5.156:1710857 | VALERIANAE RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000001092 | VALERIANAE RADIX (EXTRACT) | active | 200.2 | mg | 1.2.40.0.34.5.221:900000001092 | VALERIANAE RADIX (EXTRACT) | 200.2 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1278128 | GENOTROPIN PLV+LSM ZWKP5,3MG | Genotropin 5,3 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | 1.2.40.0.34.4.17:1-20078 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073503 | Patrone | 2.16.840.1.113883.6.73:H01AC01 | Somatropin | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1708200 | SOMATROPIN | 1.2.40.0.34.5.221:100000089188 | SOMATROPIN | active | 5.3 | mg | 1.2.40.0.34.5.221:100000089188 | SOMATROPIN | 5.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073868 | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:930057003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1278393 | TRIPRIM TBL 100MG | Triprim 100 mg - Tabletten | 1.2.40.0.34.4.17:1-20194 | GA - aufgehoben | Teva B.V. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01EA01 | Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | 100 | mg | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:931378001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1278401 | TRIPRIM TBL 200MG | Triprim 200 mg - Tabletten | 1.2.40.0.34.4.17:1-20195 | GA - zugelassen | Teva B.V. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01EA01 | Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | 200 | mg | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:931379001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1278418 | TRIPRIM TBL 200MG | Triprim 200 mg - Tabletten | 1.2.40.0.34.4.17:1-20195 | GA - zugelassen | Teva B.V. | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01EA01 | Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | 200 | mg | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:931379002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1278424 | TRIPRIM TBL 300MG | Triprim 300 mg - Tabletten | 1.2.40.0.34.4.17:1-20196 | GA - zugelassen | Teva B.V. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01EA01 | Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | 300 | mg | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:931380002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1278430 | TRIPRIM TBL 300MG | Triprim 300 mg - Tabletten | 1.2.40.0.34.4.17:1-20196 | GA - zugelassen | Teva B.V. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01EA01 | Trimethoprim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709366 | TRIMETHOPRIM | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | active | 300 | mg | 1.2.40.0.34.5.221:100000092388 | TRIMETHOPRIM | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:931380001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1278453 | FARMORUBICIN STAMP 10MG GL | Farmorubicin 10 mg Stechampulle | 1.2.40.0.34.4.17:1-20181 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01DB03 | Epirubicin | 1.2.40.0.10.1.4.3.4.3.4:100000073612 | intravesikale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | 1.2.40.0.34.5.156:1708644 | EPIRUBICIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090558 | EPIRUBICIN HYDROCHLORIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000090558 | EPIRUBICIN HYDROCHLORIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:930272001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1278594 | PHYS KOCHS.FRE GLIFL 250ML | Physiologische Kochsalzlösung "Fresenius" - Infusionslösung | 1.2.40.0.34.4.17:1-16417 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BB01 | Elektrolyte | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 2250 | mg | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 2250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:126043023 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1279122 | PULMOZYME VERNEB 2500E/2,5ML | PULMOZYME 2.500 E./2,5 ml - Lösung für einen Vernebler | 1.2.40.0.34.4.17:1-20192 | GA - zugelassen | Roche Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:R05CB13 | Dornase alfa (Desoxyribonuclease) | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1706471 | DORNASE ALFA | 1.2.40.0.34.5.221:100000080786 | DORNASE ALFA | active | 2500 | mg | 1.2.40.0.34.5.221:100000080786 | DORNASE ALFA | 2500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073911 | Verneblungslösung | true | human | 1.2.40.0.34.4.26:934067001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1279145 | ZYRTEC OR LSG 1MG/ML | Zyrtec 1 mg/ml - orale Lösung | 1.2.40.0.34.4.17:1-20143 | GA - zugelassen | UCB Pharma Ges.m.b.H. | true | true | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R06AE07 | Cetirizin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708870 | CETIRIZIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000091468 | CETIRIZINE DIHYDROCHLORIDE | active | 0.06 | g | 1.2.40.0.34.5.221:100000091468 | CETIRIZINE DIHYDROCHLORIDE | 0.06 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:931116004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1279168 | ZYRTEC TR 10MG/ML | Zyrtec 10 mg/ml - Tropfen | 1.2.40.0.34.4.17:1-20142 | GA - zugelassen | UCB Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R06AE07 | Cetirizin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708870 | CETIRIZIN DIHYDROCHLORID | 1.2.40.0.34.5.221:100000091468 | CETIRIZINE DIHYDROCHLORIDE | active | 0.2 | g | 1.2.40.0.34.5.221:100000091468 | CETIRIZINE DIHYDROCHLORIDE | 0.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:931117003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1279292 | ZITHROMAX TRSFT 200MG/5ML | Zithromax 200 mg/5 ml - Trockensaft | 1.2.40.0.34.4.17:1-20313 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01FA10 | Azithromycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7033707 | AZITHROMYCIN DIHYDRAT | 1.2.40.0.34.5.221:100000089047 | AZITHROMYCIN DIHYDRATE | active | 629.0048 | mg | 1.2.40.0.34.5.221:100000089047 | AZITHROMYCIN DIHYDRATE | 629.0048 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:930255001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1279300 | ZITHROMAX TRSFT 200MG/5ML | Zithromax 200 mg/5 ml - Trockensaft | 1.2.40.0.34.4.17:1-20313 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01FA10 | Azithromycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7033707 | AZITHROMYCIN DIHYDRAT | 1.2.40.0.34.5.221:100000089047 | AZITHROMYCIN DIHYDRATE | active | 1257.5088 | mg | 1.2.40.0.34.5.221:100000089047 | AZITHROMYCIN DIHYDRATE | 1257.5088 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:930255002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1279464 | DIPROFORTE GEL | Diproforte - Gel | 1.2.40.0.34.4.17:1-20044 | GA - aufgehoben | Merck Sharp & Dohme Ges.m.b.H. | false | false | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.064 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.064 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:930869001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1279470 | DIPROFORTE GEL | Diproforte - Gel | 1.2.40.0.34.4.17:1-20044 | GA - aufgehoben | Merck Sharp & Dohme Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC01 | Betamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708884 | BETAMETHASON DIPROPIONAT | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | active | 0.064 | g | 1.2.40.0.34.5.221:100000091514 | BETAMETHASONE DIPROPIONATE | 0.064 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:930869002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1279493 | NAVOBAN AMP 5MG | Navoban 5 mg - Ampullen | 1.2.40.0.34.4.17:1-20296 | GA - zugelassen | EFISCIENCE | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A04AA03 | Tropisetron | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | 1.2.40.0.34.5.156:1709323 | TROPISETRON HYDROCHLORID | 1.2.40.0.34.5.221:100000092326 | TROPISETRON HYDROCHLORIDE | active | 5.64 | mg | 1.2.40.0.34.5.221:100000092326 | TROPISETRON HYDROCHLORIDE | 5.64 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:931264001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1279518 | NAVOBAN KPS 5MG | Navoban 5 mg - Kapseln | 1.2.40.0.34.4.17:1-20294 | GA - zugelassen | EFISCIENCE | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A04AA03 | Tropisetron | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709323 | TROPISETRON HYDROCHLORID | 1.2.40.0.34.5.221:100000092326 | TROPISETRON HYDROCHLORIDE | active | 5.64 | mg | 1.2.40.0.34.5.221:100000092326 | TROPISETRON HYDROCHLORIDE | 5.64 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:931263001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1279820 | COLDANGIN LPAS | Coldangin Lutschpastillen | 1.2.40.0.34.4.17:16860 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 24 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R02AA03 | Dichlorbenzylalkohol | 1.2.40.0.10.1.4.3.4.3.4:100000073620 | Anwendung in der Mundhöhle | | | | | 1.2.40.0.34.5.156:1707726 | AMYLMETACRESOL | 1.2.40.0.34.5.221:100000086938 | AMYLMETACRESOL | active | 0.8 | mg | 1.2.40.0.34.5.221:100000086938 | AMYLMETACRESOL | 0.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073703 | Lutschtablette | false | human | 1.2.40.0.34.4.26:124035001 | 1.2.40.0.34.5.156:1709393 | 2,4-DICHLORBENZYLALKOHOL | 1.2.40.0.34.5.221:100000092427 | DICHLOROBENZYL ALCOHOL | active | 1.5 | mg | 1.2.40.0.34.5.221:100000092427 | DICHLOROBENZYL ALCOHOL | 1.5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1279889 | NAPROBENE FTBL 250MG | Naprobene 250 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20171 | GA - aufgehoben | ratiopharm Arzneimittel Vertriebs GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE02 | Naproxen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708562 | NAPROXEN | 1.2.40.0.34.5.221:100000090383 | NAPROXEN | active | 250 | mg | 1.2.40.0.34.5.221:100000090383 | NAPROXEN | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:931318001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1279895 | KLACID LACTOB TRSUB INF 0,5G | Klacid - Lactobionat 0,5 g - Trockensubstanz zur Infusionsbereitung | 1.2.40.0.34.4.17:1-20013 | GA - zugelassen | Viatris Austria GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01FA09 | Clarithromycin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709351 | CLARITHROMYCIN | 1.2.40.0.34.5.221:100000092364 | CLARITHROMYCIN | active | 500 | mg | 1.2.40.0.34.5.221:100000092364 | CLARITHROMYCIN | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:931281001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1279932 | BACTROBAN NA-SLB | Bactroban - Nasensalbe | 1.2.40.0.34.4.17:1-20226 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 3 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D06AX09 | Mupirocin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:10242401 | CALCIUM MUPIROCINAT DIHYDRAT | 1.2.40.0.34.5.221:100000088393 | MUPIROCIN CALCIUM DIHYDRATE | active | 0.0645 | g | 1.2.40.0.34.5.221:100000088393 | MUPIROCIN CALCIUM DIHYDRATE | 0.0645 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073806 | Nasensalbe | true | human | 1.2.40.0.34.4.26:930997001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1280183 | NAPROBENE FTBL 500MG | Naprobene 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20173 | GA - zugelassen | Teva B.V. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE02 | Naproxen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708562 | NAPROXEN | 1.2.40.0.34.5.221:100000090383 | NAPROXEN | active | 500 | mg | 1.2.40.0.34.5.221:100000090383 | NAPROXEN | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:931315001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1280208 | NAPROBENE FTBL 500MG | Naprobene 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20173 | GA - zugelassen | Teva B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE02 | Naproxen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708562 | NAPROXEN | 1.2.40.0.34.5.221:100000090383 | NAPROXEN | active | 500 | mg | 1.2.40.0.34.5.221:100000090383 | NAPROXEN | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:931315002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1280266 | CEPHALOBENE FTBL 500MG | Cephalobene 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20280 | GA - zugelassen | Teva B.V. | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01DB01 | Cefalexin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708819 | CEFALEXIN | 1.2.40.0.34.5.221:100000091359 | CEFALEXIN | active | 526 | mg | 1.2.40.0.34.5.221:100000091359 | CEFALEXIN | 526 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:931553001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1280272 | CEPHALOBENE FTBL 1000MG | Cephalobene 1000 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20281 | GA - zugelassen | Teva B.V. | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01DB01 | Cefalexin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7034728 | CEFALEXIN MONOHYDRAT | 1.2.40.0.34.5.221:100000092402 | CEFALEXIN MONOHYDRATE | active | 1052 | mg | 1.2.40.0.34.5.221:100000091359 | CEFALEXIN | 1000.149024 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:931552002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1280668 | LIPCOR KPS 200MG | Lipcor 200 mg - Kapseln | 1.2.40.0.34.4.17:1-20108 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C10AB05 | Fenofibrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709418 | FENOFIBRAT | 1.2.40.0.34.5.221:100000092530 | FENOFIBRATE | active | 200 | mg | 1.2.40.0.34.5.221:100000092530 | FENOFIBRATE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:930560001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1280800 | ALLERGODIL FTBL | Allergodil - Filmtabletten | 1.2.40.0.34.4.17:1-19732 | GA - aufgehoben | Viatris Austria GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AX19 | Azelastin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708582 | AZELASTIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090426 | AZELASTINE HYDROCHLORIDE | active | 2.2 | mg | 1.2.40.0.34.5.221:100000090426 | AZELASTINE HYDROCHLORIDE | 2.2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929114002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1280817 | ALLERGODIL FTBL | Allergodil - Filmtabletten | 1.2.40.0.34.4.17:1-19732 | GA - aufgehoben | Viatris Austria GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AX19 | Azelastin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708582 | AZELASTIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090426 | AZELASTINE HYDROCHLORIDE | active | 2.2 | mg | 1.2.40.0.34.5.221:100000090426 | AZELASTINE HYDROCHLORIDE | 2.2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929114001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1280846 | OTREON FTBL 200MG | Otreon 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20210 | GA - aufgehoben | Daiichi Sankyo Austria GmbH | false | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:J01DD13 | Cefpodoxim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708912 | CEFPODOXIM PROXETIL | 1.2.40.0.34.5.221:100000091579 | CEFPODOXIME PROXETIL | active | 260.8 | mg | 1.2.40.0.34.5.221:100000091579 | CEFPODOXIME PROXETIL | 260.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930925002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1280852 | OTREON FTBL 200MG | Otreon 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20210 | GA - aufgehoben | Daiichi Sankyo Austria GmbH | false | false | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:J01DD13 | Cefpodoxim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708912 | CEFPODOXIM PROXETIL | 1.2.40.0.34.5.221:100000091579 | CEFPODOXIME PROXETIL | active | 260.8 | mg | 1.2.40.0.34.5.221:100000091579 | CEFPODOXIME PROXETIL | 260.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930925001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1280869 | OTREON GRAN OR SUS 50MG/5ML | Otreon 50 mg/5 ml - Granulat für orale Suspension | 1.2.40.0.34.4.17:1-20214 | GA - aufgehoben | Daiichi Sankyo Austria GmbH | false | false | 24 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:J01DD13 | Cefpodoxim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708912 | CEFPODOXIM PROXETIL | 1.2.40.0.34.5.221:100000091579 | CEFPODOXIME PROXETIL | active | 1.3 | g | 1.2.40.0.34.5.221:100000091579 | CEFPODOXIME PROXETIL | 1.3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073650 | Granulat zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:930923001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1280875 | OTREON GRAN OR SUS 100MG/5ML | Otreon 100 mg/5 ml - Granulat für orale Suspension | 1.2.40.0.34.4.17:1-20212 | GA - aufgehoben | Daiichi Sankyo Austria GmbH | false | false | 24 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:J01DD13 | Cefpodoxim | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708912 | CEFPODOXIM PROXETIL | 1.2.40.0.34.5.221:100000091579 | CEFPODOXIME PROXETIL | active | 2.608 | g | 1.2.40.0.34.5.221:100000091579 | CEFPODOXIME PROXETIL | 2.608 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073650 | Granulat zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:930927001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1280906 | TARIVID FTBL 400MG | Tarivid 400 mg Filmtabletten | 1.2.40.0.34.4.17:1-20081 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:J01MA01 | Ofloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709310 | OFLOXACIN | 1.2.40.0.34.5.221:100000092309 | OFLOXACIN | active | 400 | mg | 1.2.40.0.34.5.221:100000092309 | OFLOXACIN | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930943001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1280929 | RULIDE FTBL 300MG | Rulide 300 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20222 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:J01FA06 | Roxithromycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709172 | ROXITHROMYCIN | 1.2.40.0.34.5.221:100000092081 | ROXITHROMYCIN | active | 300 | mg | 1.2.40.0.34.5.221:100000092081 | ROXITHROMYCIN | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:931872001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281024 | NAPROXEN GEN TBL 500MG | Naproxen Genericon 500 mg Tabletten | 1.2.40.0.34.4.17:1-20205 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE02 | Naproxen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708562 | NAPROXEN | 1.2.40.0.34.5.221:100000090383 | NAPROXEN | active | 500 | mg | 1.2.40.0.34.5.221:100000090383 | NAPROXEN | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:929955004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281030 | NAPROXEN GEN TBL 500MG | Naproxen Genericon 500 mg Tabletten | 1.2.40.0.34.4.17:1-20205 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE02 | Naproxen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708562 | NAPROXEN | 1.2.40.0.34.5.221:100000090383 | NAPROXEN | active | 500 | mg | 1.2.40.0.34.5.221:100000090383 | NAPROXEN | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:929955005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281047 | SUCRALFAT GEN TBL 1G | Sucralfat Genericon 1 g Tabletten | 1.2.40.0.34.4.17:1-19954 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BX02 | Sucralfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708896 | SUCRALFAT | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | active | 1000 | mg | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930090001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281053 | SUCRALFAT GEN TBL 1G | Sucralfat Genericon 1 g Tabletten | 1.2.40.0.34.4.17:1-19954 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BX02 | Sucralfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708896 | SUCRALFAT | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | active | 1000 | mg | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930090002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281136 | ULTRAVIST 300MG J/ML IFL 200 | Ultravist 300 mg J/ml - Infusionsflaschen | 1.2.40.0.34.4.17:1-18546 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08AB05 | Iopromid | 1.2.40.0.10.1.4.3.4.3.4:100000073598 | intralymphatische Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1709106 | IOPROMID | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | active | 124680 | mg | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | 124680 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927375009 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073590 | intracardiale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281159 | ULTRAVIST 300MG J/ML IFL 500 | Ultravist 300 mg J/ml - Infusionsflaschen | 1.2.40.0.34.4.17:1-18546 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08AB05 | Iopromid | 1.2.40.0.10.1.4.3.4.3.4:100000073598 | intralymphatische Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1709106 | IOPROMID | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | active | 311700 | mg | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | 311700 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927375012 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073590 | intracardiale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281171 | ULTRAVIST 370MG J/ML IFL 500 | Ultravist 370 mg J/ml - Infusionsflaschen | 1.2.40.0.34.4.17:1-18548 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:V08AB05 | Iopromid | 1.2.40.0.10.1.4.3.4.3.4:100000073598 | intralymphatische Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.34.5.156:1709106 | IOPROMID | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | active | 384430 | mg | 1.2.40.0.34.5.221:100000091984 | IOPROMIDE | 384430 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927373005 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073590 | intracardiale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281202 | CONCOR PLUS FTBL 5/12,5MG | Concor plus 5 mg/12,5 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20079 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07BB07 | Bisoprolol und Thiazide | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709671 | BISOPROLOL HEMIFUMARAT | 1.2.40.0.34.5.221:100000115415 | BISOPROLOL HEMIFUMARATE | active | 5 | mg | 1.2.40.0.34.5.221:100000115415 | BISOPROLOL HEMIFUMARATE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930995001 | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 12.5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281219 | CONCOR PLUS FTBL 5/12,5MG | Concor plus 5 mg/12,5 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20079 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07BB07 | Bisoprolol und Thiazide | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709671 | BISOPROLOL HEMIFUMARAT | 1.2.40.0.34.5.221:100000115415 | BISOPROLOL HEMIFUMARATE | active | 5 | mg | 1.2.40.0.34.5.221:100000115415 | BISOPROLOL HEMIFUMARATE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930995002 | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 12.5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281231 | VERTIROSAN B6 VIT SUPP | Vertirosan Vitamin B6 - Zäpfchen | 1.2.40.0.34.4.17:11831 | GA - zugelassen | UMIP Limited | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:R06AA52 | Diphenhydramin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073843 | Zäpfchen | true | human | 1.2.40.0.34.4.26:126273001 | 1.2.40.0.34.5.156:1709065 | DIMENHYDRINAT | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | active | 50 | mg | 1.2.40.0.34.5.221:100000091918 | DIMENHYDRINATE | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281337 | LANOC TBL 50MG | Lanoc 50 mg - Tabletten | 1.2.40.0.34.4.17:1-20050 | GA - zugelassen | G.L. Pharma GmbH | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930902001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281343 | LANOC TBL 50MG | Lanoc 50 mg - Tabletten | 1.2.40.0.34.4.17:1-20050 | GA - zugelassen | G.L. Pharma GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930902002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281366 | LANOC TBL 100MG | Lanoc 100 mg - Tabletten | 1.2.40.0.34.4.17:1-20051 | GA - zugelassen | G.L. Pharma GmbH | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930899001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281372 | LANOC TBL 100MG | Lanoc 100 mg - Tabletten | 1.2.40.0.34.4.17:1-20051 | GA - zugelassen | G.L. Pharma GmbH | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930899002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281426 | WICK FORMEL 44 HU-STILL | Wick Formel 44 Hustenstiller - Sirup 20 mg / 15 ml | 1.2.40.0.34.4.17:1-20403 | GA - zugelassen | Wick Pharma Zweigniederlassung der Procter & Gamble GmbH | true | true | 120 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R05DA09 | Dextromethorphan | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709135 | DEXTROMETHORPHAN HYDROBROMID | 1.2.40.0.34.5.221:100000092035 | DEXTROMETHORPHAN HYDROBROMIDE | active | 160 | mg | 1.2.40.0.34.5.221:100000092035 | DEXTROMETHORPHAN HYDROBROMIDE | 160 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073652 | Sirup | true | human | 1.2.40.0.34.4.26:931286001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281455 | METRONIDAZOL SAN IFL 500MG | Metronidazol Sandoz 500 mg - Infusionsflasche | 1.2.40.0.34.4.17:1-18816 | GA - aufgehoben | Sandoz GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01XD01 | Metronidazol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708522 | METRONIDAZOL | 1.2.40.0.34.5.221:100000090285 | METRONIDAZOLE | active | 5 | mg | 1.2.40.0.34.5.221:100000090285 | METRONIDAZOLE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:927726002 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:P01AB01 | Metronidazol | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281521 | PASCOMUCIL PLV | Pascomucil Pulver zur Herstellung einer Suspension zum Einnehmen | 1.2.40.0.34.4.17:1-30348 | GA - aufgehoben | Pascoe pharmazeutische Präparate GmbH | false | false | 200 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:A06AC01 | Ispaghula (Flohsamen) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707903 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | 1.2.40.0.34.5.221:100000087827 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | active | 500 | g | 1.2.40.0.34.5.221:100000087827 | PLANTAGINIS OVATAE SEMINIS TEGUMENTUM | 500 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | false | human | 1.2.40.0.34.4.26:956353001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281538 | LODRONAT FTBL 520MG | Lodronat 520 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20266 | GA - zugelassen | Esteve Pharmaceuticals GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M05BA02 | Clodronsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7511229 | DINATRIUM CLODRONAT TETRAHYDRAT | 1.2.40.0.34.5.221:100000156397 | DISODIUM CLODRONATE TETRAHYDRATE | active | 649.73 | mg | 1.2.40.0.34.5.221:100000156397 | DISODIUM CLODRONATE TETRAHYDRATE | 649.73 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929020001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281550 | EUTHYROX TBL 50MCG | Euthyrox 50 Mikrogramm Tabletten | 1.2.40.0.34.4.17:1-24159 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA01 | Levothyroxin-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.05 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.05 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:945255002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281567 | EUTHYROX TBL 50MCG | Euthyrox 50 Mikrogramm Tabletten | 1.2.40.0.34.4.17:1-24159 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA01 | Levothyroxin-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.05 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.05 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:945255001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281573 | EUTHYROX TBL 100MCG | Euthyrox 100 Mikrogramm Tabletten | 1.2.40.0.34.4.17:1-24161 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA01 | Levothyroxin-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.1 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:945251002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281596 | EUTHYROX TBL 100MCG | Euthyrox 100 Mikrogramm Tabletten | 1.2.40.0.34.4.17:1-24161 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA01 | Levothyroxin-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.1 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:945251001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281604 | EUTHYROX TBL 125MCG | Euthyrox 125 Mikrogramm Tabletten | 1.2.40.0.34.4.17:1-24162 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA01 | Levothyroxin-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.125 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.125 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:945256002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281610 | EUTHYROX TBL 125MCG | Euthyrox 125 Mikrogramm Tabletten | 1.2.40.0.34.4.17:1-24162 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA01 | Levothyroxin-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.125 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.125 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:945256001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281627 | EUTHYROX TBL 150MCG | Euthyrox 150 Mikrogramm Tabletten | 1.2.40.0.34.4.17:1-24163 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA01 | Levothyroxin-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.15 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:945252002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281633 | EUTHYROX TBL 150MCG | Euthyrox 150 Mikrogramm Tabletten | 1.2.40.0.34.4.17:1-24163 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:H03AA01 | Levothyroxin-Natrium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708946 | LEVOTHYROXIN NATRIUM | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | active | 0.15 | mg | 1.2.40.0.34.5.221:100000091647 | LEVOTHYROXINE SODIUM | 0.15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:945252001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281656 | MAXI-KALZ BRTBL 1000MG | Maxi - Kalz 1000 mg - Brausetabletten | 1.2.40.0.34.4.17:15996 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:A12AA04 | Calciumcarbonat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708886 | CALCIUMCARBONAT | 1.2.40.0.34.5.221:100000091518 | CALCIUM CARBONATE | active | 2500 | mg | 1.2.40.0.34.5.221:100000091518 | CALCIUM CARBONATE | 2500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073681 | Brausetablette | true | human | 1.2.40.0.34.4.26:124017003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281923 | FOSITENS TBL 20MG | Fositens 20 mg - Tabletten | 1.2.40.0.34.4.17:1-20268 | GA - zugelassen | Bausch Health Ireland Limited | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA09 | Fosinopril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709337 | FOSINOPRIL NATRIUM | 1.2.40.0.34.5.221:100000092343 | FOSINOPRIL SODIUM | active | 20 | mg | 1.2.40.0.34.5.221:100000092343 | FOSINOPRIL SODIUM | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:929040001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281981 | ETALPHA AMP 1MCG/0,5ML | Etalpha 1 µg - Ampullen | 1.2.40.0.34.4.17:1-20154 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A11CC03 | Alfacalcidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708894 | ALFACALCIDOL | 1.2.40.0.34.5.221:100000091540 | ALFACALCIDOL | active | 1 | µg | 1.2.40.0.34.5.221:100000091540 | ALFACALCIDOL | 1 | µg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:930657001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1281998 | ETALPHA AMP 2MCG/1ML | Etalpha 2 µg - Ampullen | 1.2.40.0.34.4.17:1-20155 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A11CC03 | Alfacalcidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708894 | ALFACALCIDOL | 1.2.40.0.34.5.221:100000091540 | ALFACALCIDOL | active | 2 | µg | 1.2.40.0.34.5.221:100000091540 | ALFACALCIDOL | 2 | µg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:930656001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282093 | FOSITENS TBL 10MG | Fositens 10 mg - Tabletten | 1.2.40.0.34.4.17:1-20267 | GA - zugelassen | Bausch Health Ireland Limited | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA09 | Fosinopril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709337 | FOSINOPRIL NATRIUM | 1.2.40.0.34.5.221:100000092343 | FOSINOPRIL SODIUM | active | 10 | mg | 1.2.40.0.34.5.221:100000092343 | FOSINOPRIL SODIUM | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:929041001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282101 | NORFLOXACIN-SAN FTBL 400MG | Norfloxacin Sandoz 400 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20252 | GA - zugelassen | Sandoz GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01MA06 | Norfloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708743 | NORFLOXACIN | 1.2.40.0.34.5.221:100000091076 | NORFLOXACIN | active | 400 | mg | 1.2.40.0.34.5.221:100000091076 | NORFLOXACIN | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930990001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282118 | NORFLOXACIN-SAN FTBL 400MG | Norfloxacin Sandoz 400 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20252 | GA - zugelassen | Sandoz GmbH | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01MA06 | Norfloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708743 | NORFLOXACIN | 1.2.40.0.34.5.221:100000091076 | NORFLOXACIN | active | 400 | mg | 1.2.40.0.34.5.221:100000091076 | NORFLOXACIN | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930990004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282130 | HYDERGIN SRO KPS 6MG | Hydergin SRO 6 mg - Kapseln | 1.2.40.0.34.4.17:1-20522 | GA - aufgehoben | Alfasigma S.p.A. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AE01 | Ergoloidmesylat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706283 | DIHYDROERGOCORNIN METHANSULFONAT | 1.2.40.0.34.5.221:100000079764 | DIHYDROERGOCORNINE MESILATE | active | 2 | mg | 1.2.40.0.34.5.221:100000079764 | DIHYDROERGOCORNINE MESILATE | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073663 | Hartkapsel mit veränderter Wirkstofffreisetzung | true | human | 1.2.40.0.34.4.26:933414001 | 1.2.40.0.34.5.156:1706142 | DIHYDROERGOCRYPTIN METHANSULFONAT | 1.2.40.0.34.5.221:100000079201 | DIHYDROERGOCRYPTINE MESILATE | active | 2 | mg | 1.2.40.0.34.5.221:100000079201 | DIHYDROERGOCRYPTINE MESILATE | 2 | mg | 1.2.40.0.34.5.156:1708734 | DIHYDROERGOCRISTIN METHANSULFONAT | 1.2.40.0.34.5.221:100000091063 | DIHYDROERGOCRISTINE MESILATE | active | 2 | mg | 1.2.40.0.34.5.221:100000091063 | DIHYDROERGOCRISTINE MESILATE | 2 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282236 | MOBILAT SLB | Mobilat - Salbe | 1.2.40.0.34.4.17:12033 | GA - aufgehoben | STADA Arzneimittel Gesellschaft m.b.H. | false | false | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705406 | MUCOPOLYSACCHARIDPOLYSCHWEFELSÄUREESTER | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | active | 20 | g | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | 20 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:129783001 | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 200 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 200 | g | 1.2.40.0.34.5.156:1712635 | NEBENNIERE(EXTRAKT) | 1.2.40.0.34.5.221:900000004182 | ADRENAL GLAND EXTRACT | active | 100 | g | 1.2.40.0.34.5.221:900000004182 | ADRENAL GLAND EXTRACT | 100 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282242 | MOBILAT GEL | Mobilat - Gel | 1.2.40.0.34.4.17:15208 | GA - aufgehoben | STADA Arzneimittel Gesellschaft m.b.H. | false | false | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AC | Zubereitungen mit Salicylsäure-Derivaten | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705406 | MUCOPOLYSACCHARIDPOLYSCHWEFELSÄUREESTER | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | active | 20 | g | 1.2.40.0.34.5.221:100000076242 | MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER | 20 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:129784001 | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 200 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 200 | g | 1.2.40.0.34.5.156:1712635 | NEBENNIERE(EXTRAKT) | 1.2.40.0.34.5.221:900000004182 | ADRENAL GLAND EXTRACT | active | 100 | g | 1.2.40.0.34.5.221:900000004182 | ADRENAL GLAND EXTRACT | 100 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282288 | HYPREN PLUS HCT TBL 2,5/12,5 | Hypren plus HCT 2,5 mg/12,5 mg Tabletten | 1.2.40.0.34.4.17:1-20396 | GA - aufgehoben | Astrazeneca Österreich GmbH | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09BA05 | Ramipril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709271 | RAMIPRIL | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | active | 2.5 | mg | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:931257001 | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 12.5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282294 | HYPREN PLUS HCT TBL FTE 5/25 | Hypren plus HCT forte 5 mg/25 mg Tabletten | 1.2.40.0.34.4.17:1-20400 | GA - aufgehoben | Astrazeneca Österreich GmbH | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09BA05 | Ramipril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709271 | RAMIPRIL | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | active | 5 | mg | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:931254001 | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 25 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282319 | PLENDIL RET FTBL 2,5MG | Plendil retard 2,5 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20523 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08CA02 | Felodipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708427 | FELODIPIN | 1.2.40.0.34.5.221:100000089989 | FELODIPINE | active | 2.5 | mg | 1.2.40.0.34.5.221:100000089989 | FELODIPINE | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:931459001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282348 | TRITAZIDE TBL 2,5/12,5MG | Tritazide 2,5 mg/12,5 mg - Tabletten | 1.2.40.0.34.4.17:1-20398 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:C09BA05 | Ramipril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709271 | RAMIPRIL | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | active | | | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZID | active | | | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZID | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282354 | TRITAZIDE TBL 5/25MG | Tritazide 5 mg/25 mg - Tabletten | 1.2.40.0.34.4.17:1-20395 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:C09BA05 | Ramipril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709271 | RAMIPRIL | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | active | | | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26: | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZID | active | | | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZID | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282414 | DUPHASTON FTBL 10MG | Duphaston 10 mg - Filmtabletten | 1.2.40.0.34.4.17:1-15953 | GA - zugelassen | Theramex Ireland Limited | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03DB01 | Dydrogesteron | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706440 | DYDROGESTERON | 1.2.40.0.34.5.221:100000080500 | DYDROGESTERONE | active | 10 | mg | 1.2.40.0.34.5.221:100000080500 | DYDROGESTERONE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:122397003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282420 | ESKAZOLE TBL 400MG | Eskazole 400 mg - Tabletten | 1.2.40.0.34.4.17:1-20484 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:P02CA03 | Albendazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707870 | ALBENDAZOL | 1.2.40.0.34.5.221:100000087712 | ALBENDAZOLE | active | 400 | mg | 1.2.40.0.34.5.221:100000087712 | ALBENDAZOLE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933318001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282489 | MORAPID FTBL 10MG | Morapid 10 mg Filmtabletten | 1.2.40.0.34.4.17:1-20439 | GA - aufgehoben | Mundipharma Ges.m.b.H. | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705405 | MORPHINSULFAT | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | active | 10 | mg | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928872001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282495 | MORAPID FTBL 10MG | Morapid 10 mg Filmtabletten | 1.2.40.0.34.4.17:1-20439 | GA - aufgehoben | Mundipharma Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705405 | MORPHINSULFAT | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | active | 10 | mg | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928872002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282503 | MORAPID FTBL 20MG | Morapid 20 mg Filmtabletten | 1.2.40.0.34.4.17:1-20444 | GA - aufgehoben | Mundipharma Ges.m.b.H. | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705405 | MORPHINSULFAT | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | active | 20 | mg | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928871001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282526 | MORAPID FTBL 20MG | Morapid 20 mg Filmtabletten | 1.2.40.0.34.4.17:1-20444 | GA - aufgehoben | Mundipharma Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02AA01 | Morphin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705405 | MORPHINSULFAT | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | active | 20 | mg | 1.2.40.0.34.5.221:100000076239 | MORPHINE SULFATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928871002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282532 | ADRIBLASTIN INJ DFL 10MG | Adriblastin 10 mg Stechampulle | 1.2.40.0.34.4.17:1-20169 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01DB01 | Doxorubicin | 1.2.40.0.10.1.4.3.4.3.4:100000073612 | intravesikale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | 1.2.40.0.34.5.156:1708421 | DOXORUBICIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089971 | DOXORUBICIN HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000089971 | DOXORUBICIN HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:931067001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282621 | ENANTONE-MON DEP 2KSPR | Enantone Monats-Depot - Zweikammerspritze | 1.2.40.0.34.4.17:1-20237 | GA - zugelassen | Takeda Pharma Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:L02AE02 | Leuprorelin | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1708909 | LEUPRORELIN ACETAT | 1.2.40.0.34.5.221:100000091573 | LEUPRORELIN ACETATE | active | 3.75 | mg | 1.2.40.0.34.5.221:100000091573 | LEUPRORELIN ACETATE | 3.75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073869 | Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension | true | human | 1.2.40.0.34.4.26:930688001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282638 | ENANTONE-GYN MON DEP 2KSPR | Enantone-Gyn Monats-Depot - Zweikammerspritze | 1.2.40.0.34.4.17:1-20236 | GA - zugelassen | Takeda Pharma Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:L02AE02 | Leuprorelin | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1708909 | LEUPRORELIN ACETAT | 1.2.40.0.34.5.221:100000091573 | LEUPRORELIN ACETATE | active | 3.75 | mg | 1.2.40.0.34.5.221:100000091573 | LEUPRORELIN ACETATE | 3.75 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073869 | Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension | true | human | 1.2.40.0.34.4.26:930937001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282644 | ADRIBLASTIN INJ DFL 50MG | Adriblastin 50 mg Stechampulle | 1.2.40.0.34.4.17:1-20167 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 25 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01DB01 | Doxorubicin | 1.2.40.0.10.1.4.3.4.3.4:100000073612 | intravesikale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | 1.2.40.0.34.5.156:1708421 | DOXORUBICIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089971 | DOXORUBICIN HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000089971 | DOXORUBICIN HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:931066001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282650 | PENTASA RET TBL 500MG | Pentasa retard 500 mg - Tabletten | 1.2.40.0.34.4.17:1-20047 | GA - zugelassen | Ferring Arzneimittel Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07EC02 | Mesalazin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709091 | MESALAZIN | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | active | 500 | mg | 1.2.40.0.34.5.221:100000091953 | MESALAZINE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:930813003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282756 | CEREBRYL FTBL 1200MG | Cerebryl 1200 mg - Tabletten | 1.2.40.0.34.4.17:1-20450 | GA - aufgehoben | Kwizda Pharma GmbH | false | false | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:N06BX03 | Piracetam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709109 | PIRACETAM | 1.2.40.0.34.5.221:100000091987 | PIRACETAM | active | 1200 | mg | 1.2.40.0.34.5.221:100000091987 | PIRACETAM | 1200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933609002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282868 | DALACIN VAG-CR +7 APPLIK | Dalacin - Vaginalcreme | 1.2.40.0.34.4.17:1-20417 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:G01AA10 | Clindamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1708641 | CLINDAMYCIN PHOSPHAT | 1.2.40.0.34.5.221:100000090555 | CLINDAMYCIN PHOSPHATE | active | 0.952 | g | 1.2.40.0.34.5.221:100000090555 | CLINDAMYCIN PHOSPHATE | 0.952 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073811 | Vaginalcreme | true | human | 1.2.40.0.34.4.26:933289002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282928 | PENTOMER RET FTBL 400MG | Pentomer retard 400 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20392 | GA - zugelassen | Teva B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 400 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:929144001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282934 | PENTOMER RET FTBL 400MG | Pentomer retard 400 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20392 | GA - zugelassen | Teva B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 400 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:929144002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282940 | PENTOMER RET FTBL 600MG | Pentomer retard 600 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20391 | GA - zugelassen | Teva B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 600 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:929143001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282957 | PENTOMER RET FTBL 600MG | Pentomer retard 600 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20391 | GA - zugelassen | Teva B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AD03 | Pentoxifyllin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708940 | PENTOXIFYLLIN | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | active | 600 | mg | 1.2.40.0.34.5.221:100000091628 | PENTOXIFYLLINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:929143002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282986 | VERAPABENE FTBL 40MG | Verapabene 40 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20379 | GA - zugelassen | Teva B.V. | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929279001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1282992 | VERAPABENE FTBL 40MG | Verapabene 40 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20379 | GA - zugelassen | Teva B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929279002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283000 | VERAPABENE FTBL 80MG | Verapabene 80 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20380 | GA - zugelassen | Teva B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 80 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 80 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929278001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283017 | VERAPABENE FTBL 80MG | Verapabene 80 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20380 | GA - zugelassen | Teva B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 80 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 80 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929278002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283023 | VERAPABENE FTBL 120MG | Verapabene 120 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20381 | GA - zugelassen | Teva B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 120 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 120 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929277001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283046 | VERAPABENE FTBL 120MG | Verapabene 120 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20381 | GA - zugelassen | Teva B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 120 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 120 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929277002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283052 | VERAPABENE RET FTBL 240MG | Verapabene retard 240 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20394 | GA - aufgehoben | Teva B.V. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08DA01 | Verapamil | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708608 | VERAPAMIL HYDROCHLORID | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | active | 240 | mg | 1.2.40.0.34.5.221:100000090474 | VERAPAMIL HYDROCHLORIDE | 240 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:929276001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283135 | ADRIBLASTIN INJ DFL 200MG | Adriblastin 200 mg Stechampulle | 1.2.40.0.34.4.17:1-20166 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01DB01 | Doxorubicin | 1.2.40.0.10.1.4.3.4.3.4:100000073612 | intravesikale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | 1.2.40.0.34.5.156:1708421 | DOXORUBICIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089971 | DOXORUBICIN HYDROCHLORIDE | active | 200 | mg | 1.2.40.0.34.5.221:100000089971 | DOXORUBICIN HYDROCHLORIDE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:931065001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283187 | RETROVIR SFT 100MG/10ML | Retrovir 100 mg/10 ml - Saft | 1.2.40.0.34.4.17:1-20397 | GA - zugelassen | Viiv Healthcare B.V. | true | true | 200 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J05AF01 | Zidovudin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707951 | ZIDOVUDIN | 1.2.40.0.34.5.221:100000088002 | ZIDOVUDINE | active | 2 | g | 1.2.40.0.34.5.221:100000088002 | ZIDOVUDINE | 2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:930565002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283276 | FUCIDIN FTBL | Fucidin - Filmtabletten | 1.2.40.0.34.4.17:13998 | GA - zugelassen | Leo Pharma GmbH | true | true | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01XC01 | Fusidinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706178 | NATRIUM FUSIDAT | 1.2.40.0.34.5.221:100000079317 | SODIUM FUSIDATE | active | 250 | mg | 1.2.40.0.34.5.221:100000079317 | SODIUM FUSIDATE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:923329002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283313 | REGAINE LSG 2% BP3X60 | Regaine 2 % - Lösung | 1.2.40.0.34.4.17:1-20070 | GA - zugelassen | Johnson & Johnson Ges.m.b.H. | true | true | 180 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D11AX01 | Minoxidil | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708556 | MINOXIDIL | 1.2.40.0.34.5.221:100000090366 | MINOXIDIL | active | 1.2 | g | 1.2.40.0.34.5.221:100000090366 | MINOXIDIL | 1.2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:927395002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283336 | VOLTAREN OPHTHA AU-TR | Voltaren Ophtha - 1 mg/ml Augentropfen | 1.2.40.0.34.4.17:1-19877 | GA - zugelassen | Laboratoires Thea | true | true | 5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01BC03 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 0.005 | g | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 0.005 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:929304001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283371 | NEO-ANGIN ZUFR PAS | neo-angin zuckerfrei - Pastillen | 1.2.40.0.34.4.17:1-20474 | GA - zugelassen | M.C.M. Klosterfrau Healthcare GmbH | true | true | 24 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R02AA20 | Verschiedene | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707726 | AMYLMETACRESOL | 1.2.40.0.34.5.221:100000086938 | AMYLMETACRESOL | active | 0.6 | mg | 1.2.40.0.34.5.221:100000086938 | AMYLMETACRESOL | 0.6 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073704 | Pastille | false | human | 1.2.40.0.34.4.26:932012001 | 1.2.40.0.34.5.156:7255602 | LEVOMENTHOL | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | active | 5.72 | mg | 1.2.40.0.34.5.221:100000092317 | LEVOMENTHOL | 5.72 | mg | 1.2.40.0.34.5.156:1709393 | 2,4-DICHLORBENZYLALKOHOL | 1.2.40.0.34.5.221:100000092427 | DICHLOROBENZYL ALCOHOL | active | 1.2 | mg | 1.2.40.0.34.5.221:100000092427 | DICHLOROBENZYL ALCOHOL | 1.2 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283394 | RHINOSPRAY PLUS AETHERI.OELE | Rhinospray plus ätherische Öle - Nasenspray | 1.2.40.0.34.4.17:1-20514 | GA - zugelassen | Opella Healthcare Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AA09 | Tramazolin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1707097 | TRAMAZOLIN HYDROCHLORID | 1.2.40.0.34.5.221:100000084659 | TRAMAZOLINE HYDROCHLORIDE | active | 12.65 | mg | 1.2.40.0.34.5.221:100000084659 | TRAMAZOLINE HYDROCHLORIDE | 12.65 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073796 | Nasenspray, Lösung | true | human | 1.2.40.0.34.4.26:931207001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283402 | TRAMAL TR | Tramal Tropfen | 1.2.40.0.34.4.17:17689 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 96 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N02AX01 | Tilidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709643 | TRAMADOLHYDROCHLORID | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | active | 9.6 | g | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | 9.6 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | true | human | 1.2.40.0.34.4.26:921062002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283431 | DUOFILM LSG | Duofilm - Lösung zur äußerlichen Anwendung | 1.2.40.0.34.4.17:1-20422 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D11AF | Warzenmittel und Keratolytika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707758 | MILCHSÄURE | 1.2.40.0.34.5.221:100000087110 | LACTIC ACID | active | 2.505 | g | 1.2.40.0.34.5.221:100000087110 | LACTIC ACID | 2.505 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:928683001 | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 2.505 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 2.505 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283477 | MUPHORAN TRSUB STAMP +LSM | Muphoran 200 mg/4ml Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | 1.2.40.0.34.4.17:1-20502 | GA - zugelassen | Servier Austria GmbH | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01AD05 | Fotemustin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1706436 | FOTEMUSTIN | 1.2.40.0.34.5.221:100000080464 | FOTEMUSTINE | active | 208 | mg | 1.2.40.0.34.5.221:100000080464 | FOTEMUSTINE | 208 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073860 | Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:931606002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283508 | HUMINSULIN NORM PATR 3ML | Huminsulin "Lilly" Normal 100 I.E./ml - Patronen | 1.2.40.0.34.4.17:1-19528 | GA - zugelassen | Eli Lilly Ges.m.b.H. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073503 | Patrone | 2.16.840.1.113883.6.73:A10AB01 | Insulin (human) | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1708397 | INSULIN | 1.2.40.0.34.5.221:100000089878 | INSULIN | active | 0 | mg | 1.2.40.0.34.5.221:100000089878 | INSULIN | 0 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927749002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283514 | HUMINSULIN BASAL PATR 3ML | Huminsulin "Lilly" Basal 100 I.E./ml - Patronen | 1.2.40.0.34.4.17:1-19523 | GA - zugelassen | Eli Lilly Ges.m.b.H. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073503 | Patrone | 2.16.840.1.113883.6.73:A10AC01 | Insulin (human) | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1708397 | INSULIN | 1.2.40.0.34.5.221:100000089878 | INSULIN | active | 300 | IU | 1.2.40.0.34.5.221:100000089878 | INSULIN | 300 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:930213002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283543 | HUMINSULIN PROF III PATR 3ML | Huminsulin "Lilly" Profil III 100 I.E./ml - Patronen | 1.2.40.0.34.4.17:1-19525 | GA - zugelassen | Eli Lilly Ges.m.b.H. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073503 | Patrone | 2.16.840.1.113883.6.73:A10AC01 | Insulin (human) | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1708397 | INSULIN | 1.2.40.0.34.5.221:100000089878 | INSULIN | active | 300 | IU | 1.2.40.0.34.5.221:100000089878 | INSULIN | 300 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:930214002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283603 | TALOXA TBL 600MG | Taloxa 600 mg Tabletten | 1.2.40.0.34.4.17:1-21407 | GA - zugelassen | Organon Healthcare GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AX10 | Felbamat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706544 | FELBAMAT | 1.2.40.0.34.5.221:100000081237 | FELBAMATE | active | 600 | mg | 1.2.40.0.34.5.221:100000081237 | FELBAMATE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933993001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283626 | TALOXA OR SUS 600MG/5ML | Taloxa 600 mg/5 ml - orale Suspension | 1.2.40.0.34.4.17:1-21405 | GA - zugelassen | Organon Healthcare GmbH | true | true | 230 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N03AX10 | Felbamat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706544 | FELBAMAT | 1.2.40.0.34.5.221:100000081237 | FELBAMATE | active | 27.6 | g | 1.2.40.0.34.5.221:100000081237 | FELBAMATE | 27.6 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:934028001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283939 | ERYTHROCIN GRAN 1000MG | Erythrocin 1000 mg - Granulat für orale Suspension | 1.2.40.0.34.4.17:1-18178 | GA - aufgehoben | Amdipharm Limited | false | false | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:J01FA01 | Erythromycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708636 | ERYTHROMYCINETHYLSUCCINAT | 1.2.40.0.34.5.221:100000090545 | ERYTHROMYCIN ETHYLSUCCINATE | active | 1175.5 | mg | 1.2.40.0.34.5.221:100000090545 | ERYTHROMYCIN ETHYLSUCCINATE | 1175.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073650 | Granulat zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:920145002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283945 | DECODERM CR | Decoderm - Creme | 1.2.40.0.34.4.17:14349 | GA - zugelassen | Almirall Hermal GmbH | true | false | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AB07 | Flupredniden | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709051 | FLUPREDNIDEN ACETAT | 1.2.40.0.34.5.221:100000091890 | FLUPREDNIDENE ACETATE | active | 0.015 | g | 1.2.40.0.34.5.221:100000091890 | FLUPREDNIDENE ACETATE | 0.015 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:923996001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1283951 | DECODERM CP CR | Decoderm compositum - Creme | 1.2.40.0.34.4.17:14082 | GA - zugelassen | Almirall Hermal GmbH | true | false | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07CB02 | Flupredniden und Antibiotika | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1707810 | GENTAMICINSULFAT | 1.2.40.0.34.5.221:100000087360 | GENTAMICIN SULFATE | active | 25.05 | mg | 1.2.40.0.34.5.221:100000092787 | GENTAMICIN | 17.670721 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:123128002 | 1.2.40.0.34.5.156:1709051 | FLUPREDNIDEN ACETAT | 1.2.40.0.34.5.221:100000091890 | FLUPREDNIDENE ACETATE | active | 15 | mg | 1.2.40.0.34.5.221:100000091890 | FLUPREDNIDENE ACETATE | 15 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284100 | MIRANAX FTBL 550MG | Miranax 550 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19930 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE02 | Naproxen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709277 | NATRIUM NAPROXENAT | 1.2.40.0.34.5.221:100000092256 | NAPROXEN SODIUM | active | 550 | mg | 1.2.40.0.34.5.221:100000092256 | NAPROXEN SODIUM | 550 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930080002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284206 | DOSTINEX TBL 0,5MG | Dostinex 0,5 mg - Tabletten | 1.2.40.0.34.4.17:1-20438 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 2 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:G02CB03 | Cabergolin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709213 | CABERGOLIN | 1.2.40.0.34.5.221:100000092143 | CABERGOLINE | active | 0.5 | mg | 1.2.40.0.34.5.221:100000092143 | CABERGOLINE | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:931012001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284212 | DOSTINEX TBL 0,5MG | Dostinex 0,5 mg - Tabletten | 1.2.40.0.34.4.17:1-20438 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 8 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:G02CB03 | Cabergolin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709213 | CABERGOLIN | 1.2.40.0.34.5.221:100000092143 | CABERGOLINE | active | 0.5 | mg | 1.2.40.0.34.5.221:100000092143 | CABERGOLINE | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:931012002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284235 | PLENDIL RET FTBL 5MG | Plendil retard 5 mg - Filmtabletten | 1.2.40.0.34.4.17:1-18766 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08CA02 | Felodipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708427 | FELODIPIN | 1.2.40.0.34.5.221:100000089989 | FELODIPINE | active | 5 | mg | 1.2.40.0.34.5.221:100000089989 | FELODIPINE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:927586009 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284264 | ALLOPURINOL HEX TBL 300MG | Allopurinol Hexal 300 mg - Tabletten | 1.2.40.0.34.4.17:16227 | GA - zugelassen | Hexal Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M04AA01 | Allopurinol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709057 | ALLOPURINOL | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | active | 300 | mg | 1.2.40.0.34.5.221:100000091907 | ALLOPURINOL | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:123976001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284376 | FLIXONASE AQUOSUM NA-SPRAY | Flixonase aquosum - Nasenspray | 1.2.40.0.34.4.17:1-19708 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 15 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073553 | Spraydose | 2.16.840.1.113883.6.73:R01AD08 | Fluticason | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1709522 | FLUTICASONPROPIONAT | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | active | 0.05 | mg | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | 0.05 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073809 | Nasenspray, Suspension | true | human | 1.2.40.0.34.4.26:929273001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284399 | FLIXOTIDE DOSAER 0,05MG JUN | Flixotide junior 50 Mikrogramm - Dosieraerosol | 1.2.40.0.34.4.17:1-20552 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:R03BA05 | Fluticason | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1709522 | FLUTICASONPROPIONAT | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | active | 0.05 | mg | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | 0.05 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073838 | Druckgasinhalation, Suspension | true | human | 1.2.40.0.34.4.26:933584001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284407 | FLIXOTIDE DOSAER 0,125MG STA | Flixotide standard 125 Mikrogramm - Dosieraerosol | 1.2.40.0.34.4.17:1-20555 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:R03BA05 | Fluticason | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1709522 | FLUTICASONPROPIONAT | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | active | 0.125 | mg | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | 0.125 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073838 | Druckgasinhalation, Suspension | true | human | 1.2.40.0.34.4.26:933583001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284413 | FLIXOTIDE DOSAER 0,25MG FTE | Flixotide forte 250 Mikrogramm - Dosieraerosol | 1.2.40.0.34.4.17:1-20559 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:R03BA05 | Fluticason | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1709522 | FLUTICASONPROPIONAT | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | active | 0.25 | mg | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | 0.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073838 | Druckgasinhalation, Suspension | true | human | 1.2.40.0.34.4.26:933582001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284494 | DALACIN VAG-CR +3 APPLIK | Dalacin - Vaginalcreme | 1.2.40.0.34.4.17:1-20417 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:G01AA10 | Clindamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073639 | vaginale Anwendung | | | | | 1.2.40.0.34.5.156:1708641 | CLINDAMYCIN PHOSPHAT | 1.2.40.0.34.5.221:100000090555 | CLINDAMYCIN PHOSPHATE | active | 0.476 | g | 1.2.40.0.34.5.221:100000090555 | CLINDAMYCIN PHOSPHATE | 0.476 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073811 | Vaginalcreme | true | human | 1.2.40.0.34.4.26:933289001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284732 | LOSEC MSR KPS 20MG | Losec 20 mg magensaftresistente Kapseln | 1.2.40.0.34.4.17:1-19207 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A02BC01 | Omeprazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709144 | OMEPRAZOL | 1.2.40.0.34.5.221:100000092047 | OMEPRAZOLE | active | 20 | mg | 1.2.40.0.34.5.221:100000092047 | OMEPRAZOLE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073376 | magensaftresistente Hartkapsel | true | human | 1.2.40.0.34.4.26:927476003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284821 | CECLOR FTBL 500MG | Ceclor 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20493 | GA - zugelassen | Arcana Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01DC04 | Cefaclor | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709388 | CEFACLOR MONOHYDRAT | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRATE | active | 523 | mg | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRATE | 523 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933356001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284838 | CECLOR FTBL 750MG | Ceclor 750 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20492 | GA - zugelassen | Arcana Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01DC04 | Cefaclor | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709388 | CEFACLOR MONOHYDRAT | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRATE | active | 784.6 | mg | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRATE | 784.6 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933355001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284844 | CECLOR GRAN FTE 375MG/5ML | Ceclor forte 375 mg/5 ml - Granulat für orale Suspension | 1.2.40.0.34.4.17:1-20494 | GA - zugelassen | Arcana Arzneimittel GmbH | true | true | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01DC04 | Cefaclor | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709388 | CEFACLOR MONOHYDRAT | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRATE | active | 3.9 | g | 1.2.40.0.34.5.221:100000089869 | CEFACLOR MONOHYDRATE | 3.9 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073650 | Granulat zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:933319001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284896 | FENOLIP RET KPS 250MG | Fenolip retard 250 mg - Kapseln | 1.2.40.0.34.4.17:1-20483 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C10AB05 | Fenofibrat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709418 | FENOFIBRAT | 1.2.40.0.34.5.221:100000092530 | FENOFIBRATE | active | 250 | mg | 1.2.40.0.34.5.221:100000092530 | FENOFIBRATE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:933549001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284904 | PEN-V GEN FTBL 1MIO IE | Pen-V Genericon 1 Mio. I.E. Filmtabletten | 1.2.40.0.34.4.17:1-20490 | GA - aufgehoben | Genericon Pharma Ges.m.b.H. | false | false | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708516 | PHENOXYMETHYLPENICILLIN-KALIUM | 1.2.40.0.34.5.221:100000090273 | PHENOXYMETHYLPENICILLIN POTASSIUM | active | 657.9 | mg | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | 593.393563 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933282001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284910 | PEN-V GEN FTBL 1MIO IE | Pen-V Genericon 1 Mio. I.E. Filmtabletten | 1.2.40.0.34.4.17:1-20490 | GA - aufgehoben | Genericon Pharma Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708516 | PHENOXYMETHYLPENICILLIN-KALIUM | 1.2.40.0.34.5.221:100000090273 | PHENOXYMETHYLPENICILLIN POTASSIUM | active | 657.9 | mg | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | 593.393563 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933282002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284927 | PEN-V GEN FTBL 1,5MIO IE | Pen-V Genericon 1,5 Mio.I.E. Filmtabletten | 1.2.40.0.34.4.17:1-20487 | GA - aufgehoben | Genericon Pharma Ges.m.b.H. | false | false | 12 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708516 | PHENOXYMETHYLPENICILLIN-KALIUM | 1.2.40.0.34.5.221:100000090273 | PHENOXYMETHYLPENICILLIN POTASSIUM | active | 986.85 | mg | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | 890.090344 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933281001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284933 | PEN-V GEN FTBL 1,5MIO IE | Pen-V Genericon 1,5 Mio.I.E. Filmtabletten | 1.2.40.0.34.4.17:1-20487 | GA - aufgehoben | Genericon Pharma Ges.m.b.H. | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01CE02 | Phenoxymethylpenicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708516 | PHENOXYMETHYLPENICILLIN-KALIUM | 1.2.40.0.34.5.221:100000090273 | PHENOXYMETHYLPENICILLIN POTASSIUM | active | 986.85 | mg | 1.2.40.0.34.5.221:100000090361 | PHENOXYMETHYLPENICILLIN | 890.090344 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933281002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284956 | CROMOGLIN AU-TR | Cromoglin - Augentropfen | 1.2.40.0.34.4.17:1-20515 | GA - aufgehoben | ratiopharm Arzneimittel Vertriebs GmbH | false | false | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:S01GX01 | Cromoglicinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709682 | DINATRIUM CROMOGLICAT | 1.2.40.0.34.5.221:100000115606 | DISODIUM CROMOGLYCATE | active | 20 | mg | 1.2.40.0.34.5.221:100000115606 | DISODIUM CROMOGLYCATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:931890001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284962 | AEROMUC TBL LSL 600MG | Aeromuc 600 mg - lösliche Tabletten | 1.2.40.0.34.4.17:1-20548 | GA - zugelassen | INFECTOPHARM Arzneimittel und Consilium GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:R05CB01 | Acetylcystein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709282 | ACETYLCYSTEIN | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | active | 600 | mg | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073369 | Tablette zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:933788001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1284979 | IRUXOLUM MONO SLB | Iruxolum Mono Salbe | 1.2.40.0.34.4.17:1-20177 | GA - zugelassen | Smith & Nephew GmbH | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D03BA52 | Clostridiopeptidase, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1706293 | KOLLAGENASE | 1.2.40.0.34.5.221:100000079798 | COLLAGENASE | active | 0.09 | | 1.2.40.0.34.5.221:100000079798 | COLLAGENASE | 0.09 | | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:100000005765 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285016 | LOVENOX FSPR 4000IE/0,4ML | LOVENOX 4.000 IE (40 mg)/0,4 ml Injektionslösung in einer Fertigspritze | 1.2.40.0.34.4.17:1-18662 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:B01AB05 | Enoxaparin | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | 1.2.40.0.34.5.156:1708477 | ENOXAPARIN NATRIUM | 1.2.40.0.34.5.221:100000090152 | ENOXAPARIN SODIUM | active | 40 | mg | 1.2.40.0.34.5.221:100000090152 | ENOXAPARIN SODIUM | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:927581009 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285157 | MONURIL GRAN 3G | Monuril 3 g - Granulat | 1.2.40.0.34.4.17:1-20352 | GA - zugelassen | Zambon S.p.A. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:J01XX01 | Fosfomycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708393 | FOSFOMYCIN-TROMETAMOL | 1.2.40.0.34.5.221:100000089872 | FOSFOMYCIN TROMETAMOL | active | 5.631 | g | 1.2.40.0.34.5.221:100000089872 | FOSFOMYCIN TROMETAMOL | 5.631 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073365 | Granulat zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:929982001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285223 | UROFLO TBL 1MG | Uroflo 1 mg - Tabletten | 1.2.40.0.34.4.17:1-20343 | GA - zugelassen | Amdipharm Limited | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000116195 | Kalenderpackung | 2.16.840.1.113883.6.73:G04CA03 | Terazosin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:10242403 | TERAZOSINHYDROCHLORID DIHYDRAT | 1.2.40.0.34.5.221:100000086021 | TERAZOSIN HYDROCHLORIDE DIHYDRATE | active | 1.187 | mg | 1.2.40.0.34.5.221:100000086021 | TERAZOSIN HYDROCHLORIDE DIHYDRATE | 1.187 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:931418001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285246 | UROFLO TBL 2MG | Uroflo 2 mg - Tabletten | 1.2.40.0.34.4.17:1-20342 | GA - zugelassen | Amdipharm Limited | true | true | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000116195 | Kalenderpackung | 2.16.840.1.113883.6.73:G04CA03 | Terazosin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:10242403 | TERAZOSINHYDROCHLORID DIHYDRAT | 1.2.40.0.34.5.221:100000086021 | TERAZOSIN HYDROCHLORIDE DIHYDRATE | active | 2.37 | mg | 1.2.40.0.34.5.221:100000086021 | TERAZOSIN HYDROCHLORIDE DIHYDRATE | 2.37 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:931417001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285252 | UROFLO TBL 5MG | Uroflo 5 mg - Tabletten | 1.2.40.0.34.4.17:1-20341 | GA - zugelassen | Amdipharm Limited | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000116195 | Kalenderpackung | 2.16.840.1.113883.6.73:G04CA03 | Terazosin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:10242403 | TERAZOSINHYDROCHLORID DIHYDRAT | 1.2.40.0.34.5.221:100000086021 | TERAZOSIN HYDROCHLORIDE DIHYDRATE | active | 5.935 | mg | 1.2.40.0.34.5.221:100000086021 | TERAZOSIN HYDROCHLORIDE DIHYDRATE | 5.935 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:931420001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285335 | MITOMYCIN-C TRSTAMP 10MG | Mitomycin C "Kyowa" 10 mg - Trockenstechampullen | 1.2.40.0.34.4.17:1-18408 | GA - aufgehoben | Ebewe Pharma Ges.m.b.H. Nfg.KG | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:L01DC03 | Mitomycin | 1.2.40.0.10.1.4.3.4.3.4:900000000009 | intrakavitäre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | 1.2.40.0.34.5.156:1706493 | MITOMYCIN | 1.2.40.0.34.5.221:100000080898 | MITOMYCIN | active | 10 | mg | 1.2.40.0.34.5.221:100000080898 | MITOMYCIN | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:922497001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285542 | CALCIJEX AMP 1MCG 1ML | Calcijex 1 Mikrogramm - Ampullen | 1.2.40.0.34.4.17:1-20488 | GA - aufgehoben | Abbvie GmbH | false | false | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A11CC04 | Calcitriol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709558 | CALCITRIOL | 1.2.40.0.34.5.221:100000092790 | CALCITRIOL | active | 1 | µg | 1.2.40.0.34.5.221:100000092790 | CALCITRIOL | 1 | µg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:933561001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285648 | MAXIPIME TRSTAMP 1,0G | Maxipime 1 g - Trockenstechampullen | 1.2.40.0.34.4.17:1-20599 | GA - aufgehoben | Bristol-Myers Squibb Ges.m.b.H. | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01DE01 | Cefepim | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1710076 | CEFEPIMDIHYDROCHLORID | 1.2.40.0.34.5.221:100000091617 | CEFEPRIME DIHYDROCHLORIDE | active | 1.189 | g | 1.2.40.0.34.5.221:100000091617 | CEFEPRIME DIHYDROCHLORIDE | 1.189 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:934010001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285660 | MAXIPIME TRSTAMP 2,0G | Maxipime 2 g - Trockenstechampullen | 1.2.40.0.34.4.17:1-20597 | GA - aufgehoben | Bristol-Myers Squibb Ges.m.b.H. | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01DE01 | Cefepim | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1710076 | CEFEPIMDIHYDROCHLORID | 1.2.40.0.34.5.221:100000091617 | CEFEPRIME DIHYDROCHLORIDE | active | 2.404 | g | 1.2.40.0.34.5.221:100000091617 | CEFEPRIME DIHYDROCHLORIDE | 2.404 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:934009001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285708 | DICLOBENE FTBL 25MG | Diclobene 25 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20587 | GA - aufgehoben | ratiopharm Arzneimittel Vertriebs GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 25 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929104001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285714 | DICLOBENE FTBL 25MG | Diclobene 25 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20587 | GA - aufgehoben | ratiopharm Arzneimittel Vertriebs GmbH | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073560 | Tablettenbehältnis | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 25 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929104002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285720 | DICLOBENE FTBL 50MG | Diclobene 50 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20588 | GA - zugelassen | Teva B.V. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929119002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285737 | DICLOBENE FTBL 50MG | Diclobene 50 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20588 | GA - zugelassen | Teva B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929119003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285803 | METOPROLOL RTP TBL 50MG | Metoprolol "ratiopharm" 50 mg - Tabletten | 1.2.40.0.34.4.17:1-20526 | GA - zugelassen | Teva B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930681001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285826 | METOPROLOL RTP TBL 50MG | Metoprolol "ratiopharm" 50 mg - Tabletten | 1.2.40.0.34.4.17:1-20526 | GA - zugelassen | Teva B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930681002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285832 | METOPROLOL RTP TBL 100MG | Metoprolol "ratiopharm" 100 mg - Tabletten | 1.2.40.0.34.4.17:1-20528 | GA - zugelassen | Teva B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930682001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285849 | METOPROLOL RTP TBL 100MG | Metoprolol "ratiopharm" 100 mg - Tabletten | 1.2.40.0.34.4.17:1-20528 | GA - zugelassen | Teva B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930682002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285855 | METOPROLOL RTP CP TBL | Metoprolol "ratiopharm" compositum - Tabletten | 1.2.40.0.34.4.17:1-20008 | GA - zugelassen | Teva B.V. | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07BB02 | Metoprolol und Thiazide | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930679001 | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 12.5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285861 | METOPROLOL RTP CP TBL | Metoprolol "ratiopharm" compositum - Tabletten | 1.2.40.0.34.4.17:1-20008 | GA - zugelassen | Teva B.V. | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07BB02 | Metoprolol und Thiazide | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:930679002 | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 12.5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285915 | AGOPTON KPS 15MG | Agopton 15 mg - Kapseln | 1.2.40.0.34.4.17:1-20544 | GA - zugelassen | Takeda Pharma Ges.m.b.H. | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:A02BC03 | Lansoprazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708390 | LANSOPRAZOL | 1.2.40.0.34.5.221:100000089867 | LANSOPRAZOL | active | | | 1.2.40.0.34.5.221:100000089867 | LANSOPRAZOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285921 | AGOPTON KPS 30MG | Agopton 30 mg - Kapseln | 1.2.40.0.34.4.17:1-20545 | GA - zugelassen | Takeda Pharma Ges.m.b.H. | true | true | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:A02BC03 | Lansoprazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708390 | LANSOPRAZOL | 1.2.40.0.34.5.221:100000089867 | LANSOPRAZOL | active | | | 1.2.40.0.34.5.221:100000089867 | LANSOPRAZOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285938 | AGOPTON KPS 30MG | Agopton 30 mg - Kapseln | 1.2.40.0.34.4.17:1-20545 | GA - zugelassen | Takeda Pharma Ges.m.b.H. | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:A02BC03 | Lansoprazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708390 | LANSOPRAZOL | 1.2.40.0.34.5.221:100000089867 | LANSOPRAZOL | active | | | 1.2.40.0.34.5.221:100000089867 | LANSOPRAZOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1285973 | FLUANXOL DEP AMP 20MG 1ML | Fluanxol Depot 20 mg - Injektionslösung | 1.2.40.0.34.4.17:14723 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:N05AF01 | Flupentixol | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708031 | FLUPENTIXOL DECANOAT | 1.2.40.0.34.5.221:100000088415 | FLUPENTIXOL DECANOATE | active | 20 | mg | 1.2.40.0.34.5.221:100000088415 | FLUPENTIXOL DECANOATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:121333001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286091 | SOLU-MEDROL TRSTAMP 500MG | Solu - Medrol 500 mg - Trockenstechampulle mit Lösungsmittel | 1.2.40.0.34.4.17:16217 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H02AB04 | Methylprednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1708835 | METHYLPREDNISOLONHYDROGENSUCCINAT | 1.2.40.0.34.5.221:100000091386 | METHYLPREDNISOLONE HYDROGEN SUCCINATE | active | 633.6 | mg | 1.2.40.0.34.5.221:100000091386 | METHYLPREDNISOLONE HYDROGEN SUCCINATE | 633.6 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:120012002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073490 | Ampulle | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286174 | ASPIRIN KTBL 500MG | Aspirin 500 mg Kautabletten | 1.2.40.0.34.4.17:1-20680 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073550 | Einzeldosisbehältnis | 2.16.840.1.113883.6.73:N02BA | Salicylsäure und Derivate | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 500 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073684 | Kautablette | true | human | 1.2.40.0.34.4.26:928645001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286211 | TENSAN RET KPS 8MG | Tensan retard 8 mg - Kapseln | 1.2.40.0.34.4.17:1-20584 | GA - aufgehoben | Arcana Arzneimittel GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:C08CA10 | Nilvadipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706985 | NILVADIPIN | 1.2.40.0.34.5.221:100000083903 | NILVADIPINE | active | 8 | mg | 1.2.40.0.34.5.221:100000083903 | NILVADIPINE | 8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073663 | Hartkapsel mit veränderter Wirkstofffreisetzung | true | human | 1.2.40.0.34.4.26:929921001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286228 | DICLOBENE FTBL 50MG | Diclobene 50 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20588 | GA - zugelassen | Teva B.V. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:929119001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286257 | PHYTODOLOR RHEUMATR | Phytodolor - Rheumatropfen | 1.2.40.0.34.4.17:1-18397 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M01AX | Andere nichtsteroidale Antiphlogistika und Antirheumatika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712616 | FRAXINI CORTEX (AUSZUG) | 1.2.40.0.34.5.221:900000004118 | FRAXINI CORTEX (EXTRACT) | active | 2000 | ml | 1.2.40.0.34.5.221:900000004118 | FRAXINI CORTEX (EXTRACT) | 2000 | ml | 1.2.40.0.10.1.4.3.4.3.5:100000073642 | Tropfen zum Einnehmen, Lösung | false | human | 1.2.40.0.34.4.26:927042001 | 1.2.40.0.34.5.156:1712643 | POPULI TREMULAE CORTEX ET FOLIUM (AUSZUG) | 1.2.40.0.34.5.221:900000004206 | POPULI TREMULAE CORTEX ET FOLIUM (EXTRACT) | active | 6000 | ml | 1.2.40.0.34.5.221:900000004206 | POPULI TREMULAE CORTEX ET FOLIUM (EXTRACT) | 6000 | ml | 1.2.40.0.34.5.156:1712656 | SOLIDAGINIS VIRGAUREAE HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000004246 | SOLIDAGINIS VIRGAUREAE HERBA (EXTRACT) | active | 2000 | ml | 1.2.40.0.34.5.221:900000004246 | SOLIDAGINIS VIRGAUREAE HERBA (EXTRACT) | 2000 | ml | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286263 | RYTMONORMA FTBL 150MG | Rytmonorma 150 mg - Filmtabletten | 1.2.40.0.34.4.17:16590 | GA - zugelassen | Viatris Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01BC03 | Propafenon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708876 | PROPAFENON HYDROCHLORID | 1.2.40.0.34.5.221:100000091480 | PROPAFENONE HYDROCHLORIDE | active | 150 | mg | 1.2.40.0.34.5.221:100000091480 | PROPAFENONE HYDROCHLORIDE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:129079001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286286 | RYTMONORMA FTBL 150MG | Rytmonorma 150 mg - Filmtabletten | 1.2.40.0.34.4.17:16590 | GA - zugelassen | Viatris Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01BC03 | Propafenon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708876 | PROPAFENON HYDROCHLORID | 1.2.40.0.34.5.221:100000091480 | PROPAFENONE HYDROCHLORIDE | active | 150 | mg | 1.2.40.0.34.5.221:100000091480 | PROPAFENONE HYDROCHLORIDE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:129079002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286292 | RYTMONORMA FTBL 300MG | Rytmonorma 300 mg - Filmtabletten | 1.2.40.0.34.4.17:16481 | GA - zugelassen | Viatris Austria GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01BC03 | Propafenon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708876 | PROPAFENON HYDROCHLORID | 1.2.40.0.34.5.221:100000091480 | PROPAFENONE HYDROCHLORIDE | active | 300 | mg | 1.2.40.0.34.5.221:100000091480 | PROPAFENONE HYDROCHLORIDE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:125397002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286300 | RYTMONORMA FTBL 300MG | Rytmonorma 300 mg - Filmtabletten | 1.2.40.0.34.4.17:16481 | GA - zugelassen | Viatris Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C01BC03 | Propafenon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708876 | PROPAFENON HYDROCHLORID | 1.2.40.0.34.5.221:100000091480 | PROPAFENONE HYDROCHLORIDE | active | 300 | mg | 1.2.40.0.34.5.221:100000091480 | PROPAFENONE HYDROCHLORIDE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:125397001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286317 | RYTMONORMA AMP 20ML | Rytmonorma - Ampullen | 1.2.40.0.34.4.17:17435 | GA - zugelassen | Viatris Austria GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C01BC03 | Propafenon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708876 | PROPAFENON HYDROCHLORID | 1.2.40.0.34.5.221:100000091480 | PROPAFENONE HYDROCHLORIDE | active | 0.07 | g | 1.2.40.0.34.5.221:100000091480 | PROPAFENONE HYDROCHLORIDE | 0.07 | g | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:920183001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286346 | AMOXILAN TRSFT 250MG/5ML | Amoxilan 250 mg/5 ml - Trockensaft | 1.2.40.0.34.4.17:1-20613 | GA - zugelassen | G.L. Pharma GmbH | true | true | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01CA04 | Amoxicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708923 | AMOXICILLIN | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | active | 3.444 | g | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 3.444 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:933943001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286352 | AMOXILAN TRSFT 250MG/5ML | Amoxilan 250 mg/5 ml - Trockensaft | 1.2.40.0.34.4.17:1-20613 | GA - zugelassen | G.L. Pharma GmbH | true | true | 120 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01CA04 | Amoxicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708923 | AMOXICILLIN | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | active | 6.888 | g | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 6.888 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:933943002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286369 | AMOXILAN TRSFT 500MG/5ML | Amoxilan 500 mg/5 ml - Trockensaft | 1.2.40.0.34.4.17:1-20614 | GA - zugelassen | G.L. Pharma GmbH | true | true | 60 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01CA04 | Amoxicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708923 | AMOXICILLIN | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | active | 6.888 | g | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 6.888 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:933942001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286375 | AMOXILAN TRSFT 500MG/5ML | Amoxilan 500 mg/5 ml - Trockensaft | 1.2.40.0.34.4.17:1-20614 | GA - zugelassen | G.L. Pharma GmbH | true | true | 120 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01CA04 | Amoxicillin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708923 | AMOXICILLIN | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | active | 13.776 | g | 1.2.40.0.34.5.221:100000091596 | AMOXICILLIN | 13.776 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073649 | Pulver zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:933942002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286398 | SUCRALFAT OR SUS 1G/5ML BTL | Sucralfat Genericon 1 g/5 ml orale Suspension | 1.2.40.0.34.4.17:1-20571 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:A02BX02 | Sucralfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708896 | SUCRALFAT | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | active | 1000 | mg | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:933331001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286406 | SUCRALFAT OR SUS 1G/5ML BTL | Sucralfat Genericon 1 g/5 ml orale Suspension | 1.2.40.0.34.4.17:1-20571 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:A02BX02 | Sucralfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708896 | SUCRALFAT | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | active | 1000 | mg | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:933331002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286412 | SUCRALFAT OR SUS 1G/5ML | Sucralfat Genericon 1 g/5 ml orale Suspension | 1.2.40.0.34.4.17:1-20571 | GA - zugelassen | Genericon Pharma Ges.m.b.H. | true | true | 250 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A02BX02 | Sucralfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708896 | SUCRALFAT | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | active | 50000 | mg | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | 50000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:933331003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286429 | SUCRALAN OR SUS 1G/5ML BTL | Sucralan 1 g/5 ml - orale Suspension | 1.2.40.0.34.4.17:1-20564 | GA - zugelassen | G.L. Pharma GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:A02BX02 | Sucralfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708896 | SUCRALFAT | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | active | 1000 | mg | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:933330001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286435 | SUCRALAN OR SUS 1G/5ML BTL | Sucralan 1 g/5 ml - orale Suspension | 1.2.40.0.34.4.17:1-20564 | GA - zugelassen | G.L. Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:A02BX02 | Sucralfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708896 | SUCRALFAT | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | active | 1000 | mg | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:933330002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286441 | SUCRALAN OR SUS 1G/5ML | Sucralan 1 g/5 ml - orale Suspension | 1.2.40.0.34.4.17:1-20564 | GA - zugelassen | G.L. Pharma GmbH | true | true | 250 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A02BX02 | Sucralfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708896 | SUCRALFAT | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | active | 50000 | mg | 1.2.40.0.34.5.221:100000091545 | SUCRALFATE | 50000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073362 | Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:933330003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286576 | SABRIL LSL PLV 500MG | Sabril 500 mg lösliches Pulver | 1.2.40.0.34.4.17:1-20114 | GA - zugelassen | Sanofi-Aventis GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:N03AG04 | Vigabatrin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706121 | VIGABATRIN | 1.2.40.0.34.5.221:100000079084 | VIGABATRIN | active | 500 | mg | 1.2.40.0.34.5.221:100000079084 | VIGABATRIN | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073365 | Granulat zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:930827002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286760 | CONDROSULF KPS 400MG | Condrosulf 400 mg - Kapseln | 1.2.40.0.34.4.17:1-20388 | GA - zugelassen | IBSA Farmaceutici Italia S.r.l. | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AX25 | Chondroitinsulfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709154 | CHONDROITINSULFAT-NATRIUM | 1.2.40.0.34.5.221:100000092058 | CHONDROITIN SULFATE SODIUM | active | 400 | mg | 1.2.40.0.34.5.221:100000092058 | CHONDROITIN SULFATE SODIUM | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:931520003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286903 | ELEVIT PRONATAL FTBL | Elevit pronatal - Filmtabletten | 1.2.40.0.34.4.17:1-20335 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A11AA03 | Multivitamine und andere Mineralstoffe, inkl. Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7396118 | MANGANSULFAT MONOHYDRAT | 1.2.40.0.34.5.221:100000080143 | MANGANESE SULPHATE MONOHYDRATE | active | 2.52 | mg | 1.2.40.0.34.5.221:100000080143 | MANGANESE SULPHATE MONOHYDRATE | 2.52 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930649002 | 1.2.40.0.34.5.156:7611439 | KUPFERSULFAT WASSERFREI | 1.2.40.0.34.5.221:100000076078 | COPPERSULFATE ANHYDROUS | active | 2.51 | mg | 1.2.40.0.34.5.221:100000076078 | COPPERSULFATE ANHYDROUS | 2.51 | mg | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 2.6 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 2.6 | mg | | | | | | | 1.2.40.0.34.5.156:1709557 | BIOTIN | 1.2.40.0.34.5.221:100000092789 | BIOTIN | active | 0.2 | mg | 1.2.40.0.34.5.221:100000092789 | BIOTIN | 0.2 | mg | 1.2.40.0.34.5.156:1709523 | COLECALCIFEROL | 1.2.40.0.34.5.221:100000092724 | COLECALCIFEROL | active | 12.5 | µg | 1.2.40.0.34.5.221:100000092724 | COLECALCIFEROL | 12.5 | µg | 1.2.40.0.34.5.156:1706334 | ALPHA-TOCOPHEROLACETAT | 1.2.40.0.34.5.221:100000079921 | ALPHATOCOPHEROL ACETATE | active | 15 | mg | 1.2.40.0.34.5.221:100000079921 | ALPHATOCOPHEROL ACETATE | 15 | mg | | | | | 1.2.40.0.34.5.156:7611433 | CALCIUMHYDROGENPHOSPHAT, WASSERFREIES | 1.2.40.0.34.5.221:100000087353 | CALCIUM HYDROGEN PHOSPHATE, ANHYDROUS | active | 378.89 | mg | 1.2.40.0.34.5.221:100000087353 | CALCIUM HYDROGEN PHOSPHATE, ANHYDROUS | 378.89 | mg | 1.2.40.0.34.5.156:1708593 | EISEN(II)-FUMARAT | 1.2.40.0.34.5.221:100000090445 | FERROUS FUMARATE | active | 183 | mg | 1.2.40.0.34.5.221:100000090445 | FERROUS FUMARATE | 183 | mg | | | | | 1.2.40.0.34.5.156:1707857 | MAGNESIUMOXID | 1.2.40.0.34.5.221:100000087594 | MAGNESIUM OXIDE | active | 1.2.40.0.34.5.221:100000087594 | MAGNESIUM OXIDE | 1.2.40.0.34.5.156:7611431 | CALCIUMASCORBAT DIHYDRAT | 1.2.40.0.34.5.221:100000153077 | CALCIUM ASCORBATE DIHYDRATE | active | 1.2.40.0.34.5.221:100000153077 | CALCIUM ASCORBATE DIHYDRATE | 1.2.40.0.34.5.156:7611457 | ZINKSULFAT-MONOHYDRAT | 1.2.40.0.34.5.221:100000087994 | ZINC SULPHATE MONOHYDRATE | active | 1.2.40.0.34.5.221:100000087994 | ZINC SULPHATE MONOHYDRATE | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | 1.2.40.0.34.5.156:7611455 | MAGNESIUMHYDROGENPHOSPHAT TRIHYDRAT | 1.2.40.0.34.5.221:100000128493 | MAGNESIUMHYDROGENPHOSPHATE TRIHYDRATE | active | 1.2.40.0.34.5.221:100000128493 | MAGNESIUMHYDROGENPHOSPHATE TRIHYDRATE | 1.2.40.0.34.5.156:1707468 | FOLSÄURE | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | active | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | 1.2.40.0.34.5.156:1708612 | CALCIUM PANTOTHENAT | 1.2.40.0.34.5.221:100000090485 | CALCIUM PANTOTHENATE | active | 1.2.40.0.34.5.221:100000090485 | CALCIUM PANTOTHENATE | 1.2.40.0.34.5.156:1708142 | RIBOFLAVIN | 1.2.40.0.34.5.221:100000089010 | RIBOFLAVIN | active | 1.2.40.0.34.5.221:100000089010 | RIBOFLAVIN | 1.2.40.0.34.5.156:1709251 | NICOTINAMID | 1.2.40.0.34.5.221:100000092193 | NICOTINAMIDE | active | 1.2.40.0.34.5.221:100000092193 | NICOTINAMIDE | 1.2.40.0.34.5.156:1709249 | THIAMIN NITRAT | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | active | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | 1.2.40.0.34.5.156:1708781 | RETINOLPALMITAT | 1.2.40.0.34.5.221:100000091269 | RETINOL PALMITATE | active | 1.2.40.0.34.5.221:100000091269 | RETINOL PALMITATE | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 114.42 | mg | 114.42 | mg | 121 | mg | 121 | mg | 20.6 | mg | 20.6 | mg | 4 | µg | 4 | µg | 217.95 | mg | 217.95 | mg | 0.8 | mg | 0.8 | mg | 10 | mg | 10 | mg | 1.8 | mg | 1.8 | mg | 19 | mg | 19 | mg | 1.55 | mg | 1.55 | mg | 2.13 | mg | 2.13 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286926 | ELEVIT PRONATAL FTBL | Elevit pronatal - Filmtabletten | 1.2.40.0.34.4.17:1-20335 | GA - zugelassen | Bayer Austria Ges.m.b.H. | true | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A11AA03 | Multivitamine und andere Mineralstoffe, inkl. Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:7396118 | MANGANSULFAT MONOHYDRAT | 1.2.40.0.34.5.221:100000080143 | MANGANESE SULPHATE MONOHYDRATE | active | 2.52 | mg | 1.2.40.0.34.5.221:100000080143 | MANGANESE SULPHATE MONOHYDRATE | 2.52 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930649001 | 1.2.40.0.34.5.156:7611439 | KUPFERSULFAT WASSERFREI | 1.2.40.0.34.5.221:100000076078 | COPPERSULFATE ANHYDROUS | active | 2.51 | mg | 1.2.40.0.34.5.221:100000076078 | COPPERSULFATE ANHYDROUS | 2.51 | mg | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 2.6 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 2.6 | mg | | | | | | | 1.2.40.0.34.5.156:1709557 | BIOTIN | 1.2.40.0.34.5.221:100000092789 | BIOTIN | active | 0.2 | mg | 1.2.40.0.34.5.221:100000092789 | BIOTIN | 0.2 | mg | 1.2.40.0.34.5.156:1706334 | ALPHA-TOCOPHEROLACETAT | 1.2.40.0.34.5.221:100000079921 | ALPHATOCOPHEROL ACETATE | active | 15 | mg | 1.2.40.0.34.5.221:100000079921 | ALPHATOCOPHEROL ACETATE | 15 | mg | 1.2.40.0.34.5.156:1709523 | COLECALCIFEROL | 1.2.40.0.34.5.221:100000092724 | COLECALCIFEROL | active | 12.5 | µg | 1.2.40.0.34.5.221:100000092724 | COLECALCIFEROL | 12.5 | µg | | | | | 1.2.40.0.34.5.156:7611433 | CALCIUMHYDROGENPHOSPHAT, WASSERFREIES | 1.2.40.0.34.5.221:100000087353 | CALCIUM HYDROGEN PHOSPHATE, ANHYDROUS | active | 378.89 | mg | 1.2.40.0.34.5.221:100000087353 | CALCIUM HYDROGEN PHOSPHATE, ANHYDROUS | 378.89 | mg | 1.2.40.0.34.5.156:1708593 | EISEN(II)-FUMARAT | 1.2.40.0.34.5.221:100000090445 | FERROUS FUMARATE | active | 183 | mg | 1.2.40.0.34.5.221:100000090445 | FERROUS FUMARATE | 183 | mg | | | | | 1.2.40.0.34.5.156:1707857 | MAGNESIUMOXID | 1.2.40.0.34.5.221:100000087594 | MAGNESIUM OXIDE | active | 1.2.40.0.34.5.221:100000087594 | MAGNESIUM OXIDE | 1.2.40.0.34.5.156:7611431 | CALCIUMASCORBAT DIHYDRAT | 1.2.40.0.34.5.221:100000153077 | CALCIUM ASCORBATE DIHYDRATE | active | 1.2.40.0.34.5.221:100000153077 | CALCIUM ASCORBATE DIHYDRATE | 1.2.40.0.34.5.156:7611457 | ZINKSULFAT-MONOHYDRAT | 1.2.40.0.34.5.221:100000087994 | ZINC SULPHATE MONOHYDRATE | active | 1.2.40.0.34.5.221:100000087994 | ZINC SULPHATE MONOHYDRATE | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | 1.2.40.0.34.5.156:7611455 | MAGNESIUMHYDROGENPHOSPHAT TRIHYDRAT | 1.2.40.0.34.5.221:100000128493 | MAGNESIUMHYDROGENPHOSPHATE TRIHYDRATE | active | 1.2.40.0.34.5.221:100000128493 | MAGNESIUMHYDROGENPHOSPHATE TRIHYDRATE | 1.2.40.0.34.5.156:1707468 | FOLSÄURE | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | active | 1.2.40.0.34.5.221:100000085634 | FOLIC ACID | 1.2.40.0.34.5.156:1708612 | CALCIUM PANTOTHENAT | 1.2.40.0.34.5.221:100000090485 | CALCIUM PANTOTHENATE | active | 1.2.40.0.34.5.221:100000090485 | CALCIUM PANTOTHENATE | 1.2.40.0.34.5.156:1708142 | RIBOFLAVIN | 1.2.40.0.34.5.221:100000089010 | RIBOFLAVIN | active | 1.2.40.0.34.5.221:100000089010 | RIBOFLAVIN | 1.2.40.0.34.5.156:1709251 | NICOTINAMID | 1.2.40.0.34.5.221:100000092193 | NICOTINAMIDE | active | 1.2.40.0.34.5.221:100000092193 | NICOTINAMIDE | 1.2.40.0.34.5.156:1709249 | THIAMIN NITRAT | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | active | 1.2.40.0.34.5.221:100000092190 | THIAMINE NITRATE | 1.2.40.0.34.5.156:1708781 | RETINOLPALMITAT | 1.2.40.0.34.5.221:100000091269 | RETINOL PALMITATE | active | 1.2.40.0.34.5.221:100000091269 | RETINOL PALMITATE | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 114.42 | mg | 114.42 | mg | 121 | mg | 121 | mg | 20.6 | mg | 20.6 | mg | 4 | µg | 4 | µg | 217.95 | mg | 217.95 | mg | 0.8 | mg | 0.8 | mg | 10 | mg | 10 | mg | 1.8 | mg | 1.8 | mg | 19 | mg | 19 | mg | 1.55 | mg | 1.55 | mg | 2.13 | mg | 2.13 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286932 | ENTOCORT KLISTBL +DISPMTL JE | Entocort 2 mg - Klistiertabletten mit Dispersionsmittel | 1.2.40.0.34.4.17:1-20720 | GA - zugelassen | Tillotts Pharma GmbH | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07EA06 | Budesonid | 1.2.40.0.10.1.4.3.4.3.4:100000073628 | rektale Anwendung | | | | | 1.2.40.0.34.5.156:1708795 | BUDESONID | 1.2.40.0.34.5.221:100000091309 | BUDESONIDE | active | 2.3 | mg | 1.2.40.0.34.5.221:100000091309 | BUDESONIDE | 2.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:900000000026 | Tablette zur Herstellung einer Rektaldispersion | true | human | 1.2.40.0.34.4.26:931377001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.34.5.219:100000073497 | Flasche | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286955 | WICK MEDINAIT ERKAELT.SIR | WICK MediNait Erkältungssirup für die Nacht | 1.2.40.0.34.4.17:17710 | GA - zugelassen | Wick Pharma Zweigniederlassung der Procter & Gamble GmbH | true | true | 90 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N02BE51 | Paracetamol, Kombinationen exkl. Psycholeptika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705374 | DOXYLAMIN HYDROGENSUCCINAT | 1.2.40.0.34.5.221:100000076107 | DOXYLAMINE HYDROGEN SUCCINATE | active | 0.0225 | g | 1.2.40.0.34.5.221:100000076107 | DOXYLAMINE HYDROGEN SUCCINATE | 0.0225 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073652 | Sirup | true | human | 1.2.40.0.34.4.26:128733002 | 1.2.40.0.34.5.156:1708515 | PARACETAMOL | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | active | 1.8 | g | 1.2.40.0.34.5.221:100000090270 | PARACETAMOL | 1.8 | g | 1.2.40.0.34.5.156:1709135 | DEXTROMETHORPHAN HYDROBROMID | 1.2.40.0.34.5.221:100000092035 | DEXTROMETHORPHAN HYDROBROMIDE | active | 0.045 | g | 1.2.40.0.34.5.221:100000092035 | DEXTROMETHORPHAN HYDROBROMIDE | 0.045 | g | | | | | | | 1.2.40.0.34.5.156:1706087 | EPHEDRINSULFAT | 1.2.40.0.34.5.221:100000078927 | EPHEDRINE SULFATE | active | 0.02403 | g | 1.2.40.0.34.5.221:100000078927 | EPHEDRINE SULFATE | 0.02403 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1286961 | NERVENRUH FTE DRG | Nervenruh forte - Dragees | 1.2.40.0.34.4.17:736028 | GA - registriert | M.C.M. Klosterfrau Healthcare GmbH | true | true | 160 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05CX | Hypnotika und Sedativa in Kombination, exkl. Barbiturate | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712632 | LUPULI FLOS (AUSZUG) | 1.2.40.0.34.5.221:900000004166 | LUPULI FLOS (EXTRACT) | active | 15 | mg | 1.2.40.0.34.5.221:900000004166 | LUPULI FLOS (EXTRACT) | 15 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | false | human | 1.2.40.0.34.4.26:7731069001 | 1.2.40.0.34.5.156:1712638 | PASSIFLORAE HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000004191 | PASSIFLORAE HERBA (EXTRACT) | active | 18 | mg | 1.2.40.0.34.5.221:900000004191 | PASSIFLORAE HERBA (EXTRACT) | 18 | mg | 1.2.40.0.34.5.156:1710857 | VALERIANAE RADIX (AUSZUG) | 1.2.40.0.34.5.221:900000001092 | VALERIANAE RADIX (EXTRACT) | active | 30 | mg | 1.2.40.0.34.5.221:900000001092 | VALERIANAE RADIX (EXTRACT) | 30 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287009 | SPIRONOLACTON AGE TBL | Spironolacton "Agepha" - Tabletten | 1.2.40.0.34.4.17:1-18984 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03DA01 | Spironolacton | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 100 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922391001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287015 | SPIRONOLACTON AGE TBL | Spironolacton "Agepha" - Tabletten | 1.2.40.0.34.4.17:1-18984 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C03DA01 | Spironolacton | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709379 | SPIRONOLACTON | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | active | 100 | mg | 1.2.40.0.34.5.221:100000092408 | SPIRONOLACTONE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:922391004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287050 | NITROFURANTOIN AGE TBL | Nitrofurantoin "Agepha" - Tabletten | 1.2.40.0.34.4.17:1-15045 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01XE01 | Nitrofurantoin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709377 | NITROFURANTOIN | 1.2.40.0.34.5.221:100000092406 | NITROFURANTOIN | active | 50 | mg | 1.2.40.0.34.5.221:100000092406 | NITROFURANTOIN | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921737004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287067 | NITROFURANTOIN AGE TBL | Nitrofurantoin "Agepha" - Tabletten | 1.2.40.0.34.4.17:1-15045 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J01XE01 | Nitrofurantoin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709377 | NITROFURANTOIN | 1.2.40.0.34.5.221:100000092406 | NITROFURANTOIN | active | 50 | mg | 1.2.40.0.34.5.221:100000092406 | NITROFURANTOIN | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:921737001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287073 | SANDIMMUN NEOR TRILSG | Sandimmun Neoral 100 mg/ml - Trinklösung | 1.2.40.0.34.4.17:1-20694 | GA - zugelassen | Novartis Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L04AD01 | Ciclosporin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709199 | CICLOSPORIN | 1.2.40.0.34.5.221:100000092121 | CICLOSPORIN | active | 5 | g | 1.2.40.0.34.5.221:100000092121 | CICLOSPORIN | 5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:934704001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287096 | SANDIMMUN NEOR KPS 25MG | Sandimmun Neoral 25 mg - Kapseln | 1.2.40.0.34.4.17:1-20689 | GA - zugelassen | Novartis Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:L04AD01 | Ciclosporin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709199 | CICLOSPORIN | 1.2.40.0.34.5.221:100000092121 | CICLOSPORIN | active | 25 | mg | 1.2.40.0.34.5.221:100000092121 | CICLOSPORIN | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | true | human | 1.2.40.0.34.4.26:934707001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287104 | SANDIMMUN NEOR KPS 50MG | Sandimmun Neoral 50 mg - Kapseln | 1.2.40.0.34.4.17:1-20690 | GA - zugelassen | Novartis Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:L04AD01 | Ciclosporin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709199 | CICLOSPORIN | 1.2.40.0.34.5.221:100000092121 | CICLOSPORIN | active | 50 | mg | 1.2.40.0.34.5.221:100000092121 | CICLOSPORIN | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | true | human | 1.2.40.0.34.4.26:934706001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287110 | SANDIMMUN NEOR KPS 100MG | Sandimmun Neoral 100 mg - Kapseln | 1.2.40.0.34.4.17:1-20691 | GA - zugelassen | Novartis Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:L04AD01 | Ciclosporin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709199 | CICLOSPORIN | 1.2.40.0.34.5.221:100000092121 | CICLOSPORIN | active | 100 | mg | 1.2.40.0.34.5.221:100000092121 | CICLOSPORIN | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073660 | Weichkapsel | true | human | 1.2.40.0.34.4.26:934705001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287400 | DAFLON FTBL 500MG | Daflon 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20685 | GA - zugelassen | Servier Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C05CA53 | Diosmin, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705597 | FLAVONOIDE | 1.2.40.0.34.5.221:100000076859 | BIOFLAVONOIDS | active | 50 | mg | 1.2.40.0.34.5.221:100000076859 | BIOFLAVONOIDS | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | false | human | 1.2.40.0.34.4.26:933497004 | 1.2.40.0.34.5.156:1709145 | DIOSMIN | 1.2.40.0.34.5.221:100000092048 | DIOSMIN | active | 450 | mg | 1.2.40.0.34.5.221:100000092048 | DIOSMIN | 450 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287452 | LOCERYL ANTIMYKOT.NAGELLACK | Loceryl - antimykotischer Nagellack | 1.2.40.0.34.4.17:1-19917 | GA - zugelassen | Galderma International | true | true | 2.5 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D01AE16 | Amorolfin | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | | | 1.2.40.0.34.5.156:1708039 | AMOROLFIN HYDROCHLORID | 1.2.40.0.34.5.221:100000088482 | AMOROLFINE HYDROCHLORIDE | active | 0.14075 | g | 1.2.40.0.34.5.221:100000088482 | AMOROLFINE HYDROCHLORIDE | 0.14075 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073742 | wirkstoffhaltiger Nagellack | false | human | 1.2.40.0.34.4.26:930701001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287481 | NEURONTIN HARTKPS 300MG | Neurontin 300 mg - Hartkapseln | 1.2.40.0.34.4.17:1-20679 | GA - zugelassen | Upjohn EESV | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BF01 | Gabapentin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709509 | GABAPENTIN | 1.2.40.0.34.5.221:100000092663 | GABAPENTIN | active | 300 | mg | 1.2.40.0.34.5.221:100000092663 | GABAPENTIN | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:933916001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287498 | NEURONTIN HARTKPS 400MG | Neurontin 400 mg - Hartkapseln | 1.2.40.0.34.4.17:1-20678 | GA - zugelassen | Upjohn EESV | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02BF01 | Gabapentin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709509 | GABAPENTIN | 1.2.40.0.34.5.221:100000092663 | GABAPENTIN | active | 400 | mg | 1.2.40.0.34.5.221:100000092663 | GABAPENTIN | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:933915001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287794 | TANNOSYNT LOT | Tannosynt - Lotio | 1.2.40.0.34.4.17:12743 | GA - zugelassen | Almirall Hermal GmbH | true | true | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D04AX | Andere Antipruriginosa | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1710628 | PHENOL-METHANAL-HARNSTOFF-POLYKONDENSAT, SULFONIERT, NATRIUMSALZ | 1.2.40.0.34.5.221:100000134330 | UREA-PHENOL-FORMALDEHYDERESIN | active | 1 | g | 1.2.40.0.34.5.221:100000134330 | UREA-PHENOL-FORMALDEHYDERESIN | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073732 | Suspension zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:120919001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287802 | ECHINACIN MAD FLUESSIGK. | Echinacin MADAUS - Flüssigkeit zum Einnehmen | 1.2.40.0.34.4.17:1-20644 | GA - zugelassen | Viatris Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L03AX | Andere Zytokine und Immunmodulatoren | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712614 | ECHINACEAE PURPUREAE HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000004109 | ECHINACEAE PURPUREAE HERBA (EXTRACT) | active | 4000 | g | 1.2.40.0.34.5.221:900000004109 | ECHINACEAE PURPUREAE HERBA (EXTRACT) | 4000 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073645 | Flüssigkeit zum Einnehmen | false | human | 1.2.40.0.34.4.26:933831003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287819 | ECHINACIN MAD FLUESSIGK. | Echinacin MADAUS - Flüssigkeit zum Einnehmen | 1.2.40.0.34.4.17:1-20644 | GA - zugelassen | Viatris Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L03AX | Andere Zytokine und Immunmodulatoren | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712614 | ECHINACEAE PURPUREAE HERBA (AUSZUG) | 1.2.40.0.34.5.221:900000004109 | ECHINACEAE PURPUREAE HERBA (EXTRACT) | active | 8000 | g | 1.2.40.0.34.5.221:900000004109 | ECHINACEAE PURPUREAE HERBA (EXTRACT) | 8000 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073645 | Flüssigkeit zum Einnehmen | false | human | 1.2.40.0.34.4.26:933831001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287860 | SPASMOLYT DRG | Spasmolyt - Dragees | 1.2.40.0.34.4.17:1-20767 | GA - zugelassen | G.L. Pharma GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G04BD09 | Trospium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709331 | TROSPIUM CHLORID | 1.2.40.0.34.5.221:100000092335 | TROSPIUM CHLORIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000092335 | TROSPIUM CHLORIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:930933001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287877 | SPASMOLYT DRG | Spasmolyt - Dragees | 1.2.40.0.34.4.17:1-20767 | GA - zugelassen | G.L. Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G04BD09 | Trospium | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709331 | TROSPIUM CHLORID | 1.2.40.0.34.5.221:100000092335 | TROSPIUM CHLORIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000092335 | TROSPIUM CHLORIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073380 | überzogene Tablette | true | human | 1.2.40.0.34.4.26:930933002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287883 | TEGRETOL TBL 200MG | Tegretol 200 mg - Tabletten | 1.2.40.0.34.4.17:1-12844 | GA - zugelassen | Novartis Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AF01 | Carbamazepin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709201 | CARBAMAZEPIN | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | active | 200 | mg | 1.2.40.0.34.5.221:100000092127 | CARBAMAZEPINE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:128587002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287972 | COLDARGAN LSG +NEBULISATOR | Coldargan Lösung | 1.2.40.0.34.4.17:11378 | GA - zugelassen | Sigmapharm Arzneimittel GmbH | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AB05 | Ephedrin | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073621 | zur Anwendung im Mund- und Rachenraum | | | 1.2.40.0.34.5.156:1708106 | PROTEIN-SILBER | 1.2.40.0.34.5.221:100000088825 | SILVER PROTEIN | active | 250 | mg | 1.2.40.0.34.5.221:100000088825 | SILVER PROTEIN | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073691 | Lösung zur Anwendung in der Mundhöhle | true | human | 1.2.40.0.34.4.26:126270002 | 1.2.40.0.34.5.156:7191449 | EPHEDRIN HEMIHYDRAT | 1.2.40.0.34.5.221:100000091960 | EPHEDRINE HEMIHYDRATE | active | 123.9 | mg | 1.2.40.0.34.5.221:100000091960 | EPHEDRINE HEMIHYDRATE | 123.9 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073958 | Nasenspray | 1.2.40.0.10.1.4.3.4.3.5:100000073794 | Nasentropfen, Lösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1287995 | ISOZID H GEFAERBT | Isozid - H gefärbt - alkoholische Lösung zur Hautdesinfektion | 1.2.40.0.34.4.17:1-20413 | GA - zugelassen | Gebro Pharma GmbH | true | false | 500 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D08AX53 | Propanol, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1706076 | 1-PROPANOL | 1.2.40.0.34.5.221:100000078877 | PROPANOL | active | 140.75 | g | 1.2.40.0.34.5.221:100000078877 | PROPANOL | 140.75 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:931806001 | 1.2.40.0.34.5.156:1709419 | HEXETIDIN | 1.2.40.0.34.5.221:100000092531 | HEXETIDINE | active | 0.5 | g | 1.2.40.0.34.5.221:100000092531 | HEXETIDINE | 0.5 | g | 1.2.40.0.34.5.156:1705751 | 2-PROPANOL | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | active | 157 | g | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | 157 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288003 | ISOZID H GEFAERBT BP10X500ML | Isozid - H gefärbt - alkoholische Lösung zur Hautdesinfektion | 1.2.40.0.34.4.17:1-20413 | GA - zugelassen | Gebro Pharma GmbH | true | false | 5000 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D08AX53 | Propanol, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1706076 | 1-PROPANOL | 1.2.40.0.34.5.221:100000078877 | PROPANOL | active | 140.75 | g | 1.2.40.0.34.5.221:100000078877 | PROPANOL | 140.75 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | false | human | 1.2.40.0.34.4.26:931806002 | 1.2.40.0.34.5.156:1709419 | HEXETIDIN | 1.2.40.0.34.5.221:100000092531 | HEXETIDINE | active | 0.5 | g | 1.2.40.0.34.5.221:100000092531 | HEXETIDINE | 0.5 | g | 1.2.40.0.34.5.156:1705751 | 2-PROPANOL | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | active | 157 | g | 1.2.40.0.34.5.221:100000077586 | ISOPROPANOL | 157 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288138 | VISIPAQUE 270MG J/ML DFL 20 | VISIPAQUE 270 mg J/ml-parenterale Röntgenkontrastmittellösung | 1.2.40.0.34.4.17:1-20723 | GA - zugelassen | GE Healthcare Handels GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB09 | Iodixanol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.34.5.156:1708055 | IODIXANOL | 1.2.40.0.34.5.221:100000088544 | IODIXANOL | active | 11000 | mg | 1.2.40.0.34.5.221:100000088544 | IODIXANOL | 11000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:933985012 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288196 | CORMAGNESIN AMP 400MG/10ML | Cormagnesin 400 mg - Ampullen | 1.2.40.0.34.4.17:1-20802 | GA - zugelassen | Viatris Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:A12CC02 | Magnesiumsulfat | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709459 | MAGNESIUMSULFAT | 1.2.40.0.34.5.221:100000092599 | MAGNESIUM SULFATE | active | 4.095 | g | 1.2.40.0.34.5.221:100000092599 | MAGNESIUM SULFATE | 4.095 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:934114001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288227 | VENOSIN RET KPS 50MG | Venosin retard 50 mg - Kapseln | 1.2.40.0.34.4.17:14148 | GA - zugelassen | Klinge Pharma GmbH | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C05B | Antivarikosa | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712625 | HIPPOCASTANI SEMEN (AUSZUG) | 1.2.40.0.34.5.221:900000004143 | HIPPOCASTANI SEMEN (EXTRACT) | active | 240 | mg | 1.2.40.0.34.5.221:900000004143 | HIPPOCASTANI SEMEN (EXTRACT) | 240 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:122694001 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:C05CX | Andere kapillarstabilisierende Mittel | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288233 | VENOSIN RET KPS 50MG | Venosin retard 50 mg - Kapseln | 1.2.40.0.34.4.17:14148 | GA - zugelassen | Klinge Pharma GmbH | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C05B | Antivarikosa | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1712625 | HIPPOCASTANI SEMEN (AUSZUG) | 1.2.40.0.34.5.221:900000004143 | HIPPOCASTANI SEMEN (EXTRACT) | active | 240 | mg | 1.2.40.0.34.5.221:900000004143 | HIPPOCASTANI SEMEN (EXTRACT) | 240 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073662 | Hartkapsel, retardiert | true | human | 1.2.40.0.34.4.26:122694002 | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:C05CX | Andere kapillarstabilisierende Mittel | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288339 | LIVIEL TBL | Liviel - Tabletten | 1.2.40.0.34.4.17:1-20657 | GA - zugelassen | Organon Healthcare GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03CX01 | Tibolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709420 | TIBOLON | 1.2.40.0.34.5.221:100000092534 | TIBOLONE | active | 2.5 | mg | 1.2.40.0.34.5.221:100000092534 | TIBOLONE | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927835001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288345 | LIVIEL TBL 3X28 | Liviel - Tabletten | 1.2.40.0.34.4.17:1-20657 | GA - zugelassen | Organon Healthcare GmbH | true | true | 84 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G03CX01 | Tibolon | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709420 | TIBOLON | 1.2.40.0.34.5.221:100000092534 | TIBOLONE | active | 2.5 | mg | 1.2.40.0.34.5.221:100000092534 | TIBOLONE | 2.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:927835002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288440 | FELDEN QUICK LYOTBL 20MG | Felden Quick-Solve 20 mg - Schmelztabletten | 1.2.40.0.34.4.17:1-20748 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AC01 | Piroxicam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709404 | PIROXICAM | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | active | 20 | mg | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073666 | Schmelztablette | true | human | 1.2.40.0.34.4.26:933680001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288457 | FELDEN QUICK LYOTBL 20MG | Felden Quick-Solve 20 mg - Schmelztabletten | 1.2.40.0.34.4.17:1-20748 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AC01 | Piroxicam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709404 | PIROXICAM | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | active | 20 | mg | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073666 | Schmelztablette | true | human | 1.2.40.0.34.4.26:933680002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288463 | FELDEN QUICK LYOTBL 20MG | Felden Quick-Solve 20 mg - Schmelztabletten | 1.2.40.0.34.4.17:1-20748 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AC01 | Piroxicam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709404 | PIROXICAM | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | active | 20 | mg | 1.2.40.0.34.5.221:100000092492 | PIROXICAM | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073666 | Schmelztablette | true | human | 1.2.40.0.34.4.26:933680003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288718 | CUTIVATE CR 0,05% | Cutivate 0,05 % - Creme | 1.2.40.0.34.4.17:1-20994 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC17 | Fluticason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709522 | FLUTICASONPROPIONAT | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | active | 0.05 | g | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | 0.05 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | true | human | 1.2.40.0.34.4.26:933964003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288747 | CUTIVATE SLB 0,005% | Cutivate 0,005 % - Salbe | 1.2.40.0.34.4.17:1-20993 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D07AC17 | Fluticason | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709522 | FLUTICASONPROPIONAT | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | active | 0.005 | g | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | 0.005 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | true | human | 1.2.40.0.34.4.26:933965003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288776 | ENTEROBENE FTBL 2MG | Enterobene 2 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20713 | GA - zugelassen | Teva B.V. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07DA03 | Loperamid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708479 | LOPERAMID HYDROCHLORID | 1.2.40.0.34.5.221:100000090166 | LOPERAMIDE HYDROCHLORIDE | active | 2 | mg | 1.2.40.0.34.5.221:100000090166 | LOPERAMIDE HYDROCHLORIDE | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933811001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288782 | ENTEROBENE FTBL 2MG | Enterobene 2 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20713 | GA - zugelassen | Teva B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07DA03 | Loperamid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708479 | LOPERAMID HYDROCHLORID | 1.2.40.0.34.5.221:100000090166 | LOPERAMIDE HYDROCHLORIDE | active | 2 | mg | 1.2.40.0.34.5.221:100000090166 | LOPERAMIDE HYDROCHLORIDE | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933811002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288799 | ENTEROBENE FTBL 2MG | Enterobene 2 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20713 | GA - zugelassen | Teva B.V. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A07DA03 | Loperamid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708479 | LOPERAMID HYDROCHLORID | 1.2.40.0.34.5.221:100000090166 | LOPERAMIDE HYDROCHLORIDE | active | 2 | mg | 1.2.40.0.34.5.221:100000090166 | LOPERAMIDE HYDROCHLORIDE | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933811003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1288960 | VIT.B6 AGE TBL | Vit. B6 "Agepha" - Tabletten | 1.2.40.0.34.4.17:8707 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A11HA02 | Pyridoxin (Vitamin-B6) | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 24.3 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 24.3 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129686001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289014 | IMIGRAN FTBL 50MG | Imigran 50 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21119 | GA - aufgehoben | Glaxosmithkline Pharma GmbH | false | false | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N02CC01 | Sumatriptan | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705740 | SUMATRIPTAN SUCCINAT | 1.2.40.0.34.5.221:100000077527 | SUMATRIPTAN SUCCINATE | active | 70 | mg | 1.2.40.0.34.5.221:100000077527 | SUMATRIPTAN SUCCINATE | 70 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:935336003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289020 | LESCOL KPS 40MG | Lescol 40 mg - Kapseln | 1.2.40.0.34.4.17:1-21012 | GA - aufgehoben | Novartis Pharma GmbH | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C10AA04 | Fluvastatin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708394 | FLUVASTATIN NATRIUM | 1.2.40.0.34.5.221:100000089873 | FLUVASTATIN SODIUM | active | 42.12 | mg | 1.2.40.0.34.5.221:100000089873 | FLUVASTATIN SODIUM | 42.12 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:933812004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289178 | CIPROXIN IFL 400MG 200ML BP | Ciproxin 400 mg/200 ml Infusionslösung | 1.2.40.0.34.4.17:1-20997 | GA - aufgehoben | Bayer Austria Ges.m.b.H. | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01MA02 | Ciprofloxacin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709192 | CIPROFLOXACIN | 1.2.40.0.34.5.221:100000092110 | CIPROFLOXACIN | active | 400 | mg | 1.2.40.0.34.5.221:100000092110 | CIPROFLOXACIN | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:933693002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289184 | KONAKION MMIZ AMP 2MG/0,2ML | Konakion 2 mg/0,2 ml Mischmizellenlösung - Ampullen | 1.2.40.0.34.4.17:1-20786 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B02BA01 | Phytomenadion | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.34.5.156:1709068 | PHYTOMENADION | 1.2.40.0.34.5.221:100000091922 | PHYTOMENADIONE | active | 2 | mg | 1.2.40.0.34.5.221:100000091922 | PHYTOMENADIONE | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:935799001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289190 | TRAMAL KPS 50MG | Tramal 50 mg Kapseln | 1.2.40.0.34.4.17:17688 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:N02AX02 | Tramadol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709643 | TRAMADOLHYDROCHLORID | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:921064003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289362 | ZOLADEX DP IMP SPRAMP 10,8MG | Zoladex Depot 10,8 mg - Implantat | 1.2.40.0.34.4.17:1-21236 | GA - zugelassen | Astrazeneca Österreich GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:L02AE03 | Goserelin | 1.2.40.0.10.1.4.3.4.3.4:100000075249 | zur Implantation | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1707689 | GOSERELIN ACETAT | 1.2.40.0.34.5.221:100000086673 | GOSERELIN ACETATE | active | 11.4 | mg | 1.2.40.0.34.5.221:100000086673 | GOSERELIN ACETATE | 11.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073874 | Implantat | true | human | 1.2.40.0.34.4.26:936715001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289385 | OPTINEM I.V.TRSTAMP 500MG | Optinem i.v. 500 mg - Trockenstechampullen | 1.2.40.0.34.4.17:1-20895 | GA - aufgehoben | Astrazeneca Österreich GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01DH02 | Meropenem | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708975 | MEROPENEM | 1.2.40.0.34.5.221:100000091712 | MEROPENEM | active | 570 | mg | 1.2.40.0.34.5.221:100000091712 | MEROPENEM | 570 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:935813002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289391 | OPTINEM I.V.TRSTAMP 1G | Optinem i.v. 1 g - Trockenstechampullen | 1.2.40.0.34.4.17:1-20896 | GA - aufgehoben | Astrazeneca Österreich GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J01DH02 | Meropenem | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708975 | MEROPENEM | 1.2.40.0.34.5.221:100000091712 | MEROPENEM | active | 1140 | mg | 1.2.40.0.34.5.221:100000091712 | MEROPENEM | 1140 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074042 | Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | true | human | 1.2.40.0.34.4.26:935806002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289480 | DICLOVIT KPS | Diclovit - Kapseln | 1.2.40.0.34.4.17:1-22179 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB55 | Diclofenac, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | 0.25 | mg | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | 0.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:934330001 | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 50 | mg | 1.2.40.0.34.5.156:1708752 | THIAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | 50 | mg | | | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289505 | DICLOVIT KPS | Diclovit - Kapseln | 1.2.40.0.34.4.17:1-22179 | GA - zugelassen | G.L. Pharma GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB55 | Diclofenac, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708712 | CYANOCOBALAMIN | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | active | 0.25 | mg | 1.2.40.0.34.5.221:100000091035 | CYANOCOBALAMIN | 0.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:934330002 | 1.2.40.0.34.5.156:1708406 | PYRIDOXIN HYDROCHLORID | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000089922 | PYRIDOXINE HYDROCHLORIDE | 50 | mg | 1.2.40.0.34.5.156:1708752 | THIAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | active | 50 | mg | 1.2.40.0.34.5.221:100000091092 | THIAMINE HYDROCHLORIDE | 50 | mg | | | | | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 50 | mg | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289528 | TRADOLAN TR +DOSPU | Tradolan - Tropfen | 1.2.40.0.34.4.17:1-21808 | GA - zugelassen | G.L. Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000157313 | Arzneimittel zur Abgabe gegen besondere aerztliche Verschreibung, Suchtgifte | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N02AX02 | Tramadol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709643 | TRAMADOLHYDROCHLORID | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | active | 3 | g | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | 3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000116169 | Tropfen zum Einnehmen, Flüssigkeit | true | human | 1.2.40.0.34.4.26:938383002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289600 | MUTAN KPS 20MG | Mutan 20 mg - Kapseln | 1.2.40.0.34.4.17:1-20794 | GA - zugelassen | G.L. Pharma GmbH | true | false | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AB03 | Fluoxetin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708899 | FLUOXETIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091555 | FLUOXETINE HYDROCHLORIDE | active | 22.36 | mg | 1.2.40.0.34.5.221:100000091555 | FLUOXETINE HYDROCHLORIDE | 22.36 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:934266001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289617 | MUTAN KPS 20MG | Mutan 20 mg - Kapseln | 1.2.40.0.34.4.17:1-20794 | GA - zugelassen | G.L. Pharma GmbH | true | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AB03 | Fluoxetin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708899 | FLUOXETIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091555 | FLUOXETINE HYDROCHLORIDE | active | 22.36 | mg | 1.2.40.0.34.5.221:100000091555 | FLUOXETINE HYDROCHLORIDE | 22.36 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:934266002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289770 | GLU-1-PHOSPH FRE 1M AMP 10ML | Glucose-1-phosphat "Fresenius" 1 molar - Infusionszusatz - Ampullen | 1.2.40.0.34.4.17:16979 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:B05XA | Elektrolytlösungen | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707684 | D-GLUCOSE 1-PHOSPHAT DINATRIUMSALZ | 1.2.40.0.34.5.221:100000086649 | D-GLUCOSE 1-PHOSPHATE DISODIUM | active | 3.762 | g | 1.2.40.0.34.5.221:100000086649 | D-GLUCOSE 1-PHOSPHATE DISODIUM | 3.762 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:123469002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289830 | VIVIDRIN AU-TR | Vividrin - Augentropfen | 1.2.40.0.34.4.17:1-20262 | GA - aufgehoben | Dr. Gerhard Mann chem.-pharm. Fabrik GmbH | false | false | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01GX01 | Cromoglicinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1709682 | DINATRIUM CROMOGLICAT | 1.2.40.0.34.5.221:100000115606 | DISODIUM CROMOGLYCATE | active | 2 | g | 1.2.40.0.34.5.221:100000115606 | DISODIUM CROMOGLYCATE | 2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | true | human | 1.2.40.0.34.4.26:930859001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289847 | VIVIDRIN NA-SPRAY | Vividrin - Nasenspray | 1.2.40.0.34.4.17:1-20264 | GA - aufgehoben | Dr. Gerhard Mann chem.-pharm. Fabrik GmbH | false | false | 15 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R01AC01 | Cromoglicinsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073615 | nasale Anwendung | | | | | 1.2.40.0.34.5.156:1709682 | DINATRIUM CROMOGLICAT | 1.2.40.0.34.5.221:100000115606 | DISODIUM CROMOGLYCATE | active | 2 | g | 1.2.40.0.34.5.221:100000115606 | DISODIUM CROMOGLYCATE | 2 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073796 | Nasenspray, Lösung | true | human | 1.2.40.0.34.4.26:930856001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289942 | INHIBACE PLUS FTBL | Inhibace plus 5 mg/12,5 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20856 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09BA08 | Cilazapril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 12.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:934029001 | 1.2.40.0.34.5.156:1708956 | CILAZAPRIL | 1.2.40.0.34.5.221:100000091670 | CILAZAPRIL | active | 5.22 | mg | 1.2.40.0.34.5.221:100000091670 | CILAZAPRIL | 5.22 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1289994 | LOSEC MSR KPS 20MG | Losec 20 mg magensaftresistente Kapseln | 1.2.40.0.34.4.17:1-19207 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:A02BC01 | Omeprazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709144 | OMEPRAZOL | 1.2.40.0.34.5.221:100000092047 | OMEPRAZOL | active | | | 1.2.40.0.34.5.221:100000092047 | OMEPRAZOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073376 | magensaftresistente Hartkapsel | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290017 | LOSEC MSR KPS 10MG | Losec 10 mg magensaftresistente Kapseln | 1.2.40.0.34.4.17:1-20934 | GA - zugelassen | Cheplapharm Arzneimittel GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:A02BC01 | Omeprazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709144 | OMEPRAZOL | 1.2.40.0.34.5.221:100000092047 | OMEPRAZOLE | active | 10 | mg | 1.2.40.0.34.5.221:100000092047 | OMEPRAZOLE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073376 | magensaftresistente Hartkapsel | true | human | 1.2.40.0.34.4.26:930604006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290046 | PULMICORT TURBOH. 0,1/20MG | Pulmicort Turbohaler 0,1 mg - Dosier - Pulverinhalator | 1.2.40.0.34.4.17:1-21109 | GA - zugelassen | Astrazeneca Österreich GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073530 | Mehrdosenbehältnis | 2.16.840.1.113883.6.73:R03BA02 | Budesonid | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1708795 | BUDESONID | 1.2.40.0.34.5.221:100000091309 | BUDESONIDE | active | 0.1 | mg | 1.2.40.0.34.5.221:100000091309 | BUDESONIDE | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073839 | Pulver zur Inhalation | true | human | 1.2.40.0.34.4.26:931376001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290129 | AMBISOME PLV DFL 50MG | AmBisome Amphotericin B liposomal 50 mg, Pulver zur Herstellung einer Infusionsdispersion | 1.2.40.0.34.4.17:1-20606 | GA - zugelassen | Gilead Sciences Ireland Unlimited Company | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:J02AA01 | Amphotericin B | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709185 | AMPHOTERICIN B | 1.2.40.0.34.5.221:100000092100 | AMPHOTERICIN B | active | 50 | mg | 1.2.40.0.34.5.221:100000092100 | AMPHOTERICIN B | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:930315003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290135 | DERMODRIN SLB | Dermodrin - Salbe | 1.2.40.0.34.4.17:9199 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D04AA32 | Diphenhydramin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708598 | DIPHENHYDRAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | active | 1 | g | 1.2.40.0.34.5.221:100000090453 | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:122104003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290141 | HERZSCHUTZASS RTP TBL 100MG | Herzschutz ASS "ratiopharm" 100 mg - Tabletten | 1.2.40.0.34.4.17:1-20789 | GA - zugelassen | Teva B.V. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B01AC06 | Acetylsalicylsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 100 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933635002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290158 | HERZSCHUTZASS RTP TBL 100MG | Herzschutz ASS "ratiopharm" 100 mg - Tabletten | 1.2.40.0.34.4.17:1-20789 | GA - zugelassen | Teva B.V. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:B01AC06 | Acetylsalicylsäure | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709716 | ACETYLSALICYLSÄURE | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | active | 100 | mg | 1.2.40.0.34.5.221:100000124205 | ACETYL SALICYLIC ACID | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933635001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290307 | SEROPRAM FTBL 20MG | Seropram 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-19326 | GA - zugelassen | Lundbeck Austria GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N06AB04 | Citalopram | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708640 | CITALOPRAM HYDROBROMID | 1.2.40.0.34.5.221:100000090554 | CITALOPRAM HYDROBROMIDE | active | 24.98 | mg | 1.2.40.0.34.5.221:100000090554 | CITALOPRAM HYDROBROMIDE | 24.98 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:928669001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290460 | MYOCHOLINE GLENW TBL 10MG | Myocholine - Glenwood Tabletten 10 mg | 1.2.40.0.34.4.17:17338 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N07AB02 | Bethanechol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705596 | BETHANECHOLCHLORID | 1.2.40.0.34.5.221:100000076855 | BETHANECHOL CHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000076855 | BETHANECHOL CHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129407001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290477 | MYOCHOLINE GLENW TBL 25MG | Myocholine - Glenwood Tabletten 25 mg | 1.2.40.0.34.4.17:17339 | GA - zugelassen | Glenwood GmbH Pharmazeutische Erzeugnisse | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N07AB02 | Bethanechol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1705596 | BETHANECHOLCHLORID | 1.2.40.0.34.5.221:100000076855 | BETHANECHOL CHLORIDE | active | 25 | mg | 1.2.40.0.34.5.221:100000076855 | BETHANECHOL CHLORIDE | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:129406001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290483 | DEXABENE AMP 4MG 1ML | Dexabene 4 mg - Ampullen | 1.2.40.0.34.4.17:1-20848 | GA - zugelassen | Teva B.V. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB02 | Dexamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | 1.2.40.0.34.5.156:1708635 | DEXAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | active | 5.26 | mg | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | 5.26 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:933781001 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290508 | DEXABENE AMP 4MG 1ML | Dexabene 4 mg - Ampullen | 1.2.40.0.34.4.17:1-20848 | GA - zugelassen | Teva B.V. | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB02 | Dexamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | 1.2.40.0.34.5.156:1708635 | DEXAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | active | 5.26 | mg | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | 5.26 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:933781003 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290514 | DEXABENE AMP 4MG 1ML BP5X5 | Dexabene 4 mg - Ampullen | 1.2.40.0.34.4.17:1-20848 | GA - zugelassen | Teva B.V. | true | true | 25 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB02 | Dexamethason | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073588 | intraartikuläre Anwendung | 1.2.40.0.34.5.156:1708635 | DEXAMETHASON DINATRIUMPHOSPHAT | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | active | 5.26 | mg | 1.2.40.0.34.5.221:100000090542 | DEXAMETHASONE SODIUM PHOSPHATE | 5.26 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:933781002 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073632 | subkonjunktivale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290520 | DT-REDUCT MER FSPR 0,5ML | dT-reduct „Mérieux“ - Injektionssuspension in einer Fertigspritze | 1.2.40.0.34.4.17:2-00144 | GA - zugelassen | Sanofi Winthrop Industrie | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:J07AM51 | Tetanus-Toxoid, Kombinationen mit Diphtherie-Toxoid | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | 1.2.40.0.34.5.156:1708114 | CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:100000088868 | CORYNEBACTERIUM DIPHTHERIAE | active | 2 | IU | 1.2.40.0.34.5.221:100000088868 | CORYNEBACTERIUM DIPHTHERIAE | 2 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073864 | Injektionssuspension | true | human | 1.2.40.0.34.4.26:935726001 | 1.2.40.0.34.5.156:1708219 | CLOSTRIDIUM TETANI (AUSZUG, PRODUKTE) | 1.2.40.0.34.5.221:100000089278 | CLOSTRIDIUM TETANI | active | 20 | IU | 1.2.40.0.34.5.221:100000089278 | CLOSTRIDIUM TETANI | 20 | IU | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290773 | PROSICCA AU-TR | Prosicca - Augentropfen | 1.2.40.0.34.4.17:15658 | GA - zugelassen | AGEPHA Pharma s.r.o | true | true | 10 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:S01XA20 | Künstliche Tränen und andere indifferente Mittel | 1.2.40.0.10.1.4.3.4.3.4:100000073617 | Anwendung am Auge | | | | | 1.2.40.0.34.5.156:1707759 | HYPROMELLOSE | 1.2.40.0.34.5.221:100000087131 | HYPROMELLOSE | active | 0.05 | g | 1.2.40.0.34.5.221:100000087131 | HYPROMELLOSE | 0.05 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073759 | Augentropfen, Lösung | false | human | 1.2.40.0.34.4.26:120512001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290916 | PEDITRACE IFZUS STAMP 10ML | Peditrace - Infusionszusatz | 1.2.40.0.34.4.17:1-20857 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B05XA30 | Kombinationen von Elektrolyten | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708501 | ZINKCHLORID | 1.2.40.0.34.5.221:100000090232 | ZINC CHLORIDE | active | 5.21 | mg | 1.2.40.0.34.5.221:100000090232 | ZINC CHLORIDE | 5.21 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:127461001 | 1.2.40.0.34.5.156:1708898 | NATRIUMFLUORID | 1.2.40.0.34.5.221:100000091554 | SODIUM FLUORIDE | active | 1.26 | mg | 1.2.40.0.34.5.221:100000091554 | SODIUM FLUORIDE | 1.26 | mg | 1.2.40.0.34.5.156:1705487 | MANGANCHLORID | 1.2.40.0.34.5.221:100000076504 | MANGANESE CHLORIDE | active | 0.036 | mg | 1.2.40.0.34.5.221:100000076504 | MANGANESE CHLORIDE | 0.036 | mg | | | | | | | 1.2.40.0.34.5.156:1708800 | KALIUMIODID | 1.2.40.0.34.5.221:100000091320 | POTASSIUM IODIDE | active | 0.013 | mg | 1.2.40.0.34.5.221:100000091320 | POTASSIUM IODIDE | 0.013 | mg | 1.2.40.0.34.5.156:1707987 | DINATRIUMSELENIT | 1.2.40.0.34.5.221:100000088238 | SODIUM SELENITE | active | 0.044 | mg | 1.2.40.0.34.5.221:100000088238 | SODIUM SELENITE | 0.044 | mg | 1.2.40.0.34.5.156:1706294 | KUPFERDICHLORID | 1.2.40.0.34.5.221:100000079804 | COPPER CHLORIDE | active | 0.537 | mg | 1.2.40.0.34.5.221:100000079804 | COPPER CHLORIDE | 0.537 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290922 | VOLTAREN DISPERS TBL LSL | Voltaren dispers - lösliche Tabletten | 1.2.40.0.34.4.17:1-20832 | GA - aufgehoben | Novartis Pharma GmbH | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AB05 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709564 | DICLOFENAC | 1.2.40.0.34.5.221:100000092798 | DICLOFENAC | active | 46.5 | mg | 1.2.40.0.34.5.221:100000092798 | DICLOFENAC | 46.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073654 | Tablette zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:933718001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290939 | WEISSDORN KPS ARKOCAPS | Weißdorn Arkocaps Kapseln | 1.2.40.0.34.4.17:736029 | GA - aufgehoben | Laboratoires Arkopharma | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:900000000009 | Behältnis (NE) | 2.16.840.1.113883.6.73:C01EB04 | Crataegus-Glykoside | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709648 | CRATAEGI FOLIUM CUM FLORE | 1.2.40.0.34.5.221:100000093308 | CRATAEGI FOLIUM CUM FLORE | active | 350 | mg | 1.2.40.0.34.5.221:100000093308 | CRATAEGI FOLIUM CUM FLORE | 350 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | false | human | 1.2.40.0.34.4.26:959032002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1290951 | DALACIN LOT | Dalacin - Lotion | 1.2.40.0.34.4.17:1-20589 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D10AF01 | Clindamycin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708641 | CLINDAMYCIN PHOSPHAT | 1.2.40.0.34.5.221:100000090555 | CLINDAMYCIN PHOSPHATE | active | 0.396 | g | 1.2.40.0.34.5.221:100000090555 | CLINDAMYCIN PHOSPHATE | 0.396 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073719 | Emulsion zur Anwendung auf der Haut | true | human | 1.2.40.0.34.4.26:933633001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1291040 | ZADITEN SIR KIND | Zaditen - Sirup für Kinder | 1.2.40.0.34.4.17:16660 | GA - aufgehoben | Alfasigma S.p.A. | false | false | 200 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:R06AX17 | Ketotifen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709246 | KETOTIFEN HYDROGENFUMARAT | 1.2.40.0.34.5.221:100000092186 | KETOTIFEN HYDROGEN FUMARATE | active | 0.028 | g | 1.2.40.0.34.5.221:100000092186 | KETOTIFEN HYDROGEN FUMARATE | 0.028 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073652 | Sirup | true | human | 1.2.40.0.34.4.26:129902002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1291057 | VALTREX FTBL 500MG | Valtrex 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21007 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 42 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J05AB11 | Valaciclovir | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708566 | VALACICLOVIRHYDROCHLORID | 1.2.40.0.34.5.221:100000090390 | VALACICLOVIR HYDROCHLORIDE | active | 556 | mg | 1.2.40.0.34.5.221:100000090390 | VALACICLOVIR HYDROCHLORIDE | 556 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:936020004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1291123 | SUPRANE INHALNARK.ALUFL240ML | Suprane - Inhalationsnarkotikum | 1.2.40.0.34.4.17:1-20922 | GA - zugelassen | Baxter Healthcare GmbH | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:N01AB07 | Desfluran | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1706862 | DESFLURAN | 1.2.40.0.34.5.221:100000083168 | DESFLURANE | active | 240 | ml | 1.2.40.0.34.5.221:100000083168 | DESFLURANE | 240 | ml | 1.2.40.0.10.1.4.3.4.3.5:100000073854 | Flüssigkeit zur Herstellung eines Dampfs zur Inhalation | true | human | 1.2.40.0.34.4.26:933853001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1291519 | SEREVENT DISKUS PLV | Serevent Diskus - Pulver zur Trockeninhalation | 1.2.40.0.34.4.17:1-20602 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03AC12 | Salmeterol | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1708832 | SALMETEROL XINAFOAT | 1.2.40.0.34.5.221:100000091381 | SALMETEROL XINAFOATE | active | 0.072 | mg | 1.2.40.0.34.5.221:100000091381 | SALMETEROL XINAFOATE | 0.072 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073839 | Pulver zur Inhalation | true | human | 1.2.40.0.34.4.26:932019001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1291531 | FLIXOTIDE DISK JUN 0,1MG 60D | Flixotide Diskus junior 100 Mikrogramm - Pulver zur Trockeninhalation | 1.2.40.0.34.4.17:1-20577 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03BA05 | Fluticason | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1709522 | FLUTICASONPROPIONAT | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | active | 0.1 | mg | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | 0.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073839 | Pulver zur Inhalation | true | human | 1.2.40.0.34.4.26:933594001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1291548 | FLIXOTIDE DISKSTD 0,25MG 60D | Flixotide Diskus standard 250 Mikrogramm - Pulver zur Trockeninhalation | 1.2.40.0.34.4.17:1-20575 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03BA05 | Fluticason | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1709522 | FLUTICASONPROPIONAT | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | active | 0.25 | mg | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | 0.25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073839 | Pulver zur Inhalation | true | human | 1.2.40.0.34.4.26:933590001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1291554 | FLIXOTIDE DISK FTE 0,5MG 60D | Flixotide Diskus forte 500 Mikrogramm - Pulver zur Trockeninhalation | 1.2.40.0.34.4.17:1-20578 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R03BA05 | Fluticason | 1.2.40.0.10.1.4.3.4.3.4:100000073584 | zur Inhalation | | | | | 1.2.40.0.34.5.156:1709522 | FLUTICASONPROPIONAT | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | active | 0.5 | mg | 1.2.40.0.34.5.221:100000092718 | FLUTICASONE PROPIONATE | 0.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073839 | Pulver zur Inhalation | true | human | 1.2.40.0.34.4.26:933595001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1291896 | KETOTISAN KPS 1MG | Ketotisan 1 mg - Kapseln | 1.2.40.0.34.4.17:1-20620 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AX17 | Ketotifen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709246 | KETOTIFEN HYDROGENFUMARAT | 1.2.40.0.34.5.221:100000092186 | KETOTIFEN HYDROGEN FUMARATE | active | 1.38 | mg | 1.2.40.0.34.5.221:100000092186 | KETOTIFEN HYDROGEN FUMARATE | 1.38 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:933477002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1291904 | KETOTISAN KPS 1MG | Ketotisan 1 mg - Kapseln | 1.2.40.0.34.4.17:1-20620 | GA - aufgehoben | Wabosan Arzneimittelvertriebs GmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R06AX17 | Ketotifen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709246 | KETOTIFEN HYDROGENFUMARAT | 1.2.40.0.34.5.221:100000092186 | KETOTIFEN HYDROGEN FUMARATE | active | 1.38 | mg | 1.2.40.0.34.5.221:100000092186 | KETOTIFEN HYDROGEN FUMARATE | 1.38 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:933477001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1291991 | FLUIMUCIL GRAN 200MG | Fluimucil 200 mg Granulat | 1.2.40.0.34.4.17:1-20240 | GA - zugelassen | Zambon S.p.A. | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:R05CB01 | Acetylcystein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709282 | ACETYLCYSTEIN | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | active | 200 | mg | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073365 | Granulat zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:929965001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292016 | FLUIMUCIL TBL LSL 600MG | Fluimucil 600 mg lösliche Tabletten | 1.2.40.0.34.4.17:1-20242 | GA - zugelassen | Zambon S.p.A. | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:R05CB01 | Acetylcystein | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709282 | ACETYLCYSTEIN | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | active | 600 | mg | 1.2.40.0.34.5.221:100000092261 | ACETYLCYSTEINE | 600 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073369 | Tablette zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:929964001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292039 | NEODOLPASSE ILSG 250ML | Neodolpasse - Infusionslösung | 1.2.40.0.34.4.17:1-20916 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M01AB55 | Diclofenac, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709164 | ORPHENADRIN DIHYDROGENCITRAT | 1.2.40.0.34.5.221:100000092072 | ORPHENADRINE CITRATE | active | 0.03 | g | 1.2.40.0.34.5.221:100000092072 | ORPHENADRINE CITRATE | 0.03 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:936714001 | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 0.075 | g | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 0.075 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292045 | NEODOLPASSE ILSG 250ML | Neodolpasse - Infusionslösung | 1.2.40.0.34.4.17:1-20916 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:M01AB55 | Diclofenac, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709164 | ORPHENADRIN DIHYDROGENCITRAT | 1.2.40.0.34.5.221:100000092072 | ORPHENADRINE CITRATE | active | 0.03 | g | 1.2.40.0.34.5.221:100000092072 | ORPHENADRINE CITRATE | 0.03 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:936714002 | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 0.075 | g | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 0.075 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292140 | PROFENID IKONZ AMP 50MG/10ML | Profenid 50 mg Konzentrat zur Infusionsbereitung | 1.2.40.0.34.4.17:1-20909 | GA - zugelassen | Sanofi-Aventis GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M01AE03 | Ketoprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708999 | KETOPROFEN | 1.2.40.0.34.5.221:100000091768 | KETOPROFEN | active | 50 | mg | 1.2.40.0.34.5.221:100000091768 | KETOPROFEN | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:931046001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073857 | Konzentrat zur Herstellung einer Injektionslösung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292200 | ENGERIX-B FSPR 10MCG/0,5ML | ENGERIX-B 10 Mikrogramm/0,5 ml Injektionssuspension in einer Fertigspritze | 1.2.40.0.34.4.17:2-00145 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:J07BC01 | Hepatitis B, gereinigtes Antigen | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1708175 | HEPATITIS-B-VIRUS-ANTIGEN | 1.2.40.0.34.5.221:100000089111 | HEPATITIS B SURFACE ANTIGEN | active | 10 | µg | 1.2.40.0.34.5.221:100000089111 | HEPATITIS B SURFACE ANTIGEN | 10 | µg | 1.2.40.0.10.1.4.3.4.3.5:100000074063 | Injektionssuspension in einer Fertigspritze | true | human | 1.2.40.0.34.4.26:933950001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292507 | ZURCAL FTBL 40MG | Zurcal 40 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21016 | GA - zugelassen | Takeda Austria GmbH | true | true | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BC02 | Pantoprazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708553 | PANTOPRAZOL NATRIUM | 1.2.40.0.34.5.221:100000090359 | PANTOPRAZOLE SODIUM | active | 45.1 | mg | 1.2.40.0.34.5.221:100000090359 | PANTOPRAZOLE SODIUM | 45.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:934268007 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292513 | ZURCAL FTBL 40MG | Zurcal 40 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21016 | GA - zugelassen | Takeda Austria GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BC02 | Pantoprazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708553 | PANTOPRAZOL NATRIUM | 1.2.40.0.34.5.221:100000090359 | PANTOPRAZOLE SODIUM | active | 45.1 | mg | 1.2.40.0.34.5.221:100000090359 | PANTOPRAZOLE SODIUM | 45.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:934268016 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292619 | JOPAMIRO 300MG J/ML DFL500ML | Jopamiro 300 mg J/ml - Stechampullen | 1.2.40.0.34.4.17:17302 | GA - zugelassen | Bracco Österreich GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 306000 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 306000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920664006 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292625 | JOPAMIRO 370MG J/ML DFL500ML | Jopamiro 370 mg J/ml - Stechampullen | 1.2.40.0.34.4.17:17304 | GA - zugelassen | Bracco Österreich GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08AB04 | Iopamidol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | 1.2.40.0.10.1.4.3.4.3.4:900000000014 | zur Instillation | 1.2.40.0.34.5.156:1708849 | IOPAMIDOL | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | active | 377500 | mg | 1.2.40.0.34.5.221:100000091432 | IOPAMIDOL | 377500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:920665004 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292631 | PANTOLOC FTBL 40MG | Pantoloc 40 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21015 | GA - zugelassen | Takeda Pharma Ges.m.b.H. | true | true | 14 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BC02 | Pantoprazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708553 | PANTOPRAZOL NATRIUM | 1.2.40.0.34.5.221:100000090359 | PANTOPRAZOLE SODIUM | active | 45.1 | mg | 1.2.40.0.34.5.221:100000090359 | PANTOPRAZOLE SODIUM | 45.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:934269008 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292648 | PANTOLOC FTBL 40MG | Pantoloc 40 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21015 | GA - zugelassen | Takeda Pharma Ges.m.b.H. | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BC02 | Pantoprazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708553 | PANTOPRAZOL NATRIUM | 1.2.40.0.34.5.221:100000090359 | PANTOPRAZOLE SODIUM | active | 45.1 | mg | 1.2.40.0.34.5.221:100000090359 | PANTOPRAZOLE SODIUM | 45.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:934269017 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292714 | AURORIX FTBL 300MG | Aurorix 300 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21026 | GA - zugelassen | Viatris Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N06AG02 | Moclobemid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709401 | MOCLOBEMID | 1.2.40.0.34.5.221:100000092489 | MOCLOBEMIDE | active | 300 | mg | 1.2.40.0.34.5.221:100000092489 | MOCLOBEMIDE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:935249001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292720 | AURORIX FTBL 300MG | Aurorix 300 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21026 | GA - zugelassen | Viatris Austria GmbH | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000137702 | Behältnis | 2.16.840.1.113883.6.73:N06AG02 | Moclobemid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709401 | MOCLOBEMID | 1.2.40.0.34.5.221:100000092489 | MOCLOBEMIDE | active | 300 | mg | 1.2.40.0.34.5.221:100000092489 | MOCLOBEMIDE | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:935249002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292737 | SERACTIL FTBL 300MG | Seractil 300 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20002 | GA - zugelassen | Gebro Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE14 | Dexibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706866 | DEXIBUPROFEN | 1.2.40.0.34.5.221:100000083204 | DEXIBUPROFEN | active | 300 | mg | 1.2.40.0.34.5.221:100000083204 | DEXIBUPROFEN | 300 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930319001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292789 | ACECOMB-SEMI TBL | Acecomb semi - Tabletten | 1.2.40.0.34.4.17:1-21095 | GA - zugelassen | Atnahs Pharma Netherlands B.V. | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09BA03 | Lisinopril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709062 | LISINOPRIL | 1.2.40.0.34.5.221:100000091915 | LISINOPRIL | active | 10.9 | mg | 1.2.40.0.34.5.221:100000091915 | LISINOPRIL | 10.9 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933385001 | 1.2.40.0.34.5.156:1708989 | HYDROCHLOROTHIAZID | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | active | 12.5 | mg | 1.2.40.0.34.5.221:100000091737 | HYDROCHLOROTHIAZIDE | 12.5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292803 | OMNISCAN STAMP 0,5MMOL 15ML | Omniscan 0,5 mmol/ml - parenterale Kontrastmittellösung | 1.2.40.0.34.4.17:1-20968 | GA - ruhend gestellt | GE Healthcare Handels GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08CA03 | Gadodiamid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707305 | GADODIAMID | 1.2.40.0.34.5.221:100000085190 | GADODIAMIDE | active | 4305 | mg | 1.2.40.0.34.5.221:100000085190 | GADODIAMIDE | 4305 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:934388014 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292826 | OMNISCAN STAMP 0,5MMOL 20ML | Omniscan 0,5 mmol/ml - parenterale Kontrastmittellösung | 1.2.40.0.34.4.17:1-20968 | GA - ruhend gestellt | GE Healthcare Handels GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:V08CA03 | Gadodiamid | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1707305 | GADODIAMID | 1.2.40.0.34.5.221:100000085190 | GADODIAMIDE | active | 5740 | mg | 1.2.40.0.34.5.221:100000085190 | GADODIAMIDE | 5740 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:934388016 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292861 | ZAVEDOS KPS 5MG | Zavedos 5 mg Kapseln | 1.2.40.0.34.4.17:1-21099 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L01DB06 | Idarubicin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708621 | IDARUBICIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090504 | IDARUBICIN HYDROCHLORIDE | active | 5 | mg | 1.2.40.0.34.5.221:100000090504 | IDARUBICIN HYDROCHLORIDE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:933744001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292884 | ZAVEDOS KPS 10MG | Zavedos 10 mg Kapseln | 1.2.40.0.34.4.17:1-21096 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:L01DB06 | Idarubicin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708621 | IDARUBICIN HYDROCHLORID | 1.2.40.0.34.5.221:100000090504 | IDARUBICIN HYDROCHLORIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000090504 | IDARUBICIN HYDROCHLORIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:933743001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292967 | CARBOPLATIN P&U DFL 150MG | Carboplatin Pfizer CS 150 mg Konzentrat zur Infusionsbereitung | 1.2.40.0.34.4.17:1-21070 | GA - aufgehoben | Pfizer Corporation Austria Ges.m.b.H. | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01XA02 | Carboplatin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709436 | CARBOPLATIN | 1.2.40.0.34.5.221:100000092564 | CARBOPLATIN | active | 150 | mg | 1.2.40.0.34.5.221:100000092564 | CARBOPLATIN | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:934960001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1292973 | CARBOPLATIN P&U 450MG/45ML | Carboplatin Pfizer 450 mg Konzentrat zur Infusionsbereitung | 1.2.40.0.34.4.17:1-21069 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01XA02 | Carboplatin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709436 | CARBOPLATIN | 1.2.40.0.34.5.221:100000092564 | CARBOPLATIN | active | 450 | mg | 1.2.40.0.34.5.221:100000092564 | CARBOPLATIN | 450 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073871 | Konzentrat zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:934959001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293197 | LAMICTAL KAU/SCHMTBL 5MG | Lamictal 5 mg Tabletten (kaubar/suspendierbar) | 1.2.40.0.34.4.17:1-20888 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N03AX09 | Lamotrigin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709298 | LAMOTRIGIN | 1.2.40.0.34.5.221:100000092282 | LAMOTRIGINE | active | 5 | mg | 1.2.40.0.34.5.221:100000092282 | LAMOTRIGINE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073654 | Tablette zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:935083007 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073684 | Kautablette | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293211 | VALTREX FTBL 500MG | Valtrex 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21007 | GA - zugelassen | Glaxosmithkline Pharma GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:J05AB11 | Valaciclovir | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708566 | VALACICLOVIRHYDROCHLORID | 1.2.40.0.34.5.221:100000090390 | VALACICLOVIR HYDROCHLORIDE | active | 556 | mg | 1.2.40.0.34.5.221:100000090390 | VALACICLOVIR HYDROCHLORIDE | 556 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:936020001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293240 | METFORMIN ARC FTBL 850MG | Metformin Arcana 850 mg Filmtabletten | 1.2.40.0.34.4.17:1-19303 | GA - aufgehoben | Arcana Arzneimittel GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BA02 | Metformin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708825 | METFORMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | active | 850 | mg | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | 850 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:920436002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293257 | METFORMIN ARC FTBL 850MG | Metformin Arcana 850 mg Filmtabletten | 1.2.40.0.34.4.17:1-19303 | GA - aufgehoben | Arcana Arzneimittel GmbH | false | false | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BA02 | Metformin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708825 | METFORMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | active | 850 | mg | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | 850 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:920436001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293375 | NORPROLAC STPK 0,025+0,050MG | Norprolac 0,025 mg u. 0,050 mg - Tabletten (Startpackung) | 1.2.40.0.34.4.17:1-20873 | GA - zugelassen | Ferring Arzneimittel Ges.m.b.H. | true | true | 6 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:G02CB04 | Quinagolid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708433 | QUINAGOLID HYDROCHLORID | 1.2.40.0.34.5.221:100000090012 | QUINAGOLIDE HYDROCHLORIDE | active | 0.0819 | mg | 1.2.40.0.34.5.221:100000090012 | QUINAGOLIDE HYDROCHLORIDE | 0.0819 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933697001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293406 | BATRAFEN ANTIMYK. NAGELLACK | Batrafen - antimykotischer Nagellack | 1.2.40.0.34.4.17:1-21113 | GA - aufgehoben | Opella Healthcare Austria GmbH | false | false | 3 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D01AE14 | Ciclopirox | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1706665 | CICLOPIROX | 1.2.40.0.34.5.221:100000081889 | CICLOPIROX | active | 0.24 | g | 1.2.40.0.34.5.221:100000081889 | CICLOPIROX | 0.24 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073742 | wirkstoffhaltiger Nagellack | false | human | 1.2.40.0.34.4.26:934205002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293412 | BATRAFEN ANTIMYK. NAGELLACK | Batrafen - antimykotischer Nagellack | 1.2.40.0.34.4.17:1-21113 | GA - aufgehoben | Opella Healthcare Austria GmbH | false | false | 1.5 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:D01AE14 | Ciclopirox | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1706665 | CICLOPIROX | 1.2.40.0.34.5.221:100000081889 | CICLOPIROX | active | 0.12 | g | 1.2.40.0.34.5.221:100000081889 | CICLOPIROX | 0.12 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073742 | wirkstoffhaltiger Nagellack | false | human | 1.2.40.0.34.4.26:934205001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293607 | MEPRIL TBL 5MG | Mepril 5 mg - Tabletten | 1.2.40.0.34.4.17:1-22238 | GA - zugelassen | Kwizda Pharma GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA02 | Enalapril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708809 | ENALAPRIL MALEAT | 1.2.40.0.34.5.221:100000091343 | ENALAPRIL MALEATE | active | 5 | mg | 1.2.40.0.34.5.221:100000091343 | ENALAPRIL MALEATE | 5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:940936001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293613 | MEPRIL TBL 10MG | Mepril 10 mg - Tabletten | 1.2.40.0.34.4.17:1-22213 | GA - zugelassen | Kwizda Pharma GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA02 | Enalapril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708809 | ENALAPRIL MALEAT | 1.2.40.0.34.5.221:100000091343 | ENALAPRIL MALEATE | active | 10 | mg | 1.2.40.0.34.5.221:100000091343 | ENALAPRIL MALEATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:940937001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293636 | MEPRIL TBL 20MG | Mepril 20 mg - Tabletten | 1.2.40.0.34.4.17:1-22214 | GA - zugelassen | Kwizda Pharma GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA02 | Enalapril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708809 | ENALAPRIL MALEAT | 1.2.40.0.34.5.221:100000091343 | ENALAPRIL MALEATE | active | 20 | mg | 1.2.40.0.34.5.221:100000091343 | ENALAPRIL MALEATE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:940935001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293642 | ERGOTOP FTBL 30MG | Ergotop 30 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21027 | GA - zugelassen | Kwizda Pharma GmbH | true | true | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C04AE02 | Nicergolin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709127 | NICERGOLIN | 1.2.40.0.34.5.221:100000092017 | NICERGOLINE | active | 30 | mg | 1.2.40.0.34.5.221:100000092017 | NICERGOLINE | 30 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933613002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293671 | SOLU-DACORTIN PLV+LSM 50MG | Solu - Dacortin 50 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung oder Infusionslösung | 1.2.40.0.34.4.17:13017 | GA - zugelassen | Merck Ges.m.b.H. | true | false | 3 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H02AB06 | Prednisolon | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | 1.2.40.0.34.5.156:1709059 | NATRIUM PREDNISOLON SUCCINAT | 1.2.40.0.34.5.221:100000091910 | PREDNISOLONE SODIUM SUCCINATE | active | 50 | mg | 1.2.40.0.34.5.221:100000091910 | PREDNISOLONE SODIUM SUCCINATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:129372002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293843 | BERIRAB P FSPR 2ML | Berirab P Fertigspritze | 1.2.40.0.34.4.17:2-00158 | GA - zugelassen | CSL Behring GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:J06BB05 | Tollwut-Immunglobulin | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1705771 | IMMUNGLOBULIN | 1.2.40.0.34.5.221:100000077660 | IMMUNGLOBULIN | active | 400 | mg | 1.2.40.0.34.5.221:100000077660 | IMMUNGLOBULIN | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:929543001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293866 | BERIRAB P FSPR 5ML | Berirab P Fertigspritze | 1.2.40.0.34.4.17:2-00158 | GA - zugelassen | CSL Behring GmbH | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073544 | Fertigspritze | 2.16.840.1.113883.6.73:J06BB05 | Tollwut-Immunglobulin | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | | | | | 1.2.40.0.34.5.156:1705771 | IMMUNGLOBULIN | 1.2.40.0.34.5.221:100000077660 | IMMUNGLOBULIN | active | 1000 | mg | 1.2.40.0.34.5.221:100000077660 | IMMUNGLOBULIN | 1000 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:929543002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293872 | FIBROGAMMIN PLV+LSM 250IE | Fibrogammin 250 IE Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | 1.2.40.0.34.4.17:2-00163 | GA - zugelassen | CSL Behring GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B02BD07 | Gerinnungsfaktor XIII | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709739 | GERINNUNGSFAKTOR XIII | 1.2.40.0.34.5.221:100000124487 | HUMAN COAGULATION FACTOR XIII | active | 250 | U | 1.2.40.0.34.5.221:100000124487 | HUMAN COAGULATION FACTOR XIII | 250 | U | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:935788001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293889 | FIBROGAMMIN PLV+LSM 1250IE | Fibrogammin 1250 IE Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | 1.2.40.0.34.4.17:2-00164 | GA - zugelassen | CSL Behring GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:B02BD07 | Gerinnungsfaktor XIII | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709739 | GERINNUNGSFAKTOR XIII | 1.2.40.0.34.5.221:100000124487 | HUMAN COAGULATION FACTOR XIII | active | 1250 | U | 1.2.40.0.34.5.221:100000124487 | HUMAN COAGULATION FACTOR XIII | 1250 | U | 1.2.40.0.10.1.4.3.4.3.5:100000074057 | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:935789001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293949 | ATENOLOL STA TBL 50MG | Atenolol "Stada" 50 mg Tabletten | 1.2.40.0.34.4.17:1-20766 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 50 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933672002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293955 | ATENOLOL STA TBL 50MG | Atenolol "Stada" 50 mg Tabletten | 1.2.40.0.34.4.17:1-20766 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 50 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933672003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293961 | ATENOLOL STA TBL 100MG | Atenolol "Stada" 100 mg Tabletten | 1.2.40.0.34.4.17:1-20763 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933673002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293978 | ATENOLOL STA TBL 100MG | Atenolol "Stada" 100 mg Tabletten | 1.2.40.0.34.4.17:1-20763 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB03 | Atenolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708768 | ATENOLOL | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | active | 100 | mg | 1.2.40.0.34.5.221:100000091183 | ATENOLOL | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933673003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293984 | METOPROLOL STA TBL 50MG | Metoprolol Stada 50 mg Tabletten | 1.2.40.0.34.4.17:1-20790 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933780001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1293990 | METOPROLOL STA TBL 50MG | Metoprolol Stada 50 mg Tabletten | 1.2.40.0.34.4.17:1-20790 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 50 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933780002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294009 | METOPROLOL STA TBL 100MG | Metoprolol Stada 100 mg Tabletten | 1.2.40.0.34.4.17:1-20791 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933778001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294015 | METOPROLOL STA TBL 100MG | Metoprolol Stada 100 mg Tabletten | 1.2.40.0.34.4.17:1-20791 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 100 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933778002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294021 | METOPROLOL STA RET FTBL200MG | Metoprolol "Stada" retard 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20792 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 200 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:933779002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294038 | METOPROLOL STA RET FTBL200MG | Metoprolol "Stada" retard 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20792 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C07AB02 | Metoprolol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708565 | METOPROLOL TARTRAT | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | active | 200 | mg | 1.2.40.0.34.5.221:100000090389 | METOPROLOL TARTRATE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:933779003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294050 | SOMATOSTATIN EUM PLV 0,25MG | Somatostatin "Eumedica" 0,250 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | 1.2.40.0.34.4.17:1-20975 | GA - aufgehoben | Eumedica Pharmaceuticals GmbH | false | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H01CB01 | Somatostatin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705808 | SOMATOSTATIN ACETAT | 1.2.40.0.34.5.221:100000077816 | SOMATOSTATIN ACETATE | active | | | 1.2.40.0.34.5.221:100000077816 | SOMATOSTATIN ACETATE | | | 1.2.40.0.10.1.4.3.4.3.5:100000073868 | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | true | human | 1.2.40.0.34.4.26:930760001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294067 | SOMATOSTATIN EUM PLV INF 3MG | Somatostatin "Eumedica" 3 mg - Pulver zur Herstellung einer Infusionslösung | 1.2.40.0.34.4.17:1-20974 | GA - zugelassen | Eumedica Pharmaceuticals GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:H01CB01 | Somatostatin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705808 | SOMATOSTATIN ACETAT | 1.2.40.0.34.5.221:100000077816 | SOMATOSTATIN ACETATE | active | 3.5 | mg | 1.2.40.0.34.5.221:100000077816 | SOMATOSTATIN ACETATE | 3.5 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073860 | Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:930761001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294073 | SOMATOSTATIN EUM PLV INF 6MG | Somatostatin "Eumedica" 6 mg - Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | 1.2.40.0.34.4.17:1-20990 | GA - zugelassen | Eumedica Pharmaceuticals GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:H01CB01 | Somatostatin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1705808 | SOMATOSTATIN ACETAT | 1.2.40.0.34.5.221:100000077816 | SOMATOSTATIN ACETATE | active | | | 1.2.40.0.34.5.221:100000077816 | SOMATOSTATIN ACETATE | | | 1.2.40.0.10.1.4.3.4.3.5:100000073860 | Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:930762001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294133 | EBETREXAT 10MG/ML STAMP 50ML | Ebetrexat 10 mg/ml - Parenterale Lösung | 1.2.40.0.34.4.17:1-20293 | GA - zugelassen | Ebewe Pharma Ges.m.b.H. Nfg.KG | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01BA01 | Methotrexat | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073587 | intraarterielle Anwendung | 1.2.40.0.34.5.156:1708507 | METHOTREXAT | 1.2.40.0.34.5.221:100000090250 | METHOTREXATE | active | 500 | mg | 1.2.40.0.34.5.221:100000090250 | METHOTREXATE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:931205004 | | | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.4:100000073600 | intramuskuläre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073633 | subkutane Anwendung | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294179 | ACERBINE SBL | Acerbine Salbe | 1.2.40.0.34.4.17:16169 | GA - zugelassen | Pharmazeutische Fabrik Montavit Ges.m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D03AX | Andere Wundbehandlungsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708587 | BENZOESÄURE | 1.2.40.0.34.5.221:100000090433 | BENZOIC ACID | active | 0.015 | g | 1.2.40.0.34.5.221:100000090433 | BENZOIC ACID | 0.015 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:121989002 | 1.2.40.0.34.5.156:1709003 | ÄPFELSÄURE | 1.2.40.0.34.5.221:100000091777 | MALIC ACID | active | 0.21 | g | 1.2.40.0.34.5.221:100000091777 | MALIC ACID | 0.21 | g | 1.2.40.0.34.5.156:1708443 | SALICYLSÄURE | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | active | 0.00399 | g | 1.2.40.0.34.5.221:100000090038 | SALICYLIC ACID | 0.00399 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294311 | DICLOFENAC GEN GEL 1% | Diclofenac Genericon 1 % Gel | 1.2.40.0.34.4.17:1-18916 | GA - aufgehoben | Genericon Pharma Ges.m.b.H. | false | false | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:M02AA15 | Diclofenac | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000075243 | zur lokalen Anwendung | | | 1.2.40.0.34.5.156:1709290 | DICLOFENAC NATRIUM | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | active | 1 | g | 1.2.40.0.34.5.221:100000092272 | DICLOFENAC SODIUM | 1 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | true | human | 1.2.40.0.34.4.26:928593002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294328 | LEUKICHTAN SLB | Leukichtan - Salbe | 1.2.40.0.34.4.17:4531 | GA - zugelassen | Ichthyol-Gesellschaft Cordes, Hermanni & Co. (GmbH & Co.) KG | true | true | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D08AX | Andere Antiseptika und Desinfektionsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1705770 | NATRIUM SULFOBITUMINOSUM | 1.2.40.0.34.5.221:100000077657 | ICHTHAMMOL SODIUM | active | 600 | g | 1.2.40.0.34.5.221:100000077657 | ICHTHAMMOL SODIUM | 600 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:120518001 | 1.2.40.0.34.5.156:1708881 | JECORIS ASELLI OLEUM | 1.2.40.0.34.5.221:100000091501 | COD-LIVER OIL | active | 480 | g | 1.2.40.0.34.5.221:100000091501 | COD-LIVER OIL | 480 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294334 | ICHTHOLAN SLB 20% | Ichtholan 20% - Salbe | 1.2.40.0.34.4.17:16338 | GA - zugelassen | Ichthyol-Gesellschaft Cordes, Hermanni & Co. (GmbH & Co.) KG | true | true | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D08AX | Andere Antiseptika und Desinfektionsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709356 | ICHTHAMMOLUM | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | active | 8 | g | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | 8 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:123214001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294340 | ICHTHOLAN SLB 50% | Ichtholan 50 % - Salbe | 1.2.40.0.34.4.17:16339 | GA - zugelassen | Ichthyol-Gesellschaft Cordes, Hermanni & Co. (GmbH & Co.) KG | true | true | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:D08AX | Andere Antiseptika und Desinfektionsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709356 | ICHTHAMMOLUM | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | active | 20 | g | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | 20 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:123215002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294363 | ICHTHOLAN SLB 50% | Ichtholan 50 % - Salbe | 1.2.40.0.34.4.17:16339 | GA - zugelassen | Ichthyol-Gesellschaft Cordes, Hermanni & Co. (GmbH & Co.) KG | true | false | 250 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073530 | Mehrdosenbehältnis | 2.16.840.1.113883.6.73:D08AX | Andere Antiseptika und Desinfektionsmittel | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1709356 | ICHTHAMMOLUM | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | active | 125 | g | 1.2.40.0.34.5.221:100000092371 | ICHTHAMMOL | 125 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073713 | Salbe | false | human | 1.2.40.0.34.4.26:123215001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294417 | AGOPTON KPS 30MG | Agopton 30 mg - Kapseln | 1.2.40.0.34.4.17:1-20545 | GA - zugelassen | Takeda Pharma Ges.m.b.H. | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | | | 2.16.840.1.113883.6.73:A02BC03 | Lansoprazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708390 | LANSOPRAZOL | 1.2.40.0.34.5.221:100000089867 | LANSOPRAZOL | active | | | 1.2.40.0.34.5.221:100000089867 | LANSOPRAZOL | | | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294423 | METFORMIN HEX FTBL 500MG | Metformin Hexal 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20785 | GA - zugelassen | Hexal Pharma GmbH | true | true | 40 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BA02 | Metformin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708825 | METFORMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | active | 500 | mg | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933666001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294446 | METFORMIN HEX FTBL 500MG | Metformin Hexal 500 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20785 | GA - zugelassen | Hexal Pharma GmbH | true | true | 200 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BA02 | Metformin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708825 | METFORMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | active | 500 | mg | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | 500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933666002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294452 | METFORMIN HEX FTBL 850MG | Metformin Hexal 850 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20788 | GA - zugelassen | Hexal Pharma GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BA02 | Metformin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708825 | METFORMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | active | 850 | mg | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | 850 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933659001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294469 | METFORMIN HEX FTBL 850MG | Metformin Hexal 850 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20788 | GA - zugelassen | Hexal Pharma GmbH | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A10BA02 | Metformin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708825 | METFORMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | active | 850 | mg | 1.2.40.0.34.5.221:100000091366 | METFORMIN HYDROCHLORIDE | 850 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933659002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294682 | ZURCAL FTBL 40MG | Zurcal 40 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21016 | GA - zugelassen | Takeda Austria GmbH | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BC02 | Pantoprazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708553 | PANTOPRAZOL NATRIUM | 1.2.40.0.34.5.221:100000090359 | PANTOPRAZOLE SODIUM | active | 45.1 | mg | 1.2.40.0.34.5.221:100000090359 | PANTOPRAZOLE SODIUM | 45.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:934268044 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294788 | CONDROSULF KPS 400MG | Condrosulf 400 mg - Kapseln | 1.2.40.0.34.4.17:1-20388 | GA - zugelassen | IBSA Farmaceutici Italia S.r.l. | true | true | 180 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AX25 | Chondroitinsulfat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709154 | CHONDROITINSULFAT-NATRIUM | 1.2.40.0.34.5.221:100000092058 | CHONDROITIN SULFATE SODIUM | active | 400 | mg | 1.2.40.0.34.5.221:100000092058 | CHONDROITIN SULFATE SODIUM | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:931520001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294877 | LIORESAL ITH AMP 10MG/20ML | Lioresal intrathekal 10 mg/20 ml - Ampulle | 1.2.40.0.34.4.17:1-21126 | GA - zugelassen | Novartis Pharma GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M03BX01 | Baclofen | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | | | | | 1.2.40.0.34.5.156:1708544 | BACLOFEN | 1.2.40.0.34.5.221:100000090335 | BACLOFEN | active | 10 | mg | 1.2.40.0.34.5.221:100000090335 | BACLOFEN | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:934494001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294883 | LIORESAL ITH AMP 10MG/5ML | Lioresal intrathekal 10 mg/5 ml - Ampulle | 1.2.40.0.34.4.17:1-21123 | GA - zugelassen | Novartis Pharma GmbH | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M03BX01 | Baclofen | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | | | | | 1.2.40.0.34.5.156:1708544 | BACLOFEN | 1.2.40.0.34.5.221:100000090335 | BACLOFEN | active | 10 | mg | 1.2.40.0.34.5.221:100000090335 | BACLOFEN | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:934492001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294908 | LIORESAL ITH AMP 0,05MG/1ML | Lioresal intrathekal 0,05 mg/1 ml - Ampullen | 1.2.40.0.34.4.17:1-21127 | GA - zugelassen | Novartis Pharma GmbH | true | true | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M03BX01 | Baclofen | 1.2.40.0.10.1.4.3.4.3.4:100000073608 | intrathekale Anwendung | | | | | 1.2.40.0.34.5.156:1708544 | BACLOFEN | 1.2.40.0.34.5.221:100000090335 | BACLOFEN | active | 0.05 | mg | 1.2.40.0.34.5.221:100000090335 | BACLOFEN | 0.05 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073863 | Injektionslösung | true | human | 1.2.40.0.34.4.26:934493001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1294943 | VIBRAVENOES AMP 100MG/5ML | Vibravenös 100 mg/5 ml Ampullen | 1.2.40.0.34.4.17:1-15051 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | false | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:J01AA02 | Doxycyclin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709488 | DOXYCYCLINHYCLAT | 1.2.40.0.34.5.221:100000092638 | DOXYCYCLINE HYCLATE | active | 126.85 | mg | 1.2.40.0.34.5.221:100000092212 | DOXYCYCLINE | 109.833326 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:121709001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1295055 | VETREN CR 60.000IE/100G | Vetren 60.000 I.E./100 g - Creme | 1.2.40.0.34.4.17:1-21322 | GA - aufgehoben | Takeda Pharma Ges.m.b.H. | false | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA03 | Heparin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 2400000 | IU | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 2400000 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | false | human | 1.2.40.0.34.4.26:933856002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1295061 | VETREN CR 60.000IE/100G | Vetren 60.000 I.E./100 g - Creme | 1.2.40.0.34.4.17:1-21322 | GA - aufgehoben | Takeda Pharma Ges.m.b.H. | false | false | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA03 | Heparin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 6000000 | IU | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 6000000 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073712 | Creme | false | human | 1.2.40.0.34.4.26:933856001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1295090 | VETREN GEL 60.000IE/100G | Vetren 60.000 I.E./100 g - Gel | 1.2.40.0.34.4.17:1-21320 | GA - aufgehoben | Takeda Pharma Ges.m.b.H. | false | false | 40 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA03 | Heparin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 2400000 | IU | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 2400000 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:933857002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1295109 | VETREN GEL 60.000IE/100G | Vetren 60.000 I.E./100 g - Gel | 1.2.40.0.34.4.17:1-21320 | GA - aufgehoben | Takeda Pharma Ges.m.b.H. | false | false | 100 | 2.16.840.1.113883.6.8:g | Gramm | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073561 | Tube | 2.16.840.1.113883.6.73:C05BA03 | Heparin | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | | | | | 1.2.40.0.34.5.156:1708475 | HEPARIN NATRIUM | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | active | 6000000 | IU | 1.2.40.0.34.5.221:100000090150 | HEPARIN SODIUM | 6000000 | IU | 1.2.40.0.10.1.4.3.4.3.5:100000073726 | Gel | false | human | 1.2.40.0.34.4.26:933857001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1295517 | TRAMAL RET FTBL 100MG | Tramal retard 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21219 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:N02AX02 | Tramadol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709643 | TRAMADOLHYDROCHLORID | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:936085001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1295523 | TRAMAL RET FTBL 100MG | Tramal retard 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21219 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:N02AX02 | Tramadol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709643 | TRAMADOLHYDROCHLORID | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | active | 100 | mg | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:936085002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1295546 | TRAMAL RET FTBL 150MG | Tramal retard 150 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21218 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:N02AX02 | Tramadol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709643 | TRAMADOLHYDROCHLORID | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | active | 150 | mg | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:936726001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1295552 | TRAMAL RET FTBL 150MG | Tramal retard 150 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21218 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:N02AX02 | Tramadol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709643 | TRAMADOLHYDROCHLORID | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | active | 150 | mg | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | 150 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:936726002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1295569 | TRAMAL RET FTBL 200MG | Tramal retard 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21217 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:N02AX02 | Tramadol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709643 | TRAMADOLHYDROCHLORID | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | active | 200 | mg | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:936733001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1295575 | TRAMAL RET FTBL 200MG | Tramal retard 200 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21217 | GA - zugelassen | Grünenthal Österreich GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073559 | Folienstreifen | 2.16.840.1.113883.6.73:N02AX02 | Tramadol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709643 | TRAMADOLHYDROCHLORID | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | active | 200 | mg | 1.2.40.0.34.5.221:100000093275 | TRAMADOL HYDROCHLORIDE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:936733002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1295598 | PANTOLOC FTBL 40MG | Pantoloc 40 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21015 | GA - zugelassen | Takeda Pharma Ges.m.b.H. | true | true | 7 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BC02 | Pantoprazol | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708553 | PANTOPRAZOL NATRIUM | 1.2.40.0.34.5.221:100000090359 | PANTOPRAZOLE SODIUM | active | 45.1 | mg | 1.2.40.0.34.5.221:100000090359 | PANTOPRAZOLE SODIUM | 45.1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:934269045 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1295836 | GILUDOP ILSG 250MG/50ML | Giludop 250 mg - Infusionslösung | 1.2.40.0.34.4.17:1-20718 | GA - zugelassen | Pharmaselect International Beteiligungs GmbH | true | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C01CA04 | Dopamin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1709122 | DOPAMIN HYDROCHLORID | 1.2.40.0.34.5.221:100000092011 | DOPAMINE HYDROCHLORIDE | active | 250 | mg | 1.2.40.0.34.5.221:100000092011 | DOPAMINE HYDROCHLORIDE | 250 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:931252002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1295894 | DOLGIT FTBL 800MG | Dolgit 800 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21142 | GA - zugelassen | Dolorgiet GmbH & Co. KG | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 800 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 800 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:934452002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1295902 | DOLGIT FTBL 800MG | Dolgit 800 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21142 | GA - zugelassen | Dolorgiet GmbH & Co. KG | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE01 | Ibuprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708555 | IBUPROFEN | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | active | 800 | mg | 1.2.40.0.34.5.221:100000090365 | IBUPROFEN | 800 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:934452003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1296178 | SOMNUBENE FILMTBL 1MG | Somnubene 1 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21214 | GA - aufgehoben | ratiopharm Arzneimittel Vertriebs GmbH | false | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N05CD03 | Flunitrazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709505 | FLUNITRAZEPAM | 1.2.40.0.34.5.221:100000092658 | FLUNITRAZEPAM | active | 1 | mg | 1.2.40.0.34.5.221:100000092658 | FLUNITRAZEPAM | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:935432001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1296184 | SOMNUBENE FILMTBL 1MG | Somnubene 1 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21214 | GA - aufgehoben | ratiopharm Arzneimittel Vertriebs GmbH | false | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:N05CD03 | Flunitrazepam | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709505 | FLUNITRAZEPAM | 1.2.40.0.34.5.221:100000092658 | FLUNITRAZEPAM | active | 1 | mg | 1.2.40.0.34.5.221:100000092658 | FLUNITRAZEPAM | 1 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:935432002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1296190 | IVADAL FTBL | Ivadal Filmtabletten | 1.2.40.0.34.4.17:1-20472 | GA - zugelassen | Sanofi-Aventis GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05CF02 | Zolpidem | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708714 | ZOLPIDEMTARTRAT | 1.2.40.0.34.5.221:100000091037 | ZOLPIDEM TARTRATE | active | 10 | mg | 1.2.40.0.34.5.221:100000091037 | ZOLPIDEM TARTRATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933363001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1296209 | IVADAL FTBL | Ivadal Filmtabletten | 1.2.40.0.34.4.17:1-20472 | GA - zugelassen | Sanofi-Aventis GmbH | true | false | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N05CF02 | Zolpidem | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708714 | ZOLPIDEMTARTRAT | 1.2.40.0.34.5.221:100000091037 | ZOLPIDEM TARTRATE | active | 10 | mg | 1.2.40.0.34.5.221:100000091037 | ZOLPIDEM TARTRATE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:933363003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1296994 | CAMPRAL FTBL | Campral - Filmtabletten | 1.2.40.0.34.4.17:1-21427 | GA - zugelassen | Merck Ges.m.b.H. | true | true | 84 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N07BB03 | Acamprosat | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706051 | CALCIUM ACAMPROSAT | 1.2.40.0.34.5.221:100000078804 | ACAMPROSATE CALCIUM | active | 333 | mg | 1.2.40.0.34.5.221:100000078804 | ACAMPROSATE CALCIUM | 333 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:936378002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297077 | KLACID GRAN OR SUS 250MG | Klacid 250 mg/5 ml - Granulat für orale Suspension | 1.2.40.0.34.4.17:1-21047 | GA - zugelassen | Viatris Austria GmbH | true | true | 70 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:J01FA09 | Clarithromycin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709351 | CLARITHROMYCIN | 1.2.40.0.34.5.221:100000092364 | CLARITHROMYCIN | active | 3.5 | g | 1.2.40.0.34.5.221:100000092364 | CLARITHROMYCIN | 3.5 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073650 | Granulat zur Herstellung einer Suspension zum Einnehmen | true | human | 1.2.40.0.34.4.26:933995002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297195 | MOVICOL PLV BTL | Movicol - Pulver | 1.2.40.0.34.4.17:1-21661 | GA - zugelassen | Norgine Healthcare B.V. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:A06AD65 | Macrogol, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 0.047 | g | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 0.047 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073364 | Pulver zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:941102001 | 1.2.40.0.34.5.156:1709692 | MACROGOL | 1.2.40.0.34.5.221:100000115769 | MACROGOL | active | 13.125 | g | 1.2.40.0.34.5.221:100000115769 | MACROGOL | 13.125 | g | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 0.351 | g | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 0.351 | g | | | | | | | 1.2.40.0.34.5.156:1706182 | NATRIUMHYDROGENCARBONAT | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | active | 0.178 | g | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | 0.178 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297203 | MOVICOL PLV BTL | Movicol - Pulver | 1.2.40.0.34.4.17:1-21661 | GA - zugelassen | Norgine Healthcare B.V. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:A06AD65 | Macrogol, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 0.047 | g | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 0.047 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073364 | Pulver zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:941102004 | 1.2.40.0.34.5.156:1709692 | MACROGOL | 1.2.40.0.34.5.221:100000115769 | MACROGOL | active | 13.125 | g | 1.2.40.0.34.5.221:100000115769 | MACROGOL | 13.125 | g | 1.2.40.0.34.5.156:1706182 | NATRIUMHYDROGENCARBONAT | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | active | 0.178 | g | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | 0.178 | g | | | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 0.351 | g | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 0.351 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297232 | MOVICOL PLV BTL | Movicol - Pulver | 1.2.40.0.34.4.17:1-21661 | GA - zugelassen | Norgine Healthcare B.V. | true | true | 100 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:A06AD65 | Macrogol, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 0.047 | g | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 0.047 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073364 | Pulver zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:941102002 | 1.2.40.0.34.5.156:1709692 | MACROGOL | 1.2.40.0.34.5.221:100000115769 | MACROGOL | active | 13.125 | g | 1.2.40.0.34.5.221:100000115769 | MACROGOL | 13.125 | g | 1.2.40.0.34.5.156:1706182 | NATRIUMHYDROGENCARBONAT | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | active | 0.178 | g | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | 0.178 | g | | | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 0.351 | g | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 0.351 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297255 | TAMOXIFEN ARC TBL 20MG | Tamoxifen Arcana 20 mg Tabletten | 1.2.40.0.34.4.17:1-20377 | GA - zugelassen | Arcana Arzneimittel GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:L02BA01 | Tamoxifen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708489 | TAMOXIFENCITRAT | 1.2.40.0.34.5.221:100000090201 | TAMOXIFEN CITRATE | active | 30.4 | mg | 1.2.40.0.34.5.221:100000090201 | TAMOXIFEN CITRATE | 30.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:931134002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297344 | THYMOGLOBULINE PLV INF 25MG | Thymoglobuline 5 mg/ml - Pulver zur Herstellung einer Infusionslösung | 1.2.40.0.34.4.17:2-00167 | GA - zugelassen | Sanofi B.V. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L04AA04 | Antithymocytäres Immunglobulin (Kaninchen) | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1712679 | IMMUNSERUM | 1.2.40.0.34.5.221:900000004294 | IMMUNSERUM | active | 25 | mg | 1.2.40.0.34.5.221:900000004294 | IMMUNSERUM | 25 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:929011001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297367 | ARAVA FTBL 10MG | Arava 10 mg Filmtabletten | 1.2.40.0.34.4.17:EU/1/99/118 | GA - zugelassen | Sanofi-Aventis Deutschland GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:L04AA13 | Leflunomid | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1707417 | LEFLUNOMID | 1.2.40.0.34.5.221:100000085463 | LEFLUNOMIDE | active | 10 | mg | 1.2.40.0.34.5.221:100000085463 | LEFLUNOMIDE | 10 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:944461001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297396 | LASITACE KPS 5/20MG | Lasitace 5 mg/20 mg Kapseln | 1.2.40.0.34.4.17:1-21360 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09BA05 | Ramipril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 20 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:934323001 | 1.2.40.0.34.5.156:1709271 | RAMIPRIL | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | active | 5 | mg | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | 5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297404 | LASITACE KPS 5/40MG | Lasitace 5 mg/40 mg Kapseln | 1.2.40.0.34.4.17:1-21361 | GA - aufgehoben | Sanofi-Aventis GmbH | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09BA05 | Ramipril und Diuretika | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708536 | FUROSEMID | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | active | 40 | mg | 1.2.40.0.34.5.221:100000090317 | FUROSEMIDE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:934322001 | 1.2.40.0.34.5.156:1709271 | RAMIPRIL | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | active | 5 | mg | 1.2.40.0.34.5.221:100000092240 | RAMIPRIL | 5 | mg | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297574 | MANNIT FRE IFL 15% 250ML | Mannit 15 % "Fresenius" - Infusionsflasche | 1.2.40.0.34.4.17:1-20984 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073497 | Flasche | 2.16.840.1.113883.6.73:B05BC01 | Mannitol | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708833 | MANNITOL, E-421 | 1.2.40.0.34.5.221:100000091382 | MANNITOL | active | 37500 | mg | 1.2.40.0.34.5.221:100000091382 | MANNITOL | 37500 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073870 | Infusionslösung | true | human | 1.2.40.0.34.4.26:924406001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297640 | HEPAMERZ GRAN | Hepa-Merz 3 g Granulat | 1.2.40.0.34.4.17:1-20706 | GA - zugelassen | Merz Pharma Austria GmbH | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:A05BA | Lebertherapie | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706357 | ORNITHIN ASPARTAT | 1.2.40.0.34.5.221:100000080065 | ORNITHINE ASPARTATE | active | 3 | g | 1.2.40.0.34.5.221:100000080065 | ORNITHINE ASPARTATE | 3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073365 | Granulat zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:933579001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297657 | HEPAMERZ GRAN | Hepa-Merz 3 g Granulat | 1.2.40.0.34.4.17:1-20706 | GA - zugelassen | Merz Pharma Austria GmbH | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073547 | Beutel | 2.16.840.1.113883.6.73:A05BA | Lebertherapie | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706357 | ORNITHIN ASPARTAT | 1.2.40.0.34.5.221:100000080065 | ORNITHINE ASPARTATE | active | 3 | g | 1.2.40.0.34.5.221:100000080065 | ORNITHINE ASPARTATE | 3 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073365 | Granulat zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:933579002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297798 | TOMUDEX TRSUB INF DFL 2MG | Tomudex 2 mg Pulver zur Herstellung einer Infusionslösung | 1.2.40.0.34.4.17:1-22452 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 1 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073563 | Durchstechflasche | 2.16.840.1.113883.6.73:L01BA03 | Raltitrexed | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1706417 | RALTITREXED | 1.2.40.0.34.5.221:100000080291 | RALTITREXED | active | 2 | mg | 1.2.40.0.34.5.221:100000080291 | RALTITREXED | 2 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073859 | Pulver zur Herstellung einer Infusionslösung | true | human | 1.2.40.0.34.4.26:938288001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297806 | ACEMIN TBL 2,5MG | Acemin 2,5 mg - Tabletten | 1.2.40.0.34.4.17:1-21290 | GA - aufgehoben | Atnahs Pharma Netherlands B.V. | false | false | 28 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C09AA03 | Lisinopril | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709062 | LISINOPRIL | 1.2.40.0.34.5.221:100000091915 | LISINOPRIL | active | 2.72 | mg | 1.2.40.0.34.5.221:100000091915 | LISINOPRIL | 2.72 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:935241013 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1297953 | KLEAN-PREP PLV | Klean-Prep - Pulver | 1.2.40.0.34.4.17:1-20823 | GA - zugelassen | Norgine GmbH | true | false | 4 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073493 | Beutel | 2.16.840.1.113883.6.73:A06AD65 | Macrogol, Kombinationen | 1.2.40.0.10.1.4.3.4.3.4:100000073577 | zur Anwendung mittels Magensonde | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | 1.2.40.0.34.5.156:1709016 | KALIUMCHLORID | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | active | 0.743 | g | 1.2.40.0.34.5.221:100000091807 | POTASSIUM CHLORIDE | 0.743 | g | 1.2.40.0.10.1.4.3.4.3.5:100000073364 | Pulver zur Herstellung einer Lösung zum Einnehmen | true | human | 1.2.40.0.34.4.26:933988001 | 1.2.40.0.34.5.156:1705889 | NATRIUMSULFAT | 1.2.40.0.34.5.221:100000078123 | SODIUM SULFATE | active | 5.685 | g | 1.2.40.0.34.5.221:100000078123 | SODIUM SULFATE | 5.685 | g | 1.2.40.0.34.5.156:1709692 | MACROGOL | 1.2.40.0.34.5.221:100000115769 | MACROGOL | active | 59 | g | 1.2.40.0.34.5.221:100000115769 | MACROGOL | 59 | g | | | | | | | 1.2.40.0.34.5.156:1709195 | NATRIUMCHLORID | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | active | 1.465 | g | 1.2.40.0.34.5.221:100000092115 | SODIUM CHLORIDE | 1.465 | g | 1.2.40.0.34.5.156:1706182 | NATRIUMHYDROGENCARBONAT | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | active | 1.685 | g | 1.2.40.0.34.5.221:100000079337 | SODIUM HYDROGEN CARBONATE | 1.685 | g | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298059 | NIMBEX 2MG/ML AMP 5ML | Nimbex 2 mg/ml - Injektions-/Infusionslösung | 1.2.40.0.34.4.17:1-21326 | GA - aufgehoben | Aspen Pharma Trading Limited | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M03AC11 | Cisatracurium | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708610 | CISATRACURIUM BESILAT | 1.2.40.0.34.5.221:100000090476 | CISATRACURIUM BESILATE | active | 13.4 | mg | 1.2.40.0.34.5.221:100000090476 | CISATRACURIUM BESILATE | 13.4 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:939714004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298065 | NIMBEX 2MG/ML AMP 10ML | Nimbex 2 mg/ml - Injektions-/Infusionslösung | 1.2.40.0.34.4.17:1-21326 | GA - aufgehoben | Aspen Pharma Trading Limited | false | false | 5 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:M03AC11 | Cisatracurium | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | | | | | 1.2.40.0.34.5.156:1708610 | CISATRACURIUM BESILAT | 1.2.40.0.34.5.221:100000090476 | CISATRACURIUM BESILATE | active | 26.8 | mg | 1.2.40.0.34.5.221:100000090476 | CISATRACURIUM BESILATE | 26.8 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:939714002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298094 | MELISSENGEIST DR.FISCHER'S | Melissengeist Dr. Fischer's | 1.2.40.0.34.4.17:7-00699 | GA - aufgehoben | Pharmonta Dr. Fischer GmbH | false | false | 100 | 2.16.840.1.113883.6.8:mL | Milliliter | 1.2.40.0.10.1.4.3.4.3.7:100000072076 | Arzneimittel zur Abgabe ohne aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073498 | Schachtel | 2.16.840.1.113883.6.73:M02AX | Andere topische Mittel gegen Gelenk- und Muskelschmerzen | 1.2.40.0.10.1.4.3.4.3.4:100000073566 | Anwendung auf der Haut | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | 1.2.40.0.34.5.156:1706373 | CITRONELLAE AETHEROLEUM | 1.2.40.0.34.5.221:100000080114 | CITRONELLA OIL | active | 50 | mg | 1.2.40.0.34.5.221:100000080114 | CITRONELLA OIL | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073646 | Lösung zum Einnehmen | false | human | 1.2.40.0.34.4.26:935779001 | 1.2.40.0.34.5.156:1706374 | CARYOPHYLLI FLORIS AETHEROLEUM | 1.2.40.0.34.5.221:100000080119 | CLOVE OIL | active | 50 | mg | 1.2.40.0.34.5.221:100000080119 | CLOVE OIL | 50 | mg | 1.2.40.0.34.5.156:1705461 | CINNAMOMI ZEYLANICI CORTICIS AETHEROLEUM | 1.2.40.0.34.5.221:100000076405 | CINNAMON BARK OIL, CEYLON | active | 50 | mg | 1.2.40.0.34.5.221:100000076405 | CINNAMON BARK OIL, CEYLON | 50 | mg | 2.16.840.1.113883.6.73:N07X | Andere Mittel für das Nervensystem | | | | | 1.2.40.0.34.5.156:1705415 | MYRISTICAE FRAGRANTIS AETHEROLEUM | 1.2.40.0.34.5.221:100000076266 | MYRISTICA OIL | active | 50 | mg | 1.2.40.0.34.5.221:100000076266 | MYRISTICA OIL | 50 | mg | | | | | | | | | | | | | | | | | | | | | | | 1.2.40.0.10.1.4.3.4.3.5:100000073731 | Lösung zur Anwendung auf der Haut | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2.16.840.1.113883.6.73:A09A | Digestiva, Inkl. Enzyme | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298177 | ULCOSTAD TBL 200MG | Ulcostad 200 mg Tabletten | 1.2.40.0.34.4.17:1-20962 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA01 | Cimetidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709561 | CIMETIDIN | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | active | 200 | mg | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933727001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298183 | ULCOSTAD TBL 200MG | Ulcostad 200 mg Tabletten | 1.2.40.0.34.4.17:1-20962 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA01 | Cimetidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709561 | CIMETIDIN | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | active | 200 | mg | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | 200 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933727002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298208 | ULCOSTAD TBL 400MG | Ulcostad 400 mg Tabletten | 1.2.40.0.34.4.17:1-20972 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA01 | Cimetidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709561 | CIMETIDIN | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | active | 400 | mg | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933728001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298214 | ULCOSTAD TBL 400MG | Ulcostad 400 mg Tabletten | 1.2.40.0.34.4.17:1-20972 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA01 | Cimetidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709561 | CIMETIDIN | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | active | 400 | mg | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | 400 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933728002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298220 | ULCOSTAD TBL 800MG | Ulcostad 800 mg Tabletten | 1.2.40.0.34.4.17:1-20950 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA01 | Cimetidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709561 | CIMETIDIN | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | active | 800 | mg | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | 800 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933731001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298237 | ULCOSTAD TBL 800MG | Ulcostad 800 mg Tabletten | 1.2.40.0.34.4.17:1-20950 | GA - zugelassen | STADA Arzneimittel Gesellschaft m.b.H. | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:A02BA01 | Cimetidin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1709561 | CIMETIDIN | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | active | 800 | mg | 1.2.40.0.34.5.221:100000092793 | CIMETIDINE | 800 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:933731002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298295 | NIFEDIPIN STAD RET FTBL 20MG | Nifedipin "Stada" retard 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20901 | GA - aufgehoben | STADA Arzneimittel Gesellschaft m.b.H. | false | false | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08CA05 | Nifedipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708560 | NIFEDIPIN | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | active | 20 | mg | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:934258002 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298303 | NIFEDIPIN STAD RET FTBL 20MG | Nifedipin "Stada" retard 20 mg - Filmtabletten | 1.2.40.0.34.4.17:1-20901 | GA - aufgehoben | STADA Arzneimittel Gesellschaft m.b.H. | false | false | 50 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:C08CA05 | Nifedipin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708560 | NIFEDIPIN | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | active | 20 | mg | 1.2.40.0.34.5.221:100000090371 | NIFEDIPINE | 20 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073683 | Retardtablette | true | human | 1.2.40.0.34.4.26:934258003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298326 | PROFENID KPS 100MG | Profenid 100 mg Kapseln | 1.2.40.0.34.4.17:1-19745 | GA - zugelassen | Sanofi-Aventis GmbH | true | false | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:M01AE03 | Ketoprofen | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708999 | KETOPROFEN | 1.2.40.0.34.5.221:100000091768 | KETOPROFEN | active | 100 | mg | 1.2.40.0.34.5.221:100000091768 | KETOPROFEN | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073375 | Hartkapsel | true | human | 1.2.40.0.34.4.26:928452001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298332 | EDRONAX TBL 4MG BLISTER | Edronax 4 mg - Tabletten | 1.2.40.0.34.4.17:1-22230 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 20 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AX18 | Reboxetin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708862 | REBOXETIN MESILAT | 1.2.40.0.34.5.221:100000091454 | REBOXETINE MESILATE | active | 5.224 | mg | 1.2.40.0.34.5.221:100000091454 | REBOXETINE MESILATE | 5.224 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:942357006 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298349 | EDRONAX TBL 4MG BLISTER | Edronax 4 mg - Tabletten | 1.2.40.0.34.4.17:1-22230 | GA - zugelassen | Pfizer Corporation Austria Ges.m.b.H. | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AX18 | Reboxetin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1708862 | REBOXETIN MESILAT | 1.2.40.0.34.5.221:100000091454 | REBOXETINE MESILATE | active | 5.224 | mg | 1.2.40.0.34.5.221:100000091454 | REBOXETINE MESILATE | 5.224 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073664 | Tablette | true | human | 1.2.40.0.34.4.26:942357010 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298409 | FLOXYFRAL FTBL 50MG | Floxyfral 50 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21368 | GA - zugelassen | Viatris Healthcare Limited | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AB08 | Fluvoxamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706262 | FLUVOXAMINMALEAT | 1.2.40.0.34.5.221:100000091275 | FLUVOXAMINE MALEATE | active | 50 | mg | 1.2.40.0.34.5.221:100000091275 | FLUVOXAMINE MALEATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922190004 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298415 | FLOXYFRAL FTBL 50MG | Floxyfral 50 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21368 | GA - zugelassen | Viatris Healthcare Limited | true | true | 60 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AB08 | Fluvoxamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706262 | FLUVOXAMINMALEAT | 1.2.40.0.34.5.221:100000091275 | FLUVOXAMINE MALEATE | active | 50 | mg | 1.2.40.0.34.5.221:100000091275 | FLUVOXAMINE MALEATE | 50 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:922190008 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298421 | FLOXYFRAL FTBL 100MG | Floxyfral 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21364 | GA - zugelassen | Viatris Healthcare Limited | true | false | 15 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AB08 | Fluvoxamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706262 | FLUVOXAMINMALEAT | 1.2.40.0.34.5.221:100000091275 | FLUVOXAMINE MALEATE | active | 100 | mg | 1.2.40.0.34.5.221:100000091275 | FLUVOXAMINE MALEATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930190003 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298438 | FLOXYFRAL FTBL 100MG | Floxyfral 100 mg - Filmtabletten | 1.2.40.0.34.4.17:1-21364 | GA - zugelassen | Viatris Healthcare Limited | true | true | 30 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072079 | Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073496 | Blisterpackung | 2.16.840.1.113883.6.73:N06AB08 | Fluvoxamin | 1.2.40.0.10.1.4.3.4.3.4:100000073619 | zum Einnehmen | | | | | 1.2.40.0.34.5.156:1706262 | FLUVOXAMINMALEAT | 1.2.40.0.34.5.221:100000091275 | FLUVOXAMINE MALEATE | active | 100 | mg | 1.2.40.0.34.5.221:100000091275 | FLUVOXAMINE MALEATE | 100 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000073665 | Filmtablette | true | human | 1.2.40.0.34.4.26:930190005 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1298674 | L-ADRENAL FRE AMP 2MG/20ML | L-Adrenalin "Fresenius" spritzfertig 2,0 mg - Ampullen | 1.2.40.0.34.4.17:1-21272 | GA - zugelassen | Fresenius Kabi Austria GmbH | true | true | 10 | 2.16.840.1.113883.6.8:{Stueck} | Stück | 1.2.40.0.10.1.4.3.4.3.7:100000072086 | Arzneimittel zur wiederholten Abgabe gegen aerztliche Verschreibung | 1.2.40.0.34.5.219:100000073490 | Ampulle | 2.16.840.1.113883.6.73:C01CA24 | Epinephrin | 1.2.40.0.10.1.4.3.4.3.4:100000073611 | intravenöse Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073602 | intraossäre Anwendung | 1.2.40.0.10.1.4.3.4.3.4:100000073571 | endotracheopulmonale Anwendung | 1.2.40.0.34.5.156:1709361 | EPINEPHRIN | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | active | 40 | mg | 1.2.40.0.34.5.221:100000092380 | EPINEPHRINE | 40 | mg | 1.2.40.0.10.1.4.3.4.3.5:100000074038 | Injektions-/Infusionslösung | true | human | 1.2.40.0.34.4.26:936234001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |